<SEC-DOCUMENT>0000937098-24-000088.txt : 20240426
<SEC-HEADER>0000937098-24-000088.hdr.sgml : 20240426
<ACCEPTANCE-DATETIME>20240426083114
ACCESSION NUMBER:		0000937098-24-000088
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		85
CONFORMED PERIOD OF REPORT:	20240331
FILED AS OF DATE:		20240426
DATE AS OF CHANGE:		20240426

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TRINET GROUP, INC.
		CENTRAL INDEX KEY:			0000937098
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				953359658
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36373
		FILM NUMBER:		24878997

	BUSINESS ADDRESS:	
		STREET 1:		ONE PARK PLACE., SUITE 600
		CITY:			DUBLIN
		STATE:			CA
		ZIP:			94568
		BUSINESS PHONE:		5103525000

	MAIL ADDRESS:	
		STREET 1:		ONE PARK PLACE., SUITE 600
		CITY:			DUBLIN
		STATE:			CA
		ZIP:			94568

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRINET GROUP INC
		DATE OF NAME CHANGE:	20000306

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRINET EMPLOYER GROUP INC
		DATE OF NAME CHANGE:	20000126
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>tnet-20240331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:e2176350-5298-4836-b62a-d8f4e61deac6,g:394f270b-efa4-4896-8b8e-6d4db102e2a9,d:433ef95683ef4fa7b54ae19a30089fe8-->
<html xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:tnet="http://www.trinet.com/20240331" xmlns="http://www.w3.org/1999/xhtml" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>tnet-20240331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-26">0000937098</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-27">12/31</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-28">2024</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-29">Q1</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-30">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-161" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" format="ixt-sec:duryear" id="f-599">1</ix:nonNumeric><ix:nonNumeric contextRef="c-167" name="ecd:TrdArrDuration" format="ixt-sec:durday" id="f-654">371</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="tnet-20240331.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-04-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:ProfessionalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:ProfessionalServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:InsuranceServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:InsuranceServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>tnet:segment</xbrli:measure></xbrli:unit><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">us-gaap:HealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">us-gaap:HealthCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tnet:A2029NotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tnet:A2031NotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tnet:A2029NotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tnet:A2031NotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tnet:SystemsDevelopmentAndProgrammingCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tnet:SystemsDevelopmentAndProgrammingCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">tnet:BurtonMGoldfieldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000937098</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">tnet:BurtonMGoldfieldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_1"></div><div style="min-height:27pt;width:100%"><div style="margin-top:10pt;text-align:justify"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">UNITED STATES</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WASHINGTON, DC 20549</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Mark One) </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">March 31, 2024</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">or</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the transition period from </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">&#160;to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Commission File Number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-36373</ix:nonNumeric> </span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><img src="tnet-20240331_g1.jpg" alt="Logo.jpg" style="height:62px;margin-bottom:5pt;vertical-align:text-bottom;width:170px"/></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">TRINET GROUP, INC.</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(Exact Name of Registrant as Specified in its Charter)</span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:18.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.170%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.340%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">95-3359658</ix:nonNumeric></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">incorporation or organization)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Identification No.)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">One Park Place,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-10">Suite 600</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-11">Dublin,</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-12">CA</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-13">94568</ix:nonNumeric></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">510</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">352-5000</ix:nonNumeric> </span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-16">Common stock par value $0.000025 per share</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-17">TNET</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-18">New York Stock Exchange</ix:nonNumeric></span></div></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-19">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-20">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"/><td style="width:27.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.510%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-21">Large accelerated filer</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-23">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;    Yes&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">o</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-24">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">x</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The number of shares of Registrant&#8217;s Common Stock outstanding as of April&#160;19, 2024 was <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-25">50,563,849</ix:nonFraction>.</span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:10pt;text-align:justify"><span><br/></span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e67222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</span></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TRINET GROUP, INC.</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Form 10-Q - Quarterly Report </span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Quarterly Period Ended March&#160;31, 2024 </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:73.131%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.197%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Form 10-Q</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cross Reference</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Page</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_10">Glossary</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_10">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_13">Cautionary Note Regarding Forward-Looking Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_13">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_82">Unaudited Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part I, Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_82">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_85">Condensed Consolidated Statements of Income and Comprehensive Income</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_85">27</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_94">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_94">28</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_100">Condensed Consolidated Statements of Stockholders' Equity</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_100">29</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_103">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_106">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_109">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_109">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_112">Note 1. Description of Business and Significant Accounting Policies</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_112">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_115">Note 2. Cash, Cash Equivalents and Investments - Unrestricted and Restricted</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_115">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_118">Note 3. Financial Instruments and Fair Value Measurements</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_118">35</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_133">Note 4. Accrued Workers' Compensation Costs</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_133">38</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_139">Note 5. Commitments and Contingencies</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_139">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_142">Note 6. Stock Based Compensation</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_142">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_148">Note 7. Stockholders' Equity</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_148">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_151">Note 8. Income Taxes</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_151">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_154">Note 9. Earnings Per Share</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_154">40</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_16">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part I, Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_16">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_76">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part I, Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_76">25</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_79">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part I, Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_79">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_163">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part II, Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_163">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_166">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part II, Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_166">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_169">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part II, Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_169">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_172">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part II, Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_172">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_175">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part II, Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_175">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_178">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part II, Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_178">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_184">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Part II, Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_184">43</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:32.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:64.930%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e67222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GLOSSARY</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div></div><div><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%">Glossary of Acronyms and Abbreviations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acronyms and abbreviations are used throughout this report, particularly in Part I, Item 1. Unaudited Condensed Consolidated Financial Statements and Part I, Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:78.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022 Credits</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Includes both of our announced 2022 credits, each of which provides eligible clients with discretionary credits, subject to certain predefined conditions.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 Credit Agreement</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Our credit agreement dated February 26, 2021, as amended, supplemented or modified from time to time, most recently August 16, 2023.</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021 Revolver</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Our $700 million revolving line of credit included in our 2021 Credit Agreement</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2029 Notes</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Our $500 million senior unsecured notes maturing in March 2029</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2031 Notes</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Our $400 million senior unsecured notes maturing in August 2031</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">AFS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Available-for-sale</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CARES Act</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Coronavirus Aid Relief and Economic Security Act </span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CEO</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CFO</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">COBRA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Omnibus Budget Reconciliation Act</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Colleague</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">TriNet&#8217;s internal employees (as distinguished from WSEs and HRIS Users)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">COPS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of providing services </span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">COVID-19</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Novel coronavirus </span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">D&amp;A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization expenses</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EBITDA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings before interest expense, taxes, depreciation and amortization of intangible assets</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EPS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings Per Share</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ERISA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employee Retirement Income Security Act</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ESAC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Employer Services Assurance Corporation</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ETR</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective tax rate</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FFCRA</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Families First Coronavirus Response Act </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">G&amp;A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">GAAP</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Generally Accepted Accounting Principles in the United States</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">HCM</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Human capital management</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">HR</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Human Resources</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">HRIS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Human resources information system</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">HRIS User</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">A client employee who is a user of our HR Platform (for example, employees of an HRIS client)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IRS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Internal Revenue Service</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ICR</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance cost ratio</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ISR</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance service revenues</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIBOR</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">London Inter-bank Offered Rate</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MD&amp;A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Management's Discussion and Analysis of Financial Condition and Results of Operations</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PEO</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional Employer Organization</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PFC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payroll funds collected</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSR</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional service revenues</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">R&amp;D</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and Development</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Reg FD</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Regulation Fair Disclosure</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ROU</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSU</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted Stock Unit</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:32.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:64.930%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e67222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GLOSSARY</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:78.579%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SBC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock Based Compensation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">S&amp;M</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and marketing</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">S&amp;P</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Standard &amp; Poor's</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SD&amp;P</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Systems development and programming</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SEC</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. Securities and Exchange Commission</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SMB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Small and medium-size business</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TriNet Clarus R+D</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Clarus R+D Solutions, LLC</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">United States</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">WSE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">A worksite employee who is co-employed by, or otherwise receiving services from a TriNet PEO</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">YTD</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year to date</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Zenefits</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">YourPeople, Inc. and its subsidiaries</span></td></tr></table></div><div style="padding-right:-2.25pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FORWARD LOOKING STATEMENTS AND OTHER FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:3pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Cautionary Note Regarding Forward-Looking Statements</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of this Quarterly Report on Form 10-Q (Form 10-Q), the terms &#8220;TriNet,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to TriNet Group, Inc., and its subsidiaries. This Form 10-Q contains statements that are not historical in nature, are predictive in nature, or that depend upon or refer to future events or conditions or otherwise contain forward-looking statements within the meaning of Section 21 of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Forward-looking statements are often identified by the use of words such as, but not limited to, "ability," &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;can,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;design,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;forecast,&#8221; &#8220;hope,&#8221; "impact," &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;outlook,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;strategy,&#8221; &#8220;target,&#8221; "value," &#8220;will,&#8221; &#8220;would&#8221; and similar expressions or variations intended to identify forward-looking statements. Examples of forward-looking statements include, among others, TriNet&#8217;s expectations regarding: our ability to successfully diversify our overall service and technology offerings to support SMBs throughout their lifecycle; our plans and ability to grow our client base; the impact of our ongoing efforts to ensure that our billing practices best match the expectations of our customers and the impact on our WSE count; our expectations regarding medical utilization rates by our WSEs and the impact of inflation on our insurance costs; the effect that our stock repurchase program will have on our business; the impact of our notes; our ability to leverage our scale and industry HR experience to deliver vertical focused offerings; the impact of planned improvements to our technology platform and HRIS software and whether they will meet the needs of our current clients and attract new ones; the implementation of our ERP system and its impact on our internal financial controls and operations; our ability to improve operating efficiencies; the impact of our client service initiatives and whether they enhance client experience and satisfaction; our continued ability to provide access to a broad range of benefit programs on a cost-effective basis; our expectations regarding the volume and severity of insurance claims and insurance claim trends; the effectiveness of our risk strategies for, and management of, workers' compensation, health benefit insurance costs and deductibles, and EPLI risk; the metrics that may be indicators of future financial performance; the relative value of our benefit offerings versus those SMBs can independently obtain; the impact that our benefit offerings have for SMBs seeking to attract and retain employees; the principal competitive drivers in our market; the impact of our plans to improve our sales performance, grow net new clients and manage client attrition; our investment strategy and its impact on our ability to generate future interest income, net income, and Adjusted EBITDA; seasonal trends and their impact on our business; fluctuations in the period-to-period timing of when we incur certain operating expenses; the estimates and assumptions we use to prepare our financial statements; our belief we can meet our present and reasonably foreseeable cash needs and future commitments through existing liquid assets and continuing cash flows from corporate operating activities; and other expectations, outlooks and forecasts on our future business, operational and financial performance.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Important factors that could cause actual results, level of activity, performance or achievements to differ materially from those expressed or implied by these forward-looking statements are discussed above and throughout  our Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on February 15, 2024 (our 2023 Form 10-K), including those appearing under the heading &#8220;Risk Factors&#8221; in Item 1A, and under the heading &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Part II, Item 7 of our 2023 Form 10-K, and those appearing in the other periodic filings we make with the SEC, and including risk factors associated with: our ability to manage unexpected changes in workers&#8217; compensation and health insurance claims and costs by WSEs; our ability to mitigate the unique business risks we face as a co-employer; the effects of volatility in the financial and economic environment on the businesses that make up our client base; loss of clients for reasons beyond our control and the short-term contracts we typically use with our clients; the impact of regional or industry-specific economic and health factors on our operations; the impact of failures or limitations in the business systems and centers we rely upon; the impact of discontinuing our discretionary credits on our business and client loyalty and retention; changes in our insurance coverage or our relationships with key insurance carriers; our ability to improve our services and technology to satisfy client and regulatory expectations; our ability to effectively integrate businesses we have acquired or may acquire in the future; our ability to effectively manage and improve our operational effectiveness and resiliency; our ability to attract and retain qualified personnel; the effects of increased competition and our ability to compete effectively; the impact on our business of cyber-attacks, breaches, disclosures and other data-related incidents; our ability to protect against and remediate cyber-attacks, breaches, disclosures and other data-related incidents, whether intentional or inadvertent and whether attributable to us or our service providers; our ability to comply with evolving data privacy and security laws; our ability to manage changes in, uncertainty regarding, or adverse application of the complex laws and regulations that govern our business; changing laws and regulations governing health insurance and employee benefits; our ability to be recognized as an employer of worksite employees and for our benefits plans to satisfy all requirements under federal and state regulations; changes in the laws and regulations that govern what it means to be an employer, employee or independent contractor; the impact of new and changing laws regarding remote work; our ability to comply with the licensing requirements that govern our solutions; the outcome of existing and future legal and tax </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FORWARD LOOKING STATEMENTS AND OTHER FINANCIAL INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">proceedings; fluctuation in our results of operations and stock price due to factors outside of our control; our ability to comply with the restrictions of our credit facility and meet our debt obligations; and the impact of concentrated ownership in our stock by Atairos and other large stockholders. Any of these factors could cause our actual results to differ materially from our anticipated results.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements are not guarantees of future performance but are based on management&#8217;s expectations as of the date of this Form 10-Q and assumptions that are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from our current expectations and any past results, performance or achievements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information provided in this Form 10-Q is based upon the facts and circumstances known as of the date of this Form 10-Q, and any forward-looking statements made by us in this Form 10-Q speak only as of the date of this Form 10-Q. We undertake no obligation to revise or update any of the information provided in this Form 10-Q, except as required by law.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The MD&amp;A of this Form 10-Q includes references to our performance measures presented in conformity with GAAP and other non-GAAP financial measures that we use to manage our business, to make planning decisions, to allocate resources and to use as performance measures in our executive compensation plans. Refer to the Non-GAAP Financial Measures within our MD&amp;A for definitions and reconciliations from GAAP measures.</span></div><div style="margin-top:12pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:174%">Website Disclosures</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use our website (www.trinet.com) to announce material non-public information to the public and to comply with our disclosure obligations under Reg FD. We also use our website to communicate with the public about our Company, our services, and other matters. Our SEC filings, press releases and recent public conference calls and webcasts can also be found on our website. The information we post on our website could be deemed to be material information under Reg FD. We encourage investors and others interested in our Company to review the information we post on our website. Information contained in or accessible through our website is not a part of this report.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Company is the sole owner of the trademark &#8220;TriNet&#8221; and other trademarks appearing in this report. Our Company does not intend to use or display trade names or trademarks owned by others in a manner that would imply any form of association with any of those companies.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:12pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_19"></div><div style="margin-top:12pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Executive Summary</span></div><div style="margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TriNet is a leading provider of comprehensive and flexible HCM solutions designed to address a wide range of SMB needs as they change over time. Our flexible HCM solutions free SMBs from HR complexities and empower SMBs to focus on what matters most - growing their business and enabling their people.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TriNet offers access to human capital expertise, benefits, payroll, risk mitigation and compliance, all enabled by industry leading technology capabilities. TriNet's suite of products also includes&#8239;services and software-based solutions to help streamline workflows by connecting HR, benefits, payroll, time and attendance, and employee engagement. Clients can use our industry tailored PEO services and technology platform to receive the full benefit of our HCM services enabling their WSEs to participate in our TriNet-sponsored employee benefit plans. Clients can alternatively choose to use our self-directed, cloud-based</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HRIS software solution and add HR services such as payroll and access to benefits management as needed. By providing PEO and HRIS services, we believe that we can support a wider range of SMBs and create a pipeline of HRIS clients that may be able to benefit from and transition to TriNet&#8217;s higher-touch PEO services at future points in their business lifecycle. In order to better serve TriNet&#8217;s customers throughout their business lifecycle, we are investing in our technology platform so that it can accommodate both PEO and HRIS customers.</span></div><div style="margin-bottom:6pt;margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Operational Highlights</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated results for the first quarter of 2024 reflect our continuing efforts to serve our clients, attract new clients and invest in our platform.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2024, we:</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">improved sales performance and customer retention,</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continued to grow total revenues and manage expenses prudently,</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">launched a common stock dividend of $0.25 per share paid in April 2024, </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">welcomed Mike Simonds as our new President and CEO, and </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">celebrated our ten-year anniversary as a NYSE-listed company.</span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:9pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Performance Highlights</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our results for the first quarter ended March&#160;31, 2024, when compared to the same period of 2023, are noted below:</span></div><div style="margin-top:10pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Q1 2024 </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.431%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.607%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.611%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:18pt;font-weight:400;line-height:100%">$1.3B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:18pt;font-weight:400;line-height:100%">$122M</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:18pt;font-weight:400;line-height:100%">86%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Insurance cost ratio</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">increase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">decrease</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">increase</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:18pt;font-weight:400;line-height:100%">$91M</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:18pt;font-weight:400;line-height:100%">$1.78</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:18pt;font-weight:400;line-height:100%">$111M</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted Net income *</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">decrease</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">decrease</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">decrease</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:18pt;font-weight:400;line-height:100%">348,164</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:18pt;font-weight:400;line-height:100%">351,919</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:18pt;font-weight:400;line-height:100%">195,157</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average WSEs **</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total WSEs **</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average HRIS Users</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">increase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">increase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">decrease</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-GAAP measure. See definitions below under the heading "</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_25">Non-GAAP Financial Measures</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">".</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">**</span></td><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total WSEs and Average WSEs include approximately 19,600 and 17,600, respectively, for incremental WSEs that were charged a platform user access fee. Additionally, Total WSEs  and Average WSEs include approximately 5,300 and 5,400, respectively, of  incremental additional service recipients for the quarter ended March&#160;31, 2024. These were identified as a result of our ongoing effort to ensure that our billing practices best match the expectations of our customers. For details, refer to the heading "Operating Metrics &#8211; Worksite Employees (WSEs).&#8221;</span></div></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total revenues increased 1% compared to the same period in 2023, driven by rate increases, partially offset by lower health plan enrollment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2024, our Average WSEs and Total WSEs increased 6% and 7%, respectively, compared to the same period in 2023, primarily due to additional PEO Platform Users and additional service recipients identified as a result of our ongoing effort to ensure that our billing practices best match the expectations of our customers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ICR was 4 points higher compared to the same period in 2023, driven by increased health benefits utilization rates and inflation in health costs.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Higher insurance costs, operating expenses and interest expense, partially offset by higher revenues, resulted in decreases of net income and Adjusted Net income of 31% and 26%, respectively, as compared to the same period in 2023. </span></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:12pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations for the first quarter ended March&#160;31, 2024, when compared to the same period of 2023. For details of the critical accounting judgments and estimates that could affect our Results of Operations, see the </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_73">Critical Accounting Judgments and Estimates</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section within the MD&amp;A in Item 7 of our 2023 Form 10-K.</span></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:65.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.913%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.913%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.914%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions, except operating metrics data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income Statement Data:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional service revenues</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">214</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance service revenues</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,050</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,041&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total revenues</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,264</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,246&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance costs</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">907</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">235</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total costs and operating expenses</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,142</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,077&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">122</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(28)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, bank fees and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income before provision for income taxes</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">124</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(33)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">91</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(31)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Data:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(122)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(47)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(30)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(115)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-GAAP measures </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">180</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">111</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Operating Cash Flows</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">201</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Metrics:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance Cost Ratio</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">86</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average WSEs  </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">348,164</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">327,107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total WSEs </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">351,919</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">328,299&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average HRIS Users</span></div></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">195,157</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231,347&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;padding-left:24.75pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Refer to Non-GAAP measures definitions and reconciliations from GAAP measures under the heading "</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Non-GAAP Financial Measures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">".</span></div><div style="margin-top:1pt;padding-left:24.75pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Total WSEs and Average WSEs include approximately 19,600 and 17,600, respectively, for incremental WSEs that were charged a platform user access fee for the first quarter ended March&#160;31, 2024,. Additionally, Total WSEs  and Average WSEs include approximately 5,300 and 5,400, respectively,  incremental additional service recipients. These were identified as a result of our ongoing effort to ensure that our billing practices best match the expectations of our customers. For details, refer to the heading "Operating Metrics &#8211; Worksite Employees (WSEs).&#8221;</span></div><div style="margin-bottom:3pt;padding-left:24.75pt;text-indent:-22.5pt"><span><br/></span></div><div style="margin-top:2pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our balance sheet data as of March&#160;31, 2024 compared to December&#160;31, 2023. </span></div><div style="margin-top:5pt;padding-left:24.75pt;text-indent:-22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:62.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.409%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.409%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.978%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Working capital</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">171</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,968</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,693&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,093</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,093&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">143</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to financial measures presented in accordance with GAAP, we monitor other non-GAAP financial measures that we use to manage our business, to make planning decisions, to allocate resources and to use as performance measures in our executive compensation plan. These key financial measures provide an additional view of our operational performance over the long-term and provide information that we use to maintain and grow our business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The presentation of these non-GAAP financial measures is used to enhance the understanding of certain aspects of our financial performance. It is not meant to be considered in isolation from, superior to, or as a substitute for the directly comparable financial measures prepared in accordance with GAAP.</span></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.076%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-GAAP Measure</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Definition</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">How We Use The Measure</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Adjusted EBITDA</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226; Net income, excluding the effects of: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- income tax provision, </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- interest expense, bank fees and other,</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- depreciation, </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- amortization of intangible assets, </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- stock based compensation expense,</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:13.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- amortization of cloud computing arrangements, and </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- transaction and integration costs.</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226; Provides period-to-period comparisons on a consistent basis and an understanding as to how our management evaluates the effectiveness of our business strategies by excluding certain non-recurring costs, which include transaction and integration costs, as well as certain non-cash charges such as depreciation and amortization, and stock-based compensation and certain impairment charges recognized based on the estimated fair values. We believe these charges are either not directly resulting from our core operations or not indicative of our ongoing operations.<br/>&#8226; Enhances comparisons to the prior period and, accordingly, facilitates the development of future projections and earnings growth prospects.<br/>&#8226; Provides a measure, among others, used in the determination of incentive compensation for management.<br/>&#8226; We also sometimes refer to Adjusted EBITDA margin, which is the ratio of Adjusted EBITDA to total revenues.</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Adjusted Net Income</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226; Net income, excluding the effects of: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- effective income tax rate </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- stock based compensation, </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- amortization of intangible assets, net,</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- non-cash interest expense, </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- transaction and integration costs, and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:13.5pt;text-align:justify;text-indent:-4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">- the income tax effect (at our effective tax rate </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of these pre-tax adjustments.</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226; Provides information to our stockholders and board of directors to understand how our management evaluates our business, to monitor and evaluate our operating results, and analyze profitability of our ongoing operations and trends on a consistent basis by excluding certain non-cash charges.</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Corporate Operating Cash Flows</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226; Net cash provided by (used in) operating activities, excluding the effects of: <br/>- Assets associated with WSEs (accounts receivable, unbilled revenue, prepaid expenses, other payroll assets and other current assets) and<br/>- Liabilities associated with WSEs (client deposits and other client liabilities, accrued wages, payroll tax liabilities and other payroll withholdings, accrued health insurance costs, accrued workers' compensation costs, insurance premiums and other payables, and other current liabilities).</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 5.5pt 2px 1pt;text-align:justify;text-indent:-4.5pt;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226; Provides information that our stockholders and management can use to evaluate our cash flows from operations independent of the current assets and liabilities associated with our WSEs.</span><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226; Enhances comparisons to prior periods and, accordingly, used as a liquidity measure to manage liquidity between corporate and WSE related activities, and to help determine and plan our cash flow and capital strategies.</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Non-GAAP effective tax rate is 25.6% for the first quarters of 2024 and 2023, which excludes the income tax impact from stock-based compensation, changes in uncertain tax positions, and nonrecurring benefits or expenses from federal legislative changes.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reconciliation of GAAP to Non-GAAP Measures</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents a reconciliation of Net income to Adjusted EBITDA: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.866%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">91</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock based compensation</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, bank fees and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of cloud computing arrangements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted EBITDA</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">180</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted EBITDA Margin</span></div></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents a reconciliation of Net income to Adjusted Net Income: </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.866%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income </span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">91</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effective income tax rate adjustment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of other intangible assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction and integration costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax impact of pre-tax adjustments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Adjusted Net Income</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">111</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents a reconciliation of net cash provided by operating activities to Corporate Operating Cash Flows: </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.012%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(122)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Less: Change in WSE related other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(420)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(178)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Less: Change in WSE related liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(68)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash used in operating activities - WSE</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(323)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(246)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by operating activities - Corporate</span></td><td style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">201</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_28"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.491%"><div style="text-align:justify"><span><br/></span></div></div><div style="display:inline-block;max-width:7.017%;min-width:6.017%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.492%"></div></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:12pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Operating Metrics</span></div><div style="margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Worksite Employees (WSE)</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Average WSE change is a volume measure we use to monitor the performance of our PEO business. Our PEO clients generally change their payroll service providers at the beginning of the payroll tax and benefits enrollment year; as a result, we have historically experienced our highest volumes of new PEO clients joining and existing clients terminating in the month of January. PEO client attrition, new PEO client additions and changes in employment levels within our installed PEO client base all impact our Average WSEs and Total WSEs as we move through a calendar year. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We support WSEs from the date on which their co-employment with TriNet commences through the end of their co-employment with TriNet and also after their co-employment period. We define WSEs to include co-employees and other individuals receiving PEO services, such as individuals who receive COBRA benefits post co-employment or are subject to partnership tax reporting as well as individuals who utilize our PEO platform on behalf of TriNet PEO clients. As part of an ongoing effort to ensure that our billing practices best match the expectations of our customers, in the third quarter of 2023 we determined that certain individuals such as those described above and certain co-employees were not previously or consistently counted in Total WSEs and Average WSEs. This resulting adjustment increased our reported Total WSEs by approximately 5,300 for March&#160;31, 2024 and Average WSEs by approximately 5,400 for the first quarter of 2024. We intend to continue our ongoing effort to ensure that our billing practices best match the expectations of our customers and in the future we may identify additional individuals that should be included in Total WSEs and Average WSEs. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, we implemented a platform user access fee to charge clients for those users of our PEO platform that may not be co-employed by us and to charge clients for co-employees for whom payroll may not be regularly run. In addition to co-employees for whom payroll may not be regularly run, this includes individuals authorized by our clients to access and use the PEO platform for functions such as bookkeeping and benefits management. The amount of the fee is comparable to the fee we charge for users of our HRIS platform. While the amount of revenue we recognized for this service to date has not been significant, these users of the PEO platform for whose access we charged this fee increased our reported Total WSEs by approximately 19,600 as of March&#160;31, 2024 and Average WSEs by approximately 17,600 for the first quarter of 2024.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of this new fee is that we are now receiving revenue from two types of users on our PEO platform, those that are co-employed in our PEO business and those that are utilizing our PEO platform, albeit in a more limited capacity. The table below illustrates how those two components comprise our Total WSE and Average WSE metrics.</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.574%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024 vs. 2023</span></td><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Average WSEs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">348,164</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">327,107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Co-Employed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">330,566</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">327,107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;PEO Platform Users</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">17,598</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total WSEs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">351,919</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">328,299&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Co-Employed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">332,361</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">328,299&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;PEO Platform Users</span></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">19,558</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Average WSEs increased 6% when comparing the first quarter of 2024 to the same period in 2023, primarily due to the additional Co-Employed and PEO Platform Users WSEs described above. The growth in Average WSEs was driven by our Main Street, Non-Profit and Financial Services verticals, partially offset by decreases in our Technology and Professional Services verticals.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total WSEs can be used to estimate our beginning WSEs for the next period and, as a result, can be used as an indicator of our potential future success in generating revenue, growing our business and retaining clients. Total WSEs increased 7% when compared to the same period in 2023, primarily due to the additional Co-Employed and PEO Platform Users WSEs described above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anticipated revenues for future periods can diverge from the revenue expectation derived from Average WSEs or Total WSEs due to pricing differences across our HCM solutions and services and the degree to which clients and WSEs elect to participate in our solutions during future periods. In addition to focusing on growing our Average WSE </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Total WSE counts, we also focus on pricing strategies, benefit participation and service differentiation to expand the value we provide to our clients and our resulting revenue opportunities. We report the impact of client and WSE participation differences as a change in mix.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to invest in efforts intended to enhance client experience, improve our new sales performance, and manage client attrition, through product development as well as operational and process improvements. As we continue our work in combining our PEO platform and our HRIS SaaS capabilities into a single platform, these various types of TriNet users will all be served from the same platform.  In addition to focusing on retaining and growing our WSE base, we continue to review acquisition opportunities that would expand our product offering and provide further scale. </span></div><div style="margin-top:10pt;text-align:justify"><img src="tnet-20240331_g2.jpg" alt="Screenshot 2024-04-10 131640.jpg" style="height:297px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_34"></div><div style="margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">HRIS Users</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Average HRIS Users is a volume measure we use to monitor the performance of our cloud-based HRIS services. Average HRIS Users for the first quarter 2024 and 2023, was 195,157, and 231,347, respectively. This decline is being driven by both higher client attrition as compared to new client additions and lower hiring by HRIS clients similar to SMB hiring trends that we have observed in our PEO business.</span></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_40"></div><div style="margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Insurance Cost Ratio (ICR)</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ICR is a performance measure calculated as the ratio of insurance costs to insurance service revenues. We believe that ICR promotes an understanding of our insurance cost trends and our ability to align our relative pricing to risk performance.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase workers' compensation and health benefits coverage for our WSEs. Under the insurance policies for this coverage, we bear claims costs up to a defined deductible amount. Our insurance costs, which comprise a significant portion of our overall costs, are significantly affected by our WSEs&#8217; health and workers' compensation insurance claims experience. We set our insurance service fees for workers&#8217; compensation and health benefits in advance for fixed benefit periods. As a result, increases in insurance costs above our projections, reflected as a higher ICR, result in lower net income. Decreases in insurance costs below our projections, reflected as a lower ICR, result in higher net income, but can be an indicator that insurance costs are developing more slowly than our projections, which are reflected in our fees, and this can have a negative impact over time on client retention and new sales.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our fully-insured workers' compensation insurance policies, we assume the risk for losses up to $1 million per claim occurrence (deductible layer). The ultimate cost of the workers&#8217; compensation services provided cannot be known until all the claims are settled. Our ability to predict these costs is limited by unexpected increases in frequency or severity of claims, which can vary due to changes in the cost of treatments or claim settlements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our risk-based health insurance policies, we assume the risk of variability in future health claims costs for our enrollees. This variability typically results from changing trends in the volume, severity and ultimate cost of medical and pharmaceutical claims, due to changes to the components of medical cost trend, which we define as changes in participant use of services, including the introduction of new treatment options, changes in treatment guidelines and mandates, and changes in the mix, cost of providing treatment and timing of services provided to plan participants. These trends change, and other seasonal trends and variability may develop. As a result, it is difficult for us to predict our insurance costs with accuracy and a significant increase in these costs could have a material adverse effect on our business.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.574%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance costs</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">907</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">852&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance service revenues</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,050</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,041&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Insurance Cost Ratio</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">86</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ICR increased for the first quarter as compared to the same period in 2023, primarily driven by higher insurance costs. Insurance costs increased due to higher costs associated with medical services utilization, in particular pharmacy costs and outpatient services. This was partially offset by favorable prior period development in workers' compensation. </span></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_46"></div><div style="margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Total Revenues</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues consist of PSR and ISR. PSR represents fees charged to clients for processing payroll-related transactions on behalf of our PEO and HRIS clients, access to our HR expertise, employment and benefit law compliance services, other HR-related and tax credit filing services and fees charged to access our cloud-based HRIS services. ISR consists of insurance-related billings and administrative fees collected from PEO clients and withheld from WSEs for workers' compensation insurance and health benefit insurance plans provided by third-party insurance carriers.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Monthly total revenues per Average WSE is a measure we use to monitor our PEO pricing strategies. This measure was flat during the first quarter of 2024 compared to the same period in 2023.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also use the following measures to further analyze changes in total revenue:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Volume - the percentage change in period over period co-employed Average WSEs,</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Rate - the combined weighted average percentage changes in service fees for each vertical service and changes in service fees associated with each insurance service offering, </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Mix - </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">the change in composition of Average WSEs within our verticals combined with the composition of our enrolled WSEs within our insurance service offerings and the composition of products and services our clients receive, including TriNet Clarus R+D, and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HRIS - incremental HRIS cloud services revenue.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span><br/></span></div><div><img src="tnet-20240331_g3.jpg" alt="1500" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   </span><img src="tnet-20240331_g4.jpg" alt="1504" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/><img src="tnet-20240331_g5.jpg" alt="549755816558" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:38.011%"><tr><td style="width:1.0%"/><td style="width:6.207%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:89.670%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">PSR</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#0073cf;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">ISR - % represents proportion of insurance service revenues to total revenues</span></td><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#e37222;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">*Total revenues generated from PEO services only</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in total revenue for the first quarter of 2024 was primarily driven by rate increases, partially offset by lower health plan enrollment.</span></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_49"></div><div style="margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Operating Income</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating income consists of total revenues less insurance costs and OE. Our insurance costs include insurance premiums for coverage provided by insurance carriers, expenses for claims costs and risk management and administrative services, and changes in accrued costs related to contractual obligations with our workers' compensation and health benefit carriers. Our OE consists primarily of our colleagues' compensation related expenses, which includes payroll, payroll taxes, SBC, bonuses, commissions and other payroll-and benefits-related costs.</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides a view of the changes in components of operating income for the first quarter of 2024, as compared to the same period in 2023.</span></div><div style="margin-bottom:3pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.233%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:88.375%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:100%">$169</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Quarter 2023 Operating Income</span></td></tr><tr><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+18&#160;</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Higher total revenues primarily driven by rate increases from our PEO services, partially offset by lower health plan enrollment.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Higher insurance costs primarily driven by higher health insurance utilization and rate inflation.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-10&#160;</span></td><td style="border-bottom:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OE increased due to higher compensation expenses partially offset by lower transaction and integration costs and discretionary spending.</span></td></tr><tr><td colspan="6" style="border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:100%">$122</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Quarter 2024 Operating Income </span></td></tr></table></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_52"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Professional Service Revenues</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our PEO and HRIS clients are primarily billed on a fee per WSE or HRIS User per month per transaction. Our vertical approach provides us the flexibility to offer our PEO clients in different industries with varied services at different prices, which we believe potentially reduces the value of solely using Average WSE and Total WSE counts as indicators of future potential revenue performance.</span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PSR from PEO Services customers and HRIS cloud services clients was as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PEO Services</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">203</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">HRIS Cloud Services </span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">214</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also analyze changes in PSR with the following measures:</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Volume - the percentage change in period over period co-employed Average WSEs,</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Rate - the weighted average percentage change in fees for each vertical, </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mix - the change in composition of Average WSEs across our verticals and</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the composition of products and services our clients receive, including TriNet Clarus R+D, and</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HRIS - incremental HRIS cloud services revenue.</span></div><div style="margin-top:3pt"><img src="tnet-20240331_g6.jpg" alt="924" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/><img src="tnet-20240331_g7.jpg" alt="925" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/><img src="tnet-20240331_g8.jpg" alt="1649267443334" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in PSR for the first quarter of 2024 was primarily driven by higher Average WSEs and rates, partially offset by changes in composition of Average WSEs across our verticals and</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the composition of products and services our clients receive, including TriNet Clarus R+D.</span></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_55"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Insurance Service Revenues </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ISR consists of insurance services-related billings and administrative fees collected from PEO clients and withheld from WSE payroll for health benefits and workers' compensation insurance provided by third-party insurance carriers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the following measures to analyze changes in ISR:</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Volume - the percentage change in period over period co-employed Average WSEs, </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Rate - the weighted average percentage change in fees associated with each of our insurance service offerings, and</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mix - all other changes including the composition of our enrolled WSEs within our insurance service offerings (health plan enrollment).</span></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:3pt"><img src="tnet-20240331_g9.jpg" alt="734" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/><img src="tnet-20240331_g10.jpg" alt="735" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/><img src="tnet-20240331_g11.jpg" alt="1649267442869" style="height:237px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/></div><div style="margin-top:3pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The increase in ISR for the first quarter was primarily driven by rate increases, partially offset by lower health plan enrollment.</span></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_58"></div><div style="margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Insurance Costs</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance costs include insurance premiums for coverage provided by insurance carriers, payments for claims costs and expenses for other risk management and administrative services, reimbursement of claims payments made by insurance carriers or third-party administrators below a predefined deductible limit, and changes in accrued costs related to contractual obligations with our workers' compensation and health benefit carriers.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the following measures to analyze changes in insurance costs:</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Volume - the percentage change in period over period co-employed Average WSEs,</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Rate - the weighted average percentage change in cost trend associated with each of our insurance service offerings, and</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mix - all other changes including the composition of our enrolled WSEs within our insurance service offerings (health plan enrollment).</span></div><div style="margin-top:3pt;text-align:justify"><img src="tnet-20240331_g12.jpg" alt="834" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/><img src="tnet-20240331_g13.jpg" alt="835" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/><img src="tnet-20240331_g14.jpg" alt="1649267442970" style="height:240px;margin-bottom:5pt;vertical-align:text-bottom;width:220px"/></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Insurance costs increased for the first quarter, primarily due to higher utilization, primarily due to prescription and outpatient services as well as inflationary increases in rates paid for services.  This was partially offset by lower health plan enrollment. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OE includes COPS, S&amp;M, G&amp;A, SD&amp;P, and D&amp;A.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We had approximately 3,600 colleagues as of March&#160;31, 2024 primarily across the U.S. but also in India and Canada. Compensation costs for our colleagues include payroll, payroll taxes, SBC, bonuses, commissions and other payroll- and benefits-related costs. Compensation-related expense represented 68% and 65% of our OE in the first quarters of 2024 and 2023, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Transaction and integration costs associated with our acquisitions of Zenefits and Clarus R+D are included in G&amp;A. These costs include advisory, legal, and employee retention costs tied to ongoing employment.</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2024 , OE increased 4% when compared to the same period in 2023. The ratio of OE to total revenues was 19% for the first quarters of 2024 and 2023. </span></div><div style="margin-bottom:3pt;margin-top:3pt"><img src="tnet-20240331_g15.jpg" alt="837" style="height:224px;margin-bottom:5pt;vertical-align:text-bottom;width:232px"/><img src="tnet-20240331_g16.jpg" alt="838" style="height:224px;margin-bottom:5pt;vertical-align:text-bottom;width:232px"/><img src="tnet-20240331_g17.jpg" alt="839" style="height:224px;margin-bottom:5pt;vertical-align:text-bottom;width:218px"/></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"/><td style="width:169.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:24.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:25.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:22.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:24.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:22.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:24.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:27.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:39.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:112.75pt"/><td style="width:1.0pt"/></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:100%">% represents portion of compensation related expense included in operating expenses</span></td></tr></table></div><div style="margin-top:3pt"><span><br/></span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We analyze and present our OE based upon the business functions COPS, S&amp;M, G&amp;A and SD&amp;P and D&amp;A. The charts below provide a view of the expenses of the business functions. Dollars are presented in millions and percentages represent year-over-year change.</span></div><div style="margin-top:10pt"><img src="tnet-20240331_g18.jpg" alt="1099" style="height:300px;margin-bottom:5pt;vertical-align:text-bottom;width:135px"/><img src="tnet-20240331_g19.jpg" alt="1100" style="height:300px;margin-bottom:5pt;vertical-align:text-bottom;width:133px"/><img src="tnet-20240331_g20.jpg" alt="1101" style="height:300px;margin-bottom:5pt;vertical-align:text-bottom;width:140px"/><img src="tnet-20240331_g21.jpg" alt="1102" style="height:300px;margin-bottom:5pt;vertical-align:text-bottom;width:141px"/><img src="tnet-20240331_g22.jpg" alt="1103" style="height:300px;margin-bottom:5pt;vertical-align:text-bottom;width:134px"/></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.790%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="border-bottom:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="6" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$225</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Q1 2023 Operating Expenses</span></td></tr><tr><td colspan="3" style="border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+1&#160;</span></td><td style="border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COPS increased slightly due to higher compensation expense.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">S&amp;M increased, driven primarily by higher compensation to support our sales force together with higher corporate events expenses, partially offset by lower advertising costs.</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">G&amp;A increased due to higher compensation expense partially offset by lower transaction and integration expense.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SD&amp;P was consistent with the prior period as higher compensation expense was offset by lower consulting expense.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">D&amp;A was consistent with the prior period.</span></div></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$235</span></td><td colspan="3" style="border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#006ebf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Q1 2024 Operating Expense</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary spend type drivers to the changes in our OE are presented below:</span></div><div style="margin-top:10pt"><img src="tnet-20240331_g23.jpg" alt="1186" style="height:268px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_64"></div><div style="margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Other Income (Expense)</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense) consists primarily of interest income from cash and investments and interest expense on our outstanding debt.</span></div><div style="margin-top:10pt"><img src="tnet-20240331_g24.jpg" alt="173" style="height:224px;margin-bottom:5pt;vertical-align:text-bottom;width:226px"/><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">          </span><img src="tnet-20240331_g25.jpg" alt="184" style="height:224px;margin-bottom:5pt;vertical-align:text-bottom;width:226px"/></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Interest income for the first quarter of 2024 was consistent with the prior period. The higher interest expense, bank fees and other for the first quarter of 2024 was primarily due to the additional interest on our 2031 Notes issued in the third quarter of 2023. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our ETR was 27% for the first quarter of 2024 and 2023. The increase in tax benefits related to stock-based compensation from the first quarter of 2023 was offset by an increase in non-deductible compensation in the first quarter of 2024.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liquidity is a measure of our ability to access sufficient cash flows to meet the short-term and long-term cash requirements of our business operations. Our principal source of liquidity for operations is derived from cash provided by operating activities. We rely on cash provided by operating activities to meet our short-term liquidity requirements, which primarily relate to the payment of corporate payroll and other operating costs, and capital expenditures. Our cash flow related to WSE payroll and benefits is generally matched by advance collection from our PEO clients. To minimize the credit risk associated with remitting the payroll and associated taxes and benefits costs, we require PEO clients to prefund the payroll and related payroll taxes and benefits costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our balance sheets are assets and liabilities resulting from transactions directly or indirectly associated with WSEs, including payroll and related taxes and withholdings, our sponsored workers' compensation and health insurance programs, and other benefit programs. Although we are not subject to regulatory restrictions that require us to do so, we distinguish and manage our corporate assets and liabilities separately from those current assets and liabilities held by us to satisfy our employer obligations associated with our WSEs as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:51.176%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.687%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">WSE</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">WSE</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">298</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">298</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">85</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">85</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">135</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">924</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">1,059</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,247&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">1,269&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 21.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">94</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">1,304</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">1,398</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">884&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">957&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total current assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">612</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2,228</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2,840</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,131&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,578&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">441</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2,228</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">2,669</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,131&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">2,463&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">Working capital</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">171</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:700;line-height:100%">171</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2024, we did not have any material off-balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, results of operations, liquidity, capital expenditures or capital resources.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Working capital for WSEs related activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We designate funds to ensure that we have adequate current assets to satisfy our current obligations associated with WSEs. We manage our WSE payroll and benefits obligations through collections of payments from our clients which generally occur two to three days in advance of client payroll dates. We regularly review our short-term obligations associated with our WSEs (such as payroll and related taxes, insurance premium and claim payments) and designate funds required to fulfill these short-term obligations, which we refer to as PFC. PFC is included in current assets as restricted cash, cash equivalents and investments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage our sponsored benefit and workers' compensation insurance obligations by maintaining collateral funds in restricted cash, cash equivalents and investments. These collateral amounts are generally determined at the beginning of each plan year and we may be required by our insurance carriers to adjust our collateral balances when facts and circumstances change. We regularly review our collateral balances with our insurance carriers and anticipate funding further collateral in the future based upon our capital requirements. We classify our restricted cash, cash equivalents and investments as current and noncurrent assets to match against the anticipated timing of payments to carriers. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Working capital for corporate purposes</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate working capital as of March&#160;31, 2024 increased $56 million from December&#160;31, 2023, primarily due to the increases in our corporate unrestricted cash and cash equivalents, investments and other current assets, which was driven by our cash flows from operations. The increase in restricted cash, cash equivalents and investments was largely offset by the increase in total current liabilities. These increases were primarily driven by the contribution of HRIS assets into our trust. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_112">Note 1</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Item 1 of this Form 10-Q for more details.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December of 2023, TriNet created a trust for the purpose of holding funds provided by HRIS clients for the remittance to HRIS Users, tax authorities and other recipients. This trust is consolidated into our financial statements.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the first quarter of 2024, the trust assumed ownership and responsibility of certain bank accounts that hold HRIS client funds.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The associated cash is reflected on our balance sheet as restricted cash and the associated liabilities are classified as accrued wages, payroll tax liabilities and other payroll withholdings, and client deposits and other client liabilities and assumed the related liabilities.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of March 31, 2024, the balance of restricted cash in the trust was $113 million.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use our available cash and cash equivalents to satisfy our operational and regulatory requirements and to fund capital expenditures. We believe that we can meet our present and reasonably foreseeable operating cash needs and future commitments through existing liquid assets, continuing cash flows from corporate operating activities and the potential issuance of debt or equity securities. We hold both corporate cash and cash associated with WSEs across multiple financial institutions to reduce concentrations of counterparty risk. We believe our existing corporate cash and cash equivalents and positive working capital will be sufficient to meet our working capital expenditure needs for at least the next twelve months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our cash flow activities for the stated periods:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.775%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">WSE</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">WSE</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">201</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(323)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(122)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(246)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(47)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(47)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(30)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(30)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net increase (decrease) in cash and cash equivalents, unrestricted and restricted</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">124</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(323)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(199)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">348&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(248)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents, unrestricted and restricted:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Beginning of period</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">334</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,132</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,466</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,131&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,537&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">End of period</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">458</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">809</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,267</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">754&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,637&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrestricted</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted</span></td><td style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(323)</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(210)</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(248)</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(253)</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of net cash used in operating activities are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.790%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash used in operating activities:</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(122)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash used in operating activities - WSE</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(323)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(246)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by operating activities - Corporate</span></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">201</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The year-over-year change in net cash used in operating activities for WSE purposes was primarily driven by timing of client payments, payments of payroll and payroll taxes and insurance claim activities. We expect the changes in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">restricted cash and cash equivalents to correspond to WSE cash provided by (or used in) operations as we manage our obligations associated with WSEs through restricted cash.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate operating cash flows in the three months ended March&#160;31, 2024 increased, when compared to the same period in 2023, primarily due to the timing of our payments of corporate obligations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in investing activities for the periods presented below primarily consisted of purchases of investments, capital expenditures and acquisition of business, partially offset by proceeds from the sale and maturity of investments. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:70.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.248%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.249%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(82)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale and maturity of investments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">66</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash used in investments</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(29)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash used in capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash used in investing activities</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(47)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We invest a portion of available cash in investment-grade securities with effective maturities less than five years that are classified on our balance sheets as investments. We consider industry and issuer concentrations in our investment policy.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also invest funds held as collateral to satisfy our long-term obligation towards workers' compensation liabilities. These investments are classified on our balance sheets as restricted cash, cash equivalents and investments. We review the amount and the anticipated holding period of these investments regularly in conjunction with our estimated long-term workers' compensation liabilities and anticipated claims payment trend. At March&#160;31, 2024, our investments had a weighted average duration of less than two years and an average S&amp;P credit rating of AA+.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2024, we held approximately $1.8 billion in restricted and unrestricted cash, cash equivalents and investments, of which $298 million was unrestricted cash and cash equivalents and $246 million was unrestricted investments. Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_115">Note 2</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the condensed consolidated financial statements and related notes included in this Form 10-Q.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capital Expenditures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2024 and 2023, we continued to make investments in software and hardware and we enhanced our existing service offerings and technology platform. We expect capital investments in our software and hardware to continue in the future. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by (used in) financing activities in the three months ended March&#160;31, 2024 and 2023 consisted of our debt and equity-related activities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.574%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock, net of issuance costs</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(30)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Draw down from revolving credit agreement borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of revolving credit agreement borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(200)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash provided by (used in) financing activities</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(30)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, our board of directors authorized a $300 million incremental increase to our ongoing stock repurchase program initiated in May 2014. In July 2023, our board of directors authorized a further $1&#160;billion incremental increase to this stock repurchase program. We use this program to return value to our stockholders and to offset dilution from the issuance of stock under our equity-based incentive plan and employee purchase plan.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MANAGEMENT'S DISCUSSION AND ANALYSIS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 28, 2023, we completed a public tender offer through which we repurchased 5,981,308 shares of common stock at a price of $107.00 per share, for total consideration of approximately $640 million. On September 13, 2023, we repurchased 3,364,486 shares of common stock at a price of $107.00 per share, for total consideration of approximately $360 million, through a private repurchase from our largest stockholder, Atairos Group, Inc. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2024, we repurchased 197,872 shares of our common stock for approximately $23 million through our existing stock repurchase program in addition to 59,249 shares acquired to satisfy tax withholding obligations related to SBC vesting. As of March&#160;31, 2024, approximately $409 million remained available for repurchase under all authorizations by our board of directors. We plan to use current cash and cash generated from ongoing operating activities to fund this stock repurchase program. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, to ensure that we maintained liquidity during the regional banking liquidity challenges, we drew down the available $495 million of capacity under our 2021 Revolver. As concerns about market liquidity subsided, we repaid $200 million in March and $295 million in April. In September of 2023, we drew down $200 million under our 2021 Revolver to partially fund our share repurchases in the third quarter of 2023 noted above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February of 2024, our board of directors declared a cash dividend of $0.25 per share, for a total payment of approximately $13 million paid in April 2024. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Capital Resources</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2024, $500 million and $400 million aggregate principal of our 2029 Notes and 2031 Notes was outstanding, respectively. The indenture governing our 2029 Notes and 2031 Notes each includes restrictive covenants limiting our ability to: (i) create liens on certain assets to secure debt; (ii) grant a subsidiary guarantee of certain debt without also providing a guarantee of the 2029 Notes or 2031 Notes, as applicable; and (iii) consolidate or merge with or into, or sell or otherwise dispose of all or substantially all of our assets to, another person, subject, in each case, to certain customary exceptions.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 2021 Credit Agreement includes a $700 million revolver. In September of 2023, we drew down $200 million of this revolver to partially fund our third quarter of 2023 share repurchases. The 2021 Credit Agreement includes negative covenants that limit our ability to incur indebtedness and liens, sell assets and make restricted payments, including dividends and investments, subject to certain exceptions. In addition, the 2021 Credit Agreement also contains other customary affirmative and negative covenants and customary events of default. The 2021 Credit Agreement also contains a financial covenant that requires the Company to maintain certain maximum total net leverage ratios.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were in compliance with all financial covenants under our 2021 Credit Agreement, 2029 Notes and 2031 Notes at March&#160;31, 2024.</span></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_73"></div><div style="margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Critical Accounting Policies, Estimates and Judgments</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to our critical accounting policies, estimates and judgments as discussed in our 2023 Form&#160;10-K.</span></div><div style="margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_112">Note 1</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Item 1 of this Form 10-Q.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_76"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AND CONTROLS AND PROCEDURES</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:12pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our exposure to changes in interest rates relates primarily to our investment portfolio. Changes in U.S. interest rates affect the interest earned on the Company's cash, cash equivalents and the fair value of our investments.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash equivalents consist primarily of money market mutual funds, which are not significantly exposed to interest rate risk. Our investments are subject to interest rate risk because these securities generally include a fixed interest rate. As a result, the market values of these securities are affected by changes in prevailing interest rates. We attempt to limit our exposure to interest rate risk and credit risk by investing in instruments that meet the minimum credit quality, liquidity, diversification and other requirements of our investment policy. Our investments consist of liquid, investment-grade securities. The risk of rate changes on investment balances was not material at March&#160;31, 2024 and December&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2024, we had drawn down $200 million under our floating rate 2021 Revolver. The impact of a 100 basis point increase or decrease in market interest rates to interest expense on our 2021 Revolver as of March&#160;31, 2024 over the next twelve months was approximately $2 million.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_79"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">AND CONTROLS AND PROCEDURES</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:12pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Controls and Procedures</span></div><div style="margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have, with the participation of our CEO and our CFO, evaluated the effectiveness of our disclosure controls and procedures as of March&#160;31, 2024, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act. </span></div><div style="margin-bottom:8pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the evaluation of our disclosure controls and procedures as of March&#160;31, 2024, our CEO and CFO have concluded that the Company&#8217;s disclosure controls and procedures were effective as of such date in ensuring that (i) information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is accumulated and communicated to the Company&#8217;s management, including the CEO and CFO, to allow timely decisions regarding required disclosure and (ii) such information is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have concluded that the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q fairly present, in all material respects, our financial position, results of operations and cash flows for the periods presented in conformity with GAAP.</span></div><div style="margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the quarter ended March&#160;31, 2024, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Limitations on Effectiveness of Controls and Procedures </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_85"></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRINET GROUP, INC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (Unaudited)</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional service revenues</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-31">214</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-32">205</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance service revenues</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-33">1,050</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-34">1,041</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total revenues</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-35">1,264</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-36">1,246</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Insurance costs</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OperatingInsuranceAndClaimsCostsProduction" scale="6" id="f-37">907</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:OperatingInsuranceAndClaimsCostsProduction" scale="6" id="f-38">852</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of providing services</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="tnet:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction" scale="6" id="f-39">79</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="tnet:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction" scale="6" id="f-40">78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and marketing</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:SellingAndMarketingExpense" scale="6" id="f-41">72</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:SellingAndMarketingExpense" scale="6" id="f-42">69</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-43">48</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="f-44">43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Systems development and programming</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-45">18</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-46">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" scale="6" id="f-47">18</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" scale="6" id="f-48">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total costs and operating expenses</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="f-49">1,142</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="f-50">1,077</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating income</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-51">122</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-52">169</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense):</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense, bank fees and other</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="tnet:InterestExpenseBankFeesAndOther" scale="6" id="f-53">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="tnet:InterestExpenseBankFeesAndOther" scale="6" id="f-54">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:InterestIncomeOther" scale="6" id="f-55">18</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:InterestIncomeOther" scale="6" id="f-56">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Income before provision for income taxes</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-57">124</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-58">180</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-59">33</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-60">49</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-61">91</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-62">131</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of income taxes</span></td><td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-63">3</ix:nonFraction>)</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-64">3</ix:nonFraction>&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comprehensive income</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-65">88</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-66">134</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income per share:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-67">1.80</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-68">2.18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-69">1.78</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-70">2.17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average shares:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-71">51</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-72">60</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></div></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-73">51</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-74">60</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            </span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_94"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRINET GROUP, INC.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.499%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions, except share and per share data)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-75">298</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-76">287</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investments</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="f-77">85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="f-78">65</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-79">1,059</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-80">1,269</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-81">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-82">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unbilled revenue, net</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="f-83">467</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="f-84">447</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses, net</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="f-85">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="f-86">67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other payroll assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="tnet:OtherPayrollAssetsCurrent" scale="6" id="f-87">791</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="tnet:OtherPayrollAssetsCurrent" scale="6" id="f-88">381</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other current assets</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-89">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-90">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-91">2,840</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-92">2,578</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments, noncurrent</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" scale="6" id="f-93">152</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" scale="6" id="f-94">158</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investments, noncurrent</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:InvestmentsAndOtherNoncurrentAssets" scale="6" id="f-95">161</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:InvestmentsAndOtherNoncurrentAssets" scale="6" id="f-96">143</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-97">15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="f-98">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-99">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-100">24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Goodwill </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:Goodwill" scale="6" id="f-101">462</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:Goodwill" scale="6" id="f-102">462</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software and other intangible assets, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-103">174</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-104">172</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-105">142</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-106">139</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-107">3,968</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-108">3,693</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities and stockholders' equity</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and other current liabilities</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="6" id="f-109">122</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="6" id="f-110">87</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Revolving credit agreement borrowings</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:LinesOfCreditCurrent" scale="6" id="f-111">109</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:LinesOfCreditCurrent" scale="6" id="f-112">109</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Client deposits and other client liabilities </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-113">51</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-114">65</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued wages</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AccruedSalariesCurrent" scale="6" id="f-115">537</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AccruedSalariesCurrent" scale="6" id="f-116">515</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued health insurance costs, net</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="tnet:CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent" scale="6" id="f-117">167</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="tnet:CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent" scale="6" id="f-118">175</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued workers' compensation costs, net</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:WorkersCompensationLiabilityCurrent" scale="6" id="f-119">51</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:WorkersCompensationLiabilityCurrent" scale="6" id="f-120">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payroll tax liabilities and other payroll withholdings</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="tnet:AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" format="ixt:num-dot-decimal" scale="6" id="f-121">1,611</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="tnet:AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" format="ixt:num-dot-decimal" scale="6" id="f-122">1,438</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-123">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-124">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Insurance premiums and other payables</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="tnet:InsurancePremiumsAndOtherPayables" scale="6" id="f-125">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="tnet:InsurancePremiumsAndOtherPayables" scale="6" id="f-126">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-127">2,669</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-128">2,463</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Long-term debt, noncurrent</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-129">984</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-130">984</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued workers' compensation costs, noncurrent, net</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:WorkersCompensationLiabilityNoncurrent" scale="6" id="f-131">120</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:WorkersCompensationLiabilityNoncurrent" scale="6" id="f-132">120</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred taxes</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-133">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="f-134">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities, noncurrent</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-135">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-136">30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non-current liabilities</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-137">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-138">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-139">3,825</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-140">3,615</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commitments and contingencies (see </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_139">Note 5</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-8" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-141"/></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-9" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-142"/></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stockholders' equity:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="f-143">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="f-144">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-145"><ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-146">0.000025</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-147"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-148">20,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt-sec:numwordsen" scale="0" id="f-149"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt-sec:numwordsen" scale="0" id="f-150"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt-sec:numwordsen" scale="0" id="f-151"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt-sec:numwordsen" scale="0" id="f-152">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding at March&#160;31, 2024 and December&#160;31, 2023)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock and additional paid-in capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" scale="6" id="f-153">996</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:CommonStocksIncludingAdditionalPaidInCapital" scale="6" id="f-154">976</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">($<ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-155"><ix:nonFraction unitRef="usdPerShare" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-156">0.000025</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-157"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-158">750,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-159"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-160">50,573,176</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">and <ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-161"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-162">50,664,471</ix:nonFraction></ix:nonFraction> shares issued and outstanding at March&#160;31, 2024 and December&#160;31, 2023, respectively)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-163">848</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-164">896</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-165">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-166">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-167">143</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-168">78</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities &amp; stockholders' equity</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-169">3,968</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-170">3,693</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRINET GROUP, INC.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.696%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)<br/></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Stockholders' Equity, beginning balance</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-171">78</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-172">775</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common Stock and Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-173">976</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-174">899</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock based compensation expense</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-175">20</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-176">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></div></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-177">996</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-178">910</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Retained Earnings (Accumulated Deficit)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-179">896</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-180">119</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-181">91</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-182">131</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends Declared</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-183">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:fixed-zero" scale="6" id="f-184">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="f-185">23</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="f-186">91</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Awards effectively repurchased for required employee withholding taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-187">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-188">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></div></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-189">848</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-190">83</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning balance</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-191">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-192">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-193">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-194">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending balance</span></div></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-195">5</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-196">2</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Stockholders' Equity, ending balance</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-197">143</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="f-198">825</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRINET GROUP, INC.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</span></div><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.544%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating activities</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-199">91</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="f-200">131</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-201">18</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-202">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of deferred costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OtherAmortizationOfDeferredCharges" scale="6" id="f-203">11</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:OtherAmortizationOfDeferredCharges" scale="6" id="f-204">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of ROU asset, lease modification, impairment, and abandonment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="f-205">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="6" id="f-206">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="f-207">20</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="f-208">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Provision for doubtful accounts</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="f-209">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="f-210">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable, net</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-211">6</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-212">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unbilled revenue, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" scale="6" id="f-213">20</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerAsset" scale="6" id="f-214">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses, net </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="6" id="f-215">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncreaseDecreaseInPrepaidExpense" scale="6" id="f-216">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="f-217">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="f-218">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other payroll assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="tnet:IncreaseDecreaseInOtherPayrollAssets" scale="6" id="f-219">410</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="tnet:IncreaseDecreaseInOtherPayrollAssets" scale="6" id="f-220">180</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and other liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" scale="6" id="f-221">20</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" scale="6" id="f-222">30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Client deposits and other client liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="f-223">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="f-224">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued wages</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedSalaries" scale="6" id="f-225">23</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedSalaries" scale="6" id="f-226">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued health insurance costs, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" scale="6" id="f-227">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" scale="6" id="f-228">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued workers' compensation costs, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInWorkersCompensationLiabilities" scale="6" id="f-229">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInWorkersCompensationLiabilities" scale="6" id="f-230">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payroll taxes payable and other payroll withholdings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities" scale="6" id="f-231">173</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities" scale="6" id="f-232">80</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="tnet:IncreaseDecreaseInOperatingLeaseLiabilities" scale="6" id="f-233">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="tnet:IncreaseDecreaseInOperatingLeaseLiabilities" scale="6" id="f-234">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-235">122</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-236">77</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Investing activities</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="f-237">95</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="f-238">82</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from sale and maturity of marketable securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="f-239">66</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="f-240">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisitions of property and equipment and projects in process</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-241">18</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-242">17</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:29.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></div></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-243">47</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-244">23</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financing activities</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-245">23</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-246">91</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Awards effectively repurchased for required employee withholding taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-247">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="f-248">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from revolving credit agreement borrowings </span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromLinesOfCredit" format="ixt:fixed-zero" scale="6" id="f-249">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="f-250">495</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment of revolving credit agreement borrowings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:RepaymentsOfLinesOfCredit" format="ixt:fixed-zero" scale="6" id="f-251">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="f-252">200</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-253">30</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-254">200</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net change in cash and cash equivalents, unrestricted and restricted</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="6" id="f-255">199</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" scale="6" id="f-256">100</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and cash equivalents, unrestricted and restricted:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beginning of period</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-257">1,466</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-258">1,537</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">End of period</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-259">1,267</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-260">1,637</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental disclosures of cash flow information</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest paid</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="f-261">26</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="f-262">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income taxes paid, net</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="f-263">7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="f-264">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Supplemental schedule of noncash investing and financing activities</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividend declared, but not yet paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="f-265">13</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:fixed-zero" scale="6" id="f-266">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payable for purchase of property and equipment</span></td><td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="f-267">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="f-268">5</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_112"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTE 1. <ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock" id="f-269" continuedAt="f-269-1" escape="true">DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="f-269-1" continuedAt="f-269-2"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Description of Business</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TriNet Group, Inc. (TriNet, or the Company, we, our and us) provides comprehensive HCM solutions for small and medium-size businesses under both a PEO model and an HRIS services model. These HCM solutions include multi-state payroll processing and tax administration, employee benefits programs, including health insurance and retirement plans, workers' compensation insurance and claims management, employment and benefit law compliance, and other HR-related services. Through our PEO service model, we are the employer of record for certain employment-related administrative and regulatory purposes for WSEs, including:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compensation through wages and salaries,</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">certain employer payroll-related tax payments, </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">employee payroll-related tax withholdings and payments,</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">employee benefit programs, including health and life insurance, and </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">workers' compensation coverage. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our PEO clients are responsible for the day-to-day job responsibilities of the WSEs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our HRIS services model, we provide cloud-based HCM services to SMBs that allows them to manage hiring, onboarding, employee information, payroll processing, payroll tax administration, health insurance, and other benefits, from a single cloud-based software platform. We are not the co-employer or employer of record for such employees.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="f-270" escape="true">We operate in <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-271">one</ix:nonFraction> reportable segment. All of our service revenues are generated from external clients. Less than <ix:nonFraction unitRef="number" contextRef="c-30" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-272">1</ix:nonFraction>% of our revenue is generated outside of the U.S.</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Basis of Presentation and Basis of Consolidation</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-273" continuedAt="f-273-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial reporting and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the Rules and Regulations of the Securities and Exchange Commission. The unaudited condensed consolidated financial statements include the accounts of the Company and an entity consolidated under the variable interest model. Intercompany balances and transactions have been eliminated. Certain information and note disclosures included in our annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, that are normal and recurring in nature, necessary for fair financial statement presentation. The results of operations for the three months ended March&#160;31, 2024 are not necessarily indicative of the operating results anticipated for the full year. These financial statements should be read in conjunction with the audited Consolidated Financial Statements included in Part II, Item 8. Financial Statements and Supplementary Data of our Annual Report on Form 10-K for the year ended December&#160;31, 2023. Certain prior year amounts have been reclassified to conform to current period presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When entering into contractual arrangements with other entities, we assess whether we have a variable interest. If we determine that we have a variable interest, we then determine whether the arrangement is with a variable interest entity ("VIE"). If the arrangement is with a VIE, we assess whether we are the primary beneficiary of the VIE by identifying the most significant activities and determining who has the power over those activities and who has the obligation to absorb the majority of the losses or benefits of the VIE. We consolidate a VIE when we have the power to direct activities that most significantly affect the economic performance of the VIE and have the obligation to absorb the majority of their losses or benefits, making us the primary beneficiary. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, we assess whether any changes in our interest or relationship with the entity affect our determination of whether the entity is a VIE and, if so, whether we are the primary beneficiary.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, we created a trust ("the Trust") for the purpose of holding HRIS clients' payroll funds for the remittance to HRIS Users, tax authorities and other recipients. The Trust's assets are restricted and can only be used for payments on behalf of HRIS clients, payments on behalf of the HRIS Users, repayments of any advances from TriNet, or payments to TriNet of interest income earned on the balances of the Trust. In the event of any </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="f-269-2" continuedAt="f-269-3"><ix:continuation id="f-273-1"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">losses, creditors to the Trust have recourse to the Trust's property and not that of TriNet overall.  The risks associated with the Trust are similar to those that currently exist for the Company such as banking losses in excess of FDIC insurance levels, interest rate and market conditions. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined that this Trust meets the definition of a variable interest entity and as the primary beneficiary we have both the power to direct the Trust&#8217;s activities that most significantly affect its performance and we have the right to receive benefits from the Trust, in the form of interest income. As a result, this Trust is consolidated into our financial statements.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2024, the Trust assumed ownership and responsibility of certain bank accounts that hold HRIS client funds and assumed the related liabilities.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock" id="f-274" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the assets and liabilities of the Trust which are included in our consolidated balance sheet. These amounts on any particular date can vary due to timing of cash receipts and remittance to HRIS users and payroll tax agencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-275">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-276">113</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="us-gaap:AssetsCurrent" scale="6" id="f-277">114</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="us-gaap:Assets" scale="6" id="f-278">114</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and other current liabilities</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="6" id="f-279">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued wages</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="us-gaap:AccruedSalariesCurrent" scale="6" id="f-280">15</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payroll tax liabilities and other payroll withholdings</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="tnet:AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" scale="6" id="f-281">98</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="us-gaap:LiabilitiesCurrent" scale="6" id="f-282">114</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-6" name="us-gaap:Liabilities" scale="6" id="f-283">114</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Use of Estimates</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-284" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect certain reported amounts and related disclosures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates are based on historical experience and on various other assumptions that we believe to be reasonable from the facts available to us. Some of the assumptions are highly uncertain at the time of estimation. To the extent actual experience differs from the assumptions used, our condensed consolidated financial statements could be materially affected.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Revenue Recognition </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-285" continuedAt="f-285-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Variable Consideration and Pricing Allocation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may offer credits to our clients considered to be variable consideration. Incentive credits related to contract renewals are recorded as a reduction to revenue as part of the transaction price at contract inception and are allocated among the performance obligations based on their relative standalone selling prices. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocate the total transaction price to each performance obligation based on the estimated relative standalone selling prices of the promised services underlying each performance obligation. The transaction price for the payroll and payroll tax processing performance obligations is determined upon establishment of the contract that contains the final terms of the arrangement, including the description and price of each service purchased. The estimated service fee is determined based on observable inputs and includes the following key assumptions: target profit margin, pricing strategies including the mix of services purchased and competitive factors, and client and industry specifics.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fees for access to health benefits and workers' compensation insurance performance obligations are determined during client on-boarding and annually through the enrollment processes based on the types of benefits coverage the WSEs have elected and the applicable risk profile of the client. We estimate our service fees based on actuarial forecasts of our expected insurance premiums and loss sensitive premium costs and amounts to cover our costs to administer these programs.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="f-269-3" continuedAt="f-269-4"><ix:continuation id="f-285-1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We require our clients to prefund payroll and related taxes and other withholding liabilities before payroll is processed or due for payment. Under the provision of our contracts with clients, we generally will process the payment of a client&#8217;s payroll only when the client successfully funds the amount required. As a result, there is no financing arrangement for the contracts. However, certain contracts to provide payroll and payroll tax processing services permit the client to pay certain payroll tax components ratably over periods of up to 12 months rather than as payroll tax is otherwise determined and due, which may be considered a significant financing arrangement under FASB ASC Topic 606 Revenue from Contracts with Customers. However, as the period between our performing the service under the contract and when the client pays for the service is less than one year, we have elected, as a practical expedient, not to adjust the transaction price.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In previous years, we created our Recovery Credits to assist in the economic recovery of our existing PEO clients and enhance our ability to retain these clients. These credits were based on the performance of our insurance costs and were recorded as a reduction to insurance services revenues and included in client deposits and other client liabilities on the balance sheets. <ix:nonNumeric contextRef="c-1" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="f-286" continuedAt="f-286-1" escape="true">The change in balance for the liability for credits previously accrued is the following:</ix:nonNumeric></span></div><ix:continuation id="f-286-1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="f-287">7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="f-288">75</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(+) Accruals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="tnet:RevenueRemainingPerformanceObligationProvision" format="ixt:fixed-zero" scale="6" id="f-289">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="tnet:RevenueRemainingPerformanceObligationProvision" format="ixt:fixed-zero" scale="6" id="f-290">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(-) Distributions to clients</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-291">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-292">8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at end of period</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:fixed-zero" scale="6" id="f-293">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-6" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="f-294">67</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Accrued Health Insurance Costs </span></div><ix:nonNumeric contextRef="c-1" name="tnet:AccruedHealthInsuranceCostsPolicyTextBlock" id="f-295" continuedAt="f-295-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sponsor and administer a number of employee benefit plans for our PEO WSEs, including group health, dental, and vision as an employer plan sponsor under section 3(5) of the ERISA. In the three months ended March&#160;31, 2024, the majority of our group health insurance costs were related to risk-based plans. Our remaining group health insurance costs were for guaranteed-cost policies. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued health insurance costs are established to provide for the estimated unpaid costs of reimbursing the carriers for paying claims within the deductible layer in accordance with risk-based health insurance policies. These accrued costs include estimates for claims incurred but not paid. We assess accrued health insurance costs regularly based upon actuarial studies that include other relevant factors such as current and historical claims payment patterns, plan enrollment and medical trend rates. </span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-295-1">In certain carrier contracts we are required to prepay our obligations for the expected claims activity for subsequent periods. These prepaid balances by agreement permit net settlement of obligations and offset the accrued health insurance costs.</ix:continuation> As of March&#160;31, 2024 and December&#160;31, 2023, prepayments and miscellaneous receivables offsetting accrued health insurance costs were $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:PrepaidInsurance" scale="6" id="f-296">65</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:PrepaidInsurance" scale="6" id="f-297">58</ix:nonFraction> million, respectively. When the prepaid amount is in excess of our recorded liability the net asset position is included in prepaid expenses. As of March&#160;31, 2024 and December&#160;31, 2023, accrued health insurance costs offsetting prepaid expenses were $<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-6" name="us-gaap:PrepaidInsurance" format="ixt:num-dot-decimal" scale="6" id="f-298">71</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-6" name="us-gaap:PrepaidInsurance" format="ixt:num-dot-decimal" scale="6" id="f-299">68</ix:nonFraction> million, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Restricted Cash, Cash Equivalents and Investments</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="f-300" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash, cash equivalents and investments presented on our consolidated balance sheets include:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cash and cash equivalents in Trust accounts functioning as security deposits for our insurance carriers, </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">payroll funds collected representing cash collected in advance from clients which we designate as restricted for the purpose of funding WSE and HRIS User payroll and payroll taxes and other payroll related liabilities, and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">amounts held in Trust for current and future premium and claim obligations with our insurance carriers, which amounts are held in Trust according to the terms of the relevant insurance policies and by the local insurance regulations of the jurisdictions in which the policies are in force.</span></div></ix:nonNumeric><div style="margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-301" continuedAt="f-301-1" escape="true"><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently issued accounting guidance</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="f-301-1"><ix:continuation id="f-269-4"><div style="margin-bottom:9pt;margin-top:10pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (&#8220;ASU 2023-09&#8221;), which will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. ASU 2023-09 will also require the Company to disaggregate its income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions. The ASU is effective for TriNet on a prospective basis for annual periods beginning after December 15, 2024. We are currently evaluating the provisions of this ASU.</span></div><div style="margin-bottom:9pt;margin-top:10pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (&#8220;ASU 2023-07&#8221;), which will require the Company to disclose segment expenses that are significant and regularly provided to the Company&#8217;s chief operating decision maker (&#8220;CODM&#8221;). In addition, ASU 2023-07 will require the Company to disclose the title and position of its CODM and how the CODM uses segment profit or loss information in assessing segment performance and deciding how to allocate resources. The ASU is effective for TriNet for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. We are currently evaluating the provisions of this ASU.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTE 2. <ix:nonNumeric contextRef="c-1" name="tnet:CashCashEquivalentsAndInvestmentsTextBlock" id="f-302" continuedAt="f-302-1" escape="true">CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED</ix:nonNumeric></span></div><ix:continuation id="f-302-1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the agreements with certain of our workers' compensation and health benefit insurance carriers, we are required to maintain collateral in Trust accounts for the benefit of specified insurance carriers and to reimburse the carriers&#8217; claim payments within our deductible layer. We invest a portion of the collateral amounts in marketable securities. We report the current and noncurrent portions of these Trust accounts as restricted cash, cash equivalents and investments on the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We require our clients to prefund their payroll and related taxes and other withholding liabilities before payroll is processed or due for payment. This prefund, for PEO customers, as well as amounts held by our statutory Trust for our HRIS Users, is included in restricted cash, cash equivalents and investments as payroll funds collected, which is designated to pay pending payrolls, payroll tax liabilities and other payroll withholdings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also invest available corporate funds, primarily in fixed income securities which meet the requirements of our corporate investment policy and are classified as AFS.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" id="f-303" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total cash, cash equivalents and investments are summarized below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.091%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Available-for-sale marketable securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Available-for-sale marketable securities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-304">298</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-305">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-306">298</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-307">287</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-308">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-309">287</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="6" id="f-310">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="f-311">85</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="f-312">85</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="6" id="f-313">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="f-314">65</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="f-315">65</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payroll funds collected</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-316">743</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:fixed-zero" scale="6" id="f-317">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-318">743</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-319">1,067</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:fixed-zero" scale="6" id="f-320">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-321">1,067</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral for health benefits claims</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-322">32</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-323">114</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-324">146</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-325">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-326">113</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-327">144</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral for workers' compensation claims</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-328">55</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:fixed-zero" scale="6" id="f-329">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-330">55</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-331">54</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-332">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-333">56</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trust for our HRIS Users</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-334">113</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:fixed-zero" scale="6" id="f-335">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-336">113</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:fixed-zero" scale="6" id="f-337">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:fixed-zero" scale="6" id="f-338">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:fixed-zero" scale="6" id="f-339">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other security deposits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-340">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:fixed-zero" scale="6" id="f-341">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-342">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-343">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:fixed-zero" scale="6" id="f-344">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-345">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total restricted cash, cash equivalents and investments</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-346">945</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-347">114</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-348">1,059</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-349">1,154</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" scale="6" id="f-350">115</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-351">1,269</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments, noncurrent</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="6" id="f-352">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" id="f-353">161</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" id="f-354">161</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:fixed-zero" scale="6" id="f-355">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" id="f-356">143</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" id="f-357">143</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments, noncurrent</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral for workers' compensation claims</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" scale="6" id="f-358">24</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" scale="6" id="f-359">128</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" scale="6" id="f-360">152</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" scale="6" id="f-361">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" scale="6" id="f-362">133</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-6" name="us-gaap:RestrictedCashAndInvestmentsNoncurrent" scale="6" id="f-363">158</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-6" name="us-gaap:RestrictedCashAndInvestments" format="ixt:num-dot-decimal" scale="6" id="f-364">1,267</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-6" name="us-gaap:RestrictedCashAndInvestments" scale="6" id="f-365">488</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:RestrictedCashAndInvestments" format="ixt:num-dot-decimal" scale="6" id="f-366">1,755</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-6" name="us-gaap:RestrictedCashAndInvestments" format="ixt:num-dot-decimal" scale="6" id="f-367">1,466</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-6" name="us-gaap:RestrictedCashAndInvestments" scale="6" id="f-368">456</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:RestrictedCashAndInvestments" format="ixt:num-dot-decimal" scale="6" id="f-369">1,922</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i433ef95683ef4fa7b54ae19a30089fe8_118"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTE 3. <ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="f-370" continuedAt="f-370-1" escape="true">INVESTMENTS</ix:nonNumeric></span></div><ix:continuation id="f-370-1" continuedAt="f-370-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="f-371" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our financial instruments by significant categories and fair value measurement on a recurring basis as of March&#160;31, 2024 and December&#160;31, 2023 and the amortized cost, gross unrealized gains, gross unrealized losses, fair value of our AFS investments: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Level</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Cash, Cash Equivalents and Investments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market mutual funds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-372">327</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-373">327</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-374">40</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-375">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-376">287</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-377">4</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-378">4</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-379">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-380">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-381">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-382">331</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-383">331</ix:nonFraction></span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-384">41</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-385">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-386">290</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AFS Investments:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-387">38</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-388">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="f-389">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-390">38</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-391">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-392">38</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-393">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-394">148</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-395">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="f-396">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-397">148</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-398">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-399">115</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-400">33</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agency securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-401">37</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-402">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-403">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-404">36</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-405">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-406">8</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-407">28</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-408">260</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-409">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-410">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-411">256</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-412">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-413">77</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-414">179</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of deposit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-415">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-416">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="f-417">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-418">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-419">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-420">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-421">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other debt securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-422">8</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-423">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="f-424">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-425">8</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-426">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-427">8</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-428">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total AFS Investments</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-429">493</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-430">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-431">5</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-432">488</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-433">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-434">246</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-435">242</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:20.715%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.856%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.470%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Level</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Cash, Cash Equivalents and Investments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market mutual funds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-436">183</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-437">183</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-438">96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-439">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-440">87</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-441">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-442">7</ix:nonFraction></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-443">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-444">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-445">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-446">190</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-447">190</ix:nonFraction></span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-448">101</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-449">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-6" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-450">89</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AFS Investments:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-451">41</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-452">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-453">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-454">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-455">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-456">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-457">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-458">135</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-459">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="f-460">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-461">136</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-462">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-463">103</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-464">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agency securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-465">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-466">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-467">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-468">39</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-469">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-470">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-471">29</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-472">231</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-473">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-474">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-475">231</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-476">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-477">47</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-478">184</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of deposit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-479">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-480">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="f-481">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-482">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-483">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-484">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-485">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other debt securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-486">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-487">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="f-488">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-489">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-490">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-491">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-492">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total AFS Investments</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-493">457</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-494">2</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-495">3</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-496">456</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-497">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-498">208</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-499">248</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="f-500" continuedAt="f-500-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use an independent pricing source to determine the fair value of our securities. The independent pricing source utilizes various pricing models for each asset class, including the market approach. The inputs and assumptions for the pricing models are market observable inputs including trades of comparable securities, dealer quotes, credit spreads, yield curves and other market-related data.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not adjusted the prices obtained from the independent pricing service and we believe the prices received from the independent pricing service are representative of the prices that would be received to sell the assets at the measurement date (exit price).</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="f-370-2"><ix:continuation id="f-500-1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Company's cash equivalents and restricted cash equivalents approximate their fair values due to their short-term maturities.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not have any Level 3 financial instruments recognized in our condensed consolidated balance sheets as of March&#160;31, 2024 and December&#160;31, 2023. There were no transfers between levels as of March&#160;31, 2024 and December&#160;31, 2023. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Sales and Maturities</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="f-501" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of debt investments by contractual maturity are shown below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:83.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.377%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.330%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">One year or less</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="f-502">113</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Over one year through five years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="f-503">347</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Over five years through ten years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="6" id="f-504">10</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Over ten years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="6" id="f-505">18</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" scale="6" id="f-506">488</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="f-507" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross proceeds from sales and maturities of AFS securities for the three months ended March&#160;31, 2024 and March&#160;31, 2023 are presented below. We had <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" format="ixt:fixed-zero" scale="0" id="f-508">immaterial</ix:nonFraction> gross realized gains and losses from sales of investments for the first quarter of 2024 and <ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" format="ixt:fixed-zero" scale="0" id="f-509">immaterial</ix:nonFraction> gross realized gains for the first quarter of 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross proceeds from sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="f-510">39</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="f-511">32</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross proceeds from maturities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="f-512">27</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="f-513">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" scale="6" id="f-514">66</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" scale="6" id="f-515">76</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Fair Value of Long-Term Debt</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our 2029 Notes and 2031 Notes was obtained from a third-party pricing service and is based on observable market inputs. As such, the fair value of the senior notes is considered Level 2 in the hierarchy for fair value measurement. As of March&#160;31, 2024, our 2029 Notes and 2031 Notes were carried at their cost, net of issuance costs, and had a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-6" name="us-gaap:NotesPayableFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-516">449</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-6" name="us-gaap:NotesPayableFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-517">411</ix:nonFraction> million, respectively. As of December&#160;31, 2023, our 2029 Notes and 2031 Notes were carried at their cost, net of issuance costs, and had a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-6" name="us-gaap:NotesPayableFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-518">443</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-6" name="us-gaap:NotesPayableFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-519">414</ix:nonFraction> million, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 2021 Revolver is a floating rate debt. At March&#160;31, 2024 and December&#160;31, 2023, the fair value of our 2021 Revolver approximated its carrying value (exclusive of issuance costs). The fair value of our floating rate debt is estimated based on a discounted cash flow, which incorporates credit spreads, market interest rates and contractual maturities to estimate the fair value and is considered Level 3 in the hierarchy for fair value measurement.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTE 4. <ix:nonNumeric contextRef="c-1" name="us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" id="f-520" continuedAt="f-520-1" escape="true">ACCRUED WORKERS' COMPENSATION COSTS</ix:nonNumeric></span></div><ix:continuation id="f-520-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="f-521" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the accrued workers&#8217; compensation cost activity for the three months ended March&#160;31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.036%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total accrued costs, beginning of period</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" scale="6" id="f-522">175</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" scale="6" id="f-523">189</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incurred</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" scale="6" id="f-524">16</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" scale="6" id="f-525">16</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="f-526">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="f-527">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="f-528">12</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" scale="6" id="f-529">10</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Paid</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="f-530">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" scale="6" id="f-531">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="6" id="f-532">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" scale="6" id="f-533">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" scale="6" id="f-534">12</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" scale="6" id="f-535">12</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, end of period</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" scale="6" id="f-536">175</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" scale="6" id="f-537">187</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes workers' compensation liabilities on the condensed consolidated balance sheets:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:75.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.613%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, end of period</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" scale="6" id="f-538">175</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" scale="6" id="f-539">175</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral paid to carriers and offset against accrued costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" scale="6" id="f-540">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" scale="6" id="f-541">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, net of carrier collateral offset</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent" scale="6" id="f-542">171</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent" scale="6" id="f-543">170</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payable in less than 1 year<br/>(net of collateral paid to carriers of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent" scale="6" id="f-544">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> and $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent" scale="6" id="f-545">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">at March&#160;31, 2024 and December&#160;31, 2023, respectively)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:WorkersCompensationLiabilityCurrent" scale="6" id="f-546">51</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:WorkersCompensationLiabilityCurrent" scale="6" id="f-547">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payable in more than 1 year <br/>(net of collateral paid to carriers of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent" scale="6" id="f-548">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> and  $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent" scale="6" id="f-549">4</ix:nonFraction> at March&#160;31, 2024 and December&#160;31, 2023, respectively)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:WorkersCompensationLiabilityNoncurrent" scale="6" id="f-550">120</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:WorkersCompensationLiabilityNoncurrent" scale="6" id="f-551">120</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, net of carrier collateral offset</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent" scale="6" id="f-552">171</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent" scale="6" id="f-553">170</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incurred claims related to prior years represent changes in estimates for ultimate losses on workers' compensation claims. For the three months ended March&#160;31, 2024, the favorable development is due to lower than expected reported claim frequency and severity for the more recent years.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2024 and December&#160;31, 2023, we had $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="tnet:CollateralHeldByInsuranceCarriers" format="ixt:num-dot-decimal" scale="6" id="f-554">31</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="tnet:CollateralHeldByInsuranceCarriers" format="ixt:num-dot-decimal" scale="6" id="f-555">32</ix:nonFraction>&#160;million of collateral held by insurance carriers of which $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" format="ixt:num-dot-decimal" scale="6" id="f-556">4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-6" name="tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" format="ixt:num-dot-decimal" scale="6" id="f-557">5</ix:nonFraction> million, respectively, was offset against accrued workers' compensation costs as the agreements permit and are net settled of insurance obligations against collateral held.</span></div></ix:continuation><div id="i433ef95683ef4fa7b54ae19a30089fe8_139"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTE 5. <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-558" continuedAt="f-558-1" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="f-558-1"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Contingencies </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are and, from time to time, have been and may in the future become involved in various litigation matters, legal proceedings, and claims arising in the ordinary course of our business, including disputes with our clients or various class action, collective action, representative action, and other proceedings arising from the nature of our co-employment relationship with our clients and WSEs in which we are named as a defendant. In addition, due to the nature of our co-employment relationship with our clients and WSEs, we could be subject to liability for federal and state law violations, even if we do not participate in such violations. While our agreements with our clients contain indemnification provisions related to the conduct of our clients, we may not be able to avail ourselves of such provisions in every instance. We have accrued our current best estimates of probable losses with respect to these matters, which are individually and in aggregate immaterial to our consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the outcome of the matters described above cannot be predicted with certainty, management currently does not believe that any such claims or proceedings will have a materially adverse effect on our consolidated financial position, results of operations, or cash flows. However, the unfavorable resolution of any particular matter or our reassessment of our exposure for any of the above matters based on additional information obtained in the future could have a material impact on our consolidated financial position, results of operations, or cash flows.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTE 6. <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-559" continuedAt="f-559-1" escape="true">STOCK BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="f-559-1"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Restricted Stock Units (RSUs)</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Time-based RSUs generally vest over a <ix:nonNumeric contextRef="c-144" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-560">four-year</ix:nonNumeric> term. Performance-based RSUs are subject to vesting requirements and are earned, in part, based on certain financial performance metrics as defined in the grant notice. Actual number of shares earned may range from <ix:nonFraction unitRef="number" contextRef="c-145" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="f-561">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-146" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="f-562">200</ix:nonFraction>% of the target award. Performance-based awards granted in 2024 and 2023 are earned based on a single-year performance period subject to subsequent multi-year time-based vesting with <ix:nonFraction unitRef="number" contextRef="c-147" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-563">50</ix:nonFraction>% of the shares earned vesting in <ix:nonNumeric contextRef="c-147" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-564">one year</ix:nonNumeric> after the performance period and the remaining shares in the year after. RSUs are generally forfeited if the participant terminates service prior to vesting.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="f-565" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize RSU activity for the three months ended March&#160;31, 2024:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Time-based RSUs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.174%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.030%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">of Shares</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Grant Date</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at December 31, 2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-148" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-566">1,229,202</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-148" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-567">80.88</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-144" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-568">488,872</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-144" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-569">125.52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-144" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-570">155,051</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-144" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-571">76.36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-144" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-572">18,289</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-144" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-573">83.55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at March 31, 2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-149" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-574">1,544,734</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-149" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-575">95.43</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance-based RSUs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:67.128%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.056%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Grant Date</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at December 31, 2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-150" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-576">223,011</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-150" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-577">81.08</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-151" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-578">129,631</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-151" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-579">125.65</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-151" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-580">5,067</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-151" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-581">92.53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-151" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-582">2,598</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-151" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-583">77.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at March 31, 2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-152" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-584">344,977</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-152" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-585">97.69</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Stock Based Compensation</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-586" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock based compensation expense for stock-based awards made to our employees pursuant to our equity plans were as follows:&#160;&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.309%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.696%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of providing services</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-587">4</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-588">3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-589">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-590">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-591">12</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-592">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Systems development and programming costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-593">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-594">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stock based compensation expense</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-595">20</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-596">11</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stock based compensation capitalized</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="6" id="f-597">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="6" id="f-598">1</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i433ef95683ef4fa7b54ae19a30089fe8_148"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTE 7. <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-600" continuedAt="f-600-1" escape="true">STOCKHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><ix:continuation id="f-600-1" continuedAt="f-600-2"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Common Stock</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" id="f-601" continuedAt="f-601-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the beginning and ending balances of our issued and outstanding common stock for the three months ended March&#160;31, 2024 and 2023:</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="f-600-2"><ix:continuation id="f-601-1"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.597%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares issued and outstanding, beginning balance</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-602"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-603">50,664,471</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-604"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-605">60,555,661</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock from vested restricted stock units</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-162" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-606">160,118</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-163" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-607">135,074</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock from exercise of stock options</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-164" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-608">5,708</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-165" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-609">39,791</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-610">197,872</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-611">1,157,871</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Awards effectively repurchased for required employee withholding taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-612">59,249</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-613">49,701</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares issued and outstanding, ending balance</span></div></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-614"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-615">50,573,176</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-616"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-617">59,522,954</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Stock Repurchases </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2024, there is $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="f-618">409</ix:nonFraction> million remaining in the total authorization of $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="f-619">2,715</ix:nonFraction>&#160;million of our ongoing stock repurchase program.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Dividends</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In February 2024, our board of directors authorized a dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-166" decimals="2" name="us-gaap:DividendsPayableAmountPerShare" scale="0" id="f-620">0.25</ix:nonFraction> per share for an aggregate amount of approximately $<ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-621">13</ix:nonFraction>&#160;million paid in April 2024.</span></div></ix:continuation><div id="i433ef95683ef4fa7b54ae19a30089fe8_151"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTE 8. <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-622" continuedAt="f-622-1" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="f-622-1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Our ETR was <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-623"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-624">27</ix:nonFraction></ix:nonFraction>% for the first quarter of 2024 and 2023. The increase in tax benefits related to stock-based compensation from the first quarter of 2023 was offset by an increase in non-deductible compensation in the first quarter of 2024. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are subject to tax in U.S. federal and various state and local jurisdictions, as well as Canada and India. We are open to federal and significant state income tax examinations for tax years 2018 and subsequent years.</span></div></ix:continuation><div id="i433ef95683ef4fa7b54ae19a30089fe8_154"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOTE 9. <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-625" continuedAt="f-625-1" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><ix:continuation id="f-625-1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic EPS is computed based on the weighted average shares of common stock outstanding during the period. Diluted EPS is computed based on those shares used in the basic EPS computation, plus potentially dilutive shares issuable under our equity-based compensation plans using the treasury stock method. Shares that are potentially anti-dilutive are excluded.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-626" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the computation of our basic and diluted EPS attributable to our common stock:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.158%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-627">91</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" scale="6" id="f-628">131</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-629">51</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-630">60</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic EPS</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-631">1.80</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-632">2.18</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="f-633">91</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="f-634">131</ix:nonFraction>&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-635">51</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-636">60</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of stock options and restricted stock units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="6" id="f-637">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="6" id="f-638">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-639">51</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-640">60</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-641">1.78</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-642">2.17</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common stock equivalents excluded from income per diluted share because of their anti-dilutive effect</span></div></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-643">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-644">2</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_160"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_163"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the information required in this section, refer to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_139">Note 5</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the condensed consolidated financial statements and related notes included in this Form 10-Q.</span></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_166"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risk Factors </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in our risk factors disclosed in Part 1, Item 1A, of our 2023 Form 10-K.</span></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_169"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(a) Sales of Unregistered Securities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(b) Use of Proceeds from Sales of Unregistered Securities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(c) Issuer Purchases of Equity Securities </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about our purchases of TriNet common stock during the quarter ended March&#160;31, 2024:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:31.790%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.616%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.832%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.616%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.832%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.832%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.783%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of<br/>Shares</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchased </span><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Price<br/>Paid Per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number of<br/>Shares<br/>Purchased as&#160;Part&#160;of&#160;Publicly<br/> Announced&#160;Plans </span><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate Dollar Value ($ millions)<br/>of&#160;Shares&#160;that&#160;May Yet&#160;be&#160;Purchased<br/>Under&#160;the&#160;Plans </span><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 1 - January 31, 2024</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,713&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115.61&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,464&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 1 - February 29, 2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143,018&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114.75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,530&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">414&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 1 - March 31, 2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,390&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128.04&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,878&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257,121&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">197,872&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) In May 2014, our board of directors approved a stock repurchase program pursuant to which we are authorized to repurchase our common stock in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934. From time to time, our board of directors authorizes increases to our stock repurchase program and approved an aggregate total of $2,715 million as of March&#160;31, 2024. The total remaining authorization for future stock repurchases under our stock repurchase program was $409 million as of March&#160;31, 2024. The program does not have an expiration date. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Includes shares surrendered by employees to us to satisfy tax withholding obligations that arose upon vesting of restricted stock units granted pursuant to approved plans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3) We repurchased a total of approximately $23&#160;million of our outstanding stock during the three months ended March&#160;31, 2024.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We use our stock repurchase program to return value to our stockholders and to offset dilution from the issuance of stock under our equity-based incentive plans and employee purchase plan. We plan to use current cash and cash generated from ongoing operating activities to fund our stock repurchase program.</span></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_172"></div><div style="margin-top:9pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Defaults Upon Senior Securities</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_175"></div><div style="margin-top:9pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Mine Safety Disclosures</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_178"></div><div style="margin-top:9pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-645"><ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-646"><ix:nonNumeric contextRef="c-1" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-647">Other Information</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-167" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-648" continuedAt="f-648-1" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On <ix:nonNumeric contextRef="c-167" name="ecd:TrdArrAdoptionDate" id="f-649">February 23, 2024</ix:nonNumeric>, <ix:nonNumeric contextRef="c-167" name="ecd:TrdArrIndName" id="f-650">Burton M. Goldfield</ix:nonNumeric>, a <ix:nonNumeric contextRef="c-167" name="ecd:TrdArrIndTitle" id="f-651">member of the Board of Directors</ix:nonNumeric>, <ix:nonNumeric contextRef="c-167" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-652">adopted</ix:nonNumeric> a new written trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (the &#8220;Goldfield Plan&#8221;). The first possible trade date under the Goldfield Plan is May 28, 2024, and the end date of the Goldfield Plan is February 28, 2025 (subject to customary exceptions), for a duration of approximately one year. The Goldfield Plan calls for the sale of an amount of shares that Mr. Goldfield could receive upon the future vesting of certain outstanding equity awards, net of any shares withheld by us to satisfy applicable taxes. The exact number of shares to be sold pursuant to the Goldfield Plan depends on the number of shares to be withheld by us on equity awards that will vest during the duration of the Goldfield Plan, among other factors. For purposes of this disclosure, without </span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INFORMATION</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="f-648-1"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subtracting any shares to be withheld upon future vesting events, the aggregate number of shares currently expected to be sold pursuant to the Goldfield Plan is <ix:nonFraction unitRef="shares" contextRef="c-168" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" id="f-653">74,379</ix:nonFraction>.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_184"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBITS</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibits</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incorporated herein by reference is a list of the exhibits contained in the Exhibit Index below.</span></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_187"></div><div style="-sec-extract:summary;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.118%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File No.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed Herewith</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/937098/000119312514126010/d705140dex31.htm">Amended and Restated Certificate of Incorporation of TriNet Group, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-36373</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5/30/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/937098/000119312514081006/d655973dex34.htm">Amended and Restated Bylaws of TriNet Group, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-36373</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3/27/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/937098/000093709817000007/ex41.htm">Registration Rights Agreement, by and between TriNet Group, Inc. and AGI-T, L.P., dated as of February 1, 2017.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-36373</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/2/2017</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/937098/000110465923092611/tm2323813d1_ex4-1.htm">Indenture, dated August 16, 2023, among the Company, the guarantors listed therein and U.S. Bank Trust Company, National Association, as trustee</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-36373</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/16/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/937098/000093709823000199/exhibit43.htm">First Supplemental Indenture, dated August 16, 2023, to the Indenture dated February 26, 2021, among the guarantors listed therein and U.S. Bank Trust Company, National Association as trustee</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-36373</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10/25/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/937098/000093709824000023/employmentagreementmsimonds.htm">Employment Agreement between TriNet Group, Inc. and Michael Q. Simonds, dated February 12, 2024</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-36373</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/937098/000093709824000023/transitionagreementbgoldfi.htm">Transition Agreement between TriNet Group, Inc. and Burton M. Goldfield, dated February 13, 2024</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">001-36373</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-033124xexhibit311.htm">Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-033124xexhibit312.htm">Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>32.1*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="tnet-033124xexhibit321.htm">Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>101.INS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>101.SCH</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>101.CAL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>101.DEF</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>101.LAB</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;<br/>101.PRE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded with the Inline XBRL document)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:4.024%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:77.525%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Document has been furnished, is deemed not filed and is not to be incorporated by reference into any of TriNet Group, Inc.&#8217;s filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, irrespective of any general incorporation language contained in any such filing.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div><div id="i433ef95683ef4fa7b54ae19a30089fe8_190"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.108%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#e37222;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SIGNATURES</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i433ef95683ef4fa7b54ae19a30089fe8_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:53.365%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.585%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.969%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRINET GROUP, INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: April 26, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Michael Q. Simonds</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael Q. Simonds</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: April 26, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Kelly Tuminelli</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kelly Tuminelli</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.283%"/><td style="width:0.1%"/></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRINET</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024 Q1 FORM 10-Q</span></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>tnet-033124xexhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i20f0d412237b480a9ae05166a29051b2_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Mike Q. Simonds, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">I have reviewed this quarterly report on Form&#160;10-Q of TriNet Group,&#160;Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer&#160;and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) &#160;&#160;&#160;&#160;evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer&#160;and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.035%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; April 26, 2024</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Mike Q. Simonds</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mike Q. Simonds</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>tnet-033124xexhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i2362947c63204d0c984d85b4295a1c08_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Kelly Tuminelli, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">I have reviewed this quarterly report on Form&#160;10-Q of TriNet Group,&#160;Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer&#160;and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) &#160;&#160;&#160;&#160;evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The registrant&#8217;s other certifying officer&#160;and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) &#160;&#160;&#160;&#160;any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.035%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; April 26, 2024</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.25pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Kelly Tuminelli</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kelly Tuminelli</font></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>tnet-033124xexhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i881af67fa40a40fb9d77ce5b26d8d188_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION&#160;906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of TriNet Group,&#160;Inc., a Delaware corporation (the &#8220;Company&#8221;), on Form&#160;10-Q for the period ending March&#160;31, 2024 as filed with the U.S. Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), each of the undersigned officers of the Company does hereby certify, pursuant to 18 U.S.C. &#167; 1350 (section 906 of the Sarbanes-Oxley Act of 2002), that&#58;</font></div><div style="margin-top:6pt;padding-left:33.75pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.28pt">The Report containing the financial statements fully complies with the requirements of section 13(a)&#160;or 15(d)&#160;of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d))&#59; and</font></div><div style="margin-top:6pt;padding-left:33.75pt;text-align:justify;text-indent:-31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.28pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing certification (i)&#160;is given to such officers&#8217; knowledge, based upon such officers&#8217; investigation as such officers reasonably deem appropriate&#59; and (ii)&#160;is being furnished solely pursuant to 18 U.S.C. &#167; 1350 (section 906 of the Sarbanes-Oxley Act of 2002) and is not being filed as part of the Report or as a separate disclosure document and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; April 26, 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Mike Q. Simonds</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mike Q. Simonds</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; April 26, 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:2.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Kelly Tuminelli</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kelly Tuminelli</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="margin-top:7pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>tnet-20240331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:e2176350-5298-4836-b62a-d8f4e61deac6,g:394f270b-efa4-4896-8b8e-6d4db102e2a9-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:tnet="http://www.trinet.com/20240331" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.trinet.com/20240331">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tnet-20240331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tnet-20240331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tnet-20240331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tnet-20240331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.trinet.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited" roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>0000007 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTED" roleURI="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTED">
        <link:definition>0000008 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTS" roleURI="http://www.trinet.com/role/INVESTMENTS">
        <link:definition>0000009 - Disclosure - INVESTMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDWORKERSCOMPENSATIONCOSTS" roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTS">
        <link:definition>0000010 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.trinet.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>0000011 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATION">
        <link:definition>0000012 - Disclosure - STOCK BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.trinet.com/role/STOCKHOLDERSEQUITY">
        <link:definition>0000013 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.trinet.com/role/INCOMETAXES">
        <link:definition>0000014 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://www.trinet.com/role/EARNINGSPERSHARE">
        <link:definition>0000015 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>9954471 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>9954472 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDTables" roleURI="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDTables">
        <link:definition>9954473 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSTables" roleURI="http://www.trinet.com/role/INVESTMENTSTables">
        <link:definition>9954474 - Disclosure - INVESTMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDWORKERSCOMPENSATIONCOSTSTables" roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSTables">
        <link:definition>9954475 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONTables" roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONTables">
        <link:definition>9954476 - Disclosure - STOCK BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYTables" roleURI="http://www.trinet.com/role/STOCKHOLDERSEQUITYTables">
        <link:definition>9954477 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://www.trinet.com/role/EARNINGSPERSHARETables">
        <link:definition>9954478 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails">
        <link:definition>9954479 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails" roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails">
        <link:definition>9954480 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Assets and Liabilities of the Trust (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofChangeinBalanceoftheRecoveryCreditUnsatisfiedPerformanceObligationDetails" roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofChangeinBalanceoftheRecoveryCreditUnsatisfiedPerformanceObligationDetails">
        <link:definition>9954481 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Change in Balance of the Recovery Credit Unsatisfied Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails" roleURI="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails">
        <link:definition>9954482 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails" roleURI="http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails">
        <link:definition>9954483 - Disclosure - INVESTMENTS - Schedule of Financial Instruments by Significant Categories and Fair Value Measurement on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails" roleURI="http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails">
        <link:definition>9954484 - Disclosure - INVESTMENTS - Schedule of Fair value of Debt Investments by Contractual Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSAdditionalInformationDetails" roleURI="http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails">
        <link:definition>9954485 - Disclosure - INVESTMENTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails" roleURI="http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails">
        <link:definition>9954486 - Disclosure - INVESTMENTS - Schedule of Available-for-Sale Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails" roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails">
        <link:definition>9954487 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Loss Reserve Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails" roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails">
        <link:definition>9954488 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails_1" roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails_1">
        <link:definition>9954488 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDWORKERSCOMPENSATIONCOSTSAdditionalInformationDetails" roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSAdditionalInformationDetails">
        <link:definition>9954489 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONAdditionalInformationDetails" roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails">
        <link:definition>9954490 - Disclosure - STOCK BASED COMPENSATION - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails" roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails">
        <link:definition>9954491 - Disclosure - STOCK BASED COMPENSATION - Schedule of RSU and RSA Activity under Equity-Based Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails">
        <link:definition>9954492 - Disclosure - STOCK BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYScheduleofCommonStockDetails" roleURI="http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails">
        <link:definition>9954493 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYAdditionalInformationDetails" roleURI="http://www.trinet.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails">
        <link:definition>9954494 - Disclosure - STOCKHOLDERS' EQUITY - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.trinet.com/role/INCOMETAXESDetails">
        <link:definition>9954495 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails" roleURI="http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails">
        <link:definition>9954496 - Disclosure - EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted EPS Attributable to Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="tnet_CollateralbyTypeAxis" abstract="true" name="CollateralbyTypeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent" abstract="false" name="CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_WorkersCompensationClaimsCollateralMember" abstract="true" name="WorkersCompensationClaimsCollateralMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_BurtonMGoldfieldMember" abstract="true" name="BurtonMGoldfieldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="tnet_UnsatisfiedPerformanceObligationRollForward" abstract="true" name="UnsatisfiedPerformanceObligationRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="tnet_OtherPayrollAssetsCurrent" abstract="false" name="OtherPayrollAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent" abstract="false" name="CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_AvailableForSaleMarketableSecuritiesMember" abstract="true" name="AvailableForSaleMarketableSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_TimeBasedRestrictedStockUnitsMember" abstract="true" name="TimeBasedRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_IncreaseDecreaseInOtherPayrollAssets" abstract="false" name="IncreaseDecreaseInOtherPayrollAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_AccruedHealthInsuranceCostsPolicyTextBlock" abstract="false" name="AccruedHealthInsuranceCostsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="tnet_HealthBenefitClaimsCollateralMember" abstract="true" name="HealthBenefitClaimsCollateralMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_RevenueRemainingPerformanceObligationProvision" abstract="false" name="RevenueRemainingPerformanceObligationProvision" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember" abstract="true" name="RestrictedCashAndCashEquivalentsAndInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_TrustForOurHRISUsersCollateralMember" abstract="true" name="TrustForOurHRISUsersCollateralMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="tnet_CollateralByTypeDomain" abstract="true" name="CollateralByTypeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember" abstract="true" name="PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_InsuranceCarriersSecurityDepositsMember" abstract="true" name="InsuranceCarriersSecurityDepositsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_PayrollFundsCollectedMember" abstract="true" name="PayrollFundsCollectedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_A2029NotesPayableMember" abstract="true" name="A2029NotesPayableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" abstract="false" name="LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent" abstract="false" name="CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_InsuranceServicesMember" abstract="true" name="InsuranceServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" abstract="false" name="AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_A2031NotesPayableMember" abstract="true" name="A2031NotesPayableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="tnet_InsurancePremiumsAndOtherPayables" abstract="false" name="InsurancePremiumsAndOtherPayables" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_CollateralHeldByInsuranceCarriers" abstract="false" name="CollateralHeldByInsuranceCarriers" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_CashCashEquivalentsAndInvestmentsTextBlock" abstract="false" name="CashCashEquivalentsAndInvestmentsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="tnet_SystemsDevelopmentAndProgrammingCostsMember" abstract="true" name="SystemsDevelopmentAndProgrammingCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction" abstract="false" name="CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_IncreaseDecreaseInOperatingLeaseLiabilities" abstract="false" name="IncreaseDecreaseInOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_PerformanceBasedRestrictedStockUnitsMember" abstract="true" name="PerformanceBasedRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="tnet_InterestExpenseBankFeesAndOther" abstract="false" name="InterestExpenseBankFeesAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="tnet_ProfessionalServicesMember" abstract="true" name="ProfessionalServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>tnet-20240331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:e2176350-5298-4836-b62a-d8f4e61deac6,g:394f270b-efa4-4896-8b8e-6d4db102e2a9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="simple" xlink:href="tnet-20240331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_fa46854f-0373-480b-a801-387f986458f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ebc9b003-1d9f-4f1f-bf1e-30ca72d5ddba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_fa46854f-0373-480b-a801-387f986458f4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ebc9b003-1d9f-4f1f-bf1e-30ca72d5ddba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_294912b9-b76c-4d54-b6c3-31f59560273d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_fa46854f-0373-480b-a801-387f986458f4" xlink:to="loc_us-gaap_CostsAndExpenses_294912b9-b76c-4d54-b6c3-31f59560273d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f3e3e6f9-7c72-4452-8eae-e4bd06bbffc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d2e78308-0de8-4780-b1a8-6123144ade32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f3e3e6f9-7c72-4452-8eae-e4bd06bbffc5" xlink:to="loc_us-gaap_OperatingIncomeLoss_d2e78308-0de8-4780-b1a8-6123144ade32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InterestExpenseBankFeesAndOther_2e73b3aa-e8ae-4648-8aef-baca31754fd1" xlink:href="tnet-20240331.xsd#tnet_InterestExpenseBankFeesAndOther"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f3e3e6f9-7c72-4452-8eae-e4bd06bbffc5" xlink:to="loc_tnet_InterestExpenseBankFeesAndOther_2e73b3aa-e8ae-4648-8aef-baca31754fd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther_00d9e2fe-a9ab-4939-bc17-b9a3fe814231" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_f3e3e6f9-7c72-4452-8eae-e4bd06bbffc5" xlink:to="loc_us-gaap_InterestIncomeOther_00d9e2fe-a9ab-4939-bc17-b9a3fe814231" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ee2c1c31-ed49-4315-8f96-f87a04214325" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fec0d27c-1ad5-46eb-82a6-a93465175ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ee2c1c31-ed49-4315-8f96-f87a04214325" xlink:to="loc_us-gaap_NetIncomeLoss_fec0d27c-1ad5-46eb-82a6-a93465175ba0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_42169f75-2b02-4cb4-bfb0-3f1413623204" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ee2c1c31-ed49-4315-8f96-f87a04214325" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_42169f75-2b02-4cb4-bfb0-3f1413623204" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_96d9919c-a9f2-4d7e-b1be-0b2da784f5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingInsuranceAndClaimsCostsProduction_eea717ae-2182-465f-82fb-5d4705872b22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingInsuranceAndClaimsCostsProduction"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_96d9919c-a9f2-4d7e-b1be-0b2da784f5e9" xlink:to="loc_us-gaap_OperatingInsuranceAndClaimsCostsProduction_eea717ae-2182-465f-82fb-5d4705872b22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction_7bd0ba62-6aaa-45ce-824b-6a7cf2ac1040" xlink:href="tnet-20240331.xsd#tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_96d9919c-a9f2-4d7e-b1be-0b2da784f5e9" xlink:to="loc_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction_7bd0ba62-6aaa-45ce-824b-6a7cf2ac1040" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_e892eb49-eb51-4ba3-94cf-9ccb846f9bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_96d9919c-a9f2-4d7e-b1be-0b2da784f5e9" xlink:to="loc_us-gaap_SellingAndMarketingExpense_e892eb49-eb51-4ba3-94cf-9ccb846f9bdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_f46bc9dd-0005-4fc6-948a-9a711625b82d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_96d9919c-a9f2-4d7e-b1be-0b2da784f5e9" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_f46bc9dd-0005-4fc6-948a-9a711625b82d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_4256a44e-7a23-4d5b-98cc-43bc9754dca8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_96d9919c-a9f2-4d7e-b1be-0b2da784f5e9" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_4256a44e-7a23-4d5b-98cc-43bc9754dca8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_39160ec7-775d-4d3e-b61e-1251970d53bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_96d9919c-a9f2-4d7e-b1be-0b2da784f5e9" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_39160ec7-775d-4d3e-b61e-1251970d53bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d453bcf6-c59f-4b23-ac68-787b6bcf5b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_73698140-af79-42c2-869b-57d3b680e3ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_d453bcf6-c59f-4b23-ac68-787b6bcf5b2e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_73698140-af79-42c2-869b-57d3b680e3ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2b9e0bab-0cba-44d4-ac0f-d4efd441c48c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_d453bcf6-c59f-4b23-ac68-787b6bcf5b2e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2b9e0bab-0cba-44d4-ac0f-d4efd441c48c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="tnet-20240331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_230dcae2-8609-4b54-9935-e4c1525ef052" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_3e8fb931-de8e-4c0d-8565-0149ac0277da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_230dcae2-8609-4b54-9935-e4c1525ef052" xlink:to="loc_us-gaap_PreferredStockValue_3e8fb931-de8e-4c0d-8565-0149ac0277da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_fa1c623f-aadc-4d74-9bab-09be3c1ea481" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_230dcae2-8609-4b54-9935-e4c1525ef052" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_fa1c623f-aadc-4d74-9bab-09be3c1ea481" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fa37f0bb-ab51-4823-9a53-491cd2bb1dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_230dcae2-8609-4b54-9935-e4c1525ef052" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fa37f0bb-ab51-4823-9a53-491cd2bb1dd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_516c1425-ddb1-4759-9f95-961526eafe18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_230dcae2-8609-4b54-9935-e4c1525ef052" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_516c1425-ddb1-4759-9f95-961526eafe18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e2bb21a0-c8a7-4c51-b8a1-2484f8915dda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_9241a90d-1b7c-43d6-9a49-cdbda782de52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e2bb21a0-c8a7-4c51-b8a1-2484f8915dda" xlink:to="loc_us-gaap_AssetsCurrent_9241a90d-1b7c-43d6-9a49-cdbda782de52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_ed2c56e7-0778-4d6f-8070-f7a6c9a6abf8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e2bb21a0-c8a7-4c51-b8a1-2484f8915dda" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_ed2c56e7-0778-4d6f-8070-f7a6c9a6abf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndOtherNoncurrentAssets_1cb41a95-983d-4561-8720-e26254731381" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAndOtherNoncurrentAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e2bb21a0-c8a7-4c51-b8a1-2484f8915dda" xlink:to="loc_us-gaap_InvestmentsAndOtherNoncurrentAssets_1cb41a95-983d-4561-8720-e26254731381" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4ae8fbad-82b5-4ff5-920c-c30298a6fdaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e2bb21a0-c8a7-4c51-b8a1-2484f8915dda" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4ae8fbad-82b5-4ff5-920c-c30298a6fdaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_47e99a31-4c07-4e02-911f-cf343b09611c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e2bb21a0-c8a7-4c51-b8a1-2484f8915dda" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_47e99a31-4c07-4e02-911f-cf343b09611c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b616ec30-c9e6-4540-8574-13c078a60993" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e2bb21a0-c8a7-4c51-b8a1-2484f8915dda" xlink:to="loc_us-gaap_Goodwill_b616ec30-c9e6-4540-8574-13c078a60993" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_25031571-7807-419c-b19c-2bbc4b205fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e2bb21a0-c8a7-4c51-b8a1-2484f8915dda" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_25031571-7807-419c-b19c-2bbc4b205fdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_edbead94-0add-4190-95fc-6eeb703ab0b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e2bb21a0-c8a7-4c51-b8a1-2484f8915dda" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_edbead94-0add-4190-95fc-6eeb703ab0b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1d6d4793-c30a-4a18-9ce1-584ce5468e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f32329e8-91fd-4aea-8687-74b84122108d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d6d4793-c30a-4a18-9ce1-584ce5468e5e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f32329e8-91fd-4aea-8687-74b84122108d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_048f9854-cc01-4c5c-b4ab-87220e543bb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d6d4793-c30a-4a18-9ce1-584ce5468e5e" xlink:to="loc_us-gaap_ShortTermInvestments_048f9854-cc01-4c5c-b4ab-87220e543bb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_52da7d44-d748-4b46-88d5-f8ec7b817ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d6d4793-c30a-4a18-9ce1-584ce5468e5e" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_52da7d44-d748-4b46-88d5-f8ec7b817ed9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_bb3efab5-9e73-42d2-83e9-0f4ee254f63b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d6d4793-c30a-4a18-9ce1-584ce5468e5e" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_bb3efab5-9e73-42d2-83e9-0f4ee254f63b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_8b5aa336-5a6e-47f4-887d-cc515e2e4a31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d6d4793-c30a-4a18-9ce1-584ce5468e5e" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_8b5aa336-5a6e-47f4-887d-cc515e2e4a31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_ff17bac7-88cf-4e83-a575-af09fe232db0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d6d4793-c30a-4a18-9ce1-584ce5468e5e" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_ff17bac7-88cf-4e83-a575-af09fe232db0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_OtherPayrollAssetsCurrent_8aba6150-0bec-428e-919a-8c1198dabc8d" xlink:href="tnet-20240331.xsd#tnet_OtherPayrollAssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d6d4793-c30a-4a18-9ce1-584ce5468e5e" xlink:to="loc_tnet_OtherPayrollAssetsCurrent_8aba6150-0bec-428e-919a-8c1198dabc8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_2c3922a3-051d-4c9b-96f9-eac98bc290db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_1d6d4793-c30a-4a18-9ce1-584ce5468e5e" xlink:to="loc_us-gaap_OtherAssetsCurrent_2c3922a3-051d-4c9b-96f9-eac98bc290db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_98dd38a8-3765-477c-9ab2-9227c76df1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_af4b5b29-4f3c-4324-946c-8fd8df8d71f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_98dd38a8-3765-477c-9ab2-9227c76df1e7" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_af4b5b29-4f3c-4324-946c-8fd8df8d71f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_0a547413-1c35-41d7-a6cf-e590066c91ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_98dd38a8-3765-477c-9ab2-9227c76df1e7" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_0a547413-1c35-41d7-a6cf-e590066c91ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_d4a7b8b0-6e3b-41b3-b334-15e9b3f55c12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_98dd38a8-3765-477c-9ab2-9227c76df1e7" xlink:to="loc_us-gaap_AccruedSalariesCurrent_d4a7b8b0-6e3b-41b3-b334-15e9b3f55c12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent_1b60ee6f-86ee-4537-a352-93c419482a8d" xlink:href="tnet-20240331.xsd#tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_98dd38a8-3765-477c-9ab2-9227c76df1e7" xlink:to="loc_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent_1b60ee6f-86ee-4537-a352-93c419482a8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_00a43e46-d3e8-491c-8f07-98a813931308" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_98dd38a8-3765-477c-9ab2-9227c76df1e7" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_00a43e46-d3e8-491c-8f07-98a813931308" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_41185e0b-4012-402a-b63a-41c17932f9d3" xlink:href="tnet-20240331.xsd#tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_98dd38a8-3765-477c-9ab2-9227c76df1e7" xlink:to="loc_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_41185e0b-4012-402a-b63a-41c17932f9d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_b6445d7b-9ae1-4653-a687-31ebe4fe2d19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_98dd38a8-3765-477c-9ab2-9227c76df1e7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_b6445d7b-9ae1-4653-a687-31ebe4fe2d19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InsurancePremiumsAndOtherPayables_dc1bb387-968f-4036-ac9a-250715209edf" xlink:href="tnet-20240331.xsd#tnet_InsurancePremiumsAndOtherPayables"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_98dd38a8-3765-477c-9ab2-9227c76df1e7" xlink:to="loc_tnet_InsurancePremiumsAndOtherPayables_dc1bb387-968f-4036-ac9a-250715209edf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_674d87be-e96e-4011-96ab-da44b588c6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_98dd38a8-3765-477c-9ab2-9227c76df1e7" xlink:to="loc_us-gaap_LinesOfCreditCurrent_674d87be-e96e-4011-96ab-da44b588c6b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ae1db710-3409-4581-b6e9-0f625d3d3a43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ef582722-84bc-4f26-945f-e1a74c07120f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ae1db710-3409-4581-b6e9-0f625d3d3a43" xlink:to="loc_us-gaap_LiabilitiesCurrent_ef582722-84bc-4f26-945f-e1a74c07120f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c7d2ce8e-4113-486c-8c4c-4fddaac57630" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ae1db710-3409-4581-b6e9-0f625d3d3a43" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c7d2ce8e-4113-486c-8c4c-4fddaac57630" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_ff78b19b-fcc3-4344-93ae-4aaf82fa7fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ae1db710-3409-4581-b6e9-0f625d3d3a43" xlink:to="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_ff78b19b-fcc3-4344-93ae-4aaf82fa7fa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_6451e8ec-8d0a-49a9-922f-229b41bc7717" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ae1db710-3409-4581-b6e9-0f625d3d3a43" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_6451e8ec-8d0a-49a9-922f-229b41bc7717" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7b618885-020c-4f8a-8ed8-9f694b679936" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ae1db710-3409-4581-b6e9-0f625d3d3a43" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7b618885-020c-4f8a-8ed8-9f694b679936" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_fceef795-7083-48e6-8e16-4391696e9c47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ae1db710-3409-4581-b6e9-0f625d3d3a43" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_fceef795-7083-48e6-8e16-4391696e9c47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b7c148ab-0e66-409a-bdca-a2a8ee022688" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_df5b00c0-6adb-4dfc-9fdf-91facea262ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b7c148ab-0e66-409a-bdca-a2a8ee022688" xlink:to="loc_us-gaap_Liabilities_df5b00c0-6adb-4dfc-9fdf-91facea262ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d2d3ccc3-c536-4fa2-b004-84df586f34e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b7c148ab-0e66-409a-bdca-a2a8ee022688" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d2d3ccc3-c536-4fa2-b004-84df586f34e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_35af05ad-dc99-405a-9f09-3fd7e99d8311" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b7c148ab-0e66-409a-bdca-a2a8ee022688" xlink:to="loc_us-gaap_StockholdersEquity_35af05ad-dc99-405a-9f09-3fd7e99d8311" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="tnet-20240331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_45a4c590-db29-4efd-8bf8-574302c81c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1a274d43-50fd-4c7e-a729-008df9b442e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_45a4c590-db29-4efd-8bf8-574302c81c4e" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_1a274d43-50fd-4c7e-a729-008df9b442e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c323ae58-0dab-4cb3-90cf-3eee2c740de4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_45a4c590-db29-4efd-8bf8-574302c81c4e" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c323ae58-0dab-4cb3-90cf-3eee2c740de4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_6a31b21f-ee09-44c3-86ab-b8c1f72d9f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_45a4c590-db29-4efd-8bf8-574302c81c4e" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_6a31b21f-ee09-44c3-86ab-b8c1f72d9f8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_1a28b3fd-f677-4974-a8be-50ddc07b8660" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_45a4c590-db29-4efd-8bf8-574302c81c4e" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_1a28b3fd-f677-4974-a8be-50ddc07b8660" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7119d893-12e1-4d8f-9fb6-eb0313dc57ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_913f74cb-e521-4efe-9fe1-ec271f729b45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7119d893-12e1-4d8f-9fb6-eb0313dc57ad" xlink:to="loc_us-gaap_NetIncomeLoss_913f74cb-e521-4efe-9fe1-ec271f729b45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_591492c6-6bb5-4c55-ad65-40c17d5fd19c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7119d893-12e1-4d8f-9fb6-eb0313dc57ad" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_591492c6-6bb5-4c55-ad65-40c17d5fd19c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_ab39d188-02c9-4883-b99a-9e58dfdaceb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7119d893-12e1-4d8f-9fb6-eb0313dc57ad" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_ab39d188-02c9-4883-b99a-9e58dfdaceb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_f9a86436-2eb5-4db3-bedf-f12233e8c65c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7119d893-12e1-4d8f-9fb6-eb0313dc57ad" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_f9a86436-2eb5-4db3-bedf-f12233e8c65c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_8dbbfa56-a208-4260-b7a2-47a8cbe45a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7119d893-12e1-4d8f-9fb6-eb0313dc57ad" xlink:to="loc_us-gaap_ShareBasedCompensation_8dbbfa56-a208-4260-b7a2-47a8cbe45a2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_5324f29a-3eef-46f0-85b7-fd70b839b1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7119d893-12e1-4d8f-9fb6-eb0313dc57ad" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_5324f29a-3eef-46f0-85b7-fd70b839b1e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_12086626-f218-4c6c-bbac-6a5f8f08cfd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7119d893-12e1-4d8f-9fb6-eb0313dc57ad" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_12086626-f218-4c6c-bbac-6a5f8f08cfd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_761c36e2-26fc-4dac-a830-1aac668916c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7119d893-12e1-4d8f-9fb6-eb0313dc57ad" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_761c36e2-26fc-4dac-a830-1aac668916c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_b2a505c4-aba6-49c4-b95c-d7ab4cf23587" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7119d893-12e1-4d8f-9fb6-eb0313dc57ad" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_b2a505c4-aba6-49c4-b95c-d7ab4cf23587" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_35416a21-3b31-414f-8e4e-6c26d521a31f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7119d893-12e1-4d8f-9fb6-eb0313dc57ad" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_35416a21-3b31-414f-8e4e-6c26d521a31f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_IncreaseDecreaseInOtherPayrollAssets_5c059e6c-a491-40f1-b648-00b3e4ed4068" xlink:href="tnet-20240331.xsd#tnet_IncreaseDecreaseInOtherPayrollAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7119d893-12e1-4d8f-9fb6-eb0313dc57ad" xlink:to="loc_tnet_IncreaseDecreaseInOtherPayrollAssets_5c059e6c-a491-40f1-b648-00b3e4ed4068" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_c06ca053-a66d-417e-9e30-33efe8299e49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7119d893-12e1-4d8f-9fb6-eb0313dc57ad" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_c06ca053-a66d-417e-9e30-33efe8299e49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4aefbee2-cbb0-4fb6-b442-e16b22532907" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7119d893-12e1-4d8f-9fb6-eb0313dc57ad" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4aefbee2-cbb0-4fb6-b442-e16b22532907" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedSalaries_7bb516f7-710d-441e-a382-50a5afd499de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedSalaries"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7119d893-12e1-4d8f-9fb6-eb0313dc57ad" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedSalaries_7bb516f7-710d-441e-a382-50a5afd499de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_d46e6d84-c547-44ab-bb1a-0fb197b6e6df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7119d893-12e1-4d8f-9fb6-eb0313dc57ad" xlink:to="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_d46e6d84-c547-44ab-bb1a-0fb197b6e6df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities_ed683281-1321-4ee6-b03e-6d09e14a5a93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7119d893-12e1-4d8f-9fb6-eb0313dc57ad" xlink:to="loc_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities_ed683281-1321-4ee6-b03e-6d09e14a5a93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities_937b6080-374f-4898-9a77-64124149d493" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7119d893-12e1-4d8f-9fb6-eb0313dc57ad" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities_937b6080-374f-4898-9a77-64124149d493" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_IncreaseDecreaseInOperatingLeaseLiabilities_2b33b61b-5b40-493e-8f6c-f003c6e22522" xlink:href="tnet-20240331.xsd#tnet_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7119d893-12e1-4d8f-9fb6-eb0313dc57ad" xlink:to="loc_tnet_IncreaseDecreaseInOperatingLeaseLiabilities_2b33b61b-5b40-493e-8f6c-f003c6e22522" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3aa53380-47d4-49fa-b838-d0ba47cdd706" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_32016cdb-17e5-4905-9d47-bacce591d722" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3aa53380-47d4-49fa-b838-d0ba47cdd706" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_32016cdb-17e5-4905-9d47-bacce591d722" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_32716163-a195-46f8-9655-1eb803fa4a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3aa53380-47d4-49fa-b838-d0ba47cdd706" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_32716163-a195-46f8-9655-1eb803fa4a1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9cbac6da-24b9-4e2b-95ea-8c33fcced44e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3aa53380-47d4-49fa-b838-d0ba47cdd706" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9cbac6da-24b9-4e2b-95ea-8c33fcced44e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_107c0565-5fc4-41f8-be47-293c195f07d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_9ff5d8e9-de61-4e55-9042-8564efb3c76c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_107c0565-5fc4-41f8-be47-293c195f07d0" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_9ff5d8e9-de61-4e55-9042-8564efb3c76c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_3dc81200-8c28-4a91-9a1d-e6011e099699" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_107c0565-5fc4-41f8-be47-293c195f07d0" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_3dc81200-8c28-4a91-9a1d-e6011e099699" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5bbcecf9-24d9-4b77-8752-7749e5ad0af4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_107c0565-5fc4-41f8-be47-293c195f07d0" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5bbcecf9-24d9-4b77-8752-7749e5ad0af4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestments_b7c80773-049d-4e7e-a290-d3ae22461b06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_68e10708-4bd6-4bb8-b8e6-e790ebfe4eab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestrictedCashAndInvestments_b7c80773-049d-4e7e-a290-d3ae22461b06" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_68e10708-4bd6-4bb8-b8e6-e790ebfe4eab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_78f327d7-c76a-4cf1-ba6a-c71f003e8fd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestrictedCashAndInvestments_b7c80773-049d-4e7e-a290-d3ae22461b06" xlink:to="loc_us-gaap_ShortTermInvestments_78f327d7-c76a-4cf1-ba6a-c71f003e8fd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_e3273c7a-c73b-4c48-8a6d-8a82844088c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestrictedCashAndInvestments_b7c80773-049d-4e7e-a290-d3ae22461b06" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_e3273c7a-c73b-4c48-8a6d-8a82844088c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_9e4b9865-ebee-4b6e-8fc9-fd5fbdd38252" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestrictedCashAndInvestments_b7c80773-049d-4e7e-a290-d3ae22461b06" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_9e4b9865-ebee-4b6e-8fc9-fd5fbdd38252" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_baabeb42-a61c-4537-9845-3790dab8b433" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestrictedCashAndInvestments_b7c80773-049d-4e7e-a290-d3ae22461b06" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_baabeb42-a61c-4537-9845-3790dab8b433" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_38402813-ccc7-4aee-ad44-1eef9f3b9f34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7b12f735-9e7c-4a53-871f-3d677953925d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_38402813-ccc7-4aee-ad44-1eef9f3b9f34" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7b12f735-9e7c-4a53-871f-3d677953925d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_2bf86717-b146-4b98-b8da-e1fe688f50fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_38402813-ccc7-4aee-ad44-1eef9f3b9f34" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_2bf86717-b146-4b98-b8da-e1fe688f50fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5d0caf34-e6bf-4599-ac23-1aa3eda19466" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_38402813-ccc7-4aee-ad44-1eef9f3b9f34" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5d0caf34-e6bf-4599-ac23-1aa3eda19466" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_498b1acc-9e2e-4a5a-bb27-306b1b37aadd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_659943d9-5304-4fae-bd6a-33d89d4759fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_498b1acc-9e2e-4a5a-bb27-306b1b37aadd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_659943d9-5304-4fae-bd6a-33d89d4759fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_a7f3d2d1-2514-465a-86b1-c664ab53c62f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_498b1acc-9e2e-4a5a-bb27-306b1b37aadd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_a7f3d2d1-2514-465a-86b1-c664ab53c62f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_d5ca51cd-863b-47f1-845f-008a2a16ccc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_498b1acc-9e2e-4a5a-bb27-306b1b37aadd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_d5ca51cd-863b-47f1-845f-008a2a16ccc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_ec1d24c5-8293-472b-976b-b2a39ec21300" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_498b1acc-9e2e-4a5a-bb27-306b1b37aadd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_ec1d24c5-8293-472b-976b-b2a39ec21300" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_57de4148-ef18-4069-87ba-259476586165" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_fbd390f9-eb45-4e9f-a3cc-92d6b6874577" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_57de4148-ef18-4069-87ba-259476586165" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_fbd390f9-eb45-4e9f-a3cc-92d6b6874577" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_86d06d8e-0434-45d0-8b0e-3c7ecd40ec41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_57de4148-ef18-4069-87ba-259476586165" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_86d06d8e-0434-45d0-8b0e-3c7ecd40ec41" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_542ef428-6bed-4a47-b632-22d16a5973cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_2937f83d-d29d-477b-8acc-e67b45955ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_542ef428-6bed-4a47-b632-22d16a5973cc" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_2937f83d-d29d-477b-8acc-e67b45955ca0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_969a3cc8-7e6b-4377-a0e9-7f21ccd7ce0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_542ef428-6bed-4a47-b632-22d16a5973cc" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_969a3cc8-7e6b-4377-a0e9-7f21ccd7ce0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_8985f379-d787-4210-a391-acf45025fc82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_e70a7dad-4d69-4c28-b6ae-546b9ac62811" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_8985f379-d787-4210-a391-acf45025fc82" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_e70a7dad-4d69-4c28-b6ae-546b9ac62811" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_517c8f35-bc60-4c49-bf61-f4208cc378b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_8985f379-d787-4210-a391-acf45025fc82" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_517c8f35-bc60-4c49-bf61-f4208cc378b3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_08261596-4f29-40bf-ad32-858bf3fb16f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_31d9345f-020d-48a3-9ec9-7ab51f98b411" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_08261596-4f29-40bf-ad32-858bf3fb16f6" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_31d9345f-020d-48a3-9ec9-7ab51f98b411" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral_92034793-5d82-4b05-b173-0ba24aeb1c7b" xlink:href="tnet-20240331.xsd#tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_08261596-4f29-40bf-ad32-858bf3fb16f6" xlink:to="loc_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral_92034793-5d82-4b05-b173-0ba24aeb1c7b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails_1" xlink:type="simple" xlink:href="tnet-20240331.xsd#ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_03d76240-a77a-405d-8bff-7d8e4afdb7e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_47f234a1-ccdc-49ea-8e96-62a9360b417a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_03d76240-a77a-405d-8bff-7d8e4afdb7e7" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_47f234a1-ccdc-49ea-8e96-62a9360b417a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_6bd09b88-5825-4532-b38c-f33783217f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_03d76240-a77a-405d-8bff-7d8e4afdb7e7" xlink:to="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_6bd09b88-5825-4532-b38c-f33783217f9f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails"/>
  <link:calculationLink xlink:role="http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_36e8f6b2-f9d9-4036-99dc-20734b12b0cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3598c4cf-88d4-4a26-b549-726e2aba5b64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_36e8f6b2-f9d9-4036-99dc-20734b12b0cd" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3598c4cf-88d4-4a26-b549-726e2aba5b64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b49fc336-8b95-489b-9a4e-dfc0187258e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_36e8f6b2-f9d9-4036-99dc-20734b12b0cd" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b49fc336-8b95-489b-9a4e-dfc0187258e1" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>tnet-20240331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:e2176350-5298-4836-b62a-d8f4e61deac6,g:394f270b-efa4-4896-8b8e-6d4db102e2a9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="simple" xlink:href="tnet-20240331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_604b56b9-34e3-45e6-bc6d-78670f940b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_StatementTable_604b56b9-34e3-45e6-bc6d-78670f940b0c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e9ead2ea-0c88-49e1-81a8-2d0063adca29" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_604b56b9-34e3-45e6-bc6d-78670f940b0c" xlink:to="loc_srt_ProductOrServiceAxis_e9ead2ea-0c88-49e1-81a8-2d0063adca29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e9ead2ea-0c88-49e1-81a8-2d0063adca29_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e9ead2ea-0c88-49e1-81a8-2d0063adca29" xlink:to="loc_srt_ProductsAndServicesDomain_e9ead2ea-0c88-49e1-81a8-2d0063adca29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b09130ae-d013-4de0-b332-4c3c3db9ed18" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e9ead2ea-0c88-49e1-81a8-2d0063adca29" xlink:to="loc_srt_ProductsAndServicesDomain_b09130ae-d013-4de0-b332-4c3c3db9ed18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ProfessionalServicesMember_bf0f0ee6-3bcb-4c4b-9ce7-75f8eca885e6" xlink:href="tnet-20240331.xsd#tnet_ProfessionalServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b09130ae-d013-4de0-b332-4c3c3db9ed18" xlink:to="loc_tnet_ProfessionalServicesMember_bf0f0ee6-3bcb-4c4b-9ce7-75f8eca885e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InsuranceServicesMember_42b9dbb3-e58f-492d-9fee-536c05c49421" xlink:href="tnet-20240331.xsd#tnet_InsuranceServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b09130ae-d013-4de0-b332-4c3c3db9ed18" xlink:to="loc_tnet_InsuranceServicesMember_42b9dbb3-e58f-492d-9fee-536c05c49421" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_20fbefbe-9f20-4182-8a87-9c79579295aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_20fbefbe-9f20-4182-8a87-9c79579295aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_a215f8cf-ca3d-4865-b9cf-827eb5be7fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_a215f8cf-ca3d-4865-b9cf-827eb5be7fbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingInsuranceAndClaimsCostsProduction_e84bb1f3-f772-4dfe-a285-cbb1f09eca39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingInsuranceAndClaimsCostsProduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_a215f8cf-ca3d-4865-b9cf-827eb5be7fbf" xlink:to="loc_us-gaap_OperatingInsuranceAndClaimsCostsProduction_e84bb1f3-f772-4dfe-a285-cbb1f09eca39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction_2158bf50-2d3b-4e3b-a7f7-1750fdf7af67" xlink:href="tnet-20240331.xsd#tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_a215f8cf-ca3d-4865-b9cf-827eb5be7fbf" xlink:to="loc_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction_2158bf50-2d3b-4e3b-a7f7-1750fdf7af67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_0a104baf-2226-425e-9df9-7ab45b1258de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_a215f8cf-ca3d-4865-b9cf-827eb5be7fbf" xlink:to="loc_us-gaap_SellingAndMarketingExpense_0a104baf-2226-425e-9df9-7ab45b1258de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_bf5b09e7-80a8-4eae-a042-1ca57cee7209" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_a215f8cf-ca3d-4865-b9cf-827eb5be7fbf" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_bf5b09e7-80a8-4eae-a042-1ca57cee7209" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1b093137-562a-4658-8e79-4f731dfcc5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_a215f8cf-ca3d-4865-b9cf-827eb5be7fbf" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1b093137-562a-4658-8e79-4f731dfcc5e7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_b60a7117-408b-4c35-a3ff-5de19662f22f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_a215f8cf-ca3d-4865-b9cf-827eb5be7fbf" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_b60a7117-408b-4c35-a3ff-5de19662f22f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_e9f26515-7157-41a0-816e-b3b9f05dda0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_a215f8cf-ca3d-4865-b9cf-827eb5be7fbf" xlink:to="loc_us-gaap_CostsAndExpenses_e9f26515-7157-41a0-816e-b3b9f05dda0a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_62a11036-7aba-4f9e-81a5-f40df63787cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_OperatingIncomeLoss_62a11036-7aba-4f9e-81a5-f40df63787cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_52935f39-db96-4dd2-b73a-486c26b852db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_52935f39-db96-4dd2-b73a-486c26b852db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InterestExpenseBankFeesAndOther_7190718d-e3aa-4559-886e-094953a9560b" xlink:href="tnet-20240331.xsd#tnet_InterestExpenseBankFeesAndOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_52935f39-db96-4dd2-b73a-486c26b852db" xlink:to="loc_tnet_InterestExpenseBankFeesAndOther_7190718d-e3aa-4559-886e-094953a9560b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther_98daa20a-f9ad-46ce-96f4-8a43816652ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_52935f39-db96-4dd2-b73a-486c26b852db" xlink:to="loc_us-gaap_InterestIncomeOther_98daa20a-f9ad-46ce-96f4-8a43816652ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_242ede34-6fce-43ee-a2a4-e4d368fa2385" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_242ede34-6fce-43ee-a2a4-e4d368fa2385" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e6e0743f-5979-4a15-b8eb-c83882f5e8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e6e0743f-5979-4a15-b8eb-c83882f5e8a7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6736ecea-e0ac-4942-a8b5-5f1eddf19196" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_NetIncomeLoss_6736ecea-e0ac-4942-a8b5-5f1eddf19196" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_36fab06b-323d-4fc4-b9b1-d3d34191cc15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_36fab06b-323d-4fc4-b9b1-d3d34191cc15" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_7bec1436-d7bc-4e18-949d-348352468dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_7bec1436-d7bc-4e18-949d-348352468dd7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1177a917-6b1a-482c-b793-c9d2fb4f06fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_EarningsPerShareAbstract_1177a917-6b1a-482c-b793-c9d2fb4f06fa" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b011105e-9dcf-4ed4-beb3-86c97cb9881a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1177a917-6b1a-482c-b793-c9d2fb4f06fa" xlink:to="loc_us-gaap_EarningsPerShareBasic_b011105e-9dcf-4ed4-beb3-86c97cb9881a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_94541652-4f8f-4bc8-8ef6-cbd76ac4a196" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1177a917-6b1a-482c-b793-c9d2fb4f06fa" xlink:to="loc_us-gaap_EarningsPerShareDiluted_94541652-4f8f-4bc8-8ef6-cbd76ac4a196" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_39e8a154-b79d-4c03-bdca-e1b631a06024" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_39e8a154-b79d-4c03-bdca-e1b631a06024" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c35a14c0-1b4d-4341-8474-b06ccb27accc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_39e8a154-b79d-4c03-bdca-e1b631a06024" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c35a14c0-1b4d-4341-8474-b06ccb27accc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9dcba2bc-aa28-41f6-a9c8-36af2f42ea27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_39e8a154-b79d-4c03-bdca-e1b631a06024" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9dcba2bc-aa28-41f6-a9c8-36af2f42ea27" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="tnet-20240331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7b7c18c8-f9a4-4824-b35c-a40125c79029" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4ee1ac0b-cbe9-4983-85c3-a422d504cf68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_7b7c18c8-f9a4-4824-b35c-a40125c79029" xlink:to="loc_us-gaap_StatementTable_4ee1ac0b-cbe9-4983-85c3-a422d504cf68" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_17b3c850-94e3-4530-8611-41dc520b4851" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4ee1ac0b-cbe9-4983-85c3-a422d504cf68" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_17b3c850-94e3-4530-8611-41dc520b4851" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_17b3c850-94e3-4530-8611-41dc520b4851_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_17b3c850-94e3-4530-8611-41dc520b4851" xlink:to="loc_us-gaap_EquityComponentDomain_17b3c850-94e3-4530-8611-41dc520b4851_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0ad28cb9-252a-47a9-9e05-99021f6d72d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_17b3c850-94e3-4530-8611-41dc520b4851" xlink:to="loc_us-gaap_EquityComponentDomain_0ad28cb9-252a-47a9-9e05-99021f6d72d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_72aa29c0-27ee-4724-8372-64b2dab6cbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0ad28cb9-252a-47a9-9e05-99021f6d72d6" xlink:to="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_72aa29c0-27ee-4724-8372-64b2dab6cbb2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_7c887640-9d71-4915-84e1-c644d1488635" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0ad28cb9-252a-47a9-9e05-99021f6d72d6" xlink:to="loc_us-gaap_RetainedEarningsMember_7c887640-9d71-4915-84e1-c644d1488635" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c90acb5d-bd92-4eb7-a0cf-9ca9e4477c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0ad28cb9-252a-47a9-9e05-99021f6d72d6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c90acb5d-bd92-4eb7-a0cf-9ca9e4477c1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ecf0c749-24cb-4f07-827c-12a6d174a570" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_7b7c18c8-f9a4-4824-b35c-a40125c79029" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ecf0c749-24cb-4f07-827c-12a6d174a570" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a098c6df-beac-4805-a6e2-78be21313f67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ecf0c749-24cb-4f07-827c-12a6d174a570" xlink:to="loc_us-gaap_StockholdersEquity_a098c6df-beac-4805-a6e2-78be21313f67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d1e343a9-8287-458f-b454-ac5d0aa3f639" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ecf0c749-24cb-4f07-827c-12a6d174a570" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d1e343a9-8287-458f-b454-ac5d0aa3f639" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f0549566-b14f-4a1b-9fac-646e7498f750" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ecf0c749-24cb-4f07-827c-12a6d174a570" xlink:to="loc_us-gaap_NetIncomeLoss_f0549566-b14f-4a1b-9fac-646e7498f750" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_064df281-68c3-4ab4-942b-b0617fb47d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ecf0c749-24cb-4f07-827c-12a6d174a570" xlink:to="loc_us-gaap_DividendsCommonStockCash_064df281-68c3-4ab4-942b-b0617fb47d2c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_c2007dd0-a065-4495-98f1-7555b755710f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ecf0c749-24cb-4f07-827c-12a6d174a570" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_c2007dd0-a065-4495-98f1-7555b755710f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_d541415d-f238-4a21-943f-4ad5d509d8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ecf0c749-24cb-4f07-827c-12a6d174a570" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_d541415d-f238-4a21-943f-4ad5d509d8b1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e44dce9b-735f-4a61-8b83-1490b4d42cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ecf0c749-24cb-4f07-827c-12a6d174a570" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e44dce9b-735f-4a61-8b83-1490b4d42cc6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4b939f2c-cf9a-405d-a44e-709fa95de090" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_95dfc3bc-ea02-4667-bdea-5c563fd3b4b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_0bb1d342-d5e5-40fd-b64a-936f8df3dee6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_95dfc3bc-ea02-4667-bdea-5c563fd3b4b5" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_0bb1d342-d5e5-40fd-b64a-936f8df3dee6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_31c23629-8233-4a85-b9eb-48e52e47fd12" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_0bb1d342-d5e5-40fd-b64a-936f8df3dee6" xlink:to="loc_srt_StatementGeographicalAxis_31c23629-8233-4a85-b9eb-48e52e47fd12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_31c23629-8233-4a85-b9eb-48e52e47fd12_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_31c23629-8233-4a85-b9eb-48e52e47fd12" xlink:to="loc_srt_SegmentGeographicalDomain_31c23629-8233-4a85-b9eb-48e52e47fd12_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ad294dc2-9a91-476a-ac3e-f41782fa9d40" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_31c23629-8233-4a85-b9eb-48e52e47fd12" xlink:to="loc_srt_SegmentGeographicalDomain_ad294dc2-9a91-476a-ac3e-f41782fa9d40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_4585f0d4-f8ac-4ede-8034-206c3508a332" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ad294dc2-9a91-476a-ac3e-f41782fa9d40" xlink:to="loc_us-gaap_NonUsMember_4585f0d4-f8ac-4ede-8034-206c3508a332" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2d4dfa24-1661-4342-a2bd-9243c044f6db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_0bb1d342-d5e5-40fd-b64a-936f8df3dee6" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2d4dfa24-1661-4342-a2bd-9243c044f6db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2d4dfa24-1661-4342-a2bd-9243c044f6db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2d4dfa24-1661-4342-a2bd-9243c044f6db" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2d4dfa24-1661-4342-a2bd-9243c044f6db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6e88a0bc-054b-4977-9b17-b83a113bbb96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2d4dfa24-1661-4342-a2bd-9243c044f6db" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6e88a0bc-054b-4977-9b17-b83a113bbb96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_c51d2827-9310-4425-acea-650c65726979" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6e88a0bc-054b-4977-9b17-b83a113bbb96" xlink:to="loc_us-gaap_SalesRevenueNetMember_c51d2827-9310-4425-acea-650c65726979" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_4e1a7e2e-4743-4676-bdeb-7d278a926612" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_0bb1d342-d5e5-40fd-b64a-936f8df3dee6" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_4e1a7e2e-4743-4676-bdeb-7d278a926612" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_4e1a7e2e-4743-4676-bdeb-7d278a926612_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_4e1a7e2e-4743-4676-bdeb-7d278a926612" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_4e1a7e2e-4743-4676-bdeb-7d278a926612_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_87992512-1ab3-4373-86ad-718d6011d7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_4e1a7e2e-4743-4676-bdeb-7d278a926612" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_87992512-1ab3-4373-86ad-718d6011d7d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_64e0ce78-253c-43a4-b527-868ff782bac6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_87992512-1ab3-4373-86ad-718d6011d7d3" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_64e0ce78-253c-43a4-b527-868ff782bac6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_ec04f553-2cc8-4f47-9603-17e7b8a68f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_0bb1d342-d5e5-40fd-b64a-936f8df3dee6" xlink:to="loc_us-gaap_NatureOfExpenseAxis_ec04f553-2cc8-4f47-9603-17e7b8a68f3f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_ec04f553-2cc8-4f47-9603-17e7b8a68f3f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NatureOfExpenseAxis_ec04f553-2cc8-4f47-9603-17e7b8a68f3f" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_ec04f553-2cc8-4f47-9603-17e7b8a68f3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_714e7c16-254e-4025-bc16-31f3b898e548" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NatureOfExpenseAxis_ec04f553-2cc8-4f47-9603-17e7b8a68f3f" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_714e7c16-254e-4025-bc16-31f3b898e548" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareMember_137f1520-97a5-4bfc-a563-72909e34765b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_714e7c16-254e-4025-bc16-31f3b898e548" xlink:to="loc_us-gaap_HealthCareMember_137f1520-97a5-4bfc-a563-72909e34765b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_532dc492-960b-46e6-a3df-25608640c294" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_95dfc3bc-ea02-4667-bdea-5c563fd3b4b5" xlink:to="loc_us-gaap_NumberOfReportableSegments_532dc492-960b-46e6-a3df-25608640c294" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_0941456a-a593-46a1-967e-f87389ceffef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_95dfc3bc-ea02-4667-bdea-5c563fd3b4b5" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_0941456a-a593-46a1-967e-f87389ceffef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_c498ca71-225c-4637-adb5-d5b2af01c05b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidInsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_95dfc3bc-ea02-4667-bdea-5c563fd3b4b5" xlink:to="loc_us-gaap_PrepaidInsurance_c498ca71-225c-4637-adb5-d5b2af01c05b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_4d269a12-d866-4cba-b717-d7ccf4f7bff5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4a3aed68-1bd3-4f5d-858b-be14fde95981" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4d269a12-d866-4cba-b717-d7ccf4f7bff5" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4a3aed68-1bd3-4f5d-858b-be14fde95981" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_6a068c1d-a972-4511-8808-1c6c1e46b049" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4a3aed68-1bd3-4f5d-858b-be14fde95981" xlink:to="loc_srt_ConsolidatedEntitiesAxis_6a068c1d-a972-4511-8808-1c6c1e46b049" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_6a068c1d-a972-4511-8808-1c6c1e46b049_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_6a068c1d-a972-4511-8808-1c6c1e46b049" xlink:to="loc_srt_ConsolidatedEntitiesDomain_6a068c1d-a972-4511-8808-1c6c1e46b049_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_7ab680f3-813f-4d3a-8817-626e788b2122" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_6a068c1d-a972-4511-8808-1c6c1e46b049" xlink:to="loc_srt_ConsolidatedEntitiesDomain_7ab680f3-813f-4d3a-8817-626e788b2122" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_9fea023b-42c3-428a-ada7-8a1eeaf42ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_7ab680f3-813f-4d3a-8817-626e788b2122" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_9fea023b-42c3-428a-ada7-8a1eeaf42ed1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c5c5d478-20ce-418b-b200-75d002c4a885" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4d269a12-d866-4cba-b717-d7ccf4f7bff5" xlink:to="loc_us-gaap_AssetsAbstract_c5c5d478-20ce-418b-b200-75d002c4a885" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_cc671fa7-82a0-4b25-8081-3944a247678f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_c5c5d478-20ce-418b-b200-75d002c4a885" xlink:to="loc_us-gaap_AssetsCurrentAbstract_cc671fa7-82a0-4b25-8081-3944a247678f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_116e238a-2d30-4f22-9b49-bc1f02382803" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cc671fa7-82a0-4b25-8081-3944a247678f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_116e238a-2d30-4f22-9b49-bc1f02382803" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_021ad659-4654-4e04-9523-84191f9f129a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cc671fa7-82a0-4b25-8081-3944a247678f" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_021ad659-4654-4e04-9523-84191f9f129a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_efb3944d-e229-475d-8205-d2ed6b7cb128" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cc671fa7-82a0-4b25-8081-3944a247678f" xlink:to="loc_us-gaap_AssetsCurrent_efb3944d-e229-475d-8205-d2ed6b7cb128" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d74e92ba-e529-46c5-a1ac-32af350376f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_c5c5d478-20ce-418b-b200-75d002c4a885" xlink:to="loc_us-gaap_Assets_d74e92ba-e529-46c5-a1ac-32af350376f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_04133187-7c1c-4d32-92d2-48c698d0a866" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4d269a12-d866-4cba-b717-d7ccf4f7bff5" xlink:to="loc_us-gaap_LiabilitiesAbstract_04133187-7c1c-4d32-92d2-48c698d0a866" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_b5a8d533-dbc3-45ba-811e-da93f565580c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_04133187-7c1c-4d32-92d2-48c698d0a866" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_b5a8d533-dbc3-45ba-811e-da93f565580c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_8b8ea3e8-4bdc-452d-b596-43bcdd658182" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b5a8d533-dbc3-45ba-811e-da93f565580c" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_8b8ea3e8-4bdc-452d-b596-43bcdd658182" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_42496906-1ed9-44d1-a012-cda5475756c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b5a8d533-dbc3-45ba-811e-da93f565580c" xlink:to="loc_us-gaap_AccruedSalariesCurrent_42496906-1ed9-44d1-a012-cda5475756c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_c4127cd8-8592-4b08-9697-d9e5a6cb111d" xlink:href="tnet-20240331.xsd#tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b5a8d533-dbc3-45ba-811e-da93f565580c" xlink:to="loc_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_c4127cd8-8592-4b08-9697-d9e5a6cb111d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d32fb33f-ba11-44d0-9431-e5c3eb884d41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b5a8d533-dbc3-45ba-811e-da93f565580c" xlink:to="loc_us-gaap_LiabilitiesCurrent_d32fb33f-ba11-44d0-9431-e5c3eb884d41" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a1d00aa4-06e8-4d16-a0d8-9f9e8d1afc0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract_04133187-7c1c-4d32-92d2-48c698d0a866" xlink:to="loc_us-gaap_Liabilities_a1d00aa4-06e8-4d16-a0d8-9f9e8d1afc0e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_67b1c7fb-b16c-406d-a89b-9f08eba50a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_1397cf83-93f4-4468-8b4f-d41a19a604b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_67b1c7fb-b16c-406d-a89b-9f08eba50a4e" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_1397cf83-93f4-4468-8b4f-d41a19a604b7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b6fa4865-731c-4f81-983e-b06813e45c32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_1397cf83-93f4-4468-8b4f-d41a19a604b7" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b6fa4865-731c-4f81-983e-b06813e45c32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6fa4865-731c-4f81-983e-b06813e45c32_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b6fa4865-731c-4f81-983e-b06813e45c32" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b6fa4865-731c-4f81-983e-b06813e45c32_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e148824-48b3-4080-8ba3-c0cd48855755" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b6fa4865-731c-4f81-983e-b06813e45c32" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e148824-48b3-4080-8ba3-c0cd48855755" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_30f037f7-30d2-448c-9275-0132e4748508" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e148824-48b3-4080-8ba3-c0cd48855755" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_30f037f7-30d2-448c-9275-0132e4748508" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AvailableForSaleMarketableSecuritiesMember_5ab314d9-b4af-4d34-b320-3691fa7bfe50" xlink:href="tnet-20240331.xsd#tnet_AvailableForSaleMarketableSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e148824-48b3-4080-8ba3-c0cd48855755" xlink:to="loc_tnet_AvailableForSaleMarketableSecuritiesMember_5ab314d9-b4af-4d34-b320-3691fa7bfe50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralbyTypeAxis_1a3f9786-a1cf-476a-9cf0-432b9f978047" xlink:href="tnet-20240331.xsd#tnet_CollateralbyTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_1397cf83-93f4-4468-8b4f-d41a19a604b7" xlink:to="loc_tnet_CollateralbyTypeAxis_1a3f9786-a1cf-476a-9cf0-432b9f978047" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralByTypeDomain_1a3f9786-a1cf-476a-9cf0-432b9f978047_default" xlink:href="tnet-20240331.xsd#tnet_CollateralByTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_tnet_CollateralbyTypeAxis_1a3f9786-a1cf-476a-9cf0-432b9f978047" xlink:to="loc_tnet_CollateralByTypeDomain_1a3f9786-a1cf-476a-9cf0-432b9f978047_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralByTypeDomain_4aaeab67-96a9-46d0-a1bb-c46b8b89f093" xlink:href="tnet-20240331.xsd#tnet_CollateralByTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_tnet_CollateralbyTypeAxis_1a3f9786-a1cf-476a-9cf0-432b9f978047" xlink:to="loc_tnet_CollateralByTypeDomain_4aaeab67-96a9-46d0-a1bb-c46b8b89f093" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PayrollFundsCollectedMember_79de5487-56b6-44d5-b8f3-fcc034e5c155" xlink:href="tnet-20240331.xsd#tnet_PayrollFundsCollectedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tnet_CollateralByTypeDomain_4aaeab67-96a9-46d0-a1bb-c46b8b89f093" xlink:to="loc_tnet_PayrollFundsCollectedMember_79de5487-56b6-44d5-b8f3-fcc034e5c155" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_HealthBenefitClaimsCollateralMember_ed224ea1-2235-4f5e-a151-180e05f0d39d" xlink:href="tnet-20240331.xsd#tnet_HealthBenefitClaimsCollateralMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tnet_CollateralByTypeDomain_4aaeab67-96a9-46d0-a1bb-c46b8b89f093" xlink:to="loc_tnet_HealthBenefitClaimsCollateralMember_ed224ea1-2235-4f5e-a151-180e05f0d39d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_WorkersCompensationClaimsCollateralMember_b61367ac-3c13-4c9a-a11f-078588977a73" xlink:href="tnet-20240331.xsd#tnet_WorkersCompensationClaimsCollateralMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tnet_CollateralByTypeDomain_4aaeab67-96a9-46d0-a1bb-c46b8b89f093" xlink:to="loc_tnet_WorkersCompensationClaimsCollateralMember_b61367ac-3c13-4c9a-a11f-078588977a73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_TrustForOurHRISUsersCollateralMember_2479b1e1-0b51-4f99-89df-c51a4ced0017" xlink:href="tnet-20240331.xsd#tnet_TrustForOurHRISUsersCollateralMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tnet_CollateralByTypeDomain_4aaeab67-96a9-46d0-a1bb-c46b8b89f093" xlink:to="loc_tnet_TrustForOurHRISUsersCollateralMember_2479b1e1-0b51-4f99-89df-c51a4ced0017" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InsuranceCarriersSecurityDepositsMember_cef6a196-c73f-4a48-b015-ba5cc49147f4" xlink:href="tnet-20240331.xsd#tnet_InsuranceCarriersSecurityDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_tnet_CollateralByTypeDomain_4aaeab67-96a9-46d0-a1bb-c46b8b89f093" xlink:to="loc_tnet_InsuranceCarriersSecurityDepositsMember_cef6a196-c73f-4a48-b015-ba5cc49147f4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5778e991-f562-4d88-b63b-ac983c38029b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_67b1c7fb-b16c-406d-a89b-9f08eba50a4e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5778e991-f562-4d88-b63b-ac983c38029b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_de14e3df-880e-4de7-b665-d1f974181b12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_67b1c7fb-b16c-406d-a89b-9f08eba50a4e" xlink:to="loc_us-gaap_ShortTermInvestments_de14e3df-880e-4de7-b665-d1f974181b12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_0eece7b6-3bd9-46fd-a2e6-5cecd7110c54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_67b1c7fb-b16c-406d-a89b-9f08eba50a4e" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_0eece7b6-3bd9-46fd-a2e6-5cecd7110c54" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_5654b26e-240a-4803-a627-03466070cb61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_67b1c7fb-b16c-406d-a89b-9f08eba50a4e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_5654b26e-240a-4803-a627-03466070cb61" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_88cf589c-1610-448d-9afe-ddfb9de28fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_67b1c7fb-b16c-406d-a89b-9f08eba50a4e" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_88cf589c-1610-448d-9afe-ddfb9de28fbb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestments_64ad123e-9233-4d01-a5fe-3911e0f268ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_67b1c7fb-b16c-406d-a89b-9f08eba50a4e" xlink:to="loc_us-gaap_RestrictedCashAndInvestments_64ad123e-9233-4d01-a5fe-3911e0f268ea" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5d50d4ad-7bcf-4156-a60c-2bc8d76f00fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_85fa7317-cdc4-47aa-8278-3088917b3b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5d50d4ad-7bcf-4156-a60c-2bc8d76f00fc" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_85fa7317-cdc4-47aa-8278-3088917b3b5a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_2a6a41ff-6ce7-4661-bed4-5b4c39a22df9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_85fa7317-cdc4-47aa-8278-3088917b3b5a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_2a6a41ff-6ce7-4661-bed4-5b4c39a22df9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2a6a41ff-6ce7-4661-bed4-5b4c39a22df9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_2a6a41ff-6ce7-4661-bed4-5b4c39a22df9" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_2a6a41ff-6ce7-4661-bed4-5b4c39a22df9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6812f9a3-fb24-4e5c-96bb-3f68d04bd32e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_2a6a41ff-6ce7-4661-bed4-5b4c39a22df9" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6812f9a3-fb24-4e5c-96bb-3f68d04bd32e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_d096ee4f-e6f0-4eaa-812d-09c7dbe57983" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6812f9a3-fb24-4e5c-96bb-3f68d04bd32e" xlink:to="loc_us-gaap_MoneyMarketFundsMember_d096ee4f-e6f0-4eaa-812d-09c7dbe57983" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_26ba92ed-f4d5-48d7-93e1-db6002576286" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6812f9a3-fb24-4e5c-96bb-3f68d04bd32e" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_26ba92ed-f4d5-48d7-93e1-db6002576286" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_c85e9619-3216-41ae-b803-b7fb3710ebfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_85fa7317-cdc4-47aa-8278-3088917b3b5a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_c85e9619-3216-41ae-b803-b7fb3710ebfc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c85e9619-3216-41ae-b803-b7fb3710ebfc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c85e9619-3216-41ae-b803-b7fb3710ebfc" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c85e9619-3216-41ae-b803-b7fb3710ebfc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4f4634ed-8d52-49c7-9306-20f2a03d2853" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c85e9619-3216-41ae-b803-b7fb3710ebfc" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4f4634ed-8d52-49c7-9306-20f2a03d2853" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_ed6ac92b-fb00-4bf2-8bde-11c758bc1819" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4f4634ed-8d52-49c7-9306-20f2a03d2853" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_ed6ac92b-fb00-4bf2-8bde-11c758bc1819" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_577d16fd-89d4-44fe-a2de-823e7e838b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4f4634ed-8d52-49c7-9306-20f2a03d2853" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_577d16fd-89d4-44fe-a2de-823e7e838b1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cc1eb167-4cfb-4012-b1d4-5b8602f4a06f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4f4634ed-8d52-49c7-9306-20f2a03d2853" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cc1eb167-4cfb-4012-b1d4-5b8602f4a06f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_cd356724-fa64-408c-ab0b-e92941ddef7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4f4634ed-8d52-49c7-9306-20f2a03d2853" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_cd356724-fa64-408c-ab0b-e92941ddef7d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_ddc0fffd-ab35-4e26-b137-50e5e294c8db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4f4634ed-8d52-49c7-9306-20f2a03d2853" xlink:to="loc_us-gaap_CertificatesOfDepositMember_ddc0fffd-ab35-4e26-b137-50e5e294c8db" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_6620d7dd-69ed-44dd-94cc-b05979c66259" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4f4634ed-8d52-49c7-9306-20f2a03d2853" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_6620d7dd-69ed-44dd-94cc-b05979c66259" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0fd7538b-cad2-4f18-b059-b25ebe09cf2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_85fa7317-cdc4-47aa-8278-3088917b3b5a" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0fd7538b-cad2-4f18-b059-b25ebe09cf2c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0fd7538b-cad2-4f18-b059-b25ebe09cf2c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0fd7538b-cad2-4f18-b059-b25ebe09cf2c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0fd7538b-cad2-4f18-b059-b25ebe09cf2c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0682aa5f-0b4e-4d4b-ac07-820cc7652f38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0fd7538b-cad2-4f18-b059-b25ebe09cf2c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0682aa5f-0b4e-4d4b-ac07-820cc7652f38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_96461da0-847b-4557-8301-30bee9728fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_0682aa5f-0b4e-4d4b-ac07-820cc7652f38" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_96461da0-847b-4557-8301-30bee9728fa6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_656fe3d5-a83e-4784-b569-9773b2bc31c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_85fa7317-cdc4-47aa-8278-3088917b3b5a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_656fe3d5-a83e-4784-b569-9773b2bc31c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_656fe3d5-a83e-4784-b569-9773b2bc31c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_656fe3d5-a83e-4784-b569-9773b2bc31c7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_656fe3d5-a83e-4784-b569-9773b2bc31c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c24ca7ef-b865-4eea-994c-6e79e4797af9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_656fe3d5-a83e-4784-b569-9773b2bc31c7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c24ca7ef-b865-4eea-994c-6e79e4797af9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3b1c4522-3090-4199-ba7b-6e3ff189db41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c24ca7ef-b865-4eea-994c-6e79e4797af9" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3b1c4522-3090-4199-ba7b-6e3ff189db41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_342486bd-5e20-444c-9a5b-380824cecc50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c24ca7ef-b865-4eea-994c-6e79e4797af9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_342486bd-5e20-444c-9a5b-380824cecc50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_08fdea25-7c8a-4427-b58f-49ad2055738a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_85fa7317-cdc4-47aa-8278-3088917b3b5a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_08fdea25-7c8a-4427-b58f-49ad2055738a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_08fdea25-7c8a-4427-b58f-49ad2055738a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_08fdea25-7c8a-4427-b58f-49ad2055738a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_08fdea25-7c8a-4427-b58f-49ad2055738a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_80efae47-84c7-4f75-8b4b-561916d3d46b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_08fdea25-7c8a-4427-b58f-49ad2055738a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_80efae47-84c7-4f75-8b4b-561916d3d46b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_a94cc02b-30bd-43b8-95de-bf8455acf0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_80efae47-84c7-4f75-8b4b-561916d3d46b" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_a94cc02b-30bd-43b8-95de-bf8455acf0f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember_176aa7e6-9a7e-4a6b-844b-fe93329cf71a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_80efae47-84c7-4f75-8b4b-561916d3d46b" xlink:to="loc_us-gaap_InvestmentsMember_176aa7e6-9a7e-4a6b-844b-fe93329cf71a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember_3a01b077-dc5d-4b52-b15b-be69c70dc849" xlink:href="tnet-20240331.xsd#tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_80efae47-84c7-4f75-8b4b-561916d3d46b" xlink:to="loc_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember_3a01b077-dc5d-4b52-b15b-be69c70dc849" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_2a891c9e-57af-49ad-918c-9d503e222dac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5d50d4ad-7bcf-4156-a60c-2bc8d76f00fc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_2a891c9e-57af-49ad-918c-9d503e222dac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_894bbf24-90c1-4d21-95d7-a3f209d35219" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_2a891c9e-57af-49ad-918c-9d503e222dac" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_894bbf24-90c1-4d21-95d7-a3f209d35219" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a3ab5338-332b-4c9e-a5a8-e5a3cf3f5c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_2a891c9e-57af-49ad-918c-9d503e222dac" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a3ab5338-332b-4c9e-a5a8-e5a3cf3f5c2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9f6fc477-c015-44e2-81b2-c3e729afe99a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_2a891c9e-57af-49ad-918c-9d503e222dac" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9f6fc477-c015-44e2-81b2-c3e729afe99a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_05385784-094a-4311-8f21-9be362fbbcb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_2a891c9e-57af-49ad-918c-9d503e222dac" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_05385784-094a-4311-8f21-9be362fbbcb1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a75b0fab-abbd-4c74-9983-c7db69e05f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_2a891c9e-57af-49ad-918c-9d503e222dac" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a75b0fab-abbd-4c74-9983-c7db69e05f8b" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#INVESTMENTSAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e4b1daee-a0a8-4987-a0c3-0e40e0b41b90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_88180a77-5db7-482f-ab22-cb38ab0fc9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e4b1daee-a0a8-4987-a0c3-0e40e0b41b90" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_88180a77-5db7-482f-ab22-cb38ab0fc9e2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cecba939-005b-4aab-8cf7-aa2c487c5a09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_88180a77-5db7-482f-ab22-cb38ab0fc9e2" xlink:to="loc_us-gaap_DebtInstrumentAxis_cecba939-005b-4aab-8cf7-aa2c487c5a09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cecba939-005b-4aab-8cf7-aa2c487c5a09_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_cecba939-005b-4aab-8cf7-aa2c487c5a09" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cecba939-005b-4aab-8cf7-aa2c487c5a09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d075d8b4-9513-4b27-9b69-ed6b41e5ed39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_cecba939-005b-4aab-8cf7-aa2c487c5a09" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d075d8b4-9513-4b27-9b69-ed6b41e5ed39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_A2029NotesPayableMember_b7a68d44-a383-46fa-a14b-d8da816ecdaa" xlink:href="tnet-20240331.xsd#tnet_A2029NotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d075d8b4-9513-4b27-9b69-ed6b41e5ed39" xlink:to="loc_tnet_A2029NotesPayableMember_b7a68d44-a383-46fa-a14b-d8da816ecdaa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_A2031NotesPayableMember_e4ba8a90-f5e0-40fa-b69e-4f1bf58b43ee" xlink:href="tnet-20240331.xsd#tnet_A2031NotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d075d8b4-9513-4b27-9b69-ed6b41e5ed39" xlink:to="loc_tnet_A2031NotesPayableMember_e4ba8a90-f5e0-40fa-b69e-4f1bf58b43ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_2f44d6a0-55f5-4e8d-950a-7a1dfccd5d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e4b1daee-a0a8-4987-a0c3-0e40e0b41b90" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_2f44d6a0-55f5-4e8d-950a-7a1dfccd5d6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableFairValueDisclosure_695e76d4-65a5-4262-82af-d7ef81f0e565" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e4b1daee-a0a8-4987-a0c3-0e40e0b41b90" xlink:to="loc_us-gaap_NotesPayableFairValueDisclosure_695e76d4-65a5-4262-82af-d7ef81f0e565" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#STOCKBASEDCOMPENSATIONAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3956b0ef-ccd4-4d20-9e43-b241e1610751" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cf459a58-a7e3-4db2-acfd-c92843f650ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3956b0ef-ccd4-4d20-9e43-b241e1610751" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cf459a58-a7e3-4db2-acfd-c92843f650ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_23739b3b-ecdb-43d0-bc45-b541ffec5527" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cf459a58-a7e3-4db2-acfd-c92843f650ff" xlink:to="loc_us-gaap_AwardTypeAxis_23739b3b-ecdb-43d0-bc45-b541ffec5527" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23739b3b-ecdb-43d0-bc45-b541ffec5527_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_23739b3b-ecdb-43d0-bc45-b541ffec5527" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23739b3b-ecdb-43d0-bc45-b541ffec5527_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a35b8754-1a94-428c-a2e5-6019c8ff731a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_23739b3b-ecdb-43d0-bc45-b541ffec5527" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a35b8754-1a94-428c-a2e5-6019c8ff731a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_TimeBasedRestrictedStockUnitsMember_6e7a4842-b502-426c-bba5-8930ff96dd6c" xlink:href="tnet-20240331.xsd#tnet_TimeBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a35b8754-1a94-428c-a2e5-6019c8ff731a" xlink:to="loc_tnet_TimeBasedRestrictedStockUnitsMember_6e7a4842-b502-426c-bba5-8930ff96dd6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember_716b69c4-3dde-4a5c-a0a1-64f72a2171bd" xlink:href="tnet-20240331.xsd#tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a35b8754-1a94-428c-a2e5-6019c8ff731a" xlink:to="loc_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember_716b69c4-3dde-4a5c-a0a1-64f72a2171bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5b4019c0-daca-4135-beb0-4ead9a8e0483" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cf459a58-a7e3-4db2-acfd-c92843f650ff" xlink:to="loc_srt_RangeAxis_5b4019c0-daca-4135-beb0-4ead9a8e0483" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5b4019c0-daca-4135-beb0-4ead9a8e0483_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5b4019c0-daca-4135-beb0-4ead9a8e0483" xlink:to="loc_srt_RangeMember_5b4019c0-daca-4135-beb0-4ead9a8e0483_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0c5fc24d-f5c3-43ca-95b6-6f050d8c6883" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5b4019c0-daca-4135-beb0-4ead9a8e0483" xlink:to="loc_srt_RangeMember_0c5fc24d-f5c3-43ca-95b6-6f050d8c6883" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_99f51da0-eff6-4ac9-a156-f11c37c3e54a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0c5fc24d-f5c3-43ca-95b6-6f050d8c6883" xlink:to="loc_srt_MinimumMember_99f51da0-eff6-4ac9-a156-f11c37c3e54a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ca1de7fb-3524-4c72-b83a-a80690a4c59e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0c5fc24d-f5c3-43ca-95b6-6f050d8c6883" xlink:to="loc_srt_MaximumMember_ca1de7fb-3524-4c72-b83a-a80690a4c59e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_600421d8-89cc-473b-a9d8-5719bf53d124" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cf459a58-a7e3-4db2-acfd-c92843f650ff" xlink:to="loc_us-gaap_VestingAxis_600421d8-89cc-473b-a9d8-5719bf53d124" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_600421d8-89cc-473b-a9d8-5719bf53d124_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_600421d8-89cc-473b-a9d8-5719bf53d124" xlink:to="loc_us-gaap_VestingDomain_600421d8-89cc-473b-a9d8-5719bf53d124_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_ea4b92a3-f821-4c6e-8c6c-7333237ff656" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_600421d8-89cc-473b-a9d8-5719bf53d124" xlink:to="loc_us-gaap_VestingDomain_ea4b92a3-f821-4c6e-8c6c-7333237ff656" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_df933015-0a86-4ce1-b8ca-d168050df934" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_ea4b92a3-f821-4c6e-8c6c-7333237ff656" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_df933015-0a86-4ce1-b8ca-d168050df934" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_47469e7f-ff28-4c71-85a9-a7723dedf082" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3956b0ef-ccd4-4d20-9e43-b241e1610751" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_47469e7f-ff28-4c71-85a9-a7723dedf082" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_6d7dd196-9505-4077-a91e-52890d630ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3956b0ef-ccd4-4d20-9e43-b241e1610751" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_6d7dd196-9505-4077-a91e-52890d630ca4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_528c464b-8464-48aa-80cc-ad8becb4141c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3956b0ef-ccd4-4d20-9e43-b241e1610751" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_528c464b-8464-48aa-80cc-ad8becb4141c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_58e4baca-9bfe-4f0d-9358-72279b3f6dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3956b0ef-ccd4-4d20-9e43-b241e1610751" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_58e4baca-9bfe-4f0d-9358-72279b3f6dc5" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8ca23d60-4051-4d85-98ca-765e90678093" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4af477bf-2414-41b7-b403-e1794e69e0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8ca23d60-4051-4d85-98ca-765e90678093" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4af477bf-2414-41b7-b403-e1794e69e0f4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1ab46831-83e0-4053-8c1d-44e39ca8f651" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4af477bf-2414-41b7-b403-e1794e69e0f4" xlink:to="loc_us-gaap_AwardTypeAxis_1ab46831-83e0-4053-8c1d-44e39ca8f651" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ab46831-83e0-4053-8c1d-44e39ca8f651_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1ab46831-83e0-4053-8c1d-44e39ca8f651" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ab46831-83e0-4053-8c1d-44e39ca8f651_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d8d9ba2-eda9-4b78-ad97-dc2b776398ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1ab46831-83e0-4053-8c1d-44e39ca8f651" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d8d9ba2-eda9-4b78-ad97-dc2b776398ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_TimeBasedRestrictedStockUnitsMember_06976167-bdfa-4515-8368-bde4049e84e4" xlink:href="tnet-20240331.xsd#tnet_TimeBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d8d9ba2-eda9-4b78-ad97-dc2b776398ba" xlink:to="loc_tnet_TimeBasedRestrictedStockUnitsMember_06976167-bdfa-4515-8368-bde4049e84e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PerformanceBasedRestrictedStockUnitsMember_4011dc65-0cab-4f77-8f00-57338b98ab03" xlink:href="tnet-20240331.xsd#tnet_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d8d9ba2-eda9-4b78-ad97-dc2b776398ba" xlink:to="loc_tnet_PerformanceBasedRestrictedStockUnitsMember_4011dc65-0cab-4f77-8f00-57338b98ab03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4e08bc4d-d56c-4fcc-92c4-2a4b9fa42e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8ca23d60-4051-4d85-98ca-765e90678093" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4e08bc4d-d56c-4fcc-92c4-2a4b9fa42e1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ad39f25b-9478-42ca-a744-a091fc4989bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4e08bc4d-d56c-4fcc-92c4-2a4b9fa42e1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ad39f25b-9478-42ca-a744-a091fc4989bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_150342ae-69e3-49b2-b467-08f78f6eb45c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4e08bc4d-d56c-4fcc-92c4-2a4b9fa42e1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_150342ae-69e3-49b2-b467-08f78f6eb45c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_52ca6782-bc31-4147-a5e1-3e44566e2622" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4e08bc4d-d56c-4fcc-92c4-2a4b9fa42e1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_52ca6782-bc31-4147-a5e1-3e44566e2622" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7252f37e-402a-48ba-9657-d79c6da5186e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4e08bc4d-d56c-4fcc-92c4-2a4b9fa42e1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7252f37e-402a-48ba-9657-d79c6da5186e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f4239507-93c1-4cdf-b64d-f309f8b921b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a93c24c-0f89-44be-866e-b9de11b70ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8ca23d60-4051-4d85-98ca-765e90678093" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a93c24c-0f89-44be-866e-b9de11b70ce0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6e8659dc-c644-416c-b9f3-3e35519680b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a93c24c-0f89-44be-866e-b9de11b70ce0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6e8659dc-c644-416c-b9f3-3e35519680b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a53817fd-667e-4cb6-8240-20b99a684941" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a93c24c-0f89-44be-866e-b9de11b70ce0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a53817fd-667e-4cb6-8240-20b99a684941" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_bc1553f1-4478-4abd-8b06-70afd46cda9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a93c24c-0f89-44be-866e-b9de11b70ce0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_bc1553f1-4478-4abd-8b06-70afd46cda9d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_35599e9c-09a4-4885-a59c-608eee378c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a93c24c-0f89-44be-866e-b9de11b70ce0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_35599e9c-09a4-4885-a59c-608eee378c0a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a670339f-5899-4da0-a468-85bb51fda8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_271180a4-5956-4f63-bd45-daace8c03a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_82907611-e8ec-4292-9fc2-54408330eafc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_271180a4-5956-4f63-bd45-daace8c03a4d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_82907611-e8ec-4292-9fc2-54408330eafc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_30396552-70c9-4e26-97f7-8aca19c9aa9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_82907611-e8ec-4292-9fc2-54408330eafc" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_30396552-70c9-4e26-97f7-8aca19c9aa9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_30396552-70c9-4e26-97f7-8aca19c9aa9c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_30396552-70c9-4e26-97f7-8aca19c9aa9c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_30396552-70c9-4e26-97f7-8aca19c9aa9c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7cb4ef01-4474-40de-8723-46a8d68934d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_30396552-70c9-4e26-97f7-8aca19c9aa9c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7cb4ef01-4474-40de-8723-46a8d68934d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_61645070-0340-4414-b611-58610899a554" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7cb4ef01-4474-40de-8723-46a8d68934d3" xlink:to="loc_us-gaap_CostOfSalesMember_61645070-0340-4414-b611-58610899a554" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_811b9ac8-1ed7-40d1-af26-00848f56d43c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7cb4ef01-4474-40de-8723-46a8d68934d3" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_811b9ac8-1ed7-40d1-af26-00848f56d43c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_382f26c7-a4c9-4bce-a899-5c211000941a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7cb4ef01-4474-40de-8723-46a8d68934d3" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_382f26c7-a4c9-4bce-a899-5c211000941a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_SystemsDevelopmentAndProgrammingCostsMember_c879f1a0-cd6c-4e45-b9de-fd9786b95ecd" xlink:href="tnet-20240331.xsd#tnet_SystemsDevelopmentAndProgrammingCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7cb4ef01-4474-40de-8723-46a8d68934d3" xlink:to="loc_tnet_SystemsDevelopmentAndProgrammingCostsMember_c879f1a0-cd6c-4e45-b9de-fd9786b95ecd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_562c62bc-1db2-4843-8881-e473b01236fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_271180a4-5956-4f63-bd45-daace8c03a4d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_562c62bc-1db2-4843-8881-e473b01236fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_64343f91-23d4-4908-a5bb-bb7a613868f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_271180a4-5956-4f63-bd45-daace8c03a4d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_64343f91-23d4-4908-a5bb-bb7a613868f7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#STOCKHOLDERSEQUITYScheduleofCommonStockDetails"/>
  <link:definitionLink xlink:role="http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb512259-b9da-44b4-b767-99a7559eb486" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_32e03d31-3bae-4d1c-a56a-f6646aef2cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb512259-b9da-44b4-b767-99a7559eb486" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_32e03d31-3bae-4d1c-a56a-f6646aef2cc9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b18d24c0-bc93-4c34-922d-546a395653bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_32e03d31-3bae-4d1c-a56a-f6646aef2cc9" xlink:to="loc_us-gaap_AwardTypeAxis_b18d24c0-bc93-4c34-922d-546a395653bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b18d24c0-bc93-4c34-922d-546a395653bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b18d24c0-bc93-4c34-922d-546a395653bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b18d24c0-bc93-4c34-922d-546a395653bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76adc37b-1001-4883-9e9f-f8ecae00e3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b18d24c0-bc93-4c34-922d-546a395653bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76adc37b-1001-4883-9e9f-f8ecae00e3b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_7dd3b154-545d-4576-881b-dc7269e7bbcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76adc37b-1001-4883-9e9f-f8ecae00e3b1" xlink:to="loc_us-gaap_RestrictedStockMember_7dd3b154-545d-4576-881b-dc7269e7bbcf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_03d8c2ce-de89-4672-9889-3114a827ee75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76adc37b-1001-4883-9e9f-f8ecae00e3b1" xlink:to="loc_us-gaap_StockOptionMember_03d8c2ce-de89-4672-9889-3114a827ee75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b15cba9f-d77a-4228-888f-bf17963934df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb512259-b9da-44b4-b767-99a7559eb486" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b15cba9f-d77a-4228-888f-bf17963934df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ca995b4a-dc80-4b5c-ab00-38a63d6185ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b15cba9f-d77a-4228-888f-bf17963934df" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ca995b4a-dc80-4b5c-ab00-38a63d6185ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_b34b67e5-0df5-4b33-af5a-f4f4723fa6c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b15cba9f-d77a-4228-888f-bf17963934df" xlink:to="loc_us-gaap_CommonStockSharesIssued_b34b67e5-0df5-4b33-af5a-f4f4723fa6c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a7c64163-e634-4b3f-be5f-139db7467e53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b15cba9f-d77a-4228-888f-bf17963934df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a7c64163-e634-4b3f-be5f-139db7467e53" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9506a482-2aaa-4410-ac5f-01ff814bca02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b15cba9f-d77a-4228-888f-bf17963934df" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9506a482-2aaa-4410-ac5f-01ff814bca02" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_bb0b09f6-8504-4e2d-8bf1-ade17bf2e4b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b15cba9f-d77a-4228-888f-bf17963934df" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_bb0b09f6-8504-4e2d-8bf1-ade17bf2e4b5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_6a1669a9-841a-4f98-b8a3-23f86eb75bac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b15cba9f-d77a-4228-888f-bf17963934df" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_6a1669a9-841a-4f98-b8a3-23f86eb75bac" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d294752e-5e13-42fd-b016-dcb467d5fc97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ab5a6424-cd90-4f17-a635-6574dc4f7417" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTypeOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_TimeBasedRestrictedStockUnitsMember_1ff7303c-0c3f-45d0-8d0d-7db14ae7dd41" xlink:href="tnet-20240331.xsd#tnet_TimeBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_tnet_TimeBasedRestrictedStockUnitsMember_1ff7303c-0c3f-45d0-8d0d-7db14ae7dd41" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember_c2b92141-45c7-476f-aa3d-5986d756aef0" xlink:href="tnet-20240331.xsd#tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember_c2b92141-45c7-476f-aa3d-5986d756aef0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PerformanceBasedRestrictedStockUnitsMember_2b72e1a3-1e6d-4aa7-9aca-b1cbd2a875b9" xlink:href="tnet-20240331.xsd#tnet_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_tnet_PerformanceBasedRestrictedStockUnitsMember_2b72e1a3-1e6d-4aa7-9aca-b1cbd2a875b9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockMember" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockOptionMember" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#IndividualsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_BurtonMGoldfieldMember_c3321cc1-aaa6-46f2-b0c0-da43c8b4aee2" xlink:href="tnet-20240331.xsd#tnet_BurtonMGoldfieldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_tnet_BurtonMGoldfieldMember_c3321cc1-aaa6-46f2-b0c0-da43c8b4aee2" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>tnet-20240331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:e2176350-5298-4836-b62a-d8f4e61deac6,g:394f270b-efa4-4896-8b8e-6d4db102e2a9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_tnet_TimeBasedRestrictedStockUnitsMember_6e1e77ec-7a14-4a4e-a448-0bc9b8dabeb1_terseLabel_en-US" xlink:label="lab_tnet_TimeBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Time-Based Restricted Stock Units</link:label>
    <link:label id="lab_tnet_TimeBasedRestrictedStockUnitsMember_label_en-US" xlink:label="lab_tnet_TimeBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Time-Based Restricted Stock Units [Member]</link:label>
    <link:label id="lab_tnet_TimeBasedRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_tnet_TimeBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Time-Based Restricted Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_TimeBasedRestrictedStockUnitsMember" xlink:href="tnet-20240331.xsd#tnet_TimeBasedRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_TimeBasedRestrictedStockUnitsMember" xlink:to="lab_tnet_TimeBasedRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_52ad9b3e-850f-4958-a421-f2f1d6634dca_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_5abade98-29a2-4216-871a-9396c1cb9d02_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross proceeds from sales</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_46130063-dcee-40df-8d83-81e77c7537c6_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_06f7d6e7-d7e0-4331-a223-85f60db9129c_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Systems development and programming</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_5df7ccd2-eeab-4656-913e-e4d74c71a37e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOther_1624bcd8-daa1-4609-bc8e-6e6dce50cb5c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOther_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOther" xlink:to="lab_us-gaap_InterestIncomeOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ae47a53b-3c97-4dd8-9507-dcc03e2e1e37_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_87d6c87e-7214-4889-a0d3-9d235d7903b0_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_c0b0a2ba-2747-4884-892e-510d945baa7a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_586f0f5d-8dcc-4056-a22c-290cb539be5d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock and Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock Including Additional Paid in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_e0a0faf6-dea4-4750-b1e8-3a2f9d94ce69_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d3828ffe-2b3b-47ed-87df-c5e7c27bf7d7_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_03e5d1df-6261-4acb-a194-3a545d52410c_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entity</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAndOtherNoncurrentAssets_7aa0dc20-3878-4505-9e51-5e9b5d995d6e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsAndOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments, noncurrent</link:label>
    <link:label id="lab_us-gaap_InvestmentsAndOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_InvestmentsAndOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments and Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAndOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAndOtherNoncurrentAssets" xlink:to="lab_us-gaap_InvestmentsAndOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_409e0a02-de37-4b22-bc10-c58d5b193e7b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Cash, Cash Equivalents and Investments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents and Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_76e61e78-0098-44ef-9f9a-fe9c41ba15ce_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_InsuranceCarriersSecurityDepositsMember_4875f0b3-ca02-4c7e-8244-7c7ae7871a3c_terseLabel_en-US" xlink:label="lab_tnet_InsuranceCarriersSecurityDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other security deposits</link:label>
    <link:label id="lab_tnet_InsuranceCarriersSecurityDepositsMember_label_en-US" xlink:label="lab_tnet_InsuranceCarriersSecurityDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance Carriers Security Deposits [Member]</link:label>
    <link:label id="lab_tnet_InsuranceCarriersSecurityDepositsMember_documentation_en-US" xlink:label="lab_tnet_InsuranceCarriersSecurityDepositsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Insurance Carriers Security Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InsuranceCarriersSecurityDepositsMember" xlink:href="tnet-20240331.xsd#tnet_InsuranceCarriersSecurityDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_InsuranceCarriersSecurityDepositsMember" xlink:to="lab_tnet_InsuranceCarriersSecurityDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_659d408b-0833-4d72-890c-669c1d1755e8_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_d871267d-4c85-4e89-a098-044d5cedc601_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies (see Note 5)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7e00185c-6121-4a7e-a9c4-2c6fe095a027_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_InsurancePremiumsAndOtherPayables_36f74ad3-65de-4808-b47f-efe9e6a4f8c7_terseLabel_en-US" xlink:label="lab_tnet_InsurancePremiumsAndOtherPayables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance premiums and other payables</link:label>
    <link:label id="lab_tnet_InsurancePremiumsAndOtherPayables_label_en-US" xlink:label="lab_tnet_InsurancePremiumsAndOtherPayables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance Premiums And Other Payables</link:label>
    <link:label id="lab_tnet_InsurancePremiumsAndOtherPayables_documentation_en-US" xlink:label="lab_tnet_InsurancePremiumsAndOtherPayables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Insurance Premiums and Other Payables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InsurancePremiumsAndOtherPayables" xlink:href="tnet-20240331.xsd#tnet_InsurancePremiumsAndOtherPayables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_InsurancePremiumsAndOtherPayables" xlink:to="lab_tnet_InsurancePremiumsAndOtherPayables" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_8a7c2046-112e-413e-934c-b0f2883b0b13_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_9922adc4-45ba-4784-8e02-3e229769de02_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance period for 2024 and 2023 awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_d171909b-e7b7-404f-81d2-7d3a1ff8495f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_148fbef4-bb54-4541-ac5d-ade3fcf5ae0b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Client deposits and other client liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_4673e4fd-6ad6-44bb-a749-7235490636db_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_SystemsDevelopmentAndProgrammingCostsMember_e396f348-30bb-42a3-834b-aa49142c1913_verboseLabel_en-US" xlink:label="lab_tnet_SystemsDevelopmentAndProgrammingCostsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Systems development and programming costs</link:label>
    <link:label id="lab_tnet_SystemsDevelopmentAndProgrammingCostsMember_label_en-US" xlink:label="lab_tnet_SystemsDevelopmentAndProgrammingCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Systems Development And Programming Costs [Member]</link:label>
    <link:label id="lab_tnet_SystemsDevelopmentAndProgrammingCostsMember_documentation_en-US" xlink:label="lab_tnet_SystemsDevelopmentAndProgrammingCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Primary financial statement caption encompassing systems development and programming costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_SystemsDevelopmentAndProgrammingCostsMember" xlink:href="tnet-20240331.xsd#tnet_SystemsDevelopmentAndProgrammingCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_SystemsDevelopmentAndProgrammingCostsMember" xlink:to="lab_tnet_SystemsDevelopmentAndProgrammingCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_IncreaseDecreaseInOperatingLeaseLiabilities_c699f884-cda6-4ee8-82b7-2384bef315e1_terseLabel_en-US" xlink:label="lab_tnet_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_tnet_IncreaseDecreaseInOperatingLeaseLiabilities_label_en-US" xlink:label="lab_tnet_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Operating Lease Liabilities</link:label>
    <link:label id="lab_tnet_IncreaseDecreaseInOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_tnet_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:href="tnet-20240331.xsd#tnet_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="lab_tnet_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_925d58d6-4aef-4030-b864-b3ba4cf04335_terseLabel_en-US" xlink:label="lab_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payroll tax liabilities and other payroll withholdings</link:label>
    <link:label id="lab_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_label_en-US" xlink:label="lab_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Payroll Tax Liabilities And Other Payroll Withholdings</link:label>
    <link:label id="lab_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_documentation_en-US" xlink:label="lab_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Payroll Tax Liabilities And Other Payroll Withholdings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" xlink:href="tnet-20240331.xsd#tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" xlink:to="lab_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_a1399b99-957e-4fb9-92c4-7ab1f0263841_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_11c60c5e-d0db-410b-809c-c18299476917_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_d5613932-56c6-49e4-8fd0-cf5d05986f7b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, ($0.000025 par value per share; 20,000,000 shares authorized; no shares issued or outstanding at March&#160;31, 2024 and December&#160;31, 2023)</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4f959ef9-5bfb-4b5a-8f74-849a2a5f703b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_8f9b7380-18af-4f17-8ac1-b270a5f53029_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_5c5e8c6b-4537-4be8-9a60-bd6d714f9f39_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted EPS (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_5b46f457-bb42-47a1-8766-7dda30f732d8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_HealthBenefitClaimsCollateralMember_7283508f-c08f-49d7-808b-bd3e136116c5_terseLabel_en-US" xlink:label="lab_tnet_HealthBenefitClaimsCollateralMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collateral for health benefits claims</link:label>
    <link:label id="lab_tnet_HealthBenefitClaimsCollateralMember_label_en-US" xlink:label="lab_tnet_HealthBenefitClaimsCollateralMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Health Benefit Claims Collateral [Member]</link:label>
    <link:label id="lab_tnet_HealthBenefitClaimsCollateralMember_documentation_en-US" xlink:label="lab_tnet_HealthBenefitClaimsCollateralMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Health Benefit Claims Collateral [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_HealthBenefitClaimsCollateralMember" xlink:href="tnet-20240331.xsd#tnet_HealthBenefitClaimsCollateralMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_HealthBenefitClaimsCollateralMember" xlink:to="lab_tnet_HealthBenefitClaimsCollateralMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_1d77f157-26fc-45e9-8976-50255a8505d6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock and additional paid-in capital, ($0.000025 par value per share; 750,000,000 shares authorized; 50,573,176 and 50,664,471 shares issued and outstanding at March&#160;31, 2024 and December&#160;31, 2023, respectively)</link:label>
    <link:label id="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stocks, Including Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:to="lab_us-gaap_CommonStocksIncludingAdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_209ac2e9-4032-494b-a58d-a114dc8a4c07_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_d2721891-5698-4bc4-8406-c621ffcf727f_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Agency securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_16b4e58e-795c-49d9-ab48-abdb620200a8_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_81df54e3-a956-40f2-96d6-591bddeed718_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_eb984e7a-8937-4458-aa2b-761f1400403e_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_0cba8e47-912b-49d6-821f-32a2f98bac97_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5ea16670-b678-4639-af2d-5e6e6a52e462_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_de9151a3-5163-409c-87a5-21f5e6b6530c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_74089f2a-1620-4260-8fe3-4000f1d732a4_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_69eafd62-c63c-4be2-b8d0-80f6896334fd_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">INVESTMENTS</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_7de75b63-f4b2-4d51-a190-686d587856b6_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_99068620-9880-4ee3-850e-c1594524f190_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_24d34b36-c9b0-413a-a08f-9d161e57744b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8d3dc68a-6fba-4fd0-83ca-68416a22794b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock from exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ddb45da4-a2f2-4814-857a-1e9fef1c397c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Computation of Basic and Diluted EPS Attributable to Common Stock</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_fa49bd93-b9fb-4e20-84c8-cdd5ea1781eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_26ffaa2c-bdcf-4d51-95b3-ea85de40ce6a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_98115ba9-a5c2-4fba-b237-2deee9a07dc4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_17d42a99-6eaa-4501-bf29-b0ca9f6efb1f_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_f2e351c2-f6d3-449c-9140-92ab1c890221_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5bae5d6e-0208-4105-933c-86161ab08335_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_9026a64c-be5f-4f37-851b-512eaf1cd289_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Certificate of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_2ffb07b5-75a5-4178-9f81-b45a4c21bcea_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_e0d99077-a784-49b3-b907-98f9cc7407f1_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_faf85905-b97e-4f55-bcff-c14e0b8ff1fa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_c23178ff-28e4-465a-ad6d-f0817f4d3d58_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_8f757fd9-3bfd-4c6c-afbe-a96b9d6c425c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_d0cd5983-d5f2-467e-a793-c8f89878b829_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_0d5d83eb-1c7e-4213-bcd1-69b5687f3458_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Total accrued costs, beginning of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_7a2f979a-daa8-42fd-a256-4f15b4ddf54c_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Total accrued costs, end of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_207e2091-fbce-4e1e-b1c0-3a9a1847478b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total accrued costs, end of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_5ad37f59-8ea4-4b68-8e39-f416314de9e8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities, noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_4ee1846d-a593-4e69-888f-fcb7eef37860_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Incurred</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_92cdc504-6b61-4e0b-a546-f84e6d6621e2_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair value of Debt Investments by Contractual Maturity</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_4ff5e6f7-4b16-46fe-aee6-2af735db72f9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_03ac64b5-091a-4103-aa9b-00daef4d2c38_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent_09a96a3e-1b84-472d-8203-3eeb657abf45_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash, cash equivalents and investments, noncurrent</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent_0c992294-6208-432a-8668-c2b825d4f9fa_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash, cash equivalents and investments, noncurrent</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Investments, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:to="lab_us-gaap_RestrictedCashAndInvestmentsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_PayrollFundsCollectedMember_c8ef0708-45e9-44ac-af70-bb4910e67936_terseLabel_en-US" xlink:label="lab_tnet_PayrollFundsCollectedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payroll funds collected</link:label>
    <link:label id="lab_tnet_PayrollFundsCollectedMember_label_en-US" xlink:label="lab_tnet_PayrollFundsCollectedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payroll Funds Collected [Member]</link:label>
    <link:label id="lab_tnet_PayrollFundsCollectedMember_documentation_en-US" xlink:label="lab_tnet_PayrollFundsCollectedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payroll Funds Collected [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PayrollFundsCollectedMember" xlink:href="tnet-20240331.xsd#tnet_PayrollFundsCollectedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_PayrollFundsCollectedMember" xlink:to="lab_tnet_PayrollFundsCollectedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareMember_77ac8ab1-7566-4b23-a1ca-55aeaf638689_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Health Care</link:label>
    <link:label id="lab_us-gaap_HealthCareMember_label_en-US" xlink:label="lab_us-gaap_HealthCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Health Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareMember" xlink:to="lab_us-gaap_HealthCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1ca75282-f2f9-4381-a22c-845011b23cb9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Awards effectively repurchased for required employee withholding taxes</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_CashCashEquivalentsAndInvestmentsTextBlock_c8026d87-22c3-45e7-9287-bfff7c57f7b3_terseLabel_en-US" xlink:label="lab_tnet_CashCashEquivalentsAndInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED</link:label>
    <link:label id="lab_tnet_CashCashEquivalentsAndInvestmentsTextBlock_label_en-US" xlink:label="lab_tnet_CashCashEquivalentsAndInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents And Investments [Text Block]</link:label>
    <link:label id="lab_tnet_CashCashEquivalentsAndInvestmentsTextBlock_documentation_en-US" xlink:label="lab_tnet_CashCashEquivalentsAndInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents and Investments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CashCashEquivalentsAndInvestmentsTextBlock" xlink:href="tnet-20240331.xsd#tnet_CashCashEquivalentsAndInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_CashCashEquivalentsAndInvestmentsTextBlock" xlink:to="lab_tnet_CashCashEquivalentsAndInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_fb45ad37-017d-491e-a2d4-62c3b1925156_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_7eca85d4-1cf3-4667-809a-4e99d43ba10c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unbilled revenue, net</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember_8c29537d-e8da-4ce2-a887-0115cd731e0a_verboseLabel_en-US" xlink:label="lab_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Performance-based RSUs and RSAs</link:label>
    <link:label id="lab_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember_label_en-US" xlink:label="lab_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance-Based Restricted Stock Units and Restricted Stock Awards [Member]</link:label>
    <link:label id="lab_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember_documentation_en-US" xlink:label="lab_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Performance-Based Restricted Stock Units and Restricted Stock Awards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember" xlink:href="tnet-20240331.xsd#tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember" xlink:to="lab_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_c8827d78-2afc-458c-9945-ebc0cc72af7e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="lab_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableFairValueDisclosure_e4a187a8-c7bc-4071-9742-7b312c436b84_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of notes payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_NotesPayableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Payable, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableFairValueDisclosure" xlink:to="lab_us-gaap_NotesPayableFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2cc2b720-55ff-4445-a13d-85da300c80d0_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock equivalents excluded from income per diluted share because of their anti-dilutive effect (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_d0d8c506-8d04-4738-a497-694f427b3c45_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9c406af6-e11d-4dad-85ac-c049c83c9344_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_09f6efeb-5cfa-45c2-87df-d14035806cf9_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_215d5eeb-79b9-4551-af8d-f846c6fbd2e8_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental schedule of noncash investing and financing activities</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_e4d41550-eed7-4717-bc24-ac3b35b1acfb_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payable for purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_4af0b607-3f19-4d2d-a49f-7589a9ea6fe5_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total paid</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a4c3d099-b8ba-4ff6-95e2-428f96cf8d47_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_21c6e702-d752-4c4d-988a-6d20e22afed1_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_017a4faf-88ab-415c-bd5d-ba1645f53f4e_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityNoncurrent_71916960-aa0d-4799-bde0-d206baa62d1b_terseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued workers' compensation costs, noncurrent, net</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityNoncurrent_9bcaafa2-ca34-4c0a-a2e2-51713e8be1aa_verboseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Payable in more than 1 year &#8232;(net of collateral paid to carriers of $3 and $4 at March&#160;31, 2024 and December&#160;31, 2023, respectively)</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Workers' Compensation Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:to="lab_us-gaap_WorkersCompensationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_87927044-e381-4ae5-bebd-075521570454_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestments_bf4049cf-74ca-4928-9e03-368476ae06d3_totalLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestments_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndInvestments" xlink:to="lab_us-gaap_RestrictedCashAndInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_247ba86e-9d9a-48d9-8749-5a9ef8663b84_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_4cbba43a-957d-4b88-a839-bc9aa474339b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of RSU Activity under Equity-Based Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_ad35a0fa-9c9e-45ff-9caa-647d1918a5e6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_4b5ca575-1917-47cb-ba8f-2ae5d74476f6_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses, net</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_ProfessionalServicesMember_e6332944-2a85-463e-aad6-170b55ed26fd_terseLabel_en-US" xlink:label="lab_tnet_ProfessionalServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Professional service revenues</link:label>
    <link:label id="lab_tnet_ProfessionalServicesMember_label_en-US" xlink:label="lab_tnet_ProfessionalServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Professional Services [Member]</link:label>
    <link:label id="lab_tnet_ProfessionalServicesMember_documentation_en-US" xlink:label="lab_tnet_ProfessionalServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Professional Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ProfessionalServicesMember" xlink:href="tnet-20240331.xsd#tnet_ProfessionalServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_ProfessionalServicesMember" xlink:to="lab_tnet_ProfessionalServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_096721d9-6435-4a83-b5a8-e51b96be04fc_totalLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_a159ea10-a5f4-4f90-86d6-470b8d2f6d42_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_687fb334-d2cd-41e4-be60-fa9135ad1195_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_a42cf9c3-e211-40fe-be58-9e1e4511cb0d_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_d5d34c07-2434-406e-900a-eb831e946e85_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidExpense_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_RevenueRemainingPerformanceObligationProvision_61c76288-87f9-4c5b-8d01-b48580499b7a_terseLabel_en-US" xlink:label="lab_tnet_RevenueRemainingPerformanceObligationProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(+) Accruals</link:label>
    <link:label id="lab_tnet_RevenueRemainingPerformanceObligationProvision_label_en-US" xlink:label="lab_tnet_RevenueRemainingPerformanceObligationProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Provision</link:label>
    <link:label id="lab_tnet_RevenueRemainingPerformanceObligationProvision_documentation_en-US" xlink:label="lab_tnet_RevenueRemainingPerformanceObligationProvision" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_RevenueRemainingPerformanceObligationProvision" xlink:href="tnet-20240331.xsd#tnet_RevenueRemainingPerformanceObligationProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_RevenueRemainingPerformanceObligationProvision" xlink:to="lab_tnet_RevenueRemainingPerformanceObligationProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_21036d73-4ae9-4da1-ab43-60f3fefabb2c_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7c3017ee-b43d-4614-a072-e73efd2cf7fa_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">End of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceAbstract_07526d6e-5c7a-4690-927c-6b7ef18b62d9_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:label id="lab_us-gaap_InsuranceAbstract_label_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceAbstract" xlink:to="lab_us-gaap_InsuranceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent_d61b641f-f20c-4f65-9670-7f1ae653fda3_terseLabel_en-US" xlink:label="lab_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued health insurance costs, net</link:label>
    <link:label id="lab_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent_label_en-US" xlink:label="lab_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collateral Paid To Insurance Carriers, Net Of Health Benefit Loss Reserves, Current</link:label>
    <link:label id="lab_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent_documentation_en-US" xlink:label="lab_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collateral Paid To Insurance Carriers, Net Of Health Benefit Loss Reserves, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent" xlink:href="tnet-20240331.xsd#tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent" xlink:to="lab_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_TrustForOurHRISUsersCollateralMember_c8ce5e5e-54af-4461-8c63-e587470cf442_terseLabel_en-US" xlink:label="lab_tnet_TrustForOurHRISUsersCollateralMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trust for our HRIS Users</link:label>
    <link:label id="lab_tnet_TrustForOurHRISUsersCollateralMember_label_en-US" xlink:label="lab_tnet_TrustForOurHRISUsersCollateralMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trust For our HRIS Users Collateral [Member]</link:label>
    <link:label id="lab_tnet_TrustForOurHRISUsersCollateralMember_documentation_en-US" xlink:label="lab_tnet_TrustForOurHRISUsersCollateralMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Trust For our HRIS Users Collateral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_TrustForOurHRISUsersCollateralMember" xlink:href="tnet-20240331.xsd#tnet_TrustForOurHRISUsersCollateralMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_TrustForOurHRISUsersCollateralMember" xlink:to="lab_tnet_TrustForOurHRISUsersCollateralMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_34f19f1e-5baa-414b-b989-b6431dcae1dc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_cddb903c-d068-4ef8-9134-3622574fb35f_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Shares issued and outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_8e688843-81dc-43d1-9b51-2d601a354925_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Shares issued and outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f97aa609-6d26-4a48-bcbe-372b1e45a861_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8aa9e06f-359a-4d8e-8b8b-d9501e32ba10_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock from vested restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_b69cea52-98d1-487a-a9ca-cc9c98b50bd5_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Client deposits and other client liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_cdcdeb24-c7c9-44a3-8a1d-f45f52cbe4e7_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e926b838-e673-46e3-996d-4c53f601d147_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_97ca1d29-e36b-49e3-bf9b-259903c02a50_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of shares that are expected to vesting percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_29ddde64-e3e3-48c0-839f-cd69f7e1f0b9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_f365b5e6-4826-4620-a049-5fe35586634a_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total costs and operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_IncreaseDecreaseInOtherPayrollAssets_12e4124a-c9b1-4471-b18a-1c518c94ddb9_negatedTerseLabel_en-US" xlink:label="lab_tnet_IncreaseDecreaseInOtherPayrollAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other payroll assets</link:label>
    <link:label id="lab_tnet_IncreaseDecreaseInOtherPayrollAssets_label_en-US" xlink:label="lab_tnet_IncreaseDecreaseInOtherPayrollAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase Decrease In Other Payroll Assets</link:label>
    <link:label id="lab_tnet_IncreaseDecreaseInOtherPayrollAssets_documentation_en-US" xlink:label="lab_tnet_IncreaseDecreaseInOtherPayrollAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase Decrease In Other Payroll Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_IncreaseDecreaseInOtherPayrollAssets" xlink:href="tnet-20240331.xsd#tnet_IncreaseDecreaseInOtherPayrollAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_IncreaseDecreaseInOtherPayrollAssets" xlink:to="lab_tnet_IncreaseDecreaseInOtherPayrollAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_dc527208-8570-4e7d-a569-492ed10eb3f8_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_73f6160c-ae81-4c10-bf1e-b93da50d92ba_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_b70df111-5956-4cf8-92b3-42336f2605c3_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents:</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_1e171136-ab72-4558-b938-ff9130648cbf_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_046c8312-1f4a-42b5-9d25-fe8d87a89f90_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Sales</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_af9c337d-0d98-4fce-b423-702bbe264a7b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_f150e23c-c679-49ca-a88a-23618e45fbc0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2c2f467f-0a35-454e-b771-b817af61f28e_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">STOCK BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_927b8416-5f8d-44ec-9a5c-cd2a7d8a4a79_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net change in cash and cash equivalents, unrestricted and restricted</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_28284b39-0fe5-4056-be80-f3778d230882_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Basis of Consolidation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_7b80c339-beb5-4731-9a96-8105c8c6b490_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Number of Shares, Par Value and Other Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:to="lab_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_05c154d0-36ea-49c3-983b-af74b29567c3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_57a41195-51cc-4633-8d16-60aa298d3d90_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unbilled revenue, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_4edaad7a-dbeb-4a43-a06e-d66c2bf9847f_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Costs and operating expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_3f811c71-6142-42c9-98ad-14060fa93cfa_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ec1d1a9e-684b-48ad-b513-49a8605266c6_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_406f026f-ff4f-4c04-a45f-f07e6b94a5c2_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_880e8c84-642c-4667-b76a-27438fd1fba8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_UnsatisfiedPerformanceObligationRollForward_156611f0-001a-49a0-9060-0000621d5d6e_terseLabel_en-US" xlink:label="lab_tnet_UnsatisfiedPerformanceObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unsatisfied Performance Obligation [Roll Forward]</link:label>
    <link:label id="lab_tnet_UnsatisfiedPerformanceObligationRollForward_label_en-US" xlink:label="lab_tnet_UnsatisfiedPerformanceObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unsatisfied Performance Obligation [Roll Forward]</link:label>
    <link:label id="lab_tnet_UnsatisfiedPerformanceObligationRollForward_documentation_en-US" xlink:label="lab_tnet_UnsatisfiedPerformanceObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unsatisfied Performance Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_UnsatisfiedPerformanceObligationRollForward" xlink:href="tnet-20240331.xsd#tnet_UnsatisfiedPerformanceObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_UnsatisfiedPerformanceObligationRollForward" xlink:to="lab_tnet_UnsatisfiedPerformanceObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_6518ea1b-356a-4e3e-886f-35710d511b4c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_2f3beae8-072e-4066-a54a-e6b3a3c3ab33_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Activities in Liability for Unpaid Claims and Claims Adjustment Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2d8108c9-2edc-4a4f-9f23-15ed6893cc7d_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_3f75d05d-13da-4eed-926c-d1bcee85c025_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_A2031NotesPayableMember_6f5c7714-d46c-4d20-882c-51a5a8d31786_terseLabel_en-US" xlink:label="lab_tnet_A2031NotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2031 Notes</link:label>
    <link:label id="lab_tnet_A2031NotesPayableMember_label_en-US" xlink:label="lab_tnet_A2031NotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2031 Notes Payable [Member]</link:label>
    <link:label id="lab_tnet_A2031NotesPayableMember_documentation_en-US" xlink:label="lab_tnet_A2031NotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2031 Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_A2031NotesPayableMember" xlink:href="tnet-20240331.xsd#tnet_A2031NotesPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_A2031NotesPayableMember" xlink:to="lab_tnet_A2031NotesPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_1f737e4a-bc56-43e5-a87b-7a4c115933d3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_0170295f-61b4-4e33-8fd7-3798ab1a025a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total stock based compensation capitalized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Amount Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_33afcbd6-0a60-4a80-a4b0-8ac04236c2f0_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_c804ed01-b709-4507-8ace-859ebaac0c16_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_dfa53cf6-a141-4561-8064-48b417005f5e_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_153022fb-7fb1-4268-b732-4a5a59116e7c_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_7750b64a-dc2b-48b7-b333-c3a5c63da096_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_bb09a590-2307-475e-a95d-d25cb4689e87_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents, unrestricted and restricted:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_9c257c12-e9e2-4f41-b268-441e4989868f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_32fdb55b-96e7-4cb7-9a19-ef5e472879ca_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_84990dc7-0386-4f70-a5c3-42de74f4850d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_977e9089-9fa0-4e36-91b8-b24174e549df_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_bab8da78-d55c-434d-a552-9d462a1207a1_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_dc774866-c33a-496b-bd29-a1cdab84165f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_9acd0a39-91e6-4e84-82c3-b6d54a50d0fd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_88574b83-adc8-45d6-af7b-e4906f63f386_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other debt securities</link:label>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDebtSecuritiesMember" xlink:to="lab_us-gaap_OtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_cdb00ea8-e1ac-4b3c-802c-a0ff2e8a21de_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedSalaries_2ffc4f43-2bb7-40b5-9982-df671c0a6324_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued wages</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedSalaries_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Salaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedSalaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedSalaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_cdd05e6d-235c-4043-a9fe-19a65049b4aa_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_b6b774d5-99c6-4aad-be6b-c5ceecd786e6_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_26dce6f0-80c2-48d1-ab3d-8347bd1fb88b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_4a66e3ad-b40d-4b57-b6a1-7764f069c80f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_7f203f5a-3241-44f7-8cb7-e0e8e90e6d50_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_710bf5a1-2383-4794-b795-c82fd8742cf1_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Shares issued and outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_5e846a72-3bbd-4e59-860c-895b1457cb36_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Shares issued and outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_8b8762ce-fa02-4e9d-a046-68b6e34fd340_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross proceeds from maturities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsMember_dd2e54d4-4e17-4be2-90c1-dc5d9a0b8ec8_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsMember_label_en-US" xlink:label="lab_us-gaap_InvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsMember" xlink:to="lab_us-gaap_InvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_cbf68709-a8cf-4cb2-a2cc-4633e2fe3134_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Issued and Outstanding Common Stock</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Common Stock Outstanding Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfExpenseAxis_2061fd6d-8806-4bdd-8757-690a58287edc_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nature of Expense [Axis]</link:label>
    <link:label id="lab_us-gaap_NatureOfExpenseAxis_label_en-US" xlink:label="lab_us-gaap_NatureOfExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nature of Expense [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfExpenseAxis" xlink:to="lab_us-gaap_NatureOfExpenseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_dc27aadd-c16e-424e-a6bb-eecc0ce844b8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_1230b9db-f860-422d-a69e-ed7367fc7999_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_c4a74e96-d97b-423b-972e-75f9c08f9918_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a176fe34-bbdc-41b4-bf6f-efb0c3ddd404_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_17e37835-8752-45a1-90ca-df14a18302d8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f4f79fcd-ec7e-4ee9-8cfc-69e4e619a694_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_9c2aa3a7-d92c-41d7-904e-28f4814c0d6b_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_3e16f093-c7a7-46f2-86c0-530cee1bada0_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_340042bf-9fd0-4b8c-bf9a-fcfee5ac800c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_54f01189-ba5c-4cda-ab87-aaffcb8cd979_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_9511568a-84fb-4a7d-8f89-116c755bd36a_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_65a587eb-4011-4a3c-898d-b60aea1d00e7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_b0d23eb1-20d8-4d2c-83f2-caf209dd8387_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Assets and Liabilities in our Consolidated Balance Sheet</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Variable Interest Entities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_119c81b6-b460-4f39-9b12-8b517d02dede_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_ccdd0917-20dd-4e23-a983-07541b0a9062_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_27d7eaf8-93f7-4cfb-a71d-948ee647f36c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Over one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36c6efbe-1c8b-431e-8751-59008ac66c23_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_127528ce-301d-4537-88d3-c357a91c43a0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of ROU asset, lease modification, impairment, and abandonment</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_5e667f8d-41fd-4b38-8d5b-2f2c61ae8296_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_3f999b90-0858-4a9c-8135-d2636d6171c9_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_260031ba-8b07-4f5a-9e93-ad3e9801f779_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_b76ad6a7-19bf-4a44-8117-afda6e15e947_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosures of cash flow information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_affa25e5-3a27-4dd2-84f3-f831c1ef8a8b_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_eca4ef3a-dc28-4a96-9087-ed17f78a35ec_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost, Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_5dadba06-27c8-4f34-98c1-843ed086e301_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities_fc64b8f9-93db-4436-a6cd-f313cf0120ec_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued workers' compensation costs, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Workers' Compensation Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_5d463a5c-61c5-4e14-b2c4-da8d41666652_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_3e51f406-7a79-4863-a315-56c2a4d5f947_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_714e96a3-cf2e-48cc-9135-1a10b9ef831c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_e83bfa0a-dd20-4655-91ca-40bf09202c20_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percent of concentration risk (less than)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_3d37edfd-0741-4ecf-80df-4a9ae1b92ae8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_6b57175a-6eb3-4a32-b325-1df2c903c04d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_306f594e-2e8a-4f91-abc1-20a8b472f6fe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral_0014596f-710b-46b7-bef1-57d930c506c3_negatedTerseLabel_en-US" xlink:label="lab_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Collateral paid to carriers and offset against accrued costs</link:label>
    <link:label id="lab_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral_eaec8233-d166-4b70-b125-e69242dbbf60_terseLabel_en-US" xlink:label="lab_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collateral paid to carriers and offset against loss reserves</link:label>
    <link:label id="lab_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral_label_en-US" xlink:label="lab_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Collateral</link:label>
    <link:label id="lab_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral_documentation_en-US" xlink:label="lab_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Collateral</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" xlink:href="tnet-20240331.xsd#tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" xlink:to="lab_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidInsurance_a4f1db2b-756a-4f8c-a6a4-5009bc128806_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepayments offsetting accrued health insurance costs</link:label>
    <link:label id="lab_us-gaap_PrepaidInsurance_label_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidInsurance" xlink:to="lab_us-gaap_PrepaidInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_f98ef9b7-e5cf-4cdb-b78b-6d7132edfc07_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_38fc64dd-47db-4e7b-b523-fbb626e3e632_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_InsuranceServicesMember_dbb03b45-d0df-40c7-ac8d-121aeac86d91_terseLabel_en-US" xlink:label="lab_tnet_InsuranceServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance service revenues</link:label>
    <link:label id="lab_tnet_InsuranceServicesMember_label_en-US" xlink:label="lab_tnet_InsuranceServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance Services [Member]</link:label>
    <link:label id="lab_tnet_InsuranceServicesMember_documentation_en-US" xlink:label="lab_tnet_InsuranceServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Insurance Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InsuranceServicesMember" xlink:href="tnet-20240331.xsd#tnet_InsuranceServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_InsuranceServicesMember" xlink:to="lab_tnet_InsuranceServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_ed06a356-adfc-4a96-a48f-7abb8cac245c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_7e048e7b-0a7c-479d-9d72-6f73ad113209_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued wages</link:label>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Salaries, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalariesCurrent" xlink:to="lab_us-gaap_AccruedSalariesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_dcdae595-670e-45ed-9416-ccbf0e090dba_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving credit agreement borrowings</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditCurrent" xlink:to="lab_us-gaap_LinesOfCreditCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_a7e9e8b1-2d4f-4020-8229-9a8ec30a06cc_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Cash and Cash Equivalents Items [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Cash Equivalents Items [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction_63d44583-7dcd-4082-81c1-1916ab7b2418_terseLabel_en-US" xlink:label="lab_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of providing services</link:label>
    <link:label id="lab_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction_label_en-US" xlink:label="lab_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost Of Goods And Service, Excluding Depreciation, Depletion, And Amortization, And Operating Insurance And Claims Costs, Production</link:label>
    <link:label id="lab_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction_documentation_en-US" xlink:label="lab_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cost Of Goods And Service, Excluding Depreciation, Depletion, And Amortization, And Operating Insurance And Claims Costs, Production</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction" xlink:href="tnet-20240331.xsd#tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction" xlink:to="lab_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_9ac0b18a-270b-4b32-8fc0-ad0ed02ab7be_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_022dfa26-3edd-48e2-9e61-1e07d30d6f60_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_64ececb1-78cc-4211-8731-0be8de0e2cb5_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_ef62c44f-f7bf-4356-9686-3e20f3c9cce3_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_ad5673f7-3d47-4c0a-9717-c3d48397f449_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_61da3fb3-371a-4d99-a1b4-dff2ee796d48_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_ce5cae00-995d-441b-ad17-19afd768bc85_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">(-) Distributions to clients</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_d021c487-1b3c-4bb7-9886-3618a418cd13_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d5a93d03-b691-41ce-b211-9c93372c52b9_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_BurtonMGoldfieldMember_label_en-US" xlink:label="lab_tnet_BurtonMGoldfieldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Burton M Goldfield [Member]</link:label>
    <link:label id="lab_tnet_BurtonMGoldfieldMember_documentation_en-US" xlink:label="lab_tnet_BurtonMGoldfieldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Burton M Goldfield</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_BurtonMGoldfieldMember" xlink:href="tnet-20240331.xsd#tnet_BurtonMGoldfieldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_BurtonMGoldfieldMember" xlink:to="lab_tnet_BurtonMGoldfieldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_66231b2e-fe5e-4459-9d45-90c016ae1dfd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_2ef6f551-7bca-40bb-a4ca-e1ba557f360e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_58844959-6872-4c2c-b434-81197d1424bf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_aff5ae57-b586-42aa-a7a7-2e5b0b045423_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_09c75e16-dd00-43e9-a7b2-d5df689af475_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_0cdabd91-b832-4d6a-a46c-4892c65d4e9f_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Software and other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_InterestExpenseBankFeesAndOther_5a5db44c-4a67-4129-aec6-1806726b7890_negatedTerseLabel_en-US" xlink:label="lab_tnet_InterestExpenseBankFeesAndOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense, bank fees and other</link:label>
    <link:label id="lab_tnet_InterestExpenseBankFeesAndOther_label_en-US" xlink:label="lab_tnet_InterestExpenseBankFeesAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Bank Fees and Other</link:label>
    <link:label id="lab_tnet_InterestExpenseBankFeesAndOther_documentation_en-US" xlink:label="lab_tnet_InterestExpenseBankFeesAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Expense, Bank Fees and Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InterestExpenseBankFeesAndOther" xlink:href="tnet-20240331.xsd#tnet_InterestExpenseBankFeesAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_InterestExpenseBankFeesAndOther" xlink:to="lab_tnet_InterestExpenseBankFeesAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6f3fddca-b7d3-472d-b672-08459ccab331_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_6b958ac6-62d5-4f53-a335-034e6aec689c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_a427ea6f-5fc6-4299-87e2-d9445902b9f8_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends authorized (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DividendsPayableAmountPerShare_label_en-US" xlink:label="lab_us-gaap_DividendsPayableAmountPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends Payable, Amount Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableAmountPerShare" xlink:to="lab_us-gaap_DividendsPayableAmountPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_a10fac1a-03bd-4103-bd0f-df317aaffcdd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_556f1855-d593-4e62-9c61-41d5297b6a10_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Investments, noncurrent</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_b595a113-cbf5-4f8d-8ccb-8e70b88f429b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_e110fdf1-99fb-408d-bd47-a41a605891e9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_e2263a7f-defd-4163-b823-c9637dcf6e67_totalLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accrued costs, net of carrier collateral offset</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_d741cbfc-8449-4339-8b46-4d73e0717a6a_terseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total accrued costs, net of carrier collateral offset</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Workers' Compensation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent" xlink:to="lab_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_d98660ed-fdd1-4c05-9ea7-fdc2b32f9dab_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_6533db03-28d8-448d-bbf4-0d69cd0e058b_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_3ca1e080-035d-4165-b350-9797e411c3c1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_3948c2ac-f9a5-4410-858a-34c511acf512_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ACCRUED WORKERS' COMPENSATION COSTS</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities_18e54a25-4ccb-4e58-89a3-0ecbc413a834_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payroll taxes payable and other payroll withholdings</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Employee-Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_a9f89347-1e66-49e8-a6c5-f7815b3711cc_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_41be9bbf-af30-45c8-bcca-65a563bb5807_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_17087d6d-53a3-40a9-bd1a-4e19e4da12c6_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_98f7bb3f-dedd-4c3e-8078-02f7a0453d36_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of deferred costs</link:label>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_label_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Other Deferred Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:to="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_138a26f1-4683-4f22-9f3e-8cc0a0d6c35c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_da882c68-0fd2-4c19-b7af-f799111da153_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_2f51b972-d5c3-4b24-898d-d2ef26ff858a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_0c8a7fd6-54b3-47f2-be5d-6c1353305af5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Dividends Declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_59f5e458-bd1b-46b9-9c66-c85488ea17ce_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash dividend declared, but not yet paid</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_5f3c419f-dc9c-41e4-93e9-4f5ac991aecd_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_796a0485-28a8-4a42-8b44-79961328072c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total incurred</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_08ac0253-c857-4d67-96c9-7c6b738bb7bf_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Over ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_6080ae85-43c5-472f-a7d8-a89d79d56e5d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Awards effectively repurchased for required employee withholding taxes</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_9ac99bf2-ee33-4efc-98a3-9ff874b1ff09_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_1d91ab23-c5fb-4207-8458-49f3daf8ee6d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_6886130d-0aa8-4c65-a68d-919649a061b3_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S. treasuries</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_95b3156b-60b2-4623-943d-dfc00a7e2bb9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes paid, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_49b2f78a-1dfc-4e06-881d-0cb92dcc3ef3_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_a57ea39a-7278-4beb-a055-4a08f3a04d52_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Financial Instruments by Significant Categories and Fair Value Measurement on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_bd7957ca-55ff-4efe-8faa-e6e4ba269ed8_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember_1759bd86-9f68-42bf-8976-c4040bc3daa9_terseLabel_en-US" xlink:label="lab_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Cash, Cash Equivalents and Investments</link:label>
    <link:label id="lab_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember_label_en-US" xlink:label="lab_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, and Cash Equivalents and Investments [Member]</link:label>
    <link:label id="lab_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember_documentation_en-US" xlink:label="lab_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restricted Cash, and Cash Equivalents and Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember" xlink:href="tnet-20240331.xsd#tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember" xlink:to="lab_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_46bf0e6c-9d10-4004-b6e2-3df3af67f9f0_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_6bcaab69-c985-4454-943b-df8c5a1f836a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_4faadffc-eee9-49e2-83df-cf8f9506042b_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities &amp; stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2cadcfe0-9e2e-4875-a1dc-19a348c6af37_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_9a61cbb9-8cf1-464e-a976-9010207dc5b0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_e642f709-e72b-40e8-a0a2-faa145b3015f_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_3e4c597f-3a09-47d8-86b6-c4a5b0a63acb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_495360d6-f22e-4e65-a1d1-afd2a3076dfc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_457d02a3-26f3-40a0-8d36-aa59e8234157_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic EPS (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_129edaa2-366a-4d0e-a700-2604e7e59fb8_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_ce610df1-6a0c-4b42-a571-5abcd0f34f82_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_0f9748fb-d298-43bc-9b11-cf8ccfcb901d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_54e6766e-6ea5-47ac-a150-fb3a0d1464bd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_CollateralbyTypeAxis_3357d1f4-6cd9-4757-b175-f492b58a50f0_terseLabel_en-US" xlink:label="lab_tnet_CollateralbyTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collateral, by Type [Axis]</link:label>
    <link:label id="lab_tnet_CollateralbyTypeAxis_label_en-US" xlink:label="lab_tnet_CollateralbyTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collateral, by Type [Axis]</link:label>
    <link:label id="lab_tnet_CollateralbyTypeAxis_documentation_en-US" xlink:label="lab_tnet_CollateralbyTypeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collateral, by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralbyTypeAxis" xlink:href="tnet-20240331.xsd#tnet_CollateralbyTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_CollateralbyTypeAxis" xlink:to="lab_tnet_CollateralbyTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_a5c31ed9-1617-46d6-89d7-2116ccfd5668_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_05b0c476-a1df-4003-b294-f147858ae30d_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_965d8e7e-ae43-4372-bc67-5e21d30ca385_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase program, remaining authorized repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_WorkersCompensationClaimsCollateralMember_9797d833-a8bc-4343-b2cf-7b1393fc9637_terseLabel_en-US" xlink:label="lab_tnet_WorkersCompensationClaimsCollateralMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collateral for workers' compensation claims</link:label>
    <link:label id="lab_tnet_WorkersCompensationClaimsCollateralMember_label_en-US" xlink:label="lab_tnet_WorkersCompensationClaimsCollateralMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Workers' Compensation Claims Collateral [Member]</link:label>
    <link:label id="lab_tnet_WorkersCompensationClaimsCollateralMember_documentation_en-US" xlink:label="lab_tnet_WorkersCompensationClaimsCollateralMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Workers' Compensation Claims Collateral [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_WorkersCompensationClaimsCollateralMember" xlink:href="tnet-20240331.xsd#tnet_WorkersCompensationClaimsCollateralMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_WorkersCompensationClaimsCollateralMember" xlink:to="lab_tnet_WorkersCompensationClaimsCollateralMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_7f4f14da-057a-4514-8ceb-9f1488667ad5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale and maturity of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_f13f28bb-90e5-4af1-9c3d-acbaac2c75bb_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_610a4e9d-cb67-4989-98f0-40b711aea752_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued health insurance costs, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Health Care Insurance Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_317253bc-25c6-4bb4-9955-5a135bee0b1f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_e0fd2d56-f207-4586-b38c-2465e7884124_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repayment of revolving credit agreement borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_7369d6a8-3401-40ea-aa2e-6edb736222e6_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Paid</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_1c82403a-5666-4f89-a1ef-7f6b72cf9d2b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7aa5c6bf-ea67-4db2-8b62-d1b91816ae76_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_1a3819d0-b69d-4387-9e69-3fafb385905f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Cash, Cash Equivalents and Investments</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_PerformanceBasedRestrictedStockUnitsMember_b8e7b503-a8f1-4540-b8ed-ed4401cb54ec_terseLabel_en-US" xlink:label="lab_tnet_PerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance-Based Restricted Stock Units</link:label>
    <link:label id="lab_tnet_PerformanceBasedRestrictedStockUnitsMember_label_en-US" xlink:label="lab_tnet_PerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance-Based Restricted Stock Units [Member]</link:label>
    <link:label id="lab_tnet_PerformanceBasedRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_tnet_PerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Performance-Based Restricted Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PerformanceBasedRestrictedStockUnitsMember" xlink:href="tnet-20240331.xsd#tnet_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_PerformanceBasedRestrictedStockUnitsMember" xlink:to="lab_tnet_PerformanceBasedRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_47f6dda0-f29e-49d0-a807-3543152e2633_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends authorized</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_6d218385-d2ff-4af0-bb35-a4306f18b02a_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_7dfb004c-a951-48ca-bc08-0f88e83d862a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Over five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_7aa52ed7-7eae-47a8-a055-b3ac78ade542_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6e308fb3-d8ad-44f8-9dcd-d62f3d085cef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_98019fe7-f1ee-412f-8f1f-ec8e6a58b1ee_terseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued workers' compensation costs, net</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_f247c4ff-55e7-4e82-bb2c-d1459cee43ff_verboseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Payable in less than 1 year&#8232;(net of collateral paid to carriers of $1 and $1 at March&#160;31, 2024 and December&#160;31, 2023, respectively)</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Workers' Compensation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WorkersCompensationLiabilityCurrent" xlink:to="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_47b28266-57f7-49ec-82f7-91db0f4f6386_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1d0c625f-a6a7-4cd3-b81e-94bccb74fb57_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dilutive effect of stock options and restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_c69bda86-520d-45fb-a86d-c6c6e4d240c0_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_b32ee8f2-a752-434d-b073-335a5fc0b92f_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cost of providing services</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingInsuranceAndClaimsCostsProduction_5e9f8524-ad67-47c4-85bc-ce324c4039df_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingInsuranceAndClaimsCostsProduction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance costs</link:label>
    <link:label id="lab_us-gaap_OperatingInsuranceAndClaimsCostsProduction_label_en-US" xlink:label="lab_us-gaap_OperatingInsuranceAndClaimsCostsProduction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Insurance and Claims Costs, Production</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingInsuranceAndClaimsCostsProduction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingInsuranceAndClaimsCostsProduction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingInsuranceAndClaimsCostsProduction" xlink:to="lab_us-gaap_OperatingInsuranceAndClaimsCostsProduction" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_AccruedHealthInsuranceCostsPolicyTextBlock_3c33ed48-89f6-4a84-a2c2-955293d8eabd_terseLabel_en-US" xlink:label="lab_tnet_AccruedHealthInsuranceCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued Health Insurance Costs</link:label>
    <link:label id="lab_tnet_AccruedHealthInsuranceCostsPolicyTextBlock_label_en-US" xlink:label="lab_tnet_AccruedHealthInsuranceCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Health Insurance Costs [Policy Text Block]</link:label>
    <link:label id="lab_tnet_AccruedHealthInsuranceCostsPolicyTextBlock_documentation_en-US" xlink:label="lab_tnet_AccruedHealthInsuranceCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Health Insurance Costs [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AccruedHealthInsuranceCostsPolicyTextBlock" xlink:href="tnet-20240331.xsd#tnet_AccruedHealthInsuranceCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_AccruedHealthInsuranceCostsPolicyTextBlock" xlink:to="lab_tnet_AccruedHealthInsuranceCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_3dfe32ba-a6af-4b13-ae37-a2271ca3acbe_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent_dd2aab0b-0d31-450d-84c0-4357ef6ca5ca_terseLabel_en-US" xlink:label="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net of collateral paid to carriers, payable in more than 1 year</link:label>
    <link:label id="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent_label_en-US" xlink:label="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collateral Paid To Insurance Carriers, Net Of Workers' Compensation Loss Reserves, Noncurrent</link:label>
    <link:label id="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent_documentation_en-US" xlink:label="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collateral Paid To Insurance Carriers, Net Of Workers' Compensation Loss Reserves, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent" xlink:href="tnet-20240331.xsd#tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent" xlink:to="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_d5fc34c5-c1d1-4428-9c68-32aea06d75c4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from revolving credit agreement borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_f2c83fe1-b5a1-4825-9be9-975dc2378286_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_d216852a-5264-4f9b-aecf-468bf3a7636a_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total stock based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsCurrent_6e3774fb-211b-4215-ba06-bbb5f886b653_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash, cash equivalents and investments</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsCurrent_57737eda-f733-4371-be6d-6be7c97f2d0d_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total restricted cash, cash equivalents and investments</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndInvestmentsCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Investments, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:to="lab_us-gaap_RestrictedCashAndInvestmentsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_09597f1c-f381-4bef-9a74-65aba9b6839e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_a022dcf4-f699-4ee9-89a8-05d77c79d112_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-US</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_4717b95b-51c7-4e2a-841c-3ed9561921ed_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_c38162bb-6e05-4320-93ac-2e999b5ed75f_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_9b460a7c-abde-4528-88ef-6d53e610c34e_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_28c936be-b2ad-43b7-ab68-a78c683b4c9d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), net of income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_be023062-6ff1-48f9-9fb9-333473e30e8d_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_16cb3b34-2e12-408a-b1cc-ba4ac6637608_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_6c077a4b-9738-46a3-a264-519fdac61e79_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9526b0b9-0fa1-4dd7-9edd-4c20d20eefdc_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_3850c408-7025-4a8e-a79a-312e267270cd_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_22ea5d90-1ca5-46f2-a734-5bd8a626dde5_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money market mutual funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_395e6fd7-d262-4f93-b1f1-a111e4fb2c53_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_9c94fdfc-ad8c-4701-8b8d-622fbda6b529_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_4fa926bf-12d0-4605-8b8d-0973ac62cf92_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_97b97ac0-c21f-46d3-8e6a-cc5ee5aebae3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Awards effectively repurchased for required employee withholding taxes (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_86eacd71-bfef-47cb-ad11-b71e841d2a67_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_c3ccbc29-bba4-4df4-8d69-a7d24211f846_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">One year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_5464384b-e35c-4fcc-b4d4-303838010d73_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_1e987232-4473-49e7-96b8-9fb8af6ac9e8_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt, noncurrent</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_7bcb82fc-523a-4b4f-9d48-13d53d10fd51_verboseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_be61f66b-d20e-4e4f-8d55-ac79bed11581_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_348460d6-39cf-49a4-bc19-f8bdcdfd7a35_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares of common stock outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_CollateralHeldByInsuranceCarriers_14a26d2d-234d-4743-823c-596a37678c11_terseLabel_en-US" xlink:label="lab_tnet_CollateralHeldByInsuranceCarriers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collateral held by insurance carriers</link:label>
    <link:label id="lab_tnet_CollateralHeldByInsuranceCarriers_label_en-US" xlink:label="lab_tnet_CollateralHeldByInsuranceCarriers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collateral Held By Insurance Carriers</link:label>
    <link:label id="lab_tnet_CollateralHeldByInsuranceCarriers_documentation_en-US" xlink:label="lab_tnet_CollateralHeldByInsuranceCarriers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collateral Held by Insurance Carriers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralHeldByInsuranceCarriers" xlink:href="tnet-20240331.xsd#tnet_CollateralHeldByInsuranceCarriers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_CollateralHeldByInsuranceCarriers" xlink:to="lab_tnet_CollateralHeldByInsuranceCarriers" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_CollateralByTypeDomain_bee8e8f2-82a7-4a00-af05-fb13236f31a9_terseLabel_en-US" xlink:label="lab_tnet_CollateralByTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collateral, by Type [Domain]</link:label>
    <link:label id="lab_tnet_CollateralByTypeDomain_label_en-US" xlink:label="lab_tnet_CollateralByTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collateral, by Type [Domain]</link:label>
    <link:label id="lab_tnet_CollateralByTypeDomain_documentation_en-US" xlink:label="lab_tnet_CollateralByTypeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collateral, by Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralByTypeDomain" xlink:href="tnet-20240331.xsd#tnet_CollateralByTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_CollateralByTypeDomain" xlink:to="lab_tnet_CollateralByTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_c9e1c1fe-a1f1-49ee-b98f-b954b3158399_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AFS securities, gross realized gain (loss)</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_ad79f2b5-9116-4611-85bd-070eec4d15e0_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Change in Balance of the Recovery Credit Unsatisfied Performance Obligation</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7bba5656-fdec-4422-bbcc-d3897708740d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Acquisitions of property and equipment and projects in process</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_645ff9b3-1a93-4c6e-8ce1-e606c5daafd3_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_1355f1e5-dab8-48fa-8109-0d20b948d305_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_b0b0e341-4b01-40e5-9f53-3c562d0b8e34_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_abb4ef1d-2173-4c29-86d3-36d364a7f3d7_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_43712111-56d9-4c01-856a-0894e6b37b31_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_0b2fa006-8fc6-4554-bc01-ccbd3b2698d9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_d5905c56-d0d5-4881-943c-37699c86f0d9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_982df86d-b69c-47bd-ad50-ae2c24bccc48_periodStartLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_31b7962a-bad9-4c62-933e-449f8ec0c989_periodEndLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_b699d274-aff5-4a2e-ba78-910b429bd135_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_f34449d2-6507-4c83-9656-1cc2f6f0bc6f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent_aaca2cdd-0144-476e-9ddd-7ec88cdfea64_terseLabel_en-US" xlink:label="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net of collateral paid to carriers, payable in less than one year</link:label>
    <link:label id="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent_label_en-US" xlink:label="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collateral Paid To Insurance Carriers, Net Of Workers' Compensation Loss Reserves, Current</link:label>
    <link:label id="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent_documentation_en-US" xlink:label="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collateral Paid to Insurance Carriers, Net of Workers' Compensation Loss Reserves, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent" xlink:href="tnet-20240331.xsd#tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent" xlink:to="lab_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_OtherPayrollAssetsCurrent_c11a45a7-80ac-499c-8ddf-6f1fa08ea811_terseLabel_en-US" xlink:label="lab_tnet_OtherPayrollAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other payroll assets</link:label>
    <link:label id="lab_tnet_OtherPayrollAssetsCurrent_label_en-US" xlink:label="lab_tnet_OtherPayrollAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Payroll Assets Current</link:label>
    <link:label id="lab_tnet_OtherPayrollAssetsCurrent_documentation_en-US" xlink:label="lab_tnet_OtherPayrollAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Payroll Assets Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_OtherPayrollAssetsCurrent" xlink:href="tnet-20240331.xsd#tnet_OtherPayrollAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_OtherPayrollAssetsCurrent" xlink:to="lab_tnet_OtherPayrollAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_883ff61a-e067-4051-b270-92b5c1118531_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_28e3901c-2759-4c24-b6e2-900f77b5cd7f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percent of share value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_A2029NotesPayableMember_dd9c8daa-e19f-41eb-b12b-70f20b1d46f0_terseLabel_en-US" xlink:label="lab_tnet_A2029NotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029 Notes</link:label>
    <link:label id="lab_tnet_A2029NotesPayableMember_label_en-US" xlink:label="lab_tnet_A2029NotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2029 Notes Payable [Member]</link:label>
    <link:label id="lab_tnet_A2029NotesPayableMember_documentation_en-US" xlink:label="lab_tnet_A2029NotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2029 Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_A2029NotesPayableMember" xlink:href="tnet-20240331.xsd#tnet_A2029NotesPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_A2029NotesPayableMember" xlink:to="lab_tnet_A2029NotesPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0e34e550-17e7-4110-81fd-a7cbc6cf9b54_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_627c3a06-c751-4888-be56-9ca76bd00687_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares of common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_093f8527-81ef-4709-8f5f-2162f06858a9_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_aff3b67f-b216-45d8-9cce-db506ad7a392_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_29694592-4d97-4d31-8362-1dbe96ba7c1c_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_06722683-daf2-4426-bea5-d625602e3394_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_1b843294-df04-40b3-8ec8-f992cc5819bf_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_4d5bfb4e-ff3c-46e5-ba0e-4be4892e3517_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_b91ecc5c-bc9a-4b3b-ae18-fd2cde516b1a_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_tnet_AvailableForSaleMarketableSecuritiesMember_8869b602-8ff0-4381-ab79-2a534a8cc32b_terseLabel_en-US" xlink:label="lab_tnet_AvailableForSaleMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Available-for-sale marketable securities</link:label>
    <link:label id="lab_tnet_AvailableForSaleMarketableSecuritiesMember_label_en-US" xlink:label="lab_tnet_AvailableForSaleMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Available-for-Sale Marketable Securities [Member]</link:label>
    <link:label id="lab_tnet_AvailableForSaleMarketableSecuritiesMember_documentation_en-US" xlink:label="lab_tnet_AvailableForSaleMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Available-for-Sale Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AvailableForSaleMarketableSecuritiesMember" xlink:href="tnet-20240331.xsd#tnet_AvailableForSaleMarketableSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_tnet_AvailableForSaleMarketableSecuritiesMember" xlink:to="lab_tnet_AvailableForSaleMarketableSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductInformationLineItems_60fd223c-24ae-491e-a341-efff707cfbb6_terseLabel_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductInformationLineItems_label_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductInformationLineItems" xlink:to="lab_us-gaap_ProductInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_1c2c605a-811a-4fef-a104-871f62b4efcc_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_e57d8194-26a2-4d4d-a953-11d2be76a430_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterimPeriodCostsNotAllocableDomain_114b62e3-5719-4ac0-8260-f60354ab81f3_terseLabel_en-US" xlink:label="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interim Period, Costs Not Allocable [Domain]</link:label>
    <link:label id="lab_us-gaap_InterimPeriodCostsNotAllocableDomain_label_en-US" xlink:label="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interim Period, Costs Not Allocable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:to="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_7dbfc2a1-63f1-4a1e-b9d2-88fa976dc222_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Available-for-Sale Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_34ddb454-feff-4300-84bd-529344996497_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Tranche One</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>tnet-20240331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:e2176350-5298-4836-b62a-d8f4e61deac6,g:394f270b-efa4-4896-8b8e-6d4db102e2a9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.trinet.com/role/Cover" xlink:type="simple" xlink:href="tnet-20240331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_c9d89153-996a-465c-a581-5ced0f5059b4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_DocumentType_c9d89153-996a-465c-a581-5ced0f5059b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_e0afb226-6114-49a7-b4c6-4e677c82051e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_DocumentQuarterlyReport_e0afb226-6114-49a7-b4c6-4e677c82051e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_f177202a-23f7-450f-acba-f4f48309c8c0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_DocumentPeriodEndDate_f177202a-23f7-450f-acba-f4f48309c8c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_1a1d4d4b-f16b-47df-b282-d09bd5573ed2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_DocumentTransitionReport_1a1d4d4b-f16b-47df-b282-d09bd5573ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e572d7ff-063d-4cbc-bb77-d1922c53cedc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_EntityFileNumber_e572d7ff-063d-4cbc-bb77-d1922c53cedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5c288154-ea46-4998-bc5f-a72c557f3d19" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_EntityRegistrantName_5c288154-ea46-4998-bc5f-a72c557f3d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_a3d105df-1fb6-4e57-80b4-d3a1baf0b9dc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_EntityIncorporationStateCountryCode_a3d105df-1fb6-4e57-80b4-d3a1baf0b9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_88873310-8dc4-49ab-814d-342de3917a3f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_EntityTaxIdentificationNumber_88873310-8dc4-49ab-814d-342de3917a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_5d94c010-95d2-4a47-abd7-be7c786276e0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_EntityAddressAddressLine1_5d94c010-95d2-4a47-abd7-be7c786276e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_052a2136-5b50-4c74-9550-254043c3cdc6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_EntityAddressAddressLine2_052a2136-5b50-4c74-9550-254043c3cdc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_880ea8ba-4dc4-4bb6-a9fc-298ce789f16a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_EntityAddressCityOrTown_880ea8ba-4dc4-4bb6-a9fc-298ce789f16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f8238a58-917a-4f6d-bfe4-597dd15319ae" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_EntityAddressStateOrProvince_f8238a58-917a-4f6d-bfe4-597dd15319ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_3bb1840e-e65e-4c05-8ab0-0f9aecbc0958" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_EntityAddressPostalZipCode_3bb1840e-e65e-4c05-8ab0-0f9aecbc0958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f18c1d14-a1c2-4987-b8c1-62c0e1cc791f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_CityAreaCode_f18c1d14-a1c2-4987-b8c1-62c0e1cc791f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b83cb801-e281-4b0b-b94d-fad7ee9a17aa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_LocalPhoneNumber_b83cb801-e281-4b0b-b94d-fad7ee9a17aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ed869333-153b-4bd1-bd96-61cbd07f8165" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_Security12bTitle_ed869333-153b-4bd1-bd96-61cbd07f8165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_36af1bc1-f657-4cad-975a-57f6fae3d57e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_TradingSymbol_36af1bc1-f657-4cad-975a-57f6fae3d57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_d4af15be-d0bf-42ff-81e5-7aebf1469e8d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_SecurityExchangeName_d4af15be-d0bf-42ff-81e5-7aebf1469e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_703a345b-7c89-43cd-b143-bf74564f0c5d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_EntityCurrentReportingStatus_703a345b-7c89-43cd-b143-bf74564f0c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ae02ff3d-6f0c-437b-8c64-956836131fa5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_EntityInteractiveDataCurrent_ae02ff3d-6f0c-437b-8c64-956836131fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_2c4cff31-3c55-4237-baff-597f6a7a584a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_EntityFilerCategory_2c4cff31-3c55-4237-baff-597f6a7a584a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_bb517223-fddd-447c-b7b3-421cb7ac6818" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_EntitySmallBusiness_bb517223-fddd-447c-b7b3-421cb7ac6818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_961b6f7f-59f5-473b-87ea-004b8fed7467" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_EntityEmergingGrowthCompany_961b6f7f-59f5-473b-87ea-004b8fed7467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_6f509011-9c7b-487f-9ada-4c420c8a0422" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_EntityShellCompany_6f509011-9c7b-487f-9ada-4c420c8a0422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_0fe4b9f9-f2bc-4670-a13b-3d9c63b63e6f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_0fe4b9f9-f2bc-4670-a13b-3d9c63b63e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_a8238fb2-51c7-4944-8f81-5e3a09c1b5cc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_EntityCentralIndexKey_a8238fb2-51c7-4944-8f81-5e3a09c1b5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_44c5d13a-e65d-4f1a-8fb5-bf3f0defb6bd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_CurrentFiscalYearEndDate_44c5d13a-e65d-4f1a-8fb5-bf3f0defb6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_9e01dfea-2b74-49fa-b19b-51b66817c754" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_DocumentFiscalYearFocus_9e01dfea-2b74-49fa-b19b-51b66817c754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_5b2d25a4-2158-41b0-b2f0-49fe9c1415c0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_DocumentFiscalPeriodFocus_5b2d25a4-2158-41b0-b2f0-49fe9c1415c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_07b345ff-8bed-49a1-8783-ba388e5d80be" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_1a1520b7-391b-4efa-a022-4ffbffc8a531" xlink:to="loc_dei_AmendmentFlag_07b345ff-8bed-49a1-8783-ba388e5d80be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="simple" xlink:href="tnet-20240331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_cfbf4305-461e-40ea-be7f-b44082f4b6ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_604b56b9-34e3-45e6-bc6d-78670f940b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cfbf4305-461e-40ea-be7f-b44082f4b6ba" xlink:to="loc_us-gaap_StatementTable_604b56b9-34e3-45e6-bc6d-78670f940b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e9ead2ea-0c88-49e1-81a8-2d0063adca29" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_604b56b9-34e3-45e6-bc6d-78670f940b0c" xlink:to="loc_srt_ProductOrServiceAxis_e9ead2ea-0c88-49e1-81a8-2d0063adca29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b09130ae-d013-4de0-b332-4c3c3db9ed18" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e9ead2ea-0c88-49e1-81a8-2d0063adca29" xlink:to="loc_srt_ProductsAndServicesDomain_b09130ae-d013-4de0-b332-4c3c3db9ed18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_ProfessionalServicesMember_bf0f0ee6-3bcb-4c4b-9ce7-75f8eca885e6" xlink:href="tnet-20240331.xsd#tnet_ProfessionalServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b09130ae-d013-4de0-b332-4c3c3db9ed18" xlink:to="loc_tnet_ProfessionalServicesMember_bf0f0ee6-3bcb-4c4b-9ce7-75f8eca885e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InsuranceServicesMember_42b9dbb3-e58f-492d-9fee-536c05c49421" xlink:href="tnet-20240331.xsd#tnet_InsuranceServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b09130ae-d013-4de0-b332-4c3c3db9ed18" xlink:to="loc_tnet_InsuranceServicesMember_42b9dbb3-e58f-492d-9fee-536c05c49421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_604b56b9-34e3-45e6-bc6d-78670f940b0c" xlink:to="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_20fbefbe-9f20-4182-8a87-9c79579295aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_20fbefbe-9f20-4182-8a87-9c79579295aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_a215f8cf-ca3d-4865-b9cf-827eb5be7fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_a215f8cf-ca3d-4865-b9cf-827eb5be7fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingInsuranceAndClaimsCostsProduction_e84bb1f3-f772-4dfe-a285-cbb1f09eca39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingInsuranceAndClaimsCostsProduction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_a215f8cf-ca3d-4865-b9cf-827eb5be7fbf" xlink:to="loc_us-gaap_OperatingInsuranceAndClaimsCostsProduction_e84bb1f3-f772-4dfe-a285-cbb1f09eca39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction_2158bf50-2d3b-4e3b-a7f7-1750fdf7af67" xlink:href="tnet-20240331.xsd#tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_a215f8cf-ca3d-4865-b9cf-827eb5be7fbf" xlink:to="loc_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction_2158bf50-2d3b-4e3b-a7f7-1750fdf7af67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_0a104baf-2226-425e-9df9-7ab45b1258de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_a215f8cf-ca3d-4865-b9cf-827eb5be7fbf" xlink:to="loc_us-gaap_SellingAndMarketingExpense_0a104baf-2226-425e-9df9-7ab45b1258de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_bf5b09e7-80a8-4eae-a042-1ca57cee7209" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_a215f8cf-ca3d-4865-b9cf-827eb5be7fbf" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_bf5b09e7-80a8-4eae-a042-1ca57cee7209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1b093137-562a-4658-8e79-4f731dfcc5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_a215f8cf-ca3d-4865-b9cf-827eb5be7fbf" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1b093137-562a-4658-8e79-4f731dfcc5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_b60a7117-408b-4c35-a3ff-5de19662f22f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_a215f8cf-ca3d-4865-b9cf-827eb5be7fbf" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_b60a7117-408b-4c35-a3ff-5de19662f22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_e9f26515-7157-41a0-816e-b3b9f05dda0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_a215f8cf-ca3d-4865-b9cf-827eb5be7fbf" xlink:to="loc_us-gaap_CostsAndExpenses_e9f26515-7157-41a0-816e-b3b9f05dda0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_62a11036-7aba-4f9e-81a5-f40df63787cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_OperatingIncomeLoss_62a11036-7aba-4f9e-81a5-f40df63787cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_52935f39-db96-4dd2-b73a-486c26b852db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_52935f39-db96-4dd2-b73a-486c26b852db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InterestExpenseBankFeesAndOther_7190718d-e3aa-4559-886e-094953a9560b" xlink:href="tnet-20240331.xsd#tnet_InterestExpenseBankFeesAndOther"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_52935f39-db96-4dd2-b73a-486c26b852db" xlink:to="loc_tnet_InterestExpenseBankFeesAndOther_7190718d-e3aa-4559-886e-094953a9560b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther_98daa20a-f9ad-46ce-96f4-8a43816652ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_52935f39-db96-4dd2-b73a-486c26b852db" xlink:to="loc_us-gaap_InterestIncomeOther_98daa20a-f9ad-46ce-96f4-8a43816652ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_242ede34-6fce-43ee-a2a4-e4d368fa2385" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_242ede34-6fce-43ee-a2a4-e4d368fa2385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e6e0743f-5979-4a15-b8eb-c83882f5e8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e6e0743f-5979-4a15-b8eb-c83882f5e8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6736ecea-e0ac-4942-a8b5-5f1eddf19196" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_NetIncomeLoss_6736ecea-e0ac-4942-a8b5-5f1eddf19196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_36fab06b-323d-4fc4-b9b1-d3d34191cc15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_36fab06b-323d-4fc4-b9b1-d3d34191cc15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_7bec1436-d7bc-4e18-949d-348352468dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_7bec1436-d7bc-4e18-949d-348352468dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1177a917-6b1a-482c-b793-c9d2fb4f06fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_EarningsPerShareAbstract_1177a917-6b1a-482c-b793-c9d2fb4f06fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b011105e-9dcf-4ed4-beb3-86c97cb9881a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1177a917-6b1a-482c-b793-c9d2fb4f06fa" xlink:to="loc_us-gaap_EarningsPerShareBasic_b011105e-9dcf-4ed4-beb3-86c97cb9881a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_94541652-4f8f-4bc8-8ef6-cbd76ac4a196" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1177a917-6b1a-482c-b793-c9d2fb4f06fa" xlink:to="loc_us-gaap_EarningsPerShareDiluted_94541652-4f8f-4bc8-8ef6-cbd76ac4a196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_39e8a154-b79d-4c03-bdca-e1b631a06024" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_dbe0f065-d43e-4721-9654-5fa52e52aeb5" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_39e8a154-b79d-4c03-bdca-e1b631a06024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c35a14c0-1b4d-4341-8474-b06ccb27accc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_39e8a154-b79d-4c03-bdca-e1b631a06024" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c35a14c0-1b4d-4341-8474-b06ccb27accc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9dcba2bc-aa28-41f6-a9c8-36af2f42ea27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_39e8a154-b79d-4c03-bdca-e1b631a06024" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9dcba2bc-aa28-41f6-a9c8-36af2f42ea27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="simple" xlink:href="tnet-20240331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0534b545-1aa5-4c36-a8c3-a6dfd066b556" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_305a5cb6-6048-420a-9c65-d0135e78b425" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0534b545-1aa5-4c36-a8c3-a6dfd066b556" xlink:to="loc_us-gaap_AssetsAbstract_305a5cb6-6048-420a-9c65-d0135e78b425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_cc886d59-b30e-477b-9d48-60d9cd5f35e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_305a5cb6-6048-420a-9c65-d0135e78b425" xlink:to="loc_us-gaap_AssetsCurrentAbstract_cc886d59-b30e-477b-9d48-60d9cd5f35e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ce17651c-c679-4e46-8bcd-c732bcd4c228" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cc886d59-b30e-477b-9d48-60d9cd5f35e6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ce17651c-c679-4e46-8bcd-c732bcd4c228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_cdcc9727-541f-4540-b430-c224cce08d46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cc886d59-b30e-477b-9d48-60d9cd5f35e6" xlink:to="loc_us-gaap_ShortTermInvestments_cdcc9727-541f-4540-b430-c224cce08d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_53091b33-3626-422e-a98c-42bdc005dbf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cc886d59-b30e-477b-9d48-60d9cd5f35e6" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_53091b33-3626-422e-a98c-42bdc005dbf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_c07af0f3-308e-4659-9566-a509ea9a1593" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cc886d59-b30e-477b-9d48-60d9cd5f35e6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_c07af0f3-308e-4659-9566-a509ea9a1593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_28ed8def-4ff5-46b1-9c4c-4927168313c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cc886d59-b30e-477b-9d48-60d9cd5f35e6" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_28ed8def-4ff5-46b1-9c4c-4927168313c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_a9b2213e-3dac-4d61-8c29-18c18f47678e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cc886d59-b30e-477b-9d48-60d9cd5f35e6" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_a9b2213e-3dac-4d61-8c29-18c18f47678e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_OtherPayrollAssetsCurrent_4d51ccf5-09a5-474e-80f6-4d1ca15ec330" xlink:href="tnet-20240331.xsd#tnet_OtherPayrollAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cc886d59-b30e-477b-9d48-60d9cd5f35e6" xlink:to="loc_tnet_OtherPayrollAssetsCurrent_4d51ccf5-09a5-474e-80f6-4d1ca15ec330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_6b3d61c0-15aa-474b-a523-e26982dd42f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cc886d59-b30e-477b-9d48-60d9cd5f35e6" xlink:to="loc_us-gaap_OtherAssetsCurrent_6b3d61c0-15aa-474b-a523-e26982dd42f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_155a7cd6-a612-498f-a7df-ebef4d105bec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cc886d59-b30e-477b-9d48-60d9cd5f35e6" xlink:to="loc_us-gaap_AssetsCurrent_155a7cd6-a612-498f-a7df-ebef4d105bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_284a4874-b1f7-4ee4-9c58-8b9dc0731463" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_305a5cb6-6048-420a-9c65-d0135e78b425" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_284a4874-b1f7-4ee4-9c58-8b9dc0731463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAndOtherNoncurrentAssets_40661208-ffe1-4845-bc14-f1ec30f9df2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsAndOtherNoncurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_305a5cb6-6048-420a-9c65-d0135e78b425" xlink:to="loc_us-gaap_InvestmentsAndOtherNoncurrentAssets_40661208-ffe1-4845-bc14-f1ec30f9df2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e4020907-e62a-468c-be76-a0a10711e9b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_305a5cb6-6048-420a-9c65-d0135e78b425" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e4020907-e62a-468c-be76-a0a10711e9b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_c4cfef7e-7382-47e0-ae46-cc36cdba0433" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_305a5cb6-6048-420a-9c65-d0135e78b425" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_c4cfef7e-7382-47e0-ae46-cc36cdba0433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5cbe6ef4-b2dc-4dbc-909b-c5e89beed289" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_305a5cb6-6048-420a-9c65-d0135e78b425" xlink:to="loc_us-gaap_Goodwill_5cbe6ef4-b2dc-4dbc-909b-c5e89beed289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8aa04575-28a1-452d-a1f9-e5cbac191566" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_305a5cb6-6048-420a-9c65-d0135e78b425" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_8aa04575-28a1-452d-a1f9-e5cbac191566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_7d29cfac-d0d3-4d48-aa11-db6c83236f84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_305a5cb6-6048-420a-9c65-d0135e78b425" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_7d29cfac-d0d3-4d48-aa11-db6c83236f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_96b0daf6-4747-4d4c-a03f-cd5eb7c3c651" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_305a5cb6-6048-420a-9c65-d0135e78b425" xlink:to="loc_us-gaap_Assets_96b0daf6-4747-4d4c-a03f-cd5eb7c3c651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_abd2c3c3-6e13-4634-acdd-04a11f52a0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0534b545-1aa5-4c36-a8c3-a6dfd066b556" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_abd2c3c3-6e13-4634-acdd-04a11f52a0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_53921cae-5b6f-4efa-835f-f4634be1b7b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_abd2c3c3-6e13-4634-acdd-04a11f52a0d2" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_53921cae-5b6f-4efa-835f-f4634be1b7b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_e2843d72-8b6e-401b-894d-5c8607fc5fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_53921cae-5b6f-4efa-835f-f4634be1b7b5" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_e2843d72-8b6e-401b-894d-5c8607fc5fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_c91c8197-39b0-421e-976a-bd7d30bc6472" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_53921cae-5b6f-4efa-835f-f4634be1b7b5" xlink:to="loc_us-gaap_LinesOfCreditCurrent_c91c8197-39b0-421e-976a-bd7d30bc6472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bfde3f5b-a9d1-482a-9bd1-719ae1794b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_53921cae-5b6f-4efa-835f-f4634be1b7b5" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bfde3f5b-a9d1-482a-9bd1-719ae1794b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_9a7176f2-93dc-4a2d-82f0-bfb145c20966" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_53921cae-5b6f-4efa-835f-f4634be1b7b5" xlink:to="loc_us-gaap_AccruedSalariesCurrent_9a7176f2-93dc-4a2d-82f0-bfb145c20966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent_c97a236a-f9dc-4727-ad01-570fd0a7f950" xlink:href="tnet-20240331.xsd#tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_53921cae-5b6f-4efa-835f-f4634be1b7b5" xlink:to="loc_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent_c97a236a-f9dc-4727-ad01-570fd0a7f950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_66da9826-19cb-4fbc-909e-18d2f081372b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_53921cae-5b6f-4efa-835f-f4634be1b7b5" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_66da9826-19cb-4fbc-909e-18d2f081372b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_dd508b3e-172c-46cc-ad4a-8b7837498a07" xlink:href="tnet-20240331.xsd#tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_53921cae-5b6f-4efa-835f-f4634be1b7b5" xlink:to="loc_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_dd508b3e-172c-46cc-ad4a-8b7837498a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_2207ae3a-4dfb-4d75-84b0-25a3649cce82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_53921cae-5b6f-4efa-835f-f4634be1b7b5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_2207ae3a-4dfb-4d75-84b0-25a3649cce82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InsurancePremiumsAndOtherPayables_e065ec1f-f622-4d01-b0f4-66c848cfbb1a" xlink:href="tnet-20240331.xsd#tnet_InsurancePremiumsAndOtherPayables"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_53921cae-5b6f-4efa-835f-f4634be1b7b5" xlink:to="loc_tnet_InsurancePremiumsAndOtherPayables_e065ec1f-f622-4d01-b0f4-66c848cfbb1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_be4a37fd-fae4-4264-a36c-b9c45d2737e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_53921cae-5b6f-4efa-835f-f4634be1b7b5" xlink:to="loc_us-gaap_LiabilitiesCurrent_be4a37fd-fae4-4264-a36c-b9c45d2737e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_afc4ee9e-135a-4c9e-8a2a-439ed2621ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_abd2c3c3-6e13-4634-acdd-04a11f52a0d2" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_afc4ee9e-135a-4c9e-8a2a-439ed2621ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_85db15f9-2a90-4c65-8aaa-a629b4b5e439" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_abd2c3c3-6e13-4634-acdd-04a11f52a0d2" xlink:to="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_85db15f9-2a90-4c65-8aaa-a629b4b5e439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_c5e45522-da31-442d-aee8-ffc97573ab9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_abd2c3c3-6e13-4634-acdd-04a11f52a0d2" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_c5e45522-da31-442d-aee8-ffc97573ab9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_390d0879-dc67-435b-8500-660960e34bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_abd2c3c3-6e13-4634-acdd-04a11f52a0d2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_390d0879-dc67-435b-8500-660960e34bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_5d598ceb-e0ae-4da3-b98c-cee9cd4c69ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_abd2c3c3-6e13-4634-acdd-04a11f52a0d2" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_5d598ceb-e0ae-4da3-b98c-cee9cd4c69ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5fd4b9da-7683-4340-8963-ada82bc26ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_abd2c3c3-6e13-4634-acdd-04a11f52a0d2" xlink:to="loc_us-gaap_Liabilities_5fd4b9da-7683-4340-8963-ada82bc26ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_1c9ec398-1ba4-4498-8bec-24b67df0aab1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_abd2c3c3-6e13-4634-acdd-04a11f52a0d2" xlink:to="loc_us-gaap_CommitmentsAndContingencies_1c9ec398-1ba4-4498-8bec-24b67df0aab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_b389db38-c9d3-41e3-a8be-82c8834b050e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_abd2c3c3-6e13-4634-acdd-04a11f52a0d2" xlink:to="loc_us-gaap_StockholdersEquityAbstract_b389db38-c9d3-41e3-a8be-82c8834b050e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_1a24fe27-5090-499a-924a-f83c2ae58a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b389db38-c9d3-41e3-a8be-82c8834b050e" xlink:to="loc_us-gaap_PreferredStockValue_1a24fe27-5090-499a-924a-f83c2ae58a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_69204b60-3aba-4b21-bf12-0ee07b931d67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStocksIncludingAdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b389db38-c9d3-41e3-a8be-82c8834b050e" xlink:to="loc_us-gaap_CommonStocksIncludingAdditionalPaidInCapital_69204b60-3aba-4b21-bf12-0ee07b931d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_67084d92-3f71-40c8-b9c2-2bceb0c267a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b389db38-c9d3-41e3-a8be-82c8834b050e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_67084d92-3f71-40c8-b9c2-2bceb0c267a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_04871eee-ee7a-452d-927b-a2cc1fb006b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b389db38-c9d3-41e3-a8be-82c8834b050e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_04871eee-ee7a-452d-927b-a2cc1fb006b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_540dc5f6-b296-4dca-a391-8d0c94989796" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b389db38-c9d3-41e3-a8be-82c8834b050e" xlink:to="loc_us-gaap_StockholdersEquity_540dc5f6-b296-4dca-a391-8d0c94989796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_65c11ff1-f20f-4b30-8a1c-53e94176d060" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_abd2c3c3-6e13-4634-acdd-04a11f52a0d2" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_65c11ff1-f20f-4b30-8a1c-53e94176d060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="simple" xlink:href="tnet-20240331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_dddd0b3a-a55a-423c-954b-7369c296164b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_5827b2f8-0778-496d-b905-02bd97bfb486" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dddd0b3a-a55a-423c-954b-7369c296164b" xlink:to="loc_us-gaap_StockholdersEquityAbstract_5827b2f8-0778-496d-b905-02bd97bfb486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_40d27108-5c55-4f47-acf3-6f1561f735c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5827b2f8-0778-496d-b905-02bd97bfb486" xlink:to="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_40d27108-5c55-4f47-acf3-6f1561f735c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_543d9d08-11e1-4d7d-aca0-605f42c67294" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_40d27108-5c55-4f47-acf3-6f1561f735c7" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_543d9d08-11e1-4d7d-aca0-605f42c67294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_b1ff224f-c1fa-48c4-a44a-ef10f05e8e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_40d27108-5c55-4f47-acf3-6f1561f735c7" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_b1ff224f-c1fa-48c4-a44a-ef10f05e8e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_a3a77004-206d-4982-bdd0-17b281344da1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_40d27108-5c55-4f47-acf3-6f1561f735c7" xlink:to="loc_us-gaap_PreferredStockSharesIssued_a3a77004-206d-4982-bdd0-17b281344da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_cf4e4353-1482-499d-8d22-2a5eb74d381a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract_40d27108-5c55-4f47-acf3-6f1561f735c7" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_cf4e4353-1482-499d-8d22-2a5eb74d381a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_b169b958-055d-4cef-9cea-fe3e94b2a24e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5827b2f8-0778-496d-b905-02bd97bfb486" xlink:to="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_b169b958-055d-4cef-9cea-fe3e94b2a24e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1712e383-5f95-4b67-9c26-374bde700f91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_b169b958-055d-4cef-9cea-fe3e94b2a24e" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1712e383-5f95-4b67-9c26-374bde700f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_76c8cb20-bc9c-4abb-a690-8e950284960d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_b169b958-055d-4cef-9cea-fe3e94b2a24e" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_76c8cb20-bc9c-4abb-a690-8e950284960d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_1511dd97-98b2-43b7-b6a7-5412cce3c6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_b169b958-055d-4cef-9cea-fe3e94b2a24e" xlink:to="loc_us-gaap_CommonStockSharesIssued_1511dd97-98b2-43b7-b6a7-5412cce3c6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_566de6af-531e-4b9a-b5c9-24577ce9869a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract_b169b958-055d-4cef-9cea-fe3e94b2a24e" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_566de6af-531e-4b9a-b5c9-24577ce9869a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="simple" xlink:href="tnet-20240331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_102c4a06-27d2-4f61-beb5-a7d06b76a8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4ee1ac0b-cbe9-4983-85c3-a422d504cf68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_102c4a06-27d2-4f61-beb5-a7d06b76a8ff" xlink:to="loc_us-gaap_StatementTable_4ee1ac0b-cbe9-4983-85c3-a422d504cf68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_17b3c850-94e3-4530-8611-41dc520b4851" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4ee1ac0b-cbe9-4983-85c3-a422d504cf68" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_17b3c850-94e3-4530-8611-41dc520b4851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0ad28cb9-252a-47a9-9e05-99021f6d72d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_17b3c850-94e3-4530-8611-41dc520b4851" xlink:to="loc_us-gaap_EquityComponentDomain_0ad28cb9-252a-47a9-9e05-99021f6d72d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_72aa29c0-27ee-4724-8372-64b2dab6cbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0ad28cb9-252a-47a9-9e05-99021f6d72d6" xlink:to="loc_us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember_72aa29c0-27ee-4724-8372-64b2dab6cbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_7c887640-9d71-4915-84e1-c644d1488635" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0ad28cb9-252a-47a9-9e05-99021f6d72d6" xlink:to="loc_us-gaap_RetainedEarningsMember_7c887640-9d71-4915-84e1-c644d1488635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c90acb5d-bd92-4eb7-a0cf-9ca9e4477c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0ad28cb9-252a-47a9-9e05-99021f6d72d6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c90acb5d-bd92-4eb7-a0cf-9ca9e4477c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_7b7c18c8-f9a4-4824-b35c-a40125c79029" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4ee1ac0b-cbe9-4983-85c3-a422d504cf68" xlink:to="loc_us-gaap_StatementLineItems_7b7c18c8-f9a4-4824-b35c-a40125c79029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ecf0c749-24cb-4f07-827c-12a6d174a570" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_7b7c18c8-f9a4-4824-b35c-a40125c79029" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ecf0c749-24cb-4f07-827c-12a6d174a570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a098c6df-beac-4805-a6e2-78be21313f67" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ecf0c749-24cb-4f07-827c-12a6d174a570" xlink:to="loc_us-gaap_StockholdersEquity_a098c6df-beac-4805-a6e2-78be21313f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d1e343a9-8287-458f-b454-ac5d0aa3f639" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ecf0c749-24cb-4f07-827c-12a6d174a570" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d1e343a9-8287-458f-b454-ac5d0aa3f639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f0549566-b14f-4a1b-9fac-646e7498f750" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ecf0c749-24cb-4f07-827c-12a6d174a570" xlink:to="loc_us-gaap_NetIncomeLoss_f0549566-b14f-4a1b-9fac-646e7498f750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_064df281-68c3-4ab4-942b-b0617fb47d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ecf0c749-24cb-4f07-827c-12a6d174a570" xlink:to="loc_us-gaap_DividendsCommonStockCash_064df281-68c3-4ab4-942b-b0617fb47d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_c2007dd0-a065-4495-98f1-7555b755710f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ecf0c749-24cb-4f07-827c-12a6d174a570" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_c2007dd0-a065-4495-98f1-7555b755710f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_d541415d-f238-4a21-943f-4ad5d509d8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ecf0c749-24cb-4f07-827c-12a6d174a570" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_d541415d-f238-4a21-943f-4ad5d509d8b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e44dce9b-735f-4a61-8b83-1490b4d42cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ecf0c749-24cb-4f07-827c-12a6d174a570" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e44dce9b-735f-4a61-8b83-1490b4d42cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4b939f2c-cf9a-405d-a44e-709fa95de090" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ecf0c749-24cb-4f07-827c-12a6d174a570" xlink:to="loc_us-gaap_StockholdersEquity_4b939f2c-cf9a-405d-a44e-709fa95de090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="simple" xlink:href="tnet-20240331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_4e816dec-5136-4431-8d62-e3e3a694dddb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_8cbb46a2-dc66-435f-b11d-efdebd62c6df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4e816dec-5136-4431-8d62-e3e3a694dddb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_8cbb46a2-dc66-435f-b11d-efdebd62c6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9e5fafda-f6bd-4b71-8810-f3da836da7de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_8cbb46a2-dc66-435f-b11d-efdebd62c6df" xlink:to="loc_us-gaap_NetIncomeLoss_9e5fafda-f6bd-4b71-8810-f3da836da7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4e6f9c80-3b86-4b84-aee3-a8cbc865595f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_8cbb46a2-dc66-435f-b11d-efdebd62c6df" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4e6f9c80-3b86-4b84-aee3-a8cbc865595f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_2ae4fe3a-5258-4667-92df-a6cc7da81913" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4e6f9c80-3b86-4b84-aee3-a8cbc865595f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_2ae4fe3a-5258-4667-92df-a6cc7da81913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_3ae37507-dded-4f83-8a4e-d363732269b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4e6f9c80-3b86-4b84-aee3-a8cbc865595f" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_3ae37507-dded-4f83-8a4e-d363732269b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_11bce3a5-e420-4426-8710-6537f9bdc9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4e6f9c80-3b86-4b84-aee3-a8cbc865595f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_11bce3a5-e420-4426-8710-6537f9bdc9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5d41e0e6-ff38-4ff1-b742-01ab5034029b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4e6f9c80-3b86-4b84-aee3-a8cbc865595f" xlink:to="loc_us-gaap_ShareBasedCompensation_5d41e0e6-ff38-4ff1-b742-01ab5034029b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_ca11e98a-0942-4950-a622-7b1a05151d57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4e6f9c80-3b86-4b84-aee3-a8cbc865595f" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_ca11e98a-0942-4950-a622-7b1a05151d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0af725e2-f2d9-4329-b2cb-b9f5caefaa23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4e6f9c80-3b86-4b84-aee3-a8cbc865595f" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0af725e2-f2d9-4329-b2cb-b9f5caefaa23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ae174761-6d91-4d01-b722-c6aa76fe0707" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0af725e2-f2d9-4329-b2cb-b9f5caefaa23" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_ae174761-6d91-4d01-b722-c6aa76fe0707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_4998f15a-5167-45c8-ab12-d18d32b2162d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0af725e2-f2d9-4329-b2cb-b9f5caefaa23" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerAsset_4998f15a-5167-45c8-ab12-d18d32b2162d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_62ea8363-70a1-485e-87e8-06691df28c84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0af725e2-f2d9-4329-b2cb-b9f5caefaa23" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidExpense_62ea8363-70a1-485e-87e8-06691df28c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_5dcb79e5-7029-4065-8020-20efa73baadd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0af725e2-f2d9-4329-b2cb-b9f5caefaa23" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_5dcb79e5-7029-4065-8020-20efa73baadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_IncreaseDecreaseInOtherPayrollAssets_2dac5e47-c6a7-4d13-a544-b463a921e0c6" xlink:href="tnet-20240331.xsd#tnet_IncreaseDecreaseInOtherPayrollAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0af725e2-f2d9-4329-b2cb-b9f5caefaa23" xlink:to="loc_tnet_IncreaseDecreaseInOtherPayrollAssets_2dac5e47-c6a7-4d13-a544-b463a921e0c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_179a26a7-8b4e-4907-b045-f1bed0cb7988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0af725e2-f2d9-4329-b2cb-b9f5caefaa23" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_179a26a7-8b4e-4907-b045-f1bed0cb7988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_d40867ba-1149-4af8-8c4c-a1edfca2f1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0af725e2-f2d9-4329-b2cb-b9f5caefaa23" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_d40867ba-1149-4af8-8c4c-a1edfca2f1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedSalaries_135aa22e-950d-4b78-9403-255f0f80e215" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedSalaries"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0af725e2-f2d9-4329-b2cb-b9f5caefaa23" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedSalaries_135aa22e-950d-4b78-9403-255f0f80e215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_18013154-5f05-47f2-84c1-d9b32af60d18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0af725e2-f2d9-4329-b2cb-b9f5caefaa23" xlink:to="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_18013154-5f05-47f2-84c1-d9b32af60d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities_56648441-aef7-4796-9eef-2c5fb5e65a43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0af725e2-f2d9-4329-b2cb-b9f5caefaa23" xlink:to="loc_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities_56648441-aef7-4796-9eef-2c5fb5e65a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities_6b2725f1-8faa-49cb-ab72-b6a44e2b6465" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0af725e2-f2d9-4329-b2cb-b9f5caefaa23" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities_6b2725f1-8faa-49cb-ab72-b6a44e2b6465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_IncreaseDecreaseInOperatingLeaseLiabilities_faab9fb6-71ed-40af-8ef8-252c5782f7d3" xlink:href="tnet-20240331.xsd#tnet_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0af725e2-f2d9-4329-b2cb-b9f5caefaa23" xlink:to="loc_tnet_IncreaseDecreaseInOperatingLeaseLiabilities_faab9fb6-71ed-40af-8ef8-252c5782f7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_08d81d27-b33a-42c1-b833-3f553db890f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_8cbb46a2-dc66-435f-b11d-efdebd62c6df" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_08d81d27-b33a-42c1-b833-3f553db890f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_dbe97a0d-f29e-49e2-8091-d1137de95817" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4e816dec-5136-4431-8d62-e3e3a694dddb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_dbe97a0d-f29e-49e2-8091-d1137de95817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_32edffd1-efdf-4103-ae9c-7a20d82072e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_dbe97a0d-f29e-49e2-8091-d1137de95817" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_32edffd1-efdf-4103-ae9c-7a20d82072e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_df818168-4346-467e-8a31-3a31d9b7bfef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_dbe97a0d-f29e-49e2-8091-d1137de95817" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_df818168-4346-467e-8a31-3a31d9b7bfef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_292f274a-9eee-4142-bb17-08e70ece1209" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_dbe97a0d-f29e-49e2-8091-d1137de95817" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_292f274a-9eee-4142-bb17-08e70ece1209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1ab0f503-c40c-46bf-b6f7-43a03f6b784c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_dbe97a0d-f29e-49e2-8091-d1137de95817" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1ab0f503-c40c-46bf-b6f7-43a03f6b784c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_affa5822-8393-4772-bca8-814c8b8e6105" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4e816dec-5136-4431-8d62-e3e3a694dddb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_affa5822-8393-4772-bca8-814c8b8e6105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_3bda8c4c-487e-4dc6-8ec4-818b840c2c54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_affa5822-8393-4772-bca8-814c8b8e6105" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_3bda8c4c-487e-4dc6-8ec4-818b840c2c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1272d8ed-64ca-47fa-bcf6-39a0dec9ff88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_affa5822-8393-4772-bca8-814c8b8e6105" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1272d8ed-64ca-47fa-bcf6-39a0dec9ff88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_24ada45b-e4b0-4efc-a51b-91dd5e916b62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_affa5822-8393-4772-bca8-814c8b8e6105" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_24ada45b-e4b0-4efc-a51b-91dd5e916b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_2a22c175-95e5-44ca-ac0e-a1fa6b51cfa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_affa5822-8393-4772-bca8-814c8b8e6105" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_2a22c175-95e5-44ca-ac0e-a1fa6b51cfa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4e2802a4-5b30-4749-97f3-8db8d9d63c14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_affa5822-8393-4772-bca8-814c8b8e6105" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4e2802a4-5b30-4749-97f3-8db8d9d63c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_9598b745-b5fa-4871-876c-b941b4f31d79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4e816dec-5136-4431-8d62-e3e3a694dddb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_9598b745-b5fa-4871-876c-b941b4f31d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_b8506c09-6571-406d-a0dd-3b0905075aca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4e816dec-5136-4431-8d62-e3e3a694dddb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_b8506c09-6571-406d-a0dd-3b0905075aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8b251ed7-9be0-4c4b-8130-ad0aa69ced9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_b8506c09-6571-406d-a0dd-3b0905075aca" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8b251ed7-9be0-4c4b-8130-ad0aa69ced9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b5f3c634-09bd-475a-8b10-d19ed7d8b5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_b8506c09-6571-406d-a0dd-3b0905075aca" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b5f3c634-09bd-475a-8b10-d19ed7d8b5a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_4dc6bb77-ba97-4f72-b154-971995b4e5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4e816dec-5136-4431-8d62-e3e3a694dddb" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_4dc6bb77-ba97-4f72-b154-971995b4e5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_a3f45f20-1723-4a8b-97b3-79d57e3e10cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4dc6bb77-ba97-4f72-b154-971995b4e5dd" xlink:to="loc_us-gaap_InterestPaidNet_a3f45f20-1723-4a8b-97b3-79d57e3e10cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_fe045032-ee86-48ed-b426-6c443c2d4db6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4dc6bb77-ba97-4f72-b154-971995b4e5dd" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_fe045032-ee86-48ed-b426-6c443c2d4db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_debf9ab8-f6fb-46f8-ad1d-3073b8084420" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4e816dec-5136-4431-8d62-e3e3a694dddb" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_debf9ab8-f6fb-46f8-ad1d-3073b8084420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_4185ffb0-c5b8-4c7d-85ea-465adf51cfdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_debf9ab8-f6fb-46f8-ad1d-3073b8084420" xlink:to="loc_us-gaap_DividendsCommonStockCash_4185ffb0-c5b8-4c7d-85ea-465adf51cfdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_e33f086d-7a16-4a74-a59b-f66bef326dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_debf9ab8-f6fb-46f8-ad1d-3073b8084420" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_e33f086d-7a16-4a74-a59b-f66bef326dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="tnet-20240331.xsd#DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6354bfc6-723f-4b23-ab73-5b826f39af1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_8155f13b-c6af-4831-b50c-8395147a7f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6354bfc6-723f-4b23-ab73-5b826f39af1c" xlink:to="loc_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_8155f13b-c6af-4831-b50c-8395147a7f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTED" xlink:type="simple" xlink:href="tnet-20240331.xsd#CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTED"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_1fd18dac-bb13-49ff-9df6-463d08e6a5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CashCashEquivalentsAndInvestmentsTextBlock_0f7411a7-24cf-4e58-9c95-d48233f5875d" xlink:href="tnet-20240331.xsd#tnet_CashCashEquivalentsAndInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_1fd18dac-bb13-49ff-9df6-463d08e6a5c1" xlink:to="loc_tnet_CashCashEquivalentsAndInvestmentsTextBlock_0f7411a7-24cf-4e58-9c95-d48233f5875d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INVESTMENTS" xlink:type="simple" xlink:href="tnet-20240331.xsd#INVESTMENTS"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/INVESTMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_960205ed-ec48-4b95-a18a-1c468e1dd63a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1a74b78b-b09b-41a8-8ca2-83d528c039be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_960205ed-ec48-4b95-a18a-1c468e1dd63a" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1a74b78b-b09b-41a8-8ca2-83d528c039be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTS" xlink:type="simple" xlink:href="tnet-20240331.xsd#ACCRUEDWORKERSCOMPENSATIONCOSTS"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_8240bfcf-05f9-4e58-b2b8-3034286ca37b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_6abdfa83-5f01-476b-a842-68b2b0d1ef9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_8240bfcf-05f9-4e58-b2b8-3034286ca37b" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_6abdfa83-5f01-476b-a842-68b2b0d1ef9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="tnet-20240331.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e2fc6edb-be43-45d3-8ce5-0ec3108fa66f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_10422d78-f876-4e33-af8f-5130a569f454" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e2fc6edb-be43-45d3-8ce5-0ec3108fa66f" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_10422d78-f876-4e33-af8f-5130a569f454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="tnet-20240331.xsd#STOCKBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f2466adb-f831-4233-acec-37477cbe74dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ddf8b3ec-be9a-43a5-b55e-4c3d34b0c188" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f2466adb-f831-4233-acec-37477cbe74dc" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ddf8b3ec-be9a-43a5-b55e-4c3d34b0c188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="tnet-20240331.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f8d141b0-435a-499a-bcbe-0a4047bb1a98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b840f4b6-52ea-4c3c-aaf6-10319a7ebabf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f8d141b0-435a-499a-bcbe-0a4047bb1a98" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_b840f4b6-52ea-4c3c-aaf6-10319a7ebabf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INCOMETAXES" xlink:type="simple" xlink:href="tnet-20240331.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9acd4cd9-5a13-4c10-8f00-d17ee31096e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_62c068ad-fcfb-4b62-b9c9-d85338239fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9acd4cd9-5a13-4c10-8f00-d17ee31096e5" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_62c068ad-fcfb-4b62-b9c9-d85338239fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="tnet-20240331.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1534117c-a71a-4dad-ac02-e9123c88536c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_60435928-ce57-4baf-89f0-9d9ffb5a81dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1534117c-a71a-4dad-ac02-e9123c88536c" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_60435928-ce57-4baf-89f0-9d9ffb5a81dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="tnet-20240331.xsd#DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_61e72207-2608-451c-bff4-f529f62bf247" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_17a6b961-0c3a-4d11-b601-5da82ebe82a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_61e72207-2608-451c-bff4-f529f62bf247" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_17a6b961-0c3a-4d11-b601-5da82ebe82a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_79f7b861-d35c-45aa-a6cf-57c53b01dbaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_61e72207-2608-451c-bff4-f529f62bf247" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_79f7b861-d35c-45aa-a6cf-57c53b01dbaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_eaab7925-1589-4258-a76d-6e586cb076a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_61e72207-2608-451c-bff4-f529f62bf247" xlink:to="loc_us-gaap_UseOfEstimates_eaab7925-1589-4258-a76d-6e586cb076a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_9e841353-b866-4cb5-8808-ad1b6534cd8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_61e72207-2608-451c-bff4-f529f62bf247" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_9e841353-b866-4cb5-8808-ad1b6534cd8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AccruedHealthInsuranceCostsPolicyTextBlock_fad23f0a-938c-4e3a-b4e1-59ac1df54d03" xlink:href="tnet-20240331.xsd#tnet_AccruedHealthInsuranceCostsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_61e72207-2608-451c-bff4-f529f62bf247" xlink:to="loc_tnet_AccruedHealthInsuranceCostsPolicyTextBlock_fad23f0a-938c-4e3a-b4e1-59ac1df54d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_1d640dcd-b3d8-4a86-996b-a77f396c7237" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_61e72207-2608-451c-bff4-f529f62bf247" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_1d640dcd-b3d8-4a86-996b-a77f396c7237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f5352031-f02c-4843-8d7a-8ab5c58b618d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_61e72207-2608-451c-bff4-f529f62bf247" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f5352031-f02c-4843-8d7a-8ab5c58b618d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9d85c13c-e9d5-48c1-b6e7-fd8e0ea3ad6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_61e72207-2608-451c-bff4-f529f62bf247" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9d85c13c-e9d5-48c1-b6e7-fd8e0ea3ad6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="tnet-20240331.xsd#DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7aff8e85-e20e-464c-8694-6918446def00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_86d6ca03-dea6-4cea-8491-cf15467a2655" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7aff8e85-e20e-464c-8694-6918446def00" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_86d6ca03-dea6-4cea-8491-cf15467a2655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_a4dcaec3-7566-4115-b26c-cb5eaea1172e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7aff8e85-e20e-464c-8694-6918446def00" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_a4dcaec3-7566-4115-b26c-cb5eaea1172e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDTables" xlink:type="simple" xlink:href="tnet-20240331.xsd#CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDTables"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_b9197ae7-3274-4543-a83b-109c0e15b76f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_1535e4b6-1116-4cbd-ab53-58dfa2a37328" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_b9197ae7-3274-4543-a83b-109c0e15b76f" xlink:to="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_1535e4b6-1116-4cbd-ab53-58dfa2a37328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INVESTMENTSTables" xlink:type="simple" xlink:href="tnet-20240331.xsd#INVESTMENTSTables"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/INVESTMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ecf37751-2245-4060-91e1-70b283b5373a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_b791c67b-570b-47ec-bc84-a2bd5e7fdc91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ecf37751-2245-4060-91e1-70b283b5373a" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_b791c67b-570b-47ec-bc84-a2bd5e7fdc91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_de0f695c-e1fa-436a-ad54-5b4471900a76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ecf37751-2245-4060-91e1-70b283b5373a" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_de0f695c-e1fa-436a-ad54-5b4471900a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_dcfb60c8-0ae7-4cd1-9920-a525ce0ea9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ecf37751-2245-4060-91e1-70b283b5373a" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_dcfb60c8-0ae7-4cd1-9920-a525ce0ea9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSTables" xlink:type="simple" xlink:href="tnet-20240331.xsd#ACCRUEDWORKERSCOMPENSATIONCOSTSTables"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_2db22aa7-60db-4293-83a3-21cd17b03766" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_28a5e5e8-de2a-41a1-9b39-a7b4b2e0133d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_2db22aa7-60db-4293-83a3-21cd17b03766" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_28a5e5e8-de2a-41a1-9b39-a7b4b2e0133d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="tnet-20240331.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e0908b9e-322a-4508-acd1-4841aa3d15a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_9424464d-177a-48a6-8068-226f746af512" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e0908b9e-322a-4508-acd1-4841aa3d15a4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_9424464d-177a-48a6-8068-226f746af512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_9e871cc4-ffd3-4bbe-ae03-5bbc9b8bfe5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e0908b9e-322a-4508-acd1-4841aa3d15a4" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_9e871cc4-ffd3-4bbe-ae03-5bbc9b8bfe5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="tnet-20240331.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_576fe7aa-2775-4f11-afab-a51cb8b4d9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_a927ee55-c94f-463e-b81a-b29170fa5e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_576fe7aa-2775-4f11-afab-a51cb8b4d9c4" xlink:to="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_a927ee55-c94f-463e-b81a-b29170fa5e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="tnet-20240331.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_623f44ad-d14e-4139-8a9c-9e721174d6df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_cef4e9c6-0949-4242-9679-7b35c337f4af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_623f44ad-d14e-4139-8a9c-9e721174d6df" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_cef4e9c6-0949-4242-9679-7b35c337f4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_79fd3649-b3fc-45ce-89d9-ee663c2d1e03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_0bb1d342-d5e5-40fd-b64a-936f8df3dee6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_79fd3649-b3fc-45ce-89d9-ee663c2d1e03" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_0bb1d342-d5e5-40fd-b64a-936f8df3dee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_31c23629-8233-4a85-b9eb-48e52e47fd12" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_0bb1d342-d5e5-40fd-b64a-936f8df3dee6" xlink:to="loc_srt_StatementGeographicalAxis_31c23629-8233-4a85-b9eb-48e52e47fd12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ad294dc2-9a91-476a-ac3e-f41782fa9d40" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_31c23629-8233-4a85-b9eb-48e52e47fd12" xlink:to="loc_srt_SegmentGeographicalDomain_ad294dc2-9a91-476a-ac3e-f41782fa9d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_4585f0d4-f8ac-4ede-8034-206c3508a332" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ad294dc2-9a91-476a-ac3e-f41782fa9d40" xlink:to="loc_us-gaap_NonUsMember_4585f0d4-f8ac-4ede-8034-206c3508a332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2d4dfa24-1661-4342-a2bd-9243c044f6db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_0bb1d342-d5e5-40fd-b64a-936f8df3dee6" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2d4dfa24-1661-4342-a2bd-9243c044f6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6e88a0bc-054b-4977-9b17-b83a113bbb96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2d4dfa24-1661-4342-a2bd-9243c044f6db" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6e88a0bc-054b-4977-9b17-b83a113bbb96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_c51d2827-9310-4425-acea-650c65726979" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6e88a0bc-054b-4977-9b17-b83a113bbb96" xlink:to="loc_us-gaap_SalesRevenueNetMember_c51d2827-9310-4425-acea-650c65726979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_4e1a7e2e-4743-4676-bdeb-7d278a926612" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_0bb1d342-d5e5-40fd-b64a-936f8df3dee6" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_4e1a7e2e-4743-4676-bdeb-7d278a926612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_87992512-1ab3-4373-86ad-718d6011d7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_4e1a7e2e-4743-4676-bdeb-7d278a926612" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_87992512-1ab3-4373-86ad-718d6011d7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_64e0ce78-253c-43a4-b527-868ff782bac6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_87992512-1ab3-4373-86ad-718d6011d7d3" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_64e0ce78-253c-43a4-b527-868ff782bac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_ec04f553-2cc8-4f47-9603-17e7b8a68f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_0bb1d342-d5e5-40fd-b64a-936f8df3dee6" xlink:to="loc_us-gaap_NatureOfExpenseAxis_ec04f553-2cc8-4f47-9603-17e7b8a68f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_714e7c16-254e-4025-bc16-31f3b898e548" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NatureOfExpenseAxis_ec04f553-2cc8-4f47-9603-17e7b8a68f3f" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_714e7c16-254e-4025-bc16-31f3b898e548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareMember_137f1520-97a5-4bfc-a563-72909e34765b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HealthCareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_714e7c16-254e-4025-bc16-31f3b898e548" xlink:to="loc_us-gaap_HealthCareMember_137f1520-97a5-4bfc-a563-72909e34765b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_95dfc3bc-ea02-4667-bdea-5c563fd3b4b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_0bb1d342-d5e5-40fd-b64a-936f8df3dee6" xlink:to="loc_us-gaap_ProductInformationLineItems_95dfc3bc-ea02-4667-bdea-5c563fd3b4b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_532dc492-960b-46e6-a3df-25608640c294" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_95dfc3bc-ea02-4667-bdea-5c563fd3b4b5" xlink:to="loc_us-gaap_NumberOfReportableSegments_532dc492-960b-46e6-a3df-25608640c294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_0941456a-a593-46a1-967e-f87389ceffef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_95dfc3bc-ea02-4667-bdea-5c563fd3b4b5" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_0941456a-a593-46a1-967e-f87389ceffef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_c498ca71-225c-4637-adb5-d5b2af01c05b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidInsurance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_95dfc3bc-ea02-4667-bdea-5c563fd3b4b5" xlink:to="loc_us-gaap_PrepaidInsurance_c498ca71-225c-4637-adb5-d5b2af01c05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d88a2a5f-5a49-48ea-97c5-23beb26b689d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4a3aed68-1bd3-4f5d-858b-be14fde95981" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d88a2a5f-5a49-48ea-97c5-23beb26b689d" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4a3aed68-1bd3-4f5d-858b-be14fde95981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_6a068c1d-a972-4511-8808-1c6c1e46b049" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4a3aed68-1bd3-4f5d-858b-be14fde95981" xlink:to="loc_srt_ConsolidatedEntitiesAxis_6a068c1d-a972-4511-8808-1c6c1e46b049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_7ab680f3-813f-4d3a-8817-626e788b2122" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_6a068c1d-a972-4511-8808-1c6c1e46b049" xlink:to="loc_srt_ConsolidatedEntitiesDomain_7ab680f3-813f-4d3a-8817-626e788b2122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_9fea023b-42c3-428a-ada7-8a1eeaf42ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_7ab680f3-813f-4d3a-8817-626e788b2122" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_9fea023b-42c3-428a-ada7-8a1eeaf42ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_4d269a12-d866-4cba-b717-d7ccf4f7bff5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_4a3aed68-1bd3-4f5d-858b-be14fde95981" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_4d269a12-d866-4cba-b717-d7ccf4f7bff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c5c5d478-20ce-418b-b200-75d002c4a885" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4d269a12-d866-4cba-b717-d7ccf4f7bff5" xlink:to="loc_us-gaap_AssetsAbstract_c5c5d478-20ce-418b-b200-75d002c4a885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_cc671fa7-82a0-4b25-8081-3944a247678f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c5c5d478-20ce-418b-b200-75d002c4a885" xlink:to="loc_us-gaap_AssetsCurrentAbstract_cc671fa7-82a0-4b25-8081-3944a247678f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_116e238a-2d30-4f22-9b49-bc1f02382803" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cc671fa7-82a0-4b25-8081-3944a247678f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_116e238a-2d30-4f22-9b49-bc1f02382803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_021ad659-4654-4e04-9523-84191f9f129a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cc671fa7-82a0-4b25-8081-3944a247678f" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_021ad659-4654-4e04-9523-84191f9f129a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_efb3944d-e229-475d-8205-d2ed6b7cb128" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_cc671fa7-82a0-4b25-8081-3944a247678f" xlink:to="loc_us-gaap_AssetsCurrent_efb3944d-e229-475d-8205-d2ed6b7cb128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d74e92ba-e529-46c5-a1ac-32af350376f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c5c5d478-20ce-418b-b200-75d002c4a885" xlink:to="loc_us-gaap_Assets_d74e92ba-e529-46c5-a1ac-32af350376f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_04133187-7c1c-4d32-92d2-48c698d0a866" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4d269a12-d866-4cba-b717-d7ccf4f7bff5" xlink:to="loc_us-gaap_LiabilitiesAbstract_04133187-7c1c-4d32-92d2-48c698d0a866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_b5a8d533-dbc3-45ba-811e-da93f565580c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_04133187-7c1c-4d32-92d2-48c698d0a866" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_b5a8d533-dbc3-45ba-811e-da93f565580c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_8b8ea3e8-4bdc-452d-b596-43bcdd658182" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b5a8d533-dbc3-45ba-811e-da93f565580c" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_8b8ea3e8-4bdc-452d-b596-43bcdd658182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_42496906-1ed9-44d1-a012-cda5475756c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b5a8d533-dbc3-45ba-811e-da93f565580c" xlink:to="loc_us-gaap_AccruedSalariesCurrent_42496906-1ed9-44d1-a012-cda5475756c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_c4127cd8-8592-4b08-9697-d9e5a6cb111d" xlink:href="tnet-20240331.xsd#tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b5a8d533-dbc3-45ba-811e-da93f565580c" xlink:to="loc_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings_c4127cd8-8592-4b08-9697-d9e5a6cb111d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d32fb33f-ba11-44d0-9431-e5c3eb884d41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b5a8d533-dbc3-45ba-811e-da93f565580c" xlink:to="loc_us-gaap_LiabilitiesCurrent_d32fb33f-ba11-44d0-9431-e5c3eb884d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a1d00aa4-06e8-4d16-a0d8-9f9e8d1afc0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_04133187-7c1c-4d32-92d2-48c698d0a866" xlink:to="loc_us-gaap_Liabilities_a1d00aa4-06e8-4d16-a0d8-9f9e8d1afc0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofChangeinBalanceoftheRecoveryCreditUnsatisfiedPerformanceObligationDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofChangeinBalanceoftheRecoveryCreditUnsatisfiedPerformanceObligationDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofChangeinBalanceoftheRecoveryCreditUnsatisfiedPerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_458bc3c2-d396-4676-be07-065abdea3b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_UnsatisfiedPerformanceObligationRollForward_d4464faa-30a8-43b0-9af1-998b44222479" xlink:href="tnet-20240331.xsd#tnet_UnsatisfiedPerformanceObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_458bc3c2-d396-4676-be07-065abdea3b3d" xlink:to="loc_tnet_UnsatisfiedPerformanceObligationRollForward_d4464faa-30a8-43b0-9af1-998b44222479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_91972a8e-3a84-486a-a432-f4bbc0f2eac0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_UnsatisfiedPerformanceObligationRollForward_d4464faa-30a8-43b0-9af1-998b44222479" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_91972a8e-3a84-486a-a432-f4bbc0f2eac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_RevenueRemainingPerformanceObligationProvision_eb0b78d1-a8cf-4b26-bb96-e3a7add0808c" xlink:href="tnet-20240331.xsd#tnet_RevenueRemainingPerformanceObligationProvision"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_UnsatisfiedPerformanceObligationRollForward_d4464faa-30a8-43b0-9af1-998b44222479" xlink:to="loc_tnet_RevenueRemainingPerformanceObligationProvision_eb0b78d1-a8cf-4b26-bb96-e3a7add0808c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_e82b78f9-9215-4058-a553-4163acaef87a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_UnsatisfiedPerformanceObligationRollForward_d4464faa-30a8-43b0-9af1-998b44222479" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_e82b78f9-9215-4058-a553-4163acaef87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_465366d8-f497-4017-8df8-2c58aa094593" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_UnsatisfiedPerformanceObligationRollForward_d4464faa-30a8-43b0-9af1-998b44222479" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_465366d8-f497-4017-8df8-2c58aa094593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_28dadc98-a75f-4d6c-ba5a-d40dbc97276e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_1397cf83-93f4-4468-8b4f-d41a19a604b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_28dadc98-a75f-4d6c-ba5a-d40dbc97276e" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_1397cf83-93f4-4468-8b4f-d41a19a604b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b6fa4865-731c-4f81-983e-b06813e45c32" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_1397cf83-93f4-4468-8b4f-d41a19a604b7" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b6fa4865-731c-4f81-983e-b06813e45c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e148824-48b3-4080-8ba3-c0cd48855755" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b6fa4865-731c-4f81-983e-b06813e45c32" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e148824-48b3-4080-8ba3-c0cd48855755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_30f037f7-30d2-448c-9275-0132e4748508" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e148824-48b3-4080-8ba3-c0cd48855755" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_30f037f7-30d2-448c-9275-0132e4748508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_AvailableForSaleMarketableSecuritiesMember_5ab314d9-b4af-4d34-b320-3691fa7bfe50" xlink:href="tnet-20240331.xsd#tnet_AvailableForSaleMarketableSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6e148824-48b3-4080-8ba3-c0cd48855755" xlink:to="loc_tnet_AvailableForSaleMarketableSecuritiesMember_5ab314d9-b4af-4d34-b320-3691fa7bfe50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralbyTypeAxis_1a3f9786-a1cf-476a-9cf0-432b9f978047" xlink:href="tnet-20240331.xsd#tnet_CollateralbyTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_1397cf83-93f4-4468-8b4f-d41a19a604b7" xlink:to="loc_tnet_CollateralbyTypeAxis_1a3f9786-a1cf-476a-9cf0-432b9f978047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralByTypeDomain_4aaeab67-96a9-46d0-a1bb-c46b8b89f093" xlink:href="tnet-20240331.xsd#tnet_CollateralByTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_CollateralbyTypeAxis_1a3f9786-a1cf-476a-9cf0-432b9f978047" xlink:to="loc_tnet_CollateralByTypeDomain_4aaeab67-96a9-46d0-a1bb-c46b8b89f093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PayrollFundsCollectedMember_79de5487-56b6-44d5-b8f3-fcc034e5c155" xlink:href="tnet-20240331.xsd#tnet_PayrollFundsCollectedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_CollateralByTypeDomain_4aaeab67-96a9-46d0-a1bb-c46b8b89f093" xlink:to="loc_tnet_PayrollFundsCollectedMember_79de5487-56b6-44d5-b8f3-fcc034e5c155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_HealthBenefitClaimsCollateralMember_ed224ea1-2235-4f5e-a151-180e05f0d39d" xlink:href="tnet-20240331.xsd#tnet_HealthBenefitClaimsCollateralMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_CollateralByTypeDomain_4aaeab67-96a9-46d0-a1bb-c46b8b89f093" xlink:to="loc_tnet_HealthBenefitClaimsCollateralMember_ed224ea1-2235-4f5e-a151-180e05f0d39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_WorkersCompensationClaimsCollateralMember_b61367ac-3c13-4c9a-a11f-078588977a73" xlink:href="tnet-20240331.xsd#tnet_WorkersCompensationClaimsCollateralMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_CollateralByTypeDomain_4aaeab67-96a9-46d0-a1bb-c46b8b89f093" xlink:to="loc_tnet_WorkersCompensationClaimsCollateralMember_b61367ac-3c13-4c9a-a11f-078588977a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_TrustForOurHRISUsersCollateralMember_2479b1e1-0b51-4f99-89df-c51a4ced0017" xlink:href="tnet-20240331.xsd#tnet_TrustForOurHRISUsersCollateralMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_CollateralByTypeDomain_4aaeab67-96a9-46d0-a1bb-c46b8b89f093" xlink:to="loc_tnet_TrustForOurHRISUsersCollateralMember_2479b1e1-0b51-4f99-89df-c51a4ced0017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_InsuranceCarriersSecurityDepositsMember_cef6a196-c73f-4a48-b015-ba5cc49147f4" xlink:href="tnet-20240331.xsd#tnet_InsuranceCarriersSecurityDepositsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_tnet_CollateralByTypeDomain_4aaeab67-96a9-46d0-a1bb-c46b8b89f093" xlink:to="loc_tnet_InsuranceCarriersSecurityDepositsMember_cef6a196-c73f-4a48-b015-ba5cc49147f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_67b1c7fb-b16c-406d-a89b-9f08eba50a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable_1397cf83-93f4-4468-8b4f-d41a19a604b7" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_67b1c7fb-b16c-406d-a89b-9f08eba50a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5778e991-f562-4d88-b63b-ac983c38029b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_67b1c7fb-b16c-406d-a89b-9f08eba50a4e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5778e991-f562-4d88-b63b-ac983c38029b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_de14e3df-880e-4de7-b665-d1f974181b12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_67b1c7fb-b16c-406d-a89b-9f08eba50a4e" xlink:to="loc_us-gaap_ShortTermInvestments_de14e3df-880e-4de7-b665-d1f974181b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_0eece7b6-3bd9-46fd-a2e6-5cecd7110c54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndInvestmentsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_67b1c7fb-b16c-406d-a89b-9f08eba50a4e" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsCurrent_0eece7b6-3bd9-46fd-a2e6-5cecd7110c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_5654b26e-240a-4803-a627-03466070cb61" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_67b1c7fb-b16c-406d-a89b-9f08eba50a4e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_5654b26e-240a-4803-a627-03466070cb61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_88cf589c-1610-448d-9afe-ddfb9de28fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndInvestmentsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_67b1c7fb-b16c-406d-a89b-9f08eba50a4e" xlink:to="loc_us-gaap_RestrictedCashAndInvestmentsNoncurrent_88cf589c-1610-448d-9afe-ddfb9de28fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndInvestments_64ad123e-9233-4d01-a5fe-3911e0f268ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems_67b1c7fb-b16c-406d-a89b-9f08eba50a4e" xlink:to="loc_us-gaap_RestrictedCashAndInvestments_64ad123e-9233-4d01-a5fe-3911e0f268ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1474ad41-427d-4c63-b1b8-919d1aa80325" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_85fa7317-cdc4-47aa-8278-3088917b3b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1474ad41-427d-4c63-b1b8-919d1aa80325" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_85fa7317-cdc4-47aa-8278-3088917b3b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_2a6a41ff-6ce7-4661-bed4-5b4c39a22df9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_85fa7317-cdc4-47aa-8278-3088917b3b5a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_2a6a41ff-6ce7-4661-bed4-5b4c39a22df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6812f9a3-fb24-4e5c-96bb-3f68d04bd32e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_2a6a41ff-6ce7-4661-bed4-5b4c39a22df9" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6812f9a3-fb24-4e5c-96bb-3f68d04bd32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_d096ee4f-e6f0-4eaa-812d-09c7dbe57983" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6812f9a3-fb24-4e5c-96bb-3f68d04bd32e" xlink:to="loc_us-gaap_MoneyMarketFundsMember_d096ee4f-e6f0-4eaa-812d-09c7dbe57983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_26ba92ed-f4d5-48d7-93e1-db6002576286" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6812f9a3-fb24-4e5c-96bb-3f68d04bd32e" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_26ba92ed-f4d5-48d7-93e1-db6002576286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_c85e9619-3216-41ae-b803-b7fb3710ebfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_85fa7317-cdc4-47aa-8278-3088917b3b5a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_c85e9619-3216-41ae-b803-b7fb3710ebfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4f4634ed-8d52-49c7-9306-20f2a03d2853" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_c85e9619-3216-41ae-b803-b7fb3710ebfc" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4f4634ed-8d52-49c7-9306-20f2a03d2853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_ed6ac92b-fb00-4bf2-8bde-11c758bc1819" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4f4634ed-8d52-49c7-9306-20f2a03d2853" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_ed6ac92b-fb00-4bf2-8bde-11c758bc1819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_577d16fd-89d4-44fe-a2de-823e7e838b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4f4634ed-8d52-49c7-9306-20f2a03d2853" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_577d16fd-89d4-44fe-a2de-823e7e838b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cc1eb167-4cfb-4012-b1d4-5b8602f4a06f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4f4634ed-8d52-49c7-9306-20f2a03d2853" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_cc1eb167-4cfb-4012-b1d4-5b8602f4a06f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_cd356724-fa64-408c-ab0b-e92941ddef7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4f4634ed-8d52-49c7-9306-20f2a03d2853" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_cd356724-fa64-408c-ab0b-e92941ddef7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_ddc0fffd-ab35-4e26-b137-50e5e294c8db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4f4634ed-8d52-49c7-9306-20f2a03d2853" xlink:to="loc_us-gaap_CertificatesOfDepositMember_ddc0fffd-ab35-4e26-b137-50e5e294c8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_6620d7dd-69ed-44dd-94cc-b05979c66259" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4f4634ed-8d52-49c7-9306-20f2a03d2853" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_6620d7dd-69ed-44dd-94cc-b05979c66259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0fd7538b-cad2-4f18-b059-b25ebe09cf2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_85fa7317-cdc4-47aa-8278-3088917b3b5a" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0fd7538b-cad2-4f18-b059-b25ebe09cf2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0682aa5f-0b4e-4d4b-ac07-820cc7652f38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0fd7538b-cad2-4f18-b059-b25ebe09cf2c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0682aa5f-0b4e-4d4b-ac07-820cc7652f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_96461da0-847b-4557-8301-30bee9728fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_0682aa5f-0b4e-4d4b-ac07-820cc7652f38" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_96461da0-847b-4557-8301-30bee9728fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_656fe3d5-a83e-4784-b569-9773b2bc31c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_85fa7317-cdc4-47aa-8278-3088917b3b5a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_656fe3d5-a83e-4784-b569-9773b2bc31c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c24ca7ef-b865-4eea-994c-6e79e4797af9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_656fe3d5-a83e-4784-b569-9773b2bc31c7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c24ca7ef-b865-4eea-994c-6e79e4797af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_3b1c4522-3090-4199-ba7b-6e3ff189db41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c24ca7ef-b865-4eea-994c-6e79e4797af9" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_3b1c4522-3090-4199-ba7b-6e3ff189db41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_342486bd-5e20-444c-9a5b-380824cecc50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c24ca7ef-b865-4eea-994c-6e79e4797af9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_342486bd-5e20-444c-9a5b-380824cecc50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_08fdea25-7c8a-4427-b58f-49ad2055738a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_85fa7317-cdc4-47aa-8278-3088917b3b5a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_08fdea25-7c8a-4427-b58f-49ad2055738a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_80efae47-84c7-4f75-8b4b-561916d3d46b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_08fdea25-7c8a-4427-b58f-49ad2055738a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_80efae47-84c7-4f75-8b4b-561916d3d46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_a94cc02b-30bd-43b8-95de-bf8455acf0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_80efae47-84c7-4f75-8b4b-561916d3d46b" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_a94cc02b-30bd-43b8-95de-bf8455acf0f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember_176aa7e6-9a7e-4a6b-844b-fe93329cf71a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_80efae47-84c7-4f75-8b4b-561916d3d46b" xlink:to="loc_us-gaap_InvestmentsMember_176aa7e6-9a7e-4a6b-844b-fe93329cf71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember_3a01b077-dc5d-4b52-b15b-be69c70dc849" xlink:href="tnet-20240331.xsd#tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_80efae47-84c7-4f75-8b4b-561916d3d46b" xlink:to="loc_tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember_3a01b077-dc5d-4b52-b15b-be69c70dc849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5d50d4ad-7bcf-4156-a60c-2bc8d76f00fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_85fa7317-cdc4-47aa-8278-3088917b3b5a" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5d50d4ad-7bcf-4156-a60c-2bc8d76f00fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_2a891c9e-57af-49ad-918c-9d503e222dac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5d50d4ad-7bcf-4156-a60c-2bc8d76f00fc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_2a891c9e-57af-49ad-918c-9d503e222dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_894bbf24-90c1-4d21-95d7-a3f209d35219" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_2a891c9e-57af-49ad-918c-9d503e222dac" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_894bbf24-90c1-4d21-95d7-a3f209d35219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a3ab5338-332b-4c9e-a5a8-e5a3cf3f5c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_2a891c9e-57af-49ad-918c-9d503e222dac" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_a3ab5338-332b-4c9e-a5a8-e5a3cf3f5c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9f6fc477-c015-44e2-81b2-c3e729afe99a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_2a891c9e-57af-49ad-918c-9d503e222dac" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9f6fc477-c015-44e2-81b2-c3e729afe99a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_05385784-094a-4311-8f21-9be362fbbcb1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_2a891c9e-57af-49ad-918c-9d503e222dac" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_05385784-094a-4311-8f21-9be362fbbcb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a75b0fab-abbd-4c74-9983-c7db69e05f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_2a891c9e-57af-49ad-918c-9d503e222dac" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a75b0fab-abbd-4c74-9983-c7db69e05f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5da279ed-2e7d-4ffa-aa82-640b08d12f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_a26b7168-f0a4-4e60-b353-c44f175898e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5da279ed-2e7d-4ffa-aa82-640b08d12f7d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_a26b7168-f0a4-4e60-b353-c44f175898e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_2bbd4597-57b3-4207-afc0-6be38ce738f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5da279ed-2e7d-4ffa-aa82-640b08d12f7d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_2bbd4597-57b3-4207-afc0-6be38ce738f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_0f93d792-b56d-4218-9f31-33068a2465b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5da279ed-2e7d-4ffa-aa82-640b08d12f7d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_0f93d792-b56d-4218-9f31-33068a2465b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_c2acda5c-c0f9-40e6-a11d-65663f64b76e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5da279ed-2e7d-4ffa-aa82-640b08d12f7d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_c2acda5c-c0f9-40e6-a11d-65663f64b76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_6a225e2f-381d-488e-8a36-9cb72629d015" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5da279ed-2e7d-4ffa-aa82-640b08d12f7d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_6a225e2f-381d-488e-8a36-9cb72629d015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#INVESTMENTSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_975bb7b7-59f3-4cb7-998a-3f341ea10a62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_88180a77-5db7-482f-ab22-cb38ab0fc9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_975bb7b7-59f3-4cb7-998a-3f341ea10a62" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_88180a77-5db7-482f-ab22-cb38ab0fc9e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cecba939-005b-4aab-8cf7-aa2c487c5a09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_88180a77-5db7-482f-ab22-cb38ab0fc9e2" xlink:to="loc_us-gaap_DebtInstrumentAxis_cecba939-005b-4aab-8cf7-aa2c487c5a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d075d8b4-9513-4b27-9b69-ed6b41e5ed39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_cecba939-005b-4aab-8cf7-aa2c487c5a09" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d075d8b4-9513-4b27-9b69-ed6b41e5ed39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_A2029NotesPayableMember_b7a68d44-a383-46fa-a14b-d8da816ecdaa" xlink:href="tnet-20240331.xsd#tnet_A2029NotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d075d8b4-9513-4b27-9b69-ed6b41e5ed39" xlink:to="loc_tnet_A2029NotesPayableMember_b7a68d44-a383-46fa-a14b-d8da816ecdaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_A2031NotesPayableMember_e4ba8a90-f5e0-40fa-b69e-4f1bf58b43ee" xlink:href="tnet-20240331.xsd#tnet_A2031NotesPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d075d8b4-9513-4b27-9b69-ed6b41e5ed39" xlink:to="loc_tnet_A2031NotesPayableMember_e4ba8a90-f5e0-40fa-b69e-4f1bf58b43ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e4b1daee-a0a8-4987-a0c3-0e40e0b41b90" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_88180a77-5db7-482f-ab22-cb38ab0fc9e2" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e4b1daee-a0a8-4987-a0c3-0e40e0b41b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_2f44d6a0-55f5-4e8d-950a-7a1dfccd5d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e4b1daee-a0a8-4987-a0c3-0e40e0b41b90" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_2f44d6a0-55f5-4e8d-950a-7a1dfccd5d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableFairValueDisclosure_695e76d4-65a5-4262-82af-d7ef81f0e565" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_e4b1daee-a0a8-4987-a0c3-0e40e0b41b90" xlink:to="loc_us-gaap_NotesPayableFairValueDisclosure_695e76d4-65a5-4262-82af-d7ef81f0e565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d10ef8f4-df7b-4495-902b-1a304e5f169a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_ee17d742-4045-44d9-9ee2-e0c65e668574" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d10ef8f4-df7b-4495-902b-1a304e5f169a" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_ee17d742-4045-44d9-9ee2-e0c65e668574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_39c516c0-ab4a-49fd-b25e-ab6f601f87dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d10ef8f4-df7b-4495-902b-1a304e5f169a" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_39c516c0-ab4a-49fd-b25e-ab6f601f87dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_751f89e7-5e2d-4c8d-b498-f6e0ba23cec5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d10ef8f4-df7b-4495-902b-1a304e5f169a" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_751f89e7-5e2d-4c8d-b498-f6e0ba23cec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_4cdd8d30-a2d3-4ce1-9f80-641d241471a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_5bb588d5-0ae2-4bba-8e3b-046b2c03b225" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_4cdd8d30-a2d3-4ce1-9f80-641d241471a2" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_5bb588d5-0ae2-4bba-8e3b-046b2c03b225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_e544e1d7-69de-4ab4-a2bd-d76148547e97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_5bb588d5-0ae2-4bba-8e3b-046b2c03b225" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_e544e1d7-69de-4ab4-a2bd-d76148547e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_7f9cabe9-6245-4ba2-9776-043f522a3fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_5bb588d5-0ae2-4bba-8e3b-046b2c03b225" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_7f9cabe9-6245-4ba2-9776-043f522a3fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_4d091279-cd44-40b4-9a7a-bab23a48a5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_7f9cabe9-6245-4ba2-9776-043f522a3fd1" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_4d091279-cd44-40b4-9a7a-bab23a48a5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_3ed2fa55-cfae-4732-989c-b56c39fb6662" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_7f9cabe9-6245-4ba2-9776-043f522a3fd1" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_3ed2fa55-cfae-4732-989c-b56c39fb6662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_57beedca-09f6-4458-bdbd-3bdfcb3ee260" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_7f9cabe9-6245-4ba2-9776-043f522a3fd1" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_57beedca-09f6-4458-bdbd-3bdfcb3ee260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_093710c0-e86b-4395-9c9d-5696321a0654" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_5bb588d5-0ae2-4bba-8e3b-046b2c03b225" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_093710c0-e86b-4395-9c9d-5696321a0654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_cbedcf67-dc81-4895-9516-dde7f307b3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_093710c0-e86b-4395-9c9d-5696321a0654" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_cbedcf67-dc81-4895-9516-dde7f307b3eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_d5e75964-6f99-41c6-9aa3-a197f0ae67cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_093710c0-e86b-4395-9c9d-5696321a0654" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_d5e75964-6f99-41c6-9aa3-a197f0ae67cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_b067b16d-5380-4cfa-b1eb-2468a1b7b2dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_093710c0-e86b-4395-9c9d-5696321a0654" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_b067b16d-5380-4cfa-b1eb-2468a1b7b2dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_d01a1864-e454-4b5b-86de-95f6fb10c719" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_5bb588d5-0ae2-4bba-8e3b-046b2c03b225" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_d01a1864-e454-4b5b-86de-95f6fb10c719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_a357a30b-f1ed-4b1e-9a75-f7033d8651ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_c22459e6-fccc-420e-9f43-239fd129e474" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_a357a30b-f1ed-4b1e-9a75-f7033d8651ca" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments_c22459e6-fccc-420e-9f43-239fd129e474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral_254d5561-fc7b-4b26-a268-3bae983ed572" xlink:href="tnet-20240331.xsd#tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_a357a30b-f1ed-4b1e-9a75-f7033d8651ca" xlink:to="loc_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral_254d5561-fc7b-4b26-a268-3bae983ed572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_e0b013b0-165c-4262-8aed-b356a609c84c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_a357a30b-f1ed-4b1e-9a75-f7033d8651ca" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_e0b013b0-165c-4262-8aed-b356a609c84c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_8da2bb91-d768-4707-840e-34f51f2d523c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_a357a30b-f1ed-4b1e-9a75-f7033d8651ca" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_8da2bb91-d768-4707-840e-34f51f2d523c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_30c67d90-e521-4cde-bee0-6ac98d7371ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WorkersCompensationLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_a357a30b-f1ed-4b1e-9a75-f7033d8651ca" xlink:to="loc_us-gaap_WorkersCompensationLiabilityNoncurrent_30c67d90-e521-4cde-bee0-6ac98d7371ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_73e57a00-aa42-414d-967c-64886df886c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_a357a30b-f1ed-4b1e-9a75-f7033d8651ca" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_73e57a00-aa42-414d-967c-64886df886c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent_a47d896c-aa16-4291-a0e5-2d937eba9b66" xlink:href="tnet-20240331.xsd#tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_a357a30b-f1ed-4b1e-9a75-f7033d8651ca" xlink:to="loc_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent_a47d896c-aa16-4291-a0e5-2d937eba9b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent_61d42144-a5e2-4931-ad87-d7fa4a1a6e0c" xlink:href="tnet-20240331.xsd#tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_a357a30b-f1ed-4b1e-9a75-f7033d8651ca" xlink:to="loc_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent_61d42144-a5e2-4931-ad87-d7fa4a1a6e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSAdditionalInformationDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#ACCRUEDWORKERSCOMPENSATIONCOSTSAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_c6f029eb-1748-46f3-ab5e-dddc1bfd4ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_CollateralHeldByInsuranceCarriers_0730023d-9ca2-461a-94d6-a6827e9b7586" xlink:href="tnet-20240331.xsd#tnet_CollateralHeldByInsuranceCarriers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_c6f029eb-1748-46f3-ab5e-dddc1bfd4ee9" xlink:to="loc_tnet_CollateralHeldByInsuranceCarriers_0730023d-9ca2-461a-94d6-a6827e9b7586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral_2eb283c1-de17-4ba0-9198-0d210c9b8cec" xlink:href="tnet-20240331.xsd#tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_c6f029eb-1748-46f3-ab5e-dddc1bfd4ee9" xlink:to="loc_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral_2eb283c1-de17-4ba0-9198-0d210c9b8cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#STOCKBASEDCOMPENSATIONAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7eb311d3-07c2-4308-b4cd-91ca64901717" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cf459a58-a7e3-4db2-acfd-c92843f650ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7eb311d3-07c2-4308-b4cd-91ca64901717" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cf459a58-a7e3-4db2-acfd-c92843f650ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_23739b3b-ecdb-43d0-bc45-b541ffec5527" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cf459a58-a7e3-4db2-acfd-c92843f650ff" xlink:to="loc_us-gaap_AwardTypeAxis_23739b3b-ecdb-43d0-bc45-b541ffec5527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a35b8754-1a94-428c-a2e5-6019c8ff731a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_23739b3b-ecdb-43d0-bc45-b541ffec5527" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a35b8754-1a94-428c-a2e5-6019c8ff731a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_TimeBasedRestrictedStockUnitsMember_6e7a4842-b502-426c-bba5-8930ff96dd6c" xlink:href="tnet-20240331.xsd#tnet_TimeBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a35b8754-1a94-428c-a2e5-6019c8ff731a" xlink:to="loc_tnet_TimeBasedRestrictedStockUnitsMember_6e7a4842-b502-426c-bba5-8930ff96dd6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember_716b69c4-3dde-4a5c-a0a1-64f72a2171bd" xlink:href="tnet-20240331.xsd#tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a35b8754-1a94-428c-a2e5-6019c8ff731a" xlink:to="loc_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember_716b69c4-3dde-4a5c-a0a1-64f72a2171bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5b4019c0-daca-4135-beb0-4ead9a8e0483" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cf459a58-a7e3-4db2-acfd-c92843f650ff" xlink:to="loc_srt_RangeAxis_5b4019c0-daca-4135-beb0-4ead9a8e0483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0c5fc24d-f5c3-43ca-95b6-6f050d8c6883" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5b4019c0-daca-4135-beb0-4ead9a8e0483" xlink:to="loc_srt_RangeMember_0c5fc24d-f5c3-43ca-95b6-6f050d8c6883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_99f51da0-eff6-4ac9-a156-f11c37c3e54a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0c5fc24d-f5c3-43ca-95b6-6f050d8c6883" xlink:to="loc_srt_MinimumMember_99f51da0-eff6-4ac9-a156-f11c37c3e54a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ca1de7fb-3524-4c72-b83a-a80690a4c59e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0c5fc24d-f5c3-43ca-95b6-6f050d8c6883" xlink:to="loc_srt_MaximumMember_ca1de7fb-3524-4c72-b83a-a80690a4c59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_600421d8-89cc-473b-a9d8-5719bf53d124" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cf459a58-a7e3-4db2-acfd-c92843f650ff" xlink:to="loc_us-gaap_VestingAxis_600421d8-89cc-473b-a9d8-5719bf53d124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_ea4b92a3-f821-4c6e-8c6c-7333237ff656" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_600421d8-89cc-473b-a9d8-5719bf53d124" xlink:to="loc_us-gaap_VestingDomain_ea4b92a3-f821-4c6e-8c6c-7333237ff656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_df933015-0a86-4ce1-b8ca-d168050df934" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_ea4b92a3-f821-4c6e-8c6c-7333237ff656" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_df933015-0a86-4ce1-b8ca-d168050df934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3956b0ef-ccd4-4d20-9e43-b241e1610751" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cf459a58-a7e3-4db2-acfd-c92843f650ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3956b0ef-ccd4-4d20-9e43-b241e1610751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_47469e7f-ff28-4c71-85a9-a7723dedf082" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3956b0ef-ccd4-4d20-9e43-b241e1610751" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_47469e7f-ff28-4c71-85a9-a7723dedf082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_6d7dd196-9505-4077-a91e-52890d630ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3956b0ef-ccd4-4d20-9e43-b241e1610751" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_6d7dd196-9505-4077-a91e-52890d630ca4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_528c464b-8464-48aa-80cc-ad8becb4141c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3956b0ef-ccd4-4d20-9e43-b241e1610751" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_528c464b-8464-48aa-80cc-ad8becb4141c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_58e4baca-9bfe-4f0d-9358-72279b3f6dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3956b0ef-ccd4-4d20-9e43-b241e1610751" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_58e4baca-9bfe-4f0d-9358-72279b3f6dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_41c20190-87d2-44ec-a998-147c25a2dedd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4af477bf-2414-41b7-b403-e1794e69e0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_41c20190-87d2-44ec-a998-147c25a2dedd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4af477bf-2414-41b7-b403-e1794e69e0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1ab46831-83e0-4053-8c1d-44e39ca8f651" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4af477bf-2414-41b7-b403-e1794e69e0f4" xlink:to="loc_us-gaap_AwardTypeAxis_1ab46831-83e0-4053-8c1d-44e39ca8f651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d8d9ba2-eda9-4b78-ad97-dc2b776398ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1ab46831-83e0-4053-8c1d-44e39ca8f651" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d8d9ba2-eda9-4b78-ad97-dc2b776398ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_TimeBasedRestrictedStockUnitsMember_06976167-bdfa-4515-8368-bde4049e84e4" xlink:href="tnet-20240331.xsd#tnet_TimeBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d8d9ba2-eda9-4b78-ad97-dc2b776398ba" xlink:to="loc_tnet_TimeBasedRestrictedStockUnitsMember_06976167-bdfa-4515-8368-bde4049e84e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PerformanceBasedRestrictedStockUnitsMember_4011dc65-0cab-4f77-8f00-57338b98ab03" xlink:href="tnet-20240331.xsd#tnet_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d8d9ba2-eda9-4b78-ad97-dc2b776398ba" xlink:to="loc_tnet_PerformanceBasedRestrictedStockUnitsMember_4011dc65-0cab-4f77-8f00-57338b98ab03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8ca23d60-4051-4d85-98ca-765e90678093" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4af477bf-2414-41b7-b403-e1794e69e0f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8ca23d60-4051-4d85-98ca-765e90678093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4e08bc4d-d56c-4fcc-92c4-2a4b9fa42e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8ca23d60-4051-4d85-98ca-765e90678093" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4e08bc4d-d56c-4fcc-92c4-2a4b9fa42e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ad39f25b-9478-42ca-a744-a091fc4989bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4e08bc4d-d56c-4fcc-92c4-2a4b9fa42e1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ad39f25b-9478-42ca-a744-a091fc4989bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_150342ae-69e3-49b2-b467-08f78f6eb45c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4e08bc4d-d56c-4fcc-92c4-2a4b9fa42e1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_150342ae-69e3-49b2-b467-08f78f6eb45c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_52ca6782-bc31-4147-a5e1-3e44566e2622" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4e08bc4d-d56c-4fcc-92c4-2a4b9fa42e1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_52ca6782-bc31-4147-a5e1-3e44566e2622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7252f37e-402a-48ba-9657-d79c6da5186e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4e08bc4d-d56c-4fcc-92c4-2a4b9fa42e1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7252f37e-402a-48ba-9657-d79c6da5186e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f4239507-93c1-4cdf-b64d-f309f8b921b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_4e08bc4d-d56c-4fcc-92c4-2a4b9fa42e1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f4239507-93c1-4cdf-b64d-f309f8b921b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a93c24c-0f89-44be-866e-b9de11b70ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8ca23d60-4051-4d85-98ca-765e90678093" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a93c24c-0f89-44be-866e-b9de11b70ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6e8659dc-c644-416c-b9f3-3e35519680b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a93c24c-0f89-44be-866e-b9de11b70ce0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6e8659dc-c644-416c-b9f3-3e35519680b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a53817fd-667e-4cb6-8240-20b99a684941" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a93c24c-0f89-44be-866e-b9de11b70ce0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a53817fd-667e-4cb6-8240-20b99a684941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_bc1553f1-4478-4abd-8b06-70afd46cda9d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a93c24c-0f89-44be-866e-b9de11b70ce0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_bc1553f1-4478-4abd-8b06-70afd46cda9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_35599e9c-09a4-4885-a59c-608eee378c0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a93c24c-0f89-44be-866e-b9de11b70ce0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_35599e9c-09a4-4885-a59c-608eee378c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a670339f-5899-4da0-a468-85bb51fda8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_8a93c24c-0f89-44be-866e-b9de11b70ce0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a670339f-5899-4da0-a468-85bb51fda8ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ba113b25-f3a0-4c86-9e5c-ee441c31802f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_82907611-e8ec-4292-9fc2-54408330eafc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ba113b25-f3a0-4c86-9e5c-ee441c31802f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_82907611-e8ec-4292-9fc2-54408330eafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_30396552-70c9-4e26-97f7-8aca19c9aa9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_82907611-e8ec-4292-9fc2-54408330eafc" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_30396552-70c9-4e26-97f7-8aca19c9aa9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7cb4ef01-4474-40de-8723-46a8d68934d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_30396552-70c9-4e26-97f7-8aca19c9aa9c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7cb4ef01-4474-40de-8723-46a8d68934d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_61645070-0340-4414-b611-58610899a554" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7cb4ef01-4474-40de-8723-46a8d68934d3" xlink:to="loc_us-gaap_CostOfSalesMember_61645070-0340-4414-b611-58610899a554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_811b9ac8-1ed7-40d1-af26-00848f56d43c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7cb4ef01-4474-40de-8723-46a8d68934d3" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_811b9ac8-1ed7-40d1-af26-00848f56d43c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_382f26c7-a4c9-4bce-a899-5c211000941a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7cb4ef01-4474-40de-8723-46a8d68934d3" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_382f26c7-a4c9-4bce-a899-5c211000941a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_SystemsDevelopmentAndProgrammingCostsMember_c879f1a0-cd6c-4e45-b9de-fd9786b95ecd" xlink:href="tnet-20240331.xsd#tnet_SystemsDevelopmentAndProgrammingCostsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7cb4ef01-4474-40de-8723-46a8d68934d3" xlink:to="loc_tnet_SystemsDevelopmentAndProgrammingCostsMember_c879f1a0-cd6c-4e45-b9de-fd9786b95ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_271180a4-5956-4f63-bd45-daace8c03a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_82907611-e8ec-4292-9fc2-54408330eafc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_271180a4-5956-4f63-bd45-daace8c03a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_562c62bc-1db2-4843-8881-e473b01236fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_271180a4-5956-4f63-bd45-daace8c03a4d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_562c62bc-1db2-4843-8881-e473b01236fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_64343f91-23d4-4908-a5bb-bb7a613868f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_271180a4-5956-4f63-bd45-daace8c03a4d" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_64343f91-23d4-4908-a5bb-bb7a613868f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#STOCKHOLDERSEQUITYScheduleofCommonStockDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a2815d17-b1fb-46c3-b26f-ea5ad7924602" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_32e03d31-3bae-4d1c-a56a-f6646aef2cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a2815d17-b1fb-46c3-b26f-ea5ad7924602" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_32e03d31-3bae-4d1c-a56a-f6646aef2cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b18d24c0-bc93-4c34-922d-546a395653bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_32e03d31-3bae-4d1c-a56a-f6646aef2cc9" xlink:to="loc_us-gaap_AwardTypeAxis_b18d24c0-bc93-4c34-922d-546a395653bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76adc37b-1001-4883-9e9f-f8ecae00e3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b18d24c0-bc93-4c34-922d-546a395653bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76adc37b-1001-4883-9e9f-f8ecae00e3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_7dd3b154-545d-4576-881b-dc7269e7bbcf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76adc37b-1001-4883-9e9f-f8ecae00e3b1" xlink:to="loc_us-gaap_RestrictedStockMember_7dd3b154-545d-4576-881b-dc7269e7bbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_03d8c2ce-de89-4672-9889-3114a827ee75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_76adc37b-1001-4883-9e9f-f8ecae00e3b1" xlink:to="loc_us-gaap_StockOptionMember_03d8c2ce-de89-4672-9889-3114a827ee75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb512259-b9da-44b4-b767-99a7559eb486" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_32e03d31-3bae-4d1c-a56a-f6646aef2cc9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb512259-b9da-44b4-b767-99a7559eb486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b15cba9f-d77a-4228-888f-bf17963934df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb512259-b9da-44b4-b767-99a7559eb486" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b15cba9f-d77a-4228-888f-bf17963934df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ca995b4a-dc80-4b5c-ab00-38a63d6185ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b15cba9f-d77a-4228-888f-bf17963934df" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ca995b4a-dc80-4b5c-ab00-38a63d6185ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_b34b67e5-0df5-4b33-af5a-f4f4723fa6c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b15cba9f-d77a-4228-888f-bf17963934df" xlink:to="loc_us-gaap_CommonStockSharesIssued_b34b67e5-0df5-4b33-af5a-f4f4723fa6c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a7c64163-e634-4b3f-be5f-139db7467e53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b15cba9f-d77a-4228-888f-bf17963934df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a7c64163-e634-4b3f-be5f-139db7467e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9506a482-2aaa-4410-ac5f-01ff814bca02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b15cba9f-d77a-4228-888f-bf17963934df" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9506a482-2aaa-4410-ac5f-01ff814bca02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_bb0b09f6-8504-4e2d-8bf1-ade17bf2e4b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b15cba9f-d77a-4228-888f-bf17963934df" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_bb0b09f6-8504-4e2d-8bf1-ade17bf2e4b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_6a1669a9-841a-4f98-b8a3-23f86eb75bac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b15cba9f-d77a-4228-888f-bf17963934df" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_6a1669a9-841a-4f98-b8a3-23f86eb75bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d294752e-5e13-42fd-b016-dcb467d5fc97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b15cba9f-d77a-4228-888f-bf17963934df" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d294752e-5e13-42fd-b016-dcb467d5fc97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_ab5a6424-cd90-4f17-a635-6574dc4f7417" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_b15cba9f-d77a-4228-888f-bf17963934df" xlink:to="loc_us-gaap_CommonStockSharesIssued_ab5a6424-cd90-4f17-a635-6574dc4f7417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#STOCKHOLDERSEQUITYAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_18a45622-58d1-4244-9c52-79655f67698c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_d9bfbdab-5a2d-4e74-b06f-37258b70f1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_18a45622-58d1-4244-9c52-79655f67698c" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_d9bfbdab-5a2d-4e74-b06f-37258b70f1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_17c3fe74-09a3-4564-b6e4-1ceb7f476359" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_18a45622-58d1-4244-9c52-79655f67698c" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_17c3fe74-09a3-4564-b6e4-1ceb7f476359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableAmountPerShare_744ab84e-82d7-4c9a-8339-6181b51fadb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableAmountPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_18a45622-58d1-4244-9c52-79655f67698c" xlink:to="loc_us-gaap_DividendsPayableAmountPerShare_744ab84e-82d7-4c9a-8339-6181b51fadb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_979a1916-dc0f-42ad-a01a-23acd792efc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_18a45622-58d1-4244-9c52-79655f67698c" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_979a1916-dc0f-42ad-a01a-23acd792efc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c3846398-33c6-4cfa-b8a4-6db5c2fb332e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_179d27a7-4519-4190-91f6-5060b47acb9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c3846398-33c6-4cfa-b8a4-6db5c2fb332e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_179d27a7-4519-4190-91f6-5060b47acb9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails" xlink:type="simple" xlink:href="tnet-20240331.xsd#EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails"/>
  <link:presentationLink xlink:role="http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_12549ba0-a8f6-42ea-b995-d78888d0236e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_712b84ab-3dd1-452f-897c-9f3af258d906" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_12549ba0-a8f6-42ea-b995-d78888d0236e" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_712b84ab-3dd1-452f-897c-9f3af258d906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_666380ef-a45a-44db-a22f-73dd47468e97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_12549ba0-a8f6-42ea-b995-d78888d0236e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_666380ef-a45a-44db-a22f-73dd47468e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_07ef089b-88fb-4f77-8485-a3255a983a2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_12549ba0-a8f6-42ea-b995-d78888d0236e" xlink:to="loc_us-gaap_EarningsPerShareBasic_07ef089b-88fb-4f77-8485-a3255a983a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_227d27dd-5c64-41a3-a9bb-b5fa0c51b32e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_12549ba0-a8f6-42ea-b995-d78888d0236e" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_227d27dd-5c64-41a3-a9bb-b5fa0c51b32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7a2b3a62-eb58-4e5a-a67e-b07158fbac8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5e5ff641-728d-4c6d-a22d-0886fee0742b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_12549ba0-a8f6-42ea-b995-d78888d0236e" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5e5ff641-728d-4c6d-a22d-0886fee0742b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f1587288-d20a-4697-9cd3-8ddaf9451ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_12549ba0-a8f6-42ea-b995-d78888d0236e" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f1587288-d20a-4697-9cd3-8ddaf9451ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_cbcbb97d-f8a0-4af7-8edb-031ee1664a43" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_12549ba0-a8f6-42ea-b995-d78888d0236e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_cbcbb97d-f8a0-4af7-8edb-031ee1664a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4df120ea-6831-46e8-aa88-dc26111e3a78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_12549ba0-a8f6-42ea-b995-d78888d0236e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4df120ea-6831-46e8-aa88-dc26111e3a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_TimeBasedRestrictedStockUnitsMember" xlink:href="tnet-20240331.xsd#tnet_TimeBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_tnet_TimeBasedRestrictedStockUnitsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember" xlink:href="tnet-20240331.xsd#tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_PerformanceBasedRestrictedStockUnitsMember" xlink:href="tnet-20240331.xsd#tnet_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_tnet_PerformanceBasedRestrictedStockUnitsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_tnet_BurtonMGoldfieldMember" xlink:href="tnet-20240331.xsd#tnet_BurtonMGoldfieldMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_tnet_BurtonMGoldfieldMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>tnet-20240331_g1.jpg
<TEXT>
begin 644 tnet-20240331_g1.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X1#H17AI9@  34T *@    @ ! $[  (
M   *   (2H=I  0    !   (5)R=  $    4   0S.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $%N;F$@3&EA
M;P  !9 #  (    4   0HI $  (    4   0MI*1  (    #.3(  )*2  (
M   #.3(  .H<  <   @,   (E@     <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
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M%1%E!+$G  K'VU/^9?>;?5ZR^P_N9J4445J8A1110!\H?M2?\E0T[_L#1?\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tnet-20240331_g10.jpg
<TEXT>
begin 644 tnet-20240331_g10.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-&559MP.=Q+ ?[AKOOV>_C)8_M ?!_1_B[INARZ;!JXG*64\PD>/RIY(3E@
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MH KX;RRK@ LK\C(R?&OV9O%G[?G[7_AG5+#PG^T"-)M] O4EFU2\)CFN995
M2 -%&3L01LQ& ,R<[N-JEQS@IT\,\-0J5)U^?EC%1YDZ;2E&5Y))KU:LM]5=
MQX"QT*F)6)Q%.E"A[/FG)RY6JB;A*-HMM/M9.[VT=OT+HJ'3K::RT^"SN;V2
MYDBA5)+F4 -*P !<@ #)ZG QS4U?;)MH^%:2=D%%%%,04444 %%%% !1110
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MXGZM>G;MEQIAL-1I4,NP:HTXU85I+GE-RE!W2O+X5Z)OS[_.G[%_P@TSQO\
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MQ#IOXI2Y53O97E=RO?5MK79= HHHKZT^/"BBB@ HHHH **** "BBB@ HHHH
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M-6$*L%>]HU(J5KO5V=TF]6EKJ%%%%?1'S04444 %%%% !1110 4444 %%%%
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MUEK'PQNO"?AR71!8Z?;7T)CEU&0Q11&3&!N!5&9G QDJ 6(8CAO@#XR^(O\
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M"Z7P]92:19W:VLEW$H%W-F?=+)DKYC.(\1A0.T_X*9_M2?%S]GKP#\/OAO\
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MC_B)3_ZLN_\ ,C?_ 'NH_P"(6<>?] ?_ )4I?_)A_P 13X#_ .@S_P IU?\
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M#^I"BBBO\^S_ $$"BBB@ HHHH *_+.OU,K\LZ "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *_4RORSK]3* "BBB@ HHHH **** "BBB@ HHHH
M**** /Y;Z***_P!!#_/L**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#^I"BBBO\ /L_T$"BBB@ HHHH *_+.OU,K\LZ "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *_4RORSK]3* "BBB@ HHHH **** "BBB@ HHH
MH **** /Y;Z***_T$/\ /L**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@#^I"BBBO\^S_ $$"BBB@ HHHH *_+.OU,K\LZ "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *_4RORSK]3* "BBB@ HHHH **** "BBB@ H
MHHH **** /Y;Z***_P!!#_/L**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@#^I"BBBO\ /L_T$"BBB@ HHHH *_+.OU,K\LZ "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *_4RORSK]3* "BBB@ HHHH **** "BBB@
M HHHH **** /Y;Z***_T$/\ /L**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#^I"BBBO\^S_ $$"BBB@ HHHH *_+.OU,K\LZ "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *_4RORSK]3* "BBB@ HHHH **** "BB
MB@ HHHH **** /Y;Z***_P!!#_/L**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#^I"BBBO\ /L_T$"BBB@ HHHH *_+.OU,K\LZ "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *_4RORSK]3* "BBB@ HHHH **** "
MBBB@#R?]JS]CGX7_ +8.C:/HGQ-\0>)K"+1+F6>T;PUK1LV=I%56$A"MO&%&
M/3GUKQ3_ (<D?LG_ /11?BG_ .%PW_QJOL.B@#X\_P"')'[)_P#T47XI_P#A
M<-_\:H_X<D?LG_\ 11?BG_X7#?\ QJOL.B@#X\_X<D?LG_\ 11?BG_X7#?\
MQJC_ (<D?LG_ /11?BG_ .%PW_QJOL.B@#X\_P"')'[)_P#T47XI_P#A<-_\
M:H_X<D?LG_\ 11?BG_X7#?\ QJOL.B@#X\_X<D?LG_\ 11?BG_X7#?\ QJC_
M (<D?LG_ /11?BG_ .%PW_QJOL.B@#X\_P"')'[)_P#T47XI_P#A<-_\:H_X
M<D?LG_\ 11?BG_X7#?\ QJOL.B@#X\_X<D?LG_\ 11?BG_X7#?\ QJC_ (<D
M?LG_ /11?BG_ .%PW_QJOL.B@#X\_P"')'[)_P#T47XI_P#A<-_\:H_X<D?L
MG_\ 11?BG_X7#?\ QJOL.B@#X\_X<D?LG_\ 11?BG_X7#?\ QJC_ (<D?LG_
M /11?BG_ .%PW_QJOL.B@#X\_P"')'[)_P#T47XI_P#A<-_\:H_X<D?LG_\
M11?BG_X7#?\ QJOL.B@#X\_X<D?LG_\ 11?BG_X7#?\ QJC_ (<D?LG_ /11
M?BG_ .%PW_QJOL.B@#X\_P"')'[)_P#T47XI_P#A<-_\:H_X<D?LG_\ 11?B
MG_X7#?\ QJOL.B@#X\_X<D?LG_\ 11?BG_X7#?\ QJC_ (<D?LG_ /11?BG_
M .%PW_QJOL.B@#X\_P"')'[)_P#T47XI_P#A<-_\:H_X<D?LG_\ 11?BG_X7
M#?\ QJOL.B@#X\_X<D?LG_\ 11?BG_X7#?\ QJC_ (<D?LG_ /11?BG_ .%P
MW_QJOL.B@#X\_P"')'[)_P#T47XI_P#A<-_\:H_X<D?LG_\ 11?BG_X7#?\
MQJOL.B@#X\_X<D?LG_\ 11?BG_X7#?\ QJC_ (<D?LG_ /11?BG_ .%PW_QJ
MOL.B@#X\_P"')'[)_P#T47XI_P#A<-_\:H_X<D?LG_\ 11?BG_X7#?\ QJOL
M.B@#X\_X<D?LG_\ 11?BG_X7#?\ QJC_ (<D?LG_ /11?BG_ .%PW_QJOL.B
M@#X\_P"')'[)_P#T47XI_P#A<-_\:H_X<D?LG_\ 11?BG_X7#?\ QJOL.B@#
MX\_X<D?LG_\ 11?BG_X7#?\ QJC_ (<D?LG_ /11?BG_ .%PW_QJOL.B@#X\
M_P"')'[)_P#T47XI_P#A<-_\:H_X<D?LG_\ 11?BG_X7#?\ QJOL.B@#X\_X
M<D?LG_\ 11?BG_X7#?\ QJC_ (<D?LG_ /11?BG_ .%PW_QJOL.B@#X\_P"'
M)'[)_P#T47XI_P#A<-_\:H_X<D?LG_\ 11?BG_X7#?\ QJOL.B@#X\_X<D?L
MG_\ 11?BG_X7#?\ QJC_ (<D?LG_ /11?BG_ .%PW_QJOL.B@#P_]E?]@+X,
M_LA>)]3\6?#/Q1XQO[G5K!;2YC\2>(6O(E0.'RBE5"MD#GTR.]>X444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7,_%[XS?"KX!>!+OXF_&?Q]IGA
MO0;+ N-3U6Y$<89ONHO=W8\*B@LQX -=-7R7^T1I^G_$/_@JW\#_ (=_$>UC
MN?#NB^!-?\2^'+"[4-!<Z]'+;PB0H?EDD@@=I$)!*%BPP>: /3?@M_P4)_8]
M_:"\<Q_#/X8_&2*;Q#<6YGL]%UG1;[2;F\C R7MX[Z"%K@  L3&&X!/0$UZ#
M\8?C'\,?@!\.-4^+GQC\96F@>'-&A$NHZI>EBD8)"J J@L[,Q"JB@LQ( !)Q
M7SE_P6HTG2++]A36_B_9*EOXN\ ZYI&L^ ]7B0?:;+51J5M'&(2/FS(',94?
M>#>PQR__  6V_9O\!?$/]C/QW\?O'<^LWNJ>%?!D:>'M#EUB3^RM.NVNE#WR
MVRX1[HI,T7FONVHJ[0IR2 ?;8(8!@>".**;#_JE_W13J "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#F?B]\9OA5\ O EW\3?C/X
M^TSPWH-E@7&IZK<B.,,WW47N[L>%1068\ &O/O@M_P %"?V/?V@O',?PS^&/
MQDBF\0W%N9[/1=9T6^TFYO(P,E[>.^@A:X  +$QAN 3T!->9?M$:?I_Q#_X*
MM_ _X=_$>UCN?#NB^!-?\2^'+"[4-!<Z]'+;PB0H?EDD@@=I$)!*%BPP>:7_
M (+4:3I%E^PIK?Q?LE2W\7> =<TC6? >KQ(/M-EJHU*VCC$)'S9D#F,J/O!O
M88 /HWXP_&/X8_ #X<:I\7/C'XRM- \.:-")=1U2]+%(P2%4!5!9V9B%5%!9
MB0 "3BNF!# ,#P1Q7Q)_P6V_9O\  7Q#_8S\=_'[QW/K-[JGA7P9&GA[0Y=8
MD_LK3KMKI0]\MLN$>Z*3-%YK[MJ*NT*<D_;,/^J7_=% #J*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O+?VH
M?V4?!G[3VE:'=7_B?6?#'BGPCJ3:CX,\:^&KA8M0T:Z9-CE"ZLDD4B?)+"ZE
M)%X(R 13^/O[6MK\(/B/H7P-\!?"/Q%\0O'OB'39]3M/#'AN6U@-KI\+K')>
M7-Q=S10P1>8ZQJ2Q+N=H!KG]$_X**?!G_A1WCGXQ_$3PUXC\)7GPUU,:7XU\
M&ZO91OJMGJ#^7]GMHDAD>.X-P9HA"\;E)/,7D<X /&?&G_!(GXL>-?B4W[0'
MBW]M2Z\2>-;36--U>SL=6\$VUMX>U.]L!MMY=3L+25/M4BH BRJZ-& , @;:
M^G/VKOV>+/\ :N_9L\4?LZ^(O%,NDQ>*=,6TNM5LK4.T)$B2%DC9L'E,8+=#
MUKF?@U^V;-X\^+=O\"OB_P# #Q9\,?%.K:'+K/AFQ\4SV,\6LV<3(LWDS6<\
MJ+/%YD9D@<JZJX;!&2.&N_\ @J7X7B\(7/QXL/V:_B!>?!NRU-[2Y^+%LEB;
M,QI.8'ODL_M/VR2S60',XB^Z"P4@4 ?4RKM4*#T&*6N"_:(_:/\ AA^S)\#=
M8_: ^(^K_P#$DTFR$T2VA#RW\KX$%O ,XDDE=E1!G&6R2 "1J? WXJZ7\=?@
MKX1^-FAZ9<65EXP\,V&M6EG=E3+!%=6Z3K&Y4D%E#@''&10!U-%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%>0_'W]K6U^$'Q'T+X&^
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3 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tnet-20240331_g11.jpg
<TEXT>
begin 644 tnet-20240331_g11.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC_P4:\!>&O&G[)WB;4-;L8GNM$@COM+NG0;[>59$!VGMN4LA'<-["O//V6/
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M[)_QB\4_LQR7WB6\_8R\3^)_%6HRN;CQ)>W-Q%(L;')2-#9N4R<EFW%G)Y.
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MC HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#A/VD/CEI_[.?PEO_BQJGA^;4X;":"-K.WG$;/Y
MLJQ@AB"!C=G\*Q(OVN?AWI_[,ME^T_XRM;G2]*OK421:>K":X>0R,B0IC =V
M*^P R20 37*?\%/_ /DS?Q%_U_:?_P"E<5>>VO[._B#]I;_@F1X*\$^$;R*/
M5K"--2TV*>39'<21O<(8F;^'*2O@GC<%S@9(^#S7.<[H9_B<'@TI\N&]I"%E
MK4YVM]WITOJ?H&49)D5?A["XS&MPY\5[.<[O2GR*5K;+7[5KKT&M_P %8-8C
ML_\ A*I?V3/$:^&2WRZ\=0;85)P#_P >_EY]O,Z\9KW_ ,+_ +3GP]\>_L]:
ME^T5X&\^^TS3-(O+VXL9,1SI);1-(]NXY"/\N,\C# @D$$_(=G^V)^TQ\ O
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M$E%?-W;UVL?!<0\0+._91A3<(TT[<U2=1MMW;;D_DK):;W"BBBOHCYL****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_3D3][****_AL_N0*_!/_@M)_P I+_B5_P!P;_TS6-?O97X)_P#!:3_E)?\
M$K_N#?\ IFL:_8O!+_DJZW_7B7_IRF?COC;_ ,DI1_Z_Q_\ 3=0^6Z***_J(
M_ET**** "BBB@ HHHH _>S_@BW_RC0^&O_<9_P#3S?5]25\M_P#!%O\ Y1H?
M#7_N,_\ IYOJ^I*_ASBW_DJ\?_U_J_\ IR1_<?"7_)*8#_KQ2_\ 3<0HHHKY
MX^A"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** /EO\ X+2?\HT/B5_W!O\ T\V-?@G7[V?\%I/^
M4:'Q*_[@W_IYL:_!.OZC\$O^24K?]?Y?^FZ9_+GC;_R5='_KQ'_TY4"BBBOV
M$_'@HHHH **** "OJ3_@BW_RDO\ AK_W&?\ TS7U?+=?4G_!%O\ Y27_  U_
M[C/_ *9KZOG^+?\ DE,?_P!>*O\ Z;D?0<)?\E7@/^O]+_TY$_>RBBBOX;/[
MD"OP3_X+2?\ *2_XE?\ <&_],UC7[V5^"?\ P6D_Y27_ !*_[@W_ *9K&OV+
MP2_Y*NM_UXE_Z<IGX[XV_P#)*4?^O\?_ $W4/ENBBBOZB/Y="BBB@ HHHH *
M*** /WL_X(M_\HT/AK_W&?\ T\WU?4E?+?\ P1;_ .4:'PU_[C/_ *>;ZOJ2
MOX<XM_Y*O'_]?ZO_ *<D?W'PE_R2F _Z\4O_ $W$****^>/H0HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@#Y;_ ."TG_*-#XE?]P;_ -/-C7X)U^]G_!:3_E&A\2O^X-_Z>;&O
MP3K^H_!+_DE*W_7^7_INF?RYXV_\E71_Z\1_].5 HHHK]A/QX**** "BBB@
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** /EO\ X+2?\HT/B5_W!O\
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MM%W.J7/BS4= 9[N^UNS^SWM]:BXE6RNKB/:I6::T6WE?*J2TA) )Q7T!110
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M\-J_LS?]%+_\HU[_ /&:^!J* /OG_AM7]F;_ **7_P"4:]_^,T?\-J_LS?\
M12__ "C7O_QFO@:B@#]#O!7[4'P,^(GB:V\'>#O''VS4KS?]FMO[,NH]^Q&=
MOF>)5&%5CR>WK7?5\#?L5?\ )S/AK_M]_P#2*>OOF@ HHHH **** "BBB@ H
MHHH _!/_ (+2?\I+_B5_W!O_ $S6-?+=?4G_  6D_P"4E_Q*_P"X-_Z9K&OE
MNO[DX2_Y)3 ?]>*7_IN)_#?%O_)5X_\ Z_U?_3D@HHHKZ ^?"BBB@ HHHH *
M_>S_ ((M_P#*-#X:_P#<9_\ 3S?5^"=?O9_P1;_Y1H?#7_N,_P#IYOJ_'O&W
M_DE*/_7^/_INH?L/@E_R5=;_ *\2_P#3E,^I****_EP_J,**** "BBB@ HHH
MH **** "BBB@ HHHH **** "O*OVDOVH+/X#^)_AW\,M \(GQ+XR^)_C&/1?
M#7A]=0^R@6\:-<ZCJ$LOER;(+2SCEE/R'?)Y,(*F8,/5:^+?%5W-KG_!PGX-
MT#Q*2]CH'[(NM:EX6CF^XE_<^)+"WO9(\_\ +3R(K=3C^%Z +WCC_@I_\9=;
M^(/Q+T/]C_\ 8)\1?%OPS\'=<FT3Q[XJM_&EAI'F:K;P)/>6&F6UP&>_F@21
M%<,85,A**S'&>UT?_@I1\*/%7@SX!_'+PEH-Q=?##X]W46FZ5XQN+KR9=%U:
M[A\S3;.ZM=C<7$D=Q:M(),17*P1X<3;T\U_:Q_:5^-?[7/Q4\5_\$W?^"=<L
M>FZG9H+'XW_'":#=I_@*&YC^>RLP"/MVM/"WRQJ0EMN5I&#<+RG_  6 ^ GP
MV_9#_P"" _C'X*?!6SFT[3/A=X8\/+X&D=_,N8KZQU:P>SFWX!:=[E$9F !9
MY&X^;% 'HGQZ_P""J^H_!?XV>-_#>G?LXR:U\-_A/XI\,^'/BK\0/^$M2WNM
M)O\ 6_LAM_LFG&W?[=#"E_9/.YGA91,=B2F-A7M>A?M-?\)A^V%KO[+'@OP3
M_:%GX-\'VVK>./%G]I;(]*O[R7_0-+6'RSYTTMO'<7,A\Q/)C^SY5_M"E?G_
M /;Y_9"_9=^'^D^._P!N[XR>+?B!;Z/,VA>(/'GPH\.ZO;C2/'FN:2\":+#/
M"]L]P]R]Q%8VR1P3Q1SM';K*D@6O M,_::_;+_8,\*_&&;1_"OP\U3Q!\+?
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M\#4444 %%%% !1110 4444 >I_L5?\G,^&O^WW_TBGK[YKX&_8J_Y.9\-?\
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M4[?PSXY^#?Q'OETR_P QRV\T9TF*6WN(U)7S8)DFB;!(#(VTD')Z#P'\)?\
M@I#^P!X]^-'@3]EO]F3PE\6/"/Q2^)NL>//!?B/4_B%'HK>&=1U8K)=VFI6\
MD+//;1W(:5'MBSM&Q4A3C;G_ +)/_!*WXR_LD_%S]D6VAUNP\1Z+\&_AMX\L
M/B!XCCN%A\W6==NK2])@A;#O"UQ]K"G *HJ;@"<4 =='_P %=]1?_@B[8?\
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M*%M;:?\ #WQ'')(^H,UO.KVNH13LZ8NU228+"%\O "GCO!O_  2H_;D\$?\
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MJ#+/9RQQ@G +,A _4T ?D1_P:Q?$?Q7\'OA)>?LU?%?QI=WFG>-?AQIGQ?\
M U[K%Z92EI-))I6L0F1S\J0W=E;R[>BK>@GKEN,_8X^*?B;QM^VY^U3^V/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
144 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>tnet-20240331_g12.jpg
<TEXT>
begin 644 tnet-20240331_g12.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_"FTTGS):=+_ &%7!_'7]H_X6_L[Z987WQ%U:5)]6G,&DZ?:P&2>\D!4,%'
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTCM=/L;.$1PVT$:A$C1% "JJ@  <  "@"W1110 4444 %%%% !1110 4444
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M#_6WA7_H/H?^#:?_ ,D?4E%?+?\ P^D_X)H?]'*?^6=K/_R'1_P^D_X)H?\
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M-% 'U-_P\M_ZHK_Y<?\ ]S5]35^6=?J90 4444 %%%% !1110 4444 %%%%
M!1110!_+?1117^@A_GV%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!_4A1117^?9_H(%%%% !1110 5^6=?J97Y9T %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5^IE?EG7ZF4 %%%% !1110 4444 %%%% !1110
M4444 ?RWT445_H(?Y]A1110 4444 %%%% !1110 4444 %%%% !1110 4444
M ?U(4445_GV?Z"!1110 4444 %?EG7ZF5^6= !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %?J97Y9U^IE !1110 4444 %%%% !1110 4444 %
M%%% '\M]%%%?Z"'^?84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M']2%%%%?Y]G^@@4444 %%%% !7Y9U^IE?EG0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !7ZF5^6=?J90 4444 %%%% !1110 4444 %%%% !1
M110!_+?1117^@A_GV%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
M_4A1117^?9_H(%%%% !1110 5^6=?J97Y9T %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5^IE?EG7ZF4 %%%% !1110 4444 %%%% !1110 44
M44 ?RWT445_H(?Y]A1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?
MU(4445_GV?Z"!1110 4444 %?EG7ZF5^6= !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %?J97Y9U^IE !1110 4444 %%%% !1110!QGQF^!GA
M#XYZ99:3XOU36K6.QG::%M%U:2T9F*[2&*?>&.QKS[_AWO\ !/\ Z&WQW_X6
M5S_C7NE% 'A?_#O?X)_]#;X[_P#"RN?\:/\ AWO\$_\ H;?'?_A97/\ C7NE
M% 'A?_#O?X)_]#;X[_\ "RN?\:/^'>_P3_Z&WQW_ .%E<_XU[I10!X7_ ,.]
M_@G_ -#;X[_\+*Y_QH_X=[_!/_H;?'?_ (65S_C7NE% 'A?_  [W^"?_ $-O
MCO\ \+*Y_P :/^'>_P $_P#H;?'?_A97/^->Z44 >%_\.]_@G_T-OCO_ ,+*
MY_QH_P"'>_P3_P"AM\=_^%E<_P"->Z44 >%_\.]_@G_T-OCO_P +*Y_QH_X=
M[_!/_H;?'?\ X65S_C7NE% 'A?\ P[W^"?\ T-OCO_PLKG_&C_AWO\$_^AM\
M=_\ A97/^->Z44 >%_\ #O?X)_\ 0V^._P#PLKG_ !H_X=[_  3_ .AM\=_^
M%E<_XU[I10!X7_P[W^"?_0V^._\ PLKG_&C_ (=[_!/_ *&WQW_X65S_ (U[
MI10!X7_P[W^"?_0V^.__  LKG_&C_AWO\$_^AM\=_P#A97/^->Z44 >%_P##
MO?X)_P#0V^.__"RN?\:/^'>_P3_Z&WQW_P"%E<_XU[I10!X7_P .]_@G_P!#
M;X[_ /"RN?\ &C_AWO\ !/\ Z&WQW_X65S_C7NE% 'A?_#O?X)_]#;X[_P#"
MRN?\:/\ AWO\$_\ H;?'?_A97/\ C7NE% 'A?_#O?X)_]#;X[_\ "RN?\:/^
M'>_P3_Z&WQW_ .%E<_XU[I10!X7_ ,.]_@G_ -#;X[_\+*Y_QH_X=[_!/_H;
M?'?_ (65S_C7NE% 'A?_  [W^"?_ $-OCO\ \+*Y_P :/^'>_P $_P#H;?'?
M_A97/^->Z44 >%_\.]_@G_T-OCO_ ,+*Y_QH_P"'>_P3_P"AM\=_^%E<_P"-
M>Z44 >%_\.]_@G_T-OCO_P +*Y_QH_X=[_!/_H;?'?\ X65S_C7NE% 'A?\
MP[W^"?\ T-OCO_PLKG_&C_AWO\$_^AM\=_\ A97/^->Z44 >%_\ #O?X)_\
M0V^._P#PLKG_ !H_X=[_  3_ .AM\=_^%E<_XU[I10!X7_P[W^"?_0V^._\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;2YA)/ES0SQ2Q.H)&Y"59E(8^CT %%%% !1110 4444 %%%% !1110 4444
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MY[CP?\0X!#XPT'Q3XMU;78=0C",@7.IW5PT0 <_ZLISAOO*" #R7]N_;J_\
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MG^R6-K"D$$/F3,\DFV-%7<[,QQEB22: .AHHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
B4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>tnet-20240331_g13.jpg
<TEXT>
begin 644 tnet-20240331_g13.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M12.K!=QC)&>Q&0#Q2_LR?M :;^TO\+(OBCI7AR?2H9;V:V%I<3K(P,9 )W
M<YKYA_9U\'?%/1_^"=GC3Q5XH^(BZAX;U3P#J(\/:$(=ITTHUR)26Q\V]N>I
MKE?V0OAI^UA\2/V6KK4/A9\<H_!VB:+?7CZ=96=H?/U2Y"B1S+,"#&F2$&,C
MAB5X!/G8?B_.98O!.5"4E5P[J.G%0NY)KWDW*RBU=I<U[-*W-H>GB.#<EC@\
M<HUX0=+$*G&I)SLHM/W&E&[DG9-\MKIN_+J?>?Q \6P^ ? >M^.[FS:YCT72
M+F_DMT<*TJPQ-(5!/0D+C/O7&_LL?M':7^U%\-)?B3I'ABXTF*+5);(VMS<+
M*Q*)&V[*@#!W]/:O#/V9_P!H?Q]^T!^PI\3)_B7J(OM5T/0]5M/[1,:H]Q"U
M@SH7"@ N"6&0!D 9YR3Y[^SC<_%;1O\ @F=XD\8_!OQ7=Z3K&@>+;G4'DLU4
MF:V2& 3H=P(P$9I.F<QCUKKGQC.MC<-B<.I2P\Z%2JX67,W!K3U6JLG9^9QP
MX*A1P.)PV)<8XB&(ITE.\N1*:>OH]'=JZ\C[^HKY8N_VS=4'_!.-?CE%KF/%
M,E@-&%P OF?VGO\ ),N,;=VP&XQC&.W:O5/V+Y/B?J/[.GA_Q/\ &#Q1=:KK
M>MP'49)KM5#10RG,* *!@>5L;IG+FOI,#Q'@LQQU/#8=-\])5KZ649.T4]?B
M?;R9\QC^&L=EF JXG$-1Y*KHVUO*45>36EN5=_-$/[6O[5NC_LG^%-*\4ZSX
M/N=835-0:T2&UNEB,9$9?<2P.>F*]-\.:PGB+P]8>((H#$M]917"QL<E Z!L
M$]\9KY'_ ."R/_)(?"/_ &,DG_I.]1_MT?'WXN_ KP+\'+GX5>*)[#^T+!S?
MVL2J5O!'%9%(VR"<?.PXP?F->!C.*ZN49OF+Q5Y4*$:+48I7O4=GKI?5IZOT
M/H<%PC2SC)\M6$M&OB)5TY2;LU37,M-;:)K1;[GV117PI^U/J?[=?[+6E:'\
M>O$7[2*:D^I:LEK?>'[2P"65I*T;RK"J'*RQ[8W4MA7X!R2=P[+]O#]K#XG>
M"/"OPWM? GB%_"=AXWM5N]7\1Q6?VB2SB(@)2,8)^592YV_.VU0I'.>FKQO@
M\+2Q4L50J4Y4%!N,N6[51VBTU)Q6N]VN7KU.6EP)C<56PL<)B*=6-=S2E'FL
MG35Y)IQ4GIM9/FZ=#ZYHKXW^ FH_'J?XJZ)<?!S]N'0/B?H%PV_Q!I7B&X-K
M=1P@C>$@;S9E.TEE8;0"N&&.N_\ M0?''XK^"OV[OAC\+_"WC6ZLM UJ*P.J
M:9$J%+@O>S1ON)4GE54<$=*WAQ?AUEWUNK0G%<\:>\))N;23C*,G&2UUL[KL
M82X,Q+S+ZG2KPD_9SJ;3BTH)MJ4914HRTTNK/N?5-%?*W_!2?XX_%CX.>(/A
MK:?#/QK=:1'K.H7J:FELJ$7"H]F%!W*>GF/TQ]XUC_M_?M _M ?"S]HOP/X*
M^"OBN2W.LZ?&J:6\:-#=74ER\2;]PSC)48R.E/,>,<!EE3%1J4YOZO*E&5DG
M=U5>/+KK;K>WE<66<%9AFE/"3IU(+ZQ&K*-VU94G:7-II?I:_G8^P:*^<O"?
MPM_;M^%WPC\7++\8-.\7^+M4EM_[ EOKG%OIJ88SR+YL8!?YL*A^0;5..JGY
MZ^,?CS]I3]GCPOIWQ F_;VL==\427,7]I>"[2\BN?LI8$L"H=T95("G*(.>"
M<"L,QXQ>58:-?$X.K%6<I7Y%RJ[5KN:4I:7Y8W=FC?+>"EFV*E0PV-I2?,HQ
MM[1\SLG>R@W&.MN:5E=,_1*BOD+]N#]IOXM>&_V6?AK\6_AUXHFT#4?%"6MS
MJ'V%5(Q+9><8QO#?*&/'?BN5_:2O_P!NOX5?#+3?VJ-4_:*6!KRYMVG\):98
MA+73DG&Z-/FW+/M^56WKG)/S-UI8_C?"8.K6A##U*BI0A.3CRV4)J]]9)Z+I
M:_R38\OX%Q>-I4)U,13INM.=."ES7<X.UO=BUJ^M[?-I'W/17RS^TY^W!XO^
M&_[)?@GXC>$+2WM_%/CS3K=[=VA$D=D3 DD\B(V0Q#.JJ&R/FR<XP>>O_@W_
M ,%-/A=:Z)\0O"GQO?QIJES<Q_VQX4NFC6"$,I9EW3,J,@QM++Y; D;?4=&)
MXOP\,2Z6%P]2ORQA.;@D^53UCHVG)M:VBF['/AN#<14PJK8K$TJ'/*<(*HVN
M>5/26J344GIS2:5S['HKY-_;5_:H^+FA^./!O[.?PQU>S\(:]XGL[>ZU[6+Z
MXC8:8LSE/*\TY10I20LXR2 NTC//)Z/\>/C5^RA\>_"?@SQQ^TAI_P 3_"7B
MVX6VN;E)8WFL)#(D9?*N[)M,B-@L5==PV@@$98KC?+<+CYT'3FX0E&$ZGNJ,
M92M9--J;M=<S47R]37"<"YGB\!"NJD%.I&4X4_><I1A>[347!7L^5.2YEL?;
MU%%%?9GQ(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!RGQWM;J^^!_C*RLK:2::;PIJ*0PQ(69V-M( H Y))X %?"W
MAGX$>,O%'_!,+6=-N?!>IQZUHGCLZI9:?+I\BW$B[((7VH5W$;)7/ YV>U?H
MI17R^><+X?/<3[6K-K]U.G:U_CM[WK%JZ1]9D/%>(R#"^QI4T_WM.K>]O@O[
MNVTD[-GYW_#'X(^.M*_X)Q?%/Q%J_A/5F\0^*==L0MG-8RFZGAM[RV(<H1O)
MWR3D\=!FNZ\:?LQ^/_C1_P $VO OA[PUH5POB/PV#?1Z1<QF*:=-\Z21!7QA
M]KAP#C.S Y(K[6HKR:' &74J'L)U'*#H>P>B3^-U'.^NO,[VLUZGK8CQ$S*K
MB/;PIJ,UB/;K5M?PU34+::<JM>Z?H?"GB3]N'XN>-?@%-^S?8_LU>*!XYO\
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M3P'X^_9@M/"?[/O['7B"UUC3$M)?%WBFZT7>Z.N(W2*;+22F25@Q4!<*"=F
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MDQ'$P1020K,'/^RIKXY_94_X)A^&OC%\(H/B+\:M<\4:-JNHWL[06%MY4++
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MM]J:>MM+(\&^(?PFT+]F3]J_Q5XN^/'[/5_XW\!^)KFXO-,O["R,WV5YI?.
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'QW_P $];.3X;_M5_&WX0ZD
M-ERVI)=VRMP7@BN9PK@>A2ZB/_ A7%_MR?$K]JSX;:I\0/AW\2[2]U_P%XJM
M=OAK4X["..#3E^T)*BF2*,990#$RR'<WROD_Q?2'C/\ 9L\5Q_M<^'OVG/AE
MJ>F6RM8OIWC6POI9(VO;;:%22+9&P:0#;PQ4?N8^>M>G?$3X>^$_BMX+O_A]
MXYTUKS2=3B$=[;+.\1=0P8#<A##E0>".E?FT>%LQK</5LJIU9494YU?9M/W9
MPJ7DE):WB^=Q>EXM77G^G2XKRVAQ'0S:I2C6C5ITO:)KWJ<Z?+%N#TM)<BDM
M;23L_+Y4_9!\"^.?C-^U;KG[66L?#&Z\)^')=$%CI]M?0F.749#%%$9,8&X%
M49F<#&2H!8AB.&^ /C+XB_\ !.7XG>+/A7X]^#GB'7](UJ[230]0T2T,AN3&
M7$;)_"X='&Y<[D9<8-??=O!%:P);0+A(T"H,YP ,"GUWQX*]C3HU:&)<<13G
M.?M.6+4G5TFG#16:2LEM;N>?+CCV]2O2Q&&4\-4A3I^SYI)Q5+6FU/5W3;NW
MO?HCX:_9*TKXPZQ_P41\1?$OXG?#'4M ?5]&N+DQ3VSF*W65+=H83+M"EQ'M
M##@[E8$ @@9OPUU3XF_\$U/C-XPTOQ1\(M9\0>"_$=PLFG:MH\)<;8WD,)#8
MVAMLK*\;%3D @D ;OO>BHI<#_5J,)4,5)5Z=2I4C4<8MWJ*TU*.S36^WE8NK
MQW]9K5(U\)%T*E*G2E34I)6I.\'&6\6GM>^F]SXN_9V\$_%;]J3]LT_MA>-?
MA]>>&/#6CP>7HEKJ,;+)=$0-#&%W %@-[2,X&T'"@GG%[]D+PCXLTG_@H=\7
M/$&J^&-1MK"[34OLM]<64B0S9U"%AL<@*V0"1@]!7V'175A>#:.'G0JRK.52
M%65:<FE[\Y+E>BTBK6LE>UCEQ7&M;$PKTHT%&G.C&C"*;]R$9<RU>LG>]V[7
MN?$7[$7@CXK:1XP^/K:+X?U#2]5U"WG'AN[OK1X4>Z,EYY3*S@ @.R'/3D&O
M+OV=(?"GAKP[XC\ ?$+]D'Q-XN^+%_>SKIMQJ>D^?%&9$"JTQG;$.R3>YDV'
M.<EACY?TNHK@7 -.%'#0AB/X/M-X1DFJDG)M*5U&2O92U]#T/^(A5)UL3.>&
M_C>S^&<HM.G%12<HV<HNUW'3U/@C]E7PEXQTK_@G_P#&'P-JO@S5[75GEN)8
M;&XTV5)9E>UB1=BE<O\ -$XXSTKWS_@FIH&M>&OV2]&TOQ!HUUI]VNH7S26U
M[;-%(,W#X)5@#R,5[W17IY+PE2R;$X>LJKE[&DZ2TM=.?-?=ZK;\3RL\XPJY
MUAL11=%1]M5C5>M[-0Y+;+1[_@?!7QA\:>$;SXFZ_HW[<_[&$[7 D"Z)XF\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#XJ_P""F7_!3_XR?LK^.+W]
MGS]DS]GW2O''C[2_AJWCOQ)J'BS7VT_1] T4WWV&"1Q$CS7<TUPDJ+!'LP$+
MLX Q6O/_ ,%79OAS^R#K/Q^_:3_9,\;^#O'6C?$8?#^W^%=LGVRY\1>(Y9XX
M;2#1[MTACO[6X,JLET%1<)+D;HR#X?\ \%L/AM^RI\<?&/B_2O#_ ,9/&/@+
M]HGP+\$1JUM>^&9S;QZWX4N-5$?V.[2>-X-1M4O$,AB'SQ2%6W+NP>.\9?$;
MXL_M5?LW?$+X*?M3_M;>#--^)'[,7[5?AVS^%_QWE\-&WT/Q!XBA^S7&G0ZC
M9V[,D,A>\>SN5B98XVD5L?*0X!]E_ #]O7X@>*?V@M/_ &4_VMOV5=2^#WCO
MQ'X;N=>\%6TOBNSUS3M?L[5XEO(H;RV"A;NW\^%I(&0?)('1Y%R1DR_\%<OV
M;=>_X*,>$_\ @G!\))_^$Q\1ZQ!K1\5>(='NPVG>'+G3[7SVL7E",EQ=G@20
M(X: ,IDP6"'YLU;2_P!N3X@?\%NOV4&_:R\2_#)-=\&^#/'>LWG@KX22W]W:
MZ3I<^FQ6!U*\NKZ.*5C<WDMO%%%Y*I']ED^>1F)'K'[47@CP9X!_X+#?L4Z+
MX$\(Z7HMG-IOQ9O)K32;".VBDN)M.TR2:9EC4 R.[,[.>69B223F@#N?VJ?^
M"B7QK^$7[5]O^QY^S!^PIKWQK\51_#Z'QAKPTCQWI.B1:58S7T]G"'?49(T=
MWDMY"%5MV!G;@$CW7]G7X@_%SXH_"/3/&WQS^ %[\+_$UV\XU#P5J'B*RU66
MP"3.D;&ZL7>"3S(U24!&.T2!3A@17R/XR_8B_8N_;$_X*-_&W5[_ /:\^+-O
M\0M'\*^&-,\9>!/!GC'4O#$6B6WV>>?3[E9[58'OU;SY91B66".5G5UW@*O8
M?\$2?C3\7/C/^Q]K,?Q6^)M]X]A\&?%?Q1X1\'?$?4W62Y\7:%INHR6]GJ<L
MJ@+.[JK1F4??,)8DL68@'U_1110 4444 %%%% !1110 4444 %%%% !1110
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M110 4444 %%?+?\ P^D_X)H?]'*?^6=K/_R'1_P^D_X)H?\ 1RG_ )9VL_\
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MO!?^'TG_  30_P"CE/\ RSM9_P#D.C_A])_P30_Z.4_\L[6?_D.C_5+BK_H
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M#_6WA7_H/H?^#:?_ ,D?4E%?+?\ P^D_X)H?]'*?^6=K/_R'1_P^D_X)H?\
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M%%% ']2%%%%?Y]G^@@4444 %%%% !7RS_P /+?\ JBO_ )<?_P!S5]35^6=
M'U-_P\M_ZHK_ .7'_P#<U'_#RW_JBO\ Y<?_ -S5\LT4 ?4W_#RW_JBO_EQ_
M_<U'_#RW_JBO_EQ__<U?+-% 'U-_P\M_ZHK_ .7'_P#<U'_#RW_JBO\ Y<?_
M -S5\LT4 ?4W_#RW_JBO_EQ__<U'_#RW_JBO_EQ__<U?+-% 'U-_P\M_ZHK_
M .7'_P#<U'_#RW_JBO\ Y<?_ -S5\LT4 ?4W_#RW_JBO_EQ__<U'_#RW_JBO
M_EQ__<U?+-% 'U-_P\M_ZHK_ .7'_P#<U'_#RW_JBO\ Y<?_ -S5\LT4 ?4W
M_#RW_JBO_EQ__<U'_#RW_JBO_EQ__<U?+-% 'U-_P\M_ZHK_ .7'_P#<U?4U
M?EG7ZF4 %%%% !1110 4444 %%%% !1110 4444 ?RWT445_H(?Y]A1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 ?U(4445_GV?Z"!1110 4444
M%?EG7ZF5^6= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?J97
MY9U^IE !1110 4444 %%%% !1110 4444 %%%% '\M]%%%?Z"'^?84444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% ']2%%%%?Y]G^@@4444 %%%% !
M7Y9U^IE?EG0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7ZF5^
M6=?J90 4444 %%%% !1110 4444 %%%% !1110!_+?1117^@A_GV%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110!_4A1117^?9_H(%%%% !1110 5
M^6=?J97Y9T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^IE?E
MG7ZF4 %%%% !1110 4444 %%%% !1110 4444 ?RWT445_H(?Y]A1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 ?U(4445_GV?Z"!1110 4444 %?
MEG7ZF5^6= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?J97Y9
MU^IE !1110 4444 %%%% !1110 4444 %%%% '\M]%%%?Z"'^?84444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% ']2%%%%?Y]G^@@4444 %%%% !7Y
M9U^IE?EG0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7ZF5^6=
M?J90 4444 %%%% !1110 4444 %%%% !1110!_+?1117^@A_GV%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!_4A1117^?9_H(%%%% !1110 5^6
M=?J97Y9T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^IE?EG7
MZF4 %%%% !1110 4444 %%%% '&?&;X&>$/CGIEEI/B_5-:M8[&=IH6T75I+
M1F8KM(8I]X8[&O/O^'>_P3_Z&WQW_P"%E<_XU[I10!X7_P .]_@G_P!#;X[_
M /"RN?\ &C_AWO\ !/\ Z&WQW_X65S_C7NE% 'A?_#O?X)_]#;X[_P#"RN?\
M:/\ AWO\$_\ H;?'?_A97/\ C7NE% 'A?_#O?X)_]#;X[_\ "RN?\:/^'>_P
M3_Z&WQW_ .%E<_XU[I10!X7_ ,.]_@G_ -#;X[_\+*Y_QH_X=[_!/_H;?'?_
M (65S_C7NE% 'A?_  [W^"?_ $-OCO\ \+*Y_P :/^'>_P $_P#H;?'?_A97
M/^->Z44 >%_\.]_@G_T-OCO_ ,+*Y_QH_P"'>_P3_P"AM\=_^%E<_P"->Z44
M >%_\.]_@G_T-OCO_P +*Y_QH_X=[_!/_H;?'?\ X65S_C7NE% 'A?\ P[W^
M"?\ T-OCO_PLKG_&C_AWO\$_^AM\=_\ A97/^->Z44 >%_\ #O?X)_\ 0V^.
M_P#PLKG_ !H_X=[_  3_ .AM\=_^%E<_XU[I10!X7_P[W^"?_0V^._\ PLKG
M_&C_ (=[_!/_ *&WQW_X65S_ (U[I10!X7_P[W^"?_0V^.__  LKG_&C_AWO
M\$_^AM\=_P#A97/^->Z44 >%_P##O?X)_P#0V^.__"RN?\:/^'>_P3_Z&WQW
M_P"%E<_XU[I10!X7_P .]_@G_P!#;X[_ /"RN?\ &C_AWO\ !/\ Z&WQW_X6
M5S_C7NE% 'A?_#O?X)_]#;X[_P#"RN?\:/\ AWO\$_\ H;?'?_A97/\ C7NE
M% 'A?_#O?X)_]#;X[_\ "RN?\:/^'>_P3_Z&WQW_ .%E<_XU[I10!X7_ ,.]
M_@G_ -#;X[_\+*Y_QH_X=[_!/_H;?'?_ (65S_C7NE% 'A?_  [W^"?_ $-O
MCO\ \+*Y_P :/^'>_P $_P#H;?'?_A97/^->Z44 >%_\.]_@G_T-OCO_ ,+*
MY_QH_P"'>_P3_P"AM\=_^%E<_P"->Z44 >%_\.]_@G_T-OCO_P +*Y_QH_X=
M[_!/_H;?'?\ X65S_C7NE% 'A?\ P[W^"?\ T-OCO_PLKG_&C_AWO\$_^AM\
M=_\ A97/^->Z44 >%_\ #O?X)_\ 0V^._P#PLKG_ !H_X=[_  3_ .AM\=_^
M%E<_XU[I10!X7_P[W^"?_0V^._\ PLKG_&C_ (=[_!/_ *&WQW_X65S_ (U[
MI10!X7_P[W^"?_0V^.__  LKG_&C_AWO\$_^AM\=_P#A97/^->Z44 >%_P##
MO?X)_P#0V^.__"RN?\:/^'>_P3_Z&WQW_P"%E<_XU[I10!Y]\&?V:_ 7P,U.
M]U;PAK/B&ZDOX%BF76M<ENU50V05#GY3GN*]!HHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "N+^/_ .T5\#/V5_AA?_&C]HOXJ:-X.\+Z:56[UG7+
MP0Q!VX2-,_-)(QX6- SL>%!-=I7P;^UQI.D_%K_@NK^S1\(OC!8PWGA'PW\+
M_%7C+PAI5^@:UO/%$,UK;K,8V^66:VM9'EC)!,1<NN#S0![/^SC_ ,%9O^"?
M/[5_Q,B^#'P6_:'@G\6W5JUSIWASQ%X<U/0KS4854LTEK%J=M;M=J%!8F$/A
M06Z FO6/V@_VAO@K^RI\'];^/G[0WQ$L/"OA#P[;"?5];U$L4A4L%50J!GD=
MF956-%9W9@J@D@5\@_\ !QWH6@:;_P $PO$G[0&G1Q6OC[X5^)O#_B+X7:_#
M&/MFFZXNL6<40MV'S9E61HF0?>#\C@$<1_P<G_L>_"WXM?\ !.SXH?M5_$^Z
M\1:EK?@?X=11^$_#,_B"7^P](OFO5$FI)9)MCEO6CN&@\^7?MC10BH<L0#])
MU8.H93D$9%+3+?\ X]X_]P?RI] !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!Q?Q_P#VBO@9^RO\,+_XT?M%_%31O!WA?32JW>LZ
MY>"&(.W"1IGYI)&/"QH&=CPH)KRC]G'_ (*S?\$^?VK_ (F1?!CX+?M#P3^+
M;JU:YT[PYXB\.:GH5YJ,*J6:2UBU.VMVNU"@L3"'PH+= 37C'[7&DZ3\6O\
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M10BH<L?TEM_^/>/_ '!_*@!]%%% !1110 4444 %%%% !1110 4444 %%%%
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M?!FF>-[G3;F#Q%IT#1K<_9[C3[J>-;F#S8C+:R%94616P1DCS&^_X+?^"8/
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
3%%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>tnet-20240331_g14.jpg
<TEXT>
begin 644 tnet-20240331_g14.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC_P4:\!>&O&G[)WB;4-;L8GNM$@COM+NG0;[>59$!VGMN4LA'<-["O//V6/
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M[)_QB\4_LQR7WB6\_8R\3^)_%6HRN;CQ)>W-Q%(L;')2-#9N4R<EFW%G)Y.
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MGAOXF_M2?MX?&?Q;I/P?^,S^!/!_A6816\ME 3+/N>18F8J59V?RG8C>%0
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M#!;^)M2=VN+V.[E" NH63;$&\L;L;B2I)8DYKYKO/C%^T_\ MK?M">)?AA\
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M4T\">!_'MQ\,_A+\-]4\>ZM9R-'=_P!F3^7 )%.&1&6.1I"IR"0FWT)KV?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQDU]C4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+B1L,/L&BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ K^8[XK?\E1\2_P#8?O/_ $>]?TXU_,=\5O\ DJ/B
M7_L/WG_H]Z_?/ O_ 'G'^E/\YGX'XZ?[O@/6I^4# HHHK^B#^=PHHHH ****
M "OTI_X-OO\ DJ/Q0_[ &G?^CY:_-:OTI_X-OO\ DJ/Q0_[ &G?^CY:^$\3/
M^2&QGI'_ -+B?=^&?_)<X/UE_P"D2/UGHHHK^-C^R0K\UO\ @Y!_Y)=\+_\
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M^2&QGI'_ -+B?=^&?_)<X/UE_P"D2/UGHHHK^-C^R0K\UO\ @Y!_Y)=\+_\
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M^2&QGI'_ -+B?=^&?_)<X/UE_P"D2/UGHHHK^-C^R0K\UO\ @Y!_Y)=\+_\
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M(M1N;2>.X>:24R%[AGN8H&G#22IO&30!]C4444 %%%% !1110 4444 %%%%
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MQT;_ .3*/^'+?_!2_P#Z-K_\O'1O_DRC_6WA7_H/H?\ @VG_ /)!_JEQ5_T
M5_\ P54_^1/W-^%/_)+O#7_8 L__ $0E;]9'P^TN^T/P%HFBZI!Y5S9Z1;07
M$6X-LD2)589!(."#R#BM>OX@KM.O)KN_S/[?H)JA%/LOR"BBBLC4**** /(_
MVT_V/? _[:_P@MOAIXK\4ZQX;U/0_$=CXD\%^,/#LJ)J'AW7+*0R6M_;^8K(
MS*2ZLCJ5>.1U.-V1Q'[.'[ OC;X?_M%R_M=_M2_M2ZM\8/B):^%'\,^&-0N?
M#%GHNGZ!I<LR3W"V]G:Y7[1/)'&9;AW9BL:HH105/TG10!Y/)^S+/KW[9L?[
M6GCKQFFIP^'_  0?#_P^\-+8%(]">YG\W5+]I"[>;<7(BLH0P5/*BMF4;O.<
MUXM^RQ_P2IU7]G;XJ_#[6_$/[1I\3>!_@M#XAB^#7@]/"*V-UI":NY$OV^^%
MS(-1,,#/;PE(;;"N2XD;##[!HH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *_F.^*W_)4?$O_8?O/_1[U_3C7\QW
MQ6_Y*CXE_P"P_>?^CWK]\\"_]YQ_I3_.9^!^.G^[X#UJ?E P****_H@_G<**
M** "BBB@ K]*?^#;[_DJ/Q0_[ &G?^CY:_-:OTI_X-OO^2H_%#_L :=_Z/EK
MX3Q,_P"2&QGI'_TN)]WX9_\ )<X/UE_Z1(_6>BBBOXV/[)"BBB@ HHKE_BO\
M9_AI\$-%T[7_ (G^)ETV#6/$%AH>DHEK-<37NHWDZP6]M%#"CR2.SMD[5(1%
M>1BJ([* =117S_\ 'W_@J=_P3_\ V7_B3=_"'XX_M+Z-HWB'3+>&?6]/CL[N
M\&CQ3#,3W\EM#)'8*ZD,#<-&"I#=""?3;G]H;X+6WC#P5X&;X@6<E]\1]/NK
MWP-);*\MKK4-O#'<2>1=(I@9O(D$R)OWR1))(BNL4C* =G17C/Q&_P""@W['
M_P )OCS:?LT_$#XQ1V'B^[N=/MGM!HM]-:65Q?L5L;>[OHH&M+*:Y88ABN)8
MWER-BMN&>\N?C;\,+3XV6G[.LGB;=XRO?#,WB&+18;*:0QZ;%<1V[7$LJH8H
M0TL@1%D=6E*R; PBD*@'54444 %%%% !1110!^8?BW_D:M3_ .PA-_Z&:SZT
M/%O_ "-6I_\ 80F_]#-9] !1110 4444 %%%% 'TO_P3;_Y&GQ3_ -@^V_\
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M !1110!^8?BW_D:M3_["$W_H9K/K0\6_\C5J?_80F_\ 0S6?0 4444 %%%%
M!1110!]+_P#!-O\ Y&GQ3_V#[;_T-Z^M:^2O^";?_(T^*?\ L'VW_H;U]:T
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7\QWQ6
M_P"2H^)?^P_>?^CWK^G&OYCOBM_R5'Q+_P!A^\_]'O7[YX%_[SC_ $I_G,_
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5_,=\5O^2H^)?\
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M1110 4444 %%%% !1110 4444 %%%% 'YA^+?^1JU/\ ["$W_H9K/K0\6_\
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MG_)#8STC_P"EQ/N_#/\ Y+G!^LO_ $B1^L]%%%?QL?V2%%%% !1110 4444
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MHHH *_F.^*W_ "5'Q+_V'[S_ -'O7].-?S'?%;_DJ/B7_L/WG_H]Z_?/ O\
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M ,H__=0_XCM_U+O_ "M_]R/ZD**_EOK^G'X4_P#)+O#7_8 L_P#T0E? \=<
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M)M_\C3XI_P"P?;?^AO7UK0 4444 %%%% !1110 4444 ?FM_P<@_\DN^%_\
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M *-[\#_^$G9__&Z/^&9/V;?^C>_ _P#X2=G_ /&Z /+/^'M7_!.G_HZ31/\
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M6B?^!HK]3/\ AF3]FW_HWOP/_P"$G9__ !NC_AF3]FW_ *-[\#_^$G9__&Z
M/RS_ .&E?@'_ -%:T3_P-%'_  TK\ _^BM:)_P"!HK]3/^&9/V;?^C>_ _\
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M\NZJ(E>97=P20BD@,< @'JM%4M4\2>'=$L(]4UK7[*SM9G58;FZNDCC=F^Z
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MP000#0!^>?[9'A3X/?M*?\%&8_@A\*_V"] _:%\3?#KX0:=]HT3XK>-[33_
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
:**** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>tnet-20240331_g15.jpg
<TEXT>
begin 644 tnet-20240331_g15.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ=?&+X;6?PJ/QLG\56X\,#3!?C5!DJ8" 00,;MQ)"[,;MQVXSQ7S+>?\%?\
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MK?FDWI9'=E><87*LLJ0IP;K5)14F[<OLHM2<4[WO.27-I;EBEK=GY@ZWX<\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX3ZOIL^M?V9IB64-[H^JV$5Y8SI$N!N1C<0/M& 8ES\S$4 ?;-%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGQ.F,OQ ^(.KZL"V1#>7SM$A_P!F/.U?P K[C >'6;8A*6)G&FNWQ/[E9?\
MDQ^4YOXT</8.3A@:4J[77X(_>TY?^2GZ=^+?VHOV>/ [M#XD^,6@Q2I]^""_
M6>1?JD6YA^5<#K7_  4G_97TIV2R\2ZIJ6WHUEHTH!^GFA*_-ZBOJ*'AOE$%
M^]J3D_*R7Y-_B?!XOQLXCJR_V>A2@O-2D_OYDOP/T%/_  51_9]DN%M;3PAX
MOD9W548V%JJG) Z_:,_I6W!_P44^"<F!-X:\3QGN396Y _*?/Z5^<VE_\A*W
M_P"NZ?\ H0KTFOD.-<@R[(G06%3]_FO=WVY;?FS]'\+^+\YXLCBWCW%^SY.7
ME5OBY[_DC[ITO]NW]G?4&476O:A8YZFZTN0X^OEAZ[+PY^T%\$O%C+%H?Q0T
M:21_N0S7JPR-]$DVL?RK\Y**^%/U@_4N.1)4$L3AE895E.01ZTM?FAX/^)_Q
M#\ 3B?P9XTU+3L')CMKIA&W^\F=K?B#7L_P[_P""A?Q'T-TM/B)H-IKEOP&N
M8 +:X'O\H*-]-J_6@#[(HKSSX5?M0_![XN>7::#XD6TU"3@:5J>(9R?1>2LG
M_ 23]*]#H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK
MYD_;?_X+!_\ !/S_ ()Y>+M(^'O[3GQTAT[Q#J[1R#0-(T^;4;RQM&(!OKJ*
MW5FMK<9SODP6 .P/M. #Z;KR_P#:@_;#^ O[(?A'_A*?C+XQCMIIHV.FZ):8
MEOM08=HH<@D9X+L5121EAD5\X_MW_P#!9+X3_!+PS#X8_9B\0:-XW\3ZOI\=
MS;:O8W:W6EZ?;RH'CF,D9*W#LK*RQJ<8(9CC"M^2_P 3/BA\0?C+XUO?B)\4
M?%M[K>M:C)ON[^^EW.WHH'1$ X5% 51@  #% 'U3^TY_P6A_:/\ C?XC2Q^'
MT:^#?"4%T&;1["X)NM1B!Y2YN0 P##(*Q!  W.X@-4=AJ=AK5A!K6E71FM;R
M%9K>4XRR,,C=@G#<X(SP00>17QY7MW[+GCW[;IUQ\.M2N,RVH:YTK>W6,G,L
M0R>Q/F!0.C2L3Q7WO .<+ 9F\+4?N5=%Y26WW[>MC\C\7N&I9MD2S"BKU,/=
MOS@_B_\  ;*7IS'K5%%%?MY_*X4444 3::<:C;G_ *;)_,5Z57FNG\7\!_Z;
M+_,5Z57Y1XG?%A/^W_\ VP_H3P*^#,/^X7_N0****_*C^@ HHHH  2#D'!'0
MU[+\%OVU/B?\,7ATCQ+<-X@T=,*;>]E/GPK_ -,Y3D\?W6R.,#;UKQJB@#](
M?A3\:OAY\9M'_M7P1K:RO&H-U8S#9<6Y/9T]/]H94]B:ZNOS$\*^+/$G@C7(
M/$OA/69["^MFS%<6[X(]0>S ]P<@CJ*^R_V:/VQ-"^+"P>#O'30:;XCP%A8'
M;!?G_8S]V3_8[_P^@ /<**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **@U
M35-,T/3+G6M:U&"SL[.!Y[N[NIECB@B12S.[,0%4 $DDX !)K\U_B;^V%^TW
M_P %G?B!J_[*_P#P2Z\8WW@;X&Z1>OIWQ4_:BAA99-2(XFTKPUG'FR$$J]Z/
ME0'<I4>69P#M/VQ_^"F7QO\ C=\<]2_X)P?\$@]*T[Q1\5K3]S\1_BK?IYWA
MKX7P,2K//( R76H##!+50VUU(=7*21K\I_''3_V:/^":OP]\9?LJ_ :]/Q/^
M,/Q$M)K?X_\ QQ\;QIJ&I:P\ZXN+,M+O"JV2I@!*0K@,9)MTB_0G[4?Q&_9Q
M_P""-'[+&G?L(_L$>&+;0/$.HVAEO+Z!Q+>6JR#;)J5Y.?FFOIL85FY4#("(
MD2'\P;BXN+NX>[NYWEEE<O++(Q9G8G)))Y))[T 111101+!!&J(BA41%P% Z
M #L*=110 5?\+^(]3\(>(;/Q+H\@6XLIQ)&&SM?'5&P1E6&589Y!([U0I]M;
M7-[<QV=G;O+-*X2**)"S.Q. H Y))XQ51E*$E*+LT3.$*L'":NGHT^J9]>:-
MK.F^(]&M/$6C.6M+Z!9K<L02 >JDCC<K HV. RL.U6>O2O5_^"?'_!+S]H7Q
M+X,-]\?XI/!V@S7"W&EV-RH;4W5A^\4PG_4*<*1YA#*=Y\L[\U]__"/]D_X#
M_!2..7P9X#MGOHP,ZMJ(%Q=$C^(.X^3Z(%'M7[%3\1,OI993E.+G6:]Z*T5U
MI=M]'NK)VN?S35\&,WKYY6ITIQIX92]V3=VXO5)16K<;V?,XWM='YV_#_P#9
M._:*^)T:7/A+X3ZJ]O( 4O+V(6L++ZJ\Q0,/]W->L^&?^"5GQVU-%F\2>+?#
MFEJPYB%Q+/*OU"QA?R8U]_T5\UB_$7.JS_<QC!>EW][T_ ^YR_P7X7PT4\3.
MI5EUU45]T5?_ ,F9\7:7_P $DK^-X[C4/CQ#&Z,&V0^&RX.#TR;A?Y5TUU_P
M35O40FR^,44C8X$N@E!GZB=J^JZ*^6S3/,SSEP>,J<W+>VB5KVOLEV6Y]]D/
M"N1<,1J++:7)SVYO>E*_+>WQ-VM=[6/C'7O^"=WQ?L%,NA>)-#U!0.$,TD,A
M^@9"O_CU>;^,_P!G'XW^ 8WN/$GPYU%8$^_<VL8N(E'J6B+!1]<5^BU%>2?0
MGY9D$'!%%?HI\2_V<?@]\5TDD\4^#X%O) ?^)G8@0W /J74?/]'##VKYD^,W
M[!_C_P #)+K?P[N6\0Z<@+-;K'MO(E_W!Q+]5Y/]V@#P:BG2Q202-#-&R.C%
M71A@J1U!':FT %.CDDAD66*1E=6!5E."".A!IM% 'U_^R+^UVWC)K?X7?%"_
M U4*$TO596Q]MQTBD/\ SU]&_CZ'YOO?1M?EK'))#(LT,C(Z,"K*<$$="#7V
MU^QW^TNOQ8T(>!?&-Z/^$CTV#*S2'F_@''F>\B\!AW^]W. #W"BBB@ HJEXD
M\2^'/!N@7GBOQ?X@LM*TO3[=I[_4M2NT@M[:)1EI))'(5% Y+$@"OA'XA?\
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M0>Z =Z_(QF9V+NQ))R23R37UQ_P5V^+\WB;XQ:5\(+"YS9^&=/%Q>1JW6[N
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M\+;^#NFZ]=W/F:C:+]BU7)R3/& -Y]V4J_U8^E?GM7T)_P $]/B(="^(]_\
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M_ RU^#.GZ'XH^)'P^\(ZCK>MZ3XPLTBBDN+^&W:21M/N(D)21("XF8AS@@4
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M?$>E6-NO@JSOUC-]JLOV2)'O);+3K$3274G!2S1"FZ7<=+X*_P#!0#4?V-/
M4'P^^$'[+FD#]F'X-?%NS^"6J^-+GQE(OB-M66Z@T^YUG[ +0PRVHU&X"2L;
M@3R,\DP4YVT ?I31110 4444 %%%% !3998X8VFF<*B*69F.  .I-.KSS]K3
MQG+\/_V:?&_BJVDV30>';B*W?.-LLJ^4C?@SJ?PKFQF)A@\)4Q$]H1<GZ)7_
M $.G!86>-QE/#PWG)17K)I?J?DW\;_B)=?%GXO\ B3XD74A;^V-8GN(0W\$1
M<B-/HJ!5_"N6HHK^(:]:IB:\JU1WE)MM^;=V?W;AZ%+"T(4::M&*22\DK(*
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M%7Q7\$V,]AX>^(_P^O8([LV$S;I+"[AN8I8+RU+_ #^5(AVODJ5RV9_V,O\
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MMX(D+R2,>RJJDD^@K\%?!_PN\6_\&_?QP\&_%O\ X*D:+=^//A9IOA?7-9^
MMGX*U*_G\-_#;QE,EQ=SZ!#;7+2,7G0F&UO9RV"2V!B62+[/_P""Y'[9WC;6
M_P#@E7X-^&G@+X:>,-*\?_M4#2_#UCX'TG2SJ'B#3M-O+=;O5T6UA.9Y8K(2
M6[HI^_<#G&30![C_ ,$J/^"M'@;_ (*B:+XTDTOX.ZQX UGPA=:=<+H&O7R3
MSW^B:E:+=:9JJ%44+'<1^9A,-MV<L<X'UO7XP?\ #8'@3]F/_@JE^SE\?/AG
M^QG\=_A!\,_$7@VV^!WC^X^*WPQGT+31""A\.R1S,[1M-',C1NS[2L"'!(W
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M\/598S 1=3#/7O*GY2ZN/:7_ (%W:X#\2\'Q#2C@\?)4\4M.T:GG'HI=X_\
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M/$?A3PUGDW6H)X>H^L$N5OSAM_X"X^9^G<.>*W$F1P5&NUB*2Z3;YDO*>_\
MX$I>1_4A17\[?P9_X*-?MM_ .*&Q^'/[17B".QMP!%IFJSKJ%JB_W5BNA(J#
M_= KZ.\!_P#!PY^UWH$*6OCGX;^"/$")]Z=;.XM)W^I28Q_E&*_*,P\%^)\-
M)O#3IU8^KB_NDK?^3,_5\O\ &CA?$Q2Q,*E*77127WQ=_P#R5'[+45^5VF?\
M')VL10[=8_8\MIY/[UMX[:(?DUD_\Z-2_P"#DW6)82NC_L>VT$FWAKGQVTH!
M]<+9)_.O#_XA5QWS6^J?/VE+_P"3/<_XBKP)RW^M_+V=7_Y _5&BOQI\=_\
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M7"1QQJ69V)P  .22>U&P;A;6UQ>7$=I:0/++*X2**-2S.Q.  !R23VK]KO\
M@CU_P347]E'P./CG\8]$4?$3Q'9XBM)TRV@V3X/D =IWX,AZJ,1C&'+</_P2
M._X)'M\'FT[]J']I[05/BHHL_A?PM=Q@C1@1E;FX4_\ +SC[J?\ ++J?WF!'
M^B]?S=XG^(<,PYLGRR=Z:TJ37VFOLQ?\JZO[3T7N_%_2/AAX>3R]QSC,X6J/
M6G!_9O\ :DOYGT7V=WKL4445^&'[F%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:C;I&\,VHW'G/ H3@HAX!/)'6@#VRBBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
6HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>tnet-20240331_g16.jpg
<TEXT>
begin 644 tnet-20240331_g16.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ=?&+X;6?PJ/QLG\56X\,#3!?C5!DJ8" 00,;MQ)"[,;MQVXSQ7S+>?\%?\
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M/!R@ 5@0#NW<5TO[8'C?5OAU^S)XU\7:#<O!>V^B21VL\9PT3RD1!U/8J7W
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M2>P8U\A?L3_MJZ+^SM\.-;_9X^,B2^']6TFYNGT*\U.RG:""X<$FWN4B1I4
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M#).<N,9Z9*GN".*ZKX!? WPA^SM\,[3X7^"9;F:SM9I96N;UU::>21RQ9RH
MSC"\ #"BO*X7X<XARO/)XS,ZD:SE34%-2=XI._+9Q7-?1\S=]-=6>OQ7Q-PY
MFN0T\%E5.5!0J.;@XJTFXVY[J3Y6M5RI6UTLD?)/[6?_ "E*^&GUT7_TLFK[
MIKE]?^"OPG\4^.;+XE^(O &FWFOZ=Y?V'5I[<-/!Y;%DVMVVL21]:ZBOHLCR
M:OE>-QM:I)-5ZG.K7T5DK/S]#YK/L[H9M@L#0IQ:="ER.]M7=NZ\O4\P_:Z_
M:-T[]F'X-7GQ"EM$NM1FE6ST2RD.%FNG#%=V.=BJK.V.H7&02*^#/V9_BO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 445X-_P %+/VZ=%_X)O\ ['WB+]KCQ!\-[[Q;
M;>'[W3;4Z#IU^EM-<O>7T-HNV1U95VM,&.1R!B@#WFBO@+Q/_P %E/VL?@GX
M=N_B?^U-_P $5_C7X0\#:1'Y_B'Q-H7B#1]>?2[4 F2YDM;:99#%&/G=A]U
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M_%C]H'6?B/XXU3X6Z)X%T^^UC1[>T_L^QLPLEW(H@^4O>7B_:G"JBHS%5!%
M'Q9^Q9^VIH?@/_@NUXLT&P^ 'Q>^&G@']JWPG!?:?:?%WX:WOAH2>-M'@99Q
M:+=*$D6:PVO(R'<TQC!'*D_K37S[_P %!OV _#W[>'AGP"%^)-]X*\5?##XC
MZ=XS\%^+M,L$N9K*]M"V8F1V4/#*K8=-P!VJ3G;BOH*@ HK#TSXF_#C6O'FJ
M?"S1_'NC7?B;0[.WN]:\/6VIQ/>V$$^[R)9H V^-)-C;68 -M.,UN4 %%%%
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M=^U]X:_X)7?M(>-]2\9?!?XAQW9_9E^)>L2^9>Z2]M&99?"^I2<!C'%S;RG
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MT\%S:3I-;S(?FCD4AE8>X(!KZM\$^+K'QYX4L_%FGJB"Y3%Q AX@G7B2/J2
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG0O^$&\97P/B/38<K*YP;^ <>9[NO1AWX;N< 'N%%%% !1110 45D:CX_P#
MFD:_;^%=6\:Z1:ZI=R!+73;C4HDN)F(R%2,L&8D=@*UZ "BBODK]J'_@J+K/
MP]_:1N/V*/V,_P!E'Q#\>OB]I6D0ZKXJT'1]>M=&TGPQ:3#,!U+5+H-';RRJ
M=\<*H\C)\V!E=P!]:T5\A?LO?\%2?%_CO]J&U_8?_;:_9 UOX"_%?6]$GUCP
M7I=[XIM->TCQ19P F<6.I6JHDD\2@N\#1JRH"WM5;X]?\%6/&EM^TEK_ .Q]
M^P%^QCX@_:!\?>"H87^(,UCXHM- \/\ AAYEW16MSJETKH;IE&[R(XW8 $9W
M(ZJ ?8U%?(_[*_\ P5,U3XD_M(Q?L2_ME_LI^(?@)\8=1TF;5/"_AW6M=MM8
MTKQ/9Q F9M,U2U"Q7,D2@O)"41U7G!VN%X77?^"MW[7WC#]J;XN?LU_LC?\
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M&DM?7W[3/QWT3]G+X.ZK\3-5\B2X@C\G2+*XD*K=WC@^5$2H)"Y!9B 2$5B
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M73]H#4OVE?'UE)Y^D^'-7M19^"_#CGDI9:.F(IL?=,DX(D"JS1AAF@#)O_\
M@L[^T)^V;JEQX,_X(P_L2:O\3[))VMY?C;\2A-X?\$VKJ<,\+2!;K4MIX:.(
M1N,@@,*EM_\ @D5^W3^U5_Q.O^"FO_!5_P ?ZC;7)WS_  T^ >WPGH$([V\E
MPJFZOXN^90C].>*_0/2M)TO0=+M]$T/3;>RLK.!8;2TM(5CB@C4 *B(H 50
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M[/GQ.\3VL-MXUU/PKIEEJFD>)EA7;%-?:7?(T$UQ&ORK,-I +9#$DT >7?\
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M^(W[07@B/PW\#_!'B!Q9:WIFCZ=I\D$$ER-W^A7=X[9"LP:!QNW!2K5^K-%
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M!::MH>NZ;!J&C:K83"2"\M9HUDBFC8<,CHRL".H(K3H **** "BBB@ HHHH
M**** /SAO_BW^W%^V_\ MR_M'?![X??\% 5_9T\.?L_3Z=8Z+H>G>#-)U&[U
M3S[ 7;:WJ3ZG&Y^Q$DA$B\M&0'<P9=S<YX?_ ."FG[6?[1O_  28_9Z^+R>)
MK?P'XU^-GQRTGX:^)/B%X=TZ)H[.RDU2\M)M9T^.[1XD:Y2S58C(C(DEWE0=
MJ5POP-_9>_85_P""E?[5_P"UCXK_ ."MD^G:Y\1/ /Q7U;PIX>\*>)?%DVCQ
M^%O L"1OIEW;10SPY2X21YFNVSN*@C;D[O<?^",_A_0?VUO^"9_BOX$_M*6$
M'Q5^$VC?%3Q#X3^%^M>*[))?^$H\':=>(FE7SL%42.K(Z).H# VRL#N7=0 ?
M"[]O_P"*7[)GP_\ VK/!'QC^(.K_ !?F^!'C_3/#OPLUS5+>U35O%M_J^F64
M]AH4QLXHHI[I+Z\2V:5(U;:X9E&PFOL;]DWP)\9OAM^SEX1\(?M%?$R7QAX]
M@TA)?&/B&1$5+G49299UB5%55@C=VBB&,B*-,Y.2?@/XG^#OA=X \>_$K4_V
M1/@EH]C\*?V'?!NO>-(/#VGVS-:^*OBM+I$UU$)VRS7<EA9%2[LQE$^HQC.Z
M 8ZS]A/XY?M3^!OVJ_@3\,OB;^UUK?QDT?\ : _9YO/'WB&/7-,TR(>&]5@.
MFR"XL&L;:$Q:?,+]X%@E\S#0JRR9+ @'Z*4444 %%%% !1110 4V66.&-III
M J(I9F8X  ZDTZO//VM/&,O@']FCQOXHMIO+FA\.7,5O)G[DLJ^4A'N&=37-
MC,3#!82IB)[0BY/T2O\ H=."PL\;C*>'AO.2BO632_4_)OXW?$*Y^*_Q?\2?
M$>ZE9_[8UF>XAW?PQ%SY:?14"J/85RU%%?Q#7K5,37E6J.\I-MOS;NS^[</0
MIX:A"C35HQ227DE9!1UZ45Z7^QU\-XOBQ^TUX.\%W=OYMK)JZW-[&1D-! #/
M(I]BL97_ (%6N"PE3'XRGAJ?Q3DHKUD[+\S/'8NEE^"JXJI\-.,I/TBFW^1^
MFW['/P73X#?L[^'? L]L(]1>U%[K)Q@F[FP[@^NS*Q@^D8KT^BBO[8P.#H9?
M@Z>%HJT(145Z)6/X8Q^-KYCC:F*K.\ZDG)^K=PHHHKJ.0**** "BBB@ HHHH
M **** "BBB@ HHHH *X;]H[X:Q_%;X/:QX6C@WW:VYN=-P,D7$>60#_>Y3Z.
M:[FB@#\L^G6BNW_:/\%KX ^-_B/PW#"(X%U%I[5%'"Q3 2H![ .!^%<10 5N
M_##Q?)X!^(FB>,XV(&FZE#-*%ZM&&&]?Q7</QK"HH _4J*2.:-9H7#(Z@JRG
M((/0TZN._9]\2GQ=\$O"^NN^YY-&ACF8_P 4D:^6Y_[Z0UV- !1110 5\.:I
M\(_^"PW[*_QO^*%[^RQK7@+XS> OB7XHF\1>&;;XQ>/]4L[_ ,!7MPB+-9H4
M@N!<Z4K(K0V\31&(;D4#[S?<=% 'PM^S7_P0G_98T[]FNR^'/[>O@'PS\9_&
MU_XYU[QQXI\0:AITD5I_;^M20O?M:1!@8X<6]M&-W+" -A-VT<[\!O\ @@?^
MS!\ O^"I5[^USX#_ &<_A]I'P[TOP#ID?@31]/DN/MND^*(+V26;4%B9=B@P
MF-0_F,25QL'6OT+HH ^?/^"BOP'^,?[5_P +] _99\!(EGX-\<>*+>U^,6NC
M45@FM_"L0:>[LH%!WO+>F..R)4$)%<3,<8&?'OVM?V4OVNO /[76O?M*_L9_
M!7PAXVT[QW^S_'\,KSP[K7BE=%7PU/;7=U/:7R9@D6:SV7CI);QA9!Y*E=VX
M@?<E% 'E?[#?[.5U^R%^QQ\,/V7K_P 2+K%SX"\#Z;HEWJL:%4NIK>W2.21%
M;E4+ABJGD+@'I7JE%% !1110 4444 %%%% !1110!XY^T+_P3T_87_:R\5V7
MCO\ :6_9)^'_ (WUO3XUBM=7\1^%[>YN1$I)6)I67<\8))$;$IR>.37JOACP
MOX9\$>';'P?X,\.V&D:1IEJEMINEZ7:);VUI @"I%%%& L:*  %4  # %7J*
M .3^&'P,^$GP9\*ZCX)^&G@6RTS3-8UF_P!6U>V4-+]OOKV9Y[NXG:0LTKRR
M.Q8N3D$#H !QO[-_[ _[&W[(7B'5_%?[-'[.OAKP=J6N0B#4;W2+,K(;<2-(
M+:,L3Y%N'8N((]L8;D+D"O7J* "BBB@ HHHH **** "OG;_@J7KLND?L@ZM8
MQR;1J>K6-J_N!,)L?^0J^B:^4_\ @L#<RP_LT:-!&V!-XVME?W M+LX_,#\J
M^8XUJNCPGC9+_GW)?>K?J?5<#TE6XOP,7_S\B_N=_P!#\VZ***_CH_M(*^L/
M^"07A5=6_:&UGQ1-$&32?"\HC8C[LLLT2@_]\"0?C7R?7W#_ ,$7[&.34_B)
MJ9^_#!I<2_1VNR?_ $ 5]GX>T(XCC+!P?23?_@,92_0^)\1\1+#<$XR<>L5'
M_P "G&+_  9]WT445_7)_'(4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'QC_P %$=!33_B_INNQ1X&H:&GF'^])'(ZD_P#?)0?A7@-?4/\ P4JM
M52\\'7HZR17Z'Z*;<C_T(U\O4 %%%% 'W3^PEJS:E^SO86C'/V#4+J ?0R&3
M_P!J5['7@?\ P3LN'E^"FI0MTB\33!?H;>W/\\U[Y0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7Y
M0?MH?M=?'/\ :1_:@_:!^!CMH\?PN^!OB[PAI&CB"R(O+S5[[2+VZNY7FR05
MB.(=F !\IZYK]7Z_'#]C_19?C5^P%^U!^VVB>=;_ !1_:TUOQ!H-V.1+HEM=
M1:;9X/<*?.7/2OF.-:3K<)XV*_Y]R?W*_P"A]5P/55'B_ R?_/R*^]V_4\^H
MHHK^.C^T@K[A_P""+U]''J?Q$TP_>F@TN4?1&NP?_0Q7P]7UA_P2"\5+I/[0
MVL^%YY@J:OX7E,:Y^]+%-$P'_?!E/X5]GX>UXX?C+!S?637_ (%&4?U/B?$?
M#RQ/!.,@ND5+_P !G&3_ "/T@HHHK^N3^.0HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** /E3_@I5=*]YX.LA]Z.*_<_1C;@?^@FOEZO?O^"B.O)J
M'Q?TW0HI,C3]#0R#^[))([$?]\A#^-> T %%%% 'VA_P3L@>+X)ZE,W23Q-,
M5^@M[<?S!KWRO'/V$M)?3?V=["[88^WZA=3CZ"0Q_P#M.O8Z "BBB@ HHHH
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MTE4:A-72O*WNM=[I6:79/JSWZBBBOVH_#0HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#XJ_X+$?\ !.S5/VL_ABOQ6^$,$S^-_"\#2#287.S7+4#YHMG3
M[0@R8VZL,QG.4*_B/<VUQ9W$EI=P/%+$Y26*12K(P.""#R"#VK^HVOSH_P""
MN/\ P2/?XPOJ/[4/[,.@*/%01I_%'A:TC &L@#+7,"C_ )><?>3_ ):XR/WF
M1)^W^%G']#*8QR;,&HTFWR3V47)W<9>3;;4GLWKH]/Q#Q3X!KYM*6<Y>G*JD
MN>&[DHJR<?-)).*W2TU6OY#44^XMY[2=[6Z@>*6)RDD<BE61@<$$'H0>U,K^
ME=S^:M@J2UNKJQNH[VRN9(9H9 \,T3E61@<A@1R"#R"*CHH:30)M,^\/V-O^
M"[7Q]^!\%IX)_:'TZ3XA>'8<(FHRW 36+5.G^N;Y;D#KB7#D_P#+0#BOTQ_9
ML_X*+_L@?M5P06_PN^+]A'J\^!_PC>MN++4%<_PK%(1YI'<Q%U]Z_G>H!(.0
M<$="*_,>(O"GAK/)NM03P]5]8)<K?G#;_P !<?,_3N'/%;B3(X*C7:Q%)=)M
M\R7E/?\ \"4O(_J0HK^=OX-?\%&OVW/@)#%8_#G]HOQ#'90X$>FZK.NH6R+_
M '5BNED5!_N@?G7T=X$_X.'/VN]!B6U\<_#?P/KZ*!F=+.YM)V]<E)BGY(*_
M*,P\%^*,-)_5ITZL>FKB_NDK?^3,_5\O\:.%\3%+$PJ4I==%)??%W_\ )4?L
MM17Y7:;_ ,')NL10A=8_8]MIY-O+6WCMH@3ZX:R?^=&I_P#!R;K$L.W1OV/;
M:"3!^:Z\=M,OY+9)_.O#_P"(5<=\UOJGS]I3_P#D[GN?\15X$Y;_ %OY>SJ_
M_('ZHT5^-/CS_@X;_:[U^&2U\#?#?P1X?1_NSM9W%W.GT+S"/\XS7SC\9_\
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M\N<<XS.%JKUIP?V4_M27\SZ+[.[UV****_#3]S"BBB@ HHHH **** "BBB@
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M.0VWX/-_&CB'&1<,#2C03Z_'+[VE'_R4^\RCP7X>P<E/'5)5VNGP1^Y-R_\
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M"8?\)M-JRR6^N/#>FQG\F$1#:BW"3('WN&\HGC.!]B4 %%%% !1110 4444
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^'-4^$?\
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MR2(K<JA<,54\A< ]*]4HHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
2*** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>tnet-20240331_g17.jpg
<TEXT>
begin 644 tnet-20240331_g17.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@!
MP &T P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS=N52=KVWZ;=3K****^]/ST**** "BBB@ HHHH **** "BBB@ HHHH ****
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M..=6"5N7V<(^CO'70\+-,TR+&8=QPN 5&;=^;VDY>JM+34****^A/G HHHH
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M<[6V@#(&WH>:\Y_X)X?M%?%[XG>#/'_@KXJ^(GU/4O!Q3[)JDH!F(D6X4HS
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MR?3_ -C7X:?$+Q-\5OB;^U9XE^'%QX3T_P 5:=/;:)H=S"4EE#LLC2E" ?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX7\.+;MXRFDMK6>UMHK"%F3^U!-<+;O!"0HDV_= 9J]]_;U_X)M?LL_\%$O
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M<MF1X+6!($+D=6*H"?>NBH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHK(^('_(AZW_V"+G_ -%-50CSS4>Y,Y<D'+L:]%?RWT5_0'_$"?\
MJ8_^4?\ [J?S_P#\1V_ZEW_E;_[D?U(45_+?11_Q G_J8_\ E'_[J'_$=O\
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M(_\ *1;X7_\ 87N?_2*XKYRKZ-_X)(_\I%OA?_V%[G_TBN*\/B?_ ))K&_\
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M>*/_ $!X/_P77_\ F@/^)*?"O_H,QO\ X,H?_,Q\W_\ "A/BS_T*G_D]!_\
M'*/^%"?%G_H5/_)Z#_XY7TA11_Q.AXH_] >#_P#!=?\ ^: _XDI\*_\ H,QO
M_@RA_P#,Q\W_ /"A/BS_ -"I_P"3T'_QRC_A0GQ9_P"A4_\ )Z#_ ..5](44
M?\3H>*/_ $!X/_P77_\ F@/^)*?"O_H,QO\ X,H?_,Q\W_\ "A/BS_T*G_D]
M!_\ '*/^%"?%G_H5/_)Z#_XY7TA11_Q.AXH_] >#_P#!=?\ ^: _XDI\*_\
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MOWD3QZBBBOESZL**** "BBB@#[8_X(Q_\C5X]_[!]A_Z'/7WQ7P/_P $8_\
MD:O'O_8/L/\ T.>OOBOZL\,/^2+P_K/_ -+D?R-XJ?\ )<8GTI_^FXA1117Z
M ?G@4444 %%%% !1110 4444 %9_BW_D5=3_ .P?-_Z :T*S_%O_ "*NI_\
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M_I<C^1O%3_DN,3Z4_P#TW$****_0#\\"BBB@ HHHH **** "BBB@ K/\6_\
M(JZG_P!@^;_T UH5G^+?^15U/_L'S?\ H!K.M_"EZ,UH_P :/JC\/Z***_A<
M_O<**** "BBB@ HHHH **** "BBB@ HHHH **** "O9/^"??_)XO@;_L(3?^
MDTU>-U[)_P $^_\ D\7P-_V$)O\ TFFKV>'/^2AP?_7VG_Z6CQ.)O^2<QO\
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M_P"AM\=_^%E<_P"->Z44 >%_\.]_@G_T-OCO_P +*Y_QH_X=[_!/_H;?'?\
MX65S_C7NE% 'A?\ P[W^"?\ T-OCO_PLKG_&C_AWO\$_^AM\=_\ A97/^->Z
M44 >%_\ #O?X)_\ 0V^._P#PLKG_ !H_X=[_  3_ .AM\=_^%E<_XU[I10!X
M7_P[W^"?_0V^._\ PLKG_&C_ (=[_!/_ *&WQW_X65S_ (U[I10!X7_P[W^"
M?_0V^.__  LKG_&C_AWO\$_^AM\=_P#A97/^->Z44 >%_P##O?X)_P#0V^._
M_"RN?\:/^'>_P3_Z&WQW_P"%E<_XU[I10!X7_P .]_@G_P!#;X[_ /"RN?\
M&C_AWO\ !/\ Z&WQW_X65S_C7NE% 'A?_#O?X)_]#;X[_P#"RN?\:/\ AWO\
M$_\ H;?'?_A97/\ C7NE% 'A?_#O?X)_]#;X[_\ "RN?\:/^'>_P3_Z&WQW_
M .%E<_XU[I10!X7_ ,.]_@G_ -#;X[_\+*Y_QH_X=[_!/_H;?'?_ (65S_C7
MNE% 'A?_  [W^"?_ $-OCO\ \+*Y_P :/^'>_P $_P#H;?'?_A97/^->Z44
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M?QT^)5C#<_$'0_BAI_@W29;Q T^D^%[?2K::RA@W<PPW#RS3L%P)77<<D T
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M5X.79V^:@#])Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?_"/7]2\*_#Z>Z\*ZI8?\(C<K:OX;U[6]#N#J<U@VUD@N&,=O<\*1')M.W!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
#?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>tnet-20240331_g18.jpg
<TEXT>
begin 644 tnet-20240331_g18.jpg
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MNIT3_@CS\"++48[K6_B'XHOH$8%K57@B$F.Q81DX/M@^XKV+XX?$WPM^Q9\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y
M_P#VYO\ @IK^R;_P3UTNR;X^>*-7N=<U6RGO-&\'>$M N-5U>^MX642SK! I
M\J%"PS-,T<>?EW%N*BO?^"K7_!/G2OV8+/\ ;*UO]IC1]/\ AQ>:\=#_ .$@
MU"RNX6MM44N&L;BV>$7%M<+Y;[HI8T9< D $9^7/^"V7[,?QYTOQ5XM_;M_9
MF\5^"M5OE^!@\#_$3P!XNN98+B715U?[?;WNG7$*N8;C[0[HRRIY4B <AD%?
M17_!-7]HWX2_&SP]\4H]-_9?C^"GQ"\-?$>ZC^-O@F9[61DU^6V@F;4&O+8"
M.^2>W,++=$*75.0 H) )OV=?^"QO_!,O]K3XN:9\!_V<_P!KOPYXK\7ZRD[Z
M9H>GV]T)9UAA>>4@R0JHVQQNQR1POK6QX>_X*H_\$]?%?QQ/[.?A[]JGPU=>
M*_[>;0X[9&F%I-JHZZ?'?&,6DMWD%?LZ2F7=\NW/%>"_\$X?"?B#]O.Y^*G_
M  56\5ZI-:ZE\4(M4\(_ &:93GPMX+M)9;:WN84/,4][=1R7LQ!.X" *=H K
MXN_:&^)/Q-_9\_X-[?$G_!._Q?\ \$^?B=X6^('PM\(QP:WXHN/"_P!G\*VU
MS8ZA'=-XAM-;+""YDE=!-$L):X:XF"E NZ0 '[ET5E>!;[6=3\$:-J7B*(QZ
MA<:5;RWZ%=NV9HE+C';YB>*U: "BBB@ HHHH **** "OG_\ ;F_X*:_LF_\
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M,S/]GW$BOW?T^_LM5L(-4TVY2:WN85EMYHSE9$8 JP/<$$&@":BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ^*/^"G__  2X\=?M2ZMK'[0W[*OQ
MOOO GQ/U'X?GP=K=LUA;W>E>*=(%V+J*VNXI\>5+#,7>.XC97 9D.Y3@>A?
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M_+.T;_Y#KY;HKZ#_ %2X5_Z *'_@JG_\B?/_ .MO%7_0?7_\&U/_ )(^I/\
MA])_P4O_ .CE/_+.T;_Y#H_X?2?\%+_^CE/_ "SM&_\ D.OENBC_ %2X5_Z
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M2K:)_P!B\O\ Z/EK^*>/?^2RQW_7QG]K<!_\D;@?^O<3YZHHHKY$^N"BBB@
MHHHH **** "BBB@ KZO_ .":_P#R"?%W_7S9?^@S5\H5]7_\$U_^03XN_P"O
MFR_]!FH ^G:*** "BBB@ HHHH **** /PD_X+??\I'?&?_8.TG_TW05\E5]:
M_P#!;[_E([XS_P"P=I/_ *;H*^2J_N'@[_DD\!_UYI_^D(_A_C'_ )*S'_\
M7ZI_Z6PHHHKZ,^;"BBB@ HHHH **** "BBB@#]J_^#?3_DQ?4?\ LH6H?^DU
MG6]_P4;_ .2K:)_V+R_^CY:P?^#?3_DQ?4?^RA:A_P"DUG6]_P %&_\ DJVB
M?]B\O_H^6OXIX]_Y++'?]?&?VMP'_P D;@?^O<3YZHHHKY$^N"BBB@ HHHH
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MJ /IVBBB@ HHHH **** "BBB@#\)/^"WW_*1WQG_ -@[2?\ TW05\E5]:_\
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MQ&!QN$<E7I2@TTGS1:LVKI.ZT;6J[K4Q:***ZCE"BBB@#]J_^#?3_DQ?4?\
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M\,@_'?\ Z N@_P#A;Z1_\E4?ZV\*_P#0?0_\&T__ )(/]4N*O^@"O_X*J?\
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M **** "BBB@ J*^L+'5+233]3LHKBWE7;+!/&'1QZ%3P14M% &%_PJ[X9_\
M1.]"_P#!1#_\31_PJ[X9_P#1.]"_\%$/_P 36[10!A?\*N^&?_1.]"_\%$/_
M ,31_P *N^&?_1.]"_\ !1#_ /$UNT4 87_"KOAG_P!$[T+_ ,%$/_Q-'_"K
MOAG_ -$[T+_P40__ !-;M% &%_PJ[X9_]$[T+_P40_\ Q-'_  J[X9_]$[T+
M_P %$/\ \36[10!A?\*N^&?_ $3O0O\ P40__$T?\*N^&?\ T3O0O_!1#_\
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M!!J__!4']OOPA\/W_:.\>_\ !&KQEIWPJM[0ZEJ%W;?$W3+CQ;8Z4%WF[ET
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M.K_!ZV\*W2ZUHW@^^OH[:WU--7^V%+B^2*:&YD@-LD+(9%5E(!KZ&^+.L_\
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4@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>tnet-20240331_g19.jpg
<TEXT>
begin 644 tnet-20240331_g19.jpg
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M **** "BBB@ HHHH I>(_$6B>$?#][XI\2ZE'9Z?IUK)<WMU,<+%$BEF8_0
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M_#7AK1[73M.TZUCMM/T^QMUA@MH(U")%&B *B*H"A0    !0!:HHHH ****
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M/_I3)7[UX%_[WCO\-/\ .1^"^.G^Z8'_ !5/RB<I1117]%'\ZA1110 4444
M%%%% !1110 4444 ?TT_!/\ Y(SX1_[%BP_])XZ^&?VIO^3A/%?_ &%#_P"@
MK7W-\$_^2,^$?^Q8L/\ TGCKX9_:F_Y.$\5_]A0_^@K7\!XK_>JG^)_F?WYA
M/]TI_P"%?D<!1117.= 4444 %%%% !1110 4444 %%%% 'Z'_LN_\F^^%/\
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M%% !1110 4444 ?H?^R[_P F^^%/^P2O\S7>UP7[+O\ R;[X4_[!*_S-=[0
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M #-=[7!?LN_\F^^%/^P2O\S7>T %%%% !1110 5_,U\=_P#DN'C/_L:]1_\
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MS-=[7!?LN_\ )OOA3_L$K_,UWM !1110 4444 %?S-?'?_DN'C/_ +&O4?\
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MBB@ HHHH **** /T/_9=_P"3??"G_8)7^9KO:X+]EW_DWWPI_P!@E?YFN]H
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M (T ?$]%?;'_  [W^"?_ $-OCO\ \+*Y_P :/^'>_P $_P#H;?'?_A97/^-
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M-$LRS/I"WZSM:"9MNP/(MO*WEABZJ%9@H="W:4 %%%% !1110 4444 %%%%
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M_$/BK3&;Q7<ZI*FR\;4]1$I2_7$<'E,(HW0%U;=@,0#Q?_@E-^S-\(OV1O\
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MA)<_LYZQHWB'5O'OP\^S:OJ^K:CXITZZO?$VH_OV/V9Y][3W.2(VD2-5VA0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
***** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>tnet-20240331_g2.jpg
<TEXT>
begin 644 tnet-20240331_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" ')!!L# 2(  A$! Q$!_\0
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MU70 4444 %%%% !1110 4444 %%%% !1110 4444 >5?M+?\DZTC_L<_"?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /*OVL?\ DUGXR?\
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M!QO$,*.^W.1N*XR#SQ6CX0_:%^&WCSX;W?C_ $/QGI-YX.L]WVO5VG$,5J5
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MKHRJ1P@4\ "NK_X)CZ79Z'X%^-6G:?;165A9_%36[>WMH5"QQ1I%:JJ*!T
M  ]J /J'QA\4/!OP]FLH?%/BW0O#4MZX2UCUC4H;1IV)P%02,-QSV%3>+OB)
MX4^'^D1:KXI\3Z/X:TN5@D=]J]_%:P.Q&0 \C!22.V:^5/V\/!?@#QK%=^$=
M-\"Z9XV^.WC735TS1_,@66XTNU1VS?/*P/V6&(R.=XVEVPO/..#N/@YH-G^V
M)\%/A-\0X['QAX5\,?"4QV46NHLEM<7\<QAFD6-\J3Y42D @E54'^$$ 'W%K
MWQ.\'>%?#=OXAUKQ9H>D:!<!3#JM_J4,%K*#T*RLP4Y[8-2:E\1O">C^$T\4
MW_BC1K'PPZ+(FM7.H0QV3*WW6$Q8(0>QSS7YU?L_-\+-%_9'L;SQOX-L/B1-
M8>)]?T3X=^';B#[=-J2SSH1';Q-N4Y=,F7;^[5201GYO3_ W[(^N?#_]COX?
M_#B[L_A]XG^)%K?R:O::3\13+/I,,TI<S1I#$297CCE(^ZR[RS="* /M/PSX
MJT7QIHMOK'A[6+#7M)N 3#?Z9=)<P28.#MD0E3SZ&M6OBO\ X);I!X?^''Q,
M\(2:=%I^OZ)XUOAK"V$Z2Z<;EUC7%GM V0A8E 0Y(QUYP/?/AO\ M _\+&^)
M/B#P?_PK;XA>&/['$Y_M[Q)H7V32KWRIEBQ;3^8WF%]V].!E%)XQB@#MO&GQ
M'\)_#:QAO?%WBC1?"UG,^R.XUK4(;.-V_NJTC*">1P*T-#\2Z1XGT:'5]'U6
MRU;29E+Q7]C<)-!(HR"5D4E2.#T/:OBG3?!_A+XQ?\%)OBQI'Q/TS3?$PT'P
M]I:>$]%UZ%+BW^SR0I)=2QP2 HY$K$%L$C<?3BI^QU\//!_B+XE?M7?#K2[6
M.^^#@US34LM-L[AULA.T4AO8HV1A\N^.)64'&U54Y7@@'VSX5\:>'O'6GRW_
M (:U[3/$-C#.]M)=:5>1W423)C?&6C8@,,C*GD9%4?%GQ2\%^ ;ZRL_$_B[0
M?#EY?'%I;ZMJ<-K)<'.,1K(P+<\<9KYG_P""85E;Z;\$_&]I:01VUK;^/-8B
MAAB4*D:*T055 X    %8_P"WA\/_  %\19KOP)H/@?2_%_QW\:VT,%I=R0B2
M;1;*-PK7\TS FU@0;@-N#(QP QS0!];>,OB-X3^'6GP7_BOQ/HWABQN)/*AN
MM9U"*TBD<C(56D8 G'85%XD^*'@WP;H-KKFO^+="T/1+H*;?4M2U*&WMI@P!
M4I([!6R",8/.17Q(WPE\,7G[<7@SX9?$J*R\7>&/"OP9BATR/Q$JR0SW$=RD
M,MUM?Y?-,<<A+=0(P>-@(\^^!#?#>#]AWP;/XQ\%V?Q-\5S76N:!\/\ 0KJ
M7EU?"2Z?B%'RJ*K+EY]H\M4ZC@$ _32'7M,N=%&L0ZC:2Z083<C4$G4P&(#<
M9/,!V[<<[LXQ53PCXU\/?$#18]8\+Z]IGB32)':-+_2+R.Z@9E.&421L5)!X
M(SQ7YR_$^6Q_9#_97^"W[/'Q!\5OH=GXLGN9/%FN013W"6>G+-]INK. 0JSE
MI6F2 ,H(P9&( 85[#_P2K\<>$_$'P-\2:%X8NUE&C^);^5K5()8U@MKB9WM<
M%U (:-3P"2,8.#0!]IT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'_8Y^$__ %(=.KU6O*OVEO\ DG6D?]CGX3_]2'3J]5H **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** /*OVL?^36?C)_V)FL_^D,U>JUY5^UC_
M ,FL_&3_ +$S6?\ TAFKU6@#RK]I;_DG6D?]CGX3_P#4ATZO5:\J_:6_Y)UI
M'_8Y^$__ %(=.KU6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#RK]I;_DG6D?\ 8Y^$_P#U(=.KU6O*OVEO
M^2=:1_V.?A/_ -2'3J]5H **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** /*OVL?^36?C)_V)FL_P#I#-7JM>5?M8_\FL_&3_L3-9_](9J]5H \
MJ_:6_P"2=:1_V.?A/_U(=.KU6O*OVEO^2=:1_P!CGX3_ /4ATZO5: "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \J_:6_Y)UI'_8Y^
M$_\ U(=.KU6O*OVEO^2=:1_V.?A/_P!2'3J]5H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** /*OVL?\ DUGXR?\ 8F:S_P"D,U>JUY5^UC_R
M:S\9/^Q,UG_TAFKU6@#RK]I;_DG6D?\ 8Y^$_P#U(=.KU6O*OVEO^2=:1_V.
M?A/_ -2'3J]5H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@#RK]I;_DG6D?]CGX3_\ 4ATZO5:\J_:6_P"2=:1_V.?A/_U(=.KU6@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **^1M3TG3O"O[4'PK\06MAI>E:5K,FJ6
MUEJ/AF^.H76O/(JD/J$DBQGRPIWY#3[6&-P&UA%\%M)TWX)^*/ G@CQ#X1\+
M7^K^*+?5+FS\?>';T37<L9,EQF1_(CE1#%($$BR,/E&"!]T ^OJ*^7_@?X3T
MSQ1\?-2^('@+34T#X=6.DG0A=01F-?$=V)F9[D#K,J$E3.^2[ X9L-M^H* "
MBBB@#RK]K'_DUGXR?]B9K/\ Z0S5ZK7E7[6/_)K/QD_[$S6?_2&:O5: /*OV
MEO\ DG6D?]CGX3_]2'3J]5KRK]I;_DG6D?\ 8Y^$_P#U(=.KU6@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MYN8[.&5ML;W$D4;+ &/3S"O'/2O0(9DN(DEB=9(W4,KH<A@>00>XH ?1110
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M2X9_"2/+'%;1Z3J")80-H/EZE/,[ND+*JR/ \&XVRD,R%>G)^E:** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!12$A02>!7F'Q0_:4\ _"7S8=9UJ.?4X\_\ $KL/WUSD=BH.$/IO*CWKHH8>
MMBIJG0@Y2[)7.>OB*.%@ZE>:C'NW8]0KF_&WQ&\,_#G33?>)-;L](M^=OVB0
M!Y,<D(GWG..R@FOA;XH_M^^+?$WFVGA&RA\,6)^474@$]VPYYY&Q,CMAB.S5
M\RZYKVI^)M2EU#5]0NM3OI?OW-Y,TLC?5F)-?H&7\%XBM:>-ER+LM7_DOQ/S
M_,.-,/1O#!1YWW>B_P W^!]K?%#_ (*'6UNTUGX#T4W;#*C4]6!2/ZK$IW,"
M.06*D8Y!KS;]F[XM>+OBG^U)X-N/$^NW6J!6O&CMV;;!$?L4XRD:X53CC(&3
MW-?,=>W?L6_\G,>#O^WS_P!(IZ^TKY+@<MRW$/#T_>Y)ZO5_"^O3Y6/BZ&=8
M[,LRPZQ%3W>>&BT7Q+I_G<_4BBBBOP,_? HHHH \J_:6_P"2=:1_V.?A/_U(
M=.KU6O*OVEO^2=:1_P!CGX3_ /4ATZO5: "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>&!ARKN]7]VR_$]N^*'[8'Q$^)AEMQJ?_".Z4W LM()B)'^W+G>W!P0"%/\
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M 5[=^Q;_ ,G,>#O^WS_TBGKQ&O;OV+?^3F/!W_;Y_P"D4]>5FW_(NQ'^"?\
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MT:-+#P5.C%1BNB/S2M6JXB;J5I.4GU>H4445L8A1110 4444 %%%% !1110
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7MW[%O_ "<QX._[?/\
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M#_7;,?\ GW#[I?\ R1^I'_#:7P:_Z''_ ,I=Y_\ &:/^&TO@U_T./_E+O/\
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M;;^W(-+7@6L?B/40@7!&P?Z1]S!.4^Z?2NXM[>*SMXH((D@@B4)''&H544#
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M -*84445ZIY04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 ?MM1117\I']6A1110!Y5^UC_P FL_&3_L3-
M9_\ 2&:O5:\J_:Q_Y-9^,G_8F:S_ .D,U>JT >5?M+?\DZTC_L<_"?\ ZD.G
M5ZK7E7[2W_).M(_['/PG_P"I#IU>JT %%%% !1110!^=O_!1+_DM>B?]B]!_
MZ4W-?+=?4G_!1+_DM>B?]B]!_P"E-S7RW7]&\/\ _(KP_P#A/YRX@_Y&M?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5XC7],93_P B[#_X(?\ I*/YGS;_ )&.(_QS_P#2F%%%%>J>4%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% '[;4445_*1_5H4444 >5?M8_\ )K/QD_[$S6?_ $AFKU6O*OVL?^36?C)_
MV)FL_P#I#-7JM 'E7[2W_).M(_['/PG_ .I#IU>JUY5^TM_R3K2/^QS\)_\
MJ0Z=7JM !1110 4444 ?G;_P42_Y+7HG_8O0?^E-S7RW7U)_P42_Y+7HG_8O
M0?\ I3<U\MU_1O#_ /R*\/\ X3^<N(/^1K7_ ,04445] ?/A1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 5[=^Q;_ ,G,>#O^WS_TBGKQ&O;OV+?^3F/!W_;Y_P"D4]>5FW_(NQ'^"?\
MZ2SU<I_Y&.'_ ,</_2D?J11117\SG],!1110!Y5^TM_R3K2/^QS\)_\ J0Z=
M7JM>5?M+?\DZTC_L<_"?_J0Z=7JM !1110 4444 ?EO^VE_R<QXQ_P"W/_TB
M@KQ&O;OVTO\ DYCQC_VY_P#I%!7B-?TQE/\ R+L/_@A_Z2C^9\V_Y&.(_P <
M_P#TIA1117JGE!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!^VU%%%?RD?U:%%%% 'E7[6/\ R:S\9/\
ML3-9_P#2&:O5:\J_:Q_Y-9^,G_8F:S_Z0S5ZK0!Y5^TM_P DZTC_ +'/PG_Z
MD.G5ZK7E7[2W_).M(_['/PG_ .I#IU>JT %%%% !1110!^=O_!1+_DM>B?\
M8O0?^E-S7RW7U)_P42_Y+7HG_8O0?^E-S7RW7]&\/_\ (KP_^$_G+B#_ )&M
M?_$%%%%?0'SX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MV_\ B*/]>,/_ ,^9?>@_U'Q/_/Z/W,_("BOU_P#^%&_#C_HG_A;_ ,$MM_\
M$4?\*-^''_1/_"W_ ();;_XBC_7C#_\ /F7WH/\ 4?$_\_H_<S\@**_7_P#X
M4;\./^B?^%O_  2VW_Q%'_"C?AQ_T3_PM_X);;_XBC_7C#_\^9?>@_U'Q/\
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MHWX<?]$_\+?^"6V_^(H_UXP__/F7WH/]1\3_ ,_H_<S\@**_7_\ X4;\./\
MHG_A;_P2VW_Q%'_"C?AQ_P!$_P#"W_@EMO\ XBC_ %XP_P#SYE]Z#_4?$_\
M/Z/W,_("BOU__P"%&_#C_HG_ (6_\$MM_P#$4?\ "C?AQ_T3_P +?^"6V_\
MB*/]>,/_ ,^9?>@_U'Q/_/Z/W,_("BOU_P#^%&_#C_HG_A;_ ,$MM_\ $4?\
M*-^''_1/_"W_ ();;_XBC_7C#_\ /F7WH/\ 4?$_\_H_<S\@**_7_P#X4;\.
M/^B?^%O_  2VW_Q%'_"C?AQ_T3_PM_X);;_XBC_7C#_\^9?>@_U'Q/\ S^C]
MS/R HK]?_P#A1OPX_P"B?^%O_!+;?_$4?\*-^''_ $3_ ,+?^"6V_P#B*/\
M7C#_ //F7WH/]1\3_P _H_<S\@**_7__ (4;\./^B?\ A;_P2VW_ ,11_P *
M-^''_1/_  M_X);;_P"(H_UXP_\ SYE]Z#_4?$_\_H_<S\@**_7_ /X4;\./
M^B?^%O\ P2VW_P 11_PHWX<?]$_\+?\ @EMO_B*/]>,/_P ^9?>@_P!1\3_S
M^C]S/R HK]?_ /A1OPX_Z)_X6_\ !+;?_$4?\*-^''_1/_"W_@EMO_B*/]>,
M/_SYE]Z#_4?$_P#/Z/W,_("BOU__ .%&_#C_ *)_X6_\$MM_\11_PHWX<?\
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M_P#D3\M_^&+?C+_T)W_E4LO_ (]1_P ,6_&7_H3O_*I9?_'J_4BBC_7;,?\
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MW#[I?_)!_J3EW_/R?WQ_^1/RW_X8M^,O_0G?^52R_P#CU'_#%OQE_P"A._\
M*I9?_'J_4BBC_7;,?^?</NE_\D'^I.7?\_)_?'_Y$_+-OV,_C&LR1?\ "&MN
M92P(U&T*X! .6\W /(X)R><=#B3_ (8M^,O_ $)W_E4LO_CU?J111_KMF/\
MS[A]TO\ Y(/]2<N_Y^3^^/\ \B?EO_PQ;\9?^A._\JEE_P#'J/\ ABWXR_\
M0G?^52R_^/5^I%%'^NV8_P#/N'W2_P#D@_U)R[_GY/[X_P#R)^6__#%OQE_Z
M$[_RJ67_ ,>H_P"&+?C+_P!"=_Y5++_X]7ZD44?Z[9C_ ,^X?=+_ .2#_4G+
MO^?D_OC_ /(GY;_\,6_&7_H3O_*I9?\ QZC_ (8M^,O_ $)W_E4LO_CU?J11
M1_KMF/\ S[A]TO\ Y(/]2<N_Y^3^^/\ \B?EO_PQ;\9?^A._\JEE_P#'J/\
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M45^9?BKPUX@^'_[+?[3GQ3\%Z==_#7P9XTGTE_#7AJQ@-E)96$<L-M=7P@4
M6YN8G=\* VT G/RX[FZT_P"%WP>_:*^*&E7FF:=8_!.T\':/JM]X=TU,Z=<Z
MG)-)%;(;2,[+B6>(<1LK>:51F!*JP /ONBOC?]GWX(ZAX0_9UU?1_%/AG0W?
MQCXMNM>\/?#7Q/JCV&GV-O.1+%I<@6*8,8XHYIS;B%TW*<J"K.-G_@G>D6A^
M!/B5X4W/'?>'_'FK6UWI]J%.E:;(TBN;33F5LM;H#N^98V#2/NC4T ?5]%%%
M !1110 4444 %%9OB2YO;/P[JEQIL'VG48K662VAQGS)0A*+^+8%?FA)X?\
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M]D'7K3Q-^S#\,[^QO]6U2U;1+>%;[78A%>7!C7RVDD0.X7<4) WM\I7YFZD
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MVOKV'2]-TW3X?.N]2OIB1#:P)D!I'*G&XJHP22 ":Y;0OVFM%O/&.J^$-?\
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MKU6B@#RK_AI;PC_T"/B!_P"&X\0__(-'_#2WA'_H$?$#_P -QXA_^0:]5HH
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MA'_H$?$#_P -QXA_^0:]5HH \J_X:6\(_P#0(^('_AN/$/\ \@T?\-+>$?\
MH$?$#_PW'B'_ .0:]5HH \J_X:6\(_\ 0(^('_AN/$/_ ,@T?\-+>$?^@1\0
M/_#<>(?_ )!KU6B@#RK_ (:6\(_] CX@?^&X\0__ "#1_P -+>$?^@1\0/\
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MPN=TLJ(,<L!S7H'_  N3Q=_T0GX@?^!WA[_Y:UZK10!Y5_PN3Q=_T0GX@?\
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MA[_Y:UZK10!Y5_PN3Q=_T0GX@?\ @=X>_P#EK1_PN3Q=_P!$)^('_@=X>_\
MEK7JM% 'E7_"Y/%W_1"?B!_X'>'O_EK1_P +D\7?]$)^('_@=X>_^6M>JT4
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MD\7?]$)^('_@=X>_^6M>JT4 >5?\+D\7?]$)^('_ ('>'O\ Y:T?\+D\7?\
M1"?B!_X'>'O_ ):UZK10!Y5_PN3Q=_T0GX@?^!WA[_Y:T?\ "Y/%W_1"?B!_
MX'>'O_EK7JM% 'E7_"Y/%W_1"?B!_P"!WA[_ .6M'_"Y/%W_ $0GX@?^!WA[
M_P"6M>JT4 >5?\+D\7?]$)^('_@=X>_^6M'_  N3Q=_T0GX@?^!WA[_Y:UZK
M10!Y5_PN3Q=_T0GX@?\ @=X>_P#EK1_PN3Q=_P!$)^('_@=X>_\ EK7JM% '
MSK\;O%WCSXE?!?Q]X1TSX'>.(-2\0>']0TJUEN]0\/K"DL]M)$C.5U1B%#.,
-D G&< ]*^BJ** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>tnet-20240331_g20.jpg
<TEXT>
begin 644 tnet-20240331_g20.jpg
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MU8L$",2GRU]1:3I.EZ#I=MH>AZ;;V5E96Z06=G:0K'%!$BA4C1% "JJ@ *
M  !5BB@#SSPQ^R9^S;X0^ EW^RYHOP9T/_A7FH"_%_X0O+3[58W(O;F6ZNA)
M',7WB2:>60@Y&7.,8&.2_9I_X)M?L._L?^,+CXA?L[?L[Z/X?UZYTX:?_;37
M%Q>W<%D"&^RPRW4LKV\&0"8HBJ':N5X&/<** "BBB@ HHHH **** "BBB@ H
MHHH *_'_ /:#^'?PSU;]IV7]K3_@EQ^V=K?PN\16_P 4_'H^)&B^)].CO?#%
MEXJTK1+B34KF?3;U%>TDNDB"37,;J&C=9E4LH)_8"OE7]I/_ ((Q_P#!/O\
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MYQC P ?%7Q%^'_BW]E3_ (+=_ [XBZU\<M6^+MS\<++Q7X?M-!\9K UU\/\
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M'?\ X65S_C1_P[W^"?\ T-OCO_PLKG_&C_B.W_4N_P#*W_W(/^($_P#4Q_\
M*/\ ]U/YXZ*_H<_X=[_!/_H;?'?_ (65S_C1_P .]_@G_P!#;X[_ /"RN?\
M&C_B.W_4N_\ *W_W(/\ B!/_ %,?_*/_ -U/YXZ*_H<_X=[_  3_ .AM\=_^
M%E<_XT?\.]_@G_T-OCO_ ,+*Y_QH_P"([?\ 4N_\K?\ W(/^($_]3'_RC_\
M=3^>.BOZ'/\ AWO\$_\ H;?'?_A97/\ C1_P[W^"?_0V^.__  LKG_&C_B.W
M_4N_\K?_ '(/^($_]3'_ ,H__=3^>.BOZ'/^'>_P3_Z&WQW_ .%E<_XT?\.]
M_@G_ -#;X[_\+*Y_QH_XCM_U+O\ RM_]R#_B!/\ U,?_ "C_ /=3\)/V2?\
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M8ZG\0M2U!(^6ATL>&V@D>0#I&T\UL@)X+E>XX *M]_P6_P#!,'@"]_:BTO\
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MG\*]!_LKPQX/T"ST7P[IGVJ6?[)8VL*000^9,SR2;8T5=SLS'&6)))KH:**
M"BBB@ HHHH **** "BBB@#YP_:M_X)+?L$?MM_&"Q^/G[2GP>U76_%VFZ FB
M6.LZ?\0M>TEH;!9I)A $T^^@CQYDKL3MW,2,D[5QH_!W_@E]^PW\"O@_XT^
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K **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>tnet-20240331_g21.jpg
<TEXT>
begin 644 tnet-20240331_g21.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_(='_#Z3_@I?_P!'*?\ EG:-_P#(=?+=%'^J7"O_ $ 4/_!5/_Y$/];>*O\
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M )1KW_XS1_PVK^S-_P!%+_\ *->__&:^!J* /OG_ (;5_9F_Z*7_ .4:]_\
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M4445[QX(4444 %?U!^&?^1<T_P#Z\8O_ $ 5_+Y7]0?AG_D7-/\ ^O&+_P!
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M '(/^($_]3'_ ,H__=3^>.OZ@_#/_(N:?_UXQ?\ H KQC_AWO\$_^AM\=_\
MA97/^-'_  [W^"?_ $-OCO\ \+*Y_P :_/\ COCS_76.'7U?V7LN;[?-?FY?
M[L;6Y?.]S] X$X#_ -2I8A_6/:^UY?L<MN7F_O2O?F\K6/G3]L;_ ).2\3_]
M=[?_ -)HJ\RK[8_X=[_!/_H;?'?_ (65S_C1_P .]_@G_P!#;X[_ /"RN?\
M&OST_0CXGHK[8_X=[_!/_H;?'?\ X65S_C1_P[W^"?\ T-OCO_PLKG_&@#XG
MHK[8_P"'>_P3_P"AM\=_^%E<_P"-'_#O?X)_]#;X[_\ "RN?\: /B>BOMC_A
MWO\ !/\ Z&WQW_X65S_C1_P[W^"?_0V^._\ PLKG_&@#XGHK[8_X=[_!/_H;
M?'?_ (65S_C1_P .]_@G_P!#;X[_ /"RN?\ &@#XGHK[8_X=[_!/_H;?'?\
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MBL[LP5020* .SHI%8.H93D$9%+0 4444 %%%% !1110 4444 %%%% !1110
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MG[.FA:Q_9'QN^+FFVB6]KJ2V\ZR7/AKP\B +-([KY=S> >3"I=5\QF /E?\
MP4=^+WCO6OC[\2=(^,?["GQTU/X8?!CX;ZEIOP7C\)_#MK[0KK6KG2)HKGQ)
M=SF5%"VL,GV6V #^4K7,W#LH4 _2S]F7XY:)^T[^SAX _:2\-:+=:;IWQ \%
MZ7XCL-/OF4SVL-]:1W*12%"5+JLH4X)&0<5W%?*'_!#WXJ?\+4_X)5? Q_\
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M1KB223==2W#R2 R.!+Y@4A0J* ?:U%%% !1110 4444 %%%% !1110 4444
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M8=*T72XBL4*EB[,226=V=F=Y')=V9F8EB2>MHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
>*** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>tnet-20240331_g22.jpg
<TEXT>
begin 644 tnet-20240331_g22.jpg
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M&.S7*\K47C:\*2EMSRC&]M[<S5['TQ17RW_P^D_X)H?]'*?^6=K/_P AT?\
M#Z3_ ()H?]'*?^6=K/\ \AUZ7^J7%7_0!7_\%5/_ )$\W_6WA7_H/H?^#:?_
M ,D?4E%?+?\ P^D_X)H?]'*?^6=K/_R'1_P^D_X)H?\ 1RG_ )9VL_\ R'1_
MJEQ5_P! %?\ \%5/_D0_UMX5_P"@^A_X-I__ "1]&^!? 7@_X9^&8?!O@+P_
M;Z7I=O-/-#96H(1'FF>:5ADGEI)'<^[&M>OEO_A])_P30_Z.4_\ +.UG_P"0
MZ/\ A])_P30_Z.4_\L[6?_D.C_5+BK_H K_^"JG_ ,B'^MO"O_0?0_\ !M/_
M .2/J2BOEO\ X?2?\$T/^CE/_+.UG_Y#H_X?2?\ !-#_ *.4_P#+.UG_ .0Z
M/]4N*O\ H K_ /@JI_\ (A_K;PK_ -!]#_P;3_\ DCZDHKY;_P"'TG_!-#_H
MY3_RSM9_^0Z/^'TG_!-#_HY3_P L[6?_ )#H_P!4N*O^@"O_ ."JG_R(?ZV\
M*_\ 0?0_\&T__DCZDHKY;_X?2?\ !-#_ *.4_P#+.UG_ .0Z/^'TG_!-#_HY
M3_RSM9_^0Z/]4N*O^@"O_P""JG_R(?ZV\*_]!]#_ ,&T_P#Y(^I**POAC\3/
M!'QD\ :3\4?AOK?]I:%KEFMUI=]]FEA\^)NC;)55UZ=&4'VK$\?_ +2/P7^%
M_B ^%O'7C/[#?K"LI@_LZYE^1LX.Z.-E['O7@U*=2C4=.HFI)V:>C36Z:Z-'
MO4ZE.M352FTXM736J:>S3ZIG<45Y9_PVK^S-_P!%+_\ *->__&:/^&U?V9O^
MBE_^4:]_^,U!9ZG17EG_  VK^S-_T4O_ ,HU[_\ &:/^&U?V9O\ HI?_ )1K
MW_XS0!WFE> O!^A^+]7\?:3X?MX-9UZ&UAUC4(P?,NTM@X@5^>B"60#_ 'C6
MO7EG_#:O[,W_ $4O_P HU[_\9H_X;5_9F_Z*7_Y1KW_XS0!ZG17EG_#:O[,W
M_12__*->_P#QFC_AM7]F;_HI?_E&O?\ XS0!ZG17EG_#:O[,W_12_P#RC7O_
M ,9H_P"&U?V9O^BE_P#E&O?_ (S0!ZG17EG_  VK^S-_T4O_ ,HU[_\ &:/^
M&U?V9O\ HI?_ )1KW_XS0!ZG17-_#?XM_#WXN6%SJGP\\0?VA!:3"*X?[)+%
ML<C(&)44GCTKI* "BBB@ HHHH *_F=_: _Y+QXV_[&[4O_2J2OZ8J_F=_: _
MY+QXV_[&[4O_ $JDK]Y\#/\ ?,=_AA^<C\&\<_\ <\#_ (I_E$Y&BBBOZ+/Y
MT"BBNX^#/[-/Q\_:(_M+_A1_PGUKQ1_8_D_VI_9%H9?LWF[_ "]^.F[RI,?[
MAK&OB*&%I.K6FHQ6[;22Z;O3?0VH8>OBJJI48.4GLDFV^NB6NQP]%>X?\.U/
MV]_^C3_&G_@I:O2/V7O"?CK]@[QKK]Y^T_I.M?"/5?&7@F]T[P!XYU?0)Y_[
M,OH[BU>61$A1Y1F(F,O&I9?- Z,2/(Q/$.71H2>$J0K5.D(S3D^]E'FD[*[=
MHMV3LF>OAN'LPE7BL73G1I]9R@U%=KN7+%7=DKR2NU=H^1Z*_07XN^!]1^*$
M/Q)\>?L??#EGUCX^:C-<:9&[P:<-,\&6T\<4]U(T[QI;_P!HZBH"JQ!=(6 &
M7Q7P7XN\)>)? /BG4?!'C/1+C3=6TF]DM-2L+I-LEO/&Q5T8=B""*K)L[I9O
M"6BA)6O%R3DM%S7CNN6=X7ZN+:T:)SG)*N42CJYQ=[246HO5\MI;/FA:=NBD
MD]4S.HHHKVSQ HHHH _H:_X)C_\ )@7PH_[%&#^;5XI^WU_R<!+_ -@>V_\
M9J]K_P""8_\ R8%\*/\ L48/YM7BG[?7_)P$O_8'MO\ V:OX3XA_Y'^+_P"O
MM3_TMG]V</?\B#"?]>J?_I"/%****\<]@**** "BBB@ HHHH **** "BBB@#
MZ^_X)O\ _(@^(O\ L,1_^BA7T=7SC_P3?_Y$'Q%_V&(__10KZ.H **** "BB
MB@ K^9W]H#_DO'C;_L;M2_\ 2J2OZ8J_F=_: _Y+QXV_[&[4O_2J2OWGP,_W
MS'?X8?G(_!O'/_<\#_BG^43D:***_HL_G0*M:9KFMZ+O_L?6+JT\W'F?9KAH
M]^,XSM(SC)_.JM%)I25F--Q=T:G_  G/C;_H<-5_\&$G_P 54;:_>:MJ%K)X
MNU'4-0M89@98FO3O\LD;PC.&",0.N",XR#C%9]%0J5-;*Q?M:CW=SZ=T7_@H
MI8K\6O&OB#QA\%1J'@?Q7H6FZ)8^"[#Q";-]'T_39X)=/@@N?)?A/(&_]V/,
M+NWRDUXE^T#\8]:_:$^-GBCXV^(=-@LKOQ/K,U_+9VQ)CMP[96-2>6"K@9/)
MQGO7'T5Y^#R7+,OK^VH4^67*HWNWHE%;-M7M&-WN[*[=CT,9G69YA0]CB*G-
M'F<K62U;D]TD[7E*RV5W9*X4445ZAY84444 ?T-?\$Q_^3 OA1_V*,'\VKQ3
M]OK_ ). E_[ ]M_[-7M?_!,?_DP+X4?]BC!_-J\4_;Z_Y. E_P"P/;?^S5_"
M?$/_ "/\7_U]J?\ I;/[LX>_Y$&$_P"O5/\ ](1XI1117CGL!1110 4444 %
M%%% !1110 4444 ?7W_!-_\ Y$'Q%_V&(_\ T4*^CJ^<?^";_P#R(/B+_L,1
M_P#HH5]'4 %%%% !1110 5_,[^T!_P EX\;?]C=J7_I5)7]%_P 9O@9X0^.>
MF66D^+]4UJUCL9VFA;1=6DM&9BNTABGWACL:\^_X=[_!/_H;?'?_ (65S_C7
MWO O&_\ J76KU/J_M?:**^/EMRW_ +LKWOY'P7'7!'^NE&A3^L>R]FY/X.:_
M-;^]&UK>9_/'17]#G_#O?X)_]#;X[_\ "RN?\:/^'>_P3_Z&WQW_ .%E<_XU
M^B_\1V_ZEW_E;_[D?G7_ ! G_J8_^4?_ +J?SQT5_0Y_P[W^"?\ T-OCO_PL
MKG_&C_AWO\$_^AM\=_\ A97/^-'_ !';_J7?^5O_ +D'_$"?^IC_ .4?_NI_
M/'17]#G_  [W^"?_ $-OCO\ \+*Y_P :/^'>_P $_P#H;?'?_A97/^-'_$=O
M^I=_Y6_^Y!_Q G_J8_\ E'_[J?SQT5_0Y_P[W^"?_0V^._\ PLKG_&C_ (=[
M_!/_ *&WQW_X65S_ (T?\1V_ZEW_ )6_^Y!_Q G_ *F/_E'_ .ZG\\=%?T.?
M\.]_@G_T-OCO_P +*Y_QH_X=[_!/_H;?'?\ X65S_C1_Q';_ *EW_E;_ .Y!
M_P 0)_ZF/_E'_P"ZG\\=%?T.?\.]_@G_ -#;X[_\+*Y_QH_X=[_!/_H;?'?_
M (65S_C1_P 1V_ZEW_E;_P"Y!_Q G_J8_P#E'_[J-_X)C_\ )@7PH_[%&#^;
M5XI^WU_R<!+_ -@>V_\ 9J]M_P"'>_P3_P"AM\=_^%E<_P"-'_#O?X)_]#;X
M[_\ "RN?\:_"<PQ?U_'UL3RV]I*4K7O;F;=KZ7M?>R/W;+\)]0P%'#<U_9QC
M&]K7Y4E>VMKVVNSXGHK[8_X=[_!/_H;?'?\ X65S_C1_P[W^"?\ T-OCO_PL
MKG_&N,[#XGHK[8_X=[_!/_H;?'?_ (65S_C1_P .]_@G_P!#;X[_ /"RN?\
M&@#XGHK[8_X=[_!/_H;?'?\ X65S_C1_P[W^"?\ T-OCO_PLKG_&@#XGHK[8
M_P"'>_P3_P"AM\=_^%E<_P"-'_#O?X)_]#;X[_\ "RN?\: /B>BOMC_AWO\
M!/\ Z&WQW_X65S_C1_P[W^"?_0V^._\ PLKG_&@#XGHK[8_X=[_!/_H;?'?_
M (65S_C1_P .]_@G_P!#;X[_ /"RN?\ &@#%_P"";_\ R(/B+_L,1_\ HH5]
M'5X7_P .]_@G_P!#;X[_ /"RN?\ &O;=+T^#2-,MM)MGD:.U@2*-I7+,550
M23U.!R: )Z*** "BBB@ HHHH **** "BBB@ HKYG^/?_  6(_P"";_[-/Q,U
M/X/?%C]I:V3Q)H2AO$.F>'O#>J:V=%!_Y_GTVUG2R..2)V0@<G KW+X.?&CX
M3?M"_#;2OC#\#OB+H_BOPOK<'G:5KNA7R7%M<*"5.'0D;E8%64X964JP!!%
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M*** "BBB@ KD_CUXD\6^#?@9XT\7^ ;,W&NZ5X3U&\T6W$>_S;N*VD>%=O\
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ML'X*?!31KNUT>S\)_#*ZFGU/5)[Z\O[R>WUR6XN[FYG9I)YY969W=F));C
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M/#?_  CO['WP\\766HZEXL:U\A_BC?:5<+);:=I,.!Y6C0W$*-)=D#SVA6.
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J444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>tnet-20240331_g23.jpg
<TEXT>
begin 644 tnet-20240331_g23.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<6I)V::U3VM;>]]+$]%>:>$_VQ/V8O'/BN/P3X6^,^C76IS2^5;V_FL@F?.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW?Q"MY+GQ6-'CL]%T6?)FFNI"S00,O7$494..PCVCD@'PO\ 96^'?C_X<_\
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M0 <DY[5HU\\>$O\ @F=^S]X,^)UA\6-*UWQ2^IZ=K*:G!'/J,!A,RR>8 RB
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MZ278_5:L,=EV84<!5DY25+$JG6E.-YUZD4WR^\W"*VA>S;?<J?"_2-&^"/\
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M1W"FZGG\N E&3SB0-[3#_5CA!SW/GGP$_;%^(?Q6TOXQ7VN^'=&@;X=^=_9
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MNRC.S:3:M?5GTW1117Z8?EP4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5D>,?A_X"^(MA%I7Q!\$:1KMK#-YL-MK.
MFQ74<<F"-ZK(K -@D9'."?6M>BHJ4Z=6#A-)I]'JBZ=2I1FITY--;-.S^\15
M5%"(H  P !TI:**L@**** "BBB@ HHHH *I^(/#OA_Q9I$_A_P 4Z'9ZE87*
M[;BRO[99HI1G.&1P0>?45<HJ91C.+C)73*C*4)*479K9G&>#_P!G/X"> -:7
MQ)X*^#GAO3-0CSY5[9Z/$DL?8[&"Y3\,5V=%%94,-AL+#DHP45V227X&N(Q6
M)Q<^>O-S?>3;?XA1116Y@%17ME9ZE9RZ=J-I%<6]Q$T<\$T8=)$88964\$$$
M@@\$&I:*32:LQIM.Z,SPEX*\&^ =)_L'P+X2TS1;'S6D^Q:381VT6\XRVR-0
M,G R<9XK3HHJ80A2@H0226R6B*G4G5FYS;;>[>K844459 4444 %%%% !111
M0 4444 %%%% !1110 4444 4?$?AGPYXPT>;P[XMT"RU33[A<7%CJ%JDT,@S
MGYD<$'GU%<WX-_9W^ _P\UE?$7@?X/\ AS2]00$1WMGI$22Q@C!VN%RN>^",
MUV5%<]3"82M5C5J4XN4=FTFUZ/='33QF+HT94J=22C+=)M)^JV84445T',%8
M^G> /!>C^+]0\?:5X9M+?6=5ACBU+488@LMTB ! Y'WMH  ST%;%%1.G3J-.
M23L[J_1[779V;7S+A4J4TU&35U9V>ZWL^ZND_D%%%%60%%%% !1110 4444
M%%%% !1110!1\2^&M!\8Z#=^%_%&EQ7NGWT)BO+2<92:,]58=P>XJ31=%TGP
MWH]KX?T#3H;.QL;=(+.TMXPL<,: *J*!P    *M45'LZ?M/:67-:U^MNU^Q?
MM:GL_9\SY;WM?2_>W?S"BBBK("BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<1^8X#NU 'Z6T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^%O#OQ)\3:%\*_$^KW+3SZKX5L]1DAL)C*W,J@+)$K= D2J.%%?<M !1110
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M%:-<79NKVVT>V(DO+@C!FGF<M+<28 &^1F;  S@ 4 >D4444 %%%% !1110
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M6&)I92H9 /EC1F//137T70 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M5Y-^TC^W)^RW^R+J6E:1^T-\4/\ A'KC6X)9M,C_ +$OKOSDC*JYS;0R!<%E
MX;!.>*\T_P"'TG_!-#_HY3_RSM9_^0Z]G"\.<0XVA&OA\'5G"6THTYR3Z:-)
MIZZ'C8KB/A[!5Y4,1C*4)QWC*I"+775-IK34^I**^6_^'TG_  30_P"CE/\
MRSM9_P#D.C_A])_P30_Z.4_\L[6?_D.NC_5+BK_H K_^"JG_ ,B<_P#K;PK_
M -!]#_P;3_\ DCW?PA\"?A#X!^*?C#XW>#? -AI_BSX@#3QXSUVW0B?5OL,#
M06?FDG!\J)V1< <'O7F'[3W_  2Y_P""?O[9GCJV^)W[2_[+'AGQ3XBM;1;4
M:W<1RV]S/;J<K!/);O&US$.T<I=1DX'-<O\ \/I/^":'_1RG_EG:S_\ (='_
M  ^D_P"":'_1RG_EG:S_ /(='^J7%7_0!7_\%5/_ )$/];>%?^@^A_X-I_\
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MQE*<Y;1C4A)OKHDVWIJ>LT445XQ[(4444 %%%% !1110!P7[1/[3WP-_9/\
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MG:S_ /(=?+?_ !#6?]7H_P#F.?\ [XT?\0UG_5Z/_F.?_OC1_8O@Q_T,J_\
MX"__ )G#^VO&?_H6T/\ P)?_ #0?4G_#Z3_@FA_T<I_Y9VL__(='_#Z3_@FA
M_P!'*?\ EG:S_P#(=?+?_$-9_P!7H_\ F.?_ +XT?\0UG_5Z/_F.?_OC1_8O
M@Q_T,J__ ("__F</[:\9_P#H6T/_  )?_-!]2?\ #Z3_ ()H?]'*?^6=K/\
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MG>^F^UO,^?SO+L]Q\H/+L=]72OS?NHU.:]K?$U:VNV]_(_+'_B)=_P"K*O\
MS(__ -[J/^(EW_JRK_S(_P#][J_4ZBOH/]9. ?\ H1?^757_ "/"_P!7^./^
MAW_Y;4O\S\L?^(EW_JRK_P R/_\ >ZC_ (B7?^K*O_,C_P#WNK]3J*/]9. ?
M^A%_Y=5?\@_U?XX_Z'?_ );4O\S\L?\ B)=_ZLJ_\R/_ />ZC_B)=_ZLJ_\
M,C__ 'NK]3J*/]9. ?\ H1?^757_ "#_ %?XX_Z'?_EM2_S/RQ_XB7?^K*O_
M #(__P![J/\ B)=_ZLJ_\R/_ />ZOU.HH_UDX!_Z$7_EU5_R#_5_CC_H=_\
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M&8[^'3=,CFL;>Q#1R3PB(M/-+&Q+]67^[@_0?["WAK]L;2O"VK^(?VK?VNO
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M9_T,*_\ X-J?_)'E_P"JO"__ $ T?_!4/_D3Y8_X<I_\$RO^C:?_ "\M:_\
MDRC_ (<I_P#!,K_HVG_R\M:_^3*^IZ*/];N+/^AA7_\ !M3_ .2#_57A?_H!
MH_\ @J'_ ,B?+'_#E/\ X)E?]&T_^7EK7_R91_PY3_X)E?\ 1M/_ )>6M?\
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M\.4_^"97_1M/_EY:U_\ )E'_ !$+PG_Z%/\ Y0H?_)A_J'XH?]#3_P KU_\
MY$\7_P""(G[='[4_[7OC;X@:1^T1\4?^$AM]$TJPFTN/^Q+&T\EY))E<YMH(
MRV0J\-D#'&*_0^O)?V:_V%_V6/V0M2U75_V=_A=_PCUQK<$4.J2?VW?7?G)&
MS,@Q<SR!<%FY7!.><UZU7X[Q;F63YMGM7%971]E1DHVCRQA:T4G[L6XJ[3>C
MUW>I^L\+9?FV5Y)3PV95?:UDY7ES2E>\FUK))NRLM4%%%%?-GT(4444 %%%%
M !117R'_ ,%I/VH?CI^R9^RWH/Q&_9^\<?V!K-[X_M=-N;S^S+6[WVKV-]*T
M>RYBD09>&,[@ WRXS@D'T\FRK$9YFE+ 4&E.H[)RNE?SLF_P9YV;YGA\FRVK
MC:Z;A35VHVO\KM+\4?7E%?@5_P /K/\ @IK_ -'+?^6;HO\ \AT?\/K/^"FO
M_1RW_EFZ+_\ (=?J7_$#^+/^?]#_ ,"J?_*S\T_XC-PO_P ^:W_@,/\ Y8?O
MK17X%?\ #ZS_ (*:_P#1RW_EFZ+_ /(='_#ZS_@IK_T<M_Y9NB__ "'1_P 0
M/XL_Y_T/_ JG_P K#_B,W"__ #YK?^ P_P#EA^^M%?@5_P /K/\ @IK_ -'+
M?^6;HO\ \AT?\/K/^"FO_1RW_EFZ+_\ (='_ ! _BS_G_0_\"J?_ "L/^(S<
M+_\ /FM_X##_ .6'[ZT5^!7_  ^L_P""FO\ T<M_Y9NB_P#R'1_P^L_X*:_]
M'+?^6;HO_P AT?\ $#^+/^?]#_P*I_\ *P_XC-PO_P ^:W_@,/\ Y8?OK17Y
M.?\ !)W_ (*7_MM_M+_MHZ)\)OC;\:_[;\/WFE:A-<:?_P (WIMMO>*W9T.^
MWMD<88 X#8/?-?K'7Y[Q1POC^$LR6"QDHRFXJ5X-M6;:ZQB[Z/H?><-<28'B
MG+WC,)&48J3C:22=TD^CDK:]PHHHKYP^@"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ I&574HZ@@C!!'!%<+X[_:7^"7PT\1R^$_&WC7[%J$,:/);_V;
M<R85AE3NCC9>0?6L?_AM7]F;_HI?_E&O?_C- '@VC_\ !!;_ ()G:'^UTW[5
MVG_LO>$(RMA"UIX171S_ &9;:NEU),=42W\S[.)"KJ@00A5\L.,,:]+_ &D?
M^"5?_!/#]K_XDM\8/VF?V3O"OC/Q,UC%9'6=9@D>;[/%GRX\AP J[FP,=S77
M?\-J_LS?]%+_ /*->_\ QFC_ (;5_9F_Z*7_ .4:]_\ C- 'G_P\_P""/O\
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M5?\ 0!7_ /!53_Y$^6Z*^I/^'+?_  4O_P"C:_\ R\=&_P#DRC_ARW_P4O\
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MWZG?^:9&,]S<K';0A@L8CA@*8<R,U>RT %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;3_T4M>/5[#^W7_R<5J7_7C:?^BEKQZ@ HHHH **** "BBB@ K[0_P""=/\
MR1+5/^QJG_\ 2:VKXOK[0_X)T_\ )$M4_P"QJG_])K:@#WRBBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KX%_X.+_ /DR7PM_
MV52Q_P#3;J=??5? O_!Q?_R9+X6_[*I8_P#IMU.OLO#W_DM<#_C7Y,^1X]_Y
M(_&_X'^:/Q=HHHK^VC^.0HHHH **** "BBB@#[#_ ."$_P#RD6\-_P#8#U7_
M -)'K]V:_";_ ((3_P#*1;PW_P!@/5?_ $D>OW9K^4O&S_DKX?\ 7F'_ *5,
M_IWP=_Y)2?\ U]E_Z3 ****_(#]7"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#X4_;K_ .3BM2_Z\;3_ -%+7CU>P_MU_P#)Q6I?]>-I_P"BEKQZ@ HH
MHH **** "BBB@ K[0_X)T_\ )$M4_P"QJG_])K:OB^OM#_@G3_R1+5/^QJG_
M /2:VH ]\HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *^!?\ @XO_ .3)?"W_ &52Q_\ 3;J=??5? O\ P<7_ /)DOA;_ +*I
M8_\ IMU.OLO#W_DM<#_C7Y,^1X]_Y(_&_P"!_FC\7:***_MH_CD**** "BBB
M@ HHHH ^P_\ @A/_ ,I%O#?_ & ]5_\ 21Z_=FOPF_X(3_\ *1;PW_V ]5_]
M)'K]V:_E+QL_Y*^'_7F'_I4S^G?!W_DE)_\ 7V7_ *3 ****_(#]7"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@#X4_;K_P"3BM2_Z\;3_P!%+7CU>P_M
MU_\ )Q6I?]>-I_Z*6O'J "BBB@ HHHH **** "OM#_@G3_R1+5/^QJG_ /2:
MVKXOK[0_X)T_\D2U3_L:I_\ TFMJ /?**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MK4O^O&T_]%+7CU>P_MU_\G%:E_UXVG_HI:\>H **** "BBB@ HHHH *^T/\
M@G3_ ,D2U3_L:I__ $FMJ^+Z^T/^"=/_ "1+5/\ L:I__2:VH ]\HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD>/?^2/QO^!_FC\7:***_MH_CD**** "BBB@ HHHH ^P_P#@A/\ \I%O#?\
MV ]5_P#21Z_=FOPF_P""$_\ RD6\-_\ 8#U7_P!)'K]V:_E+QL_Y*^'_ %YA
M_P"E3/Z=\'?^24G_ -?9?^DP"BBBOR _5PHHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^"$__*1;PW_V ]5_])'K]V:_E+QL_P"2OA_UYA_Z5,_IWP=_Y)2?_7V7_I,
MHHHK\@/U<**** "BBB@ HHHH **** "BBB@ HHHH **** /A3]NO_DXK4O\
MKQM/_12UX]7L/[=?_)Q6I?\ 7C:?^BEKQZ@ HHHH **** "BBB@ K[0_X)T_
M\D2U3_L:I_\ TFMJ^+Z^T/\ @G3_ ,D2U3_L:I__ $FMJ /?**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>_P3_P"AM\=_^%E<_P"- 'Q/17VQ_P .]_@G_P!#;X[_ /"RN?\ &C_AWO\
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M_"RN?\: /=**\+_X=[_!/_H;?'?_ (65S_C1_P .]_@G_P!#;X[_ /"RN?\
M&@#W2BO"_P#AWO\ !/\ Z&WQW_X65S_C1_P[W^"?_0V^._\ PLKG_&@#W2BO
M"_\ AWO\$_\ H;?'?_A97/\ C1_P[W^"?_0V^.__  LKG_&@#W2BO"_^'>_P
M3_Z&WQW_ .%E<_XT?\.]_@G_ -#;X[_\+*Y_QH ]THKPO_AWO\$_^AM\=_\
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M'_#O?X)_]#;X[_\ "RN?\: /=**\+_X=[_!/_H;?'?\ X65S_C1_P[W^"?\
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MW_X65S_C1_P[W^"?_0V^._\ PLKG_&@#W2BO"_\ AWO\$_\ H;?'?_A97/\
MC1_P[W^"?_0V^.__  LKG_&@#W2BO"_^'>_P3_Z&WQW_ .%E<_XT?\.]_@G_
M -#;X[_\+*Y_QH ]THKPO_AWO\$_^AM\=_\ A97/^-'_  [W^"?_ $-OCO\
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M%'_#O?X)_P#0V^.__"RN?\:/^'>_P3_Z&WQW_P"%E<_XT?\ $>?^I=_Y6_\
MN0?\00_ZF'_E+_[H?SKT5_11_P .]_@G_P!#;X[_ /"RN?\ &C_AWO\ !/\
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MBLWQEXO\._#[PAJOCWQ?J'V32=$TV?4-4N_*>3R;>&-I)'VH"S816.%!)Q@
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M?M#V&H>,Y=1O=/LK1=)OH[+4+VS!-U:VFH20+9WD\05M\4$SNNULJ-IQ[]0
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M%SX7M%37]$\0M9W-J+^S1!#YZQ7#0SF 1;@H*>6Q+5Z5\3_"?_!1CX>_MC_
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M=GX3_P#!/3]H.T^,O@KXH_M4_P#!1+QM\4]/^&[33>#_  RGARRT&VFNWA,
MN]4:R^;4Y4C8[0VR,.2^PDD4 ?5E%%% !1110 4444 %?#_Q_P#^4_?[.W_9
M!O''_I5IM?<%>,^.OV.=#\<?MS> ?VW[CQO=V^H> _!&L^'+?0$M%:&[CU"6
MWD:9I"VY63[. % (.X\C% 'YT^*/^"C_ .T/^TA\8/C=KFA?M,?M _#:'X??
M$C6?"'PL\-_"3]FRY\4:'</I<GV=[[6+S^R;LWC3W"R;K6*:#R8@G.YB:]8\
M!?MD_MO_ +?WQ"^ '[*</B+Q#^SGKWBGX$7WQ(^--U8^%X4UV%K;48-)73;&
M+58)EL5DNGDG+RPR.(?* (R6;U_QE_P2V^+/A[X@_$?7?V.?V^?%OP>\,_%W
M7+C7/'GA+3_"FGZJB:M<HL=Y?Z9<7($FG3W"J&<_O5$O[Q54X U_B%_P2RT:
MWM/A1XJ_9=_:*\5_#7X@_![PM-X9\.^.[F&'7I=6T><1&YL]5AO/EOEDDA2<
M-NC:.4%D*_=H ^6O^"DGPC_;]\#?"G]G[X2_%#]J+0_%'B,_MT>&(/A9\3[K
MP]%_:-OI<NFZD(I=4LHHH+6:\MW,V/* CG5(BX4EQ7H4'Q8_;$_9!_;!^*?[
M(_B[]L#Q#\4M%F_91U?XG>%-?\9Z!I4.J:#J]E>BR>)'L+6"&:W?SHY0DD1V
M&/:."V[TC1O^"0&@&+PQXM^(7[2'B3Q5X^L?V@])^+7C/QQJFEV\<GB'4=/L
M9K&WL$MH=L5E9QV\B)&B;B@CZMN)'I7QA_8)\._%[]J36?VG[WXB7ME=ZS\
M-6^%LFDQ6*/'%;7U]'=M?!RP)D0QA1'C!!SF@#X:\.?&[_@I/\+/V'_V:?\
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MKH6E0M':V5LD%M&TC.5C10J@LQ+-P!R22>YJS0 4444 %%%% !7P]_P<D?\
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M(ZI#8232//:<O<R7D#Q2N1A-H _7J*6*>)9H9%='4,CJ<A@>A![BOB#XF?\
M!'SXE?$3P?XS_9N_X>&>.;?X$^/M>N]0U_X;7GANPO[^&WN[G[3=:?::Q<!I
MX+5I2VU621XT<JK]Z^U]$T;3/#FC6GA[1+1;>RL+6.WM($)(CB10J*,\X  '
M/I0!:HHHH **** "BBB@ KXE_;<_9]_:)U/]O;PG^V/^P1\2?A1K7Q8\$?#*
M[\.^(OA+\3M0E1+O0;V]2X6]MI+7?-87!F@:(3-&8Y5RA8!2&^VJ^9?VP?\
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MIXKTJ73M=TFZ)"W$$@P0&4AD8'#*ZD,C*K*00"/D:3_@DW^U;<?#P_LT7?\
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M;;Z26B02VEI':QJ?LXE#LGFL[JI5<G!+>N444 %%%% !1110 4444 %?#_\
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M_!)/XY_%B_\ A+JO[2/_  4:\3^,&^"GCW1/$_@G3;+P'INE:?)/I[CYKV&
ME[J9X0T(E$B+&LLA6+<Q- 'D?AK7O^"CG[5R_M;_ !%\-_\ !1/Q!\/M+^"'
MQ?\ $^A?#;1/#G@S19UE>QT^UO434)+JUE:XM5$Z1K$GEN<RL\CY0)D?&3]O
M/]LKXB_ C]F+]H7QMXD^+?@'X0?$#X*0>(/B;X\_9Y^']IKNI67B>6*T>.*Z
MCN;6\>RTS8UQ('C@=F<K&6P,C[:^"7["WA[X*^$?COX3L/B#>7Z?'/XC:YXM
MU"::Q1#I4NI6%K9O;Q@,?,5!:APQP27((&*\PT?_ ()5_$/X2^ _@]I_[+/[
M<?BKP#XH^$WPQ@\!OJ\OAZVU72_$>E1^4P-UI=PXC2=9(@Z31.KJ'9"74@
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MOA/\.I_&EH+SPEX.M==BDU+7M0MO-W6UU>F!)I2Z@VUI#;QL03+G]*_V6_\
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MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^4?VE?\
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MF;Q+^T-X&T*X^+7C7XVI?>+?&]AJDPCNH-2T^U>>.8W<#/--YLP,17:J 94
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M^43'[-__ &1?P[_Z00U]+T %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH.C6^B&+_B71M<VMJU[<%V&V%9KVW3CEB^!R*^"?V]/!?B2+_@H/^UM^U/\
M#O2I+OQ9^SSI'PB^)VAP0#Y[F#3$U@ZG;9Z[9M,EOHRHZDKZ BC^W-XN\._M
MD_%K_AOOPOJD>I^$='_:=^$_PP^%VI1_<GL[75X-2U>ZC]1+?W<5N3W_ ++
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX)4?L._M0?$O4_B_\4OA=JL/B'Q!IL6G>*M0\*>.-8T'_A(K.-=L<&HIIMU
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M &$?BC\7?$/QH\6_"74SJ7C&XBN/&VDZ;XWUBRT;Q+-&@19-1TNWNTLKX[0
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M_P"E:7X@W742:I9-<;I8PJ2JD<C(T+GD^H?\$]/^"6O@3]G#]DSX*_#;X_\
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MTJ1&0JK,%D) QFNC^-O_  6H_9:@N/!/PV_89\<^$?V@_B;\0?$MAI^@>!O
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MG:CI$T*Q3:5?V,<UM)&,81HG!4J,# (P,"D\)^#O"/@+08/"W@7PKINBZ9;
MBVT[2;&.V@BR<G;'& JY// H TJ*** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
&BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>tnet-20240331_g24.jpg
<TEXT>
begin 644 tnet-20240331_g24.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVE?3ST/JOX%_'SP!^T1X;U#QA\-IKJ;3+#6)=.6ZN;<Q?:'2.-S(BGY@A$@
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MHWTA'ENY.[;;;;\E>RZ)!1117L'BA1110 4444 %%%% !1110 4444 %%%%
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ME)\G.^_)&[^9]UDM"E1X<^L*E[2=7$TZ;CU<(KG<%VYY<J^1\T? 7P=^TO\
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M^3Z'S9X=_P""9/[/FB?&FZ\<S^$;>Y\."SA;3?#]Q>3R+#>"1C([!FP\978
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MWXMV/[</_!-SP+^V=\4?A#I&G>*]>^$<VLVRRZ>LCZ3/=Z>1<-9R2@R112@
MC#9:-D#%NM?%NN^-['PI_P &KOP@\,:QX/T#5-.\<^!_!OA'4KWQ7'*VF:'!
MJ5];6IU6Y\F2-PML7$J,LB%95B;<,4 ?8OP)_P""BGQ4UW]ICPS^RA^V!^QG
MJ_P<\4?$#PW?ZU\.Y7\8V6NV>L)8B)KVTDEM0IMKN&.>*1HRK1E2=LI( /U3
M7YE:=^SOXL_8&_X*G_LQW/CC]J3Q?^T#?_$?P_K_ (+T^3XIW<5SJ_A.*WT[
M[?/JFE_95BB$,QMXH;EYHY9MK1?OVY5OTUH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HKYV^)/\ P5?_ & OA%X]U;X8
M_$/X]_V?KFA7SV>JV/\ PBVJR^1,APR;XK5D;![JQ'O6)_P^D_X)H?\ 1RG_
M )9VL_\ R'7O4^%N)ZM-3A@:SBU=-4IM-/9I\NJ9X-3BGABE4<)XZBI)V:=6
M"::W37-HT?4E%?+?_#Z3_@FA_P!'*?\ EG:S_P#(='_#Z3_@FA_T<I_Y9VL_
M_(=7_JEQ5_T 5_\ P54_^1(_UMX5_P"@^A_X-I__ "1]25X%^WK_ ,$VOV6?
M^"B7@*/PM\?/A]:3ZOI]O+%X=\6VZ-'J6CB4KYHAFC9'V.% :,ML;@E20*YC
M_A])_P $T/\ HY3_ ,L[6?\ Y#H_X?2?\$T/^CE/_+.UG_Y#H_U2XJ_Z *__
M (*J?_(A_K;PK_T'T/\ P;3_ /DCV_\ 9^_9S^!O[*OPQL_@W^SO\,-*\)>&
M;&226#2M)@V*TLC;I)I&)+RRN>6D<L['J35OX?\ P0^%/PK\5>+?&_P^\%VN
MEZKX[UE-6\6WL#.6U*]2WCMUF?<Q 8111I\H P@XS7@O_#Z3_@FA_P!'*?\
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M":S]NL1.T/G_ &>2+YUP2-LBJ>XYQBMR@ HHHH **** "BBB@ HHHH ****
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MG_L>+[_T8:\3K^[\A_Y$>%_Z]P_])1_"&??\CS%?]?)_^E,****]4\H****
M"BBB@ HHHH **** "BBB@#]$?^#<O_DY'Q[_ -B.O_I9#7Z_U^0'_!N7_P G
M(^/?^Q'7_P!+(:_7^OY'\7/^2VK?X8?^DH_KCPC_ .2)H_XI_P#I3"BBBOS,
M_3 HHHH **** "BBB@ K#^)W_)-O$/\ V [O_P!$O6Y6'\3O^2;>(?\ L!W?
M_HEZ /S/HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^W?^"?W_)!&_P"P
MY<_^@QU[?7B'_!/[_D@C?]ARY_\ 08Z]OH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#^=O_@I%_R?G\6?^QXOO_1AKQ.O;/\ @I%_R?G\6?\
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M@ HHHH **** "BBB@ HHHH _1'_@W+_Y.1\>_P#8CK_Z60U^O]?D!_P;E_\
M)R/CW_L1U_\ 2R&OU_K^1_%S_DMJW^&'_I*/ZX\(_P#DB:/^*?\ Z4PHHHK\
MS/TP**** "BBB@ HHHH *P_B=_R3;Q#_ -@.[_\ 1+UN5A_$[_DFWB'_ + =
MW_Z)>@#\SZ*** "BBB@ HHHH **** "BBB@ HHHH **** /MW_@G]_R01O\
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M;_L.7/\ Z#'7M]>(?\$_O^2"-_V'+G_T&.O;Z "BBB@ HHHH **** "BBB@
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M/*"BBB@ HHHH **** "BBB@ HHHH _1'_@W+_P"3D?'O_8CK_P"ED-?K_7Y
M?\&Y?_)R/CW_ +$=?_2R&OU_K^1_%S_DMJW^&'_I*/ZX\(_^2)H_XI_^E,**
M**_,S],"BBB@ HHHH **** "L/XG?\DV\0_]@.[_ /1+UN5A_$[_ ))MXA_[
M =W_ .B7H _,^BBB@ HHHH **** "BBB@ HHHH **** "BBB@#[=_P""?W_)
M!&_[#ES_ .@QU[?7B'_!/[_D@C?]ARY_]!CKV^@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** /YV_\ @I%_R?G\6?\ L>+[_P!&&O$Z]L_X*1?\
MGY_%G_L>+[_T8:\3K^[\A_Y$>%_Z]P_])1_"&??\CS%?]?)_^E,****]4\H*
M*** "BBB@ HHHH **** "BBB@#]$?^#<O_DY'Q[_ -B.O_I9#7Z_U^0'_!N7
M_P G(^/?^Q'7_P!+(:_7^OY'\7/^2VK?X8?^DH_KCPC_ .2)H_XI_P#I3"BB
MBOS,_3 HHHH **** "BBB@ K#^)W_)-O$/\ V [O_P!$O6Y6'\3O^2;>(?\
ML!W?_HEZ /S/HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^W?^"?W_)!&
M_P"PY<_^@QU[?7B'_!/[_D@C?]ARY_\ 08Z]OH **** "BBB@ HHHH ****
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M@ HHHH YGXF?&7X7?!NQM=3^*'C6RT2WO9C%:RWKD"1P,E1@'G'-<=_PW/\
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MHA_^)H X7_AN?]D?_HO6@_\ ?Y__ (FC_AN?]D?_ *+UH/\ W^?_ .)KNO\
MA5WPS_Z)WH7_ (*(?_B:/^%7?#/_ *)WH7_@HA_^)H X7_AN?]D?_HO6@_\
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M:!_T-^@_^#^U_P#CE?IG_P *N^&?_1.]"_\ !1#_ /$T?\*N^&?_ $3O0O\
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M#<FC0?$+P/I7B.'2)KD3/9+>VD5R(6D"J'*"3:6"C.,X'2@#OZ*** "BBB@
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M\-X4_9]^%_[#G_!6_P#9=^"7@RU?3_!-I^R]XI\%> ?M\P9Y]2M+_2[R8%\
M-<26RR2L0 6Q(0, @>L_$7_@A)_P20^+7C_7/BG\2/V(?"^K^(?$NKW.J:[J
MMW=WIEO+RXE:6:9\3@;F=V8X &37I/B+_@G!^P_XK_9Q\._LD^(/V<]"N/A]
MX1N%N/"F@%IE.C3J[NLUK<+()[>0&23YTD#8=AG!(H ^8_A#\<O@[\%O^"DW
M[>_[5WQ4\9V&E?#;P9X<^'NF^*/$$_[RV&HV6FWTMQ"-H/F3QK=VL7E*"YDF
M2, MA:ZK]G'X3?M ?\% _P!ISP?_ ,%&/VK_  +>_#_P-X!AO)_@!\(-2 &J
M+)>0&"3Q#K8!*QW3V[%8+,9^S+(2Q\S=GVNZ_P""9W["%Y^R_/\ L83?LTZ
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MPKJ/B>_U>/5=3GFBE%IJ%^ARMW<V0<6MS/GDRRQ,Y/))/-?0X  P!0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
$ '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>tnet-20240331_g25.jpg
<TEXT>
begin 644 tnet-20240331_g25.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS_:0\5>*+;QEK'V;6K/7+MFADVSVZ2@1;BBJRW'R #,97@UB_M<?&V']G?\
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MU_#+]F3XJ?"OQ38Z<FK>+;26/1T@U!7C9FMWC&]L?+\Q%=U\*OV=/B5X1_8
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M#X?:%-X&TZTTW2XK&SNA(C2QQQQB-#DA@6  .=O45:\%?\$[?%/A/]CWQ?\
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M>SU73V'_ ()W^,?%GCW]E+0/$_C;Q+?:OJ,]U?+-?:C=--*X6ZD5078DG
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M=FCR!$3[V44;PPZ%"NX'J*\YUW_@I#^R#H,6GS3?$Q[@:C")D%II5Q(T"$D
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M]*A2Y>6%&"A%?-RE+UE)M^6BZ!1117I'EA1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?\EM6_PP_P#24?UQX1_\D31_Q3_]*84445^9GZ8%%%% !1110 4444 %%%%
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110!_.W_P %(O\ D_/XL_\
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M?\DV\0_]@.[_ /1+UN5A_$[_ ))MXA_[ =W_ .B7H _,^BBB@ HHHH ****
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MV/\ AD'X[_\ 0%T'_P +?2/_ )*H_P"&0?CO_P! 70?_  M](_\ DJOZ)_\
MA5WPS_Z)WH7_ (*(?_B:/^%7?#/_ *)WH7_@HA_^)H_XC;Q5_P ^:'_@-3_Y
M8'_$$N%?^?U?_P "I_\ RL_*7_@BQ80?LE?&WQ=XO_:"\1Z#X?T[4_"JV=C<
M?\)'9W?FS?:8WV;;:61E^52<D <=:_2#_AN?]D?_ *+UH/\ W^?_ .)KNO\
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M5R(6D"J'*"3:6"C.,X'2@#OZ*** "BBB@ HHHH **** "BBB@ HHHH ****
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M?#WP?UJ31?'OBB#QI8:0'U:&!+BZT_3+>X#/?SP1RQAPQA7>VQ68XS:\5?\
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M-!/$LD,L9RKHPR&![@@YH EHHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P $D/BUX_USXI_$C]B'POJ_B'Q+J]SJFNZK=W=Z9;R\N)6EFF?$X&YG=F.
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>1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>tnet-20240331_g3.jpg
<TEXT>
begin 644 tnet-20240331_g3.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!QQUKXD^$WQ:\3:#X-_9W_X)Y6\FH7$NWQ$_B>PF2WLLX'RRQ285%Y)>0 D
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MBBON#X,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#/QPT'XU:)^UI\%/#8UTZ3H<EAJNFK"97A0I.C2",$,ZM'.X^3)4J&]QE?\
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MI,[FBBBON#X,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M ]W-X?@A;P[XL2V6]B6%1$LK"VFFCV2J@E3#D[)%W!6RH]6H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#,\9>-O!GPZ\-77C/X@^+M,T+1[%
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M_!83]D3]KJ\\2:IHWPA\6>(?'>E?![P<P>$:KI%KX6O7;Q'=QG#%[Z5@UNC
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MJX\#^"M3UYO&EWJWQ\UF6[T>W?1Y(;!=.,MR9( ]QLBE$&W="2CY3(K]+**
M/AH_!/\ ;G_85_:M^-?Q1_9%_9G\-_%SP;\=-;M/$RV5UX\AT"]\,^($LH[2
MY%P9XG6ZLIO*BF#1'S8V\U?+;(8^U_\ !,K]DCQ-^Q!^Q;X2_9[\=^)K'6/$
MEI-J6J^*+_2HV2S?4]1U"XU"Z2W5P&$"2W+QQD@$HBL0"2*]ZHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _EOHHHK_ $$/\^PHHHH
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MXB4_^K+O_,C?_>ZORWHH_P"(6<!_] ?_ )4J_P#R8?\ $4^//^@S_P ITO\
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MW&_]Q']!>!/_ #,?^X/_ +E"BBBOY]/Z""BBB@ HHHH **** "BBB@ HHHH
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M&5__ )F/F^BOI#_A0GPF_P"A4_\ )Z?_ ..4?\*$^$W_ $*G_D]/_P#'*/\
MB=#PN_Z \9_X+H?_ #0'_$E/BI_T&8+_ ,&5_P#YF/F^BOI#_A0GPF_Z%3_R
M>G_^.4?\*$^$W_0J?^3T_P#\<H_XG0\+O^@/&?\ @NA_\T!_Q)3XJ?\ 09@O
M_!E?_P"9CYOHKZ0_X4)\)O\ H5/_ ">G_P#CE'_"A/A-_P!"I_Y/3_\ QRC_
M (G0\+O^@/&?^"Z'_P T!_Q)3XJ?]!F"_P#!E?\ ^9C^@"BBBOS4_1 HHHH
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M$_\ RD/^)6_';_H4?^7&%_\ EYX_17L'_#*/_4^_^4O_ .VT?\,H_P#4^_\
ME+_^VT?\3/\ @9_T-O\ RAB?_E(?\2M^.W_0H_\ +C"__+SQ^BO8/^&4?^I]
M_P#*7_\ ;:/^&4?^I]_\I?\ ]MH_XF?\#/\ H;?^4,3_ /*0_P")6_';_H4?
M^7&%_P#EYX_17L'_  RC_P!3[_Y2_P#[;1_PRC_U/O\ Y2__ +;1_P 3/^!G
M_0V_\H8G_P"4A_Q*WX[?]"C_ ,N,+_\ +SQ^BO8/^&4?^I]_\I?_ -MH_P"&
M4?\ J??_ "E__;:/^)G_  ,_Z&W_ )0Q/_RD/^)6_';_ *%'_EQA?_EYX_17
ML'_#*/\ U/O_ )2__MM'_#*/_4^_^4O_ .VT?\3/^!G_ $-O_*&)_P#E(?\
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MB@ HHHH **** "BBB@#]T****_NP_@,**** "BBB@ K\+Z_="OPOK\)\:_\
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M %%%% !1110 4444 %%%% !7[H5^%]?NA7[MX*?\Q_\ W"_]R'X#XY?\R_\
M[B_^X@HHHK]V/P$**** "BBB@ HHHH **** "BBB@#\+Z***_A,_OP**** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#]T****_NP_@,**** "BBB@
MK\+Z_="OPOK\)\:_^8#_ +B_^XS]^\#?^9A_W"_]RA1117X2?OP4444 %%%%
M !1110 4444 %%%% !1110 4444 %?NA7X7U^Z%?NW@I_P Q_P#W"_\ <A^
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M^[#^ PHHHH **** "OPOK]T*_"^OPGQK_P"8#_N+_P"XS]^\#?\ F8?]PO\
MW*%%%%?A)^_!1110 4444 %%%% !1110 4444 %%%% !1110 5^Z%?A?7[H5
M^[>"G_,?_P!PO_<A^ ^.7_,O_P"XO_N(****_=C\!"BBB@ HHHH **** "BB
MB@ HHHH _"^BBBOX3/[\"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH _="BBBO[L/X#"BBB@ HHHH *_"^OW0K\+Z_"?&O\ Y@/^XO\ [C/W[P-_
MYF'_ '"_]RA1117X2?OP4444 %%%% !1110 4444 %%%% !1110 4444 %?N
MA7X7U^Z%?NW@I_S'_P#<+_W(?@/CE_S+_P#N+_[B"BBBOW8_ 0HHHH ****
M"BBB@ HHHH **** /POHHHK^$S^_ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** /W0HHHK^[#^ PHHHH **** "OPOK]T*_"^OPGQK_Y@/\ N+_[
MC/W[P-_YF'_<+_W*%%%%?A)^_!1110 4444 %%%% !1110 4444 %%%% !11
M10 5^Z%?A?7[H5^[>"G_ #'_ /<+_P!R'X#XY?\ ,O\ ^XO_ +B"BBBOW8_
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M1110 4444 %%%% !1110 4444 %%%% !1110!^Z%%%%?W8?P&%%%% !1110
M5^%]?NA7X7U^$^-?_,!_W%_]QG[]X&_\S#_N%_[E"BBBOPD_?@HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *_="OPOK]T*_=O!3_ )C_ /N%_P"Y#\!\
M<O\ F7_]Q?\ W$%%%%?NQ^ A1110 4444 %%%% '&?&;X&>$/CGIEEI/B_5-
M:M8[&=IH6T75I+1F8KM(8I]X8[&O/O\ AWO\$_\ H;?'?_A97/\ C7NE% 'A
M?_#O?X)_]#;X[_\ "RN?\:/^'>_P3_Z&WQW_ .%E<_XU[I10!X7_ ,.]_@G_
M -#;X[_\+*Y_QH_X=[_!/_H;?'?_ (65S_C7NE% 'A?_  [W^"?_ $-OCO\
M\+*Y_P :/^'>_P $_P#H;?'?_A97/^->Z44 >%_\.]_@G_T-OCO_ ,+*Y_QH
M_P"'>_P3_P"AM\=_^%E<_P"->Z44 >%_\.]_@G_T-OCO_P +*Y_QH_X=[_!/
M_H;?'?\ X65S_C7NE% 'A?\ P[W^"?\ T-OCO_PLKG_&C_AWO\$_^AM\=_\
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MPI!!#YDS/))MC15W.S,<98DDF@#H:*** "BBB@ HHHH **** "BBB@ HHHH
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B1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>tnet-20240331_g4.jpg
<TEXT>
begin 644 tnet-20240331_g4.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOH$'Q!:_ECYW& 0C-Q[$V8W#W;K7ZFVMK;6-K'96<"10PQA(HHUPJ*!@ #L
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M12:6MC]1RW@SAFOF,<3B(-86K1H."4I:5:TN1*][NSC)M-Z7['Z"_M7?M/\
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MJFOFWX8_MQ?M5>'/AMX>\/:)^PIXGU*RL-#M+:TU&&SOBEU$D**DJE;4@A@
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M_: _95U#1?$VB?MSZ?X_U&:ZQK'AR&X6YBM\*&*N-[C8>5R!&XR" ,\>K?\
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M63FN:3M?EC=V(PW =7%T)XBGBZ;I1ER*:51Q<N52=VH/DBKVYI65SZY_:?\
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MO&GA5;6&W\3Z-;PM(R^674E@N2%:-UVMC >/YL9&:/P9?X;?&GX^Z+:? O\
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M &/?SW86YCO+I0K0F/$BJA4_H+_P2?UKXM>(_P#@FY\%]=^.OQ4T[QOXLNO
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MX@Z7:V^E?$_XL6FO>$I8+U)6GLH]%L;1F=5.8F\V"0;6YP >AKZ3HH _/?\
M:7^-?_!4K]MK_@GU;R?L8?!73= \5Z_\3-7\/>,+G0_B3;V<T'AO3M1NK.>?
M2M2F@9([B[^SA8[E8I1"KNZ!R$<;?['WP1_:%O?@!K?_  3N^)O_  2K\+_
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M4W%5+;1] T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P#X-J?_ "1]2?\ #Z3_ (*7_P#1RG_EG:-_\AT?\/I/^"E__1RG_EG:-_\
M(=?+=%'^J7"O_0!0_P#!5/\ ^1#_ %MXJ_Z#Z_\ X-J?_)'U)_P^D_X*7_\
M1RG_ )9VC?\ R'1_P^D_X*7_ /1RG_EG:-_\AU\MT4?ZI<*_] %#_P %4_\
MY$/];>*O^@^O_P"#:G_R1_4A1117\-G]R!1110 4444 %? W_#:O[3/_ $4O
M_P HUE_\9K[YK\LZ /4_^&U?VF?^BE_^4:R_^,T?\-J_M,_]%+_\HUE_\9KR
MRB@#U/\ X;5_:9_Z*7_Y1K+_ .,T?\-J_M,_]%+_ /*-9?\ QFO+** /4_\
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M% !1110!_4A1117^?9_H(%%%% !1110 5^6=?J97Y9T %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5^IE?EG7ZF4 %%%% !1110 4444 %%%%
M!1110 4444 ?RWT445_H(?Y]A1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 ?U(4445_GV?Z"!1110 4444 %?EG7ZF5^6= !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %?J97Y9U^IE !1110 4444 %%%% !1110
M4444 %%%% '\M]%%%?Z"'^?84444 %%%% !1110 4444 %%%% !1110 4444
M %%%% ']2%%%%?Y]G^@@4444 %%%% !7Y9U^IE?EG0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !7ZF5^6=?J90 4444 %%%% !1110 4444 %
M%%% !1110!_+?1117^@A_GV%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!_4A1117^?9_H(%%%% !1110 5^6=?J97Y9T %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5^IE?EG7ZF4 %%%% !1110 4444 %%%% !1
M110 4444 ?RWT445_H(?Y]A1110 4444 %%%% !1110 4444 %%%% !1110
M4444 ?U(4445_GV?Z"!1110 4444 %?EG7ZF5^6= !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %?J97Y9U^IE !1110 4444 %%%% !1110 44
M44 %%%% '\M]%%%?Z"'^?84444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% ']2%%%%?Y]G^@@4444 %%%% !7Y9U^IE?EG0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !7ZF5^6=?J90 4444 %%%% !1110 4444 %%%
M% !1110!_+?1117^@A_GV%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!_4A1117^?9_H(%%%% !1110 5^6=?J97Y9T %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5^IE?EG7ZF4 %%%% !1110 4444 %%%% !111
M0 4444 ?RWT445_H(?Y]A1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 ?U(4445_GV?Z"!1110 4444 %?EG7ZF5^6= !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %?J97Y9U^IE !1110 4444 %%%% !1110!Y/\
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M?6;W5/"O@R-/#VARZQ)_96G7;72A[Y;9<(]T4F:+S7W;45=H4Y)^V8?]4O\
MNB@!U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !7EO[4/[*/@S]I[2M#NK_Q/K/ACQ3X1U)M1\&>-?#5PL6H:
M-=,FQRA=622*1/DEA=2DB\$9 (I_'W]K6U^$'Q'T+X&^ OA'XB^(7CWQ#IL^
MIVGACPW+:P&UT^%UCDO+FXNYHH8(O,=8U)8EW.T US^B?\%%/@S_ ,*.\<_&
M/XB>&O$?A*\^&NIC2_&O@W5[*-]5L]0?R_L]M$D,CQW!N#-$(7C<I)YB\CG
M!XSXT_X)$_%CQK\2F_: \6_MJ77B3QK::QINKV=CJW@FVMO#VIWM@-MO+J=A
M:2I]JD5 $6571HP!@$#;7TY^U=^SQ9_M7?LV>*/V=?$7BF728O%.F+:76JV5
MJ':$B1)"R1LV#RF,%NAZUS/P:_;-F\>?%NW^!7Q?^ 'BSX8^*=6T.76?#-CX
MIGL9XM9LXF19O)FLYY46>+S(S) Y5U5PV",D<-=_\%2_"\7A"Y^/%A^S7\0+
MSX-V6IO:7/Q8MDL39F-)S ]\EG]I^V26:R YG$7W06"D"@#ZF5=JA0>@Q2UP
M7[1'[1_PP_9D^!NL?M ?$?5_^))I-D)HEM"'EOY7P(+> 9Q))*[*B#.,MDD
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M8CTKE?BOJ5[_ ,%#&U/]C+]F;28=%^#&E:E_9WQ1^(EE;K#;WRPRAYM#T95
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
F*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>tnet-20240331_g5.jpg
<TEXT>
begin 644 tnet-20240331_g5.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&^GPR^(I=0>^ATEI0Z07-QY,$43LIPP4()'"G^\ >]>5V_CK]K=_@JW[4_\
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M*$;W=U'E3=FXIR3:/MJO'_VI/VT_A7^RS!;:=XDBN=5UV_B\RRT+3BOF&/)
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M1;WVDC+.1DY()KZW\,>'=*\'^&M.\):% 8K'2[&&TLXB<[(HT"(,]\*HKY[
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-_CE_P C/!_X)?\ I2/Z0\#?^19C/\<?_26%%%%?A9^Z!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% '\Y7[?/_ "?!\7O^RDZU_P"ELM>25ZW^WS_R?!\7
MO^RDZU_Z6RUY)7]Y9-_R)\/_ ->X?^DH_@W.?^1QB/\ KY/_ -*84445Z1YH
M4444 >D_L9_\G@?"G_LI6A?^G""OZ1Z_FX_8S_Y/ ^%/_92M"_\ 3A!7](]?
MS?XY?\C/!_X)?^E(_I#P-_Y%F,_QQ_\ 26%%%%?A9^Z'\Y7[?/\ R?!\7O\
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MI/[&?_)X'PI_[*5H7_IP@K^D>OYN/V,_^3P/A3_V4K0O_3A!7](]?S?XY?\
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MY/\ ]*84445Z1YH4444 >D_L9_\ )X'PI_[*5H7_ *<(*_I'K^;C]C/_ )/
M^%/_ &4K0O\ TX05_2/7\W^.7_(SP?\ @E_Z4C^D/ W_ )%F,_QQ_P#26%%%
M%?A9^Z!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7B._\7?LV?LZ^&O!FIZI9"SU"]T.R\IYX X?RV.3E=R@_44 ? O@:X\9>!/
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MH?5G\Y7[?/\ R?!\7O\ LI.M?^ELM>25_0'X^_X)*_\ !/KXH>.-8^)'CKX
M?;M:U[4I]0U:]_X2K5HO/N)G+R/LCNE1<LQ.%  SP *R/^'+?_!-#_HVO_R\
M=9_^3*_I?+_&7A?"X"E0G1K7A&,7:,+722T_>'\T9AX-<48K'U:\*U&TY2DK
MRG>S;>O[L_!.BOWL_P"'+?\ P30_Z-K_ /+QUG_Y,H_X<M_\$T/^C:__ "\=
M9_\ DRNS_B-O"O\ SYK_ /@-/_Y8<?\ Q!+BK_G]0_\  JG_ ,K/P3HK][/^
M'+?_  30_P"C:_\ R\=9_P#DRC_ARW_P30_Z-K_\O'6?_DRC_B-O"O\ SYK_
M /@-/_Y8'_$$N*O^?U#_ ,"J?_*S\7/V,_\ D\#X4_\ 92M"_P#3A!7](]?-
MO@S_ ()%?\$\OA]XPTGQ]X0_9\^QZMH>I0:AI=W_ ,)9JTGD7,,BR1OM>[*M
MAU4X8$'&"".*^DJ_)/$?C#+.,,9AZN#A.*IQ:?.HK=WTY92_0_6_#C@_,^#\
M'B*6,G"3J237(Y/96UYHQ_4****_-S](/YROV^?^3X/B]_V4G6O_ $MEKR2O
MZ _'W_!)7_@GU\4/'&L?$CQU\ /MVM:]J4^H:M>_\)5JT7GW$SEY'V1W2HN6
M8G"@ 9X %9'_  Y;_P"":'_1M?\ Y>.L_P#R97]+Y?XR\+X7 4J$Z-:\(QB[
M1A:Z26G[P_FC,/!KBC%8^K7A6HVG*4E>4[V;;U_=GX)T5^]G_#EO_@FA_P!&
MU_\ EXZS_P#)E'_#EO\ X)H?]&U_^7CK/_R979_Q&WA7_GS7_P# :?\ \L./
M_B"7%7_/ZA_X%4_^5GX)T5^]G_#EO_@FA_T;7_Y>.L__ "91_P .6_\ @FA_
MT;7_ .7CK/\ \F4?\1MX5_Y\U_\ P&G_ /+ _P"()<5?\_J'_@53_P"5GXN?
ML9_\G@?"G_LI6A?^G""OZ1Z^;?!G_!(K_@GE\/O&&D^/O"'[/GV/5M#U*#4-
M+N_^$LU:3R+F&19(WVO=E6PZJ<,"#C!!'%?25?DGB/QAEG&&,P]7!PG%4XM/
MG45N[Z<LI?H?K?AQP?F?!^#Q%+&3A)U))KD<GLK:\T8_J%%%%?FY^D!17C7B
MS]CG_A*_%&H^)_\ AJCXRZ;_ &A>RW/]G:3XX\FUMM[%O+AC\D[(USA5R<
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M*_O+)O\ D3X?_KW#_P!)1_!N<_\ (XQ'_7R?_I3"BBBO2/-"BBB@#TG]C/\
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M*.?&'Q+#XRTS5&3X,_ RR^$7BN?1OAZ9F\I+JXN%TPPZAJ[J1NNRWDP;B(L
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M7^N75Q:3?:=OF1O*S*V& (R"." :YS_AI7X!_P#16M$_\#17ZF?\,R?LV_\
M1O?@?_PD[/\ ^-T?\,R?LV_]&]^!_P#PD[/_ .-T ?EG_P -*_ /_HK6B?\
M@:*/^&E?@'_T5K1/_ T5^IG_  S)^S;_ -&]^!__  D[/_XW1_PS)^S;_P!&
M]^!__"3L_P#XW0!^6?\ PTK\ _\ HK6B?^!HH_X:5^ ?_16M$_\  T5^IG_#
M,G[-O_1O?@?_ ,).S_\ C='_  S)^S;_ -&]^!__  D[/_XW0!^9_P ,OVK?
MV<O#WQ)\/:_K'QBT2&TL=<M+BZE^U;MD:3(S-A02< $X )K[=_X>U?\ !.G_
M *.DT3_P#N__ (S7J?\ PS)^S;_T;WX'_P#"3L__ (W1_P ,R?LV_P#1O?@?
M_P ).S_^-T 8_P !_P!M+]E[]IS7;[PS\!_C!IWB._TZT%U>VUI#,C10E@F\
M^8BY&X@<>M>H5S_@[X3?"OX>7<U_X ^&GA_0I[B,1W$VCZ-!:O*@.0K&- 6&
M><&N@H **** "BBB@ HHKQ#]K7]M'3_V1OB7\&O#'C'X>7%YX;^+/Q#3P9<^
M+(M16-- U.Y@D?3EDA*$RI<S1M#NWIL8J?FW 4 >WT5XM^WC^V-IO[$GP3LO
MB4G@&X\7:_XA\8Z/X5\%^#K._6UFUS5]1NTMX;=)61PF%,DS':<)"_%>NR>(
M-#@U>'P]=:U9QZC/$9(K!KI1-(HZLJ$[F P>0.U %RBO&])_:_TG4OV\/$?[
M#TO@N6"?P[\*M.\;S>)I-07RI(KN_N[/[-Y6S*E#:ERY<@A\8&,GU][VSCCC
MEDNXE69@L3&0 .3T ]2>V* ):*IWGB/P]I\D4-_KME \]R+:!9KI%,DQY\M0
M3R_^R.:='K>BS:M)H$.KVKWT,0EFLEN%,R(> Q3.0I]2,4 6J*J76OZ%8ZG;
MZ)?:U:0WEV&-I:2W*K+,!UV(3EL=\"K= !1110 451\3ZVGAKPUJ/B-[<S+I
M]C-<F(-@N(T+;<]LXQFOA3]GG_@JU_P4,_:F^ GA[]I?X)_\$<KW5_"7BG2_
M[0T2Y'Q[T6">Y@W,O$,T*,K$J0%;;SCD=: /OFBO(?V(OVS?AI^W3^S3I'[2
MWP]TC5=#L[V:\L]7T+Q'"L-[HM_9SR6]W:7"ABH>.6)QD'!7:W&<5Z%J7Q'\
M%:=X*U+XA1^(K2[TG2K2:XO+NPN4F55B0NX!4XW #IGN* -RBO./V5_VG?A_
M^UK^S1X2_:G\!PW6G^'O&'A^'6+&#6&B2XM;>1-ZB<([(CA""P#$#U/6N_TO
M5M*URPCU71-3M[RUF&8;FUF62-QG&0RD@\@CB@"Q1110 4444 %%%>$?\%*?
MVW(_^"=W[('B']JU_A1>^-WT/4-+LX/#&G:@+6>^EO=0M[)%20QR $-<!L;3
MG&.,YH ]WHKR#X'_ +:GPA^-/[#VA?M[1WITKP=JGP^'BS4OM$H=M+MTMC/=
M0R,, O 4EC?&!NB:O%OV$O\ @JSXV_;Y_9:\/?M*_"_]CC5[-]1^,0\%>(O#
M5]XOM8Y]!LTD5+K59'ECC$PAW FU1?-8Y"Y- 'V114,>H6$UN]U%?0M%$6$D
MBR@JF.N3T&._I4D,T-Q$MQ;RJ\;J&1T;(8'H01U% #J*** "BBB@ HKQ7_@H
MC^V3IG_!/S]C/QQ^V%K'@*?Q/;>"K.VN)="MM06U>[$UY!; "5D<)@SAONG.
MW'?-=5^UA\>;3]EC]E[XB_M,7_AJ368/A[X'U7Q'-I$-R('O5LK22X,*R%6"
M%Q'MW%3C.<'I0!Z!17Q?\6O^"K'Q8T7QO\#_ (6?LZ_L2W7Q'\4?&SX62^.+
M/2F^(5GHZZ7:116DDD3S7,)25A]K49&W.TX'/&G\,_\ @IE\9M*_:A\#_LL_
MML_L(:[\'-1^*"WT7P\\01^.=.\0Z9J=[9P&XFLI9;3:UK-Y*LZ!U(DP0#F@
M#Z]HKY0_X>T_![PU\(/VE?CI\5/ ^IZ'X>_9L\?WOA?67M+A;RXUN6"WM)8W
MMX]L81YI+R.%(V; 8@LX!)'$^)?^"K/[6O[/VEZ1\7_VX_\ @E_JWPR^$VIZ
MO86&H^.=/^*FG:Y=^'/ML\<%O/J>G10Q-!%YLL:2-%+-Y9;D$X! /N6BBB@
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M^&OA!;+XJ_$'XB>'+;XA?$=[B276?%,>K^%;ZZU :A=.QDNQ+,BL!(6$8 5
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MY37UO%(L%\5PH!N$DX '0 5] 65E9Z;9PZ=IUI%;V]O$L<$$$81(T48554<
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M]!\;>);71;5[&+5;FSM9VN))&6600R1N+B2RA1\[1C[*_P""8?P7^*_[.?\
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M1^)$, DFPGBHSM<'5/O_ .M\UF?'W,G[M 'Y1?\ !0:+X<?#C_@HGXX_9O\
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JBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>tnet-20240331_g6.jpg
<TEXT>
begin 644 tnet-20240331_g6.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y?\ BI_P4OTG
MX;?%_6_@]8_ W6];O=%NC"\NG7BDR@*I+! A('S"F?#+_@J=\+/%_CZS^'_C
MWX>ZWX2FOYTAM[O471XD=SA/-X5HU)(&[! SDX&2/"K_ ./W@[]FO_@I1XY^
M)7CK3=3N[%9;FU,6DPQR3;Y(XL'$DB#'RG//X52_::^,+_\ !1WXJ>$?!/P%
M^%NJ0RZ=YL4^IZA @E5)GCRTOE,RQPQA"V2QR7. #][\-J\9YW3E7G3QL95H
M5I0AA_9IN<5.R]Y:K2^OEW9^]4>"<BJ1H0JX&4:,Z$9SQ/M6E"3A=^[)M/6V
MGGM9'V1^U3^V-\._V5K"P@\0:;>:OK6K;CIFBZ>0'=00"[L>$3)V@X))Z X)
M'DFE_P#!5:#1==L['XV_LU^)/!]A>R;8=1EG>;Y>,OY<D$191D$[2QQT!Z59
M_;[_ &9/C7XK^('A+]HWX"0C4]<\)V\44FG/L,A\F9IXID5_ED.YW#)U/RX!
MYQY=XQ_;LA\96MI\+/V]OV3[@V<5XLYDM?M5C+%(H*^8L$A5FX=LXE P>AXK
MV,_XBSW 9Q6IU<3]6A%Q]ES4N:E-65^>HE*2UNG:UCQ>'N&L@S#):%2EAOK4
MY*7M>6MR5:;N[<E-N,6K6:O>Y]6?M,?M4^&?V<OA+IGQ>.A2>(-/U748+:T%
MA=J@=)H9)DE#$$%2L?X[A7BY_P""KJK8+JS_ ++GBP6CQB1;KSOW90C(8-Y6
M",<YSC%4?^"DTO@&;]A;P7)\+)(V\-_\)!IPT/RG=E%J+*Z$:@N2W"X&&Y&,
M'D5@^!_^"IMA\)_A+X8\%:G^S]K3S:=X<M+.UN;F_$$5YY,"1^8A,1.QL \9
MX(HSKBG%X;/IX>KF"PU)4X235-54Y2WL[7MV[AD?"F#Q7#\,32RYXFJZM2+3
MJNDU&.UU>U^ZZ'TM^R]^UO\ #/\ :KT&]U+P1%>65]I;HNI:5J*J)80^=C@J
M2'0[6 (YRIR!QGU*OD?_ ()I?L\?$WP3K_BKX[_$?PXFA+XJ0#2='0@$1/*9
MFDV GRT&55 ><;C@#!/UQ7W'"F.S3,<BI8C,(\M5WOIRW5VHRY>EU9V^>Q\'
MQ;@<JRW/ZV'RZ?-25K:\UFTG*/,M[.ZO\MPHHHKZ(^;"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^+/@]X!\1/_P %
M2/&GB#6O!=Z=)F@O/)OKK37^S2$I#C#LNTG@XP>U?9]M:6ME%Y%G;1Q(.B1(
M%'Y"I**\/(\DIY)2JPC+F]I4G4O:UN=WM\CW<^SRKGE6C.4.7V=.%.U[WY%:
M_P SY0_;>MOVJ_A5\9_#W[0WP9O/$.N^&;*.,:SX4LKV>2W61-P9GMXR04DC
M;&\*=C*6.,BO+_VD/VO_ !S^V5\.!\"?AQ^RYK@U#4+R![BXN(VG:T:-PW[O
M$8"9(VF1BH"%@1SD??\ 17B9EPCC,95Q$:&.E3HXCXX<L9[JSY92UC==K^70
M]W+.,<%@J6&E7P,*E;#_ ,.IS2AL[QYXQTG9][>?4^)?VO?@1XZ^'_\ P3O\
M!?""#2;O5]7TGQ!;-?PZ9;O<%'>&\DD V DHK2; W3@>M>UWG[.N@_M _L3^
M%?A3XRLC:7J>"],-A=3P$2Z=>I9QA7P>1@Y5EX)4L.*]OHKMH<)9?1Q56<GS
M4YTH4>1K3E@K+7=NW^9Q8CC#,:V$I0BN6I3K3K<Z>O--W>FR2?\ D?'_ /P3
M?\>_&/X<ZWJG[*GQI\):S FF33'P]J5S92FWC*$^;;+,5VE#@R1G.#\P!Y45
M]@445Z60Y54R7+8X.55U%"ZBVK-1Z1?>VR>FEE;0\SB#-J>>9G/&QHJE*=G)
M)W3EUDM-.;=K76[OJ%%%%>P>*%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5Y;^TW^TU8_L\6?A_3M/\*-XA\1>*=8CT_0]!COOLYG8LJLY
MDV/M52Z#[IR74>I'J5?'>LWC_%K_ (*V6.A:H?-L? >A;[6!ON^9]E\W?C^\
M);E3G_IFOI7SG$V98G 8.E3PSY:M:I"E%V3Y>9ZRL[IVBFU=6O8^FX6RS"YA
MC*U3%1YJ5"E.K*-VN;E6D;JS5Y.*=G>U]CUG]JS]L[PU^S6VG^$;?PO>>(/%
MVLVIET[0]-YV+RHD=L$[2ZL %4EMC<#&:Y/]CG_@H)IOQXU>P^%?Q*\-3:)X
MMNK W%I,(RMIJ8"ER8@?F0[ 6 .X$*V&[5S'[?'P9^.&@_&K1/VM/@IX;&NG
M2=#DL-5TU83*\*%)T:01@AG5HYW'R9*E0WN,K_@GQ^U!^S]XGB\)_!SQ7\/;
M;3_&VE:9]AT;Q!>6$,INU4R2"..?;YD1(=R$/RG)PQ+8/QU7/LYI<;K"8C$*
MC3YK0A*'N5(^Y:T_YY7E;6T6E&SNT?9T>'\DJ\"O&8;#NO4Y;SG&?OTY^_>\
M/Y(VC?2\DW*ZLF?:=%?%'B?XP?M7^-?V]/%?[.GPM^+"Z5I\T/EP2WMFDT>E
M0BW@EDFB3&6D^\B@DC,IZ<,O.^&OB/\ MP>"_P!J'5OV,-.^.D6LWVHE$A\2
MZQ9>:;",VZW37$2L20WE%E\MBR[NF.&KV:G'F$A5LL+5<?:RH\R4+.HKVBES
M7?-;1V25]7O;Q:?A_BZE+F>*I*7L8U^5N=U2=KR;Y&ERWU5VW9V6U_OFO)O#
M'[5%MXE_:=U?]FM?AYJ,$FE6[RG7I)@8)ML<;X"[?^FF.O\ ":\*^!7Q/_:-
M^"W[=4?[+/Q5^+MQXSTO5K1W2\O8L,C?9'N4D3)+1G*%"FXK@Y],=+\-?CC\
M5]9_X*4^*_@YJ?C6ZF\,V.GRR6FD,J>7&P@MV!!"[NKL>O>B7%BQBP[IJ=&7
MUGV$XN,9/F2;<6^:R6SYHMOL@7"+P4L2JCA6C]6]O":E.*Y7))22Y;MK5<LK
M+NSTGX.?M=Z+\8/C[XO^ MCX+NK*Y\(O<K/J,MVKI<^3<+ =J@ KDG/)-,_9
MO_; T3]HSQ/XQ\,Z7X)NM,?PA,L<TL]VL@N2SS)E0%&W_4D\Y^]7AW[$O_*1
M7XT_]=M4_P#3FE1?\$OG:/XL?&J1&PRW\)!]#Y][7EY7Q+G&)Q>!A4J756KB
M8R]U:QIIN"VTM;IOU/6S7AC)L+@\?4IT[.E1PTX^]+251I3>^M[[/1=#Z"_9
M4_:CMOVH="U;6[;X?:AX?&E7<<!AU"4.9MREMPPJ\#&*]7KX\_81_:P\?ZI^
MS_\ $;XN_&_Q=>:\OA9EF@$P17*B!F\I=J@99@ ">YKG_A%:?M\_MF^&[[XX
MZ+^T''X/T]KR6+0-'LXV2&4H<%3L&?+#?+O?S&)5N, 9[LLXQY\KPBC"IB:]
M:,I6C&$9<L9-.4ES<L5T5F[OS//S3@ODS7%N4Z>&P]&487E*<X\THIJ,7R\T
MGU=TK+R1]QT5\L_L@?M;_$OXI>!?'OPV^+12+QKX&L;DOJ$,2(9P@D0EE4;1
M)'(F"5 4AEXR"3YI^RKKO[<7[87PSU>*P_://A^STG4F7^US8A[R]G:)"(-Z
M;?*B0 -N7G,IX;  [5QM@J\<.L)1J595U-QBE%-.#M*,N:22:?G;32]U?A?
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M  +HOQ+\!ZRFHZ'XBTFVU/1M0C1E6ZM+B)9890' 8!D=6P0",\@&@#6HHHH
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M$VS^'OBF']IF70+'X6WG@"3PG?[;/R+R.WEUF2Z\G[/_ &:+*,W8NA(4964
MY) ^J/B9^TM^PO\ L?\ [:GC[P]^V3^R-8^#)-0\%Z+;^$OC5=^$KG74^(6G
MQ6ICN-/9[>Q?[+/;.!%]D+NTZ-'(!@JH /JS]DNW^(T/[/WAZX^*G[2NA?%_
M5KN"2[_X6+X:\/0:78:Q;RRO);R0V]O<3QA%A:- ZRL'V;^-V!Z/7QM_P0P^
M$'C[X/\ [%>IP^*/AYJO@KP_XG^*OBCQ)\-/ 6MVQM[OPQX7OM1DFTZPD@/-
MNPC)E\GJGG8(#9 ^R: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BOY;Z*_H+_B!/_4Q_P#*/_W4_GW_ (CM_P!2[_RM_P#<C^I"BOY;
MZ*/^($_]3'_RC_\ =0_XCM_U+O\ RM_]R/ZD**_EOHH_X@3_ -3'_P H_P#W
M4/\ B.W_ %+O_*W_ -R/ZD**_EOHH_X@3_U,?_*/_P!U#_B.W_4N_P#*W_W(
M_J0HK^6^BC_B!/\ U,?_ "C_ /=0_P"([?\ 4N_\K?\ W(_J0HK^6^BC_B!/
M_4Q_\H__ '4/^([?]2[_ ,K?_<C^I"BOY;Z*/^($_P#4Q_\ */\ ]U#_ (CM
M_P!2[_RM_P#<C^I"BOY;Z*/^($_]3'_RC_\ =0_XCM_U+O\ RM_]R/ZD**_E
MOHH_X@3_ -3'_P H_P#W4/\ B.W_ %+O_*W_ -R/ZD****_GT_H(**** "BB
MB@ HHKY9_P"'EO\ U17_ ,N/_P"YJ /J:BOEG_AY;_U17_RX_P#[FH_X>6_]
M45_\N/\ ^YJ /J:BOEG_ (>6_P#5%?\ RX__ +FH_P"'EO\ U17_ ,N/_P"Y
MJ /J:LCQYX"\'_$_PA?^ ?'_ (?M]5T;5(?)U#3[H$QSID':V".,@'\*^</^
M'EO_ %17_P N/_[FH_X>6_\ 5%?_ "X__N:@#ZFHKY9_X>6_]45_\N/_ .YJ
M/^'EO_5%?_+C_P#N:@#ZFHKY9_X>6_\ 5%?_ "X__N:C_AY;_P!45_\ +C_^
MYJ /J:BOEG_AY;_U17_RX_\ [FH_X>6_]45_\N/_ .YJ /J:BOEG_AY;_P!4
M5_\ +C_^YJ/^'EO_ %17_P N/_[FH ^IJ*^6?^'EO_5%?_+C_P#N:C_AY;_U
M17_RX_\ [FH ^IJ*^6?^'EO_ %17_P N/_[FKZFH **** "BBB@ HHHH ***
M* "BBB@ HHHH _EOHHHK_00_S["BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH _J0HHHK_/L_T$"BBB@ HHHH *_+.OU,K\LZ "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *_4RORSK]3* "BBB@ HHHH **** "BBB
M@ HHHH **** /Y;Z***_T$/\^PHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** /ZD****_S[/]! HHHH **** "ORSK]3*_+.@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "OU,K\LZ_4R@ HHHH **** "BBB@ HHHH
M **** "BBB@#^6^BBBO]!#_/L**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#^I"BBBO\^S_00**** "BBB@ K\LZ_4RORSH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ K]3*_+.OU,H **** "BBB@ HHHH ****
M"BBB@ HHHH _EOHHHK_00_S["BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH _J0HHHK_/L_T$"BBB@ HHHH *_+.OU,K\LZ "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *_4RORSK]3* "BBB@ HHHH **** "BBB@
MHHHH **** /Y;Z***_T$/\^PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** /ZD****_S[/]! HHHH **** "ORSK]3*_+.@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "OU,K\LZ_4R@ HHHH **** "BBB@ HHHH *
M*** "BBB@#^6^BBBO]!#_/L**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#^I"BBBO\^S_00**** "BBB@ K\LZ_4RORSH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ K]3*_+.OU,H **** "BBB@ HHHH **** /)
M_P!JS]CGX7_M@Z-H^B?$WQ!XFL(M$N99[1O#6M&S9VD5582$*V\848].?6O%
M/^')'[)__11?BG_X7#?_ !JOL.B@#X\_X<D?LG_]%%^*?_A<-_\ &J/^')'[
M)_\ T47XI_\ A<-_\:K[#HH ^//^')'[)_\ T47XI_\ A<-_\:H_X<D?LG_]
M%%^*?_A<-_\ &J^PZ* /CS_AR1^R?_T47XI_^%PW_P :H_X<D?LG_P#11?BG
M_P"%PW_QJOL.B@#X\_X<D?LG_P#11?BG_P"%PW_QJC_AR1^R?_T47XI_^%PW
M_P :K[#HH ^//^')'[)__11?BG_X7#?_ !JC_AR1^R?_ -%%^*?_ (7#?_&J
M^PZ* /CS_AR1^R?_ -%%^*?_ (7#?_&J/^')'[)__11?BG_X7#?_ !JOL.B@
M#X\_X<D?LG_]%%^*?_A<-_\ &J/^')'[)_\ T47XI_\ A<-_\:K[#HH ^//^
M')'[)_\ T47XI_\ A<-_\:H_X<D?LG_]%%^*?_A<-_\ &J^PZ* /CS_AR1^R
M?_T47XI_^%PW_P :H_X<D?LG_P#11?BG_P"%PW_QJOL.B@#X\_X<D?LG_P#1
M1?BG_P"%PW_QJC_AR1^R?_T47XI_^%PW_P :K[#HH ^//^')'[)__11?BG_X
M7#?_ !JC_AR1^R?_ -%%^*?_ (7#?_&J^PZ* /CS_AR1^R?_ -%%^*?_ (7#
M?_&J/^')'[)__11?BG_X7#?_ !JOL.B@#X\_X<D?LG_]%%^*?_A<-_\ &J/^
M')'[)_\ T47XI_\ A<-_\:K[#HH ^//^')'[)_\ T47XI_\ A<-_\:H_X<D?
MLG_]%%^*?_A<-_\ &J^PZ* /CS_AR1^R?_T47XI_^%PW_P :H_X<D?LG_P#1
M1?BG_P"%PW_QJOL.B@#X\_X<D?LG_P#11?BG_P"%PW_QJC_AR1^R?_T47XI_
M^%PW_P :K[#HH ^//^')'[)__11?BG_X7#?_ !JC_AR1^R?_ -%%^*?_ (7#
M?_&J^PZ* /CS_AR1^R?_ -%%^*?_ (7#?_&J/^')'[)__11?BG_X7#?_ !JO
ML.B@#X\_X<D?LG_]%%^*?_A<-_\ &J/^')'[)_\ T47XI_\ A<-_\:K[#HH
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M\4>,;^YU:P6TN8_$GB%KR)4#A\HI50K9 Y],CO7N%%% !1110 4444 %%%%
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M_M/VR2S60',XB^Z"P4@4 ?4RKM4*#T&*6N"_:(_:/^&'[,GP-UC]H#XCZO\
M\232;(31+:$/+?RO@06\ SB225V5$&<9;)( )&I\#?BKI?QU^"OA'XV:'IEQ
M967C#PS8:U:6=V5,L$5U;I.L;E2064. <<9% '4T444 %%%% !1110 4444
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MU>RC?5;/4'\O[/;1)#(\=P;@S1"%XW*2>8O(YQH?!K]LV;QY\6[?X%?%_P"
M'BSX8^*=6T.76?#-CXIGL9XM9LXF19O)FLYY46>+S(S) Y5U5PV",D '3?M7
M?L\6?[5W[-GBC]G7Q%XIETF+Q3IBVEUJME:AVA(D20LD;-@\IC!;H>M>CJNU
M0H/08KY9N_\ @J7X7B\(7/QXL/V:_B!>?!NRU-[2Y^+%LEB;,QI.8'ODL_M/
MVR2S60',XB^Z"P4@5VWQ8_;63PK\6)/@=\$O@1XI^*7B:PT"#6]?MO"MU806
M^DV,Y80-+<7EQ#&TLNQVCA0L[*I;@8) /<:*XK]GGX]^ ?VF_A!I'QJ^&CW@
MTK5UE"VVI6I@NK2>*5X9[>>,D[)8Y8W1ADC*G!(()[6@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#QG]JK]I7P9^
MSI?Z/;>&_AN_C+XJ^+HI--\"^$=(BC6_U0(1(_F3L/\ 1K*(D22S.=B#G!;
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M8?VC_P!FOQC\ OV9[+XQ_'CQ79ZSXN\7_M&>#?%7Q>U6P1DT^UMTU*VMX[.
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M'$"Q9B222S,Q9F=B69F+,22370T %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
910 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>tnet-20240331_g7.jpg
<TEXT>
begin 644 tnet-20240331_g7.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR^)^):W$M>E.<.54X\JO)SDU=N\INSD]>RL%%%%?2'S 4444 %%%% !1110
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MG97O:Q]=T5\A_L _M:?$+Q5X:^(NF_&+Q@OB.V\"VGVZUUN.,>9/;J)S)\P
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 ?%7_!3+_@I_\ &3]E?QQ>
M_L^?LF?L^Z5XX\?:7\-6\=^)-0\6:^VGZ/H&BF^^PP2.(D>:[FFN$E18(]F
MA=G &*VC_P %5KWP#^R+J_QY_:+_ &2?&WA#QYI'Q(3X?6_PK@VW4_B'Q)-<
M106<.DWDJP17UK<-,C)=X1 JRY&8R#X9_P %L/AM^RI\<?&/B_2O#_QD\8^
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MJG_R(?ZU<+_]!U'_ ,&P_P#DCZGHKY8_X?6?\$RO^CEO_+-UK_Y#H_X?6?\
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M_#ZS_@F5_P!'+?\ EFZU_P#(='_#ZS_@F5_T<M_Y9NM?_(='^J/%G_0OK_\
M@JI_\B'^M7"__0=1_P#!L/\ Y(^IZ*^6/^'UG_!,K_HY;_RS=:_^0Z/^'UG_
M  3*_P"CEO\ RS=:_P#D.C_5'BS_ *%]?_P54_\ D0_UJX7_ .@ZC_X-A_\
M)'U/17RQ_P /K/\ @F5_T<M_Y9NM?_(='_#ZS_@F5_T<M_Y9NM?_ "'1_JCQ
M9_T+Z_\ X*J?_(A_K5PO_P!!U'_P;#_Y(^IZ*^6/^'UG_!,K_HY;_P LW6O_
M )#H_P"'UG_!,K_HY;_RS=:_^0Z/]4>+/^A?7_\ !53_ .1#_6KA?_H.H_\
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M-ACGO9K4E&X;R.^T@_<=% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!_+'1117^AA_!84444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% ']3E%%%?YYG]Z!1110 4444 %?+/_  \M_P"J*_\ EQ__ '-7
MU-7Y9T ?4W_#RW_JBO\ Y<?_ -S4?\/+?^J*_P#EQ_\ W-7RS10!]3?\/+?^
MJ*_^7'_]S4?\/+?^J*_^7'_]S5\LT4 ?4W_#RW_JBO\ Y<?_ -S4?\/+?^J*
M_P#EQ_\ W-7RS10!]3?\/+?^J*_^7'_]S4?\/+?^J*_^7'_]S5\LT4 ?4W_#
MRW_JBO\ Y<?_ -S4?\/+?^J*_P#EQ_\ W-7RS10!]3?\/+?^J*_^7'_]S4?\
M/+?^J*_^7'_]S5\LT4 ?4W_#RW_JBO\ Y<?_ -S4?\/+?^J*_P#EQ_\ W-7R
MS10!]3?\/+?^J*_^7'_]S4?\/+?^J*_^7'_]S5\LT4 ?4W_#RW_JBO\ Y<?_
M -S5]35^6=?J90 4444 %%%% !1110 4444 %%%% !1110!_+'1117^AA_!8
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ']3E%%%?YYG]Z!1110
M 4444 %?EG7ZF5^6= !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %?J97Y9U^IE !1110 4444 %%%% !1110 4444 %%%% '\L=%%%?Z&'\%A1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 ?U.4445_GF?WH%%%% !
M1110 5^6=?J97Y9T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5^IE?EG7ZF4 %%%% !1110 4444 %%%% !1110 4444 ?RQT445_H8?P6%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!_4Y1117^>9_>@4444 %%
M%% !7Y9U^IE?EG0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7
MZF5^6=?J90 4444 %%%% !1110 4444 %%%% !1110!_+'1117^AA_!84444
M %%%% !1110 4444 %%%% !1110 4444 %%%% ']3E%%%?YYG]Z!1110 444
M4 %?EG7ZF5^6= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?J
M97Y9U^IE !1110 4444 %%%% !1110 4444 %%%% '\L=%%%?Z&'\%A1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?U.4445_GF?WH%%%% !1110
M 5^6=?J97Y9T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^IE
M?EG7ZF4 %%%% !1110 4444 %%%% !1110 4444 ?RQT445_H8?P6%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!_4Y1117^>9_>@4444 %%%% !
M7Y9U^IE?EG0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7ZF5^
M6=?J90 4444 %%%% !1110 4444 %%%% !1110!_+'1117^AA_!84444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% ']3E%%%?YYG]Z!1110 4444 %?
MEG7ZF5^6= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?J97Y9
MU^IE !1110 4444 %%%% !1110 4444 %%%% '\L=%%%?Z&'\%A1110 4444
M %%%% !1110 4444 %%%% !1110 4444 ?U.4445_GF?WH%%%% !1110 5^6
M=?J97Y9T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5^IE?EG7
MZF4 %%%% !1110 4444 %%%% 'D_[5G['/PO_;!T;1]$^)OB#Q-81:)<RSVC
M>&M:-FSM(JJPD(5MXPHQZ<^M>*?\.2/V3_\ HHOQ3_\ "X;_ .-5]AT4 ?'G
M_#DC]D__ **+\4__  N&_P#C5'_#DC]D_P#Z*+\4_P#PN&_^-5]AT4 ?'G_#
MDC]D_P#Z*+\4_P#PN&_^-4?\.2/V3_\ HHOQ3_\ "X;_ .-5]AT4 ?'G_#DC
M]D__ **+\4__  N&_P#C5'_#DC]D_P#Z*+\4_P#PN&_^-5]AT4 ?'G_#DC]D
M_P#Z*+\4_P#PN&_^-4?\.2/V3_\ HHOQ3_\ "X;_ .-5]AT4 ?'G_#DC]D__
M **+\4__  N&_P#C5'_#DC]D_P#Z*+\4_P#PN&_^-5]AT4 ?'G_#DC]D_P#Z
M*+\4_P#PN&_^-4?\.2/V3_\ HHOQ3_\ "X;_ .-5]AT4 ?'G_#DC]D__ **+
M\4__  N&_P#C5'_#DC]D_P#Z*+\4_P#PN&_^-5]AT4 ?'G_#DC]D_P#Z*+\4
M_P#PN&_^-4?\.2/V3_\ HHOQ3_\ "X;_ .-5]AT4 ?'G_#DC]D__ **+\4__
M  N&_P#C5'_#DC]D_P#Z*+\4_P#PN&_^-5]AT4 ?'G_#DC]D_P#Z*+\4_P#P
MN&_^-4?\.2/V3_\ HHOQ3_\ "X;_ .-5]AT4 ?'G_#DC]D__ **+\4__  N&
M_P#C5'_#DC]D_P#Z*+\4_P#PN&_^-5]AT4 ?'G_#DC]D_P#Z*+\4_P#PN&_^
M-4?\.2/V3_\ HHOQ3_\ "X;_ .-5]AT4 ?'G_#DC]D__ **+\4__  N&_P#C
M5'_#DC]D_P#Z*+\4_P#PN&_^-5]AT4 ?'G_#DC]D_P#Z*+\4_P#PN&_^-4?\
M.2/V3_\ HHOQ3_\ "X;_ .-5]AT4 ?'G_#DC]D__ **+\4__  N&_P#C5'_#
MDC]D_P#Z*+\4_P#PN&_^-5]AT4 ?'G_#DC]D_P#Z*+\4_P#PN&_^-4?\.2/V
M3_\ HHOQ3_\ "X;_ .-5]AT4 ?'G_#DC]D__ **+\4__  N&_P#C5'_#DC]D
M_P#Z*+\4_P#PN&_^-5]AT4 ?'G_#DC]D_P#Z*+\4_P#PN&_^-4?\.2/V3_\
MHHOQ3_\ "X;_ .-5]AT4 ?'G_#DC]D__ **+\4__  N&_P#C5'_#DC]D_P#Z
M*+\4_P#PN&_^-5]AT4 ?'G_#DC]D_P#Z*+\4_P#PN&_^-4?\.2/V3_\ HHOQ
M3_\ "X;_ .-5]AT4 ?'G_#DC]D__ **+\4__  N&_P#C5'_#DC]D_P#Z*+\4
M_P#PN&_^-5]AT4 ?'G_#DC]D_P#Z*+\4_P#PN&_^-4?\.2/V3_\ HHOQ3_\
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M^"A/['O[07CF/X9_#'XR13>(;BW,]GHNLZ+?:3<WD8&2]O'?00M<  %B8PW
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@H **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>tnet-20240331_g8.jpg
<TEXT>
begin 644 tnet-20240331_g8.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC_P4:\!>&O&G[)WB;4-;L8GNM$@COM+NG0;[>59$!VGMN4LA'<-["O//V6/
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M[)_QB\4_LQR7WB6\_8R\3^)_%6HRN;CQ)>W-Q%(L;')2-#9N4R<EFW%G)Y.
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MC HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;N]5\'0W-CJ&FLBZIH]]M\V#?G:ZLIPZ-M8!A@Y4Y XS\E?#?XL_MM?\$_\
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MBBOICY8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[7]H?@V-\;OJF,J4/J%^23C?VMKV;5[>S/ZD**_EOHKI_P"($_\ 4Q_\H_\
MW4YO^([?]2[_ ,K?_<C^I"BOY;Z*/^($_P#4Q_\ */\ ]U#_ (CM_P!2[_RM
M_P#<C^I"BOYN/V,_^3P/A3_V4K0O_3A!7](]?F_'/!?^I>*HT?;^U]HF[\O+
M:SM_-*_X'Z1P-QI_KIA:U;V'LO9M*W-S7NK_ ,L;?B%%%%?"GW045_.5^WS_
M ,GP?%[_ +*3K7_I;+7DE?O."\$?K>#IU_K]N>*E;V5[72=K^T/P;&^-WU3&
M5*'U"_))QO[6U[-J]O9G]2%%?RWT5T_\0)_ZF/\ Y1_^ZG-_Q';_ *EW_E;_
M .Y']2%%?RWT4?\ $"?^IC_Y1_\ NH?\1V_ZEW_E;_[D?U(45_-Q^QG_ ,G@
M?"G_ +*5H7_IP@K^D>OS?CG@O_4O%4:/M_:^T3=^7EM9V_FE?\#](X&XT_UT
MPM:M[#V7LVE;FYKW5_Y8V_$****^%/N@HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#^<K]OG_D^#XO?]E)UK_TMEKR2O6_V^?^3X/B]_V4G6O_ $MEKR2O
M[RR;_D3X?_KW#_TE'\&YS_R.,1_U\G_Z4PHHHKTCS0HHHH ])_8S_P"3P/A3
M_P!E*T+_ -.$%?TCU_-Q^QG_ ,G@?"G_ +*5H7_IP@K^D>OYO\<O^1G@_P#!
M+_TI'](>!O\ R+,9_CC_ .DL****_"S]T/YROV^?^3X/B]_V4G6O_2V6O)*]
M;_;Y_P"3X/B]_P!E)UK_ -+9:\DK^\LF_P"1/A_^O</_ $E'\&YS_P CC$?]
M?)_^E,****](\T**** /2?V,_P#D\#X4_P#92M"_].$%?TCU_-Q^QG_R>!\*
M?^RE:%_Z<(*_I'K^;_'+_D9X/_!+_P!*1_2'@;_R+,9_CC_Z2PHHHK\+/W0*
M*** "BBOFO\ X*W^ OBM\2OV%/$WA/X3>&];UR636]!F\3^'?#)?^T=9\/1:
MQ9RZO8VP1E9Y)=/2Z3RU(:4,T:Y+@$ ^E**_*CP-<>,O G@/XE_LF_LY^#/$
M?P@\%?M#?%=K+X.:%XBT6?0KKP3X,MM"L/\ A+/$$5A>*DNEVPD6\^S1R+%M
MNKVW<(JR\_HK^R_XV_9A\6_!K1]'_9!^(G@WQ%X&\,6D6A:1)X&U^VU&PL8[
M6)(TM1+;R.H,:!!M)R!C/6@#T*BBB@ HHHH **** "BO@"S_ ."GWQG^+W_!
M7_X8_LW_  8LK./X#ZM%XTT:\\3O;)))XKU_1+2WDO/LKL"5L[2:XBMQ+&0)
MITNERRQ*3SOQ&_;Q_:NT?]J'Q5XNTOX\6=EI'A+]K#PO\([/X#OX?T]SK&CZ
ME;Z89M6:X:/[<+IAJ$]U"8Y%MUAL2&CD^=U /TAHKP#]F#XV_$[]I7]HSXH?
M$/1?$WE_!_PC?CP7X/L([*$KKNM64K_VQJWGE/-,44Y&G1HKB,O9W3E6W1LO
MO] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_.5
M^WS_ ,GP?%[_ +*3K7_I;+7DE>M_M\_\GP?%[_LI.M?^ELM>25_>63?\B?#_
M /7N'_I*/X-SG_D<8C_KY/\ ]*84445Z1YH4444 >D_L9_\ )X'PI_[*5H7_
M *<(*_I'K^;C]C/_ )/ ^%/_ &4K0O\ TX05_2/7\W^.7_(SP?\ @E_Z4C^D
M/ W_ )%F,_QQ_P#26%%%%?A9^Z'\Y7[?/_)\'Q>_[*3K7_I;+7DE>M_M\_\
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M ()H?]&U_P#EXZS_ /)E?4E%'^MO%7_0?7_\&U/_ )(/]4N%?^@"A_X*I_\
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M.OS8^#'_ "6'PG_V,MA_Z4)7Z3T %%%% !1110 4444 %%%% !1110 4444
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M@N/%O_!7S]BKPKX87S=0\.GX@>)M<:(;FL])&A+I^]_[J275[;Q@G@L..5H
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M44 %%%% !1110 4444 ?G#\?O^2X^,/^QEO?_1[UR-==\?O^2X^,/^QEO?\
MT>]<C0 4444 %%%% '2_!C_DL/A/_L9;#_TH2OTGK\V/@Q_R6'PG_P!C+8?^
ME"5^D] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '\Y7[
M?/\ R?!\7O\ LI.M?^ELM>25ZW^WS_R?!\7O^RDZU_Z6RUY)7]Y9-_R)\/\
M]>X?^DH_@W.?^1QB/^OD_P#TIA1117I'FA1110!Z3^QG_P G@?"G_LI6A?\
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MCI?B*Y@M/'$$TD2ZM//81XBUR6:Y:\2[EF61H$3S<Q$[S^PE !1110 4444
M?SE?M\_\GP?%[_LI.M?^ELM>25ZW^WS_ ,GP?%[_ +*3K7_I;+7DE?WEDW_(
MGP__ %[A_P"DH_@W.?\ D<8C_KY/_P!*84445Z1YH4444 >D_L9_\G@?"G_L
MI6A?^G""OZ1Z_FX_8S_Y/ ^%/_92M"_].$%?TCU_-_CE_P C/!_X)?\ I2/Z
M0\#?^19C/\<?_26%%%%?A9^Z!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!^</Q^_Y+CXP_[&6]_]'O7(UUWQ^_Y+CXP_[&6]_P#1
M[UR- !1110 4444 =+\&/^2P^$_^QEL/_2A*_2>OS8^#'_)8?"?_ &,MA_Z4
M)7Z3T %%%% !1110 4444 %%%% !17YR_'S_ (. /^%'?'#Q?\&?^&2_[4_X
M13Q+>Z3_ &E_PGGD?:OL\[Q>;Y?V!MF[;G;N;&<9/6N1_P"(E/\ ZLN_\R-_
M][J^]H^&/'&(HQJT\)>,DFG[2EL]5]L^"K>)W ^'K2I5,7:46TU[.KNM']@_
M4BF/!!)*D\D*,\>?+<J"5SUP>V:_+K_B)3_ZLN_\R-_][J/^(E/_ *LN_P#,
MC?\ WNK3_B%G'G_0'_Y4I?\ R9G_ ,13X#_Z#/\ RG5_^0/U(HK\M_\ B)3_
M .K+O_,C?_>ZC_B)3_ZLN_\ ,C?_ 'NH_P"(6<>?] ?_ )4I?_)A_P 13X#_
M .@S_P IU?\ Y _4BBOS<^#/_!PA_P +<^,'A3X4?\,C?V?_ ,)/XEL=)^W_
M /"?>;]F^TW"0^;L^P+OV[]VW<N<8R.M?I'7S>><-9WPW5A3S*E[-S3:]Z,K
MI:?9;_$^DR/B7).)*4ZF6U?:*#2?NRC9O7[27X!1117A'NG\Y7[?/_)\'Q>_
M[*3K7_I;+7DE?KM\?/\ @W__ .%X_'#Q?\9O^&M/[+_X2OQ+>ZM_9O\ P@?G
M_9?M$[R^5YGV]=^W=C=M7.,X'2N1_P"(:S_J]'_S'/\ ]\:_K;+/$[@?#Y;1
MI5,7:48137LZNZ23^P?R3F?ACQQB,RK5:>$O&4Y-/VE+9MM?;/RWHK]2/^(:
MS_J]'_S'/_WQH_XAK/\ J]'_ ,QS_P#?&NW_ (BGP'_T&?\ E.K_ /('%_Q"
MSCS_ * __*E+_P"3/RWHK]2/^(:S_J]'_P QS_\ ?&C_ (AK/^KT?_,<_P#W
MQH_XBGP'_P!!G_E.K_\ (!_Q"SCS_H#_ /*E+_Y,^ /V,_\ D\#X4_\ 92M"
M_P#3A!7](]?FY\&?^#>__A4?Q@\*?%?_ (:Y_M#_ (1CQ+8ZM]@_X0'ROM/V
M:X2;RM_V]MF[9MW;6QG.#TK](Z_$_%7B7).),=AJF6U?:*$9)^[*-FVG]I+\
M#]L\*N&L[X;P.)IYE2]FYRBU[T97237V6_Q"BBBOR@_5PHHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH _.'X_?\EQ\8?\ 8RWO_H]Z
MY&NN^/W_ "7'QA_V,M[_ .CWKD: "BBB@ HHHH Z7X,?\EA\)_\ 8RV'_I0E
M?I/7YL?!C_DL/A/_ +&6P_\ 2A*_2>@ HHHH **** "BBB@ HHHH _G*_;Y_
MY/@^+W_92=:_]+9:\DKUO]OG_D^#XO?]E)UK_P!+9:\DK^\LF_Y$^'_Z]P_]
M)1_!N<_\CC$?]?)_^E,****](\T**** /2?V,_\ D\#X4_\ 92M"_P#3A!7]
M(]?S<?L9_P#)X'PI_P"RE:%_Z<(*_I'K^;_'+_D9X/\ P2_]*1_2'@;_ ,BS
M&?XX_P#I+"BBBOPL_= HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\X?C]_P EQ\8?]C+>_P#H
M]ZY&NN^/W_)<?&'_ &,M[_Z/>N1H **** "BBB@#I?@Q_P EA\)_]C+8?^E"
M5^D]?FQ\&/\ DL/A/_L9;#_TH2OTGH **** "BBB@ HHHH **** /YROV^?^
M3X/B]_V4G6O_ $MEKR2O6_V^?^3X/B]_V4G6O_2V6O)*_O+)O^1/A_\ KW#_
M -)1_!N<_P#(XQ'_ %\G_P"E,****](\T**** /2?V,_^3P/A3_V4K0O_3A!
M7](]?S<?L9_\G@?"G_LI6A?^G""OZ1Z_F_QR_P"1G@_\$O\ TI'](>!O_(LQ
MG^./_I+"BBBOPL_= HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#\X?C]_R7'QA_P!C+>_^CWKD
M:Z[X_?\ )<?&'_8RWO\ Z/>N1H **** "BBB@#I?@Q_R6'PG_P!C+8?^E"5^
MD]?FQ\&/^2P^$_\ L9;#_P!*$K])Z "BBB@ HHHH **** . ^/?[4OP _9?T
M[3M6^/7Q,LO#=OJTTD6G27D4K^>Z %P!&C'@,.OK7F?_  ]J_P""=/\ T=)H
MG_@'=_\ QFO<O&/PZ^'WQ$MX+3X@>!-&UV*V<O;1:SI<5TL3$8)42*P4D=Q6
M!_PS)^S;_P!&]^!__"3L_P#XW0!^ G[7?]G?%#]JCXC_ !(\"^)=$OM%U[QO
MJFH:3>_V]:Q>?;S74CQOLDD5URK X8 C/(!KSO\ X076O^@CHG_A2V/_ ,>K
M^C__ (9D_9M_Z-[\#_\ A)V?_P ;H_X9D_9M_P"C>_ __A)V?_QNOUO#>,O%
M&%PT*$*-&T$HJ\9WLE;7]X?DF)\&N%\5B9UYUJUYMR=I0M=N^G[L_G _X076
MO^@CHG_A2V/_ ,>H_P"$%UK_ *".B?\ A2V/_P >K^C_ /X9D_9M_P"C>_ _
M_A)V?_QNC_AF3]FW_HWOP/\ ^$G9_P#QNM_^(V\5?\^:'_@-3_Y88?\ $$N%
M?^?U?_P*G_\ *S^<#_A!=:_Z".B?^%+8_P#QZC_A!=:_Z".B?^%+8_\ QZOZ
M/_\ AF3]FW_HWOP/_P"$G9__ !NC_AF3]FW_ *-[\#_^$G9__&Z/^(V\5?\
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MI-$_\ [O_P",T?\ #VK_ ()T_P#1TFB?^ =W_P#&:]3_ .&9/V;?^C>_ _\
MX2=G_P#&Z/\ AF3]FW_HWOP/_P"$G9__ !N@#RS_ (>U?\$Z?^CI-$_\ [O_
M .,T?\/:O^"=/_1TFB?^ =W_ /&:]3_X9D_9M_Z-[\#_ /A)V?\ \;H_X9D_
M9M_Z-[\#_P#A)V?_ ,;H \L_X>U?\$Z?^CI-$_\  .[_ /C-'_#VK_@G3_T=
M)HG_ (!W?_QFO4_^&9/V;?\ HWOP/_X2=G_\;H_X9D_9M_Z-[\#_ /A)V?\
M\;H \L_X>U?\$Z?^CI-$_P# .[_^,T?\/:O^"=/_ $=)HG_@'=__ !FO4_\
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M-$_\ [O_ .,T?\/:O^"=/_1TFB?^ =W_ /&:]3_X9D_9M_Z-[\#_ /A)V?\
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MC>_ _P#X2=G_ /&Z/^&9/V;?^C>_ _\ X2=G_P#&Z /RS_X:5^ ?_16M$_\
M T4?\-*_ /\ Z*UHG_@:*_4S_AF3]FW_ *-[\#_^$G9__&Z/^&9/V;?^C>_
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MH,=_2I(9H;B);BWE5XW4,CHV0P/0@CJ* '4444 %%%% !17BO_!1']LG3/\
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M+^_0Y6[N+(.+6XGW ,99(F<D9))YH _.OXC^+/B=\4%^/OCKXMVDP\9^(O\
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MZWBD6"^*X4 W"2< #H *^@+*RL]-LX=.TZTBM[>WB6.""",(D:*,*JJ.
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MD=G'G%!^U'AW0M!\+>'['PSX5TBUT_2].LXK73;"Q@6*"VMXT"1Q1HH"HBJ
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M@;4]+U&^CL;:SNB?-TQ;2W@LGB@B9%PRY5@^*F_9 ^'_ (1^/?\ P41_8_\
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L0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>tnet-20240331_g9.jpg
<TEXT>
begin 644 tnet-20240331_g9.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M='>?'+]J#XKW7_!/#PU\>_#/B%]'\1:E=6L5Y>6,:C<P>6.0A6! #&/=CMG
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_M,_]%+_ /*-9?\ QFC_ (;5_:9_Z*7_ .4:R_\ C->644 >I_\ #:O[3/\
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M HHHH **** /ZD****_S[/\ 00**** "BBB@ K\LZ_4RORSH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ K]3*_+.OU,H **** "BBB@ HHHH
M**** "BBB@ HHHH _EOHHHK_ $$/\^PHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** /ZD****_P ^S_00**** "BBB@ K\LZ_4RORSH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ K]3*_+.OU,H **** "BBB@ HHH
MH **** "BBB@ HHHH _EOHHHK_00_P ^PHHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** /ZD****_S[/\ 00**** "BBB@ K\LZ_4RORSH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ K]3*_+.OU,H **** "BBB@ H
MHHH **** "BBB@ HHHH _EOHHHK_ $$/\^PHHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** /ZD****_P ^S_00**** "BBB@ K\LZ_4RORSH ****
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M<-_\:H_X<D?LG_\ 11?BG_X7#?\ QJOL.B@#X\_X<D?LG_\ 11?BG_X7#?\
MQJC_ (<D?LG_ /11?BG_ .%PW_QJOL.B@#X\_P"')'[)_P#T47XI_P#A<-_\
M:H_X<D?LG_\ 11?BG_X7#?\ QJOL.B@#X\_X<D?LG_\ 11?BG_X7#?\ QJC_
M (<D?LG_ /11?BG_ .%PW_QJOL.B@#X\_P"')'[)_P#T47XI_P#A<-_\:H_X
M<D?LG_\ 11?BG_X7#?\ QJOL.B@#X\_X<D?LG_\ 11?BG_X7#?\ QJC_ (<D
M?LG_ /11?BG_ .%PW_QJOL.B@#X\_P"')'[)_P#T47XI_P#A<-_\:H_X<D?L
MG_\ 11?BG_X7#?\ QJOL.B@#X\_X<D?LG_\ 11?BG_X7#?\ QJC_ (<D?LG_
M /11?BG_ .%PW_QJOL.B@#X\_P"')'[)_P#T47XI_P#A<-_\:H_X<D?LG_\
M11?BG_X7#?\ QJOL.B@#X\_X<D?LG_\ 11?BG_X7#?\ QJC_ (<D?LG_ /11
M?BG_ .%PW_QJOL.B@#X\_P"')'[)_P#T47XI_P#A<-_\:H_X<D?LG_\ 11?B
MG_X7#?\ QJOL.B@#X\_X<D?LG_\ 11?BG_X7#?\ QJC_ (<D?LG_ /11?BG_
M .%PW_QJOL.B@#X\_P"')'[)_P#T47XI_P#A<-_\:H_X<D?LG_\ 11?BG_X7
M#?\ QJOL.B@#X\_X<D?LG_\ 11?BG_X7#?\ QJC_ (<D?LG_ /11?BG_ .%P
MW_QJOL.B@#X\_P"')'[)_P#T47XI_P#A<-_\:H_X<D?LG_\ 11?BG_X7#?\
MQJOL.B@#X\_X<D?LG_\ 11?BG_X7#?\ QJC_ (<D?LG_ /11?BG_ .%PW_QJ
MOL.B@#X\_P"')'[)_P#T47XI_P#A<-_\:H_X<D?LG_\ 11?BG_X7#?\ QJOL
M.B@#X\_X<D?LG_\ 11?BG_X7#?\ QJC_ (<D?LG_ /11?BG_ .%PW_QJOL.B
M@#X\_P"')'[)_P#T47XI_P#A<-_\:H_X<D?LG_\ 11?BG_X7#?\ QJOL.B@#
MX\_X<D?LG_\ 11?BG_X7#?\ QJC_ (<D?LG_ /11?BG_ .%PW_QJOL.B@#X\
M_P"')'[)_P#T47XI_P#A<-_\:H_X<D?LG_\ 11?BG_X7#?\ QJOL.B@#P_\
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M12)\DL+J4D7@C(!%/X^_M:VOP@^(^A? WP%\(_$7Q"\>^(=-GU.T\,>&Y;6
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MS,:3F![Y+/[3]LDLUD!S.(ON@L%(%=M\6/VUD\*_%B3X'?!+X$>*?BEXFL-
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M+PYI%MIFC6/GR2_9[2")8HH]\C,[[411N9BQQDDGF@#8HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KQG]JK]I7P9^SI?Z/;>&_AN_C+XJ
M^+HI--\"^$=(BC6_U0(1(_F3L/\ 1K*(D22S.=B#G!; /LU>*_M _P#!//\
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<0 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768228024080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Apr. 19, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TRINET GROUP, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-3359658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Park Place,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">352-5000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock par value $0.000025 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TNET<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,563,849<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000937098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768228124736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (Unaudited) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 1,264<span></span>
</td>
<td class="nump">$ 1,246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingInsuranceAndClaimsCostsProduction', window );">Insurance costs</a></td>
<td class="nump">907<span></span>
</td>
<td class="nump">852<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction', window );">Cost of providing services</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Systems development and programming</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and operating expenses</a></td>
<td class="nump">1,142<span></span>
</td>
<td class="nump">1,077<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_InterestExpenseBankFeesAndOther', window );">Interest expense, bank fees and other</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOther', window );">Interest income</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss), net of income taxes</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 88<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 1.80<span></span>
</td>
<td class="nump">$ 2.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 1.78<span></span>
</td>
<td class="nump">$ 2.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=tnet_ProfessionalServicesMember', window );">Professional service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 214<span></span>
</td>
<td class="nump">$ 205<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=tnet_InsuranceServicesMember', window );">Insurance service revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 1,050<span></span>
</td>
<td class="nump">$ 1,041<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost Of Goods And Service, Excluding Depreciation, Depletion, And Amortization, And Operating Insurance And Claims Costs, Production</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_InterestExpenseBankFeesAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Expense, Bank Fees and Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_InterestExpenseBankFeesAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest bearing assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingInsuranceAndClaimsCostsProduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Insurance and claims costs directly related to goods produced and sold, or services rendered, during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingInsuranceAndClaimsCostsProduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=tnet_ProfessionalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=tnet_ProfessionalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=tnet_InsuranceServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=tnet_InsuranceServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768228620800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 298<span></span>
</td>
<td class="nump">$ 287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Restricted cash, cash equivalents and investments</a></td>
<td class="nump">1,059<span></span>
</td>
<td class="nump">1,269<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Unbilled revenue, net</a></td>
<td class="nump">467<span></span>
</td>
<td class="nump">447<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses, net</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_OtherPayrollAssetsCurrent', window );">Other payroll assets</a></td>
<td class="nump">791<span></span>
</td>
<td class="nump">381<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,840<span></span>
</td>
<td class="nump">2,578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent', window );">Restricted cash, cash equivalents and investments, noncurrent</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsAndOtherNoncurrentAssets', window );">Investments, noncurrent</a></td>
<td class="nump">161<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use asset</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">462<span></span>
</td>
<td class="nump">462<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Software and other intangible assets, net</a></td>
<td class="nump">174<span></span>
</td>
<td class="nump">172<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">142<span></span>
</td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">3,968<span></span>
</td>
<td class="nump">3,693<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and other current liabilities</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Revolving credit agreement borrowings</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Client deposits and other client liabilities</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued wages</a></td>
<td class="nump">537<span></span>
</td>
<td class="nump">515<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent', window );">Accrued health insurance costs, net</a></td>
<td class="nump">167<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityCurrent', window );">Accrued workers' compensation costs, net</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings', window );">Payroll tax liabilities and other payroll withholdings</a></td>
<td class="nump">1,611<span></span>
</td>
<td class="nump">1,438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_InsurancePremiumsAndOtherPayables', window );">Insurance premiums and other payables</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,669<span></span>
</td>
<td class="nump">2,463<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, noncurrent</a></td>
<td class="nump">984<span></span>
</td>
<td class="nump">984<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityNoncurrent', window );">Accrued workers' compensation costs, noncurrent, net</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred taxes</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, noncurrent</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">3,825<span></span>
</td>
<td class="nump">3,615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (see Note 5)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, ($0.000025 par value per share; 20,000,000 shares authorized; no shares issued or outstanding at March&#160;31, 2024 and December&#160;31, 2023)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital', window );">Common stock and additional paid-in capital, ($0.000025 par value per share; 750,000,000 shares authorized; 50,573,176 and 50,664,471 shares issued and outstanding at March&#160;31, 2024 and December&#160;31, 2023, respectively)</a></td>
<td class="nump">996<span></span>
</td>
<td class="nump">976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(848)<span></span>
</td>
<td class="num">(896)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities &amp; stockholders' equity</a></td>
<td class="nump">$ 3,968<span></span>
</td>
<td class="nump">$ 3,693<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Payroll Tax Liabilities And Other Payroll Withholdings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collateral Paid To Insurance Carriers, Net Of Health Benefit Loss Reserves, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_InsurancePremiumsAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Insurance Premiums and Other Payables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_InsurancePremiumsAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_OtherPayrollAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Payroll Assets Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_OtherPayrollAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStocksIncludingAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of par value plus amounts in excess of par value or issuance value for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStocksIncludingAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAndOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments, and noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAndOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480632/954-210-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480602/954-210-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The noncurrent cash, cash equivalents and investments that is restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits classified as long-term; that is not expected to be released from such existing restrictions within one year of the balance sheet date or operating cycle, whichever is longer. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes noncurrent cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480632/954-210-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480602/954-210-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the noncurrent portion of the liabilities (due beyond one year; or beyond one operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768228654992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Preferred stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.000025<span></span>
</td>
<td class="nump">$ 0.000025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract', window );"><strong>Common stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.000025<span></span>
</td>
<td class="nump">$ 0.000025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="nump">750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">50,573,176<span></span>
</td>
<td class="nump">50,664,471<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">50,573,176<span></span>
</td>
<td class="nump">50,664,471<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768233689056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock and Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings (Accumulated Deficit)</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 775<span></span>
</td>
<td class="nump">$ 899<span></span>
</td>
<td class="num">$ (119)<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends Declared</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(91)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Awards effectively repurchased for required employee withholding taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="nump">825<span></span>
</td>
<td class="nump">910<span></span>
</td>
<td class="num">(83)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2023</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">976<span></span>
</td>
<td class="num">(896)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends Declared</a></td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Awards effectively repurchased for required employee withholding taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2024</a></td>
<td class="nump">$ 143<span></span>
</td>
<td class="nump">$ 996<span></span>
</td>
<td class="num">$ (848)<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768228492400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 91<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAmortizationOfDeferredCharges', window );">Amortization of deferred costs</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of ROU asset, lease modification, impairment, and abandonment</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset', window );">Unbilled revenue, net</a></td>
<td class="num">(20)<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses, net</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_IncreaseDecreaseInOtherPayrollAssets', window );">Other payroll assets</a></td>
<td class="num">(410)<span></span>
</td>
<td class="num">(180)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities', window );">Accounts payable and other liabilities</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Client deposits and other client liabilities</a></td>
<td class="num">(14)<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedSalaries', window );">Accrued wages</a></td>
<td class="nump">23<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities', window );">Accrued health insurance costs, net</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities', window );">Accrued workers' compensation costs, net</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities', window );">Payroll taxes payable and other payroll withholdings</a></td>
<td class="nump">173<span></span>
</td>
<td class="num">(80)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(122)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(95)<span></span>
</td>
<td class="num">(82)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sale and maturity of marketable securities</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Acquisitions of property and equipment and projects in process</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(91)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Awards effectively repurchased for required employee withholding taxes</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving credit agreement borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">495<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment of revolving credit agreement borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(200)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(30)<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net change in cash and cash equivalents, unrestricted and restricted</a></td>
<td class="num">(199)<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents, unrestricted and restricted:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Beginning of period</a></td>
<td class="nump">1,466<span></span>
</td>
<td class="nump">1,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">End of period</a></td>
<td class="nump">1,267<span></span>
</td>
<td class="nump">1,637<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid, net</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental schedule of noncash investing and financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividend declared, but not yet paid</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Payable for purchase of property and equipment</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_IncreaseDecreaseInOtherPayrollAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease In Other Payroll Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_IncreaseDecreaseInOtherPayrollAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedSalaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in accrued salaries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedSalaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482312/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in health care insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in employer-related costs classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due for insurance (or actual expenses) to cover the medical expenses and lost income for employees that are injured during the course of doing work-related activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAmortizationOfDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization of other deferred costs recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAmortizationOfDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768147370032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Description of Business</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TriNet Group, Inc. (TriNet, or the Company, we, our and us) provides comprehensive HCM solutions for small and medium-size businesses under both a PEO model and an HRIS services model. These HCM solutions include multi-state payroll processing and tax administration, employee benefits programs, including health insurance and retirement plans, workers' compensation insurance and claims management, employment and benefit law compliance, and other HR-related services. Through our PEO service model, we are the employer of record for certain employment-related administrative and regulatory purposes for WSEs, including:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compensation through wages and salaries,</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">certain employer payroll-related tax payments, </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">employee payroll-related tax withholdings and payments,</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">employee benefit programs, including health and life insurance, and </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">workers' compensation coverage. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our PEO clients are responsible for the day-to-day job responsibilities of the WSEs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our HRIS services model, we provide cloud-based HCM services to SMBs that allows them to manage hiring, onboarding, employee information, payroll processing, payroll tax administration, health insurance, and other benefits, from a single cloud-based software platform. We are not the co-employer or employer of record for such employees.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in one reportable segment. All of our service revenues are generated from external clients. Less than 1% of our revenue is generated outside of the U.S. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Basis of Presentation and Basis of Consolidation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial reporting and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the Rules and Regulations of the Securities and Exchange Commission. The unaudited condensed consolidated financial statements include the accounts of the Company and an entity consolidated under the variable interest model. Intercompany balances and transactions have been eliminated. Certain information and note disclosures included in our annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, that are normal and recurring in nature, necessary for fair financial statement presentation. The results of operations for the three months ended March&#160;31, 2024 are not necessarily indicative of the operating results anticipated for the full year. These financial statements should be read in conjunction with the audited Consolidated Financial Statements included in Part II, Item 8. Financial Statements and Supplementary Data of our Annual Report on Form 10-K for the year ended December&#160;31, 2023. Certain prior year amounts have been reclassified to conform to current period presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When entering into contractual arrangements with other entities, we assess whether we have a variable interest. If we determine that we have a variable interest, we then determine whether the arrangement is with a variable interest entity ("VIE"). If the arrangement is with a VIE, we assess whether we are the primary beneficiary of the VIE by identifying the most significant activities and determining who has the power over those activities and who has the obligation to absorb the majority of the losses or benefits of the VIE. We consolidate a VIE when we have the power to direct activities that most significantly affect the economic performance of the VIE and have the obligation to absorb the majority of their losses or benefits, making us the primary beneficiary. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, we assess whether any changes in our interest or relationship with the entity affect our determination of whether the entity is a VIE and, if so, whether we are the primary beneficiary.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, we created a trust ("the Trust") for the purpose of holding HRIS clients' payroll funds for the remittance to HRIS Users, tax authorities and other recipients. The Trust's assets are restricted and can only be used for payments on behalf of HRIS clients, payments on behalf of the HRIS Users, repayments of any advances from TriNet, or payments to TriNet of interest income earned on the balances of the Trust. In the event of any </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">losses, creditors to the Trust have recourse to the Trust's property and not that of TriNet overall.  The risks associated with the Trust are similar to those that currently exist for the Company such as banking losses in excess of FDIC insurance levels, interest rate and market conditions. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined that this Trust meets the definition of a variable interest entity and as the primary beneficiary we have both the power to direct the Trust&#8217;s activities that most significantly affect its performance and we have the right to receive benefits from the Trust, in the form of interest income. As a result, this Trust is consolidated into our financial statements.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2024, the Trust assumed ownership and responsibility of certain bank accounts that hold HRIS client funds and assumed the related liabilities.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the assets and liabilities of the Trust which are included in our consolidated balance sheet. These amounts on any particular date can vary due to timing of cash receipts and remittance to HRIS users and payroll tax agencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and other current liabilities</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued wages</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payroll tax liabilities and other payroll withholdings</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">98</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect certain reported amounts and related disclosures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates are based on historical experience and on various other assumptions that we believe to be reasonable from the facts available to us. Some of the assumptions are highly uncertain at the time of estimation. To the extent actual experience differs from the assumptions used, our condensed consolidated financial statements could be materially affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Revenue Recognition </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Variable Consideration and Pricing Allocation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may offer credits to our clients considered to be variable consideration. Incentive credits related to contract renewals are recorded as a reduction to revenue as part of the transaction price at contract inception and are allocated among the performance obligations based on their relative standalone selling prices. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocate the total transaction price to each performance obligation based on the estimated relative standalone selling prices of the promised services underlying each performance obligation. The transaction price for the payroll and payroll tax processing performance obligations is determined upon establishment of the contract that contains the final terms of the arrangement, including the description and price of each service purchased. The estimated service fee is determined based on observable inputs and includes the following key assumptions: target profit margin, pricing strategies including the mix of services purchased and competitive factors, and client and industry specifics.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fees for access to health benefits and workers' compensation insurance performance obligations are determined during client on-boarding and annually through the enrollment processes based on the types of benefits coverage the WSEs have elected and the applicable risk profile of the client. We estimate our service fees based on actuarial forecasts of our expected insurance premiums and loss sensitive premium costs and amounts to cover our costs to administer these programs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We require our clients to prefund payroll and related taxes and other withholding liabilities before payroll is processed or due for payment. Under the provision of our contracts with clients, we generally will process the payment of a client&#8217;s payroll only when the client successfully funds the amount required. As a result, there is no financing arrangement for the contracts. However, certain contracts to provide payroll and payroll tax processing services permit the client to pay certain payroll tax components ratably over periods of up to 12 months rather than as payroll tax is otherwise determined and due, which may be considered a significant financing arrangement under FASB ASC Topic 606 Revenue from Contracts with Customers. However, as the period between our performing the service under the contract and when the client pays for the service is less than one year, we have elected, as a practical expedient, not to adjust the transaction price.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In previous years, we created our Recovery Credits to assist in the economic recovery of our existing PEO clients and enhance our ability to retain these clients. These credits were based on the performance of our insurance costs and were recorded as a reduction to insurance services revenues and included in client deposits and other client liabilities on the balance sheets. The change in balance for the liability for credits previously accrued is the following:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.936%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(+) Accruals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(-) Distributions to clients</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at end of period</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Accrued Health Insurance Costs </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sponsor and administer a number of employee benefit plans for our PEO WSEs, including group health, dental, and vision as an employer plan sponsor under section 3(5) of the ERISA. In the three months ended March&#160;31, 2024, the majority of our group health insurance costs were related to risk-based plans. Our remaining group health insurance costs were for guaranteed-cost policies. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued health insurance costs are established to provide for the estimated unpaid costs of reimbursing the carriers for paying claims within the deductible layer in accordance with risk-based health insurance policies. These accrued costs include estimates for claims incurred but not paid. We assess accrued health insurance costs regularly based upon actuarial studies that include other relevant factors such as current and historical claims payment patterns, plan enrollment and medical trend rates. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain carrier contracts we are required to prepay our obligations for the expected claims activity for subsequent periods. These prepaid balances by agreement permit net settlement of obligations and offset the accrued health insurance costs. As of March&#160;31, 2024 and December&#160;31, 2023, prepayments and miscellaneous receivables offsetting accrued health insurance costs were $65 million and $58 million, respectively. When the prepaid amount is in excess of our recorded liability the net asset position is included in prepaid expenses. As of March&#160;31, 2024 and December&#160;31, 2023, accrued health insurance costs offsetting prepaid expenses were $71 million and $68 million, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Restricted Cash, Cash Equivalents and Investments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash, cash equivalents and investments presented on our consolidated balance sheets include:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cash and cash equivalents in Trust accounts functioning as security deposits for our insurance carriers, </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">payroll funds collected representing cash collected in advance from clients which we designate as restricted for the purpose of funding WSE and HRIS User payroll and payroll taxes and other payroll related liabilities, and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">amounts held in Trust for current and future premium and claim obligations with our insurance carriers, which amounts are held in Trust according to the terms of the relevant insurance policies and by the local insurance regulations of the jurisdictions in which the policies are in force.</span></div><div style="margin-top:11pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently issued accounting guidance</span></div><div style="margin-bottom:9pt;margin-top:10pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (&#8220;ASU 2023-09&#8221;), which will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. ASU 2023-09 will also require the Company to disaggregate its income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions. The ASU is effective for TriNet on a prospective basis for annual periods beginning after December 15, 2024. We are currently evaluating the provisions of this ASU.</span></div><div style="margin-bottom:9pt;margin-top:10pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (&#8220;ASU 2023-07&#8221;), which will require the Company to disclose segment expenses that are significant and regularly provided to the Company&#8217;s chief operating decision maker (&#8220;CODM&#8221;). In addition, ASU 2023-07 will require the Company to disclose the title and position of its CODM and how the CODM uses segment profit or loss information in assessing segment performance and deciding how to allocate resources. The ASU is effective for TriNet for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. We are currently evaluating the provisions of this ASU.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768228202384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CashCashEquivalentsAndInvestmentsTextBlock', window );">CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED</a></td>
<td class="text">CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the agreements with certain of our workers' compensation and health benefit insurance carriers, we are required to maintain collateral in Trust accounts for the benefit of specified insurance carriers and to reimburse the carriers&#8217; claim payments within our deductible layer. We invest a portion of the collateral amounts in marketable securities. We report the current and noncurrent portions of these Trust accounts as restricted cash, cash equivalents and investments on the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We require our clients to prefund their payroll and related taxes and other withholding liabilities before payroll is processed or due for payment. This prefund, for PEO customers, as well as amounts held by our statutory Trust for our HRIS Users, is included in restricted cash, cash equivalents and investments as payroll funds collected, which is designated to pay pending payrolls, payroll tax liabilities and other payroll withholdings.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also invest available corporate funds, primarily in fixed income securities which meet the requirements of our corporate investment policy and are classified as AFS.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total cash, cash equivalents and investments are summarized below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.091%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Available-for-sale marketable securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Available-for-sale marketable securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">298</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">298</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">85</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">85</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payroll funds collected</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">743</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">743</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,067&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,067&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral for health benefits claims</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">146</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral for workers' compensation claims</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trust for our HRIS Users</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other security deposits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total restricted cash, cash equivalents and investments</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">945</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,059</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,269&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments, noncurrent</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">161</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">161</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments, noncurrent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral for workers' compensation claims</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">128</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">152</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,267</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">488</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,755</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,466&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,922&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CashCashEquivalentsAndInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents and Investments [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CashCashEquivalentsAndInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768147454512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">INVESTMENTS</a></td>
<td class="text">INVESTMENTS<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our financial instruments by significant categories and fair value measurement on a recurring basis as of March&#160;31, 2024 and December&#160;31, 2023 and the amortized cost, gross unrealized gains, gross unrealized losses, fair value of our AFS investments: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Level</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Cash, Cash Equivalents and Investments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market mutual funds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">327</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">327</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">40</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">287</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">331</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">331</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">290</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AFS Investments:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">148</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">148</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">115</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agency securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">37</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">28</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">260</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">256</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">77</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">179</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of deposit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other debt securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total AFS Investments</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">493</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(5)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">488</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">246</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">242</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:20.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Level</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Cash, Cash Equivalents and Investments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market mutual funds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AFS Investments:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agency securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of deposit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other debt securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total AFS Investments</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use an independent pricing source to determine the fair value of our securities. The independent pricing source utilizes various pricing models for each asset class, including the market approach. The inputs and assumptions for the pricing models are market observable inputs including trades of comparable securities, dealer quotes, credit spreads, yield curves and other market-related data.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not adjusted the prices obtained from the independent pricing service and we believe the prices received from the independent pricing service are representative of the prices that would be received to sell the assets at the measurement date (exit price).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Company's cash equivalents and restricted cash equivalents approximate their fair values due to their short-term maturities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not have any Level 3 financial instruments recognized in our condensed consolidated balance sheets as of March&#160;31, 2024 and December&#160;31, 2023. There were no transfers between levels as of March&#160;31, 2024 and December&#160;31, 2023. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Sales and Maturities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of debt investments by contractual maturity are shown below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.171%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.330%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">One year or less</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Over one year through five years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">347</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Over five years through ten years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Over ten years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">488</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross proceeds from sales and maturities of AFS securities for the three months ended March&#160;31, 2024 and March&#160;31, 2023 are presented below. We had immaterial gross realized gains and losses from sales of investments for the first quarter of 2024 and immaterial gross realized gains for the first quarter of 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross proceeds from sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">39</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross proceeds from maturities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">66</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Fair Value of Long-Term Debt</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our 2029 Notes and 2031 Notes was obtained from a third-party pricing service and is based on observable market inputs. As such, the fair value of the senior notes is considered Level 2 in the hierarchy for fair value measurement. As of March&#160;31, 2024, our 2029 Notes and 2031 Notes were carried at their cost, net of issuance costs, and had a fair value of $449 million and $411 million, respectively. As of December&#160;31, 2023, our 2029 Notes and 2031 Notes were carried at their cost, net of issuance costs, and had a fair value of $443 million and $414 million, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 2021 Revolver is a floating rate debt. At March&#160;31, 2024 and December&#160;31, 2023, the fair value of our 2021 Revolver approximated its carrying value (exclusive of issuance costs). The fair value of our floating rate debt is estimated based on a discounted cash flow, which incorporates credit spreads, market interest rates and contractual maturities to estimate the fair value and is considered Level 3 in the hierarchy for fair value measurement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//320/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6B<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-6B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br> -Publisher SEC<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//946-320/tableOfContent<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 940<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//940-320/tableOfContent<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//942-320/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768228655248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED WORKERS' COMPENSATION COSTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock', window );">ACCRUED WORKERS' COMPENSATION COSTS</a></td>
<td class="text">ACCRUED WORKERS' COMPENSATION COSTS<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the accrued workers&#8217; compensation cost activity for the three months ended March&#160;31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total accrued costs, beginning of period</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">175</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incurred</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(12)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, end of period</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">175</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes workers' compensation liabilities on the condensed consolidated balance sheets:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:75.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, end of period</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">175</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral paid to carriers and offset against accrued costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, net of carrier collateral offset</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">171</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payable in less than 1 year<br/>(net of collateral paid to carriers of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> and $1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">at March&#160;31, 2024 and December&#160;31, 2023, respectively)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payable in more than 1 year <br/>(net of collateral paid to carriers of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> and  $4 at March&#160;31, 2024 and December&#160;31, 2023, respectively)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">120</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, net of carrier collateral offset</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">171</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Incurred claims related to prior years represent changes in estimates for ultimate losses on workers' compensation claims. For the three months ended March&#160;31, 2024, the favorable development is due to lower than expected reported claim frequency and severity for the more recent years.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2024 and December&#160;31, 2023, we had $31 million and $32&#160;million of collateral held by insurance carriers of which $4 million and $5 million, respectively, was offset against accrued workers' compensation costs as the agreements permit and are net settled of insurance obligations against collateral held.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//944-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768233739712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Contingencies </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are and, from time to time, have been and may in the future become involved in various litigation matters, legal proceedings, and claims arising in the ordinary course of our business, including disputes with our clients or various class action, collective action, representative action, and other proceedings arising from the nature of our co-employment relationship with our clients and WSEs in which we are named as a defendant. In addition, due to the nature of our co-employment relationship with our clients and WSEs, we could be subject to liability for federal and state law violations, even if we do not participate in such violations. While our agreements with our clients contain indemnification provisions related to the conduct of our clients, we may not be able to avail ourselves of such provisions in every instance. We have accrued our current best estimates of probable losses with respect to these matters, which are individually and in aggregate immaterial to our consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the outcome of the matters described above cannot be predicted with certainty, management currently does not believe that any such claims or proceedings will have a materially adverse effect on our consolidated financial position, results of operations, or cash flows. However, the unfavorable resolution of any particular matter or our reassessment of our exposure for any of the above matters based on additional information obtained in the future could have a material impact on our consolidated financial position, results of operations, or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768228443376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK BASED COMPENSATION</a></td>
<td class="text">STOCK BASED COMPENSATION<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Restricted Stock Units (RSUs)</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Time-based RSUs generally vest over a four-year term. Performance-based RSUs are subject to vesting requirements and are earned, in part, based on certain financial performance metrics as defined in the grant notice. Actual number of shares earned may range from 0% to 200% of the target award. Performance-based awards granted in 2024 and 2023 are earned based on a single-year performance period subject to subsequent multi-year time-based vesting with 50% of the shares earned vesting in one year after the performance period and the remaining shares in the year after. RSUs are generally forfeited if the participant terminates service prior to vesting.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize RSU activity for the three months ended March&#160;31, 2024:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Time-based RSUs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.174%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.030%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">of Shares</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Grant Date</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at December 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,229,202&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80.88&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">488,872&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125.52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(155,051)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,289)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83.55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at March 31, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,544,734&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.43&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance-based RSUs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.128%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.056%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Grant Date</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at December 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">223,011&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81.08&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125.65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,067)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92.53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,598)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at March 31, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">344,977&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.69&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Stock Based Compensation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock based compensation expense for stock-based awards made to our employees pursuant to our equity plans were as follows:&#160;&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.696%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of providing services</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Systems development and programming costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stock based compensation expense</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stock based compensation capitalized</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768228264848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the beginning and ending balances of our issued and outstanding common stock for the three months ended March&#160;31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.597%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares issued and outstanding, beginning balance</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">50,664,471</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,555,661&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock from vested restricted stock units</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">160,118</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135,074&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock from exercise of stock options</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,708</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,791&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(197,872)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,157,871)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Awards effectively repurchased for required employee withholding taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(59,249)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(49,701)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares issued and outstanding, ending balance</span></div></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">50,573,176</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,522,954&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Stock Repurchases </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2024, there is $409 million remaining in the total authorization of $2,715&#160;million of our ongoing stock repurchase program.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Dividends</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In February 2024, our board of directors authorized a dividend of $0.25 per share for an aggregate amount of approximately $13&#160;million paid in April 2024.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768147538384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Our ETR was 27% for the first quarter of 2024 and 2023. The increase in tax benefits related to stock-based compensation from the first quarter of 2023 was offset by an increase in non-deductible compensation in the first quarter of 2024. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are subject to tax in U.S. federal and various state and local jurisdictions, as well as Canada and India. We are open to federal and significant state income tax examinations for tax years 2018 and subsequent years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768228675200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic EPS is computed based on the weighted average shares of common stock outstanding during the period. Diluted EPS is computed based on those shares used in the basic EPS computation, plus potentially dilutive shares issuable under our equity-based compensation plans using the treasury stock method. Shares that are potentially anti-dilutive are excluded.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the computation of our basic and diluted EPS attributable to our common stock:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.158%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">91</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic EPS</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.80</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.18&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">91</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of stock options and restricted stock units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.78</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.17&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common stock equivalents excluded from income per diluted share because of their anti-dilutive effect</span></div></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768233693840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 91<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768228554368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2024 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=tnet_BurtonMGoldfieldMember', window );">Burton M Goldfield [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 23, 2024, Burton M. Goldfield, a member of the Board of Directors, adopted a new written trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (the &#8220;Goldfield Plan&#8221;). The first possible trade date under the Goldfield Plan is May 28, 2024, and the end date of the Goldfield Plan is February 28, 2025 (subject to customary exceptions), for a duration of approximately one year. The Goldfield Plan calls for the sale of an amount of shares that Mr. Goldfield could receive upon the future vesting of certain outstanding equity awards, net of any shares withheld by us to satisfy applicable taxes. The exact number of shares to be sold pursuant to the Goldfield Plan depends on the number of shares to be withheld by us on equity awards that will vest during the duration of the Goldfield Plan, among other factors. For purposes of this disclosure, without </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subtracting any shares to be withheld upon future vesting events, the aggregate number of shares currently expected to be sold pursuant to the Goldfield Plan is 74,379.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Burton M. Goldfield<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">member of the Board of Directors<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">February 23, 2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">371 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">74,379<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MtrlTermsOfTrdArrTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MtrlTermsOfTrdArrTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrSecuritiesAggAvailAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrSecuritiesAggAvailAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=tnet_BurtonMGoldfieldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=tnet_BurtonMGoldfieldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768144682976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text">We operate in one reportable segment. All of our service revenues are generated from external clients. Less than 1% of our revenue is generated outside of the U.S.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Basis of Consolidation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial reporting and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the Rules and Regulations of the Securities and Exchange Commission. The unaudited condensed consolidated financial statements include the accounts of the Company and an entity consolidated under the variable interest model. Intercompany balances and transactions have been eliminated. Certain information and note disclosures included in our annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, that are normal and recurring in nature, necessary for fair financial statement presentation. The results of operations for the three months ended March&#160;31, 2024 are not necessarily indicative of the operating results anticipated for the full year. These financial statements should be read in conjunction with the audited Consolidated Financial Statements included in Part II, Item 8. Financial Statements and Supplementary Data of our Annual Report on Form 10-K for the year ended December&#160;31, 2023. Certain prior year amounts have been reclassified to conform to current period presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When entering into contractual arrangements with other entities, we assess whether we have a variable interest. If we determine that we have a variable interest, we then determine whether the arrangement is with a variable interest entity ("VIE"). If the arrangement is with a VIE, we assess whether we are the primary beneficiary of the VIE by identifying the most significant activities and determining who has the power over those activities and who has the obligation to absorb the majority of the losses or benefits of the VIE. We consolidate a VIE when we have the power to direct activities that most significantly affect the economic performance of the VIE and have the obligation to absorb the majority of their losses or benefits, making us the primary beneficiary. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, we assess whether any changes in our interest or relationship with the entity affect our determination of whether the entity is a VIE and, if so, whether we are the primary beneficiary.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, we created a trust ("the Trust") for the purpose of holding HRIS clients' payroll funds for the remittance to HRIS Users, tax authorities and other recipients. The Trust's assets are restricted and can only be used for payments on behalf of HRIS clients, payments on behalf of the HRIS Users, repayments of any advances from TriNet, or payments to TriNet of interest income earned on the balances of the Trust. In the event of any </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">losses, creditors to the Trust have recourse to the Trust's property and not that of TriNet overall.  The risks associated with the Trust are similar to those that currently exist for the Company such as banking losses in excess of FDIC insurance levels, interest rate and market conditions. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined that this Trust meets the definition of a variable interest entity and as the primary beneficiary we have both the power to direct the Trust&#8217;s activities that most significantly affect its performance and we have the right to receive benefits from the Trust, in the form of interest income. As a result, this Trust is consolidated into our financial statements.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2024, the Trust assumed ownership and responsibility of certain bank accounts that hold HRIS client funds and assumed the related liabilities.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the assets and liabilities of the Trust which are included in our consolidated balance sheet. These amounts on any particular date can vary due to timing of cash receipts and remittance to HRIS users and payroll tax agencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and other current liabilities</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued wages</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payroll tax liabilities and other payroll withholdings</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">98</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect certain reported amounts and related disclosures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates are based on historical experience and on various other assumptions that we believe to be reasonable from the facts available to us. Some of the assumptions are highly uncertain at the time of estimation. To the extent actual experience differs from the assumptions used, our condensed consolidated financial statements could be materially affected.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Variable Consideration and Pricing Allocation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may offer credits to our clients considered to be variable consideration. Incentive credits related to contract renewals are recorded as a reduction to revenue as part of the transaction price at contract inception and are allocated among the performance obligations based on their relative standalone selling prices. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocate the total transaction price to each performance obligation based on the estimated relative standalone selling prices of the promised services underlying each performance obligation. The transaction price for the payroll and payroll tax processing performance obligations is determined upon establishment of the contract that contains the final terms of the arrangement, including the description and price of each service purchased. The estimated service fee is determined based on observable inputs and includes the following key assumptions: target profit margin, pricing strategies including the mix of services purchased and competitive factors, and client and industry specifics.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fees for access to health benefits and workers' compensation insurance performance obligations are determined during client on-boarding and annually through the enrollment processes based on the types of benefits coverage the WSEs have elected and the applicable risk profile of the client. We estimate our service fees based on actuarial forecasts of our expected insurance premiums and loss sensitive premium costs and amounts to cover our costs to administer these programs.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We require our clients to prefund payroll and related taxes and other withholding liabilities before payroll is processed or due for payment. Under the provision of our contracts with clients, we generally will process the payment of a client&#8217;s payroll only when the client successfully funds the amount required. As a result, there is no financing arrangement for the contracts. However, certain contracts to provide payroll and payroll tax processing services permit the client to pay certain payroll tax components ratably over periods of up to 12 months rather than as payroll tax is otherwise determined and due, which may be considered a significant financing arrangement under FASB ASC Topic 606 Revenue from Contracts with Customers. However, as the period between our performing the service under the contract and when the client pays for the service is less than one year, we have elected, as a practical expedient, not to adjust the transaction price.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_AccruedHealthInsuranceCostsPolicyTextBlock', window );">Accrued Health Insurance Costs</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sponsor and administer a number of employee benefit plans for our PEO WSEs, including group health, dental, and vision as an employer plan sponsor under section 3(5) of the ERISA. In the three months ended March&#160;31, 2024, the majority of our group health insurance costs were related to risk-based plans. Our remaining group health insurance costs were for guaranteed-cost policies. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued health insurance costs are established to provide for the estimated unpaid costs of reimbursing the carriers for paying claims within the deductible layer in accordance with risk-based health insurance policies. These accrued costs include estimates for claims incurred but not paid. We assess accrued health insurance costs regularly based upon actuarial studies that include other relevant factors such as current and historical claims payment patterns, plan enrollment and medical trend rates. </span></div>In certain carrier contracts we are required to prepay our obligations for the expected claims activity for subsequent periods. These prepaid balances by agreement permit net settlement of obligations and offset the accrued health insurance costs.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash, Cash Equivalents and Investments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash, cash equivalents and investments presented on our consolidated balance sheets include:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cash and cash equivalents in Trust accounts functioning as security deposits for our insurance carriers, </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">payroll funds collected representing cash collected in advance from clients which we designate as restricted for the purpose of funding WSE and HRIS User payroll and payroll taxes and other payroll related liabilities, and</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">amounts held in Trust for current and future premium and claim obligations with our insurance carriers, which amounts are held in Trust according to the terms of the relevant insurance policies and by the local insurance regulations of the jurisdictions in which the policies are in force.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently issued accounting guidance</span></div><div style="margin-bottom:9pt;margin-top:10pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (&#8220;ASU 2023-09&#8221;), which will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. ASU 2023-09 will also require the Company to disaggregate its income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions. The ASU is effective for TriNet on a prospective basis for annual periods beginning after December 15, 2024. We are currently evaluating the provisions of this ASU.</span></div><div style="margin-bottom:9pt;margin-top:10pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (&#8220;ASU 2023-07&#8221;), which will require the Company to disclose segment expenses that are significant and regularly provided to the Company&#8217;s chief operating decision maker (&#8220;CODM&#8221;). In addition, ASU 2023-07 will require the Company to disclose the title and position of its CODM and how the CODM uses segment profit or loss information in assessing segment performance and deciding how to allocate resources. The ASU is effective for TriNet for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. We are currently evaluating the provisions of this ASU.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use an independent pricing source to determine the fair value of our securities. The independent pricing source utilizes various pricing models for each asset class, including the market approach. The inputs and assumptions for the pricing models are market observable inputs including trades of comparable securities, dealer quotes, credit spreads, yield curves and other market-related data.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not adjusted the prices obtained from the independent pricing service and we believe the prices received from the independent pricing service are representative of the prices that would be received to sell the assets at the measurement date (exit price).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Company's cash equivalents and restricted cash equivalents approximate their fair values due to their short-term maturities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_AccruedHealthInsuranceCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Health Insurance Costs [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_AccruedHealthInsuranceCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768147124896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">Schedule of Assets and Liabilities in our Consolidated Balance Sheet</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the assets and liabilities of the Trust which are included in our consolidated balance sheet. These amounts on any particular date can vary due to timing of cash receipts and remittance to HRIS users and payroll tax agencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable and other current liabilities</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued wages</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payroll tax liabilities and other payroll withholdings</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">98</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Change in Balance of the Recovery Credit Unsatisfied Performance Obligation</a></td>
<td class="text">The change in balance for the liability for credits previously accrued is the following:<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.936%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(+) Accruals</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(-) Distributions to clients</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at end of period</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-9<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768254184032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock', window );">Schedule of Cash, Cash Equivalents and Investments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total cash, cash equivalents and investments are summarized below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.940%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.091%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Available-for-sale marketable securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Available-for-sale marketable securities</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">298</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">298</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">85</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">85</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payroll funds collected</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">743</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">743</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,067&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,067&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral for health benefits claims</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">146</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral for workers' compensation claims</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trust for our HRIS Users</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other security deposits</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total restricted cash, cash equivalents and investments</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">945</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">114</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,059</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,269&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investments, noncurrent</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">161</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">161</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash, cash equivalents and investments, noncurrent</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral for workers' compensation claims</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">128</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">152</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,267</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">488</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,755</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,466&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,922&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash, cash equivalents, and investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768228733840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of Financial Instruments by Significant Categories and Fair Value Measurement on a Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our financial instruments by significant categories and fair value measurement on a recurring basis as of March&#160;31, 2024 and December&#160;31, 2023 and the amortized cost, gross unrealized gains, gross unrealized losses, fair value of our AFS investments: </span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Level</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Cash, Cash Equivalents and Investments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market mutual funds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">327</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">327</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">40</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">287</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">331</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">331</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">290</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AFS Investments:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">148</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">148</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">115</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agency securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">37</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">36</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">28</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">260</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">256</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">77</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">179</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of deposit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other debt securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total AFS Investments</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">493</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(5)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">488</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">246</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">242</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:20.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.470%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value Level</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investments</span></td><td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Cash, Cash Equivalents and Investments</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Money market mutual funds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 1</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AFS Investments:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Agency securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">U.S. treasuries</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificate of deposit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other debt securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total AFS Investments</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">248&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Fair value of Debt Investments by Contractual Maturity</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of debt investments by contractual maturity are shown below:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:83.171%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.330%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">One year or less</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">113</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Over one year through five years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">347</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Over five years through ten years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Over ten years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total fair value</span></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">488</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Available-for-Sale Securities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gross proceeds from sales and maturities of AFS securities for the three months ended March&#160;31, 2024 and March&#160;31, 2023 are presented below. We had immaterial gross realized gains and losses from sales of investments for the first quarter of 2024 and immaterial gross realized gains for the first quarter of 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross proceeds from sales</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">39</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross proceeds from maturities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">66</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768228549424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED WORKERS' COMPENSATION COSTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Schedule of Activities in Liability for Unpaid Claims and Claims Adjustment Expenses</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the accrued workers&#8217; compensation cost activity for the three months ended March&#160;31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total accrued costs, beginning of period</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">175</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incurred</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Paid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(12)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, end of period</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">175</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes workers' compensation liabilities on the condensed consolidated balance sheets:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:75.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, end of period</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">175</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collateral paid to carriers and offset against accrued costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, net of carrier collateral offset</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">171</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payable in less than 1 year<br/>(net of collateral paid to carriers of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> and $1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">at March&#160;31, 2024 and December&#160;31, 2023, respectively)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payable in more than 1 year <br/>(net of collateral paid to carriers of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> and  $4 at March&#160;31, 2024 and December&#160;31, 2023, respectively)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">120</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total accrued costs, net of carrier collateral offset</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">171</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768233826048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Schedule of RSU Activity under Equity-Based Plans</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize RSU activity for the three months ended March&#160;31, 2024:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Time-based RSUs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.174%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.030%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">of Shares</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Grant Date</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at December 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,229,202&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80.88&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">488,872&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125.52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(155,051)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,289)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83.55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at March 31, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,544,734&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.43&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance-based RSUs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:67.128%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.056%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Number of Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Grant Date</span></div><div style="text-align:center"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at December 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">223,011&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81.08&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125.65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,067)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92.53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,598)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nonvested at March 31, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">344,977&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.69&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-Based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock based compensation expense for stock-based awards made to our employees pursuant to our equity plans were as follows:&#160;&#160;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.696%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of providing services</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Systems development and programming costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stock based compensation expense</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total stock based compensation capitalized</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768228282336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock', window );">Schedule of Issued and Outstanding Common Stock</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the beginning and ending balances of our issued and outstanding common stock for the three months ended March&#160;31, 2024 and 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.597%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares issued and outstanding, beginning balance</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">50,664,471</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,555,661&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock from vested restricted stock units</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">160,118</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135,074&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock from exercise of stock options</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">5,708</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,791&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(197,872)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,157,871)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Awards effectively repurchased for required employee withholding taxes</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(59,249)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(49,701)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares issued and outstanding, ending balance</span></div></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">50,573,176</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,522,954&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768144248752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted EPS Attributable to Common Stock</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the computation of our basic and diluted EPS attributable to our common stock:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.158%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">91</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Basic EPS</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.80</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.18&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">91</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive effect of stock options and restricted stock units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares of common stock outstanding</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted EPS</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.78</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.17&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common stock equivalents excluded from income per diluted share because of their anti-dilutive effect</span></div></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768233699584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepayments offsetting accrued health insurance costs</a></td>
<td class="nump">$ 65<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfExpenseAxis=us-gaap_HealthCareMember', window );">Health Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepayments offsetting accrued health insurance costs</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Non-US | Revenue | Foreign Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percent of concentration risk (less than)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=us-gaap_HealthCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=us-gaap_HealthCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768233717184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Assets and Liabilities of the Trust (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 298<span></span>
</td>
<td class="nump">$ 287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Restricted cash, cash equivalents and investments</a></td>
<td class="nump">1,059<span></span>
</td>
<td class="nump">1,269<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,840<span></span>
</td>
<td class="nump">2,578<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">3,968<span></span>
</td>
<td class="nump">3,693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and other current liabilities</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued wages</a></td>
<td class="nump">537<span></span>
</td>
<td class="nump">515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings', window );">Payroll tax liabilities and other payroll withholdings</a></td>
<td class="nump">1,611<span></span>
</td>
<td class="nump">1,438<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,669<span></span>
</td>
<td class="nump">2,463<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">3,825<span></span>
</td>
<td class="nump">$ 3,615<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Restricted cash, cash equivalents and investments</a></td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and other current liabilities</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued wages</a></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings', window );">Payroll tax liabilities and other payroll withholdings</a></td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">$ 114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Payroll Tax Liabilities And Other Payroll Withholdings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480632/954-210-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480602/954-210-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768144465712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Change in Balance of the Recovery Credit Unsatisfied Performance Obligation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_UnsatisfiedPerformanceObligationRollForward', window );"><strong>Unsatisfied Performance Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Balance at beginning of period</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_RevenueRemainingPerformanceObligationProvision', window );">(+) Accruals</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">(-) Distributions to clients</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Balance at end of period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_RevenueRemainingPerformanceObligationProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Remaining Performance Obligation, Provision</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_RevenueRemainingPerformanceObligationProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_UnsatisfiedPerformanceObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unsatisfied Performance Obligation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_UnsatisfiedPerformanceObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768144752096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 298<span></span>
</td>
<td class="nump">$ 287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">1,059<span></span>
</td>
<td class="nump">1,269<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Investments, noncurrent</a></td>
<td class="nump">161<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent', window );">Restricted cash, cash equivalents and investments, noncurrent</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestments', window );">Total</a></td>
<td class="nump">1,755<span></span>
</td>
<td class="nump">1,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CollateralbyTypeAxis=tnet_PayrollFundsCollectedMember', window );">Payroll funds collected</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">743<span></span>
</td>
<td class="nump">1,067<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CollateralbyTypeAxis=tnet_HealthBenefitClaimsCollateralMember', window );">Collateral for health benefits claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">144<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CollateralbyTypeAxis=tnet_WorkersCompensationClaimsCollateralMember', window );">Collateral for workers' compensation claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent', window );">Restricted cash, cash equivalents and investments, noncurrent</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CollateralbyTypeAxis=tnet_TrustForOurHRISUsersCollateralMember', window );">Trust for our HRIS Users</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CollateralbyTypeAxis=tnet_InsuranceCarriersSecurityDepositsMember', window );">Other security deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">298<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">945<span></span>
</td>
<td class="nump">1,154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Investments, noncurrent</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestments', window );">Total</a></td>
<td class="nump">1,267<span></span>
</td>
<td class="nump">1,466<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents | Payroll funds collected</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">743<span></span>
</td>
<td class="nump">1,067<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents | Collateral for health benefits claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents | Collateral for workers' compensation claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent', window );">Restricted cash, cash equivalents and investments, noncurrent</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents | Trust for our HRIS Users</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents | Other security deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=tnet_AvailableForSaleMarketableSecuritiesMember', window );">Available-for-sale marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Investments, noncurrent</a></td>
<td class="nump">161<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestments', window );">Total</a></td>
<td class="nump">488<span></span>
</td>
<td class="nump">456<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=tnet_AvailableForSaleMarketableSecuritiesMember', window );">Available-for-sale marketable securities | Payroll funds collected</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=tnet_AvailableForSaleMarketableSecuritiesMember', window );">Available-for-sale marketable securities | Collateral for health benefits claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=tnet_AvailableForSaleMarketableSecuritiesMember', window );">Available-for-sale marketable securities | Collateral for workers' compensation claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent', window );">Restricted cash, cash equivalents and investments, noncurrent</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=tnet_AvailableForSaleMarketableSecuritiesMember', window );">Available-for-sale marketable securities | Trust for our HRIS Users</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=tnet_AvailableForSaleMarketableSecuritiesMember', window );">Available-for-sale marketable securities | Other security deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems', window );"><strong>Restricted Cash and Cash Equivalents Items [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndInvestmentsCurrent', window );">Total restricted cash, cash equivalents and investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash and investments whose use in whole or in part is restricted for the long-term, generally by contractual agreements or regulatory requirements. For use in an unclassified balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480632/954-210-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480602/954-210-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480632/954-210-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480602/954-210-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndInvestmentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The noncurrent cash, cash equivalents and investments that is restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits classified as long-term; that is not expected to be released from such existing restrictions within one year of the balance sheet date or operating cycle, whichever is longer. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes noncurrent cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480632/954-210-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480602/954-210-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndInvestmentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CollateralbyTypeAxis=tnet_PayrollFundsCollectedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CollateralbyTypeAxis=tnet_PayrollFundsCollectedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CollateralbyTypeAxis=tnet_HealthBenefitClaimsCollateralMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CollateralbyTypeAxis=tnet_HealthBenefitClaimsCollateralMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CollateralbyTypeAxis=tnet_WorkersCompensationClaimsCollateralMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CollateralbyTypeAxis=tnet_WorkersCompensationClaimsCollateralMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CollateralbyTypeAxis=tnet_TrustForOurHRISUsersCollateralMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CollateralbyTypeAxis=tnet_TrustForOurHRISUsersCollateralMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CollateralbyTypeAxis=tnet_InsuranceCarriersSecurityDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CollateralbyTypeAxis=tnet_InsuranceCarriersSecurityDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=tnet_AvailableForSaleMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=tnet_AvailableForSaleMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768136906304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENTS - Schedule of Financial Instruments by Significant Categories and Fair Value Measurement on a Recurring Basis (Details) - Fair Value Measurement on a Recurring Basis - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="nump">$ 331<span></span>
</td>
<td class="nump">$ 190<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">493<span></span>
</td>
<td class="nump">457<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">488<span></span>
</td>
<td class="nump">456<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">246<span></span>
</td>
<td class="nump">208<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Restricted Cash, Cash Equivalents and Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="nump">290<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">242<span></span>
</td>
<td class="nump">248<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities | Level 2 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities | Level 2 | Restricted Cash, Cash Equivalents and Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds | Level 2 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds | Level 2 | Restricted Cash, Cash Equivalents and Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency securities | Level 2 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency securities | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Agency securities | Level 2 | Restricted Cash, Cash Equivalents and Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasuries | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">260<span></span>
</td>
<td class="nump">231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">256<span></span>
</td>
<td class="nump">231<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasuries | Level 2 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasuries | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasuries | Level 2 | Restricted Cash, Cash Equivalents and Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">179<span></span>
</td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificate of deposit | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificate of deposit | Level 2 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificate of deposit | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificate of deposit | Level 2 | Restricted Cash, Cash Equivalents and Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other debt securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other debt securities | Level 2 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other debt securities | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other debt securities | Level 2 | Restricted Cash, Cash Equivalents and Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market mutual funds | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="nump">327<span></span>
</td>
<td class="nump">183<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market mutual funds | Level 1 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market mutual funds | Level 1 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember', window );">Money market mutual funds | Level 1 | Restricted Cash, Cash Equivalents and Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="nump">287<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasuries | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasuries | Level 2 | Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasuries | Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasuries | Level 2 | Restricted Cash, Cash Equivalents and Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents:</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_InvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_InvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768147381200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENTS - Schedule of Fair value of Debt Investments by Contractual Maturity (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">One year or less</a></td>
<td class="nump">$ 113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Over one year through five years</a></td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">Over five years through ten years</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Over ten years</a></td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate', window );">Total fair value</a></td>
<td class="nump">$ 488<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768234043360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss', window );">AFS securities, gross realized gain (loss)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tnet_A2029NotesPayableMember', window );">2029 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableFairValueDisclosure', window );">Fair value of notes payable</a></td>
<td class="nump">449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 443<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tnet_A2031NotesPayableMember', window );">2031 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableFairValueDisclosure', window );">Fair value of notes payable</a></td>
<td class="nump">$ 411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 414<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of notes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20,22)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=tnet_A2029NotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=tnet_A2029NotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=tnet_A2031NotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=tnet_A2031NotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768141561936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENTS - Schedule of Available-for-Sale Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Gross proceeds from sales</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Gross proceeds from maturities</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Total</a></td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768233807296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Loss Reserve Activity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments', window );">Total accrued costs, beginning of period</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract', window );"><strong>Incurred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current year</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior years</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total incurred</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Paid</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Current year</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Prior years</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total paid</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments', window );">Total accrued costs, end of period</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 187<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -SubTopic 40<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -SubTopic 40<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of adjustments to the estimated reserve for unpaid claims and claims adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -SubTopic 40<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768228220048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments', window );">Total accrued costs, end of period</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 187<span></span>
</td>
<td class="nump">$ 189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral', window );">Collateral paid to carriers and offset against accrued costs</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent', window );">Total accrued costs, net of carrier collateral offset</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityCurrent', window );">Payable in less than 1 year&#8232;(net of collateral paid to carriers of $1 and $1 at March&#160;31, 2024 and December&#160;31, 2023, respectively)</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityNoncurrent', window );">Payable in more than 1 year &#8232;(net of collateral paid to carriers of $3 and $4 at March&#160;31, 2024 and December&#160;31, 2023, respectively)</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent', window );">Total accrued costs, net of carrier collateral offset</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent', window );">Net of collateral paid to carriers, payable in less than one year</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent', window );">Net of collateral paid to carriers, payable in more than 1 year</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collateral Paid to Insurance Carriers, Net of Workers' Compensation Loss Reserves, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collateral Paid To Insurance Carriers, Net Of Workers' Compensation Loss Reserves, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability for Unpaid Claims and Claims Adjustment Expense, Collateral</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of adjustments to the estimated reserve for unpaid claims and claims adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the noncurrent portion of the liabilities (due beyond one year; or beyond one operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768146950352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCRUED WORKERS' COMPENSATION COSTS - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_CollateralHeldByInsuranceCarriers', window );">Collateral held by insurance carriers</a></td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral', window );">Collateral paid to carriers and offset against loss reserves</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_CollateralHeldByInsuranceCarriers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collateral Held by Insurance Carriers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_CollateralHeldByInsuranceCarriers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability for Unpaid Claims and Claims Adjustment Expense, Collateral</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tnet_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768233697152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2024</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=tnet_TimeBasedRestrictedStockUnitsMember', window );">Time-Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=tnet_TimeBasedRestrictedStockUnitsMember', window );">Time-Based Restricted Stock Units | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Percent of share value</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=tnet_TimeBasedRestrictedStockUnitsMember', window );">Time-Based Restricted Stock Units | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Percent of share value</a></td>
<td class="nump">200.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember', window );">Performance-based RSUs and RSAs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Performance period for 2024 and 2023 awards</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember', window );">Performance-based RSUs and RSAs | Share-based Payment Arrangement, Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Amount of shares that are expected to vesting percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=tnet_TimeBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=tnet_TimeBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768228448272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION - Schedule of RSU and RSA Activity under Equity-Based Plans (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=tnet_TimeBasedRestrictedStockUnitsMember', window );">Time-Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance (in shares) | shares</a></td>
<td class="nump">1,229,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">488,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(155,051)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(18,289)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance (in shares) | shares</a></td>
<td class="nump">1,544,734<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 80.88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">125.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">76.36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">83.55<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 95.43<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=tnet_PerformanceBasedRestrictedStockUnitsMember', window );">Performance-Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance (in shares) | shares</a></td>
<td class="nump">223,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">129,631<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(5,067)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(2,598)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance (in shares) | shares</a></td>
<td class="nump">344,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 81.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">125.65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">92.53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">77.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 97.69<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=tnet_TimeBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=tnet_TimeBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=tnet_PerformanceBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=tnet_PerformanceBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768228280960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock based compensation expense</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount', window );">Total stock based compensation capitalized</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of providing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock based compensation expense</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock based compensation expense</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock based compensation expense</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=tnet_SystemsDevelopmentAndProgrammingCostsMember', window );">Systems development and programming costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock based compensation expense</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=tnet_SystemsDevelopmentAndProgrammingCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=tnet_SystemsDevelopmentAndProgrammingCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768259524384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Schedule of Common Stock (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Shares issued and outstanding, beginning balance (in shares)</a></td>
<td class="nump">50,664,471<span></span>
</td>
<td class="nump">60,555,661<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares issued and outstanding, beginning balance (in shares)</a></td>
<td class="nump">50,664,471<span></span>
</td>
<td class="nump">60,555,661<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (in shares)</a></td>
<td class="num">(197,872)<span></span>
</td>
<td class="num">(1,157,871)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Awards effectively repurchased for required employee withholding taxes (in shares)</a></td>
<td class="num">(59,249)<span></span>
</td>
<td class="num">(49,701)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Shares issued and outstanding, ending balance (in shares)</a></td>
<td class="nump">50,573,176<span></span>
</td>
<td class="nump">59,522,954<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Shares issued and outstanding, ending balance (in shares)</a></td>
<td class="nump">50,573,176<span></span>
</td>
<td class="nump">59,522,954<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Issuance of common stock from vested restricted stock units (in shares)</a></td>
<td class="nump">160,118<span></span>
</td>
<td class="nump">135,074<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock from exercise of stock options (in shares)</a></td>
<td class="nump">5,708<span></span>
</td>
<td class="nump">39,791<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768147576432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock repurchase program, remaining authorized repurchase amount</a></td>
<td class="nump">$ 409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="nump">$ 2,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableAmountPerShare', window );">Dividends authorized (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividends authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableAmountPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The per share amount of a dividend declared, but not paid, as of the financial reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableAmountPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 405<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480191/946-405-45-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768228741440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm139768233920560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted EPS Attributable to Common Stock (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income</a></td>
<td class="nump">$ 91<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares of common stock outstanding (in shares)</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic EPS (in dollars per share)</a></td>
<td class="nump">$ 1.80<span></span>
</td>
<td class="nump">$ 2.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income</a></td>
<td class="nump">$ 91<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of stock options and restricted stock units (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares of common stock outstanding - diluted (in shares)</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted EPS (in dollars per share)</a></td>
<td class="nump">$ 1.78<span></span>
</td>
<td class="nump">$ 2.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Common stock equivalents excluded from income per diluted share because of their anti-dilutive effect (in shares)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480454/718-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-28A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>79
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MBS/8E^MRI&B'QV^E?OMN_?[$ 9Q%E;VV5RF,U:I5?4%J[IW;QL"7Z7&V4"]
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M3*"_Y(!%MH'2&G*E-30+7D]AZ++^.*(^46)7?5_P()02674(%3E(U@9P?2V
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M6,MV+[]V-YRN\K<[3Y1SFN272XS$""P-Q.\+2OG;C7QA5+R"'/\#4$L#!!0
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M^(,/-F9MRLZ(@A?@H&&+9 [,]]8T)9*?-X(#]0L%:0B^5,?_$7;R.RCKDO6
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M;A$Z4$]F'7D4)U8*:FNRL+P37Z9R:,$"T6XI&J_;4&_<"[,=Q:[0A.I[(2B
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M&1Y]<%\3R\-%A9)+Z2ID#8)BUC<QY3I=Z&[T)9*>4\D13?WXN>2[>',[N;6
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MV!6!C%[ \WE5M>$/.B#^P/;=_P%02P,$%     @ Y4.:6/$H, U9!0  WPT
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M,VDWAZW#Y9_+;E0!?+5'J,44*1C8J4R(8E<$'D\ _VF/;8VUH[1BBHYCUT@
M-**Z9LV0_R?"[7PT4WM'7.PY!YB PE2K\*ED;$2-:0:2O/9;SN\\R]"[6@X^
MY'3!W-L^EQL0F'FIZ=[*,.K%6$P%LQ2G-F8-QLJCQZY<0]Q!;#TJ772=].9Q
M1'-$4X<C N/*I)8]5ZQR.6@/CN'2LY\IA9+ C?6=]?G:;;<X&%9:"IL\DG&S
M]BZ5N66_NI_Z+LJP\W%[&1DQ'&S06+@H:I@NCWY^-A.AC&'E)?DNCSZ53QBD
M\F.#R94";\#WVOLTO;"#_2R\_A=02P,$%     @ Y4.:6'P;IA0(!0  ? L
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M+7EJEIVPK;E60/?M!L$4@G'L^DGT$RS<HTRYLM+N6#2F&RF(W<2?PGCF)K,
M;K!I*1],_1_F73!+W&D2OJ>5&\1F';R'U8[)C'*YW:)M:^4#\3U@9#;Q$JGF
M)6VP:DKQ0$G=<5T4HLRZ.]]3(M_%,S>,9H0=$1&?@'^2X:?%8-(;)V,W2"9
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M\5$:!9)OA="'C7$P_(=8_@!02P,$%     @ Y4.:6,DNS(3G @  708  !D
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M^F- PQ?HO-!4.-V"%?3_(/,_ %!+ P04    " #E0YI8I)LS0#L"  "4!0
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MT@:8^YT0^KBQ"89!G/T&4$L#!!0    ( .5#FE@(&IK2_00  *T/   9
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MKL65JEQ=.N--U<H7]4)]MI6N,JL+-<.7!H[;>O4_9W/?.GC>_^ZRD CP?+<
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M JK?39E8CW@I"_* -4&2!IRS W\AS> XUJ_*0-]#GT\V3Y@R_@(:^,"6Z+"
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M,&7Z4N:8T<Q&JI09^E3;MLX5LM@YI:+=ZW1NVBGCF3<>NK&%&@]E803/<*%
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M!_V^YMRW>P,XH_RP57[XV\I?*!X_-RJ?\9SZDV3FBK]]T6,\)?JSZ*=%;]Q
MG:/XV W6;HS2I8FE-F)[)A))MW-"ZN? *P&8EQE_1<ID60E9Z=P=5DRM0JFK
M%/8H$)AL:DQ299CB.;Y'C\[X,BVH%609Q2*OZA,W:9YQJ?3YE(+OTD17JF:2
MQN3] K0" U@P7;FL2"A*\8Q*&Y$^X!,6I*_,K+"$^DRJ;T#=,$D<$,+BE5*=
M2^IW.^KCI;DFM2VYV@B6YQHG)O<22$V-F.6OSN^"PJ:']\L-,2M3,J"K)M'V
MYG=*4\Y1'\Q1;$RWEX15%:INB>W;]H-B4O?1G^;UUPB=]B:ES&2XIJVNW2<!
MB;K#UQ/%2]-55UQ1CS;#+7T4H= &M+[F7!TFVD'[F37^ 5!+ P04    " #E
M0YI861@"0D #   >!P  &0   'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6R%
M56UOXS8,_BN$!]Q:P*C?XZ1+ K2]#E?<#NTUN0W#L ^*3<=";<LGR77[[T?)
MB2_%TMR7A!3)AP\IBI[W0CZI$E'#2UTU:N&46K>7GJ>R$FNF+D2+#5D*(6NF
M295;3[4266Z#ZLH+?7_BU8PWSG)NSQ[D<BXZ7?$&'R2HKJZ9?+W&2O0+)W#V
M!X]\6VISX"WG+=OB"O6W]D&2YHTH.:^Q45PT(+%8.%?!Y75L_*W#GQQ[=2"#
MJ60CQ)-1[O*%XQM"6&&F#0*COV>\P:HR0$3C^P[3&5.:P$-YC_Z[K9UJV3"%
M-Z+ZB^>Z7#A3!W(L6%?I1]%_PET]B<'+1*7L+_2#;TS.6:>TJ'?!Q*#FS?#/
M7G9]. B8^N\$A+N T/(>$EF6'YEFR[D4/4CC36A&L*7::"+'&W,I*RW)RBE.
M+U?K^YO/G^[_^'C[N/H5;K]^NUO_#6=KMJE0G<\]32F,HY?MX*X'N/ =N B^
MB$:7"FZ;'/.W\1Y1&_F%>W[7X4G +TQ>0!2X$/IA? (O&NN-+%[T#M[M]X[K
M5_CG:J.TI)'X]UB- T1\',(\DTO5L@P7#KT#A?(9G>6'7X*)_]L)@O%(,#Z%
MOES1L\N["D$4<*=4ASFP)H?[3BM- F^V<"/JF@9ZI47V=(S^R03'Z:]+A$)4
M]$1- FVN'U0I>@6:+!O<\J8Q%D,%!Q8;5K$F0V6(BDX"_T%6')#-!K+*D*44
MT@+J4B)"/8P*FE$!NNBL'&_:PI 07<+:^AZ.U>!AK+ J&=7P3F[W@/B.+22^
M.YG$;IP&,/'=)$E(#6RCK9EJ>4M8BAJ>46E"IT1:\LR(@[%KN%9 ]^X&P12"
M*'']-/X)%KZ@S+BRUN%8M&8]*4C<U)]"-'/360"/V';4#Z;^#W,6S%)WFH;G
M)+E!8N3@'*YZ)G/J95&@W7/5*_'=8^2V\1)I]B4I6+>5>*6F]ER7I:CRX<Y?
MJ)%GR<P-XQEAQT3$)^"?=/CM,)CV)FGD!ND$""D)0W>6Q'#L67@'.ZM&N;6;
M65&I7:.']36>CLO_:MAY/]R'+P>-#EVS@@H+"O4OTL0!.6SC0=&BM1MP(S3M
M4RN6] %#:1S(7@BA]XI),'X2E_\!4$L#!!0    ( .5#FEB,58]1*P,  %@'
M   9    >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;*U52V_;.!#^*P.U*%J@
MM1YV$F]J&[!3M^FA@6&GV\-B#[0TLHA0I$I2<?;?[Y"45:=P?-F]B"(Y\\TW
M3T[V2C^8"M'"4RVDF4:5M<UU')N\PIJ9@6I0TDVI=,TL;?4N-HU&5GBE6L19
MDES&->,RFDW\V4K/)JJU@DM<:3!M73/]SP*%VD^C-#H<K/FNLNX@GDT:ML,-
MVN_-2M,N[E$*7J,T7$G06$ZC>7J]&#EY+_ GQ[TY^@?GR5:I![?Y6DRCQ!%"
M@;EU"(R61[Q!(1P0T?C984:]2:=X_'] _^Q])U^VS."-$C]X8:MI-(Z@P)*U
MPJ[5_A8[?RX<7JZ$\5_8!]DK$LY;8U7=*1.#FLNPLJ<N#D<*X^0%A:Q3R#SO
M8,BS_,0LFTVTVH-VTH3F?KRK7IO(<>F2LK&:;CGIV=EROK[[>O=E ZOE&C:W
M\_42WMZSK4#S;A);,N#$XKP#6P2P[ 6P(7Q3TE8&EK+ XKE^3,1Z=MF!W2([
M"_B-Z0$,T_>0)=GH#-ZP]W;H\88O><NTY')G8(4:-A73"'_-M\9J*HZ_3_D;
MX$:GX5S#7)N&Y3B-J",,ZD>,9F]>I9?)QS-D1SW9T3GTV88:L&@%@BKA1M5-
M:YDO9-HNF.$Y,%G )RY:BP4L5QN86ZOYEL0H?6"54ZI)?F-5_G#*N;/F3SMW
M7R&42E K4Q@A6/*WTAJP=)D_)ZI:WS0=V>*(+/N-K)/, V'C"%_#?:41GU44
MO.62FD (0C?O 9]R;"PTE$OC<UE0![SSM>(^0[BCH<8EH2*\AC]2^J3#%'[X
M3B4T]HB:!D]0-H[N,0%B9(TEVL[3BQ0NDR[LCCTA#<8)+=D@'?_O=GQ2:5@!
MEB5-+Z?1B38NL,8'DZ H@KDS$"Y;R2D);UZ-LS3[V*__D467+>?OU3CX>W4H
MK*"(/UO^R(2O ,J(:%VB2JWJ0TA<?@Z9#WG:8LY:XPN;:H9K\L?R#\5O7J>0
MP:DVBH^F78UZYV>Z(6]::</@ZT_[9V,>IN4O\?#FT'S9<8JGP))4D\'5100Z
MS/&PL:KQLW.K+$UB_UO1TX?:"=!]J90];)R!_C&=_0M02P,$%     @ Y4.:
M6'?Q%[)Z P  50P  !D   !X;"]W;W)K<VAE971S+W-H965T,C8N>&ULO5==
M;Z,X%/TK5^QHU4H[A4#ST6Z"E)!V!FF:1J79?5CM@P,W 17LC&V2&6E__-A
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MG%TN"9X3G@:H_Q>,R;>;]#5?\5IW\!]02P,$%     @ Y4.:6-X0?@ 0 P
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M0=9,3\7V,^[\M"Q?(IARO[#=Q=8\2-9*BWP'-@IRRHLG^;W+PP' \%0#ZCM
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M*&UJ7&HG='KC-V) ,ZV@:1!J>8HB$M[(R^&M0['3WDOG<7T-7",2UTAON$9
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ME6Z4[##3K2D*LT$_7W&N#A/CH&YV)_\ 4$L#!!0    ( .5#FEAF6QOF4P0
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M,%5!OI]3*EX*JH/F5&SX'U!+ P04    " #E0YI8!$QH3]X#   K$@  &0
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MP%E.+5,<MX%) ?P^IU2L-])!-\"'_P%02P,$%     @ Y4.:6*W *9R] @
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MVFX1>U&HMLM!0ERXR:2QUK&#[33E[?$A#=U56KC@IK&=^;_,/_5,W'+Q($L
MA0X593+Q2J7JJ>_+K(0*RQ&O@>DW!1<55GHK=KZL!>#<BBKJAT%PY5>8,"^-
M[=E:I#%O%"4,U@+)IJJP^#4'RMO$&WO'@SNR*Y4Y\-.XQCO8@/I<KX7>^3TE
M)Q4P23A# HK$FXVGBXF)MP%?"+3R9(V,DRWG#V9SFR=>8!(""IDR!*P?>U@
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
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MS[H_1_-/4$L! A0#%     @ Y4.:6 =!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #E0YI8&:="X>\
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M=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ Y4.:6.LM?3F>!P
MKB(  !@              ("!_1,  'AL+W=O<FMS:&5E=',O<VAE970S+GAM
M;%!+ 0(4 Q0    ( .5#FEB;33M]"0,  $<+   8              " @=$;
M  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " #E0YI86Y<F
M@D0%  ".'   &               @($0'P  >&PO=V]R:W-H965T<R]S:&5E
M=#4N>&UL4$L! A0#%     @ Y4.:6/-!@G #"   PR0  !@
M ("!BB0  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( .5#
MFEA#$^"#,Q4  &P[   8              " @<,L  !X;"]W;W)K<VAE971S
M+W-H965T-RYX;6Q02P$"% ,4    " #E0YI8\2@P#5D%  #?#0  &
M        @($L0@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%
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M+GAM;%!+ 0(4 Q0    ( .5#FE@D''F=V ,  $\(   9              "
M@?E>  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ Y4.:
M6,DNS(3G @  708  !D              ("!"&,  'AL+W=O<FMS:&5E=',O
M<VAE970Q-"YX;6Q02P$"% ,4    " #E0YI8XH?FA8@#  "/"   &0
M        @($F9@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0
M   ( .5#FEBDFS- .P(  )0%   9              " @>5I  !X;"]W;W)K
M<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ Y4.:6 @:FM+]!   K0\
M !D              ("!5VP  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q0
M2P$"% ,4    " #E0YI8JNO/FGL3   9-P  &0              @(&+<0
M>&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( .5#FEC8>E[B
M3@0  ,,)   9              " @3V%  !X;"]W;W)K<VAE971S+W-H965T
M,3DN>&UL4$L! A0#%     @ Y4.:6.]1C!>\ P  &@D  !D
M ("!PHD  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " #E
M0YI8_&;:_*\%  !Q$0  &0              @(&UC0  >&PO=V]R:W-H965T
M<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( .5#FEA(>B6?O ,  /4(   9
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M970R-BYX;6Q02P$"% ,4    " #E0YI8_N_SJ7\$  #B%0  &0
M    @(%JI@  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    (
M .5#FEC>$'X $ ,  !0(   9              " @2"K  !X;"]W;W)K<VAE
M971S+W-H965T,C@N>&UL4$L! A0#%     @ Y4.:6'H2.;2B!P  X$$  !D
M             ("!9ZX  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"
M% ,4    " #E0YI8\QUH(-(+  "_<   &0              @(% M@  >&PO
M=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( .5#FEA?5YK$E (
M %\&   9              " @4G"  !X;"]W;W)K<VAE971S+W-H965T,S$N
M>&UL4$L! A0#%     @ Y4.:6$(=KJQ! P  YPT  !D              ("!
M%,4  'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " #E0YI8
M,M%(J;D"   0!P  &0              @(&,R   >&PO=V]R:W-H965T<R]S
M:&5E=#,S+GAM;%!+ 0(4 Q0    ( .5#FE@<O,54C0,  "P,   9
M      " @7S+  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%
M  @ Y4.:6(;UP@[Q P  31$  !D              ("!0,\  'AL+W=O<FMS
M:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " #E0YI8\GEZQ'H"  #M!0
M&0              @(%HTP  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+
M 0(4 Q0    ( .5#FE@H1<B8DP,  /@.   9              " @1G6  !X
M;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ Y4.:6&9;&^93
M!   (1,  !D              ("!X]D  'AL+W=O<FMS:&5E=',O<VAE970S
M."YX;6Q02P$"% ,4    " #E0YI8!$QH3]X#   K$@  &0
M@(%MW@  >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( .5#
MFEAI2C!P_@,  ,P/   9              " @8+B  !X;"]W;W)K<VAE971S
M+W-H965T-# N>&UL4$L! A0#%     @ Y4.:6*W *9R] @  ^@<  !D
M         ("!M^8  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4
M    " #E0YI8;R_3AT<"  "*!0  &0              @(&KZ0  >&PO=V]R
M:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( .5#FE@MQM\KN@,  &0+
M   9              " @2GL  !X;"]W;W)K<VAE971S+W-H965T-#,N>&UL
M4$L! A0#%     @ Y4.:6 DB8\4B P  $A(   T              ( !&O
M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #E0YI8EXJ[',     3 @  "P
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52P4&     #, ,P#<#0  &/P

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>168</ContextCount>
  <ElementCount>233</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>46</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTED</Role>
      <ShortName>CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - INVESTMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/INVESTMENTS</Role>
      <ShortName>INVESTMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTS</Role>
      <ShortName>ACCRUED WORKERS' COMPENSATION COSTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - STOCK BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9954471 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9954472 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9954473 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDTables</Role>
      <ShortName>CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTED</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9954474 - Disclosure - INVESTMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/INVESTMENTSTables</Role>
      <ShortName>INVESTMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.trinet.com/role/INVESTMENTS</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9954475 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSTables</Role>
      <ShortName>ACCRUED WORKERS' COMPENSATION COSTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTS</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9954476 - Disclosure - STOCK BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.trinet.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9954477 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.trinet.com/role/STOCKHOLDERSEQUITY</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9954478 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.trinet.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9954479 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9954480 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Assets and Liabilities of the Trust (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Assets and Liabilities of the Trust (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9954481 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Change in Balance of the Recovery Credit Unsatisfied Performance Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofChangeinBalanceoftheRecoveryCreditUnsatisfiedPerformanceObligationDetails</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Change in Balance of the Recovery Credit Unsatisfied Performance Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954482 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails</Role>
      <ShortName>CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954483 - Disclosure - INVESTMENTS - Schedule of Financial Instruments by Significant Categories and Fair Value Measurement on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails</Role>
      <ShortName>INVESTMENTS - Schedule of Financial Instruments by Significant Categories and Fair Value Measurement on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954484 - Disclosure - INVESTMENTS - Schedule of Fair value of Debt Investments by Contractual Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails</Role>
      <ShortName>INVESTMENTS - Schedule of Fair value of Debt Investments by Contractual Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954485 - Disclosure - INVESTMENTS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails</Role>
      <ShortName>INVESTMENTS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954486 - Disclosure - INVESTMENTS - Schedule of Available-for-Sale Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails</Role>
      <ShortName>INVESTMENTS - Schedule of Available-for-Sale Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954487 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Loss Reserve Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails</Role>
      <ShortName>ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Loss Reserve Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954488 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails</Role>
      <ShortName>ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954489 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSAdditionalInformationDetails</Role>
      <ShortName>ACCRUED WORKERS' COMPENSATION COSTS - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954490 - Disclosure - STOCK BASED COMPENSATION - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails</Role>
      <ShortName>STOCK BASED COMPENSATION - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954491 - Disclosure - STOCK BASED COMPENSATION - Schedule of RSU and RSA Activity under Equity-Based Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails</Role>
      <ShortName>STOCK BASED COMPENSATION - Schedule of RSU and RSA Activity under Equity-Based Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954492 - Disclosure - STOCK BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails</Role>
      <ShortName>STOCK BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954493 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Schedule of Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954494 - Disclosure - STOCKHOLDERS' EQUITY - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954495 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.trinet.com/role/INCOMETAXES</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="tnet-20240331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954496 - Disclosure - EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted EPS Attributable to Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails</Role>
      <ShortName>EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted EPS Attributable to Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: ecd:TrdArrDuration, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1 -  tnet-20240331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="tnet-20240331.htm">tnet-20240331.htm</File>
    <File>tnet-20240331.xsd</File>
    <File>tnet-20240331_cal.xml</File>
    <File>tnet-20240331_def.xml</File>
    <File>tnet-20240331_lab.xml</File>
    <File>tnet-20240331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>tnet-20240331_g1.jpg</File>
    <File>tnet-20240331_g10.jpg</File>
    <File>tnet-20240331_g11.jpg</File>
    <File>tnet-20240331_g12.jpg</File>
    <File>tnet-20240331_g13.jpg</File>
    <File>tnet-20240331_g14.jpg</File>
    <File>tnet-20240331_g15.jpg</File>
    <File>tnet-20240331_g16.jpg</File>
    <File>tnet-20240331_g17.jpg</File>
    <File>tnet-20240331_g18.jpg</File>
    <File>tnet-20240331_g19.jpg</File>
    <File>tnet-20240331_g2.jpg</File>
    <File>tnet-20240331_g20.jpg</File>
    <File>tnet-20240331_g21.jpg</File>
    <File>tnet-20240331_g22.jpg</File>
    <File>tnet-20240331_g23.jpg</File>
    <File>tnet-20240331_g24.jpg</File>
    <File>tnet-20240331_g25.jpg</File>
    <File>tnet-20240331_g3.jpg</File>
    <File>tnet-20240331_g4.jpg</File>
    <File>tnet-20240331_g5.jpg</File>
    <File>tnet-20240331_g6.jpg</File>
    <File>tnet-20240331_g7.jpg</File>
    <File>tnet-20240331_g8.jpg</File>
    <File>tnet-20240331_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="583">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="10">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>86
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tnet-20240331.htm": {
   "nsprefix": "tnet",
   "nsuri": "http://www.trinet.com/20240331",
   "dts": {
    "inline": {
     "local": [
      "tnet-20240331.htm"
     ]
    },
    "schema": {
     "local": [
      "tnet-20240331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "tnet-20240331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "tnet-20240331_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "tnet-20240331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tnet-20240331_pre.xml"
     ]
    }
   },
   "keyStandard": 218,
   "keyCustom": 15,
   "axisStandard": 18,
   "axisCustom": 1,
   "memberStandard": 28,
   "memberCustom": 16,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/dei/2023": 5,
    "http://fasb.org/us-gaap/2023": 1,
    "http://xbrl.sec.gov/ecd/2023": 1
   },
   "contextCount": 168,
   "entityCount": 1,
   "segmentCount": 46,
   "elementCount": 446,
   "unitCount": 5,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 583,
    "http://xbrl.sec.gov/dei/2023": 30,
    "http://xbrl.sec.gov/ecd/2023": 10
   },
   "report": {
    "R1": {
     "role": "http://www.trinet.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (Unaudited)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIES",
     "longName": "0000007 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTED",
     "longName": "0000008 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED",
     "shortName": "CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "tnet:CashCashEquivalentsAndInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "tnet:CashCashEquivalentsAndInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.trinet.com/role/INVESTMENTS",
     "longName": "0000009 - Disclosure - INVESTMENTS",
     "shortName": "INVESTMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTS",
     "longName": "0000010 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS",
     "shortName": "ACCRUED WORKERS' COMPENSATION COSTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.trinet.com/role/COMMITMENTSANDCONTINGENCIES",
     "longName": "0000011 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.trinet.com/role/STOCKBASEDCOMPENSATION",
     "longName": "0000012 - Disclosure - STOCK BASED COMPENSATION",
     "shortName": "STOCK BASED COMPENSATION",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.trinet.com/role/STOCKHOLDERSEQUITY",
     "longName": "0000013 - Disclosure - STOCKHOLDERS' EQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.trinet.com/role/INCOMETAXES",
     "longName": "0000014 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.trinet.com/role/EARNINGSPERSHARE",
     "longName": "0000015 - Disclosure - EARNINGS PER SHARE",
     "shortName": "EARNINGS PER SHARE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R17": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:Rule10b51ArrTrmntdFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:Rule10b51ArrTrmntdFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "longName": "9954471 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESTables",
     "longName": "9954472 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "shortName": "DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDTables",
     "longName": "9954473 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Tables)",
     "shortName": "CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.trinet.com/role/INVESTMENTSTables",
     "longName": "9954474 - Disclosure - INVESTMENTS (Tables)",
     "shortName": "INVESTMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSTables",
     "longName": "9954475 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS (Tables)",
     "shortName": "ACCRUED WORKERS' COMPENSATION COSTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONTables",
     "longName": "9954476 - Disclosure - STOCK BASED COMPENSATION (Tables)",
     "shortName": "STOCK BASED COMPENSATION (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.trinet.com/role/STOCKHOLDERSEQUITYTables",
     "longName": "9954477 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
     "shortName": "STOCKHOLDERS' EQUITY (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.trinet.com/role/EARNINGSPERSHARETables",
     "longName": "9954478 - Disclosure - EARNINGS PER SHARE (Tables)",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails",
     "longName": "9954479 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)",
     "shortName": "DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails",
     "longName": "9954480 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Assets and Liabilities of the Trust (Details)",
     "shortName": "DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Assets and Liabilities of the Trust (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-31",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofChangeinBalanceoftheRecoveryCreditUnsatisfiedPerformanceObligationDetails",
     "longName": "9954481 - Disclosure - DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Change in Balance of the Recovery Credit Unsatisfied Performance Obligation (Details)",
     "shortName": "DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES - Schedule of Change in Balance of the Recovery Credit Unsatisfied Performance Obligation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-9",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-9",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails",
     "longName": "9954482 - Disclosure - CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Details)",
     "shortName": "CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails",
     "longName": "9954483 - Disclosure - INVESTMENTS - Schedule of Financial Instruments by Significant Categories and Fair Value Measurement on a Recurring Basis (Details)",
     "shortName": "INVESTMENTS - Schedule of Financial Instruments by Significant Categories and Fair Value Measurement on a Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-76",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-76",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails",
     "longName": "9954484 - Disclosure - INVESTMENTS - Schedule of Fair value of Debt Investments by Contractual Maturity (Details)",
     "shortName": "INVESTMENTS - Schedule of Fair value of Debt Investments by Contractual Maturity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails",
     "longName": "9954485 - Disclosure - INVESTMENTS - Additional Information (Details)",
     "shortName": "INVESTMENTS - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails",
     "longName": "9954486 - Disclosure - INVESTMENTS - Schedule of Available-for-Sale Securities (Details)",
     "shortName": "INVESTMENTS - Schedule of Available-for-Sale Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails",
     "longName": "9954487 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Loss Reserve Activity (Details)",
     "shortName": "ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Loss Reserve Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-9",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails",
     "longName": "9954488 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Liabilities (Details)",
     "shortName": "ACCRUED WORKERS' COMPENSATION COSTS - Schedule of Workers' Compensation Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSAdditionalInformationDetails",
     "longName": "9954489 - Disclosure - ACCRUED WORKERS' COMPENSATION COSTS - Additional Information (Details)",
     "shortName": "ACCRUED WORKERS' COMPENSATION COSTS - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "tnet:CollateralHeldByInsuranceCarriers",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "tnet:CollateralHeldByInsuranceCarriers",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails",
     "longName": "9954490 - Disclosure - STOCK BASED COMPENSATION - Additional Information (Details)",
     "shortName": "STOCK BASED COMPENSATION - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-144",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-144",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails",
     "longName": "9954491 - Disclosure - STOCK BASED COMPENSATION - Schedule of RSU and RSA Activity under Equity-Based Plans (Details)",
     "shortName": "STOCK BASED COMPENSATION - Schedule of RSU and RSA Activity under Equity-Based Plans (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-148",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-148",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails",
     "longName": "9954492 - Disclosure - STOCK BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)",
     "shortName": "STOCK BASED COMPENSATION - Schedule of Stock-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails",
     "longName": "9954493 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Common Stock (Details)",
     "shortName": "STOCKHOLDERS' EQUITY - Schedule of Common Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-9",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockSharesIssued",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-10",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockSharesIssued",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.trinet.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails",
     "longName": "9954494 - Disclosure - STOCKHOLDERS' EQUITY - Additional Information (Details)",
     "shortName": "STOCKHOLDERS' EQUITY - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-8",
      "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.trinet.com/role/INCOMETAXESDetails",
     "longName": "9954495 - Disclosure - INCOME TAXES (Details)",
     "shortName": "INCOME TAXES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails",
     "longName": "9954496 - Disclosure - EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted EPS Attributable to Common Stock (Details)",
     "shortName": "EARNINGS PER SHARE - Schedule of Computation of Basic and Diluted EPS Attributable to Common Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tnet-20240331.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "tnet_A2029NotesPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "A2029NotesPayableMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029 Notes",
        "label": "2029 Notes Payable [Member]",
        "documentation": "2029 Notes Payable"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_A2031NotesPayableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "A2031NotesPayableMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2031 Notes",
        "label": "2031 Notes Payable [Member]",
        "documentation": "2031 Notes Payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and other current liabilities",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, net",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r214"
     ]
    },
    "tnet_AccruedHealthInsuranceCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "AccruedHealthInsuranceCostsPolicyTextBlock",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued Health Insurance Costs",
        "label": "Accrued Health Insurance Costs [Policy Text Block]",
        "documentation": "Accrued Health Insurance Costs [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payroll tax liabilities and other payroll withholdings",
        "label": "Accrued Payroll Tax Liabilities And Other Payroll Withholdings",
        "documentation": "Accrued Payroll Tax Liabilities And Other Payroll Withholdings"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedSalariesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedSalariesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued wages",
        "label": "Accrued Salaries, Current",
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r603"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r74",
      "r128",
      "r481",
      "r504",
      "r505"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r10",
      "r24",
      "r400",
      "r403",
      "r428",
      "r500",
      "r501",
      "r728",
      "r729",
      "r730",
      "r736",
      "r737",
      "r738"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r676"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r682"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r682"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r682"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r682"
     ]
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Awards effectively repurchased for required employee withholding taxes",
        "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r51",
      "r340"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r647",
      "r658",
      "r668",
      "r693"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r650",
      "r661",
      "r671",
      "r696"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r682"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r689"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r654",
      "r662",
      "r672",
      "r689",
      "r697",
      "r701",
      "r709"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r707"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total stock based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r370",
      "r378"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization of intangible assets",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r45",
      "r47"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock equivalents excluded from income per diluted share because of their anti-dilutive effect (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetBackedSecuritiesMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset-backed securities",
        "label": "Asset-Backed Securities [Member]",
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans."
       }
      }
     },
     "auth_ref": [
      "r621",
      "r749",
      "r754",
      "r755"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r126",
      "r153",
      "r191",
      "r203",
      "r207",
      "r250",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r395",
      "r397",
      "r418",
      "r477",
      "r538",
      "r626",
      "r638",
      "r770",
      "r771",
      "r807"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r131",
      "r153",
      "r250",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r395",
      "r397",
      "r418",
      "r626",
      "r770",
      "r771",
      "r807"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Unrealized Gains",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r223"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gross Unrealized Losses",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r224"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Amortized Cost",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r259",
      "r476"
     ]
    },
    "tnet_AvailableForSaleMarketableSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "AvailableForSaleMarketableSecuritiesMember",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Available-for-sale marketable securities",
        "label": "Available-for-Sale Marketable Securities [Member]",
        "documentation": "Available-for-Sale Marketable Securities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesAbstract",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities",
        "label": "Debt Securities, Available-for-Sale [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over five years through ten years",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r473"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over one year through five years",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r472"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over ten years",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r230",
      "r474"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total fair value",
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date."
       }
      }
     },
     "auth_ref": [
      "r748",
      "r749",
      "r817"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFairvalueofDebtInvestmentsbyContractualMaturityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "One year or less",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r471"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "label": "Debt Securities, Available-for-Sale",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r259",
      "r467",
      "r741"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails": {
       "parentTag": "us-gaap_RestrictedCashAndInvestments",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Investments, noncurrent",
        "label": "Debt Securities, Available-for-Sale, Noncurrent",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r217",
      "r259"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r704"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r705"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r700"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r700"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r700"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r700"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r700"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r700"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails",
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r703"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r702"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r701"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r701"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Axis]",
        "label": "Balance Sheet Location [Axis]",
        "documentation": "Information by location on balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Domain]",
        "label": "Balance Sheet Location [Domain]",
        "documentation": "Location in the balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation and Basis of Consolidation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "tnet_BurtonMGoldfieldMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "BurtonMGoldfieldMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Burton M Goldfield [Member]",
        "documentation": "Burton M Goldfield"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES",
        "label": "Business Description and Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the business description and accounting policies concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r87"
     ]
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payable for purchase of property and equipment",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r34",
      "r35"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Abstract]",
        "label": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails": {
       "parentTag": "us-gaap_RestrictedCashAndInvestments",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r122",
      "r600"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Axis]",
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsMember",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails",
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents [Member]",
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Cash, Cash Equivalents and Investments",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r95"
     ]
    },
    "tnet_CashCashEquivalentsAndInvestmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "CashCashEquivalentsAndInvestmentsTextBlock",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTED"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED",
        "label": "Cash, Cash Equivalents And Investments [Text Block]",
        "documentation": "Cash, Cash Equivalents and Investments [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning of period",
        "periodEndLabel": "End of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r83",
      "r151"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents, unrestricted and restricted:",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net change in cash and cash equivalents, unrestricted and restricted",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r83"
     ]
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents:",
        "label": "Cash Equivalents, at Carrying Value",
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r725",
      "r819"
     ]
    },
    "us-gaap_CertificatesOfDepositMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CertificatesOfDepositMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Certificate of deposit",
        "label": "Certificates of Deposit [Member]",
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r631",
      "r632",
      "r633",
      "r634"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r681"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r681"
     ]
    },
    "tnet_CollateralByTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "CollateralByTypeDomain",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collateral, by Type [Domain]",
        "label": "Collateral, by Type [Domain]",
        "documentation": "Collateral, by Type [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_CollateralHeldByInsuranceCarriers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "CollateralHeldByInsuranceCarriers",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collateral held by insurance carriers",
        "label": "Collateral Held By Insurance Carriers",
        "documentation": "Collateral Held by Insurance Carriers"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued health insurance costs, net",
        "label": "Collateral Paid To Insurance Carriers, Net Of Health Benefit Loss Reserves, Current",
        "documentation": "Collateral Paid To Insurance Carriers, Net Of Health Benefit Loss Reserves, Current"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net of collateral paid to carriers, payable in less than one year",
        "label": "Collateral Paid To Insurance Carriers, Net Of Workers' Compensation Loss Reserves, Current",
        "documentation": "Collateral Paid to Insurance Carriers, Net of Workers' Compensation Loss Reserves, Current"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net of collateral paid to carriers, payable in more than 1 year",
        "label": "Collateral Paid To Insurance Carriers, Net Of Workers' Compensation Loss Reserves, Noncurrent",
        "documentation": "Collateral Paid To Insurance Carriers, Net Of Workers' Compensation Loss Reserves, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_CollateralbyTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "CollateralbyTypeAxis",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collateral, by Type [Axis]",
        "label": "Collateral, by Type [Axis]",
        "documentation": "Collateral, by Type [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (see Note 5)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r62",
      "r479",
      "r525"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.trinet.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "COMMITMENTS AND CONTINGENCIES",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r268",
      "r269",
      "r584",
      "r766"
     ]
    },
    "us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockIncludingAdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock and Additional Paid-In Capital",
        "label": "Common Stock Including Additional Paid in Capital [Member]",
        "documentation": "Common stock held by shareholders with par value plus amounts in excess of par value or issuance value (in cases of no-par value stock)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock",
        "label": "Common Stock, Number of Shares, Par Value and Other Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r526"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical",
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "periodStartLabel": "Shares issued and outstanding, beginning balance (in shares)",
        "periodEndLabel": "Shares issued and outstanding, ending balance (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical",
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "periodStartLabel": "Shares issued and outstanding, beginning balance (in shares)",
        "periodEndLabel": "Shares issued and outstanding, ending balance (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r68",
      "r526",
      "r544",
      "r822",
      "r823"
     ]
    },
    "us-gaap_CommonStocksIncludingAdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStocksIncludingAdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock and additional paid-in capital, ($0.000025 par value per share; 750,000,000 shares authorized; 50,573,176 and 50,664,471 shares issued and outstanding at March\u00a031, 2024 and December\u00a031, 2023, respectively)",
        "label": "Common Stocks, Including Additional Paid in Capital",
        "documentation": "Amount of par value plus amounts in excess of par value or issuance value for common stock issued."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r69",
      "r91"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r686"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r685"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r687"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r684"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive income",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r134",
      "r136",
      "r140",
      "r468",
      "r488"
     ]
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r40",
      "r60",
      "r61",
      "r212",
      "r583"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r40",
      "r60",
      "r61",
      "r212",
      "r506",
      "r583"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Axis]",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r40",
      "r60",
      "r61",
      "r212",
      "r583",
      "r716"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percent of concentration risk (less than)",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r40",
      "r60",
      "r61",
      "r212"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Domain]",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r40",
      "r60",
      "r61",
      "r212",
      "r583"
     ]
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Axis]",
        "label": "Consolidated Entities [Axis]"
       }
      }
     },
     "auth_ref": [
      "r155",
      "r395",
      "r396",
      "r397",
      "r398",
      "r429",
      "r594",
      "r769",
      "r772",
      "r773"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Domain]",
        "label": "Consolidated Entities [Domain]"
       }
      }
     },
     "auth_ref": [
      "r155",
      "r395",
      "r396",
      "r397",
      "r398",
      "r429",
      "r594",
      "r769",
      "r772",
      "r773"
     ]
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Change in Balance of the Recovery Credit Unsatisfied Performance Obligation",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability."
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerAssetNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unbilled revenue, net",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r317",
      "r328"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Client deposits and other client liabilities",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r316",
      "r328"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofChangeinBalanceoftheRecoveryCreditUnsatisfiedPerformanceObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "(-) Distributions to clients",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r329"
     ]
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CorporateDebtSecuritiesMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate bonds",
        "label": "Corporate Debt Securities [Member]",
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment."
       }
      }
     },
     "auth_ref": [
      "r621",
      "r623",
      "r821"
     ]
    },
    "tnet_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of providing services",
        "label": "Cost Of Goods And Service, Excluding Depreciation, Depletion, And Amortization, And Operating Insurance And Claims Costs, Production",
        "documentation": "Cost Of Goods And Service, Excluding Depreciation, Depletion, And Amortization, And Operating Insurance And Claims Costs, Production"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfGoodsAndServicesSoldDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization of intangible assets",
        "label": "Cost, Depreciation and Amortization",
        "documentation": "Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service."
       }
      }
     },
     "auth_ref": [
      "r731"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cost of providing services",
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total costs and operating expenses",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostsAndExpensesAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Costs and operating expenses:",
        "label": "Costs and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r64",
      "r65",
      "r97",
      "r99",
      "r155",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r425",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r734"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r155",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r425",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r734"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleRealizedGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AFS securities, gross realized gain (loss)",
        "label": "Debt Securities, Available-for-Sale, Realized Gain (Loss)",
        "documentation": "Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r756"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails",
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Available-for-sale [Table]",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Available-for-Sale Securities",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r756"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred taxes",
        "label": "Deferred Income Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r381",
      "r382",
      "r478"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATION"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "STOCK BASED COMPENSATION",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r338",
      "r343",
      "r372",
      "r373",
      "r374",
      "r625"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DividendsCommonStockCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsCommonStockCash",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Dividends Declared",
        "terseLabel": "Cash dividend declared, but not yet paid",
        "label": "Dividends, Common Stock, Cash",
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_DividendsPayableAmountPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsPayableAmountPerShare",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends authorized (in dollars per share)",
        "label": "Dividends Payable, Amount Per Share",
        "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends authorized",
        "label": "Dividends Payable",
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r66",
      "r98",
      "r635",
      "r818"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r642"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r675"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income per share:",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Basic EPS (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r170",
      "r173",
      "r183",
      "r184",
      "r185",
      "r189",
      "r408",
      "r409",
      "r469",
      "r489",
      "r605"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Diluted EPS (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r173",
      "r183",
      "r184",
      "r185",
      "r189",
      "r408",
      "r409",
      "r469",
      "r489",
      "r605"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.trinet.com/role/EARNINGSPERSHARE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EARNINGS PER SHARE",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r186",
      "r187",
      "r188"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://www.trinet.com/role/INCOMETAXESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective income tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r384"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total stock based compensation capitalized",
        "label": "Share-Based Payment Arrangement, Amount Capitalized",
        "documentation": "Amount of cost capitalized for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r371"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Option",
        "label": "Employee Stock Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r640"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r640"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r640"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r714"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r640"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r640"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r640"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r640"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r118",
      "r137",
      "r138",
      "r139",
      "r156",
      "r157",
      "r158",
      "r160",
      "r166",
      "r168",
      "r190",
      "r251",
      "r252",
      "r314",
      "r375",
      "r376",
      "r377",
      "r388",
      "r389",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r407",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r428",
      "r500",
      "r501",
      "r502",
      "r511",
      "r564"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r683"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r647",
      "r658",
      "r668",
      "r693"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r644",
      "r655",
      "r665",
      "r690"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r689"
     ]
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Financial Instruments by Significant Categories and Fair Value Measurement on a Recurring Basis",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r93"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r412",
      "r433",
      "r434",
      "r435",
      "r614",
      "r615",
      "r621",
      "r622",
      "r623"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Axis]",
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r411",
      "r412",
      "r413",
      "r414",
      "r415"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r331",
      "r336",
      "r412",
      "r433",
      "r621",
      "r622",
      "r623"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r331",
      "r336",
      "r412",
      "r434",
      "r614",
      "r615",
      "r621",
      "r622",
      "r623"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Domain]",
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value of Financial Instruments",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r433",
      "r434",
      "r435",
      "r614",
      "r615",
      "r621",
      "r622",
      "r623"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement on a Recurring Basis",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r410",
      "r415"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails",
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument [Axis]",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r253",
      "r254",
      "r256",
      "r257",
      "r258",
      "r260",
      "r261",
      "r262",
      "r299",
      "r312",
      "r405",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r487",
      "r610",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r756",
      "r757",
      "r758",
      "r759"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r651",
      "r662",
      "r672",
      "r697"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r651",
      "r662",
      "r672",
      "r697"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r651",
      "r662",
      "r672",
      "r697"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r651",
      "r662",
      "r672",
      "r697"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r651",
      "r662",
      "r672",
      "r697"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r548"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "General and administrative",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeographicConcentrationRiskMember",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Sales",
        "label": "Geographic Concentration Risk [Member]",
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa)."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r583"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Goodwill",
        "label": "Goodwill",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r265",
      "r466",
      "r612",
      "r626",
      "r763",
      "r764"
     ]
    },
    "tnet_HealthBenefitClaimsCollateralMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "HealthBenefitClaimsCollateralMember",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collateral for health benefits claims",
        "label": "Health Benefit Claims Collateral [Member]",
        "documentation": "Health Benefit Claims Collateral [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HealthCareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HealthCareMember",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Health Care",
        "label": "Health Care [Member]",
        "documentation": "Service provided for prevention, maintenance, diagnosis or treatment of physical and mental health."
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before provision for income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r75",
      "r103",
      "r191",
      "r202",
      "r206",
      "r208",
      "r470",
      "r485",
      "r607"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r266",
      "r267",
      "r549"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Income Statement Location [Domain]",
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r267",
      "r549"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.trinet.com/role/INCOMETAXES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INCOME TAXES",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r380",
      "r385",
      "r386",
      "r387",
      "r390",
      "r392",
      "r393",
      "r394",
      "r510"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r115",
      "r167",
      "r168",
      "r194",
      "r383",
      "r391",
      "r490"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes paid, net",
        "label": "Income Taxes Paid, Net",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and other liabilities",
        "label": "Increase (Decrease) in Accounts Payable and Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r732"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accounts receivable, net",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedSalaries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccruedSalaries",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued wages",
        "label": "Increase (Decrease) in Accrued Salaries",
        "documentation": "The increase (decrease) during the period in accrued salaries."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInContractWithCustomerAsset",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unbilled revenue, net",
        "label": "Increase (Decrease) in Contract with Customer, Asset",
        "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r732"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Client deposits and other client liabilities",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r464",
      "r732"
     ]
    },
    "us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInHealthCareInsuranceLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued health insurance costs, net",
        "label": "Increase (Decrease) in Health Care Insurance Liabilities",
        "documentation": "The increase (decrease) in health care insurance liability balances during the period."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Increase (Decrease) In Operating Lease Liabilities",
        "documentation": "Increase (Decrease) In Operating Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherEmployeeRelatedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherEmployeeRelatedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payroll taxes payable and other payroll withholdings",
        "label": "Increase (Decrease) in Other Employee-Related Liabilities",
        "documentation": "Amount of increase (decrease) in employer-related costs classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other assets",
        "label": "Increase (Decrease) in Other Operating Assets",
        "documentation": "Amount of increase (decrease) in operating assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "tnet_IncreaseDecreaseInOtherPayrollAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "IncreaseDecreaseInOtherPayrollAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other payroll assets",
        "label": "Increase Decrease In Other Payroll Assets",
        "documentation": "Increase Decrease In Other Payroll Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses, net",
        "label": "Increase (Decrease) in Prepaid Expense",
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited",
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInWorkersCompensationLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInWorkersCompensationLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued workers' compensation costs, net",
        "label": "Increase (Decrease) in Workers' Compensation Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amount due for insurance (or actual expenses) to cover the medical expenses and lost income for employees that are injured during the course of doing work-related activities."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "calculation": {
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dilutive effect of stock options and restricted stock units (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r175",
      "r176",
      "r185",
      "r342"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r654",
      "r662",
      "r672",
      "r689",
      "r697",
      "r701",
      "r709"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r707"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r643",
      "r713"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r643",
      "r713"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r643",
      "r713"
     ]
    },
    "us-gaap_InsuranceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InsuranceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance [Abstract]",
        "label": "Insurance [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_InsuranceCarriersSecurityDepositsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "InsuranceCarriersSecurityDepositsMember",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other security deposits",
        "label": "Insurance Carriers Security Deposits [Member]",
        "documentation": "Insurance Carriers Security Deposits [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_InsurancePremiumsAndOtherPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "InsurancePremiumsAndOtherPayables",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance premiums and other payables",
        "label": "Insurance Premiums And Other Payables",
        "documentation": "Insurance Premiums and Other Payables"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_InsuranceServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "InsuranceServicesMember",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance service revenues",
        "label": "Insurance Services [Member]",
        "documentation": "Insurance Services [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software and other intangible assets, net",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r46"
     ]
    },
    "tnet_InterestExpenseBankFeesAndOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "InterestExpenseBankFeesAndOther",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest expense, bank fees and other",
        "label": "Interest Expense, Bank Fees and Other",
        "documentation": "Interest Expense, Bank Fees and Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestIncomeOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeOther",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Interest Income, Other",
        "documentation": "Amount of interest income earned from interest bearing assets classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest paid",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r149",
      "r150"
     ]
    },
    "us-gaap_InterimPeriodCostsNotAllocableDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterimPeriodCostsNotAllocableDomain",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interim Period, Costs Not Allocable [Domain]",
        "label": "Interim Period, Costs Not Allocable [Domain]",
        "documentation": "This element represents the type of costs and expenses incurred during an interim period that cannot be readily identified with the activities or benefits of other interim periods and are charged to the interim period in which incurred."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_InvestmentsAndOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsAndOtherNoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments, noncurrent",
        "label": "Investments and Other Noncurrent Assets",
        "documentation": "Amount of investments, and noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair value of Debt Investments by Contractual Maturity",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]",
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INVESTMENTS",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "documentation": "The entire disclosure for investments in certain debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r105",
      "r108",
      "r117",
      "r215",
      "r218",
      "r416",
      "r417"
     ]
    },
    "us-gaap_InvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments",
        "label": "Investments [Member]",
        "documentation": "Assets held for their financial return, rather than for the entity's operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r153",
      "r250",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r396",
      "r397",
      "r398",
      "r418",
      "r524",
      "r606",
      "r638",
      "r770",
      "r807",
      "r808"
     ]
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES",
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities &amp; stockholders' equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r100",
      "r483",
      "r626",
      "r735",
      "r760",
      "r806"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and stockholders' equity",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r121",
      "r153",
      "r250",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r396",
      "r397",
      "r398",
      "r418",
      "r626",
      "r770",
      "r807",
      "r808"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ACCRUED WORKERS' COMPENSATION COSTS",
        "label": "Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]",
        "documentation": "The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments."
       }
      }
     },
     "auth_ref": [
      "r497"
     ]
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract",
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Paid",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails": {
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Current year",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails": {
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Prior years",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "tnet_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails": {
       "parentTag": "us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSAdditionalInformationDetails",
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Collateral paid to carriers and offset against accrued costs",
        "terseLabel": "Collateral paid to carriers and offset against loss reserves",
        "label": "Liability For Unpaid Claims And Claims Adjustment Expense, Collateral",
        "documentation": "Liability for Unpaid Claims and Claims Adjustment Expense, Collateral"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total incurred",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process."
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract",
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Incurred",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract",
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails": {
       "parentTag": "us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails",
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Total accrued costs, beginning of period",
        "periodEndLabel": "Total accrued costs, end of period",
        "terseLabel": "Total accrued costs, end of period",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Adjustments",
        "documentation": "Sum of adjustments to the estimated reserve for unpaid claims and claims adjustment expense."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "us-gaap_LinesOfCreditCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LinesOfCreditCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving credit agreement borrowings",
        "label": "Line of Credit, Current",
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r97"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Long-term debt, noncurrent",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r270",
      "r271",
      "r272",
      "r273",
      "r337",
      "r463",
      "r499",
      "r516",
      "r517",
      "r569",
      "r571",
      "r573",
      "r574",
      "r576",
      "r595",
      "r596",
      "r609",
      "r618",
      "r624",
      "r628",
      "r774",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r681"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r681"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r270",
      "r271",
      "r272",
      "r273",
      "r337",
      "r463",
      "r499",
      "r516",
      "r517",
      "r569",
      "r571",
      "r573",
      "r574",
      "r576",
      "r595",
      "r596",
      "r609",
      "r618",
      "r624",
      "r628",
      "r774",
      "r809",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r700"
     ]
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market mutual funds",
        "label": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r778"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r708"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r682"
     ]
    },
    "us-gaap_NatureOfExpenseAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NatureOfExpenseAxis",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nature of Expense [Axis]",
        "label": "Nature of Expense [Axis]",
        "documentation": "Information by type of cost or expense."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r84",
      "r85"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income",
        "terseLabel": "Net income",
        "verboseLabel": "Net income",
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r85",
      "r104",
      "r119",
      "r132",
      "r135",
      "r139",
      "r153",
      "r159",
      "r161",
      "r162",
      "r163",
      "r164",
      "r167",
      "r168",
      "r181",
      "r191",
      "r202",
      "r206",
      "r208",
      "r250",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r409",
      "r418",
      "r486",
      "r546",
      "r562",
      "r563",
      "r607",
      "r636",
      "r770"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net income",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r161",
      "r162",
      "r163",
      "r164",
      "r170",
      "r171",
      "r182",
      "r185",
      "r191",
      "r202",
      "r206",
      "r208",
      "r607"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r172",
      "r177",
      "r178",
      "r179",
      "r180",
      "r182",
      "r185"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recent Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r681"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r651",
      "r662",
      "r672",
      "r689",
      "r697"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r679"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r678"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r689"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r708"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r708"
     ]
    },
    "us-gaap_NonUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonUsMember",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-US",
        "label": "Non-US [Member]",
        "documentation": "Countries excluding the United States of America (US)."
       }
      }
     },
     "auth_ref": [
      "r824",
      "r825",
      "r826",
      "r827"
     ]
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental schedule of noncash investing and financing activities",
        "label": "Noncash Investing and Financing Items [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense):",
        "label": "Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayableFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesPayableFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of notes payable",
        "label": "Notes Payable, Fair Value Disclosure",
        "documentation": "Fair value portion of notes payable."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r740"
     ]
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating income",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r202",
      "r206",
      "r208",
      "r607"
     ]
    },
    "us-gaap_OperatingInsuranceAndClaimsCostsProduction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingInsuranceAndClaimsCostsProduction",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance costs",
        "label": "Operating Insurance and Claims Costs, Production",
        "documentation": "Insurance and claims costs directly related to goods produced and sold, or services rendered, during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities, noncurrent",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use asset",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of ROU asset, lease modification, impairment, and abandonment",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r733"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAmortizationOfDeferredCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAmortizationOfDeferredCharges",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of deferred costs",
        "label": "Amortization of Other Deferred Charges",
        "documentation": "Amount of amortization of other deferred costs recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r80"
     ]
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current assets",
        "label": "Other Assets, Current",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r626"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss), net of income taxes",
        "verboseLabel": "Other comprehensive income (loss)",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r9",
      "r92",
      "r133",
      "r136"
     ]
    },
    "us-gaap_OtherDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherDebtSecuritiesMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other debt securities",
        "label": "Other Debt Obligations [Member]",
        "documentation": "Investments in debt securities classified as other."
       }
      }
     },
     "auth_ref": [
      "r761",
      "r778",
      "r805"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "tnet_OtherPayrollAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "OtherPayrollAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other payroll assets",
        "label": "Other Payroll Assets Current",
        "documentation": "Other Payroll Assets Current"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r681"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r649",
      "r660",
      "r670",
      "r695"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r652",
      "r663",
      "r673",
      "r698"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r652",
      "r663",
      "r673",
      "r698"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total paid",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r12"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchase of common stock",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Awards effectively repurchased for required employee withholding taxes",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireMarketableSecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of marketable securities",
        "label": "Payments to Acquire Marketable Securities",
        "documentation": "Amount of cash outflow for purchase of marketable security."
       }
      }
     },
     "auth_ref": [
      "r742"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisitions of property and equipment and projects in process",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "tnet_PayrollFundsCollectedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "PayrollFundsCollectedMember",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payroll funds collected",
        "label": "Payroll Funds Collected [Member]",
        "documentation": "Payroll Funds Collected [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r679"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r689"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r682"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r678"
     ]
    },
    "tnet_PerformanceBasedRestrictedStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "PerformanceBasedRestrictedStockUnitsMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance-Based Restricted Stock Units",
        "label": "Performance-Based Restricted Stock Units [Member]",
        "documentation": "Performance-Based Restricted Stock Units [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "tnet_PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Performance-based RSUs and RSAs",
        "label": "Performance-Based Restricted Stock Units and Restricted Stock Awards [Member]",
        "documentation": "Performance-Based Restricted Stock Units and Restricted Stock Awards [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockNumberOfSharesParValueAndOtherDisclosuresAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock",
        "label": "Preferred Stock, Number of Shares, Par Value and Other Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r301"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r526"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r301"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r526",
      "r544",
      "r822",
      "r823"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, ($0.000025 par value per share; 20,000,000 shares authorized; no shares issued or outstanding at March\u00a031, 2024 and December\u00a031, 2023)",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r480",
      "r626"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses, net",
        "label": "Prepaid Expense, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r263",
      "r264",
      "r601"
     ]
    },
    "us-gaap_PrepaidInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidInsurance",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayments offsetting accrued health insurance costs",
        "label": "Prepaid Insurance",
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r602",
      "r611",
      "r762"
     ]
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromLinesOfCredit",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from revolving credit agreement borrowings",
        "label": "Proceeds from Lines of Credit",
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r734"
     ]
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails": {
       "parentTag": "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross proceeds from maturities",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r145",
      "r742"
     ]
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r145",
      "r742"
     ]
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale and maturity of marketable securities",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails": {
       "parentTag": "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofAvailableforSaleSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross proceeds from sales",
        "label": "Proceeds from Sale of Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r144",
      "r216",
      "r249"
     ]
    },
    "us-gaap_ProductInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProductInformationLineItems",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product Information [Line Items]",
        "label": "Product Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r209",
      "r465",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r598",
      "r619",
      "r627",
      "r717",
      "r767",
      "r768",
      "r776",
      "r820"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r209",
      "r465",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r598",
      "r619",
      "r627",
      "r717",
      "r767",
      "r768",
      "r776",
      "r820"
     ]
    },
    "tnet_ProfessionalServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "ProfessionalServicesMember",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional service revenues",
        "label": "Professional Services [Member]",
        "documentation": "Professional Services [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r475",
      "r484",
      "r626"
     ]
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProvisionForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for doubtful accounts",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r255"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r677"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r270",
      "r271",
      "r272",
      "r273",
      "r330",
      "r337",
      "r366",
      "r367",
      "r368",
      "r436",
      "r463",
      "r499",
      "r516",
      "r517",
      "r569",
      "r571",
      "r573",
      "r574",
      "r576",
      "r595",
      "r596",
      "r609",
      "r618",
      "r624",
      "r628",
      "r629",
      "r765",
      "r774",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r270",
      "r271",
      "r272",
      "r273",
      "r330",
      "r337",
      "r366",
      "r367",
      "r368",
      "r436",
      "r463",
      "r499",
      "r516",
      "r517",
      "r569",
      "r571",
      "r573",
      "r574",
      "r576",
      "r595",
      "r596",
      "r609",
      "r618",
      "r624",
      "r628",
      "r629",
      "r765",
      "r774",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r644",
      "r655",
      "r665",
      "r690"
     ]
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfLinesOfCredit",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repayment of revolving credit agreement borrowings",
        "label": "Repayments of Lines of Credit",
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r734"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Systems development and programming",
        "label": "Research and Development Expense",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r379",
      "r815"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r645",
      "r656",
      "r666",
      "r691"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r646",
      "r657",
      "r667",
      "r692"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r653",
      "r664",
      "r674",
      "r699"
     ]
    },
    "tnet_RestrictedCashAndCashEquivalentsAndInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "RestrictedCashAndCashEquivalentsAndInvestmentsMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Cash, Cash Equivalents and Investments",
        "label": "Restricted Cash, and Cash Equivalents and Investments [Member]",
        "documentation": "Restricted Cash, and Cash Equivalents and Investments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Domain]",
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsItemsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashAndCashEquivalentsItemsLineItems",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Cash and Cash Equivalents Items [Line Items]",
        "label": "Restricted Cash and Cash Equivalents Items [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "us-gaap_RestrictedCashAndInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashAndInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Restricted Cash and Investments",
        "documentation": "Cash and investments whose use in whole or in part is restricted for the long-term, generally by contractual agreements or regulatory requirements. For use in an unclassified balance sheet."
       }
      }
     },
     "auth_ref": [
      "r581",
      "r582"
     ]
    },
    "us-gaap_RestrictedCashAndInvestmentsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashAndInvestmentsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails": {
       "parentTag": "us-gaap_RestrictedCashAndInvestments",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash, cash equivalents and investments",
        "verboseLabel": "Total restricted cash, cash equivalents and investments",
        "label": "Restricted Cash and Investments, Current",
        "documentation": "The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal."
       }
      }
     },
     "auth_ref": [
      "r581",
      "r582",
      "r727"
     ]
    },
    "us-gaap_RestrictedCashAndInvestmentsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashAndInvestmentsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails": {
       "parentTag": "us-gaap_RestrictedCashAndInvestments",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash, cash equivalents and investments, noncurrent",
        "verboseLabel": "Restricted cash, cash equivalents and investments, noncurrent",
        "label": "Restricted Cash and Investments, Noncurrent",
        "documentation": "The noncurrent cash, cash equivalents and investments that is restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits classified as long-term; that is not expected to be released from such existing restrictions within one year of the balance sheet date or operating cycle, whichever is longer. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes noncurrent cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal."
       }
      }
     },
     "auth_ref": [
      "r581",
      "r582"
     ]
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Restricted Stock",
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r91",
      "r482",
      "r503",
      "r505",
      "r509",
      "r527",
      "r626"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained Earnings (Accumulated Deficit)",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r156",
      "r157",
      "r158",
      "r160",
      "r166",
      "r168",
      "r251",
      "r252",
      "r375",
      "r376",
      "r377",
      "r388",
      "r389",
      "r399",
      "r401",
      "r402",
      "r404",
      "r407",
      "r500",
      "r502",
      "r511",
      "r822"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total revenues",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r193",
      "r201",
      "r204",
      "r205",
      "r209",
      "r210",
      "r212",
      "r326",
      "r327",
      "r465"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r597"
     ]
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueRemainingPerformanceObligation",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofChangeinBalanceoftheRecoveryCreditUnsatisfiedPerformanceObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "tnet_RevenueRemainingPerformanceObligationProvision": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "RevenueRemainingPerformanceObligationProvision",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofChangeinBalanceoftheRecoveryCreditUnsatisfiedPerformanceObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(+) Accruals",
        "label": "Revenue, Remaining Performance Obligation, Provision",
        "documentation": "Revenue, Remaining Performance Obligation, Provision"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r708"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r708"
     ]
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r212",
      "r715"
     ]
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSAdditionalInformationDetails",
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230"
     ]
    },
    "us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash, Cash Equivalents and Investments",
        "label": "Cash, Cash Equivalents and Investments [Table Text Block]",
        "documentation": "Tabular disclosure of the components of cash, cash equivalents, and investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Issued and Outstanding Common Stock",
        "label": "Schedule of Common Stock Outstanding Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in common stock outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.trinet.com/role/EARNINGSPERSHARETables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Computation of Basic and Diluted EPS Attributable to Common Stock",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r739"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Activities in Liability for Unpaid Claims and Claims Adjustment Expenses",
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfProductInformationTable",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Product Information [Table]",
        "label": "Schedule of Product Information [Table]",
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTable",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restrictions on Cash and Cash Equivalents [Table]",
        "label": "Restrictions on Cash and Cash Equivalents [Table]",
        "documentation": "Disclosure of information about cash and cash equivalents restricted as to withdrawal or usage."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r95",
      "r819"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails",
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails",
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r341",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of RSU Activity under Equity-Based Plans",
        "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Variable Interest Entities [Table]",
        "label": "Schedule of Variable Interest Entities [Table]",
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r53",
      "r54",
      "r55",
      "r56",
      "r395",
      "r396",
      "r397",
      "r398",
      "r444",
      "r445",
      "r446"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assets and Liabilities in our Consolidated Balance Sheet",
        "label": "Schedule of Variable Interest Entities [Table Text Block]",
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r53",
      "r54",
      "r55",
      "r56"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r639"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r641"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r210",
      "r211",
      "r513",
      "r514",
      "r515",
      "r570",
      "r572",
      "r575",
      "r577",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r599",
      "r620",
      "r629",
      "r776",
      "r820"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Information",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r210",
      "r608"
     ]
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales and marketing",
        "label": "Selling and Marketing Expense",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingAndMarketingExpenseMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Sales and marketing",
        "label": "Selling and Marketing Expense [Member]",
        "documentation": "Primary financial statement caption encompassing selling and marketing expense."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance period for 2024 and 2023 awards",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period",
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r625"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r625"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r358"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r358"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance (in shares)",
        "periodEndLabel": "Balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r355",
      "r356"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance (in dollars per share)",
        "periodEndLabel": "Balance (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r355",
      "r356"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Grant Date Fair Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails",
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Vested (in shares)",
        "terseLabel": "Issuance of common stock from vested restricted stock units (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r359"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r359"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails",
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails",
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r341",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails",
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369"
     ]
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based Payment Arrangement, Tranche One",
        "label": "Share-Based Payment Arrangement, Tranche One [Member]",
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of shares that are expected to vesting percentage",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "documentation": "Percentage of vesting of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r779"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percent of share value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Awards effectively repurchased for required employee withholding taxes (in shares)",
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails": {
       "parentTag": "us-gaap_RestrictedCashAndInvestments",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments",
        "label": "Short-Term Investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r726"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r22",
      "r118",
      "r137",
      "r138",
      "r139",
      "r156",
      "r157",
      "r158",
      "r160",
      "r166",
      "r168",
      "r190",
      "r251",
      "r252",
      "r314",
      "r375",
      "r376",
      "r377",
      "r388",
      "r389",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r407",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r428",
      "r500",
      "r501",
      "r502",
      "r511",
      "r564"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r210",
      "r211",
      "r513",
      "r514",
      "r515",
      "r570",
      "r572",
      "r575",
      "r577",
      "r580",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r599",
      "r620",
      "r629",
      "r776",
      "r820"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r190",
      "r465",
      "r507",
      "r512",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r526",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r545",
      "r547",
      "r548",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r564",
      "r630"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r190",
      "r465",
      "r507",
      "r512",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r526",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r545",
      "r547",
      "r548",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r564",
      "r630"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r648",
      "r659",
      "r669",
      "r694"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock from exercise of stock options (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r67",
      "r68",
      "r91",
      "r352"
     ]
    },
    "us-gaap_StockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockOptionMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options",
        "label": "Equity Option [Member]",
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option)."
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program, authorized amount",
        "label": "Stock Repurchase Program, Authorized Amount",
        "documentation": "Amount of stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program, remaining authorized repurchase amount",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "documentation": "Amount remaining of a stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITYScheduleofCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repurchase of common stock (in shares)",
        "label": "Stock Repurchased During Period, Shares",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r67",
      "r68",
      "r91",
      "r508",
      "r564",
      "r578"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repurchase of common stock",
        "label": "Stock Repurchased During Period, Value",
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r67",
      "r68",
      "r91",
      "r511",
      "r564",
      "r578",
      "r637"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders' equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r71",
      "r72",
      "r88",
      "r528",
      "r544",
      "r565",
      "r566",
      "r626",
      "r638",
      "r735",
      "r760",
      "r806",
      "r822"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' equity:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.trinet.com/role/STOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "STOCKHOLDERS' EQUITY",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r152",
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r313",
      "r314",
      "r406",
      "r567",
      "r568",
      "r579"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosures of cash flow information",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails": {
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current year",
        "label": "Current Year Claims and Claims Adjustment Expense",
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs."
       }
      }
     },
     "auth_ref": [
      "r498"
     ]
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails": {
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLossReserveActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior years",
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs."
       }
      }
     },
     "auth_ref": [
      "r498"
     ]
    },
    "tnet_SystemsDevelopmentAndProgrammingCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "SystemsDevelopmentAndProgrammingCostsMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Systems development and programming costs",
        "label": "Systems Development And Programming Costs [Member]",
        "documentation": "Primary financial statement caption encompassing systems development and programming costs."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r688"
     ]
    },
    "tnet_TimeBasedRestrictedStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "TimeBasedRestrictedStockUnitsMember",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails",
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONScheduleofRSUandRSAActivityunderEquityBasedPlansDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Time-Based Restricted Stock Units",
        "label": "Time-Based Restricted Stock Units [Member]",
        "documentation": "Time-Based Restricted Stock Units [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r680"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r687"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r707"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r709"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.trinet.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails",
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments [Domain]",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r299",
      "r312",
      "r405",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r487",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r756",
      "r757",
      "r758",
      "r759"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r710"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r709"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r709"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r712"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r710"
     ]
    },
    "tnet_TrustForOurHRISUsersCollateralMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "TrustForOurHRISUsersCollateralMember",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trust for our HRIS Users",
        "label": "Trust For our HRIS Users Collateral [Member]",
        "documentation": "Trust For our HRIS Users Collateral"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Agency securities",
        "label": "US Government Agencies Debt Securities [Member]",
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB)."
       }
      }
     },
     "auth_ref": [
      "r604",
      "r621",
      "r816"
     ]
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "USTreasurySecuritiesMember",
     "presentation": [
      "http://www.trinet.com/role/INVESTMENTSScheduleofFinancialInstrumentsbySignificantCategoriesandFairValueMeasurementonaRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. treasuries",
        "label": "US Treasury Securities [Member]",
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years)."
       }
      }
     },
     "auth_ref": [
      "r604",
      "r621",
      "r623",
      "r816"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r706"
     ]
    },
    "tnet_UnsatisfiedPerformanceObligationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "UnsatisfiedPerformanceObligationRollForward",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESScheduleofChangeinBalanceoftheRecoveryCreditUnsatisfiedPerformanceObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unsatisfied Performance Obligation [Roll Forward]",
        "label": "Unsatisfied Performance Obligation [Roll Forward]",
        "documentation": "Unsatisfied Performance Obligation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r42",
      "r43",
      "r110",
      "r111",
      "r112",
      "r113"
     ]
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityLineItems",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity [Line Items]",
        "label": "Variable Interest Entity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r395",
      "r396",
      "r397",
      "r398",
      "r444",
      "r445",
      "r446"
     ]
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "presentation": [
      "http://www.trinet.com/role/DESCRIPTIONOFBUSINESSANDSIGNIFICANTACCOUNTINGPOLICIESAssetsandLiabilitiesoftheTrustDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r395",
      "r396",
      "r397",
      "r398"
     ]
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VestingAxis",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting [Axis]",
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VestingDomain",
     "presentation": [
      "http://www.trinet.com/role/STOCKBASEDCOMPENSATIONAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting [Domain]",
        "label": "Vesting [Domain]",
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average shares of common stock outstanding - diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r185"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average shares:",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEANDCOMPREHENSIVEINCOMEUnaudited",
      "http://www.trinet.com/role/EARNINGSPERSHAREScheduleofComputationofBasicandDilutedEPSAttributabletoCommonStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average shares of common stock outstanding (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r185"
     ]
    },
    "tnet_WorkersCompensationClaimsCollateralMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.trinet.com/20240331",
     "localname": "WorkersCompensationClaimsCollateralMember",
     "presentation": [
      "http://www.trinet.com/role/CASHCASHEQUIVALENTSANDINVESTMENTSUNRESTRICTEDANDRESTRICTEDDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collateral for workers' compensation claims",
        "label": "Workers' Compensation Claims Collateral [Member]",
        "documentation": "Workers' Compensation Claims Collateral [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WorkersCompensationLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WorkersCompensationLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails_1": {
       "parentTag": "us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued workers' compensation costs, net",
        "verboseLabel": "Payable in less than 1 year\u2028(net of collateral paid to carriers of $1 and $1 at March\u00a031, 2024 and December\u00a031, 2023, respectively)",
        "label": "Workers' Compensation Liability, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WorkersCompensationLiabilityCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total accrued costs, net of carrier collateral offset",
        "terseLabel": "Total accrued costs, net of carrier collateral offset",
        "label": "Workers' Compensation Liability",
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r66",
      "r98"
     ]
    },
    "us-gaap_WorkersCompensationLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WorkersCompensationLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails_1": {
       "parentTag": "us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.trinet.com/role/ACCRUEDWORKERSCOMPENSATIONCOSTSScheduleofWorkersCompensationLiabilitiesDetails",
      "http://www.trinet.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued workers' compensation costs, noncurrent, net",
        "verboseLabel": "Payable in more than 1 year \u2028(net of collateral paid to carriers of $3 and $4 at March\u00a031, 2024 and December\u00a031, 2023, respectively)",
        "label": "Workers' Compensation Liability, Noncurrent",
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the noncurrent portion of the liabilities (due beyond one year; or beyond one operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481047/942-405-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19,20,22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "270",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-8"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "((a)(1),(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-9"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "940",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//940-320/tableOfContent"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//942-320/tableOfContent"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//946-320/tableOfContent"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1403",
   "Paragraph": "(b)",
   "Publisher": "SEC"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-11"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//320/tableOfContent"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-2"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-10"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5A"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-11"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-14"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-7"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-9"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-3"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6B"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481444/860-30-45-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-7"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-3"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481229/860-50-50-4"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482312/912-310-45-11"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//944-40/tableOfContent"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-3"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480632/954-210-45-4"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480602/954-210-50-2"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-8"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479081/326-30-55-8"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "405",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480191/946-405-45-2"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r715": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r716": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r717": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r718": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r719": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r720": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r721": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r722": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r723": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r724": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r725": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r729": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r730": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r731": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r732": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r733": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r734": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r737": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r738": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r739": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18"
  },
  "r741": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-11"
  },
  "r743": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r744": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r745": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r746": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r747": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r748": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r749": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r750": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r751": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r752": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r753": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r754": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5"
  },
  "r755": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-5B"
  },
  "r756": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r757": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r758": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r759": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3"
  },
  "r760": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r761": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479106/326-30-50-4"
  },
  "r762": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r766": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r767": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r768": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r770": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r771": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r772": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r773": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r774": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r775": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10"
  },
  "r776": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r777": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r778": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r780": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r781": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r782": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r783": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r784": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r785": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r786": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r787": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r788": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r789": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r790": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r791": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r792": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r793": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r794": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r795": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r796": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r797": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r798": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r799": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r800": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r801": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r802": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r803": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r804": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r805": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r806": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r807": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r808": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r809": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r810": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r811": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r812": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r813": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r814": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r815": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2"
  },
  "r817": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A"
  },
  "r818": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r819": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r820": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r821": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480109/944-80-50-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r823": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r824": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r826": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r827": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>87
<FILENAME>0000937098-24-000088-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000937098-24-000088-xbrl.zip
M4$L#!!0    ( .5#FEA72(3=O <  $,C   :    =&YE="TP,S,Q,C1X97AH
M:6)I=#,Q,2YH=&WE6FUSV[@1_MY?@3K3G#TCR13]%LN.9WP^Y:J9JYVSE=[U
M4P<DEB)JD. !H&3UUW<7H%YL28DRUW,=-S.1)6)WL8M]\.R"Y'GN"G5QG@,7
M%W\Z_W.[S7[0:5U Z5AJ@#L0K+:R'+%?!-A[UFXW4E>ZFAHYRAV+H_B0_:+-
MO1SS,.ZD4W QLW.^'WZ?[_M)SA,MIA?G0HZ9%.]W9!QED3CLQO'!27+X+N*G
M'**C[O$QCT_Q;Q+_L[N#JB@>=*R;*GB_4\BRG0/-WSN,.R='E3N;2.'R7C>*
M_K+C12_.,UTZG,^@?O@:S*P8<_#@VES)4=GS(>T$U=EPJI4VO3>1_W=&(^V,
M%U)->]]=&LG5=RW+2]NV8&06AJW\-Z GZ)3_.0F.GJ"VDB7,'._&Y&K_(9>)
M=&_?=(^CLX-NI_O8V>68N1EAV$Y7J(JVE]Q.<9W!/*O?5_W;X>##X.IR.+BY
M9C<?V,?;P?75X./E3ZS_:__JTW#P]SY>1HG^[<:0_K<A?/QT>_?I\GK(AC?L
MKG]%@31IB&**:/C7/KN[O/W^\KI_U[[Y]:?^/]CEU9!&XBB*M\W3'Q32X=J0
M!BWV-WD/[.<.NY.%+H5ML12,D]F4N9PCS([>G6V-L(H+@7N_K2!SO8/CQYC[
M5VW);+@D2X'YZ[5)Z%D#[G9FT3S7G(]7)3[I')]0S .6\S$P V,)$V1-ETO+
M?JNY052K*5ZOM'%,E^R#-D6 63=J_\QTQH9&7H-C/QI=5ZTP-"C3#N;J]%7E
M*GXIN?J>6\P0YJ*8LOM23Q2($;1"RII$"0V6E1JK($[!9<EX.65UZ4P-Z#C6
M15\B,7F<%?B+'&493_&28;J0CCD=Y%8$2DC!6FZF)%)PW*PN7[)I\9I 9W!*
MY>LKSD$"J3183U&L1'7T1(!ADURF.;,U?2ST)V"@,4(!%-(J++Q4PR?2Y1B@
MK2#U#I+="EW3 L,<HYI@R71Y&5X=! ]>/ 2!9;+$)!->%DEM(?Y0'(?-TK@L
M,R03[B3:D66J:H$V$3A+&6PAZ"014(5Y)\@2E)5:8+*!@WTR-<)>2#+<(HE:
MH0 "42-:_'36^Y-RF[-,Z8F=H=3 2%IG.$[$Z6+P&[UL+8'-SIQ9\?;5X>WP
MI>!M^"@Y;]^\B[LG9[9!5-,A$$7H+)/X,U0ARMV <0,>)9AUF2B@;#) :"9*
MVIQT2*Q CB2>I-]"VE1I6Z,>L:?1*L"E,CH%@9<MVT5T"$"X!0CT']*<ER-@
META,M[4"VU3( ][N'NW"WL*?[I$(E_:\34E=8QD 2S,QXK$E' =<D5=?G)(U
MLV7!<C-1AA-1Q$_1C1)4\+=NJ(Z? O8D?HF W>5[+"SVZB>> -%17#Y?<;Z<
MY185PY37=GL5JDH)L/E,H<[IVJ !)(^QM)Z24 I*;X>:V@69+1.B <5]XIM"
MMTA>JR%+&I1(;.B+U4H*?]JU=6*ED-Q("D"&<NPINB1+M:42Z;>-]?74$YBV
M@ [A.=<K5=CTR;16G'@7P_).+$HM:H3"O=QOX+<$2!"I$?5!;$V%WPJPDFV!
MM?667L'7]F2P-<P0FF,I"#W<ZI(3_W&+R*,VC"#%C9BE%P$G>2*5=%,JA^NF
M);![)/@D!YP^$EUJXSS-/C0!5;6I$&36E^\TU49X!WQ#-X(2J[)"K.$(5 1B
M$L%F-> )P2XK3ZFO#%'I9D3!F*O:[V=:;L@R;''D&!?*KFE5YM5P"WX*/]=W
M+QY J(C<8D./E.C:;?9@&P;E<VF@!C#[<L_.DEEKZ?=$LQ+HC\\_3?":,"#V
M-I)*6-W5+-%)KJG]?F0M%+Z"2J@"Z32M#>5BB>[76"VT=7B=[G6A+9NBH>86
M =O=H)(AJ'"3/Y%N',<&'/PAE,ZG93WW:R]XE7,[KXU$#QZ$(#QO^O5H.&V*
M1\U[4,V)](E\ZW<OT5<![UOI[(]>06?O[UC-]TEKP1Q$9,M879 (H>TK"O1*
M[S7WCV/_Y;2Q\YKH+Z#)HI#. 7R&IA.-59?&A43_O)%=1#2RHB76Q;_4!<ZV
M(?Q62W3?;[FZ3/WI=>__J6VGXS[U.1+S3T<7.@2E$C!733V;M\\3X/=4H$*?
MX4N4[Y#\3:W9T?^K$-!TNN$(N89MN$!%"W.RV8B6IJ]"%4PYMC^M4"4MEDA;
M%Y@P7"P?3$/R:V^2O,H*^)F^FBI=9G!CM3 /X D!,^EO"C8I;X5"(<NQ5F.@
M:E'R47-OTS0< D6E]!1P=)+KP!G\$: 0 /^54MI92<MS+F18LFV0<>13[/QA
MH!E-$))@VNBAXI6%WNP+=2&5XM.>+/V,7NFLL95HYW1!YL[&Q--8X!MH>4B%
MX>:YYL%I)SHXHD>;SN!_,9NX>>K9\4\]]YU8'3M]USF--@]'G>Y\;-_;#O8Q
M EOQ\OW.P<Y,H=D-O;AZ8-W'>X$VR-,@@O_/M1E\B#\@K#VULTL\]R@6'[?\
M\^EY5I>BG'DT,W 8LOK9R".*>^>/L?/MKOK;-X>XS_WGTZ>/ZQ9^4Z#-'O)-
M8(6NTRT9-O/YY:_"[XC\Y0?W$0^CDBJ<K[%7N82,]1\@K>E,RVY":[D:\K[G
MNQ5"7_-2QA+3/GFOH]+6/XCHA1MZ8UAYTV,!(,^GT4*%)XBBVFU6V?0"PL;7
M1IK/\!++OG]YYC]02P,$%     @ Y4.:6)N7S<N\!P  O"0  !H   !T;F5T
M+3 S,S$R-'AE>&AI8FET,S$R+FAT;>U:;7,B-Q+^GE^A>"N)7048!O +]KJ*
M>.V$NI2]YR65W*<K,>IA% ^CB:0!DU]_W9)X,2]97)<X#G=;M1A&W:UN]:.G
M6S-SF=I1=G69 A=77UQ^6:VR#RHN1Y!;%FO@%@0KC<R'["<!YI%5JT'J6A53
M+8>I95$]:K&?E'Z48^['K;097,WL7![[WY?';I++@1+3JTLAQTR*]P<R:IY$
MYZW3^*09U5NB'I^?M<19>]"*SMN\$=?/_MTX0%44]SK&3C-X?S"2>34%FK_3
MBFJG[<)>3*2P::=1KW]UX$2O+A.56YQ/H[[_ZLVL&;/P9*L\D\.\XT(Z\*JS
MX5AE2G?>U=V_"QJI)GPDLVGGFZZ6//NF8GANJ@:T3/RPD;\!>H).N9\3[^@I
M:F<RAYGCC8A<O7E*Y4#:K]\U3NH7S48M>N[L<LQ<#S%LJPI41=M+;L>XSJ!?
MU>_KFX=^[[9WW>WW[N_8_2W[^-"[N^Y][/[ ;GMW7?R*W^YO4>+F86M(?VT(
M'W]\^/1C]Z[/^O?LT\TU!1+24(\HHO[W-^Q3]^';[MW-I^K]SS_<_(MUK_LT
M$M7K.^?I3PJIM3&D7H7] [)LROHE;A'\)BLL!FUE,F4VY0BS]MG%S@@KN!"X
M]ZL9)+;3/'F.N5]*0V;])9D+S%^G2D*O&G"C-HOFM>9\OBK1:>WDE&+NL92/
M@6D82Y@@:]I4&O9KR36B&O.AH5#:,I6S6Z5''F:->O6?3"6LK^4=6/:=5F51
M\4.]/*YAKL[W*E?16\G5M]Q@AC 7HRE[S-4D S&$BD]92)108%BNL KB%%SF
MC.=35N96EX".8UUT)1*3Q]D(?Y&C+.$Q7M),C:1E5GFY-8$<8C"&ZRF)C/@C
MX+Q+-@U>$^@,3IFY^HISD$ L-=93%,M1'3T1H-DDE7'*3$D?"_T): A&*("1
M-!D67JKA$VE3#- 4$#L'R6Z!KBF!88Y13;#!='D9]@Z"S3</06")S#')A)=%
M4BN(/Q3'8;TT+O,$R81;B79D'F>E0)L(G*4,5A!TD@BHP+P39 G*6;; 9("#
M69D:82\D&:Z01)FA  )1(5K<=,;Y$W.3LB13$S-#J8:A-%9SG(C31>\W>EE9
M IN9.;/F[=[AK?56\-9_EIROWYU%C=,+$Q 5.@2B")4D$G_Z*D2YZS&NP:$$
MLRX'&5 V&2 T!YDT*>F0V @YDGB2?@MIXDR9$O6(/;7*/%P*K6(0>-FP0T2'
M (2;A\#-4YSR? BLB\3T4&9@0H5L\FJC?0A'"W\:;>$O'3F;DKK&W .69F+$
M8TLX]K@BKSX[)0NS)=YRF"C!B2CB572C!!7\G1NJDU7 GD9O$;"'_(CYQ5[_
MQ!,@.HK+YRK.Y[-<H6(8\]+LKD)5:0!L/I.O<ZK4: #)8RR-HR24@MS9H:9V
M06;+A*@AXR[QH= MDE<)9$F#$HD-?3$JD\*==DTY,%)(KB4%('TY=A2=DZ72
M4(ETV\:X>NH(3!E A_"<ZY0*;/ID7&:<>!?#<DXL2BUJ^,*]W&_@MP&0(%(C
MZH/8F0K_+L :[ JLG;?T&KYV)X.=88;0'$M!Z.%&Y9SXCQM$'K5A!"FNQ2R]
M"#C)!S*3=DKE<-.T!':'!)=DC]-GHDMMG*/9IQ!04>H"069<^8YCI85SP#5T
M0\BQ*M.A#T>@(!"3"#:K'D\(=EDX2MTS1,7;$05CGI5N/]-R0Y)@BR/'N%!F
M0ZLRKX8[\)/_N;E[<0!"1>06XWND@2KM=@]V85 ^EP9J )//]^QL,&LMW9X(
M*X'^N/S3!/N$ 7&TE53\ZJYGB4YRH?:[D8U0> &54 52<5QJRL42W6^P.E+&
MXG6ZUX6V3(R&PBT"=KA%)4%0X29?D0Z.8P,.[A!*Y].\G/MUY+U*N9G71J('
M!T(0CC?=>@1.F^)1\Q&R<")=D:_\UTOT(N#]73K[]AYT]NZ.U7R?5!;,042V
MC-4%B1#:7E"@UWJON7\<^R^KM)G71'<!38Y&TEJ WZ'I@<*J2^-"HG_.R"$B
M&EG1$.OB7^H"9]L0?BTENN^V7)G'[O1Z]+_4MM-QG_H<B?FGHPL=@F()F*M0
MS^;M\P3X(Q4HWV>X$N4Z)'=3:W;T?Q$"0J?KCY ;V(8+5#0P)YNM: E]%:I@
MRK']J?@J:;!$FG*$"</%<L$$DM]XDV0O*^#O]-54Z1*-&ZN">0!'")A)=U,P
MI+SB"X7,QRH; U6+G _#O4T=. 1&1::F@*.35'G.X,\ A0#X0TII;2TMK[F0
M?LEV04;;I=BZPT 8'2 D05?1PXP7!CJS+]2%%!F?=F3N9G1*%\'60%FK1F3N
M8DP\C04^0,M!R@^'YYK-\UJ]V:9'FU;C?S&;.#SUK+FGGL=6K(^=G]7.Z]N'
MZ[7&?.S8V?;V,0)3\/S]0?-@IA!V0R<JGECC^5Z@#;(:A/?_M3:#"_$#PMI1
M.^OBN2=CT4G%/9^>9W4OHEQ!ZO]C>E%,2WOZ>4-5B]I+E._>! @77WDE6LB:
M[G/U6>[*>PP[+%+@)==8%Q@ W>9B,\_?/BJVQ;]#Y#/BS54.>\-OUZF$A-W.
M2^>][^G7U^78%9JU2KKA;9BE[;#R0DVAC'L"U/%W4L>P]HK- F6ND-47*GR
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MQ"RP7<L.N>!4&HCP[=9X/0,PA)=B_;18K*IY7?/Z(7@=N(LS%]8O&+<LX/6
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M1QO4%&C:F4L[>,<#10Z-"OLD0BMPANJ&)I;4 9,3L /8ITMTO(B=CVOIOH'
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M*4Y"E:Q.J*6($^T#]+$1.>"FQT7),SZ*< WX">A'RI=KH?=C?(JD\]#X$O"
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MIA"8RKX<IRE.!_[2%$7' ZS*D'$8=_^D9!0_X_9PT.LC?=:IJ2RM=LL)K'@
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M)K/)T\*[5U*ZPBY4,0PZ#Q.?9PJ"B#N 75C?M\N;A544:9D[>?"PKZY0=0T
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MK-;0^3QUQLU_5QTY6Z.W_<MQHU1M5(].DA<"(0O*LDO5^O)6RGF"SYY9<A>
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M7F;GI-.@:N.C/P<&HW05ZLC[!CT4,0@R=,H(YP%S24K F]C]5MB)!5Z2>2\
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MVR,2C$:KU&B?'J]<S$>>\)J-EMZ=;\TY<*R[/2)),X[ '9$\J36,4MMH'Z]
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M3K<8!;*X)PWZS?XP^:>U FIE7E[ ?IC0'6/ 8B<0[#8CK)C1;]GTSN1Y@CF
MDZC>K!\4UZ.CXH7T+YK6S2Z$\^XRB00.L$G0WS (IJS)E0AE4[99;FDP2+1X
MM-Q@S#Z@93TTB]8^&33_2\T\QVD#J63L92_VF,F.W"MQ[@6<Z V-Q8E=$W];
MJ198\$T+1V<S#_5FI-#Z4.'Z:6+[H;1MJ:FHJ5T9,T6$:SVBJD90N!Z;WOV6
M2%I <:X_QZ (\^>[Q.2ERCH2XQ-E*3\LMR2\V9G;K!8>,Q,\-W3"KZN()V,&
M*#8YFV<(I6F*[XB>UX\0J18]EP>6(#@4"<C-<G$-Y7EK<JBD5-UXMK]7*@S#
MDIAV)7H78T0PG.H"<M4.Z\7AFG74^<+2/1?I$I_IF_&0\KLF0ZQ>5K7/-:+%
M\DYX!B 1&L]$CUL<KAN,_JTMH4+?4&FKNIW#JBX8")4RNCNK1O=VN3+"$UA>
MD.61L]$,"ZK=.;:6\-[FE"O2CAND[\9ZN(C\E\7,$I:ODJF=RX8<$:V]D#<P
MZ"WG#6B]P79Y [W!2MY QK*^3M4Z4=TR^^3:@G.7*A\$O7W,"OU#YU7QU1MB
M]4(/^!C-2HB,-S8UP:- 95YP/9MPH!-W*O3:9_AM%@Y""*\.E!";TZOM>ZX'
M%R![CNEH<T)^%DI=Z [17TEPV3Y#6NMQ0BTQTAK^$P F==?Q7'AUL-H'9.==
M5ZT>Y7J9 C?.P-FHJ;!,/Z$[+Y-L0QD1ZZ=HFA^6'^4:O,,M1[P<3T_6+<.,
MWB-80FNU5>7&QJ89ANOZ/#L0[V&MTY9>L:ZP0F9=R:PKF74ELZY*RKH:RJRK
M.K3"Z,M6&#)52Z9JR52M8TK52BG3+K\1-3-$'K%[056K^&_!Q+AZO&>FB=9/
M*>!.J-]>[ECND==H<F&L\;+KV?K/4UZ$M1!^8 Z"M#>UEZ(2Q%IXF65;I[%>
MT$NS$=/7G^Y.D,:1-(ZD<22-H[+L"6D<U< XZK>D<22-(VD<2>/H^(VCX@;'
M:YELHZ_&OWQC;.#8%]8G;FY@/ZE[ZMJ^HV_;-+"X360S\,)-U':V>H0&PU5(
M,!8FZ'5'1H:)O^&0&%W'UA6N/YD8.FO[SH*[$]-^8<D',PJ6&FL@-K4=[Q2.
MK1G#K&E;3_PO=KU#X7T.Y9%@\9:P+X;H8\(:8Z!=.G? Z#/F0!><*O &,UPP
M:R 8WH'K!PX#4VT<BSW'9R-%75(PX?(9C#7L.O\#^\-A"-O*=D>X5Y:.'.TU
M6E=\BPWE96KHTUC0CYO&0=Q/3$GBW5Z"S.6@ZV$458P6PM*3Q=@CP3,L'@EO
MQG$^'&XA9N*&^(^'JX4GA\8Z .X)/CLL075&/'W*=T_&SV*N@&E2/;+9<>-W
M5[>*;B(9P"L? 2*&9<R ['@.BD-A.7R,U'(+0)Q@Y7E!I[KX>F)7LG:/BXL4
M^WZA 7CC2Q #"B8^)L4L/3: P$(KR81G;]GZKP(L?!WO!(3L1$P^B60*9,H[
MRP!LJ<B\, W.U 9K)1,D>7)G3)2,#+P$,-:Q[L/&T'?XUS(^V=RAV."4)-!'
M(,=;IK8YYA-N& ?-X64V]A_<.( K/@?-?G+(3/ !9Y%@/%?P6U,YAYML_VF*
M1(- L&Q0<?S1/V$C2# .??)-G#2&/.EZCB$V[DV)%Q*9SVAK;(, 8L0'&C;"
MRS=$7@N?DB;ZF ;\FP)ME\Z)PSNN"M^7C8TL?<=A0]:2;YI2DS$C7P@"Q9V\
M\5DTO+VELS#.+*GC)IM50UPQ_&OS+*],A'XXRZ3;4_-:)EVUJ?9[A5@FO6:O
M(+_5(9^4_OU Z]=^=^N>M'YW.2HN<V09#W,\(,':XJRVS\KE?C:[$_M!*T$K
MZ)Q%NN\/7)=4I[,1R&<!L?8V!10'*&//YO3+6\:>R9%=86Q>!*?[.]@K* SO
M8)>/V,!ZFP8,QPD.2>#'MLM5 M]6O=G"'5QDD=X BXTRG$D7"Z;4IZ)07+DP
MKWS&+F%O7F?*6\A7DHJ#FAGFQ4,_Q#,QN>=_8]UI8A%M^1M+*4+,LH%2JW^S
MKEP;ABTD2R2$?5<;2_HI:^6B?%S2T,$Q45\:.DX9E-'>JBZ9)8.M#F26DLPU
MZ+]?F7%LR"RI;8E$Z+%PYQ:6E*9FLJ0*34O-"*WKJ.E JB]@UV9$^]U7LBHP
MZ!Z')B!@5W![J$-@Y*@4_/V@Y1 Z\[$PRC8J<TWX*1F&O7TTGZRCN"E;KZLC
M[Y=(0L>J*=V+!#C*O<Z-%=_S<A.GH]*GU/:1G!-UE'#)*!E&"482)=50IM1&
MJSL\#J2\.WU*TVI#VH< C]K0.OMPK-21^5,AU!M*A2HSO'CKS,7<_J/2F8;R
M?*X81M1&NR614CFEJ?V>X[8U8:AD&/;W,=&GCO(F&3R#0:<V\#F$RC3L'C16
M5V0R[R&.,Y:]O$&#RKO5S%'I0VPX+2J=?7>55$MZJE:U\R\/:VPCMB195I\L
MM8:F54XQDX0I"5-K##JM]T:81921U)2X\Z6HU8:XD[?5V>!FE0)0THC64-O9
M)SI+*GFO5-+M#PY')<D=A=MK.@IGK'Q\QY=M<&@$+80LVUKCA7R/5TG 2<!5
M"G#'Y7N,M6.3#L@J:PK)V^ITU/=F3DNRK#Y92@>D),R*$F:O5[D\3^F E&Z#
M(K;5;J_/A)4"4-*(=$!**LE")9W>^@0QZ8"LV679O!JB7;FV@M*Z>SU^V,Y/
M T=,\+D2ZZEZ=RA41&AMI=L7L/M*ZOYJOZJ^DD*X;O>S6)+],9)]1=MW2-*7
MI"\E?NEDOR_5+]U7=#2LM94%6'_62JF95=>W(#DTG4L:/'X:S-(I2-*AI,-W
M+0ME&I#,GSH X!:G-==HX.@YF]S+QL%QI@YFPHD1F6,V:G-*GJE"+#92EN)+
MX:;)Z<)P4H4X#K&>Q#1@-G@3!W4ZE+BV!<!Y4TSC)\[+]&SQN# IRW:4B8\C
M;Q4ZF>!$3YL//YT8%CP?WZ;;.!37L*V&F'/*YPV' X,;T<C>1N(L77Q'\+T3
MS*4N94QLSEG5(=;8<S[A@@T] QZ7'+YLH#(;%AH,;HVF'M=V..X/($CJPMMQ
M,"L."&9S5*G%IEPSB@.2Y;0UIO_R\:JEB:Q+8U=# EPS=16!R"9+Q\;#IHY?
MCC_(FSIL8JT>CEQF1"NF1+O1_.5@\#&?+AV-;[9U6)_BO=A\P+1#8?ODS<71
MP,$X9QPUS>X.ES.&E0>3L'$FKL/&5#\;]&5YR'6F4;,?7!_61-ST6<"-A5F^
M=&;X?%:X;A)C%N[V(_MN&7MB,B\;:3WQS8F!,YVGU*4IZPPF<+/)T1/JL%GF
MKG+WY:*)_\'IUT9L@/+R.%XW' Z<N3=B?2=)+U)L-)HYF*W,1C@GCFF.\!DG
MD1$*?\/RX%\F9W :L(>4*G )\,X/7>6183OV,#*S?4M,NHY884R1%&"/(,?X
M9/H1!5BSE0 /4()CV>$P4MXH<?C6</MO<%E$9"/.]-'V=#BR#-@_(Z,Q(DD,
M?PY7(TXXY$UJ*1.0H7P/NN'H_LSU^(_Z% ^^=*9+?&# 9@G+81/4+=!OC7G
M*[C1B>_P3E31XP#H" QQ>HZ("]OTY^+XC,Z[:(8]6R2PINL:0@;F1AKR4<A9
M%NH'UJJ49:/G%?($U.)RA$4; G8W9@)SH32$>X+]-Y54IA,4WM&:?;15YK;+
MM()/3"(9SU1,EN9V2OQ&P::MZ!8R L/#]])O69D">(@!V8-N^R\Y!V2WM:;:
M[A8R9!D>I14TKYD]JIUE8/,2KGMKTB#>PXB[4AT?F>S_Q_OKFZO''--6\^YD
M Q.6ME%-711$VVUU_WZ;;)L!FT[Y4U6^W-Y_4]36Z9^KTT0#([8\)65)TL?_
M.W4BV#[1TQ$8DC]/R01(X!,Q7T /1E:*ZV,@7)>.AS3)'E/4V#KK*NG[6K,W
M+$8\:]VFVAID$<^I,I#H/Y_ XK'&IX)F:+NO:=KG17?@7K.I)NR?':@T.:[Z
M[?SF_/>K;U<WCW]]4"ZO'RZ^/SQ<W]XHYS>7\._YU_]YN'[(/J"V<$ DBTLF
M=M(%3!XP91$P?+5CJMO<)?,)"($Z>!6L@1QV 0K8SI._G_R'T6FWZ638[0W@
M?YT)Z8^Z'4+5(6FW6H/AA [^MP^G&V-\4$TOX(6\/3XY2S@'$MQ^1^I&TH-I
MXLK<AT]NC3U(X6!T9OK&-TK2_*#H44 G)I@MOW1["BS%1".9>6\NJ4YG(^HL
MW-%N*'/'@'T;:+CZE'MO:/@<9BISLS!8C&\M66&),X,;BU887&$G="8.?22P
MH[$#-I$5&+[L>1/3?@E\3Z'[E-GAX0*W,N79^\#R?4(7KSV9P%+PO=[2<[VT
M:MS %1!!Z84Z- [)<"_X3!U0[1@CGSDL '%_W%\_!.:G80'$<<.> R365.X#
M5]&&Y)B=3HXD>MNK3-QU!=F%HJIJ)V<W-M"I&I>%)6J)0#C7'ITI*J+:FQJN
M\L5V9DR+91)J9COH&O:(8>;RV!U.&JD:FVD72A#<&)<=CXYQ [R#7,#<]IR*
MV3:1\(4(QNNGMBG\0NA_FSOVLS'F;B[&#8%;.;@3?;,>\U@A+[!+OL/"06!X
MY%4AOC>U'<:*,='B4-V8&X&K#N#.%P,?=/0G@O;"%AER7!2Q<3WX9=&%6@1@
MM4R W<3I>\#EI>\@+I@WSG  1O_RB>.%B.TTV$\<?""G_!F S7ZQ /Y38RZ\
MZLQ):S")^,9<^Z#P$:#]$;%^*D37N6>4!3H0]W$T<R)X'Z#&LRH6L& GDX&^
M_0G&61"N_'Q="D^N>/\9U+W%A\5.).:"%JY2 SG111PX/L9(P"(%O@EB(L@_
M"S>&_!-<@=Y>P:YP'P^/,+2-*7-(+ASG_)?E!P9$PUG97%[M^T!]+%JM1(%J
M%@\0R(:?E]$LG.2<]U!-^455VX$B5^L C^_RZ YYAI./V2VIRN-RZ#-4_D@0
MT\/ A6<[;POQ LXC-A,OB8%U%E 84:#9YR@&JP,,9LAT^*8Y7!7$"F+9 ' L
MP?>46UM\,4P=AV5;E([YFT5@0[=G<'8%F04\K$I?#9?=PB/_H?:+FJ%A^>'#
M8@IOI'!'+XS"XJ$XF-MH]^$A9@#/!50UIB.6J8#  ?'L4E!BA>8*$&#R&$AE
M&GO)(BZ2XLKP=L=V767FFYXQ-VGL_,2X"4!8A))M@-S8UYG>BRXJH;>S0P)/
M!>K,X;0!U!GNSP6,( )"2*4M;5FMYS&2YU4CZ04#M".0J/YD8NA,3&&L)\#T
M\N4Q.A$X15T$2,0$,N!1(0MX2/%>J EOFP'FIFOTMU1^._O;R/GU;&M&+LCD
M5C?YDK@%B@#_@C196\&#Y^\$3C7[A6D\C(,%D[N+AF:<NP(UE"F&0&/P;GOL
M?BH$"@?RVJJM5K/%O<MYW+;=3K/3+29 UVOV.NN]MID7U>SWD^_(_Z1V.Y]3
M.OW[@;8^9)@=3L-.\B_YG]3N]@J#^'HJJ$QGMGR2<+A#V5"X34W-[#??%@Y<
M:NP3$LM^ZY0.=2RUZQL[_90K"VWX4,-=#=(5%CA>/T=EMXTFH_P#:.)"[78_
MIF)^N#.!5P6Q:)UDCPMMD8%P5*!JYZ'UTK(V#@*S?B:8A<&,HFBLPGL%:^D=
M[)+U*LV16",)_&CV^EX)O$R=)I\UG$V-9;$:M'?C\9</OLNB(A\_E8[30J?C
M96RXL5:1KWNVYA$\HU[$L\7PZ#[/]ZN<<+A-<#-GF"!YD*+GY1WEZZQRN*KE
M;.O66D6V1MG%P[&&C+>KM9>4L]=U?VAK[15GA41BS9"H:MH>D9C11*LJKO-U
MMZ@.KE/:4_2&[U7R'A<B/VB=WCN4O$>&Q'Y_7S@\(D/AFB52KS<4HM!8XA83
M:7?=V/DRC]].P40@MO!KW0%3?+/2@YDF^T') 53%HFEU&TVQ%B2==FJK[YW7
MTP!3![@<0LW;FWU]1!K"%YX96HZ&< @O2ZL,J5L_P!R1AG L*"F)5DO2$,H7
M^%JK):EK#>-M[O+[OB&T;_J1G5!+GB2=-UFY?#L=LSS",O8/8\H_?61-!M/+
M]1?*^D6)I_@S[YBQ[9IBPW.J$!W*N*N-+%KR=M0H>[<::E=F!LHH\A">V884
M2O(K?SOK L^2$MX5):C#8?F4L-4)GF>&<L5(J:")IU4AI929R9V!/&(D-401
M]H$\8B0E@*Z[P:;>$S74/?O_8BOC+TM50#6F*!_DLEI&;9(UM]_B7>IYRP.9
M_WV(=;?;%;/ECSB![;@H1VVH;4W2CJ2=K6BGT^L='>W(;/<*!<,ZK=Y[E17'
MA4@\9U2)RN- 9;?=/V2(.O>$U:K:3U?8%76#Y53M6<)["ECD=RB5OZE.=U M
MW:?<X=>2(*M&D(/64!*D),CJ$*3:T'K]]T621?1!J259%Q1&JA99)V^JW^U(
ML2?I(W53@T%;TH>DCS7V<V^#_;Q7"DF>0ZMVL@VBU0IHY26?4=MG5'>X;_9^
MAGDSW64^P_'E,R13QW=K8PE#Y0[.(PLIRCYVDG!D(;&D'BEV9!I#'>DKI2ZA
MN]XE<,2"XK@065+YND3F,7!EMC0&,?@IW?BN@^5TG['T.]-F*T'J6\7ILFVO
MD@I0NUH:T#;,L9.?7%)F-2DS0YVX)))W3R2:FMJTJ@0BV>%P3P_\UX?6MHK=
MU8#64JJ*NU(<21+9M?!<$HDDDN[!%!MFF?[*)H/O=T)[SB'SX81V]IQ/A@<O
MT=?#4EN<1'6^VCZV;@/H+^S9W+;XN/F)8@43^,30/<5.F+JE$(<JQ!5SZ]_E
MV/F^VE2U?(/9TQZE:LW^H)BY\_BH8?)/<@SZWT]Z-1C]*:><;S'EO XS7<N?
M<E[M;18_H;P0(MZ'O^ FRZ&ZDO=5R\3:=U1OLFX,GDRZ?M])UVL&=961;5VO
M[,@=A*9RJJR;]5[E=NP'&9!:"\B4/\#P*$/G&]AJ[MC/!AH.H[<TUKJPG;D-
M/] ,#+:S^Z\B#%BYV=9E!I3JC,[MYM<>C>MS+[[!QRE5WBAQ3FW8X"E^4O0I
ML9XHGL?97(43V\$C6IG[($M<^.*%N"![#-@HK%(9.\8SM5 &><9,M';430/,
M5&5.WF:\^V?PB74O(6^.;9JL=";X[)%7=$I:N K7=XBE4W@(,6:QA325'U2A
MKW.J>XH'V^+[<''=J>Y+ 8N.QF4YK!\>90/.J0G[?*:1"Q'=A[$;!4);T2UD
M!'3E>^FW'-X3.APV!]UV7D=H6VNJ[6XAWDMXE#8HQJ?*'M7.X@A=PG4O6UUB
MMM+Z2CRCNC5TV3R C_?7-U>/.8KB\NYD Q.6ME%-6Q1$VVUU[^=NQLVTM([R
MIZI\N;W_IJBMTS]7O7W!J5C><;8DZ>/_G3H1;)_HZ<BAY.<IF0 )?"+F"WES
MD97B)S<(UZ7C(4VRQXYTMLZZ2OJ^UNP-BQ'/6K>IMM:'O#:99$3_^>38OC4^
M%31#VWU-TSXO*G1[C6%-V#\[4&FR!?+M_.;\]ZMO5S>/?WU0+J\?+KX_/%S?
MWBCG-Y?P[_G7_WFX?L@>(B@<$,GBDHF== &3!TQ9! Q?[9CJ:)ZB?@6$0!V\
M"M9 #KL 9>K0R=]/_L/HM-MT,NSV!O"_SH3T1]T.H>J0M%NMP7!"!__;A].-
M,3[HM1?P0M1Q__8K.4LX!Q+LB-I9$[$6_JG5[XIG S$[<.G<AI_A+S0>5AP6
M'\"J$&;'Q\#NL"T7DQ)>J#(C%@AQQ?8=Q1[!=L,?75LW"+[_Q?"F^&1XWQ2D
MR--465I<L[;Y'+>P:SUPW,1L,@;#">9KH,V#)I#'@L@S'D2F41"9&\QMM:&P
M4SQH8#!N*"]3L-5T>S8G#F7(P<>X9$9%4TE\,H;V&G$+SZ?!E9&)AZB)6W6Q
M!4<(*P4'):4,75O/0&#'DC(4M_J-<&=+5C]BG),%&OS415T'F)<""<;(0P=$
M&R[^@L:]#^1'T$L ?_ '"Q> 3N8(:V;!6V/#\QUA\1,=A <WLO&FD>_"<EWF
M-(#SBYCP"GLR<:F'8@-$B$XIK&?BV#-!O"!^\3DS L\TO+>E-S?3O0,U2&[:
M4M%K-;76>N,Y<T)2NZEU"LIMPD<-R\IMRN'#EVE.,LU)ICG)-*=WG^9T'1V;
M69I85=T56I$P;K+ N$O1E&0?J8-D;0Q3J[1D>X;*X3#E"!ZD9O.]RZRL%+FS
M8$%MLIZ.*#'KF$=/51D;*4VQ]SNG:0/#!N:Y95LT73?9[JIM-<3JJX<)7J-U
M*DO!$XVKH\P4-=3X$'T/AF4-N,Z5[5X]BCC,F.L#*$VI*;G[(XCJ"F?YZI)?
M7:\S+RF&(>WUPY1NI3;,D/9ZY7"8<O2HJ256!RX'.2X=?3&RNV4:?8U4MV);
MF=5!M4N1D9U-)8R[,\ >VPW5B.**;414!XI+J_#;ND/1GJV-(^I==)W@>*E;
M_M$/*LXFA2ASVPER?\@S,4R67\-RW1:\3*=/#AE3Q:4Z^JDQ18FE -+)A.+9
M1@,/-OYB4A?S F$W$_P%RY[8WQ[K>Z2;Q'6-B8$92Q9+9!L1DY4<N5-*/9:#
MN)! !*ME24Y H/##&.#EO/%B)=?U*2;K61BO#E(8#?[0Z!&P14#M6WTS$@$
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M37RU06'UJ#,#!(X\V4ZY6+D)P'T$V%X":->V*]"&)V?#@;1RJRW%LF*SW3H
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MY@/VS@O$[-U6 S" _V;  5^T0L(WEH*!:]?UES8'+*GC!E] .7:IE;2W82G
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M2 7:DW3*ME%MD#M"6EVCFX6&_U25+[?WWQ2U=?KG @(7SH@"UJ2V,LE_90G
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MH]KL9GKIS>WCU8/R>*M<W-Y<7MT\7%WBIX?;K]>7P">72A+C**DF00QZ[<*
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M&+R9VXA2?,J/AZLXZ#YMSR4+B>WJ()%O^%<&D)+E?3K%BTKE)(P/:KW/1>H
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MA<Z8.6_0+&!_<Z##9:")&G.3!@1MFF_X.YU[_%Y&T19;WP.^GA'!.4,Q8<>
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M2G/M?%2YW<J$^M-P)X8)Q/<_0'O+:\KH5;3: (]*DJ(9K\$Y%,8H2>Z^$\F
MHXH"SR\ G5!,P0R(%<@J=V);WLL$?*17_DD:$)1895CF8LO2,&T/0[' LWV^
M_9]A]Y%]G9W\JUQUE1BLX'+Q;SXL>IY<N&*Z)1^ZU!1L6"P;(O/Y?-BGYGXV
M;,;V=!)<6%4N+ W+S8S1:$HO@>42\9F*^.IGR6?^06?&9P?GBU;"K^; !ZLX
M9YZ8!\G\[N,WNKI^>09K%[8'_NL9]F-*PW<4<4(0R_+:99>"6<J?;'WZC"1
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MN&$>"Y/8=!C =#D;3=8K=+8]%KI)ZTR_43+14UX.)0O _$:GHX^+2"#ABG#
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MZLF\EALO2IE(VBY\TFQ&$N&3#"#A-!/PL1#^ME_,:*#Y&'N#'7P++P2>=[8
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MI*$>F(;:7!=$(@VUP#34]P-KM(#_3-S9M/O_ U!+ P04    " #E0YI8GRO
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MCXU6SVS?-5NU]F.CVH(&CYUNXQX:-[\U@K-/+O9M*F1IFPF1W=C20EH!'$T
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M#3UO//9<U6WY:9!=IQ;P3"_V+-[&4W8"S(_ JA[:44&07:<6V-2F] I@CX7
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M^[+E8$XY-.)U6$T[WD1> Y=AV3QD>#R&-*,V3-:/WUPJ]B*#2X_:@Z^>9TN
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MUK,TEW<8IGA8IW&_?)SB8K #9='[('F-)M!8D0GPG!=(12H9&=EDO'4 ^%Y
M?3H5;D"'=I/?+HMD,LE_#T>C033<(%$/DD=#JDDQ<-HJX)+0$!L9>0"MTT66
MS^[3B6T#*3]I2EM6\X3QIV$<G;*J.EKGJ7#GR(1FDFO+P;I*M7H@'>L7&G52
M43!=FF>,K8)K%2+8[X<(S471MIAA">JR_1HQ9*^ A9PK% 9>EP0&,5HF0V2Q
M=97.K4!6H8'[?FBP_F0WCGN<N;8\FZRLE]7B"* "=^ 3<M!.)=3*.-2M\S+N
MB1L\X2SBU!FK_U3#ZFL8+8SOV6[HNA-:8Z?')$4**3S2V'BAB0X8P!EGP:KH
M%!>",]>\8\$JP/H7-7D*+VX</#272;L,ZL^3;O8!N^-+GMJ *5>\TPI28M7R
MTJ1^58C5+1.,!BMC;.T:WX:C?P&3%F18>\:W$E [&ZFN*7A9*<A6.5!1&7 N
M:R@.DXV.6\RMJZA6@-6_*$D+9K261\NSILF<0!QB0M)>9+N1U7:&*$:))9"S
M[M%*4"(+<!(]L*(0A5;%R-8IL/?AZ5^PI 4UFDF@8<[#S19-B_%> N:B#D%*
M SH8!&6+(K+:3$I.<XT"56C>,&$%6/V+GS2Q,1K+HV&D%;^$X5FV]QF44KB-
M(5D"D HH=!*"MAI"8;X@&4(YMFX0<"N0_H596I!A_3EO4X*Z\/(.PDE-\+TZ
M.A=B,%PS8!$3Z2R'9/9ZLG@3Y][E$--U!^2.8M$[']&_N,DZDFTXG9L(F)SA
M$$EZ(8($ICGY,,E'\+6'"X;D74S"L]S:&+B)HG^ADA9K>LW9;B;U=\,0AZ/A
M;(@7Z0 N9^F" VF-IGW%)O A"B!P-EF3"T?;6.HW4;0R<FE]5?OJ[+B27N[F
MF&\9=2@JZB@\J")K$H10X)5)X$IVN;AL>6F>8?)(C'T*IZS)F[LLXHV(:Z-6
M\AFVDS-D+&AE%9? DZ1IX-E",+1#H_:,&9,\Q]8AQU5P]2G\TI@\S<72TM6N
M_#T*H]!=&FQ6@;S[R,"@C(0E2HA2*B"SW4=9M$Y\ [KF%B1]BKRTURCK3GVK
MQBVCFBK:G::D?YB<-]^H\>(A=J=YHK]C&,T^+XNE:O9H+:KNOEX Y]$PQ)IO
M99"\/2V)OU+37,BDN%=.A!5-[#9X^A28:<2<YY)6,VU3;U @A#4=F1S%9379
M=37(@I*H#&196[=Z7K=,9L'39''I)9>L=3[E"K#Z%,1IK(=:"Z6-4EIJQZ7W
M^2%\NS3J,^-K^<NZJ];<^5HN,5"<.XV,-"?C@KZ( -%(<GYXXN0)B>*OUZO<
MH86>"*!/ 9Z6:F<;\MA0@MT--D>CE,Z6O-= SK R6I*EY2Q(CA%509%YZT.F
M^Q'U*7;46+LT%$6K1MW+_?*@P^/A_/@R>ZMG-QWDQ&.4!,(;5XBRTD!(/H#0
MS'(MF,?KB5EWMNI^X%%]BARU5!9MY[AA*&F,T_VRVV$>GA]2&*NRLQ$!?3VD
M8)P3IA A!T4.O'/)Q-;VQFTX5J&"_[ZHT&S:-Q%+')"^R=%R!E+5^CKM.&U,
MBU-,(W2669+%L[D@X@:BHEBT$U8(<"HF4$74!F>Z /)@:S8S%ZQU/NEW$P%\
ME+1O\G>MN6['WLGX4TWD>8UQ=BF),=DLTJ+[ .?UIIL:8TRJHLHYA*2MD:V/
M-F]'TM, WGJR7W_.M^(]7\)6BG61^P@E)<(FE2*GOMYD$4)QH@1;0NO8W6K(
M>AK+6XL?&Y!),[Z\7K8K.6]X=&G0M?;)*,V)PT3=7$\'??!U.R\@A(^*QV0M
M;WV,]@"DGL;LUF)(2RELVD&^Q%@;#7?.:6"U'$X5%\!A=N"+\2H:Z[TTV_&1
M'Z= GB$(MQ8]VDJB;:[%9:9>TF4)L5BOP3)7]SXTA(<;TFJ>&S+F?5*MU<;=
M:'H:;EN/$FWF?A->4^UY>K-52;2)*U>;%:$A+(S\^)A3@"""0V1"&-?>A;X?
M4TM/,1<=&4L,3,@15"[D^Y9<:MU$2!B$$:%UDM&=GF)O/*KUF7"/F_6H*6_:
M5FUXWCS@M,7H)QRG!2"19:JV6]*2!D;F&A! 1?X?076F2(6MC>I[X/34TVK/
MB58B:5>_='-\4H?"=,B0DR=53]\25TGIRY)K,7EVDC>O7GI W_7&MVK/B#4%
ML.W&K9>O7M_=.?K]S;O]?V^@@>L#C]G"O?(/#:Y10]=:71"FGP^ZR=<A?=JO
M)Q^GU;5Z,QP'T@KC3SMI-OQZNH<H'532GD%>9.%AR>!B<:"MDDPDQY/:0,?S
M%=&M7>403A9:\<VD.\0O\RY])N]AOUQJ.3G@05B5E03-:GUGL@C!TDPPYG(A
MWU();%U)_C"J1UHS&^\IO0DRW:B.:"NK=I4R2UR'N.@4^&'R(7R[='9/<(\^
MAPY_);3Y<H!KD*20 76]7;E>;9JB!,]2 8GU&D"K6,;6UR@^%6O?>IAODV\;
ME6O+SECDU.9%6_\K)X4#$R2/@A<@FX#F0)&IY^H1872)%RNR+\V;!MP)ID_V
MU;9HU$0P#:O'ORQYO5^NPB'EZ2(9>U",M:"\51!<1-*E.2=FHS.F]0'8G6 >
M&<'^(?1-&\FTO/?FME&?!UHOC=IR3NZ!E\!%S3[*KI#G$ U@9)++G+0-K37,
MZNC:WO_CN2R65#J@%KP*&&FH-&A,PM9%2T9&:VNPMS=D;X@A]U^8_1@!M"OO
MN'0+U7ZYW@MKH#U77B0#)M;NATEK"+GF][#$;=8E<]^ZU>#]B/H4V-H22QJ*
MJ'&E[15@9\>8NV0Z?JH''%'ZS!W9BB+1AN&<A.A] $_V8RXY)(S-+X!^$-5W
M8*6UID]C46VGQ^EEO.?W<_K@C)(&!%:BYUKWA+E X4)(B2X9O=6VI[=@[%-Z
MPK;HM4DQ-NPJ=JL_ZW*,)6@#03 '2A@&T08!R@:7(I+-*UKW57YZ%&);B0M;
M(DX#D;0,,7P=3NGQ;R;=Z\D\SLI\=%;//=!2J")('4K$ LJ4VB V6BC9LNBD
MCQQ;)[K<AZ=/"0U;HDHS\;2\F[&K^NXUGO[[=GRS(=: $X.-$0:*X$3E9!+$
M&!*8H(LKS"6RS1H39Q5<CZPE>I8(1&L&-9?7!IET9^.L@34\28,"A"GU"C#"
M%IQDP$-(QCC/36KMHC\"WB-KE7Y07K61W@;I=;45UR"*H)E."FK#)E">OHM>
M)\@V1)6*D-JU3M9["-,C*YU^4"*M(:<-LF?A35X,_C0$(;7B)@@.,M:+$;@J
MX% AF"1,UH('R=LWJE\%V4HQ1?;#4VEMH;4JK+T5V)7^<0.=F/9(6V]0GF"Q
M4O-BE0/&HB1X63%S+57TSMK:AY^V$C^>.]N@%3\V(X,MF-37.FI=1!PNY8,F
M9E)@B^)P4QOU6P2/M+E*B06=\!Y5ZXK]M0"OQ+P?+)"]/0EOV3H_+\JHMT65
MB&3CI1@9J#HS-3<'D)LH!+FJGFW>FKH7XDK$^\%"X)N4XF;UW^7^7P,;H^:F
M6+"<T0I0'"%()T"SH$/)ROO<.E_Q05 KT>D'"WFWE=0&"73:XVLW='C>;^-*
M#84R:+)3D+2RA+(FZ$0>@)7(O8WUEYLWV^_'N!*]?K# ^$;EN$&VW5/I7%%B
M-DX*QX'+17H#DE)EDOR-S#QR10NC^=5UC\6X$MM^L-CZ1N6XZ4#$WO&7T>0$
M<9G(>AFFE\1\YL@^M.39*N<=^& M&,4%.;N>E/#FZ?8 R)7XMJVV7L\;G6@D
MR8T%*FXMPJ[H1)0R&AY!1T6VHJ>5X JYSH5DD R2N2BNI;FL'J^XZZ$K\69;
M;<&>*6K11"#M*D-I!J[=IG;C\J2K+UQZYP%VPTF^/L;S2RCIF\]A_ D/:6'L
ME8)I-I A:"EI22B;%8VQ!(A..L@L!F53SI:U/I+>[@BWF.(K!>,FY0C<HJ:Y
M9!I(I5B((274GF=[?0$_6XKO\R;%]ICCMR36;D+\F\Y /[U>[3H^RPTW$@+W
MNJ8WT.YGM :.T3%9@@J\=8K2ZNCZE(W[_=-S7?%OFIZWE87X1 O%Y !"Q5H6
M(B)X72\*35(66D%9]::&]GFS?;]_>JXK_N?0GIS9Q+31H$NB:>"T?"*2=A=>
M)EI0A=G<NO+KJ=KS"5F+RZ*J#Y.=1%SI\(] GONLGJ0<89IW2Q&5HK-##QE-
M]==)>7BF!#AM%)8HDS6MTZ97 O8]%'JO2ZF["F_;26PC5;9'87$6]T>854@G
M^^56F.2P.4ZS38M=.%#!<_++>08TC'-DWAO?^LCUT2#[9*!LBV,;%63SW@+G
M2X%PDWD^.SD8A?&,0-?M[\OQXHKA&!.FXFF3R;3)1&O!62W 6N51A\Q"V50W
M@8?1/=+&^#'56!O9;;+USL[1[_7_O?_U\>V?.^]J1YJ=]Z_?OO]S[^C#HC_-
MQ_>'].WAV]T/>Z_I-Q<_O*;E,AQ-KV)<L1'/V@]MT):G[< ;->FY[V+QVOS)
M,6LE,.4S;7^UU8FHA><RH!#*\-@\N'4?GA:AP=J:[*I%OS.KMS&=T)K\,XSF
M.# .:476BI>8#7V)M!QK\T:TGF$LJ+!Y"\&5@/4I -6,-3>:R#474</"M4DW
MJ_W%+X_5NB*%S1;($@R@4LW/"_1=LKQ&N=&5ZU<8-2A;NXFC3\;5QKBQM@ :
M]C>Y>XCGUPX0+/(/*I)Z-V!2#EPPF;XXX91BSJ76^6<KP.I3'&9C1&DMGG8M
M'K[2/EY-_MK7*5RV_.N=!1<_7>HB[%%%[\@XQ%CO_HNFGJ$E#R7K$NL]+T(W
MO]WST2C[5&R],59M6'A;44Z7L,5 ?QJ5@&!X.KU4TCNE0=(>FD-T4<G6.]=J
MR/I4@/TL*NJ)0MJ@SW;)23E*GS'/1S@IRR!T&+T=TUCF"^CQY&CX:3PLPT3>
MYVZ8X:=)S<(,X_PF#+N%\?8'ANF\P_KVR3@<UF5#3_OT:Y@.IVMX>-N&N+X_
M^*R3VLA[O*X3KVK"9<^)VE9@.EM@&4BGF'!<0DK)@@JD%D-6"CAB\45&^K]U
M .FQ&%MO\M>>E]+\>+[(K/JMFTRG'\<=AE$%\%L8CG_%,NGJQ2,#&[DH5FKP
M:&GE!RW!D4D+,AMKO99>Z-;MSIH []59PD;I^9!]L'FY;\PN715Z;99V 5W$
MXHSE%B)7U2OWU2O/ 9 7-,X5S4KK ^@FP/OD/'\7C'VZV+?N20UT9BG0' ":
M6,B"\AY"$K*6^DO,@7ME6H<P5\76)U_\67G71'A;-W_)]OI:;:])J:@OV>_Q
MY*RF;1Y&9P=^S4W;ISU^4V9K@\G8D$EZE5Q+!/33$=G'(SQ'1&INH+R+/*1$
M>Z^H]_WI #$*"Y*9R*.T(>1-VURKH]VL!KUX<JW+'([WQ_B_,73G#L? T&)4
M,GO0DJEZHPM"S": E-G5K$WMRW/-U>V(^W1\LB6./D[O-A7YEC;Z"\P[988=
M0?[PN9O,/WU^,_RZ0#^]@!]LD5ED#D)S5:^O#^!HSB 9HT+4,AG1NL:R&?@^
MFZ@](V];(CP/CROH)?X/.+X&/^L4-$^90->3"ULXN'J?-6,NB, -&62M6X\U
M ]]GD[>//&Y&A.?A\4W,F'@6*FEPPDO"7+.4K8D019 >D^"2M<X"7@]QGXZV
MO@?&KB?R;3MQYT,K-X?6UE][^$D;<LT>.<1&7MB]J:]W$VJ@;4;%E0,LM?$G
M,QZ<C8&V:J^LT<YPT_PBM*=!;9WE?=^SZCH;E)BE9\4#1J5!H2\09%W1(IMH
MG%7:MDXH>2S&/OE8VV#@0PG?366ZD?J""^V]:')Y<GY]:QB-IO?.DS.9F>P0
MF))D1>O,P$6&()/%E!7#I%JW5&X"O$^NU'-S=#O2W^"FOK.[>_AQ[_6_]P__
MY][AT>[^'P=[[X]V/KS=?[^[?W1Y%[RMD\ID6NO^L/N*RV3\=8*T&T*ROE&P
MC2EJ9#2<MWTCOGT<UY:[NZ,P/%XP\O2;_'_FIW'E92_>MZ>9,LM?\X%6 HL2
M#DS$3&9NK1XW4H @=]\$[2TIU\9*:6W0:^<ES[\0/^OGUZP1LO).50_!.:L%
MV0W3>1C-3LY;5GTD875_TU*N\CY--:I&^T/ !V3 V^)DABQJQI.U$5QU*M!8
MVK^\)H>TM?>VO='UR7C9[DJXD6C=3T:UR^1?;WP'W7#2K30Z;WPUYQQ8)(=7
M26LA,/1@B^ I99N0M59'VQI;G\RH[WJU;(9-S8M#:3C5&L *L'YS$Y[S3A=I
M/63K+"C!&?DRGD-(16DF=$FN=:;ZRN#6G87',^STY8/ZS@MUR =H6; Y$,<R
M&>VJ5OE&$Q"T,M&'9(3CK;VF5MC[M#]NAI775_:S2+W9RET'_;E2JKJ1V^2*
MU!"38;52QD,LA@/I2^92DM;%UH4"C:#W:8_J/V.?*O.^NO<7C0B?RZV_B>"9
MW?D'IJ21&W_/DT^6:I'X>*G*A3EAN/8&ZNUQH%@L$+*L759<++)$;DKK',W'
M8MR^,MZGKXL2CE&U&"]^/1U(GKU<'/2*VM+<!0D>$]F!(6I>O(NJ!S;$G?#[
M9$9LE*GKZ^8V%&C3B/<).\MD5)/'NS :>,&DLEZ"SDZ BHPV%EX+YV(0*F#D
MR<:'-/':*!YI#6RV,F4KS-NNX+X;.V# G]\2&/#>V0+7I^79K &9K:&)AV!M
M(*;K#$3Q C8[5*'D:+'U.?>VK8$5GC=0M@BI H>4<@+E:RM'I/5O1/#2,-+P
MMG6WV15@?=^[]R.8=7WW;BVR9F[^?< NC=W$S'QT#K03NE:2"XC2)2B2G#DI
MN"V^=?;S:LCZY*3WAE%/%-P&M^"]G</W;]__=G1 .\WO.X=[%YM+'<!\MOCX
M2:G%82F,\^OA:#[#O'=PM#.CCXKS1:?#V83>?#P9'\TFZ:\UO/+-@5E_4][2
M1+7:G1?+"O/.5[+W/N'[^7'$;K\L41U]#AU.]^>SZ8R@DBLRD 9=,5% \;6)
M(),&O"=E)YB5*G(166I=]O-(B&OKT]L?=^,Y"P$.I/8NJ53 N=K<.0@#42MR
MQ(1!$6+0T;3N9_ H@+W:KS?(M1O*=6-2;'N1TNFQX7*Q+\!=5@,?)HO7""3F
M90!YI^MJ?_%E!QKE2Y(T+R[6EO3.1_!!(>22&'=6:(>M(T'KH^[5AK]%2FY9
MWBO: LO7ZY=(C_W7/_X?4$L#!!0    ( .5#FE@[SCK7+B\  .P( @ 5
M=&YE="TR,#(T,#,S,5]D968N>&UL[7U;=UI)DNY[_PJ?FM>3[;Q?>DWW+%E6
M56F-2_)(<O7,$RLOD1:G$+@!N>SY]2=R [HC0.0&)'FM;I= B/UEQ)>9$9&1
M$?_^']\N>F^^PG#4'?3__A/[*_WI#?3C('7[G__^TZ>SGXG]Z3_^\9>__/O_
M(>2_WYU\>/-^$"\OH#]^LS\$/X;TYL_N^/S-^!S>_',P_*/[U;_YV//C/!A>
M$/*/YL_V!U^^#[N?S\=O..5R]K'9;X=_ \Z,%HH2Q9TET@I-@N:>))LE:);
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MZ3*.CX>G,/S:C;#WK3OJ@ .?.'A"HT7#S $CEGE+>*)4"Y^BYVX9+N #;O
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MXYU-L1,T]88Q0R2U)2 D%/$B9Z(2,*<USYRWX5VM#/2%,*A])=UGEJ[MFG?
M9:X54\0PA:"8I\0R#22(X#)5*7E:.XIS%\,+XL.317M?U::B(QX'%_!A,!IU
M<#5CC I=3!Y<U[*#<K:@2)8T92V,-3&TYW'/8#S[V,NZHFW!RS@:] >W44UY
M>,5MQ9U063B2@D/K-R5.@A&^L#QR':SBJ;;N%X)Z]DRH*_:*3L?TM&$,0QC-
MS)IWOO_'SP!ED3H>G\.P8YBCAME$0'A$I)0CUN(*19UT2GBG-+U#B;G'-8\^
M:/-JKJR704M";2'^.H,W&?4$DK/)>TX]R<[CMJ8C.KXZ2V*]%+@EZ<+QRE/_
M 1@OA06U)-W"+G"]'\W.B[K]2QS\=,,:]$?O( ^&,/G<F?\&HX-O* E\?K?O
MA]^;!1&E5G*Z4-"]1FZ347:XY)! 2*(SC@J7RA(>]I* 3$+;[+FPM?,+6QS.
ML]]Y=D75+01$KB#/EECHHW[&'=! C13H++GBBWLTK8.%0*(5UO*LP/K:H9 Y
M4%X(>]83<0N!CR,8WS2IC= 0P1.@/I*2 T&\#0H'R""ES!QZS+4MUIL GKV6
MGR[.%D(/S0:Y/[CX,H3SDAOW%:ZQ(=#CC&S\6"(E*.#Q>-@-E^.2]7HV^.B'
M*)&.T-D'J@,1O/CF.4KTS0,C220A$7R,K/;^LR;D9\^?3:JLA0C( \AGJ#LF
M0&02W?5D DX&8):@?9Z(D%8H+K5-J?9>\@B<9\^46J*^SP*[+@L._+"/QLWH
M(PQ/SY&75[8_8\9XQPS1@16+GT>T_9T@T26>@T11Y-JASWE8GKW^JPCYOO)=
M;>6_\Z-N[ 3*&*/-\6_,R,B$ZQ($0=#I<R8&9RUK6_,-D,VKO8Z>%BA_=2&W
M$ >Y"^I]MW<YAM1Q4DF&?CAN1R73-L1RM)<UB2$9[2.:O-6-RCE07JCVGR+H
M%D(A_X1RR1_2WE?TAS_#T641S7%N((Z.+\?E!GR3-SN3@7#HW#!<[W#D:*Q$
M*DA($:UE%K1@GFK*965BK(KQV6\3K2KE@45D[53F90%/EKPHE&<(DK @$2W:
MN,1*@^"ICC%PXV.L?5UU)8";YT^["G\BNU975@O[TQRPT]7S'N8.[J+!<S2@
MO>>62(8KJ7>XI@KM,\^2@^>U'985(;Y.=E51V-S][]_?WA$FKL-_M%3/X?3L
M>/\_?SW^\/[@Y/3@OSX=GOU/NU4<'GM>^[4;EAYM>Q4;3#"16:1$=DT-(8Z\
M% H)(RGC*AI'E[O1ODKZ;]L5&R0 \Y$&-// $>DL&OPJ"AP3YTE1&;->Z@[O
M4\:T[8H-J^AS0<6&5<2X[8H-]X9P\*_+[OA["0D-^OARU%QK9B:(:!4E;E*\
M0%#T!!G#A3%%Q6F05K&VB/$0H!VIZ;"2HN=Q9FV!M^%_W\8TO3B[#*A5"CRL
MXH4_!&BSA1Y:4-Q=9[R:U#=&">H3MS$XPE7)M3;>$0=4$8?+)1I-R?!4/2"S
M.2K,J?ZP+2:L(NP6&(!P+@;]T_$@_G'8GUU<3JF1L^]]]-UTV-_W7[ICWYM>
MC#<<S6>'7AHWT$0;)+'"<*)EX,D''4/@]<]I5@.YA4#>^LJ]?X#3HF9:N&1^
M F,<,Z19^'&&*EIKM,0IDPQ.%,<4>O7 2-12)B:MU:+V*?'#2%X"*2K(N(5%
M9"_&RXO+7BGW.N^ >@HT.NIC4 F=?,>)A&"(IS$3%[T#*0V:ZZDR&98&]Q+X
MT8XFVLF+'((?P7N8_/=PLM*=#WKX_:.)8$X&O=[/@^&??I@Z$#.-1J)09*FM
MDZDI5T B8=SKQ(STRM#ZF6:K0-R)HX!U'-XV5=+"=G,?7,=39Z-.F00H^506
M)XW7P(FQ 3@33-RK(5#!H[V+8O,\:%5Q]SS<M:3>QN:3_M_E:%RFP>AL,,=
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MZ>-P\'GH+Q#QY[+XS9:]:(W+S%,24TGHA-(PS:$X<G+&ZN 4Q.6Z-JWPT)?
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M&]#,!+[4IOKP]V]N#B[2PJW-KX(PYA[7S9EFT[?+/P%G_S_^\O\!4$L#!!0
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MEB>M3U]W=+YYV]7=TSL\,CKV_L/XQ.34[-S7^87%;TO+*QNZ(  *^1U_JDN
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M[[UGGWWWV>>\^^QW_W'O_;R3SW<^6:Q9L^:9[WQGGF=E%I3OE#7@O)&>H1Y
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MV@(0.%(HCLQKK)I =#^?,O#:]!/JHHY-.O9,0_SX[X$A^0108)W:]1N7J"=
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MG+J7C86%C8N#G8/K/WTPFP'>?7LF]WQDV7,2V,N[AX5W#[,=@( VLOW%O#W
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M<^?2K'BVH6NS[J#IU+!(KB85@$#E:A(G"'F_WNIA1!@F)"AJGUP6[))#[!5
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M\,FR7O(=HM.+1PX/3CV?:[\YWOO]BN8-0^7.(OZ=E[SA\D</M,?C%V?D-ID
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MP2 /:%=%;SV&[CQ'4>?T:%=N,0$8R'%>+C*!)M7=!)V_BPF4(/@ 0@<#/F^
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MAXT\BZ*;K0<E/V\VW%1*<955=35VT3 F)V? JLYAG$LSMJ"J[S!#:$KD\-P
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M2*<Q"!-\PD66W(!R\X=V(_A))D0#*M!ESE']Y"NB()Z;/^?!4YTK$MJ,PB;
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M(XXX.F+(MU>JCH$J&J"/B#V9$41%FSP5N+H/QOJ#*3>/4^..H!20$2T$1ZE
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M>YH'9VF:1WC$NV?_?A5R@>;&0<1&'!58ZZ<"WZ<.U.$.HTR32]B]I>/WJ*,
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M_M?3N/S&?@3!X0X52 POXJ/#(+"[B$C$O@9AEPJPRB-Q!933NUAS2O32:2J
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MC^UYZ^K@>T87=H:_[4JD[GS[UE,M>5#WO_H)ZO])H:/._3=02P,$%     @
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M/L339>-279[>]M";R08YOX4[#!9Q-OLZSOJ:=:/Z/YX#5@IX& E2RW7D48P
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MX:O5:H+?FJ][C^L+7_KA01['FC$=%J1YQ,Y$\::_U;FDSZ@X9<W]+&^HQC_
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MUM)04GB$F!UB[#@+M[$P+K^F.:=1-[\)3<RLNVT0XV&XJ"Y0O+4@8S8$^G&
M$<-)VQ :+Y+!3VL"L6Y0W1*GFZTCB:NN=S2L?AJ,6>@\H%I_'@_CC!QARV*
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MZ00YZ;CC+9TTLAX4='6F=\/DX3>HKD+3NU1-EA'4YX"6QD#F2CAONFP3T,,
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MC!'+-;!^(!NA71M[$8CTV0CT^"BL1"=3N94-X:V/)P\2K1-GK(E7JLN1^V2
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M<BY1?&C0R6*S[+<+LCM!U@DWIRY(2/E6RT&X!6YV5)#T;[4$F%D(F'Z/=85
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M:/Z7A'OW33X&Z+'$M-QTV5V/4#MB[%Y.+ #@]U8<(*\*V8]20\I^IB4*!(Y
M908V2RS+5\635UXRTW$UH3G8W45E,4=ST;J&)==#/BPMJ'7.9& CA5.O=%OK
M785P4@#=<FO3AV)QA3SZYSQ"2V)ZZ!>]+KL06A_FW.6]GAQ5=<;D]\=0<"I(
MH$^ -RRZ>[6>E1/$.9;^*U&2V= _/%_8";G=?HR3?? Y"/CU:O W!@%4I7.K
MD.-^GAOS2+:3MVW6J3LA\+@.N8!;QX<19/5BD@)*\^&.G>'CQ?80>9 WPQ1A
M7LC+>^B+G;C" >>QUX*"(OU,-?AZ8)PXF%9/6062*]8"W7F!JILO1F7'-IW
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M_T'I1(P&_4.>%RRVJ8,7YB*#J<B/NDS=MC[/8\&VD\+Y.S[RJ2><.U,NUU-
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M_I/2.S=<GD%RW1UIL\1_M\D-CBL[JH<_#_8<';23&09RN_(%2*XCQ.>_^G>
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MK:$]WCY@/PAH.8:79FN0M^F9CF;A%K\^-#I* ?#J5%W6V(. 5+.SEU7!7RF
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MJ!$^?,4PDBQ%EBZ\':_S0IT_+U9VX1I+97FO9)Q+HC?NLN\C6535R':37HV
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M67M(_C'U7$R;QB/.83Y70QG0F\XK&UHRR*N6%@1LJ&3@X331LJBKA *(5:
MNLTI@$UJWK6/G4"<**?@_9:)W AR4AT%H"0B1 &DRYT.DKQ1D%..]U1/]J".
M,]Z'GY;V0PYI('\=)5  OT!9FW450-0('$.M_4[5$<2.9U#RK6*R< MU -7M
MB[TH@)%!(^K(8>#L$@\%\.Y4#*]>2)5<;#N;!_Z='D[DL:$ 4O4=_LM,R5
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M</.>B+WUIR=LEUZ7,]K]#2.IQ+@NE@#_Y3E- >Q<U"#'>.DWZCI0 .)WRB@
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MC.P98TV0 S[P 2&>9W*0TGU#;]O[F2S%,H>H<Q)9\P:YNC<_[;3.8^,\^#=
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MW_\.Z4/A754778@7 3B-!U#XVQ VWUQ@H[]A:S+2X8@8,*UROE7ILUY!I_F
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M+#R#\K-*S]\80TUW2SYN $+[;YIY:-G/3NQ)VM\QR#B7,^;IG9J"D"[&"B3
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MYY"8:!'=/N#)@^SN]#4I<"%?-NDNU Z((@71SO2GD7BL1U-$^F,,OP7>X?<
M6!>HK@-@?U1VNR'^<V:!/L'J#?SV15%40R[)%WH/C(4U#E'#$$!JG\RC2"P
MZNJ@P0"!)!2I.RBF/%\J-Z>Q;(DV+MVL2)2\]D-;Q$1(?JT\[1"ST$4TI!3
M/3&L2Y%R1%> 'FM%MUF0\[Z-2!6<O->BE2,OZ1YA@/0&/1<</\M!-PB"&?F+
M-]ZAP5F,C":F4MZA?#'H6,!J3:XGZUGG4 :^H/_)[N%%7PA[X..ZE*JV@.TK
M=F_'G]RE!5;G2[6/6>LVDI?FW]'PJ=#TU'N4*'SU';P1L6N/0V4X(^(.4[KE
M5AFF'T-.189[Y1RLV'^K$DJJFO)1<W)=(L^1S\:Y:2&_?2%.[-(HX'0ZS8D
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M9UWR2[UW M%F-AJMZ"SA/07F6R!]!!%,2XA\: R (!1C_]UU0!<3_? GH+A
MJBY4LXN ZM/%G(F<<G.V:G11?MOD=YQCY@>*WPW<#_RYS)4C5> :WTT2WWE#
MLM\Z ;4X9B(O8(" 7N(WJ#[>,7VQ;X6'<&/Y\BC.?%M]X=W7U(RZP#,+FC5;
M+I^CHR9 *C 5FC@1 4Y 1/Y)/7HO6B<R/@CG :MN.?.0!2DO=J FE;<7$?'O
M]^<NQ[P;)YIF[\LT3K^_/N5FUFNN?JVX<NDQDI4V>U<UQ+]/]]R"@@$#DHH?
M/?$NH$$(FEC-KULS+Q,T14H%.@6]GMX+*_O(9LC>6F'=SJ(H'*>7?G"3=R,0
M!'OQOWW>U-8K7]O3K^IA39I382:(OE9]Z_<$>GKH$1E"*8(&X^K\-"V8DH/.
MMT'7'C0B7F0 EVO)BL6"J4F<++9<^F\$Y'[EG8 ,JQD22[4$K3C/;,CP;<L6
M;,$LR,% :AC!!W<"2@5+NYFZD#QOE^+.8GJY'DE9E;^V)ROFEZ=1)1'.5;+=
M=781+XH#_[:%P\.QOVSZOB4*^4^FF:E*OX^/9=$^E7:(^KZ-[?;@A_@AF")5
M]CC5YBS<@H)OI2?%+]\\N$#T2D>065MZ[RJL$5[@9Z@71HV>C"[ O"-WW)10
M#(Y\MMAJ0;-C(\T3D-3A(E$;4"JC0_G .2/Y<3-&-9]J/LVU_\U8^A[!-._M
M<#%&BF_ST-IC\9R(*#N*R8K-R/EB6MKAC6'\$$38X]+0S*!#Q"NS*Q"'/5YK
MHS"1N/_> X.N6KNB^"D(C>J86K+8AH-_NLMT=$Q?O"+ %3_"1%JJGOP2H7Z+
M:;WPM B7$8TNFB/BIWL@PF03;/OY!=8M9?W&N)ZT.S*W]&,?0EAQ\J!Z3)+8
MQ6+L"6C 0F#H>8/X0N<+6U,!H()="X'K2EZ[;7>+:<OUD71-XP V+U:AY]_S
M'JX1.R2<"2&XEZ8 FLR09NJ1GH4GH$_2 >L-)R#DBWG/_Z*>_L],7 >V ,%;
MBM/]TYH\>HJDZY&.:P(9,#ZH(]XBG2@F!F3ACXG,>U^>?NDT9VL/NI?/-FYS
M H+DG1=%Y%0^6B@CJOUK R+IB<:$X6<P[0 XOYX7 8++RCK?FC (YX9)>!AJ
MD.=:5_]J.A 6_Y?FWCNHJ>_K%PX"(BA&>B<J3:4J($A)+%^:J!$%Z40%I1MI
M4@R)@G00!0$%)13I)2B]2(!0%%"D-R$%!$5*0@D'4KCQ]]R9V^]]WO<^,^_[
MQY[)3.;DK+/W9ZWU^>RS]DJ7J/BC8HL[HN9G>M0<O59VA3DTPQL[:6DVCO&5
M04RK=KMH-8X^V 3O^T+&\83X.]HX.O.MZ.WSO;@EH_CIZ^?XL>. \TO'9:G9
M>2 XEL.QG[-%:."NF?LLO"=8[ (UJQ,OD0/D4N"1%H7VNN^VX_(S55,UIS.U
M_=-3G"\(]J?GK'B*DM/L*L+3_MLJ>+$-'%-,$Y%JRGH1Y'U@&C+55)M4%C!Q
M19D3-G0W;5!%' G[I"6%2/<8K$C5QW;7]2Y..,S4;^QK=4WR:C)224K9 V']
M$6'U2^&VW$,V#7AN"<X<'6<O8KXSI_/B58%?["&!70*;GY=L/8KW\'7OW.B0
MTL$>[#U^%SK_\:MPY!X(Q6\VAU 9_P&CFC#$4F\"<26R#^(%-8YM/FI2V0.=
M%Z.CY;\_5TBL>A&N2&1S2UF@S3I#DF/392+\4IWOYG/BVK73F$CH&N=FN_-L
M@_]:F/[/!O0T9]5B?ZG>H6&NCM\]+W']^_=S[,V7GY?@K/7K:#&2[A:8*5HZ
M*KS1/IZ+]CR.-X7V^G[> WU/0GWZ-]@$LCL<RKQ@U9^BRJ!H0K'S>>.G+[XD
M,^-<>ES^UO'\>?V%"K\9E[R+%^GGJSI+7]Q9^+3^O[7H?SN8;1QSDS@AT50'
M,B5"(<9C7,%1,&XCFY+?" &4JSM?(ON4YBL=1V?GFIUY=I\+JN>U6H/K$V[3
M);,9]>W%%6^&>0B$?I[U!A7$@*/,&JP'F6!RUB>'I;,O3C9XY"L;!JH /U/=
M+AO6Q!N.+R*6VQGJP")9DWFD&QQ'E*R09?X#E,V)T&PILNN=MTQ'@K)JW6;!
M_>5U0],*)W_:._D-<7!PLJGE9%(2_N</[ _<+N1FNYB-O$9;+YTU;SN[LILM
M:")J2QMD%8IM@YE"Z-T36[#83$]DMIU.H_5C!6?.^N?& V&M59S'O !4Z&"G
M9.RH+=_V>;$E7W4;WXOW> UFD#YC!!@PL'</N-ON7.M'[SW0OL3\7:P(!2IO
ME\W??='X>,$>Z,FW,Y@(F#F'O[,;8<\O_A]*K\!I,%*![>7Q[,,?!3<4;5<)
MDTD-D%U^7$89$4_*,UA?@DALS@@H]_[>E9:0^K5NOFS&6A?9P'']V\4U,-*[
MAZ$87MUSL0MPD:O).?7UD#F7'9=SC ._S:ZQWBUKQ+NN3$6-L PHE^0QZW*/
MY?Y=)U+$>M#?81"H"+H/P]MBP;B("J2AI,'/6E0*/K'K2YWV=9S(X"A)WG>3
M\7G'([ZMEN:D[VN69J[O@2(SC&I8SXR$_"@Y&#)/##V2ZLJT.H,IEH<P_#9:
M5F<1;WVKL[7KGNBV</@-[]_"Q624-341(0OEQ;0?9B++46<_U4DT08LHL 0'
M:!)%T+0SJ<]//.FX.>DCZHO,E7)24N,/[4W$<A8#C0*QJC#WP( /.&:\*3V#
M/'T"V1-70SQB)ZD+ 3O;K3)\W\T+V/48*1VV%GEA\^I%VSOP%)$"7@DEP6)V
M;U4S1-@#;''@9<4/KP3YW,*0K&[\1#J=KJR"A)Y[)A*:U&*:JZ7O'] -[F#S
M<NSLY*CX7%8LWA.2 !&#W<8< .#=,'#KV:LD#M>/9@N,'6NHIB'C=<'5JE_]
M N@>+Q.KG41TOB5^>_E!Z754#M@$X*@GWC8:I@LBC3I*D^@D3MQTIIIU0*;X
M.I&YS*- !NRY&FX5B9.Z]]@$/T1.-([XH:9Q/>Y^]_Z5_ 5(:$A69R8X\N]&
M++[+H/RL]/TT5_6%_'!_AFM]A**F8N+C4Z4I\!Q<.X*/HZ"03)EM&J$=+\Z)
MSR72ZL1DJ+AGJ\2X+O9)'5I@!+=()1*04E<R) )^'9EVJDET"526<9SLNYTR
M(9ENWLK101'SZ,G9LV.<J]/0@H G23,Z6VNH!<.P%M0DC$'YA@*KBT,BKPTC
MU<?6;$UJGRV$WOTH[-ATDK'-_=;M.U\#)TB<@I$JY/=S?BG/HU4GU1(P+ _A
MMJ=&C;U[V+3_$RIU )/G=2LAJ-"KV$94+5AHY_65LS-O/WSC&]L"VCE,_RD)
M/IG,%BA@G$.A '>&%#,8N$ =Z'01K /DYAC)\<1#[M]K!@^<0!DJ!FC7^.H$
M*)@N,RZWQ? DM:$'OG/9(81:3Z!T $.R!3.4%D!1CB+['AXI;AI#F9417#WY
MC4##5WH3LB=UFYW@/6N3>)+9BA4)#-A@:MP[WDETHV7TJ+.M,;C)N)7LD+C3
MS:8_S@[!^12FGL ,T6>8UIS4'AF!\;S*3;_%>LL>+F%_(1Y"W416H'R Y'D#
M3[;AR(K4O5KJS\BS@E\;4GTRA+GJN>S-.]7U?D%6$*1:6OURSQR2?VHJVITZ
MVI]>E;>5(GJF.P=,S[^N6DF%$/9 7$PU:E0,82T:*C"$.I?S^^&!P*\B%X?S
M:FIJ$F67XR73;NA^,3K!G3F:?F(Q+C=3-S#HU!+A:.2(]$+WG=S$#FO"@&=7
MUZZN:Q%O7/9!*;B0(%E):2D3DPNXF@3!9*&0J]2B.7!<JVR?S*E?NZ-=-3)-
M-:<6^Y" L"^RN]&+0Q9-"Z5;BD=NO7*$CQIJ,^K!+MFGGJG>#$Y,\1XLR\%=
M83UO553I2)[R;I\]T]AX9%JY*KU^Z'1'N4@D3V)XFILZYPEPVOE%E\=Y$TJ>
M=-_L' 9RE93^2 3M2,U5O:H^).:D#H]^?T_BM^(P<V!&0+5O#^2*2=)BAK+>
M,8WG0C5:OEY4M7*MV#=Y)_0 _S%H%ML>M/G"MMB6WLTG=4FK?;C+*CB1\OZ3
M="/S='*[;=^'6JW:M*)KUS1'#3E9T=GLZ/_Z8-9#8DUP9PUPD_K8CG8E>)]A
M]Y-IS[?K#Q1YKR<[M^ '!4$H,X99R* 1AH;O1"O69Z$$BW7$OX$%1<__\_[Q
MD2=LW<[K%BJ*@YSL>VN- .;[.K<'BLW4C#QZ$5,3="(W%4*0NO,)S_L#(P!B
M,.CAU#D 3LJ(VCQW=U(Q3.?,E6?ADXJ(TSVLS85F:?,Y\Y=WX_:5/A$[W\8]
ME/[OR\ _V6=18H CPQ2E3.-K&TC*/EC-T5]&5H46=RH]QGM1S:]E_<^\/Z.E
M?R_HV,LT>_/;!Y944X _M#G2VO(7:KX]\).V35%^0T;PAZ GX&5_,FL8QYY:
M\EIU6S8;GCIU0FVYMY3_Z!%P0HTFH!"\$D#%$FA,.586GE2+E68J43MF3R.+
M0F[>I+)3R[VD?7-D;DV-VS3$.EV0UA#7XIHHS7&7JMP#7>3X_'%T9Q-\66\.
M,V%I$]/5M)!,@]CX>G>WZM#XXMR::>(EE:M)X[:/&[ELFLRBE7FOFUZ^\S*R
MX4$]W8-S<1VZG5B+[?+&/,7SHS6\M$*:KP^_']%!@('F]LS*IP%E4T?5AB<K
M"WSYID9.J/UC\OI4^E'05965OPDE@/44Y@:.ET#L;]5#>33'=(;=RI+/IZ@;
M$MA"H[JI.?;F>DK?<G;#:_K<$AON+(HIF?OX&A9S$UK<.7SI)$USQ2)W J7#
M,>(E)X29H4\P_:F'G_H>#PEHO^%9)P^)TC#*B):9_KU\Y&KQCXY*>\6TF&]Z
M6K>_5?PB@O"DU%O$@]!S3$E@C8:DE]-P77*6) 2A DZ0YY?7J*N;K49<Z7 V
MM7>]/J!?O;Z\'NI!OG7?_0NTCQ9 )[->LP^QO^W:KEA2X'%67E!!FLB$"=F2
M>'#R:^E7BDS"@DUU?57$H%OZJF<"*$XZ)52%RRX!5EVT$D<5H><!B#*4/7"/
MDE7,L5UP*2/,/<&GQ?+]#T^]6?G6VNO;XO7T>D_9NH_=B94=)MS>JONL(\YS
MR"<IA_A!@H !3F0L9U&2)PTIT;C0@HF0.-^"VK'-D9M!!3/3/\S\>/L-&P[C
M).4^EO<-)H5E/-E41W;,\@VV:%,08@,X+X='J4CO8N\,+;4;7MH]POD_##0/
M#&EI6#\\>/L69'F'-MV&J%EL1QYFH@&[J4@ V146@O]>J6ML8&GQP%<J.0V6
M=O10R?&GQX7WSP<]V)K\+T?!%LV88D2R3(C[G/Q+6@"\9MJ;XFOX^=-+V^3:
M:;(_W*=SD.O/SUI4$J(26P]N&P 0Q.K*>K(SM._;:+D">^A[1Z7=CP[^B=;5
MJ+G=!N.R]=-I:?%51R,CP%YL!]HEQ5!;X=X6VT8$$4&9\AYC;[-:DO^ !:HG
M%GYH'C+"KIUXG,PT;-]U_+L-;??*R@3]$/TZG,-7>#ZP\O.!.[3[B&?RRB,\
M87H)[VX-%OBH2<<GFH:WM#.JEV81!>C4<7*B]E7?,TZ.O8-?9/:;F;;?.'R!
M)U!WMXC!C1X;@]44$10'F29A^5U3//SBU0>/2*] EYR+5V7R75=;P_8[L7?(
M>F(7 UTLXS):*G\32V>MMAR^A.I-L!_3,,^*!/J,"&8SCVQN_*(GLN1?HCV#
MC5?C3^!^@-L[_E=$LU6!58^&>>!%6T+0$$#;I>[3L)%ZD'HM8\I)+3Y(:+TW
MJ88ZR.J7OZ"YI/J7 %?^W?K0(4Y4DYYE0B)K];,HX/B*^7KJ3-5MAVZ%M!36
M>-6U..PG9?UC"$A,]@&@@G:0/!X'Z4(+T6QF*I:_.2Q=4MYJ5$Q!C?K$G5-D
MMJT'C&>R8,]:SO3K%ZF4/*=G]Q485JCX3B_EAXM8_ G7@6E1UD3\V>+?3I+"
ML;5_;GS[)@'<^/73U\'7TS<(9OX+QPNH,()"5+MG;T72H"=0L)(Z,60P]L.U
M$+;RN6<;@U^<#JW-"VR_GG_N,>;Q]HQ!M.G-%VV)$6"_>*!E(T8[6[;K\:%P
M%;[!-:G0;DNSG<H2B.=+FCR\,P2!?%):V%11 #EI%K0#34I 7,2T&T/E6AMI
M\GL@BM(/V*]=N=SXR=@_?EJJ/4-:.QR1:#MP6_CA?HM?JINJ=!? 9@\DD$RB
M9^7,3"^/:(RO-!6:'0\%[8 9I6+04G@8#>RS>>K?*[$VD%-(^A5 @8$("29
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M]AIN^8HXU:$M?:SJO5]WKNMS72[KPT^XOEN'91<4_6KR[?Y0YM+EZ^G)_37
M3SO*//^Z_;LX$HA+D6';<9^MXW?XC(:DM%4.%O$<\?@R;.?D=JA9!-,X,B7;
MH+RL=IB4_",K@WTE1&*YFN/\>%8RQJVN;@S%3YW111Z9)N'BC:[<6M]RPHB&
M6LGRX4X?EY45]OYUF<FFPIGB(O015K[1,96>M8E\]H$MREHLEN]GYAP#W#V%
MZS)6N3 2],=#T6-VJ<^BP2S=?")?DM#B>[1[_[7!3=CR!B<;R+#><A9J;<)K
MD:.SJ%T+984AFA;?@ZY:=HXY=,5D%/_R+2PO9(\M\*K7>5PYLR_G1=O)&Y?V
M84[V+-A'>\<&T=+NW4"69R%IDZ'JX-$JJ0?<JH1220.K(MZADTI_"M>^+CT>
M%:/&+(]R;O46B*2Y4XCM>$&.ET;I8J-;^5AYRP\>H/F!6;B<O=>05X0AO*XS
M,^J54)GG5]T2^R/\RE(/WR>>=AX 5,V8XMYM6*H%7HXI1^WIA$2$8>,#B?%A
MT25R[ ]%7G_^UA:R"K/'(![-(8G7W&V>;[T_)7#[_*31O)]<T52@K1QM<0[S
M]&^;W2>S&JP\5#"JC+P'V@^X;#N/%#Z_L#'M>'ZCZM+WZE-WS/S/RWEWXTFO
M$%2K=S"V0!+C%(8 ]^20-\V6 Q*=V[MJL_(CM1>"=6XXO#K43SE!M4#Y3K^,
M!^TZ_(=WD_GO2AR@P 9#!=U'K-7(.)S N(S^-LM/6ZG]^-(3DL \[5TLX[-U
M6H?V(991LK_Z;WN\B3+Z#59"H"^"@/]8U%;!W98NO;7DO$1'0^I.FP48*'<]
M<GIQP$6_*RQ)%'2+KPMSA&E$S>@@"@-EE-5\3W>RL?;YEF::\6R.>82@@;[<
MJHL39E^G;'V5+MZ::4)>.=@U"VFE%L7K)(1?NC*R_+-FQ$># A;K%SYF<3S(
MZ,S'#S? /"+G(6_V0%SX.T3@9,]R*A5Y:01/>DZD7L?%8(6A?"YV&CCJ(KFG
M>^W0%[6S3??&'KA&3]M5'5_PF+S7?_=\?,X3OR]Y$$!U+6H93WK=>H;F4LTX
M^*L)WB75>M:9*4*#M#L^CA4Q'T'Y/>H3_:+4[R5N:>'ZND_QF?"$QW:]</9B
M.P?3)II3JO2@H56H*)N I=HF)R .LL6^^*E.H(R;J0L9%/"RAYO_"K)H=C8W
M<^AH__3Y'X1S:E_3H7%^'&>\QDKFT,G;QI?HH&8\S6?W00E%A6:RW2F3%(")
M<Z==NJ)LP' 1;?^T(8;VS;HL&/4HY03WAB:Y.P;'$2;-,/D:35%,NU7@C#>E
M]6D.2J\5.8ETHG;GAD/CR,Y>M]>]T-*U]8T:8QO]BD*70D_?]PX9\6L<@I1A
M2&5[((%-V/0EMH <@X\) 2K(,I^$!RA(PD"B ;HVWTL@.:! ALCG4-8]?8UH
M()Y:FBUO%-FF2V2:<^(P^ ^LEOT&'(TG%<*H5K XHDS-5>%NCQ:IW N%=B%>
MX^8M(0Z26Q:V\/-(7*ZM\KE"I0OW?SRO[.402,Z$76%A16'WUI(@PGL@3ZQX
M2%\7I/IL'$7UH*^W<VV]-E"P%6Y@*'6_V0U49OKRY T][=NASU<:)[@I&!YF
M("UYI?EOHW16)H:4@1%2<J=MQZ%/?:'^F<O.=E,V#TSFZ5<92TP>T>V\U>3C
M]C*:/=S^IX;%QW'%U5-%RQFTJT+GK1A7 2J(#X3QM"UG'OS;/H(I]*^J#Q&
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M3"0%ZOK -K4[;5/TS8K&!2ZWQYZ"&MZ=_=*BDF["R 9]U4W4$4D2!-K!/)Z
M#Y#B,I57+O5R;;C<>N91Y4VU^A]W,BJ6 D-G-[VB.]43+B&YKW&(2-YJ+_LV
M?5S\YJU"R-OKVCXJ7.VWKRN<V'=85B'=]S(+YW8$<?T(>1\P^U)O?EA!_6!%
MKTHE(:DMEGU5G[)#Z]ZKLEJT^_.21(?01TLZ( USE,@W@IF+:W=_I3R0X96?
M?\+;6</JV"MBRB.?K$6*T1DZTIR9^W4,:[83,&ZROEUQ^W9.<_WOLOI[!\V#
M/YZ7UH5OY;XRFZR2^2:Q5Q'I*[,T57LT+U>6NGN)-E7NY?^H<.B1:RCGG.&A
MY!(2M3J:RZFBMO,M]*+\SOP0Y/-ZFGMT3>.!V;; W!"T#K)34T896V771"^L
MKTN8KY$=S#ZV1;/\N5/_XF7<6K?,RH:$<1ZH2+E5?FWI]1GD%=\T((^H"V<#
M>H/;DOI0"6T&M<%O>9R_W6,H]?K5Z;,V)/:\'XZ(ZCU.E-6H*MS(<V7!I<7?
ML1BP\B>$SF@<6B"2%KZ+F!0\"'S[\::WL?6%/SEOBH7N/)YLFCGPKO0HW4($
M(;Z6MI3V[66AF5T!42S120SK%=*8_[,OTD'_HL_% 0'Q_>_6\ZSG-CJA;6@%
MS,\#=<)=(, ;5T (PY7&^&F:^TZX5RJ.AKE?R!'TR"OTOJ?M+*@]-/]@^OZL
M6!.1D?)Y<3Q^MYVO](Q&S265#X@E=T'SUF)/MMSBUH%(M^I=)FP;*@9*!S]/
MU(.K-P)0S'-_CX:F0OM[/PYG7I>8B=1Y*H#&+K2#+I2UO^=?&SL__.?SNKIN
M]KL-"T,+LQ5YO?V%_B"HR9?E@SF;2))MWS>=PN\:.'MK'2NK-S\PV%J9=?^H
M:@.;)L=J!R>E['W+'<]3D/QUP/MP GE0[T-\_3$:B4'U('F 'R-8:'([S>L5
MWY.P H+HO:A'4]T;=6Z+R\UU4M&^;U!E0_L^Q\[:PO<J<JVW@FJ@1F[O2&2.
MPO&&-L%F5KJKQ?>"Y0/UEFQ#=]L[+"^0WZ.]EO4(#P#-"#R+PS]MTQYY#P_,
MY=GY?*O8;$-UYM^^V\E\%?#$%!4/\4"F4F-LH!)__11$>$RNAP>\\766U%[Q
M?_%:*T\*EP3BU"@RGN1/,$T:?A64U<:XR=@'?8QDHZC8+7FCN?5Y']0N+5YW
M;TZR2HH<^'[_@U@K]J,JX()>N$9)YD]$XYP5N[#.(EB1=9W*U/+;N97F=CUE
MN8[+[E+OBIQ4%IV:/+_B!KD?K9CG6/?,55K;U%2\O1-P^_LF4TMH+M'&K)-@
MNE^Z1-?G+$S^@'Q0"QTL/6,Q6^Y7Z6,6)72Y?%"2_*)Y]/&#TGP=T8Z>0OS\
M*>CA^..:4Q#]$N3,S;957,$IR/T%F"BY/>D)*Z6T():+]$LB?X:-I!(_=5$!
M%P=NL/?W&C2)PM\PJ3&35^&@*-=L+-KYQW5Z3NP45+>WW4FA)J3',YUG@/ M
ML;!B-R+3_I?G8WN*9.>@L=##'_G>O8(45<[#+Y=] FIMLNIJ0E0<M!%>#@ZU
M.?D)[OK6O?/ZVM-X'I_K&0J4E8Q*,=]*?[/E>V-S_KH$?5N"!_X&M"Z,Q#T
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M5YH@194[ 477&EH^S;9?]JON.VH^9_EI*-^+#I8A-;]D'W.V<5WSXW]]##V
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MO_!IZ>J7 @PBKA102-H^ENY97 PWZ=]7;[WK^L#GK=FE+7_U$YMO8-PMR[C
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M\UGDB%>BL(87$%Y!A Y+,_@[+^[[-[Z0\GGB&W8OR$Y .[I:MMDK?WUT'U[
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M24C9)^0BI-L7PY%!D<1]NY",<3*J:C(24;I#HT"S31<+V')>8? G7<##2VB
ME++P,2UQ[[:GZM?Y:XP%8-#^,(Z!#V]><DR_J<CTFO5R5-.->U<E'O]UJB:3
M7 J_#G?"F?><_.[\F6N<J$.E#SS9J/R?E)-K3AG__FT0]Z,:ET5A/4M4),&
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MZ#TF*C-E47<H[\K2%7)*ED?2C4SK[IHKW_5*3X!WWTD52CUK_Z/M%R,2YD$
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M4@53MV5#;P^E!HO\YZO);O;3$21(%%JVST ,62; U98^+C*%C][N+H95&A;
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M8,[T0XQ"IB3=.U)K^7S2RA<$8EW+;LQHY[C+:WC8J>6^@\>@A9(CS:_Z45#
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M>SDR0VC!'$$^/[^JH_L@176B S.1*7W/>>HU+TV3RAY^!)LJW D2/0>+:9>
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MR+]!'$,P4&F)HML?-4-D&L3MNO>BL*,_&<E"7E1 =*G=@T3G@OBM] MGN7;
MV(X^D"W7?$4%=G\8KVVQP!?#6@._4X&A1$@1N$MPG;_133?AA['R<\77]VPK
M5RQ9LC7T(XLM*LF0[YTN@_SMS@%NEU;_NW>JZI3;/KO"@H4!AU/^-%J1"N S
M-:4AAX&$2OJ&)G3#YZXBK:A )M0O2KRG @O)NV$\A!F"JLA9Z"01R,WH1ZG
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M60@34^UB>M$O)@8J$C("7TJM?!@7%QR_Y697GV3JJ5^:M7XX@I5)]WWUL-K
MP@59(Z51JJ64S"INP,Z9Y)F,5?39RG?>3&QP],OVK/=X.H)[(!>/$L8[@%3
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M)XH].S]L"<<RXTSR)=R61TJUS^;Z>01WR]0Z.2O@ K@Z"[*B#KQ6_SF#<]3
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M+R3W7Z@)[FR!?KAF^&\AI!_4*"7W@Z/U)I=%^*@ ^SXH006T/"#<PU?406:
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MFK^6]N -<E_*>\CEN"T=QA#F;*+:*52AJ]P7]1$(Q)&YY"C,0_-84(('%]]
MAQ'&S/.](-O,TQ'8<!%(\SQY_[*E6\E*]DKY!9$&B#+1D.Z[W(^>UM>L,\B"
M.U2 7A7.CE("<;.(SXAQVGGC#G?#N91DEP*R:1U>R*5<>VYL\YY\ZT/<HT_/
ML%CK'P$M(S_4UN\O>=$74DY#G)LWT:^@62 ?)LW"GI.-"$[6X+Z'&!5@)@O-
MCKG/-PYG1OVPM3-62*W4@GSX2[=$P+OK#YL?W[@,['*$P2HTH_'%Q&:PD61O
M!?:M;N_/3\?/I;-.\=IHWZ[Z.9#9$"DL1O?F:!8ADH[M$X-\VM[O \1G--["
M^'E^,YQO+W["9JX_"L4.QL_>2& O)4BTB)PWM(F.#M;TSTD<V>YS$\A[3A%H
MJ(T]>L.FUTS 7-Q/?M:/S,-,#B(4?X;BGZ)!Z81Q:;)-D<W+/WT"+0O\YZKJ
MWH\V]7H0"]T=>?F\FC#^,CMG:S_>$C?YK)8*>6#9OW.C^M^\@1T%=X-/V,QS
MM&$CIR4A[_5 -U] RN5I$T3-$/#YI;:]#[<&FH2T@F"] 4\<)HE3#VXW.<O0
M_-"S>N 8RXZ$*@N/]6'\%O$D-+4:]15=B0V-;?'7U3I,))O,H8_T%^H)&O8:
MC-X:+).=40'Z\+QO6IZ>[WW*?2<0"_7RL\\Q>$.Y$^1K!.5V]#$R#8&#2 5B
M?$BE'FVU(W ^LKFS''93[**1FBY#7D+A X>6 G-^%@#@T"?DD[G4B/*$K<]P
M)E1O/534R.A2./O#]]%N>,6IVAB?V]6Q#$NR2)*[^2/4E!#F0K.'^J99=<5[
M@&8GOL58",F)MR1S]Q /P'Y"I_FW#90@Z-2*8\/-R0PK+B?:,&%+JCY-OF%E
M."IX.SNE_R?0]"ORLDR5!:;YD'7!C\QM1HS"IY*YDQ;@+8<>S3-,*"ZK557,
M9_B+6M_7!,8HCT?N(@RC>TSZ[175GU2MQI-^/7"02NXN#KI1"!DV_?"9(FX<
M;G$8L1?_S-06J4)@_ZB(/;XB,]]H+KO7J'<]Z;"">"@;]O-[AU[6O<&O;0?.
M'$SO[Y$Y(17+_?F1%!5P0D2ER75@0]%,2*-\,+YU5&=!OZ$!K)T/ K->9I^Q
MGMXR31'0&1%ECU%;."D(D#\>YL"=<9&J)2CZPP*X*V),F1@ZA)+S_T3$XAGR
MT6?R\0-#Q@.[;,I6<OG^EOIO?K$IY KDB-Y_L+H];Z%"HT19]X=!:12?[B^G
M2\"012?R$@ZQN9-0M7I_+07CU%BQXV"E'AU1@:Q+\AV]_JXDY_X\5,_&8BK[
MF[<FY&[@-Y,)22VP25X*%R'ES3R.H_,PT].#:(<P?FWLY/5:["K%]JER"BG[
M44R)2MG@W_6O(<ZY?7#V4Q7^61N9695DE#BH_5T49WY>@5[OI1[LYUE+M5K/
MF*4H,OG[9C46E-&-)E_"DV:77D#N*GP8WR3B7]]C\KWA]DB3%MFD:;",U]!=
M33^<MGL@\V.8H&$%8\:WDL= T:#EU P/A0\47?!KY>!$"H&IN8;HN7Z>Y51K
MG48'-C*QU,O)DTM;X:JSL'B\]Z.>.N';3L_9D+ES,%!YB<*L-2NY.TZ&D>#^
MZ<:"U\KU\YH9.]!\ >?YQR[2< [[NM-QO(IM+(\"H(:;KJ*^"H_;N$1Z!/JU
M[R?8K-6@JX)<(2QQ?2G5GC/ECS9,;+&0R-%1^3EAS&^QJSB/QE_OG\#.YJ_;
M0).=066"W[S$TTVRX7P\IW]V>PJ&7ET@TT7*"[NV5> ?;98VTF]LJGQ:_]&]
MA,7NC@1WV<?<L'*X"P847UHW(]F2KZ;.YW=@7@B^2MO;C*G7K(.$%'"M/S7J
M/7ROQ[% ]IW7D9G+K"?$YO#,)F%BYO )0PKSG_KM\+!4%"\&$Z+0ZOMPM J+
M&$E]YIV&$5#8S-;,\2\)'?AFD3=^CXIR3T5>HMNX7/>Y'0C KB_@ATP.7Y*5
M"2$4ED@HP1L2RD*R_%OG93+>3LL/E=!..U/H\7N9S@\5_*<XTU82RNPV98]L
M)%HQW^2D5<Z \$<0S,=S45BL2/*4,<2Q)I4K!.,6D7-@U30C7K?5<.J,%!S4
MRALI<;I2ZK(]<?&P+NL%G[[UQH-)GE;^K_>?:R:!M!#K18>AZ ?NL/;I$Z 9
M_AY^)4-] %VA;I,+9G=,].'<"L:/S7[&KZ:F,A5=BQ-R-OT\FWCA)JH?@]>G
M F,(H@.8FD.V!>WP6/-4._Q43(T]QT>"<>Q>\!/XT8GN3V+AU\--ZC/4Z!T/
M.!(+?(^_F?#]QCA0]9\H!?^K"$T=_V]02P,$%     @ Y4.:6"RVI!A^*
M)S@  !4   !T;F5T+3(P,C0P,S,Q7V<Q."YJ<&?M>@=44VO7YD&D@Z@TD1)I
MTD&D29$(2A,!42$"0E2DB1!1D*A % 04*=)5A""(B(B1&IJ$CHI(%ZD)3:0G
ME!A(<C+';]I_O7?F?O^4-3-KOI>ULY*3DWUV>?:S]WLXK&\L$K#SN(6U!<"V
MC0TX#_T!K&5@A^DEU$5/P!. %AMK!#@*;&/[M7Z];ONUMK/_>N78OIU].R<'
M)^<_A(N'&Q(N3DYN/FX>WE\+>L?/Q\O_Z\,O)?_QI]LXV-DY>+DXN7C_W8O5
M .SBWG:6;0<[FRRP;1<;^RXV5@L @VSD^(=Y;,!_6FS;V+=S<')!9O!!)U3L
MA,QG9X>,YH LAKX-@[X'MN_BV"VC9<HIY'"!2S90^.#=I.?<<F8EC2*G>LCR
MVA>O1?#PBHKM$=^KL%]125E%1U=/_Y"!X=%CYA:65M;'3Y]Q=$*<=7;QN.3I
MY>WC>_EZ4/"-$/3-6Y'WHJ)C[C^(34Y)34O/>/SD:6[>B_R7!:\*7Y>6E5=4
MXJNJ:YJ:6UK;VC]\_-3;US_P=?#;T/#$Y-3TS/?9'W/SE-6U]0WJ3]KFUB^_
MV !VMO^\_M*O79!?VW[E@.N77VS;0GZ=L&L[AXP6YVY3!ZX+@4*R!^]R"YLE
M/2]IY)'3/D46N7BMAU=47F="@?++M7]X]L\Y%O$_Y-E_<>R_^C4,\+.S0<EC
MWP7  28C-U8)^-\F=2N3A"4/NB%C5S\+*#'9SSC3MTY?RGE_SU?A,R7B()_E
M-J/]EG)7Q8NP/!A?S;M8*?Z24&5:2L%\7U/F3)DMY9Q*T.B%-"?;ZGW> 0?-
M;U(Z2PLO@J^+&@= .Y\U#$F?0+IU\).V#PFL)*^=(6"3SQ%H(L6TK%81D8V-
M]"?>&GF%[N8HU'8OZ]GL(P_VLB5_;K\#3*>X&Q5A&LT('F%BCOY[UZ:B4C[C
MRM^_Q(8$BH;EQ^XW.]Q\L4C\R4SU-7LQ%^$5O$XJ:N[&6SL^U<]K^[_NOC?O
M&F[UR6FC],;A[-@VLF*+_3:&?;=0*US0V/7"F[E5O9[@@M$WL<5CKI)%_*L%
MVV\AM"@P:@$36[^+]HAV=-*RA2Z@>.KL;@_?J\FBW$/#1)6D+P)NYYK9CNXH
MZB_:TW?;^J-2[9+76(5LNMOCBUJ:@L?C\AU0(J+3Q>][$4Z'M\6N%BM2)YC)
M&T6T]1%8PM;.="=>K,^3YR>PB"1'RTF__O3O8\6MPU^B93-;GD?W5GVYWK=G
M5N?"=7Y. _WH(O%\@EIJ\8)7LUB&UQ[.=)6X0CQ>YQQJ+BBFQ]U@TIZFQ+5X
M>\+6<UW==2HL<M2"+OG-V<VM94<@6,F=)<C<<'](7IF,:>YZZ Z35J+Y3_$)
M>#74MV6W71UWG3*2#+9HY/(#;DHZG;U"5&G[&G25=M_.#]T6Z'_KQ8A>ZZ7-
M>MZ(XOO-_?>D>U,5A)D2UA+]#N:WN)X*.Y@#_XR(S&(K0EHS5^ZR@+*NV/#]
M<PKF5&S!O;ZA_IUX(:MW+2W2S]W-+QK==8]Q-Z7?I DB:/'T_>CVYAJ.LLZ;
M4JF(=\U[.@[ALPW&CBP?MVC8,2LR,YNFI7/MW DR"V@Y\WW*?S/5K7CV^M</
MOA-^WH]=T-B)FD>GZD??'O^Y6K*6P1 :I.K0_"GM#2'$<J[V]R:8W>[S6^5S
MGAQ+T[4'"G;;RSAQ6N\UF_HN#U3/HQ<9GBQ@>Q>!W-7^7G"R:_']E 2<>^B;
M%5Y,+R.YRR Z.."8S4=T%@]_'"F87>9=)0L@I1#V&,N\97"R@"BKX<XZE^\Q
MA><.]4VG\GCAT^IZ5-@[@,_S@7T^7PYJ]S/"6$!$!/HHJ:OMO02I/2941O&A
M)BJVM7!_TJM]Z5\FK45D[BF?PLE,IZJ]"+"[B>M<?5,;<:&QRMA)RT)_.N R
MV#=,=.R$A3,&:WYDV)QCZNM]KIH_YQ??=/[9BPS#,V/OG^;[P]3>MU3[>P_4
MX\M6<315L5;L'B+Z81.A#'9/4UIX4#;AYZE8?55JF?QW"?3C1-*.A)8@15]P
MEWL)29"V/V2Q: *UW70")XP6HM\^J3<1+'!Q>2LHW5=K[2#WV#&;9R3-?1[R
MSU(F,&3'>*%S9,TE=A(L\>K<DFZJWM4C@N2'#VT*JK[97^Q0:G_;UGX4Z1MJ
M0JO^!;V[.;1X4I?(T)BOMNL#]VF[O$7&I3=UX%)&GNKY"($;GF=/X'6FC#N]
MKL8??S1],J[7]_3,^\GLIS]&;'"9!%'_N,^K;WD^93L:G"XP"3$P+1^SNU2L
M*!508:U?7)=6+TSVPA:!#43R23]8%"@Q&%! QL5J^*L/CW\_L9F.MYUI^<+%
M,9%YZ.I!1WO;:<?$$<MF:2E* 4,8WU2_B^(?.SIW*\6'.AQ5^^F#?-2,RB=G
M*[E]V::<KQFG*2:9=&<6T'C"6)NK636J/ZAS-]C$V>]?[S,3\>7T]4 5O&WU
M016\A4Q@5K,ZLRZ4RX-B"?+*Y80>ZE_QK,0/RO1>\:ZZLXWR)N&3\_6V(X<7
M)@*?%2FTGFQJM1>4O")RB#AV>URY]JWK2,W7K5'Z*$R[ZT!5W+EG6MH-G0-I
M[V?\7/Q53?R09;W#9Y?@*-B0'-6 YD"&G:3$W%U4+Q?<Y=H!].;@OWY_@GN2
M[^@3=^K#I@1?Y0P07ZW(SD$0#$Y\F*T* <[23\LG>;SKID_9\+"Q9QPNOSTH
M^UKAO./%M12I)-Z$B)HL(9![C2S;X9"PX$J+F7SX8]==/T>T[&Z/D@OBATR^
MF4R^?S@5TT+D"V_% L45*WRAVK?'A"S2^?:L%YL$[AXYMNEXPTL@B> C/YV>
M(I]L&Q8F+=W2TWIQ3<USSWD?P]TOIZS74'5$^5,_$9YA8H64BJI$ 5>>R(X#
MC@6);TMVOLIWO+94H3.[GSD[-H*8#O6E2Z%30)Y.>/.A4 6Z*=I-G>$@7UI,
M+2S*[SAZ2&,<F28O?_^(6<ZTXKYGSR+=Z?3=X1_?,?;0,HM#3].<*1W6%*Z(
MX%<%>'Q?^5PH"TCY+,AVTS'VB8?XJ4!L5HVWB%@$"_!B =\RJ).T0*[6,5C#
M51K&H=X)'$AL'LY(48]J4+QEO4?::3&^,>[H59G:P=CP5M] L@W(*W23C)@(
M2;@T&*IU[6=ZQJ#6 :TN2:>N@T;^FS;M*O=_)A .[!&(73TX"J?NUU1+UXC:
MFYJOU!9_6;W)_Z.S0;O=;6;1C[?+RXO,9UU"S-K(3H][.)>TLVVGBRU*3T<X
MA%Q^5C'MMSB"\/3T#-Y2-A=&+%N2GIL+GV3[9\32O=SA".Q J"^4<$<&+PT[
MZ9<H2K-Q[3=6#@Q13I[OLW^@4*YA9R-O&RFN6%I)-!?I#N_$DNVP$=@R_ ,/
MRK [$1WCAN=:#*G),4_H3HKH.9;'1K8:;;V_%/MS2_7[W%4,?\]GDUI^-1&;
M<6J/R;S^C'UQ+_$T-'EAA0<[ZO.,SXVIN@PB_,K2JI_.>5&[9^N50M7(L#8D
MIQN::Q(>D]M?WE$G%FUV5"ZQ5O9 HZ74XYVWJ/OKG;_"2?$L@/=ML%-5-ZCI
M1TV_LBDZ*/KH\_QAX\9WX4880[IT+%%O(B[&N%!\ZAWE6?J#^:Q:-YWAU5N2
MFW!A"J>IW1GRG@=FFD[EEYF+?=:;Q?::S$S")?M(0BDURQ@I6#XTVX_:J4#%
M%UK)5S\Q_=)PA/=!]HU7X@U?K#A+0%FP-9P?ZC=6/L3REWE3 G;$4STORY*E
M#(7C&F7P89_V)-5FTW27A)UZ/QST/5](8MYS5/$_KN6BH/#ZEJOK3V)A'#K&
M,,'PI?;(QX%",7'K^5'W>+\P]9>90;Q?**A[=?I37?Q$M%'KEK'^EE=^0+?[
MT)=JYY,;TCD_MY^/8-N^RT4'473([(7D_K?9\8>?+G;)"F49%#8.%9]VT1D\
M$QH&=7:Y]J;,3G=7 G?HV<'U(@/KSM2OE'/^IQDRH)GE2Y)]X6&_;Q@OV+>\
M":[%TH!@)#=?IZ7S^YB/U5^#+9U2S1^="'S]ZFSW(YYY.T[KAO9W#DB#NR10
MO$/KH4ATLX6N:!<"=6S$9CIIO3I&G&+A&X$^X:1RZN5/%]6M\A2,7E.L$B[?
MY+Q2;BSP+_F7_$O^)?\WRR8+H'Z'^M]3\".!;.^F\;'>!)V'J![4=55>T4%Q
MH6V.5 T$WUY .Q\K>[-3>?6Y6;/VB9YV;$9@@(HJD:8RR!":/<Y\K,8"KA2C
MJ(][UEE C-A32C<+F-C7K_9VPL_?P2:ZI*H2;=Y:T;2)JE'VL#BW[<AV[YDN
MFGK&8CMEUH:">(@)( YEMH;S#J R2.?)\!9[ %WS_:R&0@\"00][OYP5R%L=
M/;6TXT>'RLU3^R2C39'FF$9=C _Q'D'"^##E^&%]*C*15-"B*1!J69,XA8KP
MNNTLKKOIG_.D@K.N<IO1=/9H4T>06<:9:2#G$0_!&TE30S&$-*GEM.J7H5S,
M9RS C[ #C6O=^F2WY153,#+&XWWVPLV9?1]Y7XU(!K3+7ZVO*)E8H:DD0MNB
M5HRD_>+LQ,IP03/"714<]]]A=,DWZL7PJX6"]E /T>2Q:1&ZX7'/L=6E+A$2
M@6P'XZ%%4M>J:84L@,.)XEZH^S:?8J9^N@D.>#VQ"U4GU5I#(V]UE*"6_>U@
MR8RRG7:D?;PW[JA.K@Q+3-JW$(?60($EBB)#B-#* LCVV ?CHK2[9'R35F,Q
M+7>JB05XDXLK.A.>2_6AH_M<U?95)R-,=6QX_**K'BL?J7T!P*J#G!!W4159
M]HU[]?(GE>)N1;6EH=2W1$8JO1[8Q-W8?#!9X?.'NQ@X+ L(0-&4<8N9T*9N
MHW<Q<VHV5O=VUG7'TNPU"W+(O7*^> 2B'A^5:F/8N VK(JRFK=,I>7,S1'2R
M_@ZN$_,_D=8C,(=Q:-_@1"!A#1&+C=YT3S],>5MB >-0W6!"# O@X7SN&<+G
M>CGVG&Y\:UF3AOI;L8ZP'IN]!TF[ 3D#;!F.(:H/\F3074+/]9FP@U\P%<08
M8\0DTU,Q3/MHW]+RO;(W!^I6'UV*.N.?H.^1? CI$@/R%-$M& JTH8F56(<Y
M0BD#PV$B@_:;/-R/D0@5TA[^\!'7X;^]\Y7NS+M=1'GJ=U'77.&:@GT<VS<A
M!$F<>L<LJ#.GR(%\]I32*7_L0X7^(%3DP]![!=$@;"[E0X1/=X1'.HC>7_<X
M;MD!.%W.=D1ZR -"@@M4<.C+2&FNQ0$/NB/ZFKT8_K[=7:D<H8?6NH&-?>FT
M=JI%[=@J\]D_D#36&L:#C'0*AS%?E1-H<F(Q0>]#)NQ24/2]WQ@6%91KM'F]
M,<I^3<[$G?%.4J;K)!9PR?ES7.WRJ9F7=&UM)C90EA"R3J>K.S4)G+:MMBY>
MON#L_SUNYI(%4,0^NM,TA^?5WW $+0_DQ4!HJ*(,+MD4^<'*]1>+*/7T!JS0
M!BQFMG%XK.RLZ]B<NW(OQ[>:V.%E9<J,#7_KN-']H7.<EXQ22;?$&G T10TL
M&4$-II60FU:F\/>-+:>(\=?F,\;AM*+7SJ92,U\*;GI2=;(E?,Q:M^M1U/P$
M:K)>"4DD6./R?7)VL%/=F%AC+;IZ^.?P;<S'QIJW!H>1=XW%"]"WQE=]1/7K
M;%POW?DR_^+.JK!&@]": 2XC"$>30ST(J--\$=Y)$,($=$FB\=30[E!KT>("
MANQ N8W<X=&KXV&E([:$KP<"4%<N/E/>=0#A&;_KA8QY6/-?W(^A6#*$60#(
M$SB%&\YP^@KW00TAIL)^WC51G(<+=D56U'J]P]?VUIU^P5<2+%(Q>GKJ4[KX
MP[J07:55_!]"E!OH[A#5%I$0#*$,>YHJW9!QEG8AA#+2(BU'66FK#K99@3$<
M!]1R$E9G3]>5TO?:"Y3+7(R00*?K1H_9]?/$M\L/O@KO))8A(PC>L"'[1GBI
M4SK"J;M.@N0'XW^"4D_#E%_ E]N$I)\19\L?_C*5E''8K\<G1S R%T*:$BV_
M?L=1NM \'$],""!X56GTG)Y0RY9Z)[:4_V)R(@CQM8F9_^;HG<P;#^+D/JU5
M#HY55E9^U2OY-N3ZXD#S'JN+#\Q>*^WA!4C H5;K__8MJW!;3.-I%D!Z":^<
M79R@^Z$S)Q0;$^,QW\:E^Q;7Y]2@UD"S6!])5,\OB[8TN43],JOQ^:9''.E\
M(-(8TSP')^6S@/5KV$UO'R(CQ@5.=EW9M%J)8P&+4B]8P%P-[Z8*H>30Z>A#
M?KN:]ZA47#WCJ7SJY4@0:21 90DO4;E5B9&B((4H&A(/*.6%'GX66D4.\J]M
MY5.SDH\[60=9;:6 ,&NH]#190%XJ"^@PLF !TX;PB74L^10+V#*P9Y25H\"C
MN/0?N!P6<*8* =Y1PI!>8Q@/UEC  DH$TQV&84A _B6;0.;$]&(:;5C CQGX
MZI<>PN:.1%J8(D.8 "9 )Z@M2;" 1PLS-4I_T',?4USGR ),-R B][<'_QT&
MY3%/32"W@.=0*J$VLBH#5E(03*Y!B"HKX)MR\_9_NO://QM8[YJ;N&$3A?FQ
M+0;D+6 !'V*V1EJ1ZS D"^#LARZ<6/BG*^?]E7V; ;'P 0T1%I##"Z.I0+U"
M%O:'X,!OPDD)+* <VX8;SJ,ZO*>E46;;L",UH^Y:=24)/^F&PX.B<QQE*E?P
M"3H3+ZX_\\ZVWU;! OSMA]DG9YOL[QNZQY#IK80A*M[P0+9/?2-*8\YX2,P@
M74\NBAV8BEV%,*3?!YY .K" TJA7F#G=+!2F\9=E13Y8JJ8FF)A.>$0;%(QI
M"O0Z&,^M9*;MJ_0BV2W916YK+:)$A')..;+8/>!ZJE" ;27QQOB;*<Q$!<87
MNZ6,V;0H90%3.ICFRV ??!V*PVJ\)PMH\^M0PF68Y&S :?[(86\P%@DZO"'0
M.F'D84)Y%U.8P,ASQE">KGY28H>B^/>Z<@2A($4/,%]B?D!HG]G;P0+B>EB
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MWS\V_;A  8@\4L3Z,8O/+\.V;+U=B60'PJ;*L"+S(13!O!G<9/9AZ-(=4BP
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M@WY>Y;!AA\ZZ?:GZ6[G?VB8&I7S8%^=55/D6;$^U2=G;5SG[+\LZGT\S-#S
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MS/_F(/=A4^$.(R-;DR&U-^H>$7LRKEQMNNO(E<-^1VG;\=_O^/]?(G#6T'\
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MBK>/,9>HK2MYK=Y<]!S;G_@3?^)/_(E_#V?E)0CM#$* \1P4':/?8KP!]X[
M?1N#=<PX4TJ/J:]:F[P75H/OC9!SBG[UF%_T9&=K9KKT\L)T%U6E=?'=!&;X
M)0%]'S(^TX03H/H2N1M]8Z4MGR(A\5+'5[V,<]]=3>&I,/ 2$MXZ;^YGT+'[
MD()J5?BE^PJ,%[CQ]Y!BB:4'XROB< QA)7[#6GCF4YIY)X;(ZN^I(XU8Q[-Y
MN5[/OAS26W-JO]]V&Q%E>LV\(5UA,5'[J>H(N$N4U;EHCSE;>GG3PJC'II(:
M+&*]PI*OW@&8@.4&1IIUUQCL37.9:8X7H/,R\J'N<0;U4$DMDWW$5 07V< :
MA^U?0MAEFA&M)OL+?99/>/G=W%>3!%LLP72^+9GT.+:.@SCAZ*):(%\WDM,[
M:PG&B_(X+:#39+J_%_V;WHKLO%#9\#4[+37U2^+N2\=0D43BD4]+CL F9/@T
MR.=.VXG\/&8(BT27"2[QYLYF[ 7;I>,ZXWS=0E!^'M>LV.>GU DOAAM.&B;[
M/+YS!ZZW '*09\*1!ZA:IZEQ)'QS6G#M:^]@[;'9[<[G\!3QP8K5 ]>2578G
M!5XYQBECWX8OAS3CASQ!7BP1(TXWHWJ1,M::F8 <ZH;/>3P-0EB.#=48PTSX
MG.KM\-%H&7))[FP8$]MQ^6D;7"3T2C77[5:0UX:F"!^D2#,>("%@!U0XJ'K/
MBM"-@4%LVESOA5@U[[8%6NQ6D<^#.4XM_^[63U];=NVX YA&_NN@36("(X.4
M=M1W'"$E<@._"Z%61>YZ8A(Z47NX'BU8L\^GP/)*6F[I/25X@G>^6/* 6 SO
MY-U3IM_B(Q1C@$T^M0DH5=F2+AI*><YXLZ%QNAY:8;^8(WA?LPAA]!;^\#1Y
M)2+(:$.0_Z;^I;2<YH@FP0#UD[<P^VX\./BYW2/.T>,[3GZ:>AKDYY[ B\\B
M)1EOEIC %8BL)0T*;VVB5%D\)+L$O;SLFS$V/^DX/+\Z^UB@W3&PI$1()6!O
M]( 9STXN(*S6'/&2S/*S-?GL&B6.W+JX0I-%-K'&RQ:I.C'SFZ9*"Q6@9G&/
MCRZM[3%7NZ-/:E77R(I)I/V-UA29T!['<QTQFUI#GI1DJAO-#=D%2C*RZW:-
MNGPAL+KQ[V64YS?UQ\R_%>8K-!XI)$]N!9CI^C?*AQ^%?V>WX 76^0YDWO]O
M0;892:&HD/!+Q:3-QFU1G% 0F@O^[A.H54JV;UR1H=XSS*[N+H^]LB S=N%K
MSX\37]2??^%\>.WQI(R,T%+@.>XF',DZGJJ$:T(-];6DH99D:<[T>[5D)M!T
M1,1\(!#"ZV">,^(PYRK=ARGW\KWMRO/Z2P)QKB8OP=[?UH_O_KNN:O +JG@Y
MBJ9*C27.Q*K3O8,P\U )4S4\=<2NJK;,(:.M"UN!C:GG2ZP[X%YQKO#.6<JX
M?7'/40@O=0WDW4,[YPJ.0'=#;VN%XTD74$)P2!/2!(O]<) )-.1TZR5FSUV:
MV#0.*AQ^$F"RFR,E*+9-^#.B=><GH8V\Q3G2)G&E ?_HGF\XTAC9;8 3-;'V
M4EQ"3;B8-28[GL%^73O<DCO<+,Q#_SCDSG7A-N_'R03OC[\PXA8:Y$.Q?/%]
M@:C5Z L@1!D?$/9$08%X*;I=;QD3B$2JD6K[!T*VE6/9K37103ZATB5#G2:5
M27)'+\:^V(>]6O?;>^@$;I$)D.PI&52WMW1)QNLZJ3E3#5)%@<C2L&;I3:7H
M(<E#ALL)"L#7>3,UX$*XSE'(<WPIOBE^1(> :8!*HNH-9ZC].+%UWQA8:7SS
M$>]/^9H1 MC'"!64QUO7[YD_VKS+???6I%WW2)JP7_MBOF7/9:*72;=BI$''
MG^ Y<.-Y* Z4KV]T%;Y)35:D?K=7W0Z49%F&Z$ R<;KM;&+#\]G'IIVYDAE.
M?HI>E.=*[T[VWOYA.<>]*,N:$#H8+U#C&:8R_>IU[/3#Y5'. QXI--_F%+?I
M?@S!X%"'6'673O66+2][P0Z^X-M[BQ5Q#2Q53VM1E;'AH+$ES0KN1#E/*D]Y
MLG?@VH"&+S'2IG1XWF9SY4VIIL^;2F7EKI/)UDVOAHQ>"[Y:Q[,C^Z!<3."V
MX/!A>Q8#(\!N&$>Y@$238V?J>[H;:;#92^^P-SZJJC_MPE[8"1]WE;L^?EX[
M0W:H7(OP?Z3^F</^-!/8L0"W@Y$&Z<+8!H/ML>J0 C,,M;39N/-Y <R11PGW
MH7+0-QM;K;U+0:3%_)-MRWY)C \CDPF,I^(^Q"]YDOFT8G!E6HN#;^")32I7
MD@VDT[M,!,-NQE5J+#<)RX^=R$ZW-'Q^5)$MW#S4->K-;(9DCSI=CU D-WBV
MKVS!8:F,8=HRZA8^S-,O;RZ]E^]Q 7O$SZ/7<UP%O\I0N@ZUG EP1;-TC:-Z
M$O.B:PS>@#VNYLEH(O^(MR&*(-2[IRW&:-36?^!1^@$.Q830-$8[9MI[ D=/
M$91B!>7@6R8P=R:)9O_P\B7[M*O%L7N.BUVXH-$E^770O[8RL;RK&>'1$7 &
MP_\0KKJ6/3F#M#IE4!*'^?IM,;2+;IH(\L%8Y4Z%"20'QS&!SX&HQCGH> X3
M6/=';WG>P-.C8!H]L%I4@;,:$S@J"B5=A((GZ!(,'R)F6Q##!![>1*U:]J-)
MVS94%11#)@^\/&S !/;UL$;$;)9**4R@YRMJZE46:E46@36'S*?P,8%N+D&Z
MF T3>"ZX@8W!S9KB0(%\)O %<OY?GFWYKP(&K8Z*_J,TT($Q52;P>IL)4/7S
MF(!BF-4O'@[Y9PD'VP)MP?P[& 9PC@G47V "6[N9@!/\'?AP@14)PVCZ\PWE
M/V@>R^V<!MPZFQG+C79,8-+L?\0X?>B&)<_S9$BCUBYJU.7*-8S6NMKIV,H*
MU94D@L7UAOL[K)0!-J?R=H0($TC0(4!HXNK0]0QCJB<EEPDD/B+#&!&"8'@Y
MW3SZE&%J3CE^&G6;X)0L+;#BL05Y4V8_]4KL0>5VJCGR,HM[\U^PKD79_OM+
M+IHF2Z8ZJAU8KT;O""G[VTF8_9H>&0^>COHYHGOWH]9S3X&IWEMIU!4FH-38
M@J+HS4.W[920&^,PVMAANBX3,(*$4^? N0=,0,SFJ[**N:C]NBU]7M36'/AG
MH*RAG"SK/J%:@LVQ@@SEIW52C'S<),&$11-N+-N_+@KK(-F )[L>H18=/C"!
M7O@" 3W\$CPKTHRBB$*W^09)<FJ,^3PJ>AJ%=(..LGP:@;1D-;#V1MV_>AXR
M"FS#K?K6L;K$#Z>8@([+TAU8R0K]Y4H$=%$8USX8>I1+U/:O0.G 6#PY^1'>
M!;;46C*!4]<P<\FX5,Q3)K#J;.+)!-Q=LYA SB'[%5<6M=5.X!IMUIY3M9ZB
MEW^#D"_0,_U?V)JCS"&=;W[177.O]_U[K7[@?\<L*#8B;JP %0UZ;DZ+,'K1
M5/O).RP% U[]JIGGGD4M5C.!_32"#8T3LZ8W-OBGK__T]7_2UZ$KBSDT '&<
M\=9T-\*"NB!>ER8160>A^J\R@26L^'[?I=/5H<'I0TT&[P_&\'])+&V/G_+Y
M >MCL3(:RZ+/4E[JM*G&T;J]IESH%EOXB=E"=Q]I-?*UWCU=!NQAK?#8-@5?
M\L/FL!R:-N(NXSXB8-P'14AIQ$2#AWH"H?S(SN'I)-1KESE]TE'Y5T5XVWZ%
M8,2/>>'/(GQWLG<"P,P4;(AC@KM)-GC$F<0=:RH/<T%P4GW<_8H6MH/&T+<2
M87/DT6@?W2R_J:T";$@DES[QF)26@L^6-=)])RU:.ZA83VS.XL5<G=7QCCZO
M]R=^P'2GMP+[[-NDE-XQ3.\*"HS/$KRJ+R8Y6 >TA)S*]$,LJ6@Z' M0&YJM
MS!%?=Y4BKXS;T ] J>9ELB'-4"_R_E)";)@GK+LY/H4114G_XG-K56*_E>./
M9IW\$T,SJO0F$=<P&)P>2I4EQ1-QBP^*P.]UFMU3Z*:QO:17>=$SU"=Z0V="
M3.6K!I3")XXZ79W>_6&D8.FBK3P79[%M#-6XKC&J%+9T1F;K_<S9LR)55@%J
M!FV^)1B/T%-M8_:FAQ_[8Q9KG(V$S^6+&5ZNV'+I]<<-!U>73X0L5__EI'0\
M@I44D#Z;>NB6@JD0$RB^VL@$K"8PD:B;OEN&-F*L!H557V?58 &_5YBX8YC
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MEFA+0G@'?3):2"/(+H<6;-RW?MW@?"[-H?:+SL[6@]I/Q2(F<=PB 'Z_9BJ
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MY][QNI6790=/.[8XT0#3UL)J#<U ]G1Q8? ;KZ6HCXM'"KZ^I!L[S&A"'P(
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MYNLVB42F+L^<25)ET%MUBW(MWE\L3H4R&)>&JI";I4OY+BF ;\QMR=%T$4%
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MJAY:4VXHCI>H^*)BV_DE>?D-[52>N)SP@G7<A5P0>,-X*B_9[N96&^\+BT0
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M#/ 4 "F.^H,%Y[R/(!O440"_-F1#CVUC_TE$Y@_/OZF$ 6Y'QD"V?$6H"-<
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M%$ A NM%XIA"$+@0[8E$;PK@,@70/DN4K*< <#(4@.-9"F!["1+,N@ODI #
M13_/;1V/.T)0 )&"^'DRU4%$HO F5!3O,*< &#6PW4?4_V)"S&50*6U,T1&4
M:@*#6:$KX#&8&8F<//U?%CCY_Y'WY6]Q?XO[6]S?XOY?(NZ?8VHXE67^C;"R
M>_'XBC:0X!AVK#:9;D7 JH!E4_9'_]5P?J>^=&V'&^Q/C<Y?8.#N3)R7Y:M4
ML&6,O^;M[C]^ZWO;(P^8HFQZH(T:@W3-RJA6MDPA2A9\\^^\; -(L.Y(YB5"
M.C"EN=XB+[S<O1<5$R\LILDX22Y6U1AU:9=MBR=ON-XZWW#7",/G>>8[]V?J
MT#_@\[/*J8$O?5?BTH.O O$(E\X7G^KGEX513;W+2X,Z0W3/# DO.ON#*EHI
M@"\^0)9!6FOLPR4Z2X[9_@>@P</YA:=BFLQ+I 6%D '?:I(F/D?%S<(0FRB@
MJ9JGNN< $GU(]IC]H(T(' 0K:BXUR@*(O'O91UED29@1<96*O>@6?O<C*6R5
ME5Q&4\,333NCFV\E4HR/A?%WJ;"6!"63E+VZ( ><J*W7SM20HF)7+.XP!\SG
MA!^[<Y$MLC#5^MJ!'$(9_R6)M?6N^[6F9>W>^N_C=8%DRZU9,E_#O-(1P^S^
MC7<4P/P8 LU#HG91H$T!R&9 2,$H"YDWR7^=]Z/&#&O7'*@**OV7G""8JD?8
M>+@*!3"42P&DFRB1+QC^[6#^.F4)_#^YN7GO(3_)*;'0<FY"R@"COJ:><*Q-
M)T6)!K#UZ%S86-S1U<(_3";=05HF8K#WB$ !+)CU(XAW9Q-0.]*(18M^"B"9
M:N>G[ B9Y">;I'(;!&'MR.AWXW]>XQN/R%T(OB6+_KD)P#FEP5>8,ST2(J>:
M5<Y?H&_C/XFRE"DZ"OB$6)X&K2*V]'XE\K>W_E($\%^QH-]-_Y>:#J"<P GN
M*OI4[^ONZ2Q//^;!.,?&8C?0JI/$T+LLS")! 40I$*F+>#&0?%,>1=R%%YL;
M_G6Y0<2OFHWE!3*1 MB27D3]T<1?_6[]WVA=KDF%57!" +Y7CJ@6UU42DVQ>
M&]#*C[U<G/;]I"F\]/^[J]/Z7-;+W2NG_QD)"5@L0?#**%D:T::K"J:!71S=
MV$718(@<#DZ7ANJ@3P[\E\KV:KA&^>SY%K//\S\^Q: O^5BP1A?H, S):^'&
M/X#F8Y4VW+#,&K;CE61NHM<M%+F];GAS1H:K)*)Y*2=)DR?<RG3(X&:0\V$E
MMB7_*/Z9\:$82<SRJ6#[GNB&!'!7;MKO):M[80N0Z#N7J]&)J/U10F"=FTAJ
M!(<W26./+EUN(7 W5H.4Q[\E;<ZHVQ(OB9T,^6"3;1RV2&AI"L&RO"A %Y)[
M9Q1'-ULZWQ#[6-FIU,,=9W)!;T.ISL22LS]487'!,_5MU#TKCG-+/#<Q-\)T
M@:]4K:G\JR8S;$?8Y-?A7- 9HI=A/=$;#^X0D-<"I3DSU4>PE%?+!677B]%[
MB'M\K[ZJ?-I*!5:<\.4HRX^/+ C' #E(2N#HVF0:A[4\WK?C&R2EN0R;6CZ%
M^<S><\9*Z<<.[7H&GAQJL2I)^RZK'MO[X_:[-3J?A<0[YY4$X00_T$8E9CN^
MJ)HAAMB$JBCC %1;O[-B\L!VQMUC_U F!;;:U+.7<=L^)V&(;MK/>BDCS0_%
M [Y- 41G Y-VSL#%89Z$^OB0$JCMZ(U9?V]:#YU>EE<S=^0 <;QQ!HVM]V\F
M\'A&;!R"6=Q05-;JXG#N,C$%Q]JPBF$)\_!ZLQYH[=/> ':)I!WI%;V]:%\P
M77D-WVD7@*.G*S.'9,%E\9,Q(""Y'U&[W D^L3J)8(;QSQOO9.(GHRIOJUO8
MW#*45Y^T;C\!L'OQ/'>6D<8#D$-Z_\.SELJ]9^E0KL@X@9M+666W2)RU^(#D
M\EEHH.G5U4FMG#1C[G>"1I_[8UUBO 7E@DK,GW.4M])L-LK-([[^G$LJP+)^
MG;0>)EEB<YEGNT *C9--%_"3'0=%7]SVU+=3Y&WMP^X^5TZ26<J9BG'0.-,7
M7CGO0F:827&%TQ+3L::#PC^C24$5=@ZK>P77TDM[1N1>F&JFOYM88=G,<KH]
M EH9&Z(;W_GKK58KKUA%KX<D[7)[M[>A9>9Q$S8*!5VPWHL<\<3Z$W!78RPU
M@)A&M&E8S]-P>26F#NS5$:C.(.7Q.L1KZ\GQ.5;M\R+6J2"'B%+-EZQC G)S
M$ Q:WT%K';O<X7X$O/@N5*X3([?><G;(GS,(AZA]LK4P>CMLF$<F(8&[R"Z#
ML7)S07F:=32_=J\9O]T^RY)Y@YA<Q,JUVN^7@0F,.L4,]:^ZJ&LU,Z(-LEBR
M\C1WN'6&RJ@4!UII)E\A/S=K8$6:\:/8V>\U>!3..,F+=3U/\>,+6_S"]E%A
ME\+0@+=3Z95;Z5GB:5X_/E]O]'XO6[U<.XXO!M/#Y8G2-_ O">22T'D*@(/H
MA(5$M!\5''_ZI+E88O_ZI0>#XG437.TO6KT_N@&.U I;M(BO\4#SAJ-T/R_
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MQ>4N _U'@>4HL@:B_?,D2 WJA77H+(O?()UPFTN40P?7(\N44[%(YH'.==5
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MU]18[-W84IWAASIC (>\1<H'&@#-"?'S2W6N_^=]H;.TZ#U5CQV\O+WNO'J
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M+]R49P,BEW%QY5N[,?JJ&:&WD\^>G0XY.^U%$&,#30B4H5*U<6SS:H1!7US
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ML=L;V$0P)$))&XG?2W $\1NX!$QI?H>U#3&V"1>SE9I!\8!S"IW_BO"22\V
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M(@YS\/> RO!UQ*',R/<1SD,!%1'7:V\7#S.'!L8G7S2)-78>*>@X((%#Y43
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MIK_,S,Y]_?:=MKRRND;_":UO_-*+"^#A^K?QAWJ)P7IQ__(!WR^]N+C#?_U
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M@U O@DHD5!YD21*8S]PX "T'DDL$&'-L>0>Z%P?(A\URWY_$UC5E'L O]'(
M8VT.H#)"8'HU;LZ/-EKG +>'6 \)7V$_S,C]Y #)L"]%BAFZ8+\%!^C67^(
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MP&6D\&U2FEIX,_#20)6KUN[R$\^3*L7-O</"O".V9X=Y>2DE*)?F1PNJ_.\
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MU&L)M?W^] $;;1=C4TG[IZ$MII(G.?Z)?^*?^"?^B7_B_T=@]R%MB2O&!TQ
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M\C?3*A?LWUWSN_HT33=PK_\Y'H<3.QRL7G"+'973DNJ -.AQD I-8E8TD0A
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MO/XCTN"N*]=ZU3;^G3(,#><HD\9/*ZK--B*%F5?2'ZCER6V6WGZZ_X_(HVQ
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MP;B"\3D"T&YDZ2CH-'6D!7G6LJBK8N_2_'.OR=U#S6'4GTMD(J'<QTAEH)*
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MMFIHPDUS&;QQ]!0$VK0!N]MYU-3.*6Z<%+)]AUE$O ;SVE"@ 3:&N(.ZTA8
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M_JGKUA..,06TE?,C%2/YA\0D]^\1YN%ZRO6B^*]ZC?]#@.S1?P%02P,$%
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MT?:)BS=&,SB+/#=-R>,K,9FZVS2_ELI./5IVNR<%@KO;+?150Q\M^1J<E3;
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MI?Y46L6I-[O0=Z)XZ ^[JNN<<9U/]Q+PF0N6XRRG'_<3BQX[*Q%8+&_/7-7
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MX"V;GB212QM]Y2W4=T2EQ&>]\,SZ^I;P-75R1[^_S#MJ^]$03=Z*R]#@8[!
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M+FG":!^1&9GX66[V=Y*;<!*J^$B>L4"DH&YQ%$!;OEA]BR-4017N N 2E?:
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M]7D!,%9\AI+'FD=,+V#@KJ_-,4/T!44V=1!*!*712HK0P.A#OYZZ-R@A_H.
MX*F@4R0N .J-RO0%P,4#J'0U4:#ZNBV8UC8OJ*$P9W]) *2=0))9?HB)B0#H
MZH'&?D+Y)74+:/4OZ:<$OP15KLQ"K45V@0!H,;4_8%_%1;71IQI7W-P02J%2
MXLMN_/9K_QP8E,B)*0RL:LZ+T3B#U+X2 +.)M)L'9OZ?'X[X;W25+SU;%XFZ
M^E.0A@!P/%TG ,Q*DH/G<,L%0 6*@#,.Y5*H*'QU10"D]Y\L;ZBB+VC\ @[A
M'A@:DZ"O))0^WT*<>78I$6I<9V3O;Z:PZH]#@Y6$K$;%\@XI%IU_<P['5[K!
M[Z$,:\F!7RE$?@ 1B=->]*N@+RBK"@"<HP!XL;31R[O)O_"OEASA,YP) ? @
MHITZ48N&@)&&_UP@9JI+ *A*OH*ZHC*0"!OV^&]Q])\"HUR+4@ .)H,S1PK-
MN;(9:("[N0+S]?\B2/]_=\'2R#I4FC]09A7SXTRQ?+UQG_F.I>>"A:71S(R%
M;9'Z-!*2Y+./JX6!OA9^$ !1A!,+"DN5")1#A!=2V;YHE9A*A;_^>BJXF#\(
MB$K\/]>DAV7N:$OEV+EOV,6SS6-T8>CK0S(_. %Y@.*>VHS0W"__ A:%&.:]
M%.2D&JKZ*7+F?(G"H8Y)L!C'>V*9AJ*4'GEQAUO=R]_BZ#^% US^!R7II1#]
M__EAV?]&UY\$Y4^"\B=!^9.@_$E0_B0H?Q*4/PG*?[OK?QY!45.MLU_7BFR!
MCZ*0=Z._ID\O\=ZJ35]SWSE?/:>T.96RTW]\NY!-!(L*^U$KP$6Y(#\!$!+7
MO'2(8-T\C,+487RT &#EO1, LDN+\Y4"@#$@ %8(@%$/-AV1L@*'C'G[Z8-D
MOECY?@%063_"<Q:J_#T5ZL6RIJ';T*P>/"T UJB1V:F(_#3+' FEHV-@.'HC
M.LO8!R0Y=;]O20 0 WDHS#XOKH-@ZPMHR@%!YD;!N7]@'/A[LW[&BK?@W*&J
M]XB( /C2.T3EJ>= M:3?C?.+</4<A\@3ST".Q:-0>04MKXMF'I;_U-H_#[)_
M^])SB;^W[_<#?8:YGE*F]?O1_MZJFP=:_P]/P9_6_6G=G];]:=V?UOUIW9_6
M_6G=G];]3['N#W3HK/Y_38P##0XD"8"+(V>UUYV$'#4];6F(57YQ7[.B83VU
M:.9&]SJ"N8N<MPUGP0XW;?R#8@09_5><7)>+YQF3%Q.@83SRE;!7 *P_C*1C
M%TP%0 FVZ;TD7^*_XM;H #>,(&GT!5L!\$Z8=Q"S^ @:UD)&H7VS5K,6_PZ'
M-_Z' 5CV"G#\D@!X2.4^YTVTX%K^:<;^8++8"M"XG0"(HW+O0]7K!< K(H)*
MY._$KUV\]63DM :#RETV3ET\-L?-MY?^=PS"/?0JEA0 .7NKO0;J>FQ$#<KZ
M>O?NI\<?X!1_YH-WWE[AGZY/N\T9:/UQC:JE.:9FFVA7_.[[0ZL0 ?!?.*OK
M(]8R,$V2 ?UN5BBGX#.LXBJJ<-FVIVM8[SEI7LX/RE+,;$\%/B[>^VDE_<F-
M=>W+6O_39S/LE;GGH I4_%UN[LZXT%JFS#T6Y%W0XC-U32KI&*LI.<U^G%;8
MON7^55-YPTW?3UA;*C@EY.^LVKNJ&'3$]UIQK/E%/&S@$+D'/W0TCCDAO_O'
M9&*99:2Z] V/NCT1XYT,Q:<=3>NDSG]YLEDH IB358MD6TUM8)VI &4-U+C[
M_5.9RB&4*)Z'2[ ? Q+;V.P=C'>2B65>E#P6M<%\X-HS<IR)@=75SR_3^F\"
M#K'^RV]*12RT?0!9EE185;4&$QD/KC 0YEK!WA9=<QXV9EI&N^I^B9?-GMF8
M[>9"8*\Q?5>\8_F>J[ZJP/)CV12:+2)JSEU'J$-TBV!O[E'"ET5CHFY#LHZK
M1KIN=F-[4;Q1_9K2YQX29(=B=='PC)DAY9-R=VYBO%+*&H9(4PE<#4*C !"9
MI4:#FY ]SOOT0WS&/%)8G"Q-L_J)C1=4X(V?-*K>#QTC[\O:.?Q02@A(S&9)
M<QC\!Z +E6@S70/=)LM?-[,]Q,J*S8CXGJ,4N$E'+UI;,7+4,WZO.UM&,^BK
M^4.I49%G&,N4,E7.+TL'.)!*L)!*PC&(DW-<X]&!K5U(Y7QGR<7B=X4/3A4<
MI<WKD5TB=@6*/KEZ?FW8[MT!%-_?Z?N=8F?.MND<V#UDTUDHHSXY.1CP_?OW
M]//,VTJG/W___/,Y8*/)'F"C\_(;:E_YXLB:I<,1K]F8J&P#L71"5XE)\.%S
M2..;KI$OA7NNRV5FUQRQF-AHDT/>JKY:SG/U@7!*UK[9WW58P\JHA@#_Z3-=
M.OB5_FVF'3EEVIF0(QQ!/_G>),FL?.;RD]Z3Z\D[+22^O#M:M3+&9',$[7=-
M-+(3(GG[6=Q*60HI"/<R^(%)BT[/G-CIZ?H @R3_*RY*P2_7Z&TXSSBH*@,\
M5?OZ#ARD4EG'/OJLGGT,N75+C3O3CGDD5=P8C&GQ>G>;'ZFT]EY,F\XRCJ[D
M)]XZF,$JY=R'K5X$N<%:3&B*O-8M]Y-*W"M^1"!TX$H<PWNX*7P;8\CKQ_:F
MW7NV=%G_O%+R(\\*GF8E#%Y'I(KA[*$].G[LXLCL("V&3Z((;FJQL/XXRX82
MGUV8?.EAJ/OV[FO&FR;^MI;V#BL3Y >;#F(CRM?!6YD"8%.%(Y,2)F1AB&D9
M$+&>VWII>;-?8=QQK03Q3/G)=\V;#*SL_OCQ,,D?YG446!W+$R=Q7.$'KWA;
MX5RN26\=4T/DL'^D&6L^=,[,??39/0&089CDML]Z\[4CDW?7G136_4X5):@'
M:<-CK(EC\#L6ONZ&57C9+HK-FFRL70O^-)/V?=NQONB[=VZ+QG18'[^_>MO-
M?;*_7O54DYI@@C?5R[?T!*F6LM,3L.%S\BI#9W-9/P:>O7]:*[(MPBV.N/^S
MB1(KU5 O-.;H-2./O[]PZ:^79!WA"[9 N&*ZQVD0*63_&)J.&F2-W#78O_;:
MA$W_YXWU\:^47HENS%5\]SEV&RMC^L8IX2M___)I-C;L.GXU?$, U! 4RVWM
MP!-Y\=^1X?:8M;N>^UT#E&Z^-D=C0(NA7X,GTN4-94:QF\K%X7@-IRK#':U;
M.G3$;&22-\ZT.FPTVID5D?4\[E85$/!5%!AUIL0%00)@92&:9!>#?H+#F=@0
M!5W^R\&B+MZ.[#X7A:UO[E0FOJ_KICP+COW0+);ZW-%S7:?BVSVH1_.GIS"L
M0$X&;'V)G3D(1@J XB#M5PT&OOO(G. :RJ,O]2W'#$K#ANY?:B'NU+YW+]I9
MJ/"/%V9GS&E4SB3_ 719#&O2\9??K;D7;R^[CU]]WUG6U?H"?5SV2<Q+EY6%
M<4].]S6_D52_$G7[^X68MPY"G:,49?Y#R)/:H\^AMQ1Z.''LX>9+3.]G%U[(
M<IYX:+K[B&D:KZC5=,\9BF#2_2UI#E&'/=R=7.JR4:]>,UR^%-%,B,1S8I5^
M>*I]QZ(+41BW[%38W99Z^YS'[F_,#LWG48_;U:1N'PEZ?E'HXOUK:CE_RTX6
MEHB6O[/X;BTF>6H5Z-B\C/"%(TN\-]R.O\Y5,VK%I^:U:[E7Z%L6)=Z]KY'\
ME;W2@WU0NV3*_27-:[K]CZN0Q8"]C4MG[+AL2/LOMA5R)@8_]IR-DG!\_(@%
M +'FQQ=TP<$2M%.33P87RC?@>K'&W8N/V]JJHYZ/7ZF:\J9>K<A*PDU.OZ\E
MM)!N (NTB JV= TV%-E(/EC$!DDZD2)!YUZF$4,OE[0K'NW(2=2/NU2TXIO3
MKMH9CQ/)88TM)IL$@)CA?IXR7,74DH;-&<7W!CM\L,O\[X[::Q9%B)P:HQ%C
M).ONU[2O,CS+UCN5QZC;NP)85_*'^TH_Z#0<YQ6\AHL-VD=BUDU)#U%AXR!0
M,TWJ:8( Z/&S"G@;8Q>C9U.C.*/HG?Q6YNN,V@A?%5DS@D+O@RX?E999B/9M
M3=++[U(B%R,K$GN<O[I?DN.O&595S-GW1;C[[&_./-DOO=R9-L^Y"E]A3>/@
MW"'LO45U>WD6)6(K:R1LSG1O8]\-WVR-QO>OK8]K5.4UCO0?E%/9';5%K%@8
M4(CY:W[6(&A^@A7X'B?&U>?L3+3!:CEP+>QTPCEVXG2957#K,>:>Y]%[.EXD
M6OF>.Y9JZ7=Y^2N=930+>S?N3X0N 9"?,94PV"L Y)$F<$,"+J]5UT7G_561
MV=+WAO-F[XTLW0(S]W],>5OTP$UM9;RN\OD-][WMXWX%;U8KN<9(.Y@_,DED
MU0\-24]IL?%'6?C0J9%C8$%A9'+Y]>GD^X=E;_^H_[!KP]&LKSLJG\@"T\X4
M,G05#^^$)L6YN""C!(;P!S)M^9IFJ;JK>$56T?MGKOL4TKP]EZDX:Q3N#PSP
M5 0VVBM?!#YML<H("N:G&(H2&LAB.8::/ @.O\0@K>NUZZ49IA'.A[Y]>BY4
MQF*#]5<_OU.2$D\S9%;<7-<:H?8!=,; .YTFA;B:0<=*8&-V,R>N91:_?JSH
M3=^$S75+*S]R-ZM>6R*AV6UM^,5[;R]VB<GL/#AZ<(N" # *@.JT>DTY5ORD
M<HDQK%SY[B#/%AWJ&CC4S;],_U6%FKT \##9%W _[:%OIE+"/39O?*N5\C+/
M.SHH]Z,6.4U2V*F#9@)@2I^%TD.B#V:9B]IU'XJX29#&U&RJN_8O"03?V@)_
MHN:#%8XK-@**6Q22C/S!R6$4W_;P[U+=0"Q*@;/@E=PC8S>ZPEZT)9W*:]54
MUYQ4:5?OFKY T^C;%9RWX?Z)^_A3ZTQJ;F!JJ33C0:?);^4RH!Q!V061Q\OZ
M%]55*4A&S^8&FUN5!<=S8G:J:>\O#O(X)7(94+FY_\:_L8%FN!:%V@-C-L8D
MJ@NE5Y\3#M]Q%&NN]N*:N1FN>W"J])1G%D\WW:8G_8&;0D#TJBC:!4W)GKQK
M5ENI<@5VB@QCWF9YEF(U=?74MOP.0[6@S>Q@4DUIH(2HEKL./;<QW?Y""JM5
MHYHD^IFN5S%\I^#R>VE.!-KC)=>G>C";B:$1.2;\UP9&K#.U _JMS]L(BII)
MSZS=;+0B+X9J2^RV'RN.?--7MV&FDZEO+!*W_Y;N")9ECH&W4<.7?H50 !0$
M)]1A1 @=\[CUV3Y:JQL8S1(T__FJ6SG7>R6?NF4&XC&?5HPGFCUZ%[,VWOW!
MT8IK67<U@3T"( R7VUR)Z\E$UJ1Q?^*=8J6G,C7P-=2-ZH0=./_2&GN-KN%V
M+<]8-;&]V>Y?WHFL3,OK,]V\_LCKL*P;N>K0D3*?P68,SYAU$JVX-45M9FEN
MM'.UR:^J\'Y*&P^4L0M.[VP05X_)/;IEW^Z\IP=7"-F[L;TYQBT$=:2++ RY
M!=(W]5L/\+:TE9FY.*8:.5.D7N@F!1Z3?WKH0]WPFE-'E_67C<CD_!@2OE-F
MQA9G@.%ERP:I8?I/-W;,-2Z?J3K!/DE>WN"5VJRC)6M7?>]GEVU7-VY7E7MX
M]29H"+F2U@9I\C.9+"W>!F-$Y,=@IA^KKA(O ;M.,(G167XF&4%[V@K<'GE>
M:F.47CY!Z_O6?WE#IDX81?OST0NDX^C<7'&^84ZBNE)ZB;7VAJT>TW-1ID/C
M_FZG;$<MS?6/Y+&0)_&6DUGK+O5X[14EG/FVMT[E';WG"K*:RW5#:@4 1@=W
M!UH.#KY!%%O*Y%,'Y.X\/\Q2J\S";QK^H>+RW:$XX%O\Z9,++WSOCRB'+W]O
M.@3QQ-V8GJ7L"?3+6-"!W.M635VE1=CI4N1+%;_.5ZOD[,O:]Z3S37"BV*'V
M?J!3NK)W_>/[>6^B]7;%_UPM-(*'E743)A\,@K"R7P6I]PZ'VI4U.P'V,+EU
M\88KV:'O,YO>N-BX310ONGK<-6P(-\LND_HRK&"_W.CS77TO[A:D80;I0T4O
MU1GJQ7&R8+D AGGHTBG(T +<6G^(45XRT^UJDQ ZVSVRYK5KI;3Q[<#47WR-
MWII(K'Y9_3W;G*:&K(Y*YQV!\2S,X,@D@VOIAEL3I,$]$/J6E7YO --6=G E
MDE&@?B/YZ[[;!>)]S[6/Y;!_LO94BCF4N\(OT8DGGC#D5(._O62"$P[>+CTU
MP<1&/UT+WV%4I$&._3S#%H,#FO>Y\_P<D8+N#8F.E^0R'FTZEW*F8&:U<!C2
ME8"5)FP6 !6H1G:DR!!:R**\O0SSVX92;!1J0@PQ;D^74_43?K@MIB<H1T6E
M9VZ.J>"3G91,=F?Y5C).Q%0K^5P0Y2M02#Q4Z*Z@PMDY0:=@GR%<KS:'S;:J
MM9-FK,M*K*NBKQE7D&B;?73&,D(UE'ZZW;%HY9S<HRN^,]T+KO*/ZV/KP(N_
MI9BX=:A-5;)/*=(\<<)T)4CKDH6(!M9LQ4I[!3;GN8?VD2_.^HF-6?HW/^[*
ME;>^?.6^:'V]O[M5W[D:I 67/UT)T?('(33/G7#1]M(D:Q8YLN"5#M_-W&^[
MO5[%NNBRNFU[K(PWIZ:\09EC/4SG@H3/ WOX\0:'N?MX#JRCMSQ8Z>8BIND3
M^PP8Z@5<L9W; W;6G[7)VGZKTVCGY5V9KTX_(SV8PVSFF?'3J>Y1BHC('%<6
MZ91-J,+=H8J5KQPE*)>Q,VXIYW;ZD#9J3.;1QHHZ::$9\E\A1]- <]WOOI_4
M/P]*;XG7UYV&E:2G=K'E&&_X"8@>5''!<*=_YF#!F^SHC,&%((T7-A,WBN+?
M"IF7=5T*NV F_K)';86U\J%ZVQ5=:4'.2S\ H#Q?0Q(E?,'EDNJ2IF\-Z+(H
M-QFL?<TO_#W;SK46:HE5(HZ%(8TA31+\Y)E+\?K&/W]^D?<$P) (>PETD'6*
M>D< K#)4(S24^-5-@19P(>L.)XXE?:> '"%M*%UPMFO6?'UA<N-+:OZ1]0L3
MDE6']]XT>KM]QW"NAGT<&ZR$6!8D(K4(_(#K5CRTI&[]<[CF[+J0,I<<6 #4
M%9>+?CES7B_^VIC*ZJR'UH^V/K8/4#11V+O<V%M1PGNS;?!Q+5B1=%,9WN$U
MJ+6>Y\_6?#>$7<]S:S%4]1< S*/YCI[S UL["GI+ X:(G\*,);/?F/H/1LO4
M=E_9O$KI0=W2<34G+1)V,S282<T_2F69,JTBRI9Y,9J)Y?L>$[8X$Q1(I_+?
MO/-.4_<MSFT*%;F<;# \DQR3Y/G5T;D*P.R&EXY=K^7G"8#+'OJ<N_S[E'*U
MPVS%.L.U7;R5&3R%I1-L"K0=U0KJ)6[;J857\J)E5&)KCZ7_,B8K4I?PWKC1
M/F-(WHU3N_2Z7:25O.PR',7U\$\8PMTVU/'G!PDS^:IU"IM;-3RO-UYFUHZ/
MMYUNPYD5%O]44=[2:NH2-+QZ,-/SJV\1CF5,#E'8!6]E>W_ %E!KM21X!]GD
M6OYA<RJ[J[K6-'@W(I>L?ZGU9+)D28#EKAX=5]8SS(_\QVMO?<Q$B2XXF(23
M\,%$(ZM@-M>9T&N_#6[T8>5^5X5]4OI@8_,6=7=\^LW>\C0?^6<J'-:ASV&3
MI_?,EZI?2MJ"0F WD5G,D]!B)J"D1!H1%6+C$%'%5)<B@MQ[]O<H!K36OZXJ
MT2<A5&-;;ONTQY2NALVXC&'K"0S6T.+G+[W5+Z1<Y&$L$<LZA8U46,5/ YWV
MDT)PK%-:]^AR!4N'E#=Z&*BR=_#\6'NOFZ^^4#@<U9[IE4J75ZBNVV8*^ ^:
MY C5O7L<=J9T,A(#*]55FE)@5>DHZF"2H2X<GCUN+\LN3Z/8#[@5Y1J[!;AI
MIF::O=YQ+V@TZ'':*7V'/:1O,I?5'G=!@P^7Z*JF_P1#JYI,\T9$U9AXV7%P
M55! .OR@,C&8?$NG7]$L.;M*B>Y:7*R<_C9>95<X[T/NJN 8L:G[F&B"0M O
M<#\*8CTHJ0HF=#P5A_N9T&:W17!JAWZH ?@,)AF_B6\*OHJ F%ZC+#/YJ"=G
M&@S<KDM4B:N?5A)-V:J88)C&W8?TD O!6Y#K]-UR21:UADZ[,F1%-/#)D1=G
M%I)K2#WQTU6^B6M,\8J'L\_;U;R@*3_9T+?-6+F@]83!NSP9B3[#NVQIWH8?
M'\KU.P6 ,R@"3PQ1PWPP(>0"77;GW#31)-WFL$HDT^!\2*?ZG"3N@,.][D/L
M:D:JU:EJO9]\">(H;!X G?>;WRL7A5.Y9]'_'BGS8)N;PYYM9H,"8&T&4;U
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MJJ2=@0\8@*MC)[CRW;V0L\E^&^,[OIIQU=DWWTK..55JP:KZT1J0,QE#:!4
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MLTK\\YEQAOFWK1-.B8D,-+R:/4]-HVK8P_D7"2,E)N!0%3[\_:,1>R]BPL8
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M(;U%_9PY^$Z+[:;3;63E]^( EL* XRAZH+OP/D(>])CO?L"$Z8+5\_!<D8[
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MPRTSZ'W-C?X#\Y_#/S<78"WT?!PT9Q1'<NQ$BG!A#D$%I/'<N:Z<[/D@U[Z
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MQ@:ITJ+=."+M!"['2PK\(^=BFY-K,.<ZO;P2]:5(Y]:=<_7(M^5!B4SF_&(
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M!8!!7,M>WG5&&MZY?+@"?1WQ:/,=N6G_VX.FQRJJ&NJEOZ'V@5C1YK^CKA>
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M%D$<MYG!6O9DH]+;=5.SYXN_97Y+#_D0%35?8H?3EKY-TZXZ_?;)0,9IY+M
MR:UAJ4AF$;7^[RY@&%1*# )U$*902!M.*]E%X<*2[0\J=E2>&_RGN0O]]>+1
MS_/##U/>4%)"\SZDTS8%F\R*?_=?PG:QB35:AYR%92 U\$[<LGZJ3*SE,]P
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M4?2'ML;X<$Z _HU#])?_Y/7AXOH(!\&#8J0[@T/L( _>( !=KL6RAU/FI-I
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MX\-L_^GYG_.<\UO.\_S..;]S/<]USO?CNN>:F<_[<[_OY76_WO=]S84V15L
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MW1_S!$(W/!DR2Y"R;%CNCWT?Q[UK,FM+F$PJ8#=\1-U[LJSK=A)DOF_\"FQ
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MV2,A+&1S+(:/K(&WJ\@L!7%6AC9=]1_E,\:0IO.JOJ_WY!@B3+018HS'K@[
M9/^!$.D<%'1!=QB@]%*Y2W=#D^*Q"#U@IS\3[DH#MK3GBLB<-E3FC@>$UZ$:
MZ- O\US&G(4MOE^^<Q@0A<?EFS?['59"DCW]@^>?Q(?BLOU^N:]F[7O][\=G
M35]R&06&B))/:5)?TD\NJ4UG&O"*/EA'C\#;%""KRY"MP0GX_HFD78,XU.HA
M%)6EA.Y=],%,.VI'4)->?Z/T/9-*Q) 9=,+\JXW_KG7C,A)T:+#0 %"BB 9<
M%%SWHK__%L).YJ.?.BD:[_-:X$0?RB?4(QQZLC.3>I*"")6$M]\H_IEQ<>L
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M/[DLW^6"P=\SC@SDWL 0W)>X>W#AH6)XY7CJ,3 ,<YV ZSB:@;DS9G.W^:2
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M_,"G&5G2RD2O+]0&'=E('5!U(<?2OF5$0<Q>0,F+$PQ;-V^Y=_OE.M^<G>J
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M_MEGU]_>>V4EU!_4)8#=2-]0'Z [00?<I3T ZB[ JNOJ?\\-< -HBXXZ"]P
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M>A;/15WP8/SXC:Y/.<V_-^M#'5)-@[/8.5.Z=%!A?BA84SEZ>=9Z)&^%Q&'
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MXE!3:^V-,J4Q+8&;*RM^??@P:PTM;.IJ7I.O['/:JFFYWY'- "U5^OQ0X@1
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M5X:MN@ _M2Z@KCA!+S="5DB!D^Q>0GE#<9KR;-X2\$J@\+X)87@TL<:$YDK
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M/@7KI0,P;3L>&_ZU<#UKXQE[KQU8N]1)R$E"ZU:ZT/1+:7&P^N=ES2V($O9
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M;Q;^Z B)?J=A9R6#?5@BT"%I8:1=VTZHSQG?_+(-FQP/#R5D=NK(M])'I@0
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M13@0%:?#%6Y'4(M:Q$QCJ*S+OF?R_10QG)"XC3/&8?*+X34]9WCX4APOL8)
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MX:P$FT2X*R8>S19N5@!U;Q0]Y1+9;V+:?^U2ZD=OQ-,;ME=BOFA90Z?7B85
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M@T:UG\+[=LY2=";MQ^N^U]8WCTNE:-RUU3$$/W3?X->'^O!M.Q=;4W)T6'^
M:R<[VOBP]])EKQ-Y2:BM<3]B=HE6<6K>@ULO&%;S#3Q7._$;^- \:&Q)L &K
MJ6\6U-/R=EQXIO)&IJPF(=SPJ(_URR59VYN]5I'+B.EHL!9<O;^EH>C+"EWC
MW^L<_;^E\?]N_\T<N80"9#+)W#003FH#A7N.F=XE7J<@'Z*$0TC&@.>"%N%,
M_M)@1!T%?&G8Y-?4G>3N:[L.@ZJ=1L^9PLZ>:-%@Y"%6PMQIH([[.D*P?J1P
MN/,21:Z+!A+0=EY4FI'Z@&;2K_0.P[X:;'V$B5%4-0=/;8V$+!S3'U<Z\=$)
MK&W!XSW0PL2X[CM=0IQ"+BEMD):0"<AZWTXM])-,NK6E7+E&6,Y,^"DIZ%TX
MXZT0YE7Z\45?Z)T?I\_?+B]/;7K )DBOBR*#X1W785QT$$:20&XEF1/_ILP+
MBP2%]"NP&TT&6H78=W->3.#3/= *%;>)Y-M%!Z/E"1LOHC'5(4/ F5^]9O'H
M^N.QA#ZB!:4.198A6*PO?N]AQ,JAA&9#G(ZHT$ \W0T-C=7U/9E#3#8/M///
M)$&21;A G*EF5-8G@GHD5]BLW]4GUK"+/[#6^B P/M$CG U$')H-(P[@MS<<
M\)@K!'D:B",0(1"2W0M3JL&7/-;F>FUX--ANJSY(PMV[N_9\#]/=TQFV9U[$
M)&F\S,F1P<*8X1UZX2:5U*]V)1L5I+O4P6#HX59OKT6/5M?".JIB_41=(O1J
MI.O3-7?4ZUM$8\;FT!>?!%]4B1@KJ:XBZ]&;K_!@HBX@H-Z'B#M(:RY^.2XV
MJJU9  1-03TO4&N57V[6#1RYL1+6Y,)LS<#?I<QC?0\,!@:(:I1*F KY"*6
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M[4TTBBJEY.QN;^X:9 Q<S<J4;=_8O^]C&-_MQL['(K(XEIV^5!C6EZQH&^!
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M_Z@@E"YIJG^Y)Q#& FP3[+%]L6_PZ*CPF][RRUF&R29I)S]YRR?O^TJ<O)9
MW/IX*#,N^1FCU)/;B0_N39%%=;B_FPK7JZX$U<Q<4'"8/)]J)R<C77D:82 ]
M0&@*7],MVB_[\;%J=L&NC0<I%_^HW8U/ZNUOM5K*F_J_)%=MV42IA!\P58)!
MM^KN%B)&FQ->IA9S>$0U>E\LS..*W.'';XN+0&Z>A*B/A*RQ?XVIJZZWWM]1
M9@N)>S/FL#<?Y%7HL>Y66)\7FYM]9^V>@/=M;4%3HYD-4LGXF;KF<<=UJPA6
MYE]1$'?H]$*_0U"7">"&I3 N218)/AZ^ ]]8[P@6VL\4<E&2F^L2ON._D2\,
MJLC:4@K7Q'*(T',@RNLU.1RO[2CZO&M&/_>U[?3@HSO#\G?&"D.Z>RJ?N"77
MV(Z=\W"56!1&9+2+DQ\ E00?(7NS9X[*36,*&[99(Z-.>DS7,:$3TNDWSFU-
M??KY-D*\UU'JJXJ(?9>@3K4\K^"&N5Z%_2DA'PL9INJG'X>.Y[_O.]V>I6T>
M76)>8IRKH:$)";+X)76$5)TI[]24XA&T E3Z9F:R.<M:/K=N$BQ]4X#4=FHK
MDE)ZY+>2AI0+#L)D8MLHZHLV/;YQ,(G,*X ,-E=*E^34%7:W""@XF+@2G#]U
M.T[P9W)WY#G!WM&/ML.O& WKJKR:F@!??"8NHP)[+K#,:Z(A3V:\*EP.OW3Q
M8L$)CZ @N9,&%T<N\*:_R<(-/M379?\XFW0)E?>OKA\1)",Y&*C$X[I&0Z =
M[7)J&?Z#$A_?]+.Z-&1<(S>FL$KHAP6[,!AW?^QF2/U0)7PX.";FR'!OF>G%
MAV97EU*,UJAK*=XM%1TH;/?6Y_/:MPDG44_\2A2\*VS\+?Q3@X)^S;FDW S*
M@G<G]YNQVW\A;EUVGRN3]3]_7";-'*H883?UIYW_PUC2NR"\)=69;@7YJ-\@
M#(0!JBO=:?WF,5V+H2W@QS%_Q\B#8_;,]>"L2,R3?_*Y*,O6[[)@/A;/_Z<;
M_:, H'=<."CY YR>''IAE$5?\F<('<#R;Q?)"H']ET;Y#UM)[^9;N>EVGFX$
M?Z\SC@_A_G0_#Z?TT!/.9?HRW>I;%/O/0 0(V8MNT3J:/S+LS)[_-/&<T!*8
M<;?7&R^JN^?4<LT)&>)<C=*A@6+#R%R_[P[UP0';VS108E@Q-P,6CM^&1\+W
MU(!M&HA=#DDHI(ILX\VH3S$B-!#6-8"JNI5V@X6.HJN-RDH#?9W%H<GR5?!>
M!!",[H <"(4'TT QZ4/ 9#,]N=%']O@O0.KW;9PD&@A?TT0#"4*P"S00$PVT
MZDW 4'EM(#C''WJ@$"A9"[.(I!QKUZ*!.ON_D]W_C>[?Z/Z-[E]#]QUS&'X/
MS1!^=&P[T/>(EXY8<PJ5.=YUHOZ3S[B5VN4;WY<UM^2^NO^3+WXM42'482@C
MQ!7^E.\W(G=T?)9Z5*O2FW3[-K?;K2>Z1=Y?&X6HI)S#.E_ZTA?#-.D!/4R=
M%#1-)7A1V2M(*N&G@0[G8]^CP]7QZ!['\_BGZ; GE;[:YD<G&M;/);;;WFNH
M3UY.>'%=;Z"*0X6!;@EK$62>;"KK+LF&?/WY8E^'[XPH*]D^T'/R0G"LMAYV
MT$RW=>RNM?R(74_9K'W]3 QS7+0.-^\J*^H6Y34-Y.X;B:XIZ:#XXKYO'B.<
M[.IL/X'??(>TF?AYLD?,HL-:][5;\O0K:V<]MZ [Y:RG;#Y"\'X+,:\]T/CK
M2B=A7P4?^MD!)"PTKA6RI!0S0SZ':/!H7EKG];NJ,!4^G>[B_HIE@>/C(F<W
MO.,3#52]W8EY#L6;#L6#ZZ'=)!2GIQWF"55$#QQ-5H8\DZ1VC2AE_;R:E6)[
M9FJYS7U+D$/'@>2L=Z34OYMQ+_?6A:>6+_3U%,YCJ!=QOS_VDXWXA_<!_K;Y
MP<&_O^+Z!%F#[F*G3S>X#MIC(M2QP#=J5+E06^5XQ.GXG(0',LN0'U_]VLVY
M,]*K'^(&!N34R5S?B2C@%5\'(A)3I\T%-*R-5SW</A[RO"LK+R:TM+/<MJC^
MN65#HU<]&SO7D7!IA:]<CN=(MSTNF/6@ $74QC#^.8XY03V/$X_II(%X0@8Z
M!:T/#M>W$JXJV\V^[57;=\V:F3#(.'_Y')_B>^T1&JBC[Q'ODS?TU[.MAJ1+
M'L,]7KCM&-@9/ WTK)W/"]^K,_UF_?E;VYX3C7=W[UDG%[B 0R#BCR^Q3&+J
MP)O'\#9$*P!220ZGY+>?OA5BTRDJTL"U=K!0<*M(]I9LJ=71'2UEV;?N;[<^
M\UR68-M(CRIUU61RL5GI(PLC2:)D!>#WPR ;0#[)FFS63. MK@3 V#%SP*Q+
M&8B$;EP\O8^R,BR33/%.LI](PK[>7<8TJ-R(CY6'&WK30+@%R"^6G=<LP__%
M?:5_>+_I&6P6^@[9A9ZUOX(?W"K#04\ <KU4A@E[&R"0(-[1:'B\ CL[8:9X
M12!95/-.%F1^T/=TG7\)DXN<(GS3DO1HBCI$ _%KGR,IARL +$O;SR'<K;:%
M#EXW1=GPX42UW@'#QN33F>9M+>CWD0L3'&IZ<>R:'A):UH95-EUPO(W9]"Q5
M +GD1E\" 1UY9_&B^7A?.P>N)4C7(-PDWB3 =-QE!S;@QF8_(&%S;V/NDD)1
M_!7A=O_<@:<S#+LEW5#@%*3/]QD-)"!$?$OX3N9^1.H%<VYH7RY</X"]0H6K
MU=;@\VK+/+QJ1KS=C*JS((U&R3&)4C:)2S?4GC+>)9D1UR@I*C30+(JH26C<
M>+ZT+33XN@.7R".O%#AXH=N(V&TL7#PB%2[\DA YQSBV]'YH&D-ED_$C7,'-
MEVQTD2[!^O.T 05<1%B7)1#;D>66N/5P]J6V7LFEX<JAZ2T54AG._J7V5$)#
M#4\ZK]Y]SA3M7A*5';[X4ILAC&3N :_NZ_&^0@P9K7\EKTC5FNY[HY;GE+0Z
M\ZFLIR1[:)/UX;<TX;FWX$#;R!/2C%O\7_7C'U.^,BN$^F[ZD>Z0>2C/T?>@
M)ZCC2+Z?Y! OW=&;*TSOY.0/WH[<]:Y4L-'(\/CF<JWW@7'DM1NWO&&?T<)U
M9C/!Q =XEDU);"7ONLEH^ZD0)6."R%-D>+];_=.#$:VT>-WHLD!;W9R3YX]+
M,[[_)W>=_Z/A.69*B#^K*4CJV1!GXCW 'L_1@^&%R834ZC=/O-7F6=S?\$[,
M2/4]K:=8&!8,]V-N>RMZ__E)7O^1:T'EJ9<$P0V3&U+X;>+$5[)R6'G(9+<.
M&P'].#!CG"H2?@WO/7*E' CZF3KPHM?%(.G6&<2O /N/E<)E'0)L X3)_RX!
M#I3^>R2<K2#14UN'GJ*.='A8'>4EW)UCVK(/R=SJBPKQA)\ E*\3VKYD![ \
MJUL55&TB7>Q%!FI[!;!D<V9,Z-84?*R,/'^)Q8T4"/LD"-^<) D#LT0]0G#B
MRM<[A-[X#+[FE5PGR3 GR22+'USMQZ^'=/@PK/DY=@@>&;X!;@:A8E'HQ48J
M:]0'/G0];R9)./SF&,0M4<LVI7,;UY;SR-EC17HK\6U6CEUH*_5KIJGAY<'^
MCE_6+\4.M4G1TSMWC/8QP@)T&DF\3\EL]26@>Q]!8[Q;C9<J((Q0CZ"&+-Y7
M_E\:*B].% 8RF6A3;R?RM+H6/=2=8H^\I/.JH!5'-**4M?-09R"UU"<D [)@
MY@U!T?;4\NEU7OT98N<*Z[?&IKJFZ-3EP:,$8ZY2"1]=ZU?7G%?W_G<5BF$7
MM3E <B%?H+SX">68!B"+9.0)JF;( 6L=_*D.P]=3<8$.[F(G!U;FWM$-R>A=
MIYHA/[$=G# V&T0V)MVA]M) )]"NOE,#)I1\N*>2R*V0V+X%" 4%$PWYCB,V
M%7</>ZBI):_SWJSV(/;30&>K:Q/L.Q%27[[QW?=A0WM2Q]%X0]\I<>(LW1P0
M=HEIP,7R=9CBZ$.F8?G 7,@2;UM1G1J[2NJ10QZ_OAH@SMLX!6TYZ1O.O!\&
MZ,1@:J<\I3*'@PDE'Y0.A?/EX3KH:!9/ %V7"6;/ [V#1'3/)CP)*)N_K7*)
M!;+6'_"4U'\$M .=1?N@:"#FAY2G>Q=YHK-RDTH([!9C)W7L1.1#O%\G?V,L
M\M:>^,BZV.2(2P+CJFI+Z12T0]K20)&!U%Y!;E%A2JZ*@C-)'!?<,Z@VK+ 9
M*-F8Z]*$GXQ-!MD6!4,55_ <9W@4*U:40; T2@X-M/@*7CVT48WR$E4"#.D)
MSY8Z-]&JH\*.. $\[Q-LKRV=]0 M/R395Y#*BFL;+2/%G[QP-4\RDA&]G _O
M:,;@K\'9/<S='?DIV63#DEL=+9]JWP&C2X 3(H#7NS2KE%'>4$,XQ004ODD/
M2@1HP[714VMWKC@.O"%#&+4$[N*=L>W%;\A\B$[X\1F2;O-$U<.X@B:"Y-R*
MU8V&=Y^(]G<8]XTFE1]LY,/H:3)2E&Q%=Z._G]\L!_CI!K22;(-% P;M?$#P
ME;[X/7AUKMG&S,67I,"2SPN!.2VUW'.^;##S^ -C.\!K$<T9KMP"7*ST..:'
MG=UD,Q'<ZMA:GE=([;SCGI#?^OGE)P=2XV[N]$HA?20J/D /M?.$>"TB.]M8
M2')=HAQ?Y?>@QW\@/3/@-;=F.E]<YGBEK)WBG<@3K*4L[!HGD05:=?]7OJ_R
M'3J;2?P$!)+$UMK!M7AXQ[Z.&-F?L,=%-\A'PQE?7SZYUOQ55S)SL.DN-?9-
M9X]KWM*5Y5[-+C6& ]GV!Y0*^&(*YIW!9B,ALH_N'F7P8=839(<WJZP%M]8O
MP+L5P@S=[_-ZG#G!-+K]&B'J4M6].=>=D%K_@(%@LQE%$B+K4M+1S@KJQ!A*
M:6O@W24P.(0&(K8!H3@D8F8EDTNO:&K&X*VM74_)K!RYL_?+.5\V;:36"X?J
M][(4 5+PYCB=,57(=PNQ!>]2+:O'J&*>=I$& U>*$<?J3FH_?IA8DC7-H,TG
M-^>W#F6!+V9BWF$^H**H*@#SHEGD[EP(9$GX$)C?74>&X%-9U56JS_E",5"K
MXNDST'>*K>D#3.CEX_\=3H+ JN3 B4"ZA;1<A^!-T5-=NE%=R-HW,6_A+N$^
M0-.;&<FVJJ*&W;>9.H+XG5/L*DGKRW,+#-\ZB\?#>^]PC&!XMNL@288XR!2&
M:$RIF,3Z=@\=_O'H\N3V'N2H/12S>A#XV2);E=.Q]^[#0(.9]?=]=0F%9U5Q
M,WQDH4HZ)6/Q#>F\,5C$]/_8_B.S2GND]\RVYN^UTV_3^&Z8=JMS58/1D<F-
M)U6NK_M3!TS(R: 3'[?,[_@2+_W'Y0/;ULQ'NNR'7R^X\6/VH3B+JU]T_7PU
M9/XV5>^U>R6Y;L$YOY,S#^@<2=@LQ/@$F.@=?>NL\V_T1_S@^B=[66'W#_./
MV4?E6*[:."_VMYFV3WO/YGV9>J9;LCM5)I=>V<ZOTG#B@?<S5D6G17_7QDP_
ML+_A/P/[_K3\5BO[ _\9&N;SE[SGK@AVV&[P,DIONF#$PJ"C-SM5-N^V-M[3
MY[W;V%CHR.1K%XA>74]CS/[_)@!02P,$%     @ Y4.:6-KU 3>770  /F\
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ML?/R\0L("DG+R,K)*R@^>ZZNH?E"2]O8Q-3,_)6%I;V#HY/S6Q=7'U\__X#
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M??\[G7E7$_PN_>6AR5T&_P.A]$^,?[R%HW%^&&%L&:'*=\(#R0AJ/DQ!XZU
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M5]:>:^Z9N9ZYUMAS^,8-V2?5[O(&Z2GMV"-)#U)CRF+W+]TD-B2WX_<CQ>D
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MO::G*YN7O\QLF=Z1[IQ&6*O,XTH$Q,\UR8SDY4K-ROEFMM@%HR:5;;I!=2[
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MC0P4:0J')" RQSLGBE<U_?V3LXQZ)=OSW_._*A'ZM=/B> V9!/(LC*8!SM,
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M-NW+*Y4,'-1N",JU",SP\XL;JD%]:>BX3 03@GK/<T;#W?V($F_;<L:'&GO
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MBZX\Y1UUMGBS0&TLF&(Q3N72N0+217M_+4I7$W_G.JC$7LKD?C'Z>R1ZNB<
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MX59=WYPI]%*^LW1.=$7P/86^-S4)D+18XQ_D%Y#4<BP?F(4+B(*^\V>?/QG
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MC+"U?8L%A2L/=M$"?O1JFAYOO*$Q&/,N^9#YD8?0.M^Z.^ .@10D&C#B6+G
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MT<X(Y_KWDU>,FQX,?AK2NNANL?-D=RZD-NYG[MU68<XN1@]'XC[K!1! %6@
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M\GFUY'4U5?KIWDDJ?RHYQ<?5(<6O%A(3;?KUR&$ITU(ZT&/[8B)X00^4@FJ
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M;:9M5I6VMB-"OHN!.&\2;D"XS17;<-[M32<G7V]HB&X'1T#;OT8JD57@,W2
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MO+-2?UW?H2NO$X?T_LB&7**-@NI:M@?PLCCAI-<4.X8_BKY!^?5%2AQ,O0U
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MF"XFTGE#&61LYUFWDJ39-U:+-7GS\]H\8X^?'P;O]FFY6EB?EQP0M#S/^K<
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M85>8QM1@S@J4;9-HV57I^0J20XRXFR$FI1=S_\[CBX0V4_V!+T%1O&*$<HJ
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MM;HQ=U_GQX9TOE/K'^]>"R]I[1X712B*K6)S+U)YZ,"ANM\'J667:T5ZR^A
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MU]<!-^_>HK\O_82,P<B!G->74>9=6O%M/HVZ'B;C232_K*-?) 4E,PLK&[N
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M7\&?,,'IJO&1DE:WFA-OH8>W)?X*I[_,D$]F>3+;P15<L^R)G;9EK?&>DFQ
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M3?'B7GT^Z=+6."DF'J03=JO50;S_3$(=O,05>6?D;<G64&V2-L=:R<-!*JW
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M98F+P1&-%BF2JFR^:/5^;C8;?>$336QUD81&/:+0<EAR%#+Z9_=KE\5EPA7
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M5YT:_@H>#V2!O[P"<$*>M,[,#2+LZ6%@P9EO*-,S#LK)7S<1LXY4-P"(%Q\
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MED 3^RP@5_C8?"JZG$CI@GFZ+O#^]/?JG26%$FS@NF:/96WFNUUFE"\.;[$
M6^[]FRTD,\(S9[<_E;\WAIS/Y)\];+0P#[(6_/US'=4!I<EV3=ROFO'L97H)
M#=4J-:T)KFYHT]^?FG_Q)4%T-S7WO]HD_F=04[D"1(8L#J%7L=6X)72<,8>$
MC;%>NXLW50_3Z+HMG4:.$0_N3JTD=A.7A3>'*,RJW8.HX'(\0J$XJ@'S=HA\
MY: #YVN/$6QT%N,0HY/89]9/SBIY6Y BU,531$2#6\+&92WDT?44RLS\'G$!
ML4QW@!S"Q-)@1TT_*_EM^%Y.D33'BJC[\SP"37?Q0AZABP9\;JT2U##CN?.Y
M!N5W4K"+;N#$BI?=WAJL?I_1VKH$I*KXQ[GU_44SY?H2$?_J0V3XX;KQJ:Z>
MS<!92Z<D<VW'%< @AVFK\6%*K)=Q)DBK1ME^4O[$I$#-LIF\K+25,;LI/2@<
M*!+^0^T69@+A@VRVO?P&2XU5M&= ;[;=JYL^@A9+CU3\<$S@$Y12O%$Q.DXF
M8WJC7YI3L9N'#:)Y/5E^! .,6R^<F\")H867@BP\!.,JW+-CG_HY2? Y$UEH
M4Q0E@ODDI$ G[6!>V#OQS[;\[DQD_F_);JFU;_38(PK8&Z4E'B;XYU^6BUEG
M5)=.QR:,"3@W-?M/Y'"&AF3M.4H-@ST_E!LNGND\K+*>]@QI_[J\M')Y%SU_
MF%4&<9A37_NBQHO+P:BLIY1]5H.6V-I^+&_R9VH;SCZB%K0KUHO'QG)R#7>_
M?4*JN%Y;B5$D4E1B\A#LP 2UNR"U>VA@_#&SOHKYY+J$ N*4]?DK+YHF<XOD
MA/RW3^[1K(9.&NF](]9HT1<GI$,-RG33*C:83XRL/8T6OS8O#0_,;L"_S56R
MXYZW,0F;E(EX&NO.%*QMB*.FD>?3H44LX>,K%+@:O''X8CFV%P/M.YB@!H.T
MHT8FQ0-9%YW;>,EBI=K?BI%AT_)I/J\_446='\:L\S![J*-?G"06WIN%2%<L
M6=I]+</:'"0*T[,U5&CT.7U@JB?A(_\,_;Y;^TV2;+)O/,;*W*^2LKY&2:[S
M[Y!?)W.:.2R]\YL?JF6N29!I3RLR66DRF553\5A#9MNZT_DDM!GT"Y>(Y45K
M#WCQ(7AX;#31Q.*R_;:8CHV^X."Y5,I'D^EGPRYN@#M<'W;*[\WGA(]_P)GT
MV7-A>-ZJW;]^1P0QP0.)^,5Y_9:9WT5J#T;CF:R=5!RYTGW\!?OR-[\/CES8
M:;Z6("FG?.C^]"Z!QZ.#CW]61TDAL[9$(%08M!O"@[E39= DZ-\7P;%(D,VT
M#D!]R<A\M<4":MG;A]S%B^#T$,H6!(8KP ;=.QB0S!/;UC#B*Z:@R/ZJ4FP8
M6\=[:-P:D2O$Z586ND-@,'D\UR&/%]A% N/E0#5J1X%4V^E([.*7#Z[K:-WO
MY&D)YVVBTT-@W6S]]WUS9K:=R4(Z'J!R-=#Q'YMPH:Q"WQC; YKX+[L5>,^Z
MJC^=N7$"3=:/K@"D:] D-3ET\D[_<H369>L5P(D"N?:<Y1E&\:W<7KI>MTSQ
MBI.RV'J.ZY2.Z+F5['35]1ZP(0CA8M8E6<'S@U%]UBM1:\DFY]9D>= ;#;\<
M'2=_6)#Z/N\RN0>0]D]:VSAL@U8W5;693;L;V72BF_U=<_QDGDT=J9#61VH<
M(Y[??)=/.M4J]8N%6LV?&E$3'JP_K#NSP=;E_#M_X]N4H:9SD&/+"C@__:N5
M;AQO10E+2'HFBZ@!.KKV\Y)U.WSF+]V:5]Y_[,M*R'/,GX3C>C0VUXL_*X0J
M)F%EVFWFKS\/C@1:)WHMCYV*%J'FEX6J3%4C&\F.TR88G_>P-X$\=_>#_AEC
M3+%JXI6MJGO!EI?%(Y>ZQ'3(M(_^"HSOWDHOY%6%B1H$.K<K#;6'E#D3CM^H
MVGQ<K_M;ZA";(R\BMS>52'0Q$%;<74:>?C?29/I=/A+S__?%^K_QW_AO_"^!
MARFBYQ_X6OD5@$W=)8+3GCA15.]VB"\#;PPB@7WFF-7W\G3,H*/RW0NR!)^N
MOILIO-JYQQZU]*:6?(MO8Q:[66M*KFVN>2>:[C"QFO#F\LL5P+F( _QT,%>[
M/QH7YH.NI6DVP<7U9]AJWLI7UM^LOFDQUTPC(V.W?D=D).WC#[5K1W_K.\X+
M+P+QQ:0F_H;2$9PQJ6_A[D4W"'?98;"36#<%S$$X8\OLLPBG=IT-L#R':<?3
M^_$0S'.S9HE#[FFLW75MR@5%D!$IPG_*1/0\ZQ)Q)XJK-Y0/D*S+X9+7(VC%
MV\'#'N(U;K"FA%YFYVL;9"O>WD-!R;]T_MCU,YT%3O0Z VK<IPB\_FY1O?91
M,IYWGX><8+4A20L\L >T&;)9'2!=6VE2LWV\NJ:]ZSY*?-;YDE;B_.!%>KT"
MV<G#Z8@U6 Y+X=VZRRJ)ZR+HPV 3/GI1E)CQM!Z'(@K6BV_IA%T6<4,%,XA=
MCZ2/XXV4_ 415M3WGU<0&8G#5P"8X9''QL3=B)ZG$:]XJ%/)<95=' =J'#@:
M=(AHL5@A1=W,_?[YMNB^K0RSMD7*'Y7X%KXGW':G)CN2[."E'N4) CM+&2Y"
M%^S:"<>IEX&5)W3^>7,&3CSZN;<]Y(1'K-F+WOCXB[*.+]*=]/ *@+R6SP(8
MZ+5[!/K@N<-'>;Y_[<1 !XP(:G$(=O24:G#I;IJ'N2S0T.UV\(QS,M>*WIO;
M9EX+;$MOGY\#%^=1= ,3">JW?T]P0/QQ)*%H>/^\S\,95:8*<,*(678W_WA:
M75M=<*2AC+S.8RV59^\,6.\".>W">XOJSH\<\"$0VXS^HB:A@2S<I_434K">
M-F8U$L*V\<BP3]H=(YX_;;E<,U#5?;Z_[5%V4T],>GB<*_AM]>H5H(<^7(Y@
MBYO \X"D">:XO+"-!0@;!CC ?1<=W!^F/Z=7Q.)N[5TBT%E8+E;U/]JY]F@H
MUW__"DE"<@LQ"5%($A)FB"&I='%)+I/$Q(3V=AN9,4HN)2;L*':-2RA"[FU-
M!F-<DN3>C#(S)I'(C#*]S)CYS3EGG;/.WK]]?GNO<]99ZYS?VG]\W_6^[[.>
MY_FN[_?[?)_/YWG>YUWW^DO%X#UG^MY<W=K@[1#$X!]\:OIODG!>U$TH"35
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MX\S\?8$[CIP-NR $5@U(2B* ]RQ"8(X($.4QK;]_[_Q7LW\U^U>S_US-,H5
M'6E>DHWD'N) RZ<&4A(,.!EKKZO.->69@CF=QG%;"B^OP'<7^6R/_)0U^:+C
M#WY"6HV<^MX5D8P B-*Q'$L6#-\P(#MK<495_4'ECSJWS+ C_E_FT>XGO/&
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MC!H+(>MK=#8E(ZJW]J6JI\N.+*A+0/2N'6PGNQV$;CIM;)PIU8F5840DMBJ
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MJ!8!;UA.=I::;;?,-<]47RN(F+62?=%QP]K9ZW/]CA8'*GL!PCM%GT'4=4=
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MO^ $2%VSNM@]I6QE]G@+LK;_O%S6/Z[8R<>%U89]5:]G'8J5J]AY$"."2&<
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MDY)'70R=@VVB((+8U<*?B'U;N2")!W-K6^ 6K<1@>H]I#0,HJAQ/AN^FFS"
M,R@8+3B*GIPX/_V#;G \<7\/1I,&L;]]TG?P\:)HRA\6W_L_+(6YA0QJ' $]
MGT%/35SF8D9_NPFN$D%OIX-6A@J$+O'C($+8^6=H@MG&) 1O742,6@A<S09K
MF!=9<&,37;W3##=3T.Y/8[LD^KU?TR%!6?0C=&;I)=<S&*X7G'R)^^=A40R
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MGM<633!O%L/-/4S1)Q:W8L)UV%)(*>2T$H-YLPA1C7I">>%D5XK<9XL7+QA
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M%U'T (1N"0+33\\90,?U>=@^R-)Z[J/WF'?.Q%#K_EJ;1'*T&?U-(P-05&,
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MN;J.'$*YBM(A[L92+^??7-: Q&]G7[9LI,]5IWRLC=R4%@]Y+>W<!A61$E\
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M#)6K,KII/(3PCV"HP"B-+;K<3=AJ%]3)Z!]IZ@2#D?58.7F'KJ.D3A<;G[?
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MF!-JKSK-O.KS#'-N#4@M,"N?0_QJLP[%7[?2!ACS \#0N;H,FC98Q]L3(3P
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M>_:]W(7N<]:Z?VQ/R_]Q*N7_XX%O3OPW4$L#!!0    ( .5#FEBG.GC\KR@
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MB@7H3I]4!T:B)58C6&9F,=#DTE&U.P/LKN$M6Y+O,MEY+9^[3^#4I>6J?M$
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MU__^^>;Q;P9SQ+0PU L21T$&9C#6=P;'*3F#RF=SDI@6W>DGBD'@.#I9#+3
M.<?0=X5XR5<OFUK=._JF:L[*F1]F$:'<QV' !2:Q$^.41!D6F4A$2$D6,RT#
MH4=N9*NP/3A\;1FHX]!E?2+]VO)@<LAZ$KY^VV ?%'!TWN*QIHTN-Z7U=V/@
M87+<; .7<P^:[[K?%TU\# ^8A\35.UH^N<HW.%0>DNCX<?+@4_!I4)M;V3\)
M->/E]5D-'JH/5F,:,<\A(79=3YHY-=XB\0G#J9-Y<>RG3NKZNK.A3E(9V;IU
MR8$'&)^&IM^$61,89KD@LH)F10W*<L;DJ--K3S9':E"\[E2IX0]/W FR_J..
MF<J\$@^B^))+.U%WS7-G2>)YE,O81;4$Q"12;0*%XV%?>%X2A0D7L"&2HW Y
ML@GH#EIMN@G6]:)JGZAW+O5U1%3Q![W8,\HKTXR<OO6+@)DF"ZW_F@ZW&\Y1
MRSIJ>/\.&OSI(/NMF_GU\OCWT;A/!V9K3?JTB!D/&VMN.!Q+GW W<A,G2;&(
MT@@3AV0X=KF'(^Y3-\MBD@09<+S826)CQY>?KFY_OD:/E_]Q_0 >&'8:(3TS
M:4MN: BYN5O4G>P]2HI)1T)[4[].DYIZSM>@T$<F>PT_8VMNH*IV4,UE_II7
MSU>KLI*4B_5-IK>92^(L%1G!:1HHUXRXF+* 8\J%G[$LH,(!7;$&TA^[)FF>
MUZ=3ZZ+S;3:)-;_IC! \=X)@/\[:-F(L],!FX]@LP34WZ'?)#EKS<[&YMGCZ
MN,_"0$$M*$:;*MA/_1N/%M2"9GB^H-XR-IM3?=P42I$P\@7). XI#S$A:8II
M1!(<>7Y $B?T0PXR1 /T1C8\IWHKZ152&0&H9V$LP@*S*.<A8JFYU(&<HW:3
M^CAMH1E0=+U^48>/&1QCM:.\.T.2U5"@[1SOJV6YN? F_"3,?!)CWY$F@'C4
MQ[%/I#&@)'&)Q]S$]6=?1)$NM8ZT *0AW_TN _J9A^&)YH@I?@!'.A!H-0Z[
M1H(+F*%I<>H..K]LZE$W.-6,F%R\A  &. T;"3BS<[%U_[XL7] %R^D<;2N1
M&*U;^B.A8I!76I8*S5+WF_DG2Z=I!G#UGJM!UIONA,U RIVS-I/GC:H,3@Z:
M_JC^WNE[,6-ADF1JQ _C5+II0L0X]M((>WY,9!SINX'0NJ\")3RRO[8=DCZO
MPQYP7 @&4L,8CP3/^9'@37>J?,U*MW'-2("!2A-& <ZT2,$:@-"*!3 * [4+
M^NM-6<4 EG*OG@'^O(&-O62L6-4)?2G9?+>94*>"0OU21=^JL$QR4,X2+^!!
MK")B*C(LWXB#TS@D./532ECF$-\/M.VM(1-C'XHV%%4'L*[=W2W]JC_Q>X<I
M@)4QQ5[#1$^ *,Q<MPRA-:A[3<5VZ\?J3_QU6E !9GP"<,U,^D@@P\S[F>CT
MFGK3M:<S^V=*O[,%G+N664*T0^2J;;N['E5!73])TB3!21 )3+)4_N0Q@B.:
MNIGCA=+7!ET*/TUJ[/.7MO=SQZQK=EC10$DOX6E'=I@1WNGBN,9@C&D=P\)9
M2G#V$)HTMSDL\'Y:4^,),_V]*]K^D/5-@#M:W!9U01ZO&_[=B:(NXYBY+@L=
M%@C,'9YBXCHICIV$8>;&7I*0*$Q<T T>/;)CNVQK)E"IN+B0'EJ!OM2-#M64
M6RXM)2U*5>+63+P%MGS0A%;/ -@'#&8,ME@]-%A)%N07#35,M.TA)1M-P9D]
MVP"3VY*=T"0ZJ<V  ;%O/X!/V[ E]<HS'H32#? ]'(1,AG^)(#C.N(-9%G G
M2.(P@S6_/T)C:BOQPS\Z?W+D_WE!QV!LC,0_(\^YD+]5_VL'92.ZJIZ71?[?
M@O\S6BS7_YJ7I7*_I1(M5U59R4!1Y5%HA7Z6R#__[W]P0^>???=B6U<K@_LZ
M2[KS*_\LJ]2\)!,3!(;^3'M3T[M -S5H8]F7':%&,28-A6]H.79$[#<3NQ^=
MN I??YKS7T7^]"S_>_E%%/1)_"27KCO9?:!Y48MP+S?R#\M"K3HC61(D(DMP
MD&;2D4D#*NU1)(T22:A'@RQR?-@PCN]+OI%MX9H5W/*":F::/HR*'4B_[.\4
MP;&O"WS[]PX\QC[_HD%[([PC<YM7JJ34J!7[ FT$OT!KT5'O]VR<N;3?YXO]
MUO<<1I+N[^.&Q+BOUMK=BI'9-', KFFQ4'G&=8SQ/I^O).59G"5IY,<.=F.:
M89*Y$8XI<W'J18[<AP/?\4#CQD_0&7E#;*E8R1><0BI@@8A9*+V5H)X?)F*<
MT-#!*0]YY$J')O,3O5HRBU@9E8ZMT;J^>Q@5,;TMW (*L*UT37";)[E +5%[
M^]> 5);VD5-4)K7G Z+NV]6AC\/;HMV)Y>.RHG-EIR]?*MW>9WN/C9V_N+Y%
M-;D]]^UEN=(=\GE,UGX=.U-,8*[ 2$)0-[(3LABU'-M?:[*^8B>$Z#8/._41
ML[W_DC'U"LI[P43^195E?Q)5>WXQ"U(29B2(<)H2#Y.(NCB.PA!'G%/?R2+?
MXZ ^\'W$1E:Q-6E4;&A?H$7/W#,X6GI;FBT,8/JW$?^^(S[-))#H<CY?_EXW
M"J@G2A6"YQ7ZN"RW)XKV=CX=X2UM?[VD)MT#=83>WPBUGC&H#ON+H//JN1G*
M75W-:?Y27BD/3WX1Z+PM1H^\V ^<.,-,_4$2+MU^-0PBY;YP_=!U0Z9?":9!
M<.S2@ VY^@O^7#.$TH:C$K&:)T ]D@Z$_:9@#&!@YJ ACEKJJ"&/.D@9W'?0
MP050DV49'[/ZJ_-Q@I5: 83N+:O266>Z$BJ 5#OE4I#GX)%!V^S\LBC>O=TL
M>#U:5S<\./;LR&9LW3B_DV22.W2J<K8\_Y+S%9WK1PI'91\.%\X5&V:D-"1N
M9V=;ZF?<)YY1&'%TP<EBB3YQN@%%[^?,!]$L%_4)97FS8/-538!+SU):7SJ_
MHSF_65S1UUS&,3.71U'FRBC#"S.&22 2'"=1B /'"P(:!T[ 0^AD&EWBH_L>
MBI6F*J&N#Z ;-M"KY /G"W5/3G$R7+00!;U5"_*W0>1?N%%84Y)_#4-R02)W
MKYBAKG8_IYKA0L90Y:M@5?Y%S-\,ANQH?S/T(JJQWC?,6K6ONF'C FT805M.
MD&*E[F[1,&-W. \4 HO3>K1)3SZ^!PK*L7D^X#5@-I.+?&V"']Y>TN5\YCD)
M99XT@]*K\V0 IBZE!S''U'4)9S$ES-&JY#Q8>2(7I2&F9Q<.I>]7^K-D,O,_
M!L315M:3K/?X%O*91@GE#UO=.UQI$L4Z*<!::TY_P,R-^/SPDQJ'L*B/3]LQ
M6D<G,7(O\MPX<7$0)C$F*5/50DZ(6>BY6<:RR(M K>-T"8^=M%2DW]8CLL&M
MH[3AT]MGQP %II&?']"6!;3F88(!EU#1+>VMVF0GW5>A8.SOJ>#GX;']I^7B
M3BP_B>7EEZ?ZG(15,EJ<OZG]&G *.+#,R-HOJ6-U;O9)_F]=9+5[>M:RT_B5
MT-/"(8R&TP$6X8'9 ;O(@'($FC(;I0N&UIXL<Z I9#>)H/N(F2/P251-*TMU
M+C5SPY2((!8X2@*F#B@23%,2RS]X&DI$'8?&LTJ=D>KM]CNK@Y1Z0T/_JRLJ
M&0$J8K"]?!>!V.590(2/:1*$,DS(/)R$/,1!XJ:<"\$C%W0P:XZ @5FS@H!(
MDYB(B.(X4157))"OGWHICD(W<XGCR-!)P"JNC#$PJK.R@X*>XV8L&= J2Y':
M+L _*$JG,T-@_^NH!):<K-VU)_6DCHJU[RX=_Y"MJ^ SAZ4T%B3"B2O51QK3
M$,<R:,*^1[TLB5/*D@AB3 ])C&Q1F[(B=G@!_-S[W\;WOL=3L6/WO<>\Y&U9
MU8X0^,:7ND\I7<\GX='(U;,ZO^)W0A0_%<O5ZX<%>!9KSQ)C'V$TE)$BC6K:
M%^C#<EDMEI7FUC4$P7"@84EZ8$*_1_ 1AJEJR&@45/2M.UE H2%<-YC0^;B!
M&BX?Q%RP2O"?!56M\#_1%^T3_Z,/CW]Z^$H7;VA-&;6DD:(-T+VC<FMHW;DB
M _7-2%J8CO5)9*9=1U><3J_Z!-K1J-X/GNU,7B[XX9C23?^<0% W#",'IV$4
M8Q+Z,E[//(X#$8J0!IX@(6@@ER[AD=6SVXA+G9:7'4;^"8F:%6,?M!]1L&=J
M#2=C?[6&:#UX>-P.15K"VG=I^\E^*T=7"XP>]U?O^3/&D]^+5_GM>58W)=^O
MBGSQU(R::GN3B,0-7.KCP U]3%0_HSBB 981JK0>:1CX#ILMQ)/JD_((G$[>
M1UA+)9)&)0[(:ZO'E@.TS!#K% L9C"COQ5'/8-B!Q>P.>UTBU:&-&N+MJ+N+
M@;8%9E/*=42U.9V\E][T4\EUQ#\ZC5SK03.3<"^D9<F5HW)%RV=I?-1_E-'Y
M0N>J /3XOZYO+A G3C*/8C?T'$R\T,%Q)I3=<)S,Y9'O40)Q-,YA9NS80-*L
MM]3ZAPYU].O[Y0O-%\"A+V?AKF==ID(3&':8 PDV.C80L&2/SF)E4E-E [1]
M*V9E3=.Y>:J_0UW,?K-090^2SL^T^$U4JNZZ<:^VE1"*"5%4\FNXKM(N2U&5
MQX9#AHF@&0\]S$*?J1X$'DYC+BV@DX5Q$OH^R3ALP-XXC(YL&&\^_7+]\/CS
M]:='\.3-D5Z,GG7\'N"&6<X.QZJHN:["4H9TR_4ZWNO49OU0F]J&=;2YX5$S
M_\<I!H>."[*UH8 CL3GQ],!QP3X<,S@RO3."W.-IG(B+*$AE8)N1U,.$!RZF
M;N+@, YY$$=Q("-<4*>[;Y4*>SB2^@+VWSX[V_4M\EL-G0MT64EW(ETU1J]:
MJLZ[8W7BGBRS];WDLN#9J]'R59=?:#Y7[_C#LGB0/N%NU>HE8ZN7E;J>RG\J
MEF7Y>5$(.E>7LU3EQCN1+0LUBGF6)(Y4<!F@)G'LJ,E6/HX#1V#F!@D)/)))
M$[#.:>GIO16^#%)>,"-1$T=;ZG63"6B9AIU7H&=1IH/5R/CLE;U+*[3F%TO:
M6'$L_VW+)3KZ BY06K.J9HM8;/1A$SI;'4&L\#1MZQ";,![T&+&ZN.E%88F#
MF@6MRK;O\_*W=V+!GE^DU]8D7V8>X3Y)_1"S))7&TO4IIJHM2<+=T!5!%!$"
M:@8\1'#T(_T.>:3HHPT#AIF[00CUC)U-8( 9N+,P,;@KJR>HM?NQ ^0FOA.K
M)_SA/5C-Y\Z(D9J^\=T#A;H'8%G_LFV/>OU5%"PO57-2[G,6QA2'64HQ40,+
M8I_)O\;$#:GG10G,,,!9&#N1)7FIVW+M'0TB]5:1:+E0OVW^>=FP5W?M;&[\
M Z_F&[P$0&0V&K3 <\;S>V5ONF&OV:W37XU,EN,\(]!LQG\P!J:/"XT .AHO
MFJUD:.[8L^"KN;C-]AN>RB]<SBX7O&U\6O=BV6:2.4])P"G!U,L\3&*7R,@Q
MHM@5228RE_E)Q$ VSXR/L9-)+5?*M"D5735-N]1?:[::UB2=/L7[V9=N*PZ@
M"31\,9IV<'RX@<:P@_2QSL>'<#?]EM HR?DSX;%E]@RYF-;VG0?5@0$\<[F)
MY\[4?_PBRFICJMU91DF2\L3'::*&Q@A/NH.$Q9AQKLI/H]@5TPR-.<+<R/:R
M):9:1?5Y(.._ TTK^(V0G=Q/K/^#UF_'NG\X HS?>H+),=;^/L:/](!J;79(
M'PWX;1CIR[*5:N%V12OQM"S>+K_FI>YMF*,/CVSF-C31FJCF">-I:?L-EA5!
M@>>)!S*B7Q5%2W?,>J4QNO]R?,7)[K_T"M2]_]+_P>]V;MY]9^B9%V89I1[#
M*6=94RR0!*F/!8T#+HC#1$B_L[%X]Y--O?NT4J5Y*HYIHO;O;K[=_?<XOL[P
M_4SN2<&GT^U_']"O2E;4"OOW-8ONR%OZUHZ:&?-_'Z[<62_F&PR*.\:%V8:V
M&2UWLWA=5>5'\47,W;;$/XE=-TAI@FG /$S4F4OJ^1'VN! BH4[$&>AJ10^M
MD;>*FA1R83M$'S1ZYMR2P##;NQW$J3H2*[H7J)5_A"Z)&B):,EQ]E":U,AHB
M[YL$G4?@X9Q!2X/I&AG ^A7 NA1,TIO ?BL"6PT(ODG;@8%F ^>W&%"KR#WM
M:;D0]X*I;J%J,@'DRWW\Z>_J>WY"P.&O_/FR 7>1AAY:$[SH3N"PIQ+]8AEI
MQXDE)U.4?I&Z.C/P23.'[J?EDO^>S^<S-^+$HTF"0T$I)H'CXC3S$IPZC"99
M*++4S6#=$M=+0[YU1HT2UX1@_MI&<CWGS$0:F X-B@'VMO9YMN1:;9:=U(_:
M%V;?:3KXO6F=&:WJL*L)KU1,)I5.1E=U.CCSA!^X,KS)0NYC0A*&$Y<X./%H
MZK(X<3S/A964]5 ;.UO>I$RV-(<2R09X:>:Q;*$ 3*5# 3"HT-(0S%HQ5A^M
MB>NN-,0^++'2><A,J1\+NB@SJ2*J58THON0L7SS=9A_R!5VPG,X[291'2:$\
M_JNV6#I(J0AX*+#C.3$FKA/@Q/<9CD,W=&GJQ+ZO-?QR#.9&-AD;PCN)5K.B
M=*OO1,_.?"ND@;ZT&<A@XS0&&I9LF576)C5]8X"Z;RE'H0&/OK<SKHCC?3G6
MUD S$!]<:&2KUAF_)AGXX4NWRX!^K#X,QW#8;A4)F-7I V&$7K;:DAH%]<.K
M3Q;?:PO:#?7U'S*\4R>**L]R^8*4=7@O7I=E7JV/<1POI"%A.!5!ADGF1S@.
MW!0'KB=HYC+NQ0GH.MUI6B/K=8>R.N;E#6G@U;D>I/2<#DORP[2Y2U3)WI(=
MX41'0SQ;U^1Z*$U[0VY8Y(/+<1J/G-=B]^W#LOB\4!-CFS'8JGE)\P/_SU73
M\^3ZJSI>%LT_JZD[;=_ZOPE:N#,ORU(G2@,<!32084T4XR2+79R2@!+FN2D3
MU*"/IBW^M'3E[':;+47T)DF:->8]^SWH695)83VKL>\;RI8%:GA$#1--,[WF
MQRV?J&7T8OTKQ>MFA@7Z6]\K,>X%; L_R[V"SV;KF_02M@7FJ5[#UM8W"'94
M\<SG!2_F;T^=#@CZ@P)/+C"R$R1)"DFSGE(+'!+:+[=&-&-#9& 44U^H."JS
MU1E_@Z*9A2TG5YTN7!D2;"=,&?PP?,[U]:)23=A>Z'S^;E7F"Z$FN3D\29PH
MPC2*"29)JNYP.1%.XBQA+").E&F=NIQ8?^QSEIHBJDFB-4W]T=?' .G7/0MB
M @]20!*"IF'WR&$T$_O8>I--QNX1ICL?N^]CTP<)=T6^+-3V6:HKE%D<)$X@
MU2\2F&2!_(EE&68N$4X:9YF;31TC=-B;)D2H"=8!@N'XN'-?PO@! A33;QH?
M-._C;[WO8]+PX AZWT%TT.7J[R8X. *ES=C@V/)PC^6C_#;-[YZ7"]%<*9DQ
MSW<C:0RQ%POIKH0!Q92''&=.[$89X3X/M$;O'EM\9%^E)H=J>NT%&7U'Y0"'
M82_E'.F UD9?,)!_<DH"(^?D8+')/)-38G3=DI.?,>URSPI!2_%>-/^]65PR
MIB*T\EXPD7]1?21F<18%4<83[*<9QX2%#-,L%9@F89KPD!$O,!GNHT-[&F]B
M31<5&\(7:"& IQ1:6.KY#=:@,6P8WU!%/ZSI_U%USMJ@M.7!9L=W?8FM=6_7
M(#EQ)W9]$ Z[J@.>A:?>U@7/M]EU4:BRL.UYZ$<9'-U4XD7GGK[.,N-]L=?4
MZSY*12&-Z')5SM^:ZZO[UUZ[)^^*-U0S9^GD'8*#419+B\!D"2V(N-W<%NBY
M,R]3OGMK[\,H+_5#(?YK)1:LZ3_!'<:#)/8Q#U0_MU"&W31*?,SB+$[B*$YC
M#W0:KT%S9!>S0Q9MZ!J5'NO@I[?I648%9AJ, #&_>3DLHNT;F#T4O\U-S&$(
M3M[(U'ATJA3=K?PS7SR]HW/5 W;[ZW+F\(#'ODBQRU2:SG-]G#+NXC!)@S".
M,I_( +3I!?90T:(:*TMWDD.(,NWSJ:U7C\M*AGR4L6(E-UBV+*NZD_U3OE!,
MJ8W8I!V:S?<442]+HH1B3FDLWY,,<:@7A)AD;I 2SK. L/8]72\T!SU\T[>T
MYO*\=R06_'MX.YX3"<])7)RE3&J1< 5.7>9@GR;4C4E$Y.YK,I-ZXC=CL$5_
MSV]EK.RW%:PGRX!W^/N62>]!T+Y9XOLT9]]Y\GL0TO,3X,,DS%P8N:[J_K]X
M^JBR !N^/DFHFB*<64"Y'V5!@F-!"29I&,N?_ 1GQ U]EW"1"*W,N#;%D0WE
MACZ:UUFK^78H^@5:;+B 6<MA&/5LH%5P8)9MBTM-^P)MJ-<MN(9@ 5LN;5$M
MV:-A>I-:&6WQ]VV'_H-3!34W#>7UK]?S_8@0TN4*I7\<)+[TQ4)I0N(XPQE+
M(R$R/XI#9UQ?[#AC(]N7-=&QW:T3J(_E:YV/Y62.UIK5]6?&F-=H&\!OYG2=
M8.L[][CZP3S?W1I8_^P9X7+=LLRS7/!W;U?+1;WZBLY_II4JR'Q[3RNQ-XLB
M\1AG@4-PF(8N5J5;TJZ2$&>QM*P\##U7>(9SP,',C&Q!N_,KZE9W7U06K[D2
ME5:H.Z Z5:T@-ARC-<O&(\+A[T7WA'8:M*$GMULDMVR= A4IUD8=%6(#)?NS
MNN&L?*MYW,:@]<S<-E_S[-YP[U?B<?E+OIS7)ZRWV5^6+^)*G5$7;Q_I[X![
M'-!U1[9O^XW7$%_5 XXV+"E3IYA"+5=(LG4Q=!?B?#2'S^/'!!)FNL;!\)S&
M=MI@V&AY-TSL6S7#TX:AITV>_AIFCIAR([9=-51'OK8E#<FR0(19A$GJAIB$
MF<!4B!![-(O\@*>1EX%.[D\1&MG M&[2FNY%W<W1L.7/2:ST'!\;", L@Z'P
M8&=E2#)+CLA),I,Z&4/"[CL0@Y\WKC^5IF#3=4Q5M]:-UU75B.-3%I(TP$[B
M4M7BR\>4)BEV'$Y%1KC'?%">NH?6^!DDM7%M2*,U;:.*FS[,=(,7*TA 8Q-#
M$$QJ28?$LU=">I+2U)6C0R(?*1@=?,1,J>]EJ%'DK!+\BI;/EPO>B3XZ!RA.
M0I.0^@*[J;I0&GD<QYY4<E^(- PBFF8$U,)/C^S(JKYE C')Q47])Q+_M<J_
MT'D=EZM<9[[ES/R(2A=FEB2>EQ <UIT2?8_B. QCS+PT]@).LB2CL)["]H$V
MZCC\_4&M9WWMPP<SQ!W<% ,U2C==E,8X'(0);<D\:Q*=U%+#@-@WVL"G8?:[
M6HAJ=D??"C6I9K7@Y97\02AB;:\M%HO,B905"42"":'J(E#DX#0EB>N(,$K\
M4,=B#Q$:V4:WE%&F2".VIJUG$@9!ZC<"-D6'J?U:ZIHJVI =[D8&$Y\O61TB
MU,[$)##L4!P?#FW3IRMC8^S4IY4%(X[ON[45&WQ^$KNE*\7:4FE_WLRW_(N@
M\^KYBA:B_;Y%$64Q35T<!6&(2>K)*-%E% <!%30+_3B$=4K<)S"R+6K((44/
MYI(< *'G?)PC'LS>="0;H>/A*3DL>0X'RT_J(YP2;M\;./DY,]WJ%"'>BWE]
MEW;Y2+_^-:^>GY=SGB^>/BR+XY/R9E+EHL"+/9QYF70-_-C%U/,8CM40$U=J
M)4L3@SO"9["D]<T^_^JPNCI8(I%ETL;E7\3\#17B57[XN1Z0J4I=U/V47%6O
MB)?7^?)-"/3[EGU4T:_0,:CGO"<]*S$V[&</*-T,'MU.:+Q ZZNO->J27=3A
M%]VF\_RIYM">$;( DR5[=0XGDYHV"Y#M6T$;2QH$2BH 4_^[WB8<=N.Q;4D)
MBQTOY'&$I47T5? 4X<23?TVS+(M8$&51ZFO'3?IT1W9=KBX?_G*!U)_H^M\_
MW_QR^?'ZT^,#NOST'MU\^N7ZX?'G^N\8??YT+_]V?W/U>/V^_O7VKX"@ X"W
M1@@V#HHP@W959ZWJ'$R'#72YFX_1Z_M^%EZ F&T<W,Q"N!/X41/\8%$='(7>
M( ^PW'0Q'US&G1#0X'&8$2X+&6<62[YBU78&AUC/HLE4QVSN1]AQ(XY)X@KI
MCW*5!&=^ZB9>X 9:J:I>*F/GJ1JZ]1>Z)0P\\^_'J-],6I,<F*8R$5I;>[6$
MZO/)Y (=?TS^;>N+]:\]B>)JB;=64[T/PXO^Z@GH=Z+(VDOZ@+J^(X^.K&,U
M1:1(+HL7=1,/M:3AY7G'Y.Y7,0LBPY3+7%I0(5V/3$:U<L?6FZP<KD>8;L5;
MW\?@.O18<!G:=MHY/SU=?J'Y'*!+/4N,K%.24E$G5%!-L+=1&$CR86VR)#1,
MJQX+6J<8=I(1W9[GAWA853<-H8W4KF_=R=1/0[BN&NI\W'!<4ULKK_(*5ZNR
M6KZ(XK(L1?5)5.U\@UDD&(T#Z6:Z+).!?AA&.'82BHE($D[\E+H. XUM&J8Y
MLBY_7J3Y?"XX*L07L5B9]$74 4XO+6D9#F"TWA*OL[=H35YNG(J!"T0SB2ZZ
MG,^7O]<;J\I!7A6"YZK0K2PW(U0L#GW21\/6\"<-BM,.@=*'X& 8%.!1DS**
MK8]59QVWA1L/E8QY/R_RJI0ASMX_-Z<)[8%>S+PD\&7T*F(N30@3'J9QK"):
M-V \\EWA:!9N6>)H](JN#HLXK?/\]P^?FX3._<.EYBF)+?@UDHC30@J,HSM8
M-F<FG;JOF@]4\]>@N_^K]EC+I#;D?.0A)223O@'#2I-)W@2P+,4:;OW5*^>3
MF;#(Q1HFN[4P]I8U=5Q?7I:+>M6F9_AM5I^&E7>T::=XN>!U]+IMKKKM/L'B
MV(MX%*L;4PR3(&8X24B 1<H<QB)UCTK /%IS9L8^SZI90Z7B#>KAGH&PKNL[
M#6Y0G[B&K&;KHFWIK^YI-JQ=(,D<JKFK;5N3?>KV51ZACX<-H*RYRV>P,K$?
M?3YHAPZVA37AF;.;19G+3SX6_&XYSUDNZ15+]FE97?+E:UWC QR,KKW@R.:I
MY0.MLTUK;FK54BP)KB!$DC/4LJ:?==-';3@'-PI@,+MD@-4(X]7!0!AEZ?2I
M3):S PO>S>#!'S9SB^2*RA:]J73LIK/TUA;-!*%N'-$8LRB5GH\3N3B)B(>C
MU'<]1OPPC0G$\QF@-[+UV&V[LU"\H->&&9BO,P2;GCMC$0R89:@)HY;R1=.-
MJ/%0MM3M.2.:8EKR-X:H3>I2:(J^[S7H/F98X;RH<I[/5ZI2=WM&</V5S5=<
M\ ]2"%4=N*K:-A77M% ]6DL9PM6N2W-H,_,8\]+(<W 09!DF1(9#U/4YC@-.
M?<=AL<-!?1"M<#5A<+1SQU*T;"+U%4!Y<\G[5>Z]M43RWTO%(TH%HZNR-C[2
MYY-*1Z70>"UU6S^-?L@7S>?+/P)+HJV\6#W;-?GK@EFX+GO=4\CKG1?58;&>
MAM,RJ6H#FNC-7D7 *+C9JINVPM.T%=0V83RHI;:ZN*&15JFO1_EL.WN'QRQP
M0AQS1W4)\&-,21+A,"$9\:0SQF!= G96'[L0HAZ$KH@9-?K8!4+3.)F*!S0R
MVI+!S<0Q"6RI^\[:TZKM,;$.U._HA\S4Z/B-ATZ-RKNW[4?:^S0U?56Q6[UM
MF_V4=9;F\9DN;E_5$N5/<HFJO%G<U5,H9@DC3DBS$ O7Y9APJCPARC!S2,)B
MGR4^ 05*4S$^LO+7Q.1V:^S33/8"]2S+]_A:8$:K>X%L9]1?1PC5*_7H13,E
MR05J9.ET(RO;K'8EQ4&M/!>HD4@-S;SKG]0"MHY3OP5+AG<RMB>UZ5._C/WM
M8G+Z\+G<[]LC\W]?T4(:T?G;O7A=%JKY4Q:*3*0X8!G%)& >CB.>8>X2QP]B
M)V1ZC1E[:(QLW]=4T88L:NCJ#^L^!4Z_0;8D,LQVPJ4%3? >D,=HD/>I-2>;
MYST@5'>L]]!'35/<"]43J[ET)>.TRP7_D"_H@LF?Z]FIFT-HSPUX(*0Z1DF:
M2'4,7$RSF*MF]"$+LY1[L)E VI1'5M*'U>OKO#:%=([*3AOZ1<-@VQY,G1&I
MHZ%LS2.BZC9_'?Q"T^.ZD.LFRD< $IHR;Z"ZV8%JPT4S%WF4LWRP\-82Z;IT
M)TZI ^$X3*Y#%S"L.**ON52X>O0&SRMUU+J>O_%N57U:5G\3U1W-^4P03MP@
M<+ 0/,(D<B.<,H]@ROS4#U*7L@PTW5&7\,A6ISV_J&O U[U ZK&-Q?)5%#)^
M4 JDDNBO+^!6A-K8ZMF7,1"#F9>6 ]1E83OQ)UU5]2G]FZB0XL-BH1!0<EM%
M0;IDIRT  H)Q4.P#?=[,L+0Q3/EA6:A+%4+=6U4_'(S[F1&:.6GH1-C/7.G0
M<(^KM'&&HR!.:")HF(E@TX](35K5,S#:#&CIRU[WH0T;VKK3S(A][=.+,W'4
MLR)V89EZO%C[*[OF!0R))?NB3W=2 P.&8]_"P!<P,S&;HH/.B/ER\X]_R44A
MEWQ^:ULH4,)\[B0)3N.48I)E(4X"X6'BQ5D2,AE"D0CBP("H3U$RU-3&; C7
MJO3I\A?#V1,P</5LSVB0P>S/>6B!S8N1U)9,#(SVI&;&")9]4V.VB)FY^4DL
MY')S:<PN^4N^R%7\I0[?6V/6WHCR7!:*R/$PCP)I7!CA.(ECBD/N.<+S:":X
M"^OAKD47HBU&%_Y:+FH]H3M\P.R*'HIZ]L0Z,C [TH5DEX&UPS)"-U60S):L
MB![-2:T'"(9]JP%[V*0E2%W+?ED4=3F(=A>0[E,C>PQ'&F'\&=+Y8T? ?FT]
M3S:82AX1RUK5RVDY#%MV["PU89>.8R+L-N8X^@FS7?-S*6ZSZ[+*7V3@7,X<
M-Z(DHQF6>V**B1LPG/* XY2Z(0FRP,\(Z)+B[O(C*\WG)C>X(0?;^?:0T-OB
MS.6#*<Z^:!?-19PW]&O[WU&&SAZ7SM*NM;?XI-O3<<'V]Z$3GX)O.'=B>5F/
MAIV_J=2(*C$ M)\Z_O38B??K6[2F6N=S]NI\@!W=3B PO#.=+SQ,T<Z3&[19
M]8MFM&F=6'*RS:M?I.XF-O!)L\WLK\OB-_E5[[ZQ33*S,UPJ<A,W3$('4^IP
M3"*5=.+"P3($#%-*0X^[H+,R/;(C*^PE8\5*</1[P\P_(=;]WK)EN3NURZ#[
ME":Z2<HHS:B'&?6)C+ =BJDG/!RXD>N+.!4N!4Y)LX^O64^=]BPR7Z"792&:
M0D47O0E:H/_]#['G>__\@P15[=-J$I+<,XKV2$%-7V:T*'(IA?KU/_IU4/J/
M!-$*_:Q2(/_[']S0^6??O4"J]4?]V_>"U8'.SJ_\"R0Y?%U/2 #6P6J^03W7
MQ_Y;@5GJOZZ_Z#L&>L/".,/78$);\I0TB4[J0<& V/>L@$\;WGY9MXA40POH
MO',+9U,Y%$>)%SF$8*'&K! J IR*E&,G"@+/#>2O E#!_3#)D7>!>L+SEBKP
MELPP8'JFP2X,,+.PA\#%ME,HSI8%5NR,4F&E+[.M&SC#!*>]EJ,-P,%='?TG
M[8_1G:494==K,AP11C%)O!@G0@W/#6,2A50X(?=GE7YA0Q\QD/8;%C'8F\=J
M80KK>'H^,'MUFGFKEE6ZE]1W,UOUE!IK/0._]W"]J*17\"&?BZ;YT<PC44KC
M4."$JX; ,4]P')$$!S0161R&OF8[D6.+C[P]-^20HM?V^-*_XG" 0[]VGBL=
M3!L!@H%N,YR2P.@:P\%BD]U?."5&]^+"R<\87EIM2_3;7F$'=YN.-4^L;S1=
M-O7Z;X]J1]YVJR(L32GQ*4X"-08FC6-,8S_!*4LH)1'Q_024-+',W\B*^]"Y
M\'#_\!FMF4"KA>J.U=P"6U]TE$\"/6_;+TMOX_Z&KP!F70;G%1YM WNQ?4N_
MUIR.<T@R$HJVKHM:YF[:6Z'C0'MP^7,D,F:&^_95J'*'Q=-'-8%SDQ99]_>G
MW ^HDTD[S!*!B>J;E#!*<4@B[B9N3 .A-8Y+C]S(9G5#',WK<:/SECPX=3$
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M"Z =I)QMK#ER![#N6.=M;;;'8]>)68(]P9DJ8\]PDGD^=@/!PSCQ&8OX* W
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MM<H+\3,M?A/UP,'VBE0NRIF;17XD",4I4X/H?!%@&D<ICBAAKALDOL]]@Y8
M6L2UOIQG-P.XD__^3-5]UF6&7C9LH'+#!["!D1:N>F&,/9C,FA&UY%4VNF4
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MNT:1*),X)91FC+ @BAFDG:TY:9!A@K>O58S4+1UW^LY2'1_6AY%&Y, #S,D
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M XZILGK8RZ(X9XQ0A3S,2P+1G]AAVG.#?MKS\[.>Y-%FZ1^H9@K]H=E"#5_
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M\I67G!*)99KGON\K-SD&3?J!,C"Q!=BS@TC-3S/2S[ PSAI5,Y,P)58P,W&
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M,ZP.-#2,,8E"+Y%^1KV  %L:]!*;^A2S)UVEB_*&."(-=7"3@G[0S)3>%13
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M_[<Y/^L/LK<"O]+_C VT*F9!M5C_@S;(RV_Q/V47;''^_Z^M[O*3S+Z?=;
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MY213Y_C XSB*)<7J;QRSA"4BXD'D,0_6F-^,L,6M,<QXUA>(I")V[9B@3N0
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MF1Z51G#F>SG6@P-H'F4\]$"Y=_6R$Z?4U>, 2$4*6)!>2VVF;W!98-IU.RP
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M=]'<92R4M<UYD$:82*E.\"00RERD&<Y]CT9!3KD?@D:*=Q&9V%MI48(>G3L
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M_S@-S6N&T9[CF_T,A]?Z-%:-]N;]1%>W#KUOM*3O4ZT=?2K;YG[NX#1L">B
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MC5V1^\E*\U6U=PEP4L;>^< 5*=D7I5^7:6GT/"WM7GWE;^H?[\N"B3OYMIH
M5I6?W@OU_=6)(LA$F'L^PT$:ZS2.(,(T$0'./4^FJ=KM> J[")J,U8F5NJ&B
M T-5HC3Z/IC*.O=W,KQ#^B'0AUD<!_G,>^Y1Q7[5UK>>=5=)<(,:&1SG)4^*
ML\M$XVD8G3]S>%+ .U.!IZ5H$2^\55\X_[S>BLU]?>G3G' YSUG&B3JP^+G$
MD2\HIGY <>K)P*,^CQ)IU+1[B,C$!E@311550*BL#P^#^* #*6&&[B@@:BB.
M1P  OP'FH4$'DML%!B\1<!0.')%H,!C8]^Y\H< 1[D\"@6//6H4!?U$&KZD+
M?B<VK"RJF@7PE*3QE68(%OYR>WM_Z.':X@$4/1P#Q"B@Z! +>(RQ#X8)1AB9
MBVH;BQQ;?L[PI*&H9Q%+T[?LSH<]PVLOIM;J3A5LH1N?B3CVL)^*5/D*OH<S
M7W),4D99PF1.8Z-4&BOJ$UN BH;S,=8]0"9!RD+B)9BEL:_KDS-,19S@G)$T
MH=SSDBQ=J)7H^M6A;'-A#*;-+/&9H#<[#D\&)\P> Z>'5]Q,/CM\&(1I)X?W
MT/X1YH8/PV(X-7QD$7CSRO>KK0ZQUU>^7\3SNMRJ5;\J]WNW67AY*+,X2)45
M%^KLEWHYSF0L<> G@50V*,[,!NF.$9KZOJHBO<\30 ?BJ*9NWNER$*QAP^$2
M N#=E:7TH+:8)J)9=<D<7'BVIIDFXK5[:!H];SUX38=ZRKI'6['YLS7GF$@9
MTB25F 9ZP%K,,^4Q,($YC;V$\)2$>0 <L-9':V*5/:&,-&F;F= FF)GM]XZ0
M@&FN-0@V0\K&Q',WC*R7TMQ#Q\9$[A@N-OJ*98.S9Z%773U^7"G_5U3C18,\
MR:,X#W#$<W68XJ&/LS )L,^IR!.JSE0^@TPTZ* !4F+X>(,#1514)(%=S#HP
M,5/6*R6%*>E1R)J:\ZFI ]*X:E7606'>'F7](EXT)QMXU-&&^N;EC5BQ;T^D
M_+/*H/"2- B2+,2<R$"/[4O489S$F"=!G'B!",,<%-48(SC_UGH@;S4-:!1
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MWD&>3.'Z]\[\=Y@=?$?)H>*&8S^]6MAOE'(L%ZZ317[M1BH#+CDD$)+HC%)
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ME?JRI!FQD3M2QIC;+(TVMG:5_).$]%OD61] NTN[[Z<XBUJP3_ZJU#??D\]
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MXT0EY6R$4$;1 ,8B7J!;:2.)Z">4!E':^>HC8)^EIIGT9X?8JJ.*!D"UPL1
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MLU+J!)G6[K/51D(^?H%T.8+C_ \_'18MW;3E.\ #9GZ_58%..GHJ2 )?PDC
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M,R^R,U83STI2M R7<C%3(@4/KOR$2K,6Q)[Z]%8>I7?G\=41;#O(N)YVL-Q
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MW8]+%XTA?N8R)+MZ#U\GL^%M1B!"UNBU:Q)-Z6WFI26!,E6N"V*4CDF3Y5J
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MXX6 +_WH5S]?#AZIW.%QN^4[Z]Y801IOWYE1)<]->03!H736R]D3[RTG6M)
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M9R(1)"7YY8G(0C+PC'I=>PQA8[,?++/4&Q1 0MZEQ9WC ^<D!F%]H#DZJ"V
M/]/LATWPL]7LAPW4T\ I?)U;O-]B%&+P3CA"J0I$>A^(C1EC/L^CM"8J3VO7
MI3RFX@>8];")HI\ T@Y2;PXW1_[B9L)XHD8E&R1QBN'^"ASW5]".0-(!-YB"
M)+I%SQTM_6-H%QV_")DM!=YWT?D>ZLX=3>8P^^2ORBY:UC0'X[5-4A(OK"@#
M1M'U9#*09).W3 /&-?XU5^FE!5I"PK:JFU268P-8$.P)'D &;[VC)"N@&,8B
M#^56LS2X"5FAM 2\ZC:_M$#_C>BK8V%G.39PH&Q6:(S,L>0!B*?>$NDL&E$:
M!:$@*5 46'"U7X'7?R?0[[2#'=R7[G35 !!?%M[)2G%;*0@:\"QETIX2I7)Y
M55^FOBKJB?$LY1B32M4[)F]&X8_T?F CJ&P4G.VDMP90N6K@;U.^[X>S.)J4
MS@\#[108G231RB,[7'-BN<\D&<B690I*UTZ)OD)2OR;P[7!74S,_4+76K5CS
MXXQOW<*LUU?JJ@9K0Q[?/AF:&$4094E2+DWSI%/$E=?JS LJ066FJ]?+OUTR
M]--T$@'2[ -N[B+]E[9R(64 P$PRDJ.S*TN)>7+$ 7 "-&H%6EME:E_7;TKC
M#Y,FW019#RUBIXIKX"Q>Y>_N:NO3%+[ZJXOEN^U]/QK-7F)\(%Q43$>*;G<I
M('<Y+3JWXE]UUI1E:U+M%UE5"/]ABJ=J0?AM5-P8K@LGR./-3>V+;!J%K#@P
MI0%8J4='5SJ@#T6R1M_)<Q$AUO8]MR3UARF*JFE^NU!CFQ?Q>_O[)Y\/WO]V
M?/(?!R>G^\>_?CHX.MT[.SP^VC\^777L?IM,?\=MLS^Y^ KCV?6J&!2>(!'3
M;[ 7Y\-ON[TPZ(B2"H[N6\BHFB., 51ING*[+61,R29!R["M<GD+C+AL*=&2
M)2Z9-,S7O_Q_0,2N5O;CT(?A"$6'._#S^*L?IOV1'UXL3I3K+])_7UZ;B8/O
M1?1P!/.[(IT0E+5)$>K109(A>&)!!$*E#CQ2$3BO;6MW(KAOAW<7!#TTK&^G
MN0:<@<V9/<8_A^/S9:.DNQ_/!J"D!)8,T2Z5OEA!HOA#(LEH)JV2!ESM+N@5
MR>\7PF\(NIWA7@<!6X/_*TR'DW0Z]]-Y3UO@<%R&&L#-CV^T8+*+^/&.:%[B
M6W2F2@-QC5H067'N14ZU7W[5HKW?:.]' G\%W3=@]D\OOZ)[6]BZ5_R)4L"P
M C?8_&K?SR[]:'YU>[9^1E=O^@<&$<5;+"(8STME^FOR&LA$'>/&D5@J%B0M
M=]_>>!)\X,)+ZU7U!,C;<?>C'1HUT/OPEKA-*/WXF^P3'G/3M>0B(/'LE2(Q
M^S*^0J#ZK(OED5,4+@>MJQ=+OQ5O/]K!U-X&ZP9&#6RO797#!LH$@!0]H2YK
M(J6R)"1T5T5(.08!P'7M\J*=B>XWM]G$AGA;Q3?0=6USAJ^__0E_\U;BU G#
M:*0$K Y$BI)KCBX1I9T6G'FJ5>UKTQIT_VAX[R\RV5'G/Z1%O^-YQ8]D@QAP
M=V==FF=;1J0M?"NF24I@LJ &MWCMWE:U:/_1(HI=45<1]EM#8-?&;6=-[(!;
M1P\/N*3 **<ET=DY(EDLPPJ\()XYD]$::1-KEZM6(OU'<_@;PO^V &@'_I^6
M91?(?+F$A,)V^>)QK!*H-H%I%*JPE,A8GCTP"(1+;3T+)O!4NP/9VL3]:"Y+
M90AWH\2=0=JC-_[\A4FBS#.+VQ2DDF7*1R!6)\"C*NL<4 .F>G/XM[XRZZQ=
MRX_DF]=!P(Y79@?CU1:S[93D+*6Y6TUY90KZ+L%Y12:=E=YXH8P7-)#,H(P=
M8E!2[(ID@Y).5BL6ZY>:]UYZ\_SVC)Q+Y4"3'&,L3?%0'ED*PH7+B?$R4;7_
MK$FC-0V[H:M+H[N)5OM^0+V%/S<9E<;F4S\:<"634IHAHZ7 -'!-/->6B.#!
M60%)&?Z:9=V9BKY+R6N@\&U5T4Y$]L+9=+7,MR#W1Y/K!/MX/@ :*!.!$J95
M7+Z#\RCF()3VFKIH9>WK_DUI[+L\O*95[%0_#5Q]K,'?_VWORKK;RI'S>_X+
M$N!B?\DY\M+=/G%;BJ3V9)YTL,I,4[QN+AX[OSX 24D4Q>4NN 2D]CQXVK)=
MMU!?H5 ;"C?"JDIKB6*;F0"$P_A$8S#IF'B*?&5IA3.H7.Y9EB?6LE8H%/&&
M[J%%;6P8# WC5D+@:(4 ,?%98.<@8,I(83GFZ3WB9ISEGCAY*@7KB$7Q.K;3
M/'/L@A0A!$K%BY*(6" 9-X 1(9CUX1>3NH=ZD.-SL,=1,Q^?;?#)'3D\.I\Q
MMWM=/X@NOHDX"M_XY.;G1RX W??GW2C"K9#,A(4C%OR&8.@5=!145F+NM)*:
ML4:11$JN&JDB+UL5\T+U*G1T8W\R9$F%XF@T&M.Z$H>U6\&#4^(544@Q!\WI
MU+2ET11_%TWM"%B9<U..Y'E3SXKN\[GAL]H99DIOJ[9A'E;2:8 X$7$Z(@9*
M4P>LM09I;XESJ6MJR5+86UOL-S>V;WX\VV(WD&,8> B^AU%ATS"D@"0VOL(M
M*NZDYE2T/8SW?*JT#'(;</?8K11"S7UL]LM$.ET);$*D[A"/O;<02"0%@+9"
MT$@MC&MV1KZFI'!GQ3H9%&6>?E?7YV__Z\W9U?MWFV=!ZD.OPU<2G'5]UY;H
MB'N<,G?N-SVJ2[=\OS8^)CZ[^A+T7JN9L_?M-X^M]DYCA"P&D)M@US 40!,3
M7RPUBA$)$4>I4PK].$XW8W;YC3?Q&YM<G$W#UK]=WJB9O?GQ^'?6?)S]2TWM
M:GJJ\81*1050W&% K*Z ,MX"(RM!L&<4^M1ME,F8SSP,^W0ZNW]L[2GA+Z!]
M?L5Y^,O+*?05YEAJK($S-K;P60BT(11H2I#WSE!:I=[V3Q@H92#M295@^[VD
MSH@4H$[=!?>X[(F]&*O)QOQSA:D6G!* E"2 5,( 53D*&$32".\Y1JFK*4.L
M(Z]R]U"K;5N9&^/<@=3UZ&ZUMDL7CIZ1"6?3U;PV?_XQ&<UGZQ'[S'%%!(F/
M1L(JELP-T%I1("0.>U\R:UFS>*G!QS);S>SJ4 ^(36Y=NW#39;P0PLZ]RU*3
M[1\O)7N_7(Z89M(0@.URP XU<98U HQX7JDJN$7:-E+%_KQD'OQ=E*:>&-FL
MI>W9='YS&:6\/'RH)E$X$%AE%" (AW/':0B(4U8JX2 1C=X'#U0WSO+PN\=S
M_,D'2QDWG\.K["[YC);O@>FUGD-#O:F(!9Z:L' <>)=4,\ \I- *PT0ZA<EY
MI/8 :QON#I++#/COH\GH;G&W9EQ*3Y%5$#@?IRTH(X%"E &/D,'<8$=)(Y__
M".1//IH9]"Z0U2GDEQMX]7V#<:-0O&VM :95.$\-#VZ:P HH 9F$BA@J&[T_
M?@SXS8_F.2"2 =]9?@4D##X']V8TN5T:/ 8AJ9 5P1&/-RQX"$^5#+^E'$GM
M*;:H2GUO9N/S>3N\R\@]=46C'$5:>^5.$2TKA8$7RZ9/YD#80 9PC'&%>;")
ME VC2B7D>CK#N%L=.LBT (78LX^6&R66<;^X\\F]Z;5>8@Q1O-@KV&KTLQ;!
M_EK$1#2^X8]36YX6[!6A3%V4H%GBL#<B171M'S7;^ZSVQX>GQK"D3$/G@3$V
M'-VV@D Z@H&N"'*((<AIZEG _;G.>V6EC&/SQ-B_;'U?_K(V*A?+&0/HAG#"
M9/!:@?>5B$XK H*J$+)P7F'KK(<B^3#2A/P7GH!/K'VIE+^O(I3B8^CC:]?;
M:[]83,V7\,.+Z<BLNAWNZLDRP1LD898]SI9;BR2+3X]20"#GP6]##M!*2&@9
MAD8-XI(,LIK"\_XGV"#YE>0E;Y=-4W$YNOTRGZTEH&[=35BL(8QH(,*O@ BE
M@( AUE%6:&<T000E'Q8_Q$(R)R!>Z"9)IAJE[(_.1^FE^VLQFHWF[LI-OP6+
M<7^F4N&(CB6$$.\[0#RT0.+@Z/*JXE('U]8F?X-OD(5DCC0*V!]95>,EM9(_
MSLFZO/HC%M&OSNY?I5O$,?>KQQ57LAJK29\98FD9&*P!/8E$RNA-#S:[@DA"
M(+BM "$NV',I!4"$FXJJ*C"8>HSG:^E-)\H3SK4'\3T[0)#F0 =5!@YQ25R(
MO*!/'E3\[$UOJ;/#]::W@;\ =^AIRRI2FC"!$1#8P1#K4 R$038*$TNCA&?)
MLZ.OLC>]E1(<[$UO@T@!ZC1(^Y^PPLKX$HFS2@*BN0C!A8P3Y"O-.<-2Z)^]
MZ>UZTUNIU2EZT]M@G+M?N$G_,V22,\3"OK=> 4(1#:)F\3D;1R"13A!'CKF]
M?^/>]%;JT+8WO0TVN76M20?S>ED$(F0-HP :I4.@R3D0'D) .<9"2Z$TQ(U4
MKODW"\\YGU3S!D+J)1SJQ],RPJ@*6[8\:A @5E @8ZL!9]1)R+B LE%W<7EE
M]Q?0T]['&STQ]B^[[+Y*\'R8A(V_6.)R/O_BIM=?U.3\:R01YRM]"V8A&(=Z
M//ZEGL9_=$,<%-H0"RQE)E@#8X"L# %5; /RBE0.);_,?M(5%NZ?)-;@5!MH
M>&5ZR4=+<^E\6BS/7&6Q]!750))PI),JP*=X'&\&)?*&2"%UZJ?G3K:X%[K!
M3J#AI]^,'=2MY_,Q5W,UG1>^&W\-).:S#Y-54>P&48A)I1P(S@<&1.HJ>"0A
M((/"<^&9TX0.TDYP@K45'A+]'?9B#V5[U4?BYR5^#W*AP2@%WR5(PV 41R;S
M..L3 >P(H8RYBE7%-(2V7-L+;?-Y39NPA[*5\\K*<.()X'DWVI00KVCE,7<A
MR*@4($(K(!F- W>E8591)%BC2YE%;,=GRWNAC46O:4?V4[F_PZ;<=N(]J;"D
MD ,91X$28SW0+%X>QE!ZH66%](FNK&6*&0=[I>3GANRI;DF?'"UZ+_[#Q8YC
M9\^^N:FZ=4OG_EVP*+^HT?2S&B_<)M!"!=E5Q #HA02$: =$\"Z EM8AI#DT
M#KZ\'=M&!"\T_GPQR=;!U/%5AY[-Q7?#G&!46@,,([%:%2?'28]#I( I19()
MJ%//1RUAW:\^ASO<QBG0"+32XK]=_O>X^!3% G%O 6,Q/#&: 5$1&+:NEE(Q
M020IYII^ZL6_T!/\;V4)AM3G5^T(/$T+'A><-HA2[(,CN*RC*6V!T) !#I6W
MA!FK9.J+*,4L_M5GL5^!(1A2GU^U(5AG(Q=!JX]++?A,4CH9L)<JWC$.,:&B
MX;<,"N<<YL+ D]\ .,G*7WW:_!68@,$T^57O_Q:QE&+Q\4OI 14RP!XGKBK"
M!!!4:XJ\54*]G,I8XHS 2\[0OX*]/Y 6)\WNGW06P/*NPS-1KQ_8&W $0*/O
MGN#F?_OUEW'A7RN$L*XH\#@H)C&" >FH <X1@@Q& E:IF]!?RX5_44G(&4+
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MN^ .3%'E3%F#N08(QER+$!A()SWP(3Y5#D*']<GO[[SPD=VMU.H4([O;8%R
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M?]%JYO[SW_X?4$L! A0#%     @ Y4.:6%=(A-V\!P  0R,  !H
M     ( !     '1N970M,#,S,3(T>&5X:&EB:70S,3$N:'1M4$L! A0#%
M  @ Y4.:6)N7S<N\!P  O"0  !H              ( !] <  '1N970M,#,S
M,3(T>&5X:&EB:70S,3(N:'1M4$L! A0#%     @ Y4.:6 -DQ P/!@  01P
M !H              ( !Z \  '1N970M,#,S,3(T>&5X:&EB:70S,C$N:'1M
M4$L! A0#%     @ Y4.:6+8+)N$V- $ 4]81 !$              ( !+Q8
M '1N970M,C R-# S,S$N:'1M4$L! A0#%     @ Y4.:6)\KP,[F#   BWT
M !$              ( !E$H! '1N970M,C R-# S,S$N>'-D4$L! A0#%
M  @ Y4.:6)-EUQ^\'0  K!T! !4              ( !J5<! '1N970M,C R
M-# S,S%?8V%L+GAM;%!+ 0(4 Q0    ( .5#FE@[SCK7+B\  .P( @ 5
M          "  9AU 0!T;F5T+3(P,C0P,S,Q7V1E9BYX;6Q02P$"% ,4
M" #E0YI8C6[-D8$.   B*0  %               @ 'YI $ =&YE="TR,#(T
M,#,S,5]G,2YJ<&=02P$"% ,4    " #E0YI8\$)PY(9#  !450  %0
M        @ &LLP$ =&YE="TR,#(T,#,S,5]G,3 N:G!G4$L! A0#%     @
MY4.:6'L_<N 320  L5\  !4              ( !9?<! '1N970M,C R-# S
M,S%?9S$Q+FIP9U!+ 0(4 Q0    ( .5#FE@BKKU^ZS0  $5&   5
M      "  :M  @!T;F5T+3(P,C0P,S,Q7V<Q,BYJ<&=02P$"% ,4    " #E
M0YI8N=_Q+Z%0  "B80  %0              @ ')=0( =&YE="TR,#(T,#,S
M,5]G,3,N:G!G4$L! A0#%     @ Y4.:6 *PRKIV5@  RFT  !4
M     ( !G<8" '1N970M,C R-# S,S%?9S$T+FIP9U!+ 0(4 Q0    ( .5#
MFECU^3F"@6H  ,YT   5              "  48= P!T;F5T+3(P,C0P,S,Q
M7V<Q-2YJ<&=02P$"% ,4    " #E0YI8Q>]Y [%G  #-<0  %0
M    @ 'ZAP, =&YE="TR,#(T,#,S,5]G,38N:G!G4$L! A0#%     @ Y4.:
M6/F;"R3:-P  /TL  !4              ( !WN\# '1N970M,C R-# S,S%?
M9S$W+FIP9U!+ 0(4 Q0    ( .5#FE@LMJ08?B@  "<X   5
M  "  >LG! !T;F5T+3(P,C0P,S,Q7V<Q."YJ<&=02P$"% ,4    " #E0YI8
M9VCS\% D  #E,P  %0              @ &<4 0 =&YE="TR,#(T,#,S,5]G
M,3DN:G!G4$L! A0#%     @ Y4.:6*5(A@FT<P  L+8  !0
M ( !'W4$ '1N970M,C R-# S,S%?9S(N:G!G4$L! A0#%     @ Y4.:6-\X
M!BFX(0  *#   !4              ( !!>D$ '1N970M,C R-# S,S%?9S(P
M+FIP9U!+ 0(4 Q0    ( .5#FE@0UY1*NR0  +XR   5              "
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M '1N970M,C R-# S,S%?9S0N:G!G4$L! A0#%     @ Y4.:6-J%EA>U6
MF7(  !0              ( !634' '1N970M,C R-# S,S%?9S4N:G!G4$L!
M A0#%     @ Y4.:6$IY-?;/)P  9SD  !0              ( !0(X' '1N
M970M,C R-# S,S%?9S8N:G!G4$L! A0#%     @ Y4.:6!_D;>GS4@  )60
M !0              ( !0;8' '1N970M,C R-# S,S%?9S<N:G!G4$L! A0#
M%     @ Y4.:6"QPB'^T4    6<  !0              ( !9@D( '1N970M
M,C R-# S,S%?9S@N:G!G4$L! A0#%     @ Y4.:6*<Z>/RO*   _SH  !0
M             ( !3%H( '1N970M,C R-# S,S%?9SDN:G!G4$L! A0#%
M  @ Y4.:6(P<"X+%P0  ]80' !4              ( !+8,( '1N970M,C R
M-# S,S%?;&%B+GAM;%!+ 0(4 Q0    ( .5#FEC3YW[0V&L  .X,!0 5
M          "  25%"0!T;F5T+3(P,C0P,S,Q7W!R92YX;6Q02P4&     "(
,(@#D"   ,+$)

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>tnet-20240331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:tnet="http://www.trinet.com/20240331"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="tnet-20240331.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
        </entity>
        <period>
            <instant>2024-04-19</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:ProfessionalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:ProfessionalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:InsuranceServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">tnet:InsuranceServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">us-gaap:HealthCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:PayrollFundsCollectedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:HealthBenefitClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:WorkersCompensationClaimsCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:TrustForOurHRISUsersCollateralMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">tnet:AvailableForSaleMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="tnet:CollateralbyTypeAxis">tnet:InsuranceCarriersSecurityDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">tnet:RestrictedCashAndCashEquivalentsAndInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tnet:A2029NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tnet:A2031NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tnet:A2029NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tnet:A2031NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:TimeBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tnet:SystemsDevelopmentAndProgrammingCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">tnet:SystemsDevelopmentAndProgrammingCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">tnet:PerformanceBasedRestrictedStockUnitsandRestrictedStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">tnet:BurtonMGoldfieldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000937098</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">tnet:BurtonMGoldfieldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>tnet:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-26">0000937098</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-27">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-28">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-29">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-30">false</dei:AmendmentFlag>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1 contextRef="c-161" id="f-599">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <ecd:TrdArrDuration contextRef="c-167" id="f-654">P371D</ecd:TrdArrDuration>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2024-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-36373</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">TRINET GROUP, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">95-3359658</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">One Park Place,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-10">Suite 600</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-11">Dublin,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-12">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-13">94568</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-14">510</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">352-5000</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-16">Common stock par value $0.000025 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-17">TNET</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-18">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-19">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-20">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-21">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-22">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-23">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-24">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-25" unitRef="shares">50563849</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-3" decimals="-6" id="f-31" unitRef="usd">214000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-4" decimals="-6" id="f-32" unitRef="usd">205000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-6" id="f-33" unitRef="usd">1050000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-6" id="f-34" unitRef="usd">1041000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-6" id="f-35" unitRef="usd">1264000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-6" id="f-36" unitRef="usd">1246000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingInsuranceAndClaimsCostsProduction contextRef="c-1" decimals="-6" id="f-37" unitRef="usd">907000000</us-gaap:OperatingInsuranceAndClaimsCostsProduction>
    <us-gaap:OperatingInsuranceAndClaimsCostsProduction contextRef="c-7" decimals="-6" id="f-38" unitRef="usd">852000000</us-gaap:OperatingInsuranceAndClaimsCostsProduction>
    <tnet:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction contextRef="c-1" decimals="-6" id="f-39" unitRef="usd">79000000</tnet:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction>
    <tnet:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction contextRef="c-7" decimals="-6" id="f-40" unitRef="usd">78000000</tnet:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortizationAndOperatingInsuranceAndClaimsCostsProduction>
    <us-gaap:SellingAndMarketingExpense contextRef="c-1" decimals="-6" id="f-41" unitRef="usd">72000000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-7" decimals="-6" id="f-42" unitRef="usd">69000000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-6" id="f-43" unitRef="usd">48000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-7" decimals="-6" id="f-44" unitRef="usd">43000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-6" id="f-45" unitRef="usd">18000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-7" decimals="-6" id="f-46" unitRef="usd">17000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization contextRef="c-1" decimals="-6" id="f-47" unitRef="usd">18000000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization contextRef="c-7" decimals="-6" id="f-48" unitRef="usd">18000000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:CostsAndExpenses contextRef="c-1" decimals="-6" id="f-49" unitRef="usd">1142000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-7" decimals="-6" id="f-50" unitRef="usd">1077000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-6" id="f-51" unitRef="usd">122000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-7" decimals="-6" id="f-52" unitRef="usd">169000000</us-gaap:OperatingIncomeLoss>
    <tnet:InterestExpenseBankFeesAndOther contextRef="c-1" decimals="-6" id="f-53" unitRef="usd">16000000</tnet:InterestExpenseBankFeesAndOther>
    <tnet:InterestExpenseBankFeesAndOther contextRef="c-7" decimals="-6" id="f-54" unitRef="usd">7000000</tnet:InterestExpenseBankFeesAndOther>
    <us-gaap:InterestIncomeOther contextRef="c-1" decimals="-6" id="f-55" unitRef="usd">18000000</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther contextRef="c-7" decimals="-6" id="f-56" unitRef="usd">18000000</us-gaap:InterestIncomeOther>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-6" id="f-57" unitRef="usd">124000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-7" decimals="-6" id="f-58" unitRef="usd">180000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-6" id="f-59" unitRef="usd">33000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-7" decimals="-6" id="f-60" unitRef="usd">49000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-6" id="f-61" unitRef="usd">91000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-6" id="f-62" unitRef="usd">131000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-6" id="f-63" unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-7" decimals="-6" id="f-64" unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-6" id="f-65" unitRef="usd">88000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-7" decimals="-6" id="f-66" unitRef="usd">134000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-67"
      unitRef="usdPerShare">1.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-68"
      unitRef="usdPerShare">2.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-69"
      unitRef="usdPerShare">1.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-70"
      unitRef="usdPerShare">2.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-6" id="f-71" unitRef="shares">51000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-6" id="f-72" unitRef="shares">60000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-6" id="f-73" unitRef="shares">51000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="-6" id="f-74" unitRef="shares">60000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-8" decimals="-6" id="f-75" unitRef="usd">298000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-9" decimals="-6" id="f-76" unitRef="usd">287000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments contextRef="c-8" decimals="-6" id="f-77" unitRef="usd">85000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-9" decimals="-6" id="f-78" unitRef="usd">65000000</us-gaap:ShortTermInvestments>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-8" decimals="-6" id="f-79" unitRef="usd">1059000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-9" decimals="-6" id="f-80" unitRef="usd">1269000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-8" decimals="-6" id="f-81" unitRef="usd">11000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-9" decimals="-6" id="f-82" unitRef="usd">18000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent contextRef="c-8" decimals="-6" id="f-83" unitRef="usd">467000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent contextRef="c-9" decimals="-6" id="f-84" unitRef="usd">447000000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-8" decimals="-6" id="f-85" unitRef="usd">79000000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-9" decimals="-6" id="f-86" unitRef="usd">67000000</us-gaap:PrepaidExpenseCurrent>
    <tnet:OtherPayrollAssetsCurrent contextRef="c-8" decimals="-6" id="f-87" unitRef="usd">791000000</tnet:OtherPayrollAssetsCurrent>
    <tnet:OtherPayrollAssetsCurrent contextRef="c-9" decimals="-6" id="f-88" unitRef="usd">381000000</tnet:OtherPayrollAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-8" decimals="-6" id="f-89" unitRef="usd">50000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-9" decimals="-6" id="f-90" unitRef="usd">44000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-8" decimals="-6" id="f-91" unitRef="usd">2840000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-9" decimals="-6" id="f-92" unitRef="usd">2578000000</us-gaap:AssetsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="c-8" decimals="-6" id="f-93" unitRef="usd">152000000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="c-9" decimals="-6" id="f-94" unitRef="usd">158000000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:InvestmentsAndOtherNoncurrentAssets contextRef="c-8" decimals="-6" id="f-95" unitRef="usd">161000000</us-gaap:InvestmentsAndOtherNoncurrentAssets>
    <us-gaap:InvestmentsAndOtherNoncurrentAssets contextRef="c-9" decimals="-6" id="f-96" unitRef="usd">143000000</us-gaap:InvestmentsAndOtherNoncurrentAssets>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-8" decimals="-6" id="f-97" unitRef="usd">15000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-9" decimals="-6" id="f-98" unitRef="usd">17000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-8" decimals="-6" id="f-99" unitRef="usd">22000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-9" decimals="-6" id="f-100" unitRef="usd">24000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-8" decimals="-6" id="f-101" unitRef="usd">462000000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-9" decimals="-6" id="f-102" unitRef="usd">462000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-8" decimals="-6" id="f-103" unitRef="usd">174000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-9" decimals="-6" id="f-104" unitRef="usd">172000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-8" decimals="-6" id="f-105" unitRef="usd">142000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-9" decimals="-6" id="f-106" unitRef="usd">139000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-8" decimals="-6" id="f-107" unitRef="usd">3968000000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-9" decimals="-6" id="f-108" unitRef="usd">3693000000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-8" decimals="-6" id="f-109" unitRef="usd">122000000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-9" decimals="-6" id="f-110" unitRef="usd">87000000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:LinesOfCreditCurrent contextRef="c-8" decimals="-6" id="f-111" unitRef="usd">109000000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent contextRef="c-9" decimals="-6" id="f-112" unitRef="usd">109000000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-8" decimals="-6" id="f-113" unitRef="usd">51000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-9" decimals="-6" id="f-114" unitRef="usd">65000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="c-8" decimals="-6" id="f-115" unitRef="usd">537000000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="c-9" decimals="-6" id="f-116" unitRef="usd">515000000</us-gaap:AccruedSalariesCurrent>
    <tnet:CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent contextRef="c-8" decimals="-6" id="f-117" unitRef="usd">167000000</tnet:CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent>
    <tnet:CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent contextRef="c-9" decimals="-6" id="f-118" unitRef="usd">175000000</tnet:CollateralPaidToInsuranceCarriersNetOfHealthBenefitLossReservesCurrent>
    <us-gaap:WorkersCompensationLiabilityCurrent contextRef="c-8" decimals="-6" id="f-119" unitRef="usd">51000000</us-gaap:WorkersCompensationLiabilityCurrent>
    <us-gaap:WorkersCompensationLiabilityCurrent contextRef="c-9" decimals="-6" id="f-120" unitRef="usd">50000000</us-gaap:WorkersCompensationLiabilityCurrent>
    <tnet:AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings contextRef="c-8" decimals="-6" id="f-121" unitRef="usd">1611000000</tnet:AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings>
    <tnet:AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings contextRef="c-9" decimals="-6" id="f-122" unitRef="usd">1438000000</tnet:AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-8" decimals="-6" id="f-123" unitRef="usd">14000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-9" decimals="-6" id="f-124" unitRef="usd">14000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <tnet:InsurancePremiumsAndOtherPayables contextRef="c-8" decimals="-6" id="f-125" unitRef="usd">7000000</tnet:InsurancePremiumsAndOtherPayables>
    <tnet:InsurancePremiumsAndOtherPayables contextRef="c-9" decimals="-6" id="f-126" unitRef="usd">10000000</tnet:InsurancePremiumsAndOtherPayables>
    <us-gaap:LiabilitiesCurrent contextRef="c-8" decimals="-6" id="f-127" unitRef="usd">2669000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-9" decimals="-6" id="f-128" unitRef="usd">2463000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-8" decimals="-6" id="f-129" unitRef="usd">984000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-9" decimals="-6" id="f-130" unitRef="usd">984000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:WorkersCompensationLiabilityNoncurrent contextRef="c-8" decimals="-6" id="f-131" unitRef="usd">120000000</us-gaap:WorkersCompensationLiabilityNoncurrent>
    <us-gaap:WorkersCompensationLiabilityNoncurrent contextRef="c-9" decimals="-6" id="f-132" unitRef="usd">120000000</us-gaap:WorkersCompensationLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-8" decimals="-6" id="f-133" unitRef="usd">13000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet contextRef="c-9" decimals="-6" id="f-134" unitRef="usd">13000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-8" decimals="-6" id="f-135" unitRef="usd">27000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-9" decimals="-6" id="f-136" unitRef="usd">30000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-8" decimals="-6" id="f-137" unitRef="usd">12000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-9" decimals="-6" id="f-138" unitRef="usd">5000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-8" decimals="-6" id="f-139" unitRef="usd">3825000000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-9" decimals="-6" id="f-140" unitRef="usd">3615000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-8" id="f-141" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-9" id="f-142" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockValue contextRef="c-8" decimals="-6" id="f-143" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-9" decimals="-6" id="f-144" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-8"
      decimals="INF"
      id="f-145"
      unitRef="usdPerShare">0.000025</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-9"
      decimals="INF"
      id="f-146"
      unitRef="usdPerShare">0.000025</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-8" decimals="INF" id="f-147" unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-9" decimals="INF" id="f-148" unitRef="shares">20000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c-8" decimals="INF" id="f-149" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-9" decimals="INF" id="f-150" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-9" decimals="INF" id="f-151" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-8" decimals="INF" id="f-152" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital contextRef="c-8" decimals="-6" id="f-153" unitRef="usd">996000000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:CommonStocksIncludingAdditionalPaidInCapital contextRef="c-9" decimals="-6" id="f-154" unitRef="usd">976000000</us-gaap:CommonStocksIncludingAdditionalPaidInCapital>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-8"
      decimals="INF"
      id="f-155"
      unitRef="usdPerShare">0.000025</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-9"
      decimals="INF"
      id="f-156"
      unitRef="usdPerShare">0.000025</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-9" decimals="INF" id="f-157" unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-8" decimals="INF" id="f-158" unitRef="shares">750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-8" decimals="INF" id="f-159" unitRef="shares">50573176</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-8" decimals="INF" id="f-160" unitRef="shares">50573176</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-9" decimals="INF" id="f-161" unitRef="shares">50664471</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-9" decimals="INF" id="f-162" unitRef="shares">50664471</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-8" decimals="-6" id="f-163" unitRef="usd">-848000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-9" decimals="-6" id="f-164" unitRef="usd">-896000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-8" decimals="-6" id="f-165" unitRef="usd">-5000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-9" decimals="-6" id="f-166" unitRef="usd">-2000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-6" id="f-167" unitRef="usd">143000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-6" id="f-168" unitRef="usd">78000000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-8" decimals="-6" id="f-169" unitRef="usd">3968000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-9" decimals="-6" id="f-170" unitRef="usd">3693000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-6" id="f-171" unitRef="usd">78000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-6" id="f-172" unitRef="usd">775000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-11" decimals="-6" id="f-173" unitRef="usd">976000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-12" decimals="-6" id="f-174" unitRef="usd">899000000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-13" decimals="-6" id="f-175" unitRef="usd">20000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-14" decimals="-6" id="f-176" unitRef="usd">11000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquity contextRef="c-15" decimals="-6" id="f-177" unitRef="usd">996000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-16" decimals="-6" id="f-178" unitRef="usd">910000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-17" decimals="-6" id="f-179" unitRef="usd">-896000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-6" id="f-180" unitRef="usd">-119000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-19" decimals="-6" id="f-181" unitRef="usd">91000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-20" decimals="-6" id="f-182" unitRef="usd">131000000</us-gaap:NetIncomeLoss>
    <us-gaap:DividendsCommonStockCash contextRef="c-1" decimals="-6" id="f-183" unitRef="usd">13000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-7" decimals="-6" id="f-184" unitRef="usd">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-19" decimals="-6" id="f-185" unitRef="usd">23000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="c-20" decimals="-6" id="f-186" unitRef="usd">91000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-19" decimals="-6" id="f-187" unitRef="usd">7000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-20" decimals="-6" id="f-188" unitRef="usd">4000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-6" id="f-189" unitRef="usd">-848000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-6" id="f-190" unitRef="usd">-83000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-23" decimals="-6" id="f-191" unitRef="usd">-2000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-24" decimals="-6" id="f-192" unitRef="usd">-5000000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-25" decimals="-6" id="f-193" unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-26" decimals="-6" id="f-194" unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="-6" id="f-195" unitRef="usd">-5000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="-6" id="f-196" unitRef="usd">-2000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-6" id="f-197" unitRef="usd">143000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-29" decimals="-6" id="f-198" unitRef="usd">825000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-6" id="f-199" unitRef="usd">91000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-6" id="f-200" unitRef="usd">131000000</us-gaap:NetIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-6" id="f-201" unitRef="usd">18000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-7" decimals="-6" id="f-202" unitRef="usd">18000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OtherAmortizationOfDeferredCharges contextRef="c-1" decimals="-6" id="f-203" unitRef="usd">11000000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:OtherAmortizationOfDeferredCharges contextRef="c-7" decimals="-6" id="f-204" unitRef="usd">12000000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-6" id="f-205" unitRef="usd">2000000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-7" decimals="-6" id="f-206" unitRef="usd">2000000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-6" id="f-207" unitRef="usd">20000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-7" decimals="-6" id="f-208" unitRef="usd">11000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-1" decimals="-6" id="f-209" unitRef="usd">1000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-7" decimals="-6" id="f-210" unitRef="usd">1000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-6" id="f-211" unitRef="usd">-6000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-7" decimals="-6" id="f-212" unitRef="usd">-3000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset contextRef="c-1" decimals="-6" id="f-213" unitRef="usd">20000000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInContractWithCustomerAsset contextRef="c-7" decimals="-6" id="f-214" unitRef="usd">-5000000</us-gaap:IncreaseDecreaseInContractWithCustomerAsset>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="c-1" decimals="-6" id="f-215" unitRef="usd">12000000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="c-7" decimals="-6" id="f-216" unitRef="usd">14000000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-1" decimals="-6" id="f-217" unitRef="usd">21000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-7" decimals="-6" id="f-218" unitRef="usd">10000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <tnet:IncreaseDecreaseInOtherPayrollAssets contextRef="c-1" decimals="-6" id="f-219" unitRef="usd">410000000</tnet:IncreaseDecreaseInOtherPayrollAssets>
    <tnet:IncreaseDecreaseInOtherPayrollAssets contextRef="c-7" decimals="-6" id="f-220" unitRef="usd">180000000</tnet:IncreaseDecreaseInOtherPayrollAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities contextRef="c-1" decimals="-6" id="f-221" unitRef="usd">20000000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities contextRef="c-7" decimals="-6" id="f-222" unitRef="usd">30000000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-1" decimals="-6" id="f-223" unitRef="usd">-14000000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-7" decimals="-6" id="f-224" unitRef="usd">25000000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInAccruedSalaries contextRef="c-1" decimals="-6" id="f-225" unitRef="usd">23000000</us-gaap:IncreaseDecreaseInAccruedSalaries>
    <us-gaap:IncreaseDecreaseInAccruedSalaries contextRef="c-7" decimals="-6" id="f-226" unitRef="usd">-21000000</us-gaap:IncreaseDecreaseInAccruedSalaries>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities contextRef="c-1" decimals="-6" id="f-227" unitRef="usd">-7000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities contextRef="c-7" decimals="-6" id="f-228" unitRef="usd">-5000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInWorkersCompensationLiabilities contextRef="c-1" decimals="-6" id="f-229" unitRef="usd">1000000</us-gaap:IncreaseDecreaseInWorkersCompensationLiabilities>
    <us-gaap:IncreaseDecreaseInWorkersCompensationLiabilities contextRef="c-7" decimals="-6" id="f-230" unitRef="usd">-1000000</us-gaap:IncreaseDecreaseInWorkersCompensationLiabilities>
    <us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities contextRef="c-1" decimals="-6" id="f-231" unitRef="usd">173000000</us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities contextRef="c-7" decimals="-6" id="f-232" unitRef="usd">-80000000</us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities>
    <tnet:IncreaseDecreaseInOperatingLeaseLiabilities contextRef="c-1" decimals="-6" id="f-233" unitRef="usd">-4000000</tnet:IncreaseDecreaseInOperatingLeaseLiabilities>
    <tnet:IncreaseDecreaseInOperatingLeaseLiabilities contextRef="c-7" decimals="-6" id="f-234" unitRef="usd">-4000000</tnet:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-6" id="f-235" unitRef="usd">-122000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-7" decimals="-6" id="f-236" unitRef="usd">-77000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-1" decimals="-6" id="f-237" unitRef="usd">95000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="c-7" decimals="-6" id="f-238" unitRef="usd">82000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="c-1" decimals="-6" id="f-239" unitRef="usd">66000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="c-7" decimals="-6" id="f-240" unitRef="usd">76000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-6" id="f-241" unitRef="usd">18000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-7" decimals="-6" id="f-242" unitRef="usd">17000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-6" id="f-243" unitRef="usd">-47000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-7" decimals="-6" id="f-244" unitRef="usd">-23000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-6" id="f-245" unitRef="usd">23000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-7" decimals="-6" id="f-246" unitRef="usd">91000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-6" id="f-247" unitRef="usd">7000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-7" decimals="-6" id="f-248" unitRef="usd">4000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-1" decimals="-6" id="f-249" unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit contextRef="c-7" decimals="-6" id="f-250" unitRef="usd">495000000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-1" decimals="-6" id="f-251" unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit contextRef="c-7" decimals="-6" id="f-252" unitRef="usd">200000000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-6" id="f-253" unitRef="usd">-30000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-7" decimals="-6" id="f-254" unitRef="usd">200000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c-1" decimals="-6" id="f-255" unitRef="usd">-199000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect contextRef="c-7" decimals="-6" id="f-256" unitRef="usd">100000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-9" decimals="-6" id="f-257" unitRef="usd">1466000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-10" decimals="-6" id="f-258" unitRef="usd">1537000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-8" decimals="-6" id="f-259" unitRef="usd">1267000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-29" decimals="-6" id="f-260" unitRef="usd">1637000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-6" id="f-261" unitRef="usd">26000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-7" decimals="-6" id="f-262" unitRef="usd">11000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-1" decimals="-6" id="f-263" unitRef="usd">7000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-7" decimals="-6" id="f-264" unitRef="usd">4000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:DividendsCommonStockCash contextRef="c-1" decimals="-6" id="f-265" unitRef="usd">13000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-7" decimals="-6" id="f-266" unitRef="usd">0</us-gaap:DividendsCommonStockCash>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-6" id="f-267" unitRef="usd">3000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-7" decimals="-6" id="f-268" unitRef="usd">5000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock contextRef="c-1" id="f-269">DESCRIPTION OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Description of Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;TriNet Group, Inc. (TriNet, or the Company, we, our and us) provides comprehensive HCM solutions for small and medium-size businesses under both a PEO model and an HRIS services model. These HCM solutions include multi-state payroll processing and tax administration, employee benefits programs, including health insurance and retirement plans, workers' compensation insurance and claims management, employment and benefit law compliance, and other HR-related services. Through our PEO service model, we are the employer of record for certain employment-related administrative and regulatory purposes for WSEs, including:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;compensation through wages and salaries,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;certain employer payroll-related tax payments, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;employee payroll-related tax withholdings and payments,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;employee benefit programs, including health and life insurance, and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;workers' compensation coverage. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our PEO clients are responsible for the day-to-day job responsibilities of the WSEs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Through our HRIS services model, we provide cloud-based HCM services to SMBs that allows them to manage hiring, onboarding, employee information, payroll processing, payroll tax administration, health insurance, and other benefits, from a single cloud-based software platform. We are not the co-employer or employer of record for such employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate in one reportable segment. All of our service revenues are generated from external clients. Less than 1% of our revenue is generated outside of the U.S. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Basis of Presentation and Basis of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial reporting and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the Rules and Regulations of the Securities and Exchange Commission. The unaudited condensed consolidated financial statements include the accounts of the Company and an entity consolidated under the variable interest model. Intercompany balances and transactions have been eliminated. Certain information and note disclosures included in our annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, that are normal and recurring in nature, necessary for fair financial statement presentation. The results of operations for the three months ended March&#160;31, 2024 are not necessarily indicative of the operating results anticipated for the full year. These financial statements should be read in conjunction with the audited Consolidated Financial Statements included in Part II, Item 8. Financial Statements and Supplementary Data of our Annual Report on Form 10-K for the year ended December&#160;31, 2023. Certain prior year amounts have been reclassified to conform to current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When entering into contractual arrangements with other entities, we assess whether we have a variable interest. If we determine that we have a variable interest, we then determine whether the arrangement is with a variable interest entity ("VIE"). If the arrangement is with a VIE, we assess whether we are the primary beneficiary of the VIE by identifying the most significant activities and determining who has the power over those activities and who has the obligation to absorb the majority of the losses or benefits of the VIE. We consolidate a VIE when we have the power to direct activities that most significantly affect the economic performance of the VIE and have the obligation to absorb the majority of their losses or benefits, making us the primary beneficiary. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Periodically, we assess whether any changes in our interest or relationship with the entity affect our determination of whether the entity is a VIE and, if so, whether we are the primary beneficiary.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, we created a trust ("the Trust") for the purpose of holding HRIS clients' payroll funds for the remittance to HRIS Users, tax authorities and other recipients. The Trust's assets are restricted and can only be used for payments on behalf of HRIS clients, payments on behalf of the HRIS Users, repayments of any advances from TriNet, or payments to TriNet of interest income earned on the balances of the Trust. In the event of any &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;losses, creditors to the Trust have recourse to the Trust's property and not that of TriNet overall.  The risks associated with the Trust are similar to those that currently exist for the Company such as banking losses in excess of FDIC insurance levels, interest rate and market conditions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determined that this Trust meets the definition of a variable interest entity and as the primary beneficiary we have both the power to direct the Trust&#x2019;s activities that most significantly affect its performance and we have the right to receive benefits from the Trust, in the form of interest income. As a result, this Trust is consolidated into our financial statements.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2024, the Trust assumed ownership and responsibility of certain bank accounts that hold HRIS client funds and assumed the related liabilities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the assets and liabilities of the Trust which are included in our consolidated balance sheet. These amounts on any particular date can vary due to timing of cash receipts and remittance to HRIS users and payroll tax agencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Restricted cash, cash equivalents and investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts payable and other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued wages&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payroll tax liabilities and other payroll withholdings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;98&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect certain reported amounts and related disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These estimates are based on historical experience and on various other assumptions that we believe to be reasonable from the facts available to us. Some of the assumptions are highly uncertain at the time of estimation. To the extent actual experience differs from the assumptions used, our condensed consolidated financial statements could be materially affected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Revenue Recognition &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Variable Consideration and Pricing Allocation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we may offer credits to our clients considered to be variable consideration. Incentive credits related to contract renewals are recorded as a reduction to revenue as part of the transaction price at contract inception and are allocated among the performance obligations based on their relative standalone selling prices. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocate the total transaction price to each performance obligation based on the estimated relative standalone selling prices of the promised services underlying each performance obligation. The transaction price for the payroll and payroll tax processing performance obligations is determined upon establishment of the contract that contains the final terms of the arrangement, including the description and price of each service purchased. The estimated service fee is determined based on observable inputs and includes the following key assumptions: target profit margin, pricing strategies including the mix of services purchased and competitive factors, and client and industry specifics.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fees for access to health benefits and workers' compensation insurance performance obligations are determined during client on-boarding and annually through the enrollment processes based on the types of benefits coverage the WSEs have elected and the applicable risk profile of the client. We estimate our service fees based on actuarial forecasts of our expected insurance premiums and loss sensitive premium costs and amounts to cover our costs to administer these programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We require our clients to prefund payroll and related taxes and other withholding liabilities before payroll is processed or due for payment. Under the provision of our contracts with clients, we generally will process the payment of a client&#x2019;s payroll only when the client successfully funds the amount required. As a result, there is no financing arrangement for the contracts. However, certain contracts to provide payroll and payroll tax processing services permit the client to pay certain payroll tax components ratably over periods of up to 12 months rather than as payroll tax is otherwise determined and due, which may be considered a significant financing arrangement under FASB ASC Topic 606 Revenue from Contracts with Customers. However, as the period between our performing the service under the contract and when the client pays for the service is less than one year, we have elected, as a practical expedient, not to adjust the transaction price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In previous years, we created our Recovery Credits to assist in the economic recovery of our existing PEO clients and enhance our ability to retain these clients. These credits were based on the performance of our insurance costs and were recorded as a reduction to insurance services revenues and included in client deposits and other client liabilities on the balance sheets. The change in balance for the liability for credits previously accrued is the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.935%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(+) Accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(-) Distributions to clients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Accrued Health Insurance Costs &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sponsor and administer a number of employee benefit plans for our PEO WSEs, including group health, dental, and vision as an employer plan sponsor under section 3(5) of the ERISA. In the three months ended March&#160;31, 2024, the majority of our group health insurance costs were related to risk-based plans. Our remaining group health insurance costs were for guaranteed-cost policies. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued health insurance costs are established to provide for the estimated unpaid costs of reimbursing the carriers for paying claims within the deductible layer in accordance with risk-based health insurance policies. These accrued costs include estimates for claims incurred but not paid. We assess accrued health insurance costs regularly based upon actuarial studies that include other relevant factors such as current and historical claims payment patterns, plan enrollment and medical trend rates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In certain carrier contracts we are required to prepay our obligations for the expected claims activity for subsequent periods. These prepaid balances by agreement permit net settlement of obligations and offset the accrued health insurance costs. As of March&#160;31, 2024 and December&#160;31, 2023, prepayments and miscellaneous receivables offsetting accrued health insurance costs were $65 million and $58 million, respectively. When the prepaid amount is in excess of our recorded liability the net asset position is included in prepaid expenses. As of March&#160;31, 2024 and December&#160;31, 2023, accrued health insurance costs offsetting prepaid expenses were $71 million and $68 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Restricted Cash, Cash Equivalents and Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash, cash equivalents and investments presented on our consolidated balance sheets include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;cash and cash equivalents in Trust accounts functioning as security deposits for our insurance carriers, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;payroll funds collected representing cash collected in advance from clients which we designate as restricted for the purpose of funding WSE and HRIS User payroll and payroll taxes and other payroll related liabilities, and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;amounts held in Trust for current and future premium and claim obligations with our insurance carriers, which amounts are held in Trust according to the terms of the relevant insurance policies and by the local insurance regulations of the jurisdictions in which the policies are in force.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently issued accounting guidance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (&#x201c;ASU 2023-09&#x201d;), which will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. ASU 2023-09 will also require the Company to disaggregate its income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions. The ASU is effective for TriNet on a prospective basis for annual periods beginning after December 15, 2024. We are currently evaluating the provisions of this ASU.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (&#x201c;ASU 2023-07&#x201d;), which will require the Company to disclose segment expenses that are significant and regularly provided to the Company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;). In addition, ASU 2023-07 will require the Company to disclose the title and position of its CODM and how the CODM uses segment profit or loss information in assessing segment performance and deciding how to allocate resources. The ASU is effective for TriNet for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. We are currently evaluating the provisions of this ASU.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c-1" id="f-270">We operate in one reportable segment. All of our service revenues are generated from external clients. Less than 1% of our revenue is generated outside of the U.S.</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-271"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-30"
      decimals="INF"
      id="f-272"
      unitRef="number">0.01</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-273">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial reporting and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the Rules and Regulations of the Securities and Exchange Commission. The unaudited condensed consolidated financial statements include the accounts of the Company and an entity consolidated under the variable interest model. Intercompany balances and transactions have been eliminated. Certain information and note disclosures included in our annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, that are normal and recurring in nature, necessary for fair financial statement presentation. The results of operations for the three months ended March&#160;31, 2024 are not necessarily indicative of the operating results anticipated for the full year. These financial statements should be read in conjunction with the audited Consolidated Financial Statements included in Part II, Item 8. Financial Statements and Supplementary Data of our Annual Report on Form 10-K for the year ended December&#160;31, 2023. Certain prior year amounts have been reclassified to conform to current period presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When entering into contractual arrangements with other entities, we assess whether we have a variable interest. If we determine that we have a variable interest, we then determine whether the arrangement is with a variable interest entity ("VIE"). If the arrangement is with a VIE, we assess whether we are the primary beneficiary of the VIE by identifying the most significant activities and determining who has the power over those activities and who has the obligation to absorb the majority of the losses or benefits of the VIE. We consolidate a VIE when we have the power to direct activities that most significantly affect the economic performance of the VIE and have the obligation to absorb the majority of their losses or benefits, making us the primary beneficiary. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Periodically, we assess whether any changes in our interest or relationship with the entity affect our determination of whether the entity is a VIE and, if so, whether we are the primary beneficiary.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, we created a trust ("the Trust") for the purpose of holding HRIS clients' payroll funds for the remittance to HRIS Users, tax authorities and other recipients. The Trust's assets are restricted and can only be used for payments on behalf of HRIS clients, payments on behalf of the HRIS Users, repayments of any advances from TriNet, or payments to TriNet of interest income earned on the balances of the Trust. In the event of any &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;losses, creditors to the Trust have recourse to the Trust's property and not that of TriNet overall.  The risks associated with the Trust are similar to those that currently exist for the Company such as banking losses in excess of FDIC insurance levels, interest rate and market conditions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determined that this Trust meets the definition of a variable interest entity and as the primary beneficiary we have both the power to direct the Trust&#x2019;s activities that most significantly affect its performance and we have the right to receive benefits from the Trust, in the form of interest income. As a result, this Trust is consolidated into our financial statements.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2024, the Trust assumed ownership and responsibility of certain bank accounts that hold HRIS client funds and assumed the related liabilities.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the assets and liabilities of the Trust which are included in our consolidated balance sheet. These amounts on any particular date can vary due to timing of cash receipts and remittance to HRIS users and payroll tax agencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Restricted cash, cash equivalents and investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts payable and other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued wages&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payroll tax liabilities and other payroll withholdings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;98&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock contextRef="c-1" id="f-274">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the assets and liabilities of the Trust which are included in our consolidated balance sheet. These amounts on any particular date can vary due to timing of cash receipts and remittance to HRIS users and payroll tax agencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Restricted cash, cash equivalents and investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accounts payable and other current liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Accrued wages&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Payroll tax liabilities and other payroll withholdings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;98&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-31" decimals="-6" id="f-275" unitRef="usd">1000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-31" decimals="-6" id="f-276" unitRef="usd">113000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-31" decimals="-6" id="f-277" unitRef="usd">114000000</us-gaap:AssetsCurrent>
    <us-gaap:Assets contextRef="c-31" decimals="-6" id="f-278" unitRef="usd">114000000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-31" decimals="-6" id="f-279" unitRef="usd">1000000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="c-31" decimals="-6" id="f-280" unitRef="usd">15000000</us-gaap:AccruedSalariesCurrent>
    <tnet:AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings contextRef="c-31" decimals="-6" id="f-281" unitRef="usd">98000000</tnet:AccruedPayrollTaxLiabilitiesAndOtherPayrollWithholdings>
    <us-gaap:LiabilitiesCurrent contextRef="c-31" decimals="-6" id="f-282" unitRef="usd">114000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities contextRef="c-31" decimals="-6" id="f-283" unitRef="usd">114000000</us-gaap:Liabilities>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-284">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect certain reported amounts and related disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These estimates are based on historical experience and on various other assumptions that we believe to be reasonable from the facts available to us. Some of the assumptions are highly uncertain at the time of estimation. To the extent actual experience differs from the assumptions used, our condensed consolidated financial statements could be materially affected.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-285">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Variable Consideration and Pricing Allocation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we may offer credits to our clients considered to be variable consideration. Incentive credits related to contract renewals are recorded as a reduction to revenue as part of the transaction price at contract inception and are allocated among the performance obligations based on their relative standalone selling prices. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocate the total transaction price to each performance obligation based on the estimated relative standalone selling prices of the promised services underlying each performance obligation. The transaction price for the payroll and payroll tax processing performance obligations is determined upon establishment of the contract that contains the final terms of the arrangement, including the description and price of each service purchased. The estimated service fee is determined based on observable inputs and includes the following key assumptions: target profit margin, pricing strategies including the mix of services purchased and competitive factors, and client and industry specifics.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fees for access to health benefits and workers' compensation insurance performance obligations are determined during client on-boarding and annually through the enrollment processes based on the types of benefits coverage the WSEs have elected and the applicable risk profile of the client. We estimate our service fees based on actuarial forecasts of our expected insurance premiums and loss sensitive premium costs and amounts to cover our costs to administer these programs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We require our clients to prefund payroll and related taxes and other withholding liabilities before payroll is processed or due for payment. Under the provision of our contracts with clients, we generally will process the payment of a client&#x2019;s payroll only when the client successfully funds the amount required. As a result, there is no financing arrangement for the contracts. However, certain contracts to provide payroll and payroll tax processing services permit the client to pay certain payroll tax components ratably over periods of up to 12 months rather than as payroll tax is otherwise determined and due, which may be considered a significant financing arrangement under FASB ASC Topic 606 Revenue from Contracts with Customers. However, as the period between our performing the service under the contract and when the client pays for the service is less than one year, we have elected, as a practical expedient, not to adjust the transaction price.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock contextRef="c-1" id="f-286">The change in balance for the liability for credits previously accrued is the following:&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.935%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(+) Accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(-) Distributions to clients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-9" decimals="-6" id="f-287" unitRef="usd">7000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-10" decimals="-6" id="f-288" unitRef="usd">75000000</us-gaap:RevenueRemainingPerformanceObligation>
    <tnet:RevenueRemainingPerformanceObligationProvision contextRef="c-1" decimals="-6" id="f-289" unitRef="usd">0</tnet:RevenueRemainingPerformanceObligationProvision>
    <tnet:RevenueRemainingPerformanceObligationProvision contextRef="c-7" decimals="-6" id="f-290" unitRef="usd">0</tnet:RevenueRemainingPerformanceObligationProvision>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-1" decimals="-6" id="f-291" unitRef="usd">7000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-7" decimals="-6" id="f-292" unitRef="usd">8000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-8" decimals="-6" id="f-293" unitRef="usd">0</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation contextRef="c-29" decimals="-6" id="f-294" unitRef="usd">67000000</us-gaap:RevenueRemainingPerformanceObligation>
    <tnet:AccruedHealthInsuranceCostsPolicyTextBlock contextRef="c-1" id="f-295">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sponsor and administer a number of employee benefit plans for our PEO WSEs, including group health, dental, and vision as an employer plan sponsor under section 3(5) of the ERISA. In the three months ended March&#160;31, 2024, the majority of our group health insurance costs were related to risk-based plans. Our remaining group health insurance costs were for guaranteed-cost policies. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued health insurance costs are established to provide for the estimated unpaid costs of reimbursing the carriers for paying claims within the deductible layer in accordance with risk-based health insurance policies. These accrued costs include estimates for claims incurred but not paid. We assess accrued health insurance costs regularly based upon actuarial studies that include other relevant factors such as current and historical claims payment patterns, plan enrollment and medical trend rates. &lt;/span&gt;&lt;/div&gt;In certain carrier contracts we are required to prepay our obligations for the expected claims activity for subsequent periods. These prepaid balances by agreement permit net settlement of obligations and offset the accrued health insurance costs.</tnet:AccruedHealthInsuranceCostsPolicyTextBlock>
    <us-gaap:PrepaidInsurance contextRef="c-8" decimals="-6" id="f-296" unitRef="usd">65000000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance contextRef="c-9" decimals="-6" id="f-297" unitRef="usd">58000000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance contextRef="c-32" decimals="-6" id="f-298" unitRef="usd">71000000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance contextRef="c-33" decimals="-6" id="f-299" unitRef="usd">68000000</us-gaap:PrepaidInsurance>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="c-1" id="f-300">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash, cash equivalents and investments presented on our consolidated balance sheets include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;cash and cash equivalents in Trust accounts functioning as security deposits for our insurance carriers, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;payroll funds collected representing cash collected in advance from clients which we designate as restricted for the purpose of funding WSE and HRIS User payroll and payroll taxes and other payroll related liabilities, and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;amounts held in Trust for current and future premium and claim obligations with our insurance carriers, which amounts are held in Trust according to the terms of the relevant insurance policies and by the local insurance regulations of the jurisdictions in which the policies are in force.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-301">&lt;div style="margin-bottom:9pt;margin-top:9pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently issued accounting guidance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (&#x201c;ASU 2023-09&#x201d;), which will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. ASU 2023-09 will also require the Company to disaggregate its income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions. The ASU is effective for TriNet on a prospective basis for annual periods beginning after December 15, 2024. We are currently evaluating the provisions of this ASU.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (&#x201c;ASU 2023-07&#x201d;), which will require the Company to disclose segment expenses that are significant and regularly provided to the Company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;). In addition, ASU 2023-07 will require the Company to disclose the title and position of its CODM and how the CODM uses segment profit or loss information in assessing segment performance and deciding how to allocate resources. The ASU is effective for TriNet for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. We are currently evaluating the provisions of this ASU.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <tnet:CashCashEquivalentsAndInvestmentsTextBlock contextRef="c-1" id="f-302">CASH, CASH EQUIVALENTS AND INVESTMENTS - UNRESTRICTED AND RESTRICTED&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the agreements with certain of our workers' compensation and health benefit insurance carriers, we are required to maintain collateral in Trust accounts for the benefit of specified insurance carriers and to reimburse the carriers&#x2019; claim payments within our deductible layer. We invest a portion of the collateral amounts in marketable securities. We report the current and noncurrent portions of these Trust accounts as restricted cash, cash equivalents and investments on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We require our clients to prefund their payroll and related taxes and other withholding liabilities before payroll is processed or due for payment. This prefund, for PEO customers, as well as amounts held by our statutory Trust for our HRIS Users, is included in restricted cash, cash equivalents and investments as payroll funds collected, which is designated to pay pending payrolls, payroll tax liabilities and other payroll withholdings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also invest available corporate funds, primarily in fixed income securities which meet the requirements of our corporate investment policy and are classified as AFS.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total cash, cash equivalents and investments are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.940%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.091%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Available-for-sale marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Available-for-sale marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;298&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;298&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;85&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;85&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash, cash equivalents and investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payroll funds collected&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;743&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;743&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Collateral for health benefits claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;146&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Collateral for workers' compensation claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trust for our HRIS Users&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other security deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total restricted cash, cash equivalents and investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;945&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,059&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments, noncurrent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;161&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;161&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash, cash equivalents and investments, noncurrent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Collateral for workers' compensation claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;128&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;152&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;488&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,755&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</tnet:CashCashEquivalentsAndInvestmentsTextBlock>
    <us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock contextRef="c-1" id="f-303">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total cash, cash equivalents and investments are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.940%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.091%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Available-for-sale marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Available-for-sale marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;298&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;298&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;85&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;85&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash, cash equivalents and investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payroll funds collected&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;743&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;743&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Collateral for health benefits claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;146&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Collateral for workers' compensation claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Trust for our HRIS Users&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other security deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total restricted cash, cash equivalents and investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;945&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,059&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Investments, noncurrent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;161&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;161&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash, cash equivalents and investments, noncurrent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Collateral for workers' compensation claims&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;128&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;152&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;488&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,755&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-34" decimals="-6" id="f-304" unitRef="usd">298000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-35" decimals="-6" id="f-305" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-8" decimals="-6" id="f-306" unitRef="usd">298000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-36" decimals="-6" id="f-307" unitRef="usd">287000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-37" decimals="-6" id="f-308" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-9" decimals="-6" id="f-309" unitRef="usd">287000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments contextRef="c-34" decimals="-6" id="f-310" unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-35" decimals="-6" id="f-311" unitRef="usd">85000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-8" decimals="-6" id="f-312" unitRef="usd">85000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-36" decimals="-6" id="f-313" unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-37" decimals="-6" id="f-314" unitRef="usd">65000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-9" decimals="-6" id="f-315" unitRef="usd">65000000</us-gaap:ShortTermInvestments>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-38" decimals="-6" id="f-316" unitRef="usd">743000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-39" decimals="-6" id="f-317" unitRef="usd">0</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-40" decimals="-6" id="f-318" unitRef="usd">743000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-41" decimals="-6" id="f-319" unitRef="usd">1067000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-42" decimals="-6" id="f-320" unitRef="usd">0</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-43" decimals="-6" id="f-321" unitRef="usd">1067000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-44" decimals="-6" id="f-322" unitRef="usd">32000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-45" decimals="-6" id="f-323" unitRef="usd">114000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-46" decimals="-6" id="f-324" unitRef="usd">146000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-47" decimals="-6" id="f-325" unitRef="usd">31000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-48" decimals="-6" id="f-326" unitRef="usd">113000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-49" decimals="-6" id="f-327" unitRef="usd">144000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-50" decimals="-6" id="f-328" unitRef="usd">55000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-51" decimals="-6" id="f-329" unitRef="usd">0</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-52" decimals="-6" id="f-330" unitRef="usd">55000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-53" decimals="-6" id="f-331" unitRef="usd">54000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-54" decimals="-6" id="f-332" unitRef="usd">2000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-55" decimals="-6" id="f-333" unitRef="usd">56000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-56" decimals="-6" id="f-334" unitRef="usd">113000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-57" decimals="-6" id="f-335" unitRef="usd">0</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-58" decimals="-6" id="f-336" unitRef="usd">113000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-59" decimals="-6" id="f-337" unitRef="usd">0</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-60" decimals="-6" id="f-338" unitRef="usd">0</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-61" decimals="-6" id="f-339" unitRef="usd">0</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-62" decimals="-6" id="f-340" unitRef="usd">2000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-63" decimals="-6" id="f-341" unitRef="usd">0</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-64" decimals="-6" id="f-342" unitRef="usd">2000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-65" decimals="-6" id="f-343" unitRef="usd">2000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-66" decimals="-6" id="f-344" unitRef="usd">0</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-67" decimals="-6" id="f-345" unitRef="usd">2000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-34" decimals="-6" id="f-346" unitRef="usd">945000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-35" decimals="-6" id="f-347" unitRef="usd">114000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-8" decimals="-6" id="f-348" unitRef="usd">1059000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-36" decimals="-6" id="f-349" unitRef="usd">1154000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-37" decimals="-6" id="f-350" unitRef="usd">115000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:RestrictedCashAndInvestmentsCurrent contextRef="c-9" decimals="-6" id="f-351" unitRef="usd">1269000000</us-gaap:RestrictedCashAndInvestmentsCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent contextRef="c-34" decimals="-6" id="f-352" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent contextRef="c-35" decimals="-6" id="f-353" unitRef="usd">161000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent contextRef="c-8" decimals="-6" id="f-354" unitRef="usd">161000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent contextRef="c-36" decimals="-6" id="f-355" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent contextRef="c-37" decimals="-6" id="f-356" unitRef="usd">143000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent contextRef="c-9" decimals="-6" id="f-357" unitRef="usd">143000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="c-50" decimals="-6" id="f-358" unitRef="usd">24000000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="c-51" decimals="-6" id="f-359" unitRef="usd">128000000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="c-52" decimals="-6" id="f-360" unitRef="usd">152000000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="c-53" decimals="-6" id="f-361" unitRef="usd">25000000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="c-54" decimals="-6" id="f-362" unitRef="usd">133000000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestmentsNoncurrent contextRef="c-55" decimals="-6" id="f-363" unitRef="usd">158000000</us-gaap:RestrictedCashAndInvestmentsNoncurrent>
    <us-gaap:RestrictedCashAndInvestments contextRef="c-34" decimals="-6" id="f-364" unitRef="usd">1267000000</us-gaap:RestrictedCashAndInvestments>
    <us-gaap:RestrictedCashAndInvestments contextRef="c-35" decimals="-6" id="f-365" unitRef="usd">488000000</us-gaap:RestrictedCashAndInvestments>
    <us-gaap:RestrictedCashAndInvestments contextRef="c-8" decimals="-6" id="f-366" unitRef="usd">1755000000</us-gaap:RestrictedCashAndInvestments>
    <us-gaap:RestrictedCashAndInvestments contextRef="c-36" decimals="-6" id="f-367" unitRef="usd">1466000000</us-gaap:RestrictedCashAndInvestments>
    <us-gaap:RestrictedCashAndInvestments contextRef="c-37" decimals="-6" id="f-368" unitRef="usd">456000000</us-gaap:RestrictedCashAndInvestments>
    <us-gaap:RestrictedCashAndInvestments contextRef="c-9" decimals="-6" id="f-369" unitRef="usd">1922000000</us-gaap:RestrictedCashAndInvestments>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="c-1" id="f-370">INVESTMENTS&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize our financial instruments by significant categories and fair value measurement on a recurring basis as of March&#160;31, 2024 and December&#160;31, 2023 and the amortized cost, gross unrealized gains, gross unrealized losses, fair value of our AFS investments: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.332%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.356%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Cash, Cash Equivalents and Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;327&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;327&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;331&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;331&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;290&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AFS Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;148&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;148&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;115&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;37&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;28&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;260&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;256&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;77&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;179&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Certificate of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total AFS Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;493&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;488&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;242&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.715%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.342%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.295%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.856%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.173%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.173%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.470%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Cash, Cash Equivalents and Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;190&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AFS Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Certificate of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total AFS Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use an independent pricing source to determine the fair value of our securities. The independent pricing source utilizes various pricing models for each asset class, including the market approach. The inputs and assumptions for the pricing models are market observable inputs including trades of comparable securities, dealer quotes, credit spreads, yield curves and other market-related data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have not adjusted the prices obtained from the independent pricing service and we believe the prices received from the independent pricing service are representative of the prices that would be received to sell the assets at the measurement date (exit price).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of the Company's cash equivalents and restricted cash equivalents approximate their fair values due to their short-term maturities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We did not have any Level 3 financial instruments recognized in our condensed consolidated balance sheets as of March&#160;31, 2024 and December&#160;31, 2023. There were no transfers between levels as of March&#160;31, 2024 and December&#160;31, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Sales and Maturities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of debt investments by contractual maturity are shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.171%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.377%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.330%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.522%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;One year or less&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Over one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;347&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Over five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Over ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;488&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross proceeds from sales and maturities of AFS securities for the three months ended March&#160;31, 2024 and March&#160;31, 2023 are presented below. We had immaterial gross realized gains and losses from sales of investments for the first quarter of 2024 and immaterial gross realized gains for the first quarter of 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.707%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;39&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross proceeds from maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;66&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Fair Value of Long-Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our 2029 Notes and 2031 Notes was obtained from a third-party pricing service and is based on observable market inputs. As such, the fair value of the senior notes is considered Level 2 in the hierarchy for fair value measurement. As of March&#160;31, 2024, our 2029 Notes and 2031 Notes were carried at their cost, net of issuance costs, and had a fair value of $449 million and $411 million, respectively. As of December&#160;31, 2023, our 2029 Notes and 2031 Notes were carried at their cost, net of issuance costs, and had a fair value of $443 million and $414 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our 2021 Revolver is a floating rate debt. At March&#160;31, 2024 and December&#160;31, 2023, the fair value of our 2021 Revolver approximated its carrying value (exclusive of issuance costs). The fair value of our floating rate debt is estimated based on a discounted cash flow, which incorporates credit spreads, market interest rates and contractual maturities to estimate the fair value and is considered Level 3 in the hierarchy for fair value measurement.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="c-1" id="f-371">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize our financial instruments by significant categories and fair value measurement on a recurring basis as of March&#160;31, 2024 and December&#160;31, 2023 and the amortized cost, gross unrealized gains, gross unrealized losses, fair value of our AFS investments: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.332%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.356%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Cash, Cash Equivalents and Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;327&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;327&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;331&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;331&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;290&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AFS Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;148&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;148&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;115&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;37&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;36&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;28&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;260&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;256&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;77&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;179&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Certificate of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total AFS Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;493&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;488&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;242&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.715%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.342%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.709%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.295%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.856%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.173%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.173%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.470%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Cash, Cash Equivalents and Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Money market mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;190&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;AFS Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;U.S. treasuries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Certificate of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total AFS Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-68" decimals="-6" id="f-372" unitRef="usd">327000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-68" decimals="-6" id="f-373" unitRef="usd">327000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-69" decimals="-6" id="f-374" unitRef="usd">40000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-70" decimals="-6" id="f-375" unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-71" decimals="-6" id="f-376" unitRef="usd">287000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-72" decimals="-6" id="f-377" unitRef="usd">4000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-72" decimals="-6" id="f-378" unitRef="usd">4000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-73" decimals="-6" id="f-379" unitRef="usd">1000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-74" decimals="-6" id="f-380" unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-75" decimals="-6" id="f-381" unitRef="usd">3000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-76" decimals="-6" id="f-382" unitRef="usd">331000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-76" decimals="-6" id="f-383" unitRef="usd">331000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-77" decimals="-6" id="f-384" unitRef="usd">41000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-78" decimals="-6" id="f-385" unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-79" decimals="-6" id="f-386" unitRef="usd">290000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-80" decimals="-6" id="f-387" unitRef="usd">38000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-80" decimals="-6" id="f-388" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-80" decimals="-6" id="f-389" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-80" decimals="-6" id="f-390" unitRef="usd">38000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-81" decimals="-6" id="f-391" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-82" decimals="-6" id="f-392" unitRef="usd">38000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-83" decimals="-6" id="f-393" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-84" decimals="-6" id="f-394" unitRef="usd">148000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-84" decimals="-6" id="f-395" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-84" decimals="-6" id="f-396" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-84" decimals="-6" id="f-397" unitRef="usd">148000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-85" decimals="-6" id="f-398" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-86" decimals="-6" id="f-399" unitRef="usd">115000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-87" decimals="-6" id="f-400" unitRef="usd">33000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-88" decimals="-6" id="f-401" unitRef="usd">37000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-88" decimals="-6" id="f-402" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-88" decimals="-6" id="f-403" unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-88" decimals="-6" id="f-404" unitRef="usd">36000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-89" decimals="-6" id="f-405" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-90" decimals="-6" id="f-406" unitRef="usd">8000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-91" decimals="-6" id="f-407" unitRef="usd">28000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-92" decimals="-6" id="f-408" unitRef="usd">260000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-92" decimals="-6" id="f-409" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-92" decimals="-6" id="f-410" unitRef="usd">4000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-92" decimals="-6" id="f-411" unitRef="usd">256000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-93" decimals="-6" id="f-412" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-94" decimals="-6" id="f-413" unitRef="usd">77000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-95" decimals="-6" id="f-414" unitRef="usd">179000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-96" decimals="-6" id="f-415" unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-96" decimals="-6" id="f-416" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-96" decimals="-6" id="f-417" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-96" decimals="-6" id="f-418" unitRef="usd">2000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-97" decimals="-6" id="f-419" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-98" decimals="-6" id="f-420" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-99" decimals="-6" id="f-421" unitRef="usd">2000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-100" decimals="-6" id="f-422" unitRef="usd">8000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-100" decimals="-6" id="f-423" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-100" decimals="-6" id="f-424" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-100" decimals="-6" id="f-425" unitRef="usd">8000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-101" decimals="-6" id="f-426" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-102" decimals="-6" id="f-427" unitRef="usd">8000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-103" decimals="-6" id="f-428" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-76" decimals="-6" id="f-429" unitRef="usd">493000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-76" decimals="-6" id="f-430" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-76" decimals="-6" id="f-431" unitRef="usd">5000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-76" decimals="-6" id="f-432" unitRef="usd">488000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-77" decimals="-6" id="f-433" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-78" decimals="-6" id="f-434" unitRef="usd">246000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-79" decimals="-6" id="f-435" unitRef="usd">242000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-104" decimals="-6" id="f-436" unitRef="usd">183000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-104" decimals="-6" id="f-437" unitRef="usd">183000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-105" decimals="-6" id="f-438" unitRef="usd">96000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-106" decimals="-6" id="f-439" unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-107" decimals="-6" id="f-440" unitRef="usd">87000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-108" decimals="-6" id="f-441" unitRef="usd">7000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-108" decimals="-6" id="f-442" unitRef="usd">7000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-109" decimals="-6" id="f-443" unitRef="usd">5000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-110" decimals="-6" id="f-444" unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-111" decimals="-6" id="f-445" unitRef="usd">2000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-112" decimals="-6" id="f-446" unitRef="usd">190000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-112" decimals="-6" id="f-447" unitRef="usd">190000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-113" decimals="-6" id="f-448" unitRef="usd">101000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-114" decimals="-6" id="f-449" unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-115" decimals="-6" id="f-450" unitRef="usd">89000000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-116" decimals="-6" id="f-451" unitRef="usd">41000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-116" decimals="-6" id="f-452" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-116" decimals="-6" id="f-453" unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-116" decimals="-6" id="f-454" unitRef="usd">40000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-117" decimals="-6" id="f-455" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-118" decimals="-6" id="f-456" unitRef="usd">40000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-119" decimals="-6" id="f-457" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-120" decimals="-6" id="f-458" unitRef="usd">135000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-120" decimals="-6" id="f-459" unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-120" decimals="-6" id="f-460" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-120" decimals="-6" id="f-461" unitRef="usd">136000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-121" decimals="-6" id="f-462" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-122" decimals="-6" id="f-463" unitRef="usd">103000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-123" decimals="-6" id="f-464" unitRef="usd">33000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-124" decimals="-6" id="f-465" unitRef="usd">40000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-124" decimals="-6" id="f-466" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-124" decimals="-6" id="f-467" unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-124" decimals="-6" id="f-468" unitRef="usd">39000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-125" decimals="-6" id="f-469" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-126" decimals="-6" id="f-470" unitRef="usd">10000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-127" decimals="-6" id="f-471" unitRef="usd">29000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-128" decimals="-6" id="f-472" unitRef="usd">231000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-128" decimals="-6" id="f-473" unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-128" decimals="-6" id="f-474" unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-128" decimals="-6" id="f-475" unitRef="usd">231000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-129" decimals="-6" id="f-476" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-130" decimals="-6" id="f-477" unitRef="usd">47000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-131" decimals="-6" id="f-478" unitRef="usd">184000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-132" decimals="-6" id="f-479" unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-132" decimals="-6" id="f-480" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-132" decimals="-6" id="f-481" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-132" decimals="-6" id="f-482" unitRef="usd">2000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-133" decimals="-6" id="f-483" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-134" decimals="-6" id="f-484" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-135" decimals="-6" id="f-485" unitRef="usd">2000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-136" decimals="-6" id="f-486" unitRef="usd">8000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-136" decimals="-6" id="f-487" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-136" decimals="-6" id="f-488" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-136" decimals="-6" id="f-489" unitRef="usd">8000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-137" decimals="-6" id="f-490" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-138" decimals="-6" id="f-491" unitRef="usd">8000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-139" decimals="-6" id="f-492" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-112" decimals="-6" id="f-493" unitRef="usd">457000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-112" decimals="-6" id="f-494" unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-112" decimals="-6" id="f-495" unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-112" decimals="-6" id="f-496" unitRef="usd">456000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-113" decimals="-6" id="f-497" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-114" decimals="-6" id="f-498" unitRef="usd">208000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-115" decimals="-6" id="f-499" unitRef="usd">248000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c-1" id="f-500">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use an independent pricing source to determine the fair value of our securities. The independent pricing source utilizes various pricing models for each asset class, including the market approach. The inputs and assumptions for the pricing models are market observable inputs including trades of comparable securities, dealer quotes, credit spreads, yield curves and other market-related data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have not adjusted the prices obtained from the independent pricing service and we believe the prices received from the independent pricing service are representative of the prices that would be received to sell the assets at the measurement date (exit price).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of the Company's cash equivalents and restricted cash equivalents approximate their fair values due to their short-term maturities.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock contextRef="c-1" id="f-501">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of debt investments by contractual maturity are shown below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.171%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.377%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.330%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.522%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;One year or less&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Over one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;347&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Over five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Over ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;488&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue contextRef="c-8" decimals="-6" id="f-502" unitRef="usd">113000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue contextRef="c-8" decimals="-6" id="f-503" unitRef="usd">347000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue contextRef="c-8" decimals="-6" id="f-504" unitRef="usd">10000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue contextRef="c-8" decimals="-6" id="f-505" unitRef="usd">18000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate contextRef="c-8" decimals="-6" id="f-506" unitRef="usd">488000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock contextRef="c-1" id="f-507">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gross proceeds from sales and maturities of AFS securities for the three months ended March&#160;31, 2024 and March&#160;31, 2023 are presented below. We had immaterial gross realized gains and losses from sales of investments for the first quarter of 2024 and immaterial gross realized gains for the first quarter of 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.707%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross proceeds from sales&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;39&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Gross proceeds from maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;66&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss contextRef="c-1" decimals="-6" id="f-508" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss contextRef="c-7" decimals="-6" id="f-509" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt contextRef="c-1" decimals="-6" id="f-510" unitRef="usd">39000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt contextRef="c-7" decimals="-6" id="f-511" unitRef="usd">32000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities contextRef="c-1" decimals="-6" id="f-512" unitRef="usd">27000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities contextRef="c-7" decimals="-6" id="f-513" unitRef="usd">44000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="c-1" decimals="-6" id="f-514" unitRef="usd">66000000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="c-7" decimals="-6" id="f-515" unitRef="usd">76000000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:NotesPayableFairValueDisclosure contextRef="c-140" decimals="-6" id="f-516" unitRef="usd">449000000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:NotesPayableFairValueDisclosure contextRef="c-141" decimals="-6" id="f-517" unitRef="usd">411000000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:NotesPayableFairValueDisclosure contextRef="c-142" decimals="-6" id="f-518" unitRef="usd">443000000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:NotesPayableFairValueDisclosure contextRef="c-143" decimals="-6" id="f-519" unitRef="usd">414000000</us-gaap:NotesPayableFairValueDisclosure>
    <us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock contextRef="c-1" id="f-520">ACCRUED WORKERS' COMPENSATION COSTS&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the accrued workers&#x2019; compensation cost activity for the three months ended March&#160;31, 2024 and 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total accrued costs, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;175&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total accrued costs, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;175&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes workers' compensation liabilities on the condensed consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.473%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.613%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.614%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total accrued costs, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;175&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Collateral paid to carriers and offset against accrued costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total accrued costs, net of carrier collateral offset&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;171&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payable in less than 1 year&lt;br/&gt;(net of collateral paid to carriers of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; and $1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;at March&#160;31, 2024 and December&#160;31, 2023, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payable in more than 1 year &lt;br/&gt;(net of collateral paid to carriers of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; and  $4 at March&#160;31, 2024 and December&#160;31, 2023, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;120&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total accrued costs, net of carrier collateral offset&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;171&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Incurred claims related to prior years represent changes in estimates for ultimate losses on workers' compensation claims. For the three months ended March&#160;31, 2024, the favorable development is due to lower than expected reported claim frequency and severity for the more recent years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2024 and December&#160;31, 2023, we had $31 million and $32&#160;million of collateral held by insurance carriers of which $4 million and $5 million, respectively, was offset against accrued workers' compensation costs as the agreements permit and are net settled of insurance obligations against collateral held.&lt;/span&gt;&lt;/div&gt;</us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense contextRef="c-1" id="f-521">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the accrued workers&#x2019; compensation cost activity for the three months ended March&#160;31, 2024 and 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total accrued costs, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;175&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total accrued costs, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;175&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes workers' compensation liabilities on the condensed consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.473%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.613%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.614%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total accrued costs, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;175&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Collateral paid to carriers and offset against accrued costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total accrued costs, net of carrier collateral offset&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;171&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payable in less than 1 year&lt;br/&gt;(net of collateral paid to carriers of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; and $1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;at March&#160;31, 2024 and December&#160;31, 2023, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payable in more than 1 year &lt;br/&gt;(net of collateral paid to carriers of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; and  $4 at March&#160;31, 2024 and December&#160;31, 2023, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;120&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total accrued costs, net of carrier collateral offset&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;171&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments contextRef="c-9" decimals="-6" id="f-522" unitRef="usd">175000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments contextRef="c-10" decimals="-6" id="f-523" unitRef="usd">189000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense contextRef="c-1" decimals="-6" id="f-524" unitRef="usd">16000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense contextRef="c-7" decimals="-6" id="f-525" unitRef="usd">16000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense contextRef="c-1" decimals="-6" id="f-526" unitRef="usd">-4000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense contextRef="c-7" decimals="-6" id="f-527" unitRef="usd">-6000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1 contextRef="c-1" decimals="-6" id="f-528" unitRef="usd">12000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1 contextRef="c-7" decimals="-6" id="f-529" unitRef="usd">10000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1 contextRef="c-1" decimals="-6" id="f-530" unitRef="usd">1000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1 contextRef="c-7" decimals="-6" id="f-531" unitRef="usd">1000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1 contextRef="c-1" decimals="-6" id="f-532" unitRef="usd">11000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1 contextRef="c-7" decimals="-6" id="f-533" unitRef="usd">11000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense contextRef="c-1" decimals="-6" id="f-534" unitRef="usd">12000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense contextRef="c-7" decimals="-6" id="f-535" unitRef="usd">12000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments contextRef="c-8" decimals="-6" id="f-536" unitRef="usd">175000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments contextRef="c-29" decimals="-6" id="f-537" unitRef="usd">187000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments contextRef="c-8" decimals="-6" id="f-538" unitRef="usd">175000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments contextRef="c-9" decimals="-6" id="f-539" unitRef="usd">175000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments>
    <tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral contextRef="c-8" decimals="-6" id="f-540" unitRef="usd">4000000</tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral>
    <tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral contextRef="c-9" decimals="-6" id="f-541" unitRef="usd">5000000</tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral>
    <us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent contextRef="c-8" decimals="-6" id="f-542" unitRef="usd">171000000</us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent>
    <us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent contextRef="c-9" decimals="-6" id="f-543" unitRef="usd">170000000</us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent>
    <tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent contextRef="c-8" decimals="-6" id="f-544" unitRef="usd">1000000</tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent>
    <tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent contextRef="c-9" decimals="-6" id="f-545" unitRef="usd">1000000</tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesCurrent>
    <us-gaap:WorkersCompensationLiabilityCurrent contextRef="c-8" decimals="-6" id="f-546" unitRef="usd">51000000</us-gaap:WorkersCompensationLiabilityCurrent>
    <us-gaap:WorkersCompensationLiabilityCurrent contextRef="c-9" decimals="-6" id="f-547" unitRef="usd">50000000</us-gaap:WorkersCompensationLiabilityCurrent>
    <tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent contextRef="c-8" decimals="-6" id="f-548" unitRef="usd">3000000</tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent>
    <tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent contextRef="c-9" decimals="-6" id="f-549" unitRef="usd">4000000</tnet:CollateralPaidToInsuranceCarriersNetOfWorkersCompensationLossReservesNoncurrent>
    <us-gaap:WorkersCompensationLiabilityNoncurrent contextRef="c-8" decimals="-6" id="f-550" unitRef="usd">120000000</us-gaap:WorkersCompensationLiabilityNoncurrent>
    <us-gaap:WorkersCompensationLiabilityNoncurrent contextRef="c-9" decimals="-6" id="f-551" unitRef="usd">120000000</us-gaap:WorkersCompensationLiabilityNoncurrent>
    <us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent contextRef="c-8" decimals="-6" id="f-552" unitRef="usd">171000000</us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent>
    <us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent contextRef="c-9" decimals="-6" id="f-553" unitRef="usd">170000000</us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent>
    <tnet:CollateralHeldByInsuranceCarriers contextRef="c-8" decimals="-6" id="f-554" unitRef="usd">31000000</tnet:CollateralHeldByInsuranceCarriers>
    <tnet:CollateralHeldByInsuranceCarriers contextRef="c-9" decimals="-6" id="f-555" unitRef="usd">32000000</tnet:CollateralHeldByInsuranceCarriers>
    <tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral contextRef="c-8" decimals="-6" id="f-556" unitRef="usd">4000000</tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral>
    <tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral contextRef="c-9" decimals="-6" id="f-557" unitRef="usd">5000000</tnet:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCollateral>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-558">COMMITMENTS AND CONTINGENCIES&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Contingencies &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We are and, from time to time, have been and may in the future become involved in various litigation matters, legal proceedings, and claims arising in the ordinary course of our business, including disputes with our clients or various class action, collective action, representative action, and other proceedings arising from the nature of our co-employment relationship with our clients and WSEs in which we are named as a defendant. In addition, due to the nature of our co-employment relationship with our clients and WSEs, we could be subject to liability for federal and state law violations, even if we do not participate in such violations. While our agreements with our clients contain indemnification provisions related to the conduct of our clients, we may not be able to avail ourselves of such provisions in every instance. We have accrued our current best estimates of probable losses with respect to these matters, which are individually and in aggregate immaterial to our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the outcome of the matters described above cannot be predicted with certainty, management currently does not believe that any such claims or proceedings will have a materially adverse effect on our consolidated financial position, results of operations, or cash flows. However, the unfavorable resolution of any particular matter or our reassessment of our exposure for any of the above matters based on additional information obtained in the future could have a material impact on our consolidated financial position, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-559">STOCK BASED COMPENSATION&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Restricted Stock Units (RSUs)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Time-based RSUs generally vest over a four-year term. Performance-based RSUs are subject to vesting requirements and are earned, in part, based on certain financial performance metrics as defined in the grant notice. Actual number of shares earned may range from 0% to 200% of the target award. Performance-based awards granted in 2024 and 2023 are earned based on a single-year performance period subject to subsequent multi-year time-based vesting with 50% of the shares earned vesting in one year after the performance period and the remaining shares in the year after. RSUs are generally forfeited if the participant terminates service prior to vesting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize RSU activity for the three months ended March&#160;31, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Time-based RSUs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.174%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.030%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total Number&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;of Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Grant Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nonvested at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,229,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;488,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(155,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,289)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nonvested at March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,544,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Performance-based RSUs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.128%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.516%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.056%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Grant Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nonvested at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;223,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nonvested at March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;344,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Stock Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock based compensation expense for stock-based awards made to our employees pursuant to our equity plans were as follows:&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.309%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.696%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of providing services&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Systems development and programming costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total stock based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total stock based compensation capitalized&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-144" id="f-560">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent contextRef="c-145" decimals="2" id="f-561" unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent contextRef="c-146" decimals="2" id="f-562" unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-147" decimals="2" id="f-563" unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-147" id="f-564">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock contextRef="c-1" id="f-565">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize RSU activity for the three months ended March&#160;31, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Time-based RSUs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.174%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.030%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total Number&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;of Shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Grant Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nonvested at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,229,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;80.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;488,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(155,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,289)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;83.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nonvested at March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,544,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Performance-based RSUs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.128%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.516%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.056%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Grant Date&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nonvested at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;223,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;125.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;77.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nonvested at March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;344,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-148"
      decimals="INF"
      id="f-566"
      unitRef="shares">1229202</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-148"
      decimals="2"
      id="f-567"
      unitRef="usdPerShare">80.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-144"
      decimals="INF"
      id="f-568"
      unitRef="shares">488872</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-144"
      decimals="2"
      id="f-569"
      unitRef="usdPerShare">125.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-144"
      decimals="INF"
      id="f-570"
      unitRef="shares">155051</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-144"
      decimals="2"
      id="f-571"
      unitRef="usdPerShare">76.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-144"
      decimals="INF"
      id="f-572"
      unitRef="shares">18289</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-144"
      decimals="2"
      id="f-573"
      unitRef="usdPerShare">83.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-149"
      decimals="INF"
      id="f-574"
      unitRef="shares">1544734</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-149"
      decimals="2"
      id="f-575"
      unitRef="usdPerShare">95.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-150"
      decimals="INF"
      id="f-576"
      unitRef="shares">223011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-150"
      decimals="2"
      id="f-577"
      unitRef="usdPerShare">81.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-151"
      decimals="INF"
      id="f-578"
      unitRef="shares">129631</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-151"
      decimals="2"
      id="f-579"
      unitRef="usdPerShare">125.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-151"
      decimals="INF"
      id="f-580"
      unitRef="shares">5067</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-151"
      decimals="2"
      id="f-581"
      unitRef="usdPerShare">92.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-151"
      decimals="INF"
      id="f-582"
      unitRef="shares">2598</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-151"
      decimals="2"
      id="f-583"
      unitRef="usdPerShare">77.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-152"
      decimals="INF"
      id="f-584"
      unitRef="shares">344977</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-152"
      decimals="2"
      id="f-585"
      unitRef="usdPerShare">97.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-586">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock based compensation expense for stock-based awards made to our employees pursuant to our equity plans were as follows:&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.309%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.696%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cost of providing services&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Systems development and programming costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total stock based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total stock based compensation capitalized&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-153" decimals="-6" id="f-587" unitRef="usd">4000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-154" decimals="-6" id="f-588" unitRef="usd">3000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-155" decimals="-6" id="f-589" unitRef="usd">3000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-156" decimals="-6" id="f-590" unitRef="usd">2000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-157" decimals="-6" id="f-591" unitRef="usd">12000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-158" decimals="-6" id="f-592" unitRef="usd">5000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-159" decimals="-6" id="f-593" unitRef="usd">1000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-160" decimals="-6" id="f-594" unitRef="usd">1000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-6" id="f-595" unitRef="usd">20000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-7" decimals="-6" id="f-596" unitRef="usd">11000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount contextRef="c-1" decimals="-6" id="f-597" unitRef="usd">1000000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount contextRef="c-7" decimals="-6" id="f-598" unitRef="usd">1000000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-600">STOCKHOLDERS&#x2019; EQUITY&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the beginning and ending balances of our issued and outstanding common stock for the three months ended March&#160;31, 2024 and 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.597%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares issued and outstanding, beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;50,664,471&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,555,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Issuance of common stock from vested restricted stock units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;160,118&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Issuance of common stock from exercise of stock options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;5,708&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repurchase of common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(197,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,157,871)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Awards effectively repurchased for required employee withholding taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(59,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(49,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares issued and outstanding, ending balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;50,573,176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,522,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Stock Repurchases &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2024, there is $409 million remaining in the total authorization of $2,715&#160;million of our ongoing stock repurchase program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In February 2024, our board of directors authorized a dividend of $0.25 per share for an aggregate amount of approximately $13&#160;million paid in April 2024.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock contextRef="c-1" id="f-601">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the beginning and ending balances of our issued and outstanding common stock for the three months ended March&#160;31, 2024 and 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.597%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares issued and outstanding, beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;50,664,471&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60,555,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Issuance of common stock from vested restricted stock units&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;160,118&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Issuance of common stock from exercise of stock options&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;5,708&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Repurchase of common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(197,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,157,871)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Awards effectively repurchased for required employee withholding taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(59,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(49,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares issued and outstanding, ending balance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;50,573,176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;59,522,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock>
    <us-gaap:CommonStockSharesIssued contextRef="c-9" decimals="INF" id="f-602" unitRef="shares">50664471</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-9" decimals="INF" id="f-603" unitRef="shares">50664471</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-10"
      decimals="INF"
      id="f-604"
      unitRef="shares">60555661</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-10"
      decimals="INF"
      id="f-605"
      unitRef="shares">60555661</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-162"
      decimals="INF"
      id="f-606"
      unitRef="shares">160118</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-163"
      decimals="INF"
      id="f-607"
      unitRef="shares">135074</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-164"
      decimals="INF"
      id="f-608"
      unitRef="shares">5708</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-165"
      decimals="INF"
      id="f-609"
      unitRef="shares">39791</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="c-1" decimals="INF" id="f-610" unitRef="shares">197872</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="c-7" decimals="INF" id="f-611" unitRef="shares">1157871</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="INF" id="f-612" unitRef="shares">59249</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation contextRef="c-7" decimals="INF" id="f-613" unitRef="shares">49701</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:CommonStockSharesIssued contextRef="c-8" decimals="INF" id="f-614" unitRef="shares">50573176</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-8" decimals="INF" id="f-615" unitRef="shares">50573176</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="c-29"
      decimals="INF"
      id="f-616"
      unitRef="shares">59522954</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-29"
      decimals="INF"
      id="f-617"
      unitRef="shares">59522954</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 contextRef="c-8" decimals="-6" id="f-618" unitRef="usd">409000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-8" decimals="-6" id="f-619" unitRef="usd">2715000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="c-166"
      decimals="2"
      id="f-620"
      unitRef="usdPerShare">0.25</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="c-166" decimals="-6" id="f-621" unitRef="usd">13000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-622">INCOME TAXES&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Our ETR was 27% for the first quarter of 2024 and 2023. The increase in tax benefits related to stock-based compensation from the first quarter of 2023 was offset by an increase in non-deductible compensation in the first quarter of 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We are subject to tax in U.S. federal and various state and local jurisdictions, as well as Canada and India. We are open to federal and significant state income tax examinations for tax years 2018 and subsequent years.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="2" id="f-623" unitRef="number">0.27</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-7" decimals="2" id="f-624" unitRef="number">0.27</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-625">EARNINGS PER SHARE&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic EPS is computed based on the weighted average shares of common stock outstanding during the period. Diluted EPS is computed based on those shares used in the basic EPS computation, plus potentially dilutive shares issuable under our equity-based compensation plans using the treasury stock method. Shares that are potentially anti-dilutive are excluded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the computation of our basic and diluted EPS attributable to our common stock:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.385%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.158%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;91&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1.80&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;91&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1.78&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Common stock equivalents excluded from income per diluted share because of their anti-dilutive effect&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-626">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the computation of our basic and diluted EPS attributable to our common stock:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:76.385%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.158%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#0073cf;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;91&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Basic EPS&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1.80&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;91&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares of common stock outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;51&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1.78&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Common stock equivalents excluded from income per diluted share because of their anti-dilutive effect&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-1" decimals="-6" id="f-627" unitRef="usd">91000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-7" decimals="-6" id="f-628" unitRef="usd">131000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-6" id="f-629" unitRef="shares">51000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-6" id="f-630" unitRef="shares">60000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-631"
      unitRef="usdPerShare">1.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-632"
      unitRef="usdPerShare">2.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-1" decimals="-6" id="f-633" unitRef="usd">91000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-7" decimals="-6" id="f-634" unitRef="usd">131000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-6" id="f-635" unitRef="shares">51000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-6" id="f-636" unitRef="shares">60000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-1" decimals="-6" id="f-637" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-7" decimals="-6" id="f-638" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-6" id="f-639" unitRef="shares">51000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="-6" id="f-640" unitRef="shares">60000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-641"
      unitRef="usdPerShare">1.78</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-642"
      unitRef="usdPerShare">2.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="-6" id="f-643" unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-7" decimals="-6" id="f-644" unitRef="shares">2000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-1" id="f-645">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-1" id="f-646">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-1" id="f-647">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-167" id="f-648">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 23, 2024, Burton M. Goldfield, a member of the Board of Directors, adopted a new written trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (the &#x201c;Goldfield Plan&#x201d;). The first possible trade date under the Goldfield Plan is May 28, 2024, and the end date of the Goldfield Plan is February 28, 2025 (subject to customary exceptions), for a duration of approximately one year. The Goldfield Plan calls for the sale of an amount of shares that Mr. Goldfield could receive upon the future vesting of certain outstanding equity awards, net of any shares withheld by us to satisfy applicable taxes. The exact number of shares to be sold pursuant to the Goldfield Plan depends on the number of shares to be withheld by us on equity awards that will vest during the duration of the Goldfield Plan, among other factors. For purposes of this disclosure, without &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;subtracting any shares to be withheld upon future vesting events, the aggregate number of shares currently expected to be sold pursuant to the Goldfield Plan is 74,379.&lt;/span&gt;&lt;/div&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrAdoptionDate contextRef="c-167" id="f-649">February 23, 2024</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrIndName contextRef="c-167" id="f-650">Burton M. Goldfield</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-167" id="f-651">member of the Board of Directors</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-167" id="f-652">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-168"
      decimals="INF"
      id="f-653"
      unitRef="shares">74379</ecd:TrdArrSecuritiesAggAvailAmt>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
